Last updated: 2022-08-20
Checks: 6 1
Knit directory: genie/
This reproducible R Markdown analysis was created with workflowr (version 1.7.0). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.
Great! Since the R Markdown file has been committed to the Git repository, you know the exact version of the code that produced these results.
The global environment had objects present when the code in the R
Markdown file was run. These objects can affect the analysis in your R
Markdown file in unknown ways. For reproduciblity it’s best to always
run the code in an empty environment. Use wflow_publish or
wflow_build to ensure that the code is always run in an
empty environment.
The following objects were defined in the global environment when these results were created:
| Name | Class | Size |
|---|---|---|
| rv | list | 2.9 Kb |
The command set.seed(20220803) was run prior to running
the code in the R Markdown file. Setting a seed ensures that any results
that rely on randomness, e.g. subsampling or permutations, are
reproducible.
Great job! Recording the operating system, R version, and package versions is critical for reproducibility.
Nice! There were no cached chunks for this analysis, so you can be confident that you successfully produced the results during this run.
Great job! Using relative paths to the files within your workflowr project makes it easier to run your code on other machines.
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
The results in this page were generated with repository version 540aa2c. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.
Note that you need to be careful to ensure that all relevant files for
the analysis have been committed to Git prior to generating the results
(you can use wflow_publish or
wflow_git_commit). workflowr only checks the R Markdown
file, but you know if there are other scripts or data files that it
depends on. Below is the status of the Git repository when the results
were generated:
Ignored files:
Ignored: .Rhistory
Ignored: todo.org
Unstaged changes:
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_(gene_pathways)_mutation_signature.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_agecat.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_mutation_signature.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_race.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_sample_type.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_tmb.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/cosmic_driver_mutation_(gene_pathways).csv
Modified: public/table/co_mutation_nscc_allele.Rmd/cosmic_driver_mutation_(gene_pathways)_sample_type.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/cosmic_driver_mutation_(gene_pathways)_sex.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/cosmic_driver_mutation_tmb.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/inactivating_mutation_race.csv
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
These are the previous versions of the repository in which changes were
made to the R Markdown (analysis/table_s6.Rmd) and HTML
(docs/table_s6.html) files. If you’ve configured a remote
Git repository (see ?wflow_git_remote), click on the
hyperlinks in the table below to view the files as they were in that
past version.
| File | Version | Author | Date | Message |
|---|---|---|---|---|
| Rmd | 12e3255 | abalan2 | 2022-08-19 | updated title for table S6 |
| html | 12e3255 | abalan2 | 2022-08-19 | updated title for table S6 |
| Rmd | 315fcea | abalan2 | 2022-08-19 | added table S6 |
| html | 315fcea | abalan2 | 2022-08-19 | added table S6 |
| HUGO symbol | Codon | Cancer type | Group | Variants (n) | Patients (n) | Mean | Median | 2.5% | 97.5% |
|---|---|---|---|---|---|---|---|---|---|
| RAS | 12, 13, or 61 | Appendiceal | <40 | 20 | 28 | 0.569 | 0.551 | 0.459 | 0.758 |
| RAS | 12, 13, or 61 | Appendiceal | 40-50 | 31 | 62 | 0.510 | 0.510 | 0.419 | 0.600 |
| RAS | 12, 13, or 61 | Appendiceal | 50-65 | 76 | 161 | 0.493 | 0.494 | 0.421 | 0.558 |
| RAS | 12, 13, or 61 | Appendiceal | >65 | 46 | 90 | 0.513 | 0.513 | 0.435 | 0.593 |
| RAS | 12, 13, or 61 | CRC | <40 | 225 | 565 | 0.419 | 0.421 | 0.382 | 0.447 |
| RAS | 12, 13, or 61 | CRC | 40-50 | 559 | 1280 | 0.435 | 0.435 | 0.413 | 0.457 |
| RAS | 12, 13, or 61 | CRC | 50-65 | 1242 | 2815 | 0.438 | 0.438 | 0.423 | 0.455 |
| RAS | 12, 13, or 61 | CRC | >65 | 892 | 2055 | 0.433 | 0.433 | 0.415 | 0.452 |
| RAS | 12, 13, or 61 | CUP | <40 | 14 | 167 | 0.104 | 0.101 | 0.059 | 0.162 |
| RAS | 12, 13, or 61 | CUP | 40-50 | 39 | 211 | 0.184 | 0.183 | 0.137 | 0.235 |
| RAS | 12, 13, or 61 | CUP | 50-65 | 174 | 810 | 0.213 | 0.213 | 0.186 | 0.242 |
| RAS | 12, 13, or 61 | CUP | >65 | 189 | 797 | 0.235 | 0.234 | 0.206 | 0.265 |
| RAS | 12, 13, or 61 | NSCLC | <40 | 13 | 161 | 0.093 | 0.091 | 0.052 | 0.144 |
| RAS | 12, 13, or 61 | NSCLC | 40-50 | 109 | 585 | 0.187 | 0.186 | 0.156 | 0.219 |
| RAS | 12, 13, or 61 | NSCLC | 50-65 | 1086 | 3677 | 0.295 | 0.295 | 0.281 | 0.310 |
| RAS | 12, 13, or 61 | NSCLC | >65 | 1800 | 5698 | 0.316 | 0.316 | 0.304 | 0.328 |
| RAS | 12, 13, or 61 | NSCLC | NA | 1 | 10 | 0.158 | 0.149 | 0.032 | 0.340 |
| RAS | 12, 13, or 61 | Breast | <40 | 4 | 841 | 0.006 | 0.006 | 0.002 | 0.012 |
| RAS | 12, 13, or 61 | Breast | 40-50 | 8 | 1910 | 0.005 | 0.005 | 0.002 | 0.010 |
| RAS | 12, 13, or 61 | Breast | 50-65 | 48 | 3989 | 0.012 | 0.012 | 0.009 | 0.015 |
| RAS | 12, 13, or 61 | Breast | >65 | 36 | 2583 | 0.013 | 0.013 | 0.009 | 0.018 |
| RAS | 12, 13, or 61 | Breast | NA | 1 | 10 | 0.023 | 0.012 | 0.003 | 0.114 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | <40 | 32 | 672 | 0.044 | 0.044 | 0.029 | 0.062 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | 40-50 | 3 | 367 | 0.013 | 0.012 | 0.004 | 0.025 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | 50-65 | 15 | 951 | 0.017 | 0.016 | 0.010 | 0.026 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | >65 | 19 | 777 | 0.024 | 0.024 | 0.015 | 0.036 |
| RAS | 12, 13, or 61 | Pancreatic | <40 | 23 | 87 | 0.279 | 0.278 | 0.190 | 0.379 |
| RAS | 12, 13, or 61 | Pancreatic | 40-50 | 119 | 200 | 0.596 | 0.596 | 0.528 | 0.662 |
| RAS | 12, 13, or 61 | Pancreatic | 50-65 | 723 | 1000 | 0.723 | 0.723 | 0.695 | 0.750 |
| RAS | 12, 13, or 61 | Pancreatic | >65 | 982 | 1205 | 0.814 | 0.814 | 0.792 | 0.836 |
| RAS | 12, 13, or 61 | Leukemia | <40 | 40 | 204 | 0.171 | 0.167 | 0.136 | 0.223 |
| RAS | 12, 13, or 61 | Leukemia | 40-50 | 24 | 128 | 0.166 | 0.162 | 0.130 | 0.223 |
| RAS | 12, 13, or 61 | Leukemia | 50-65 | 74 | 515 | 0.149 | 0.149 | 0.123 | 0.175 |
| RAS | 12, 13, or 61 | Leukemia | >65 | 99 | 720 | 0.145 | 0.145 | 0.121 | 0.168 |
| RAS | 12, 13, or 61 | Melanoma | <40 | 39 | 289 | 0.148 | 0.147 | 0.108 | 0.194 |
| RAS | 12, 13, or 61 | Melanoma | 40-50 | 63 | 282 | 0.224 | 0.223 | 0.179 | 0.272 |
| RAS | 12, 13, or 61 | Melanoma | 50-65 | 256 | 1016 | 0.251 | 0.251 | 0.225 | 0.277 |
| RAS | 12, 13, or 61 | Melanoma | >65 | 363 | 1259 | 0.286 | 0.286 | 0.262 | 0.312 |
| RAS | 12, 13, or 61 | Head and neck | <40 | 4 | 140 | 0.038 | 0.038 | 0.020 | 0.054 |
| RAS | 12, 13, or 61 | Head and neck | 40-50 | 7 | 216 | 0.038 | 0.038 | 0.023 | 0.053 |
| RAS | 12, 13, or 61 | Head and neck | 50-65 | 38 | 799 | 0.043 | 0.042 | 0.032 | 0.056 |
| RAS | 12, 13, or 61 | Head and neck | >65 | 21 | 582 | 0.038 | 0.038 | 0.027 | 0.051 |
| RAS | 12, 13, or 61 | Uterine | <40 | 3 | 57 | 0.115 | 0.117 | 0.034 | 0.188 |
| RAS | 12, 13, or 61 | Uterine | 40-50 | 35 | 162 | 0.199 | 0.195 | 0.150 | 0.264 |
| RAS | 12, 13, or 61 | Uterine | 50-65 | 197 | 1046 | 0.185 | 0.185 | 0.163 | 0.210 |
| RAS | 12, 13, or 61 | Uterine | >65 | 149 | 988 | 0.153 | 0.153 | 0.131 | 0.176 |
| RAS | 12, 13, or 61 | Non-melanoma skin | <40 | 1 | 27 | 0.037 | 0.035 | 0.015 | 0.071 |
| RAS | 12, 13, or 61 | Non-melanoma skin | 40-50 | 1 | 20 | 0.038 | 0.035 | 0.016 | 0.076 |
| RAS | 12, 13, or 61 | Non-melanoma skin | 50-65 | 6 | 149 | 0.037 | 0.036 | 0.020 | 0.062 |
| RAS | 12, 13, or 61 | Non-melanoma skin | >65 | 10 | 317 | 0.035 | 0.034 | 0.020 | 0.053 |
| RAS | 12, 13, or 61 | MDS/MPN | <40 | 7 | 87 | 0.064 | 0.061 | 0.038 | 0.110 |
| RAS | 12, 13, or 61 | MDS/MPN | 40-50 | 1 | 83 | 0.047 | 0.050 | 0.010 | 0.074 |
| RAS | 12, 13, or 61 | MDS/MPN | 50-65 | 19 | 373 | 0.055 | 0.054 | 0.036 | 0.074 |
| RAS | 12, 13, or 61 | MDS/MPN | >65 | 44 | 664 | 0.062 | 0.062 | 0.047 | 0.081 |
| RAS | 12, 13, or 61 | Adrenocortical | <40 | 0 | 27 | 0.007 | 0.004 | 0.000 | 0.034 |
| RAS | 12, 13, or 61 | Adrenocortical | 40-50 | 0 | 30 | 0.007 | 0.004 | 0.000 | 0.034 |
| RAS | 12, 13, or 61 | Adrenocortical | 50-65 | 0 | 51 | 0.006 | 0.004 | 0.000 | 0.028 |
| RAS | 12, 13, or 61 | Adrenocortical | >65 | 1 | 26 | 0.018 | 0.010 | 0.001 | 0.091 |
| RAS | 12, 13, or 61 | Ovarian | <40 | 38 | 141 | 0.253 | 0.252 | 0.183 | 0.330 |
| RAS | 12, 13, or 61 | Ovarian | 40-50 | 38 | 253 | 0.149 | 0.148 | 0.109 | 0.194 |
| RAS | 12, 13, or 61 | Ovarian | 50-65 | 111 | 1092 | 0.103 | 0.102 | 0.085 | 0.121 |
| RAS | 12, 13, or 61 | Ovarian | >65 | 72 | 849 | 0.087 | 0.086 | 0.069 | 0.107 |
| RAS | 12, 13, or 61 | Esophagogastric | <40 | 5 | 122 | 0.054 | 0.054 | 0.033 | 0.074 |
| RAS | 12, 13, or 61 | Esophagogastric | 40-50 | 11 | 200 | 0.056 | 0.056 | 0.039 | 0.076 |
| RAS | 12, 13, or 61 | Esophagogastric | 50-65 | 38 | 752 | 0.054 | 0.054 | 0.041 | 0.068 |
| RAS | 12, 13, or 61 | Esophagogastric | >65 | 48 | 725 | 0.060 | 0.060 | 0.047 | 0.077 |
| RAS | 12, 13, or 61 | Thyroid | <40 | 22 | 150 | 0.180 | 0.183 | 0.127 | 0.220 |
| RAS | 12, 13, or 61 | Thyroid | 40-50 | 22 | 122 | 0.190 | 0.191 | 0.144 | 0.233 |
| RAS | 12, 13, or 61 | Thyroid | 50-65 | 77 | 374 | 0.199 | 0.198 | 0.168 | 0.234 |
| RAS | 12, 13, or 61 | Thyroid | >65 | 78 | 370 | 0.201 | 0.200 | 0.170 | 0.238 |
| RAS | 12, 13, or 61 | Cervical | <40 | 4 | 85 | 0.079 | 0.080 | 0.032 | 0.123 |
| RAS | 12, 13, or 61 | Cervical | 40-50 | 8 | 99 | 0.089 | 0.088 | 0.050 | 0.132 |
| RAS | 12, 13, or 61 | Cervical | 50-65 | 18 | 144 | 0.106 | 0.103 | 0.068 | 0.159 |
| RAS | 12, 13, or 61 | Cervical | >65 | 4 | 36 | 0.097 | 0.093 | 0.051 | 0.165 |
| RAS | 12, 13, or 61 | Hepatobiliary | <40 | 6 | 138 | 0.075 | 0.071 | 0.028 | 0.130 |
| RAS | 12, 13, or 61 | Hepatobiliary | 40-50 | 16 | 110 | 0.134 | 0.131 | 0.087 | 0.196 |
| RAS | 12, 13, or 61 | Hepatobiliary | 50-65 | 65 | 525 | 0.123 | 0.122 | 0.098 | 0.151 |
| RAS | 12, 13, or 61 | Hepatobiliary | >65 | 84 | 601 | 0.136 | 0.135 | 0.111 | 0.165 |
| RAS | 12, 13, or 61 | Kidney | <40 | 1 | 191 | 0.009 | 0.009 | 0.003 | 0.016 |
| RAS | 12, 13, or 61 | Kidney | 40-50 | 2 | 159 | 0.010 | 0.009 | 0.004 | 0.019 |
| RAS | 12, 13, or 61 | Kidney | 50-65 | 5 | 628 | 0.009 | 0.009 | 0.004 | 0.015 |
| RAS | 12, 13, or 61 | Kidney | >65 | 5 | 440 | 0.010 | 0.009 | 0.005 | 0.017 |
| RAS | 12, 13, or 61 | T / NK neoplasms | <40 | 1 | 28 | 0.025 | 0.022 | 0.006 | 0.065 |
| RAS | 12, 13, or 61 | T / NK neoplasms | 40-50 | 1 | 21 | 0.026 | 0.022 | 0.006 | 0.076 |
| RAS | 12, 13, or 61 | T / NK neoplasms | 50-65 | 2 | 76 | 0.024 | 0.022 | 0.007 | 0.053 |
| RAS | 12, 13, or 61 | T / NK neoplasms | >65 | 1 | 106 | 0.020 | 0.019 | 0.004 | 0.044 |
| RAS | 12, 13, or 61 | CNS | <40 | 33 | 1602 | 0.018 | 0.018 | 0.013 | 0.026 |
| RAS | 12, 13, or 61 | CNS | 40-50 | 13 | 687 | 0.017 | 0.016 | 0.010 | 0.026 |
| RAS | 12, 13, or 61 | CNS | 50-65 | 13 | 1439 | 0.011 | 0.011 | 0.006 | 0.017 |
| RAS | 12, 13, or 61 | CNS | >65 | 8 | 836 | 0.012 | 0.012 | 0.006 | 0.018 |
| RAS | 12, 13, or 61 | Prostate | 40-50 | 0 | 70 | 0.012 | 0.012 | 0.000 | 0.022 |
| RAS | 12, 13, or 61 | Prostate | 50-65 | 14 | 960 | 0.014 | 0.013 | 0.009 | 0.020 |
| RAS | 12, 13, or 61 | Prostate | >65 | 18 | 1402 | 0.013 | 0.013 | 0.008 | 0.019 |
| RAS | 12, 13, or 61 | Anal | 40-50 | 0 | 12 | 0.033 | 0.029 | 0.001 | 0.086 |
| RAS | 12, 13, or 61 | Anal | 50-65 | 4 | 88 | 0.038 | 0.035 | 0.012 | 0.080 |
| RAS | 12, 13, or 61 | Anal | >65 | 1 | 45 | 0.032 | 0.029 | 0.005 | 0.075 |
| RAS | 12, 13, or 61 | Neuroendocrine | <40 | 4 | 22 | 0.138 | 0.124 | 0.058 | 0.291 |
| RAS | 12, 13, or 61 | Neuroendocrine | 40-50 | 10 | 55 | 0.148 | 0.142 | 0.076 | 0.258 |
| RAS | 12, 13, or 61 | Neuroendocrine | 50-65 | 15 | 161 | 0.095 | 0.094 | 0.058 | 0.139 |
| RAS | 12, 13, or 61 | Neuroendocrine | >65 | 5 | 121 | 0.063 | 0.061 | 0.023 | 0.113 |
| RAS | 12, 13, or 61 | Bladder | <40 | 4 | 25 | 0.095 | 0.091 | 0.065 | 0.159 |
| RAS | 12, 13, or 61 | Bladder | 40-50 | 7 | 78 | 0.090 | 0.089 | 0.063 | 0.126 |
| RAS | 12, 13, or 61 | Bladder | 50-65 | 47 | 511 | 0.090 | 0.089 | 0.072 | 0.111 |
| RAS | 12, 13, or 61 | Bladder | >65 | 80 | 962 | 0.086 | 0.086 | 0.071 | 0.102 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | <40 | 34 | 142 | 0.229 | 0.228 | 0.162 | 0.303 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | 40-50 | 1 | 16 | 0.081 | 0.070 | 0.009 | 0.211 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | 50-65 | 2 | 48 | 0.057 | 0.051 | 0.011 | 0.133 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | >65 | 2 | 42 | 0.062 | 0.056 | 0.012 | 0.143 |
| RAS | 12, 13, or 61 | Small bowel | 40-50 | 13 | 29 | 0.434 | 0.432 | 0.327 | 0.557 |
| RAS | 12, 13, or 61 | Small bowel | 50-65 | 45 | 96 | 0.445 | 0.444 | 0.366 | 0.535 |
| RAS | 12, 13, or 61 | Small bowel | >65 | 29 | 78 | 0.408 | 0.410 | 0.311 | 0.495 |
| RAS | 12, 13, or 61 | Sex cord stromal | <40 | 2 | 29 | 0.039 | 0.031 | 0.007 | 0.122 |
| RAS | 12, 13, or 61 | Sex cord stromal | 40-50 | 0 | 15 | 0.025 | 0.021 | 0.000 | 0.074 |
| RAS | 12, 13, or 61 | Sex cord stromal | 50-65 | 1 | 37 | 0.028 | 0.024 | 0.003 | 0.076 |
| RAS | 12, 13, or 61 | Sex cord stromal | >65 | 0 | 27 | 0.023 | 0.020 | 0.000 | 0.068 |
| RAS | 12, 13, or 61 | Bone | <40 | 2 | 342 | 0.010 | 0.009 | 0.003 | 0.020 |
| RAS | 12, 13, or 61 | Bone | 40-50 | 1 | 61 | 0.013 | 0.011 | 0.003 | 0.033 |
| RAS | 12, 13, or 61 | Bone | 50-65 | 1 | 96 | 0.012 | 0.010 | 0.003 | 0.027 |
| RAS | 12, 13, or 61 | Bone | >65 | 2 | 67 | 0.015 | 0.012 | 0.004 | 0.045 |
| RAS | 12, 13, or 61 | Vaginal | 50-65 | 3 | 34 | 0.083 | 0.077 | 0.025 | 0.172 |
| RAS | 12, 13, or 61 | Vaginal | >65 | 2 | 30 | 0.077 | 0.072 | 0.020 | 0.165 |
| RAS | 12, 13, or 61 | Thymic | <40 | 0 | 14 | 0.034 | 0.030 | 0.001 | 0.093 |
| RAS | 12, 13, or 61 | Thymic | 40-50 | 1 | 28 | 0.039 | 0.035 | 0.006 | 0.099 |
| RAS | 12, 13, or 61 | Thymic | 50-65 | 1 | 72 | 0.029 | 0.027 | 0.003 | 0.068 |
| RAS | 12, 13, or 61 | Thymic | >65 | 4 | 40 | 0.062 | 0.053 | 0.018 | 0.158 |
| RAS | 12, 13, or 61 | Ampullary | 40-50 | 3 | 12 | 0.430 | 0.452 | 0.130 | 0.650 |
| RAS | 12, 13, or 61 | Ampullary | 50-65 | 26 | 40 | 0.613 | 0.611 | 0.481 | 0.754 |
| RAS | 12, 13, or 61 | Ampullary | >65 | 30 | 50 | 0.585 | 0.586 | 0.463 | 0.706 |
| RAS | 12, 13, or 61 | SCLC | 40-50 | 0 | 22 | 0.034 | 0.034 | 0.001 | 0.069 |
| RAS | 12, 13, or 61 | SCLC | 50-65 | 5 | 144 | 0.037 | 0.036 | 0.017 | 0.063 |
| RAS | 12, 13, or 61 | SCLC | >65 | 10 | 224 | 0.040 | 0.039 | 0.022 | 0.066 |
| RAS | 12, 13, or 61 | Mesothelioma | <40 | 0 | 30 | 0.003 | 0.001 | 0.000 | 0.013 |
| RAS | 12, 13, or 61 | Mesothelioma | 40-50 | 0 | 29 | 0.003 | 0.001 | 0.000 | 0.013 |
| RAS | 12, 13, or 61 | Mesothelioma | 50-65 | 0 | 122 | 0.002 | 0.001 | 0.000 | 0.009 |
| RAS | 12, 13, or 61 | Mesothelioma | >65 | 1 | 316 | 0.003 | 0.002 | 0.000 | 0.009 |
| RAS | 12, 13, or 61 | Germ cell | <40 | 40 | 650 | 0.064 | 0.063 | 0.046 | 0.084 |
| RAS | 12, 13, or 61 | Germ cell | 40-50 | 27 | 131 | 0.190 | 0.189 | 0.126 | 0.264 |
| RAS | 12, 13, or 61 | Germ cell | 50-65 | 7 | 92 | 0.082 | 0.080 | 0.039 | 0.139 |
| RAS | 12, 13, or 61 | Germ cell | >65 | 1 | 12 | 0.100 | 0.090 | 0.019 | 0.242 |
| RAS | 12, 13, or 61 | Nerve sheath | <40 | 0 | 77 | 0.015 | 0.013 | 0.000 | 0.044 |
| RAS | 12, 13, or 61 | Nerve sheath | 40-50 | 1 | 27 | 0.026 | 0.020 | 0.003 | 0.085 |
| RAS | 12, 13, or 61 | Nerve sheath | 50-65 | 1 | 37 | 0.023 | 0.019 | 0.003 | 0.068 |
| RAS | 12, 13, or 61 | Nerve sheath | >65 | 1 | 13 | 0.033 | 0.023 | 0.004 | 0.138 |
| RAS | 12, 13, or 61 | Penile | 50-65 | 0 | 11 | 0.039 | 0.022 | 0.000 | 0.166 |
| RAS | 12, 13, or 61 | Penile | >65 | 1 | 11 | 0.068 | 0.048 | 0.003 | 0.244 |
| RAS | 12, 13, or 61 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| RAS | 12, 13, or 61 | B cell lymphoma | <40 | 0 | 87 | 0.035 | 0.038 | 0.001 | 0.070 |
| RAS | 12, 13, or 61 | B cell lymphoma | 40-50 | 7 | 105 | 0.060 | 0.058 | 0.032 | 0.104 |
| RAS | 12, 13, or 61 | B cell lymphoma | 50-65 | 23 | 357 | 0.061 | 0.060 | 0.041 | 0.085 |
| RAS | 12, 13, or 61 | B cell lymphoma | >65 | 25 | 413 | 0.058 | 0.058 | 0.041 | 0.080 |
| RAS | 12, 13, or 61 | Non-hodgkin lymphoma | >65 | 2 | 14 | 0.148 | 0.131 | 0.022 | 0.366 |
| RAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | <40 | 3 | 27 | 0.115 | 0.106 | 0.027 | 0.253 |
| RAS | 12, 13, or 61 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.010 |
| RAS | 12, 13, or 61 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| RAS | 12, 13, or 61 | Lung | >65 | 3 | 18 | 0.173 | 0.161 | 0.040 | 0.376 |
| RAS | 12, 13, or 61 | Peritoneal | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.049 |
| RAS | G12 | Appendiceal | <40 | 19 | 28 | 0.522 | 0.498 | 0.392 | 0.735 |
| RAS | G12 | Appendiceal | 40-50 | 25 | 62 | 0.427 | 0.429 | 0.328 | 0.519 |
| RAS | G12 | Appendiceal | 50-65 | 66 | 161 | 0.423 | 0.424 | 0.354 | 0.490 |
| RAS | G12 | Appendiceal | >65 | 38 | 90 | 0.433 | 0.433 | 0.349 | 0.514 |
| RAS | G12 | CRC | <40 | 163 | 565 | 0.304 | 0.305 | 0.274 | 0.328 |
| RAS | G12 | CRC | 40-50 | 405 | 1280 | 0.314 | 0.314 | 0.294 | 0.335 |
| RAS | G12 | CRC | 50-65 | 900 | 2815 | 0.317 | 0.317 | 0.302 | 0.333 |
| RAS | G12 | CRC | >65 | 632 | 2055 | 0.309 | 0.309 | 0.292 | 0.326 |
| RAS | G12 | CUP | <40 | 6 | 167 | 0.049 | 0.047 | 0.020 | 0.091 |
| RAS | G12 | CUP | 40-50 | 27 | 211 | 0.128 | 0.127 | 0.088 | 0.174 |
| RAS | G12 | CUP | 50-65 | 138 | 810 | 0.169 | 0.169 | 0.144 | 0.196 |
| RAS | G12 | CUP | >65 | 153 | 797 | 0.190 | 0.190 | 0.164 | 0.219 |
| RAS | G12 | NSCLC | <40 | 10 | 161 | 0.074 | 0.073 | 0.038 | 0.121 |
| RAS | G12 | NSCLC | 40-50 | 87 | 585 | 0.149 | 0.149 | 0.122 | 0.179 |
| RAS | G12 | NSCLC | 50-65 | 910 | 3677 | 0.247 | 0.247 | 0.233 | 0.261 |
| RAS | G12 | NSCLC | >65 | 1545 | 5698 | 0.271 | 0.271 | 0.259 | 0.282 |
| RAS | G12 | NSCLC | NA | 1 | 10 | 0.145 | 0.135 | 0.029 | 0.321 |
| RAS | G12 | Breast | <40 | 4 | 841 | 0.006 | 0.006 | 0.002 | 0.011 |
| RAS | G12 | Breast | 40-50 | 6 | 1910 | 0.005 | 0.005 | 0.002 | 0.009 |
| RAS | G12 | Breast | 50-65 | 37 | 3989 | 0.009 | 0.009 | 0.006 | 0.012 |
| RAS | G12 | Breast | >65 | 27 | 2583 | 0.010 | 0.009 | 0.007 | 0.014 |
| RAS | G12 | Breast | NA | 1 | 10 | 0.017 | 0.009 | 0.003 | 0.086 |
| RAS | G12 | Soft tissue sarcoma | <40 | 11 | 672 | 0.013 | 0.012 | 0.007 | 0.023 |
| RAS | G12 | Soft tissue sarcoma | 40-50 | 1 | 367 | 0.008 | 0.008 | 0.001 | 0.015 |
| RAS | G12 | Soft tissue sarcoma | 50-65 | 6 | 951 | 0.008 | 0.008 | 0.003 | 0.014 |
| RAS | G12 | Soft tissue sarcoma | >65 | 11 | 777 | 0.012 | 0.012 | 0.007 | 0.020 |
| RAS | G12 | Pancreatic | <40 | 22 | 87 | 0.270 | 0.269 | 0.181 | 0.369 |
| RAS | G12 | Pancreatic | 40-50 | 105 | 200 | 0.526 | 0.526 | 0.457 | 0.594 |
| RAS | G12 | Pancreatic | 50-65 | 669 | 1000 | 0.668 | 0.669 | 0.639 | 0.697 |
| RAS | G12 | Pancreatic | >65 | 883 | 1205 | 0.732 | 0.732 | 0.707 | 0.757 |
| RAS | G12 | Leukemia | <40 | 18 | 204 | 0.090 | 0.090 | 0.069 | 0.112 |
| RAS | G12 | Leukemia | 40-50 | 13 | 128 | 0.092 | 0.091 | 0.070 | 0.120 |
| RAS | G12 | Leukemia | 50-65 | 44 | 515 | 0.089 | 0.089 | 0.071 | 0.107 |
| RAS | G12 | Leukemia | >65 | 66 | 720 | 0.091 | 0.090 | 0.075 | 0.108 |
| RAS | G12 | Melanoma | <40 | 0 | 289 | 0.005 | 0.003 | 0.000 | 0.018 |
| RAS | G12 | Melanoma | 40-50 | 6 | 282 | 0.021 | 0.020 | 0.008 | 0.040 |
| RAS | G12 | Melanoma | 50-65 | 22 | 1016 | 0.022 | 0.021 | 0.014 | 0.031 |
| RAS | G12 | Melanoma | >65 | 51 | 1259 | 0.040 | 0.039 | 0.029 | 0.051 |
| RAS | G12 | Head and neck | <40 | 2 | 140 | 0.016 | 0.015 | 0.008 | 0.025 |
| RAS | G12 | Head and neck | 40-50 | 3 | 216 | 0.015 | 0.015 | 0.008 | 0.025 |
| RAS | G12 | Head and neck | 50-65 | 13 | 799 | 0.016 | 0.015 | 0.010 | 0.023 |
| RAS | G12 | Head and neck | >65 | 9 | 582 | 0.016 | 0.015 | 0.009 | 0.023 |
| RAS | G12 | Uterine | <40 | 1 | 57 | 0.062 | 0.056 | 0.007 | 0.138 |
| RAS | G12 | Uterine | 40-50 | 29 | 162 | 0.168 | 0.165 | 0.118 | 0.230 |
| RAS | G12 | Uterine | 50-65 | 158 | 1046 | 0.149 | 0.149 | 0.128 | 0.172 |
| RAS | G12 | Uterine | >65 | 111 | 988 | 0.113 | 0.113 | 0.094 | 0.134 |
| RAS | G12 | Non-melanoma skin | <40 | 1 | 27 | 0.021 | 0.018 | 0.007 | 0.058 |
| RAS | G12 | Non-melanoma skin | 40-50 | 1 | 20 | 0.022 | 0.018 | 0.007 | 0.067 |
| RAS | G12 | Non-melanoma skin | 50-65 | 2 | 149 | 0.018 | 0.017 | 0.006 | 0.034 |
| RAS | G12 | Non-melanoma skin | >65 | 5 | 317 | 0.018 | 0.017 | 0.008 | 0.032 |
| RAS | G12 | MDS/MPN | <40 | 3 | 87 | 0.037 | 0.037 | 0.014 | 0.063 |
| RAS | G12 | MDS/MPN | 40-50 | 0 | 83 | 0.029 | 0.031 | 0.001 | 0.052 |
| RAS | G12 | MDS/MPN | 50-65 | 14 | 373 | 0.038 | 0.038 | 0.023 | 0.055 |
| RAS | G12 | MDS/MPN | >65 | 32 | 664 | 0.044 | 0.043 | 0.031 | 0.061 |
| RAS | G12 | Adrenocortical | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.006 |
| RAS | G12 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.006 |
| RAS | G12 | Ovarian | <40 | 33 | 141 | 0.218 | 0.217 | 0.153 | 0.292 |
| RAS | G12 | Ovarian | 40-50 | 30 | 253 | 0.118 | 0.117 | 0.082 | 0.159 |
| RAS | G12 | Ovarian | 50-65 | 85 | 1092 | 0.079 | 0.078 | 0.064 | 0.096 |
| RAS | G12 | Ovarian | >65 | 57 | 849 | 0.069 | 0.068 | 0.053 | 0.087 |
| RAS | G12 | Esophagogastric | <40 | 4 | 122 | 0.037 | 0.037 | 0.021 | 0.055 |
| RAS | G12 | Esophagogastric | 40-50 | 8 | 200 | 0.039 | 0.038 | 0.025 | 0.056 |
| RAS | G12 | Esophagogastric | 50-65 | 23 | 752 | 0.035 | 0.035 | 0.024 | 0.046 |
| RAS | G12 | Esophagogastric | >65 | 33 | 725 | 0.041 | 0.040 | 0.030 | 0.055 |
| RAS | G12 | Thyroid | <40 | 1 | 150 | 0.010 | 0.010 | 0.001 | 0.023 |
| RAS | G12 | Thyroid | 40-50 | 0 | 122 | 0.009 | 0.008 | 0.000 | 0.021 |
| RAS | G12 | Thyroid | 50-65 | 9 | 374 | 0.018 | 0.017 | 0.008 | 0.035 |
| RAS | G12 | Thyroid | >65 | 3 | 370 | 0.010 | 0.010 | 0.003 | 0.020 |
| RAS | G12 | Cervical | <40 | 3 | 85 | 0.060 | 0.061 | 0.020 | 0.103 |
| RAS | G12 | Cervical | 40-50 | 5 | 99 | 0.065 | 0.065 | 0.029 | 0.106 |
| RAS | G12 | Cervical | 50-65 | 16 | 144 | 0.093 | 0.090 | 0.056 | 0.146 |
| RAS | G12 | Cervical | >65 | 4 | 36 | 0.086 | 0.081 | 0.041 | 0.168 |
| RAS | G12 | Hepatobiliary | <40 | 6 | 138 | 0.074 | 0.077 | 0.035 | 0.104 |
| RAS | G12 | Hepatobiliary | 40-50 | 10 | 110 | 0.088 | 0.088 | 0.058 | 0.125 |
| RAS | G12 | Hepatobiliary | 50-65 | 45 | 525 | 0.087 | 0.086 | 0.067 | 0.107 |
| RAS | G12 | Hepatobiliary | >65 | 62 | 601 | 0.096 | 0.095 | 0.076 | 0.120 |
| RAS | G12 | Kidney | <40 | 0 | 191 | 0.007 | 0.006 | 0.000 | 0.014 |
| RAS | G12 | Kidney | 40-50 | 2 | 159 | 0.009 | 0.008 | 0.003 | 0.022 |
| RAS | G12 | Kidney | 50-65 | 4 | 628 | 0.007 | 0.007 | 0.003 | 0.013 |
| RAS | G12 | Kidney | >65 | 5 | 440 | 0.009 | 0.008 | 0.004 | 0.018 |
| RAS | G12 | T / NK neoplasms | <40 | 0 | 28 | 0.005 | 0.002 | 0.000 | 0.025 |
| RAS | G12 | T / NK neoplasms | 40-50 | 1 | 21 | 0.023 | 0.009 | 0.000 | 0.125 |
| RAS | G12 | T / NK neoplasms | 50-65 | 0 | 76 | 0.004 | 0.002 | 0.000 | 0.017 |
| RAS | G12 | T / NK neoplasms | >65 | 0 | 106 | 0.003 | 0.001 | 0.000 | 0.016 |
| RAS | G12 | CNS | <40 | 13 | 1602 | 0.007 | 0.007 | 0.004 | 0.011 |
| RAS | G12 | CNS | 40-50 | 8 | 687 | 0.008 | 0.008 | 0.004 | 0.016 |
| RAS | G12 | CNS | 50-65 | 6 | 1439 | 0.005 | 0.005 | 0.002 | 0.009 |
| RAS | G12 | CNS | >65 | 2 | 836 | 0.005 | 0.005 | 0.001 | 0.009 |
| RAS | G12 | Prostate | 40-50 | 0 | 70 | 0.003 | 0.003 | 0.000 | 0.008 |
| RAS | G12 | Prostate | 50-65 | 3 | 960 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12 | Prostate | >65 | 4 | 1402 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12 | Anal | 40-50 | 0 | 12 | 0.012 | 0.007 | 0.000 | 0.053 |
| RAS | G12 | Anal | 50-65 | 2 | 88 | 0.019 | 0.015 | 0.002 | 0.053 |
| RAS | G12 | Anal | >65 | 0 | 45 | 0.009 | 0.006 | 0.000 | 0.038 |
| RAS | G12 | Neuroendocrine | <40 | 0 | 22 | 0.039 | 0.033 | 0.000 | 0.111 |
| RAS | G12 | Neuroendocrine | 40-50 | 10 | 55 | 0.150 | 0.146 | 0.062 | 0.267 |
| RAS | G12 | Neuroendocrine | 50-65 | 11 | 161 | 0.068 | 0.066 | 0.036 | 0.109 |
| RAS | G12 | Neuroendocrine | >65 | 4 | 121 | 0.042 | 0.039 | 0.013 | 0.083 |
| RAS | G12 | Bladder | <40 | 3 | 25 | 0.061 | 0.056 | 0.037 | 0.126 |
| RAS | G12 | Bladder | 40-50 | 3 | 78 | 0.052 | 0.052 | 0.028 | 0.077 |
| RAS | G12 | Bladder | 50-65 | 29 | 511 | 0.055 | 0.054 | 0.041 | 0.072 |
| RAS | G12 | Bladder | >65 | 49 | 962 | 0.053 | 0.052 | 0.041 | 0.065 |
| RAS | G12 | BLL/Lymphoma | <40 | 21 | 142 | 0.137 | 0.136 | 0.084 | 0.200 |
| RAS | G12 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.038 | 0.028 | 0.000 | 0.127 |
| RAS | G12 | BLL/Lymphoma | 50-65 | 1 | 48 | 0.037 | 0.030 | 0.003 | 0.105 |
| RAS | G12 | BLL/Lymphoma | >65 | 2 | 42 | 0.054 | 0.049 | 0.010 | 0.126 |
| RAS | G12 | Small bowel | 40-50 | 5 | 29 | 0.264 | 0.273 | 0.111 | 0.383 |
| RAS | G12 | Small bowel | 50-65 | 37 | 96 | 0.355 | 0.352 | 0.272 | 0.453 |
| RAS | G12 | Small bowel | >65 | 24 | 78 | 0.312 | 0.312 | 0.226 | 0.400 |
| RAS | G12 | Sex cord stromal | <40 | 1 | 29 | 0.023 | 0.018 | 0.003 | 0.072 |
| RAS | G12 | Sex cord stromal | 40-50 | 0 | 15 | 0.018 | 0.014 | 0.000 | 0.061 |
| RAS | G12 | Sex cord stromal | 50-65 | 1 | 37 | 0.021 | 0.017 | 0.002 | 0.064 |
| RAS | G12 | Sex cord stromal | >65 | 0 | 27 | 0.017 | 0.014 | 0.000 | 0.056 |
| RAS | G12 | Bone | <40 | 1 | 342 | 0.007 | 0.007 | 0.001 | 0.017 |
| RAS | G12 | Bone | 40-50 | 1 | 61 | 0.012 | 0.010 | 0.002 | 0.035 |
| RAS | G12 | Bone | 50-65 | 1 | 96 | 0.010 | 0.009 | 0.002 | 0.027 |
| RAS | G12 | Bone | >65 | 2 | 67 | 0.014 | 0.011 | 0.003 | 0.047 |
| RAS | G12 | Vaginal | 50-65 | 1 | 34 | 0.045 | 0.039 | 0.006 | 0.114 |
| RAS | G12 | Vaginal | >65 | 2 | 30 | 0.055 | 0.048 | 0.011 | 0.139 |
| RAS | G12 | Thymic | <40 | 0 | 14 | 0.008 | 0.005 | 0.000 | 0.036 |
| RAS | G12 | Thymic | 40-50 | 0 | 28 | 0.007 | 0.004 | 0.000 | 0.030 |
| RAS | G12 | Thymic | 50-65 | 0 | 72 | 0.006 | 0.004 | 0.000 | 0.025 |
| RAS | G12 | Thymic | >65 | 1 | 40 | 0.013 | 0.008 | 0.000 | 0.055 |
| RAS | G12 | Ampullary | 40-50 | 3 | 12 | 0.427 | 0.448 | 0.170 | 0.587 |
| RAS | G12 | Ampullary | 50-65 | 22 | 40 | 0.508 | 0.506 | 0.389 | 0.640 |
| RAS | G12 | Ampullary | >65 | 25 | 50 | 0.491 | 0.490 | 0.378 | 0.604 |
| RAS | G12 | SCLC | 40-50 | 0 | 22 | 0.028 | 0.027 | 0.000 | 0.059 |
| RAS | G12 | SCLC | 50-65 | 4 | 144 | 0.030 | 0.029 | 0.012 | 0.054 |
| RAS | G12 | SCLC | >65 | 8 | 224 | 0.032 | 0.031 | 0.016 | 0.055 |
| RAS | G12 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Germ cell | <40 | 32 | 650 | 0.052 | 0.051 | 0.036 | 0.071 |
| RAS | G12 | Germ cell | 40-50 | 20 | 131 | 0.135 | 0.134 | 0.076 | 0.202 |
| RAS | G12 | Germ cell | 50-65 | 5 | 92 | 0.062 | 0.060 | 0.026 | 0.111 |
| RAS | G12 | Germ cell | >65 | 1 | 12 | 0.084 | 0.074 | 0.017 | 0.212 |
| RAS | G12 | Nerve sheath | <40 | 0 | 77 | 0.005 | 0.003 | 0.000 | 0.023 |
| RAS | G12 | Nerve sheath | 40-50 | 1 | 27 | 0.019 | 0.010 | 0.000 | 0.092 |
| RAS | G12 | Nerve sheath | 50-65 | 0 | 37 | 0.006 | 0.003 | 0.000 | 0.028 |
| RAS | G12 | Nerve sheath | >65 | 0 | 13 | 0.008 | 0.003 | 0.000 | 0.040 |
| RAS | G12 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G12 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| RAS | G12 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| RAS | G12 | B cell lymphoma | <40 | 0 | 87 | 0.016 | 0.016 | 0.001 | 0.030 |
| RAS | G12 | B cell lymphoma | 40-50 | 1 | 105 | 0.017 | 0.017 | 0.004 | 0.031 |
| RAS | G12 | B cell lymphoma | 50-65 | 9 | 357 | 0.021 | 0.020 | 0.011 | 0.035 |
| RAS | G12 | B cell lymphoma | >65 | 8 | 413 | 0.019 | 0.018 | 0.010 | 0.030 |
| RAS | G12 | Non-hodgkin lymphoma | >65 | 1 | 14 | 0.080 | 0.062 | 0.004 | 0.254 |
| RAS | G12 | T-lymphoblastic leukemia/lymphoma | <40 | 3 | 27 | 0.115 | 0.106 | 0.027 | 0.255 |
| RAS | G12 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.007 |
| RAS | G12 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| RAS | G12 | Lung | >65 | 2 | 18 | 0.115 | 0.102 | 0.017 | 0.289 |
| RAS | G12 | Peritoneal | >65 | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.077 |
| RAS | G12C | Appendiceal | <40 | 1 | 28 | 0.016 | 0.012 | 0.003 | 0.053 |
| RAS | G12C | Appendiceal | 40-50 | 0 | 62 | 0.011 | 0.010 | 0.001 | 0.028 |
| RAS | G12C | Appendiceal | 50-65 | 2 | 161 | 0.012 | 0.011 | 0.003 | 0.029 |
| RAS | G12C | Appendiceal | >65 | 1 | 90 | 0.012 | 0.011 | 0.002 | 0.030 |
| RAS | G12C | CRC | <40 | 9 | 565 | 0.013 | 0.013 | 0.009 | 0.019 |
| RAS | G12C | CRC | 40-50 | 15 | 1280 | 0.012 | 0.012 | 0.009 | 0.016 |
| RAS | G12C | CRC | 50-65 | 35 | 2815 | 0.013 | 0.012 | 0.010 | 0.016 |
| RAS | G12C | CRC | >65 | 25 | 2055 | 0.012 | 0.012 | 0.009 | 0.016 |
| RAS | G12C | CUP | <40 | 1 | 167 | 0.011 | 0.011 | 0.005 | 0.018 |
| RAS | G12C | CUP | 40-50 | 2 | 211 | 0.011 | 0.011 | 0.005 | 0.018 |
| RAS | G12C | CUP | 50-65 | 10 | 810 | 0.011 | 0.011 | 0.007 | 0.018 |
| RAS | G12C | CUP | >65 | 9 | 797 | 0.011 | 0.011 | 0.006 | 0.017 |
| RAS | G12C | NSCLC | <40 | 1 | 161 | 0.015 | 0.014 | 0.002 | 0.037 |
| RAS | G12C | NSCLC | 40-50 | 10 | 585 | 0.019 | 0.018 | 0.009 | 0.033 |
| RAS | G12C | NSCLC | 50-65 | 172 | 3677 | 0.046 | 0.046 | 0.040 | 0.053 |
| RAS | G12C | NSCLC | >65 | 258 | 5698 | 0.045 | 0.045 | 0.040 | 0.051 |
| RAS | G12C | NSCLC | NA | 0 | 10 | 0.028 | 0.023 | 0.001 | 0.087 |
| RAS | G12C | Breast | <40 | 0 | 841 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | 50-65 | 2 | 3989 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | >65 | 2 | 2583 | 0.001 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Soft tissue sarcoma | <40 | 2 | 672 | 0.002 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Soft tissue sarcoma | 40-50 | 0 | 367 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Soft tissue sarcoma | 50-65 | 0 | 951 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Soft tissue sarcoma | >65 | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Pancreatic | <40 | 0 | 87 | 0.003 | 0.003 | 0.000 | 0.009 |
| RAS | G12C | Pancreatic | 40-50 | 0 | 200 | 0.003 | 0.003 | 0.000 | 0.007 |
| RAS | G12C | Pancreatic | 50-65 | 2 | 1000 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12C | Pancreatic | >65 | 7 | 1205 | 0.005 | 0.004 | 0.002 | 0.009 |
| RAS | G12C | Leukemia | <40 | 3 | 204 | 0.010 | 0.008 | 0.002 | 0.029 |
| RAS | G12C | Leukemia | 40-50 | 1 | 128 | 0.006 | 0.004 | 0.001 | 0.022 |
| RAS | G12C | Leukemia | 50-65 | 0 | 515 | 0.002 | 0.001 | 0.000 | 0.006 |
| RAS | G12C | Leukemia | >65 | 1 | 720 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G12C | Melanoma | <40 | 0 | 289 | 0.002 | 0.002 | 0.000 | 0.005 |
| RAS | G12C | Melanoma | 40-50 | 1 | 282 | 0.003 | 0.002 | 0.001 | 0.007 |
| RAS | G12C | Melanoma | 50-65 | 1 | 1016 | 0.002 | 0.002 | 0.000 | 0.005 |
| RAS | G12C | Melanoma | >65 | 5 | 1259 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12C | Head and neck | <40 | 0 | 140 | 0.001 | 0.001 | 0.000 | 0.005 |
| RAS | G12C | Head and neck | 40-50 | 0 | 216 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Head and neck | 50-65 | 1 | 799 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Head and neck | >65 | 1 | 582 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Uterine | <40 | 0 | 57 | 0.003 | 0.003 | 0.000 | 0.008 |
| RAS | G12C | Uterine | 40-50 | 0 | 162 | 0.003 | 0.003 | 0.000 | 0.007 |
| RAS | G12C | Uterine | 50-65 | 3 | 1046 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12C | Uterine | >65 | 4 | 988 | 0.003 | 0.003 | 0.001 | 0.007 |
| RAS | G12C | Non-melanoma skin | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-melanoma skin | 40-50 | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-melanoma skin | 50-65 | 0 | 149 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Non-melanoma skin | >65 | 0 | 317 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | 40-50 | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | 50-65 | 0 | 373 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | >65 | 0 | 664 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12C | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12C | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12C | Ovarian | <40 | 1 | 141 | 0.002 | 0.002 | 0.000 | 0.011 |
| RAS | G12C | Ovarian | 40-50 | 0 | 253 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Ovarian | 50-65 | 1 | 1092 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Ovarian | >65 | 1 | 849 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Esophagogastric | <40 | 0 | 122 | 0.001 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Esophagogastric | 40-50 | 0 | 200 | 0.001 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Esophagogastric | 50-65 | 1 | 752 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Esophagogastric | >65 | 0 | 725 | 0.001 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Thyroid | <40 | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | 40-50 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | 50-65 | 0 | 374 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | >65 | 0 | 370 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Cervical | <40 | 0 | 85 | 0.003 | 0.002 | 0.000 | 0.012 |
| RAS | G12C | Cervical | 40-50 | 0 | 99 | 0.003 | 0.002 | 0.000 | 0.012 |
| RAS | G12C | Cervical | 50-65 | 1 | 144 | 0.004 | 0.003 | 0.000 | 0.016 |
| RAS | G12C | Cervical | >65 | 0 | 36 | 0.003 | 0.002 | 0.000 | 0.015 |
| RAS | G12C | Hepatobiliary | <40 | 0 | 138 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G12C | Hepatobiliary | 40-50 | 0 | 110 | 0.002 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Hepatobiliary | 50-65 | 2 | 525 | 0.003 | 0.002 | 0.001 | 0.007 |
| RAS | G12C | Hepatobiliary | >65 | 1 | 601 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G12C | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | T / NK neoplasms | >65 | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | CNS | <40 | 0 | 1602 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | CNS | 40-50 | 0 | 687 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | CNS | 50-65 | 1 | 1439 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Prostate | 40-50 | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | 50-65 | 0 | 960 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | >65 | 0 | 1402 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Neuroendocrine | <40 | 0 | 22 | 0.007 | 0.005 | 0.000 | 0.025 |
| RAS | G12C | Neuroendocrine | 40-50 | 1 | 55 | 0.009 | 0.006 | 0.001 | 0.035 |
| RAS | G12C | Neuroendocrine | 50-65 | 1 | 161 | 0.006 | 0.005 | 0.001 | 0.018 |
| RAS | G12C | Neuroendocrine | >65 | 0 | 121 | 0.005 | 0.004 | 0.000 | 0.017 |
| RAS | G12C | Bladder | <40 | 0 | 25 | 0.003 | 0.002 | 0.000 | 0.010 |
| RAS | G12C | Bladder | 40-50 | 0 | 78 | 0.003 | 0.002 | 0.000 | 0.008 |
| RAS | G12C | Bladder | 50-65 | 2 | 511 | 0.003 | 0.003 | 0.001 | 0.007 |
| RAS | G12C | Bladder | >65 | 2 | 962 | 0.003 | 0.002 | 0.001 | 0.006 |
| RAS | G12C | BLL/Lymphoma | <40 | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | BLL/Lymphoma | 40-50 | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | BLL/Lymphoma | 50-65 | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | BLL/Lymphoma | >65 | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Small bowel | 40-50 | 0 | 29 | 0.010 | 0.006 | 0.000 | 0.040 |
| RAS | G12C | Small bowel | 50-65 | 3 | 96 | 0.024 | 0.021 | 0.004 | 0.064 |
| RAS | G12C | Small bowel | >65 | 0 | 78 | 0.008 | 0.005 | 0.000 | 0.031 |
| RAS | G12C | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Sex cord stromal | 40-50 | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Sex cord stromal | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Vaginal | 50-65 | 1 | 34 | 0.024 | 0.017 | 0.001 | 0.086 |
| RAS | G12C | Vaginal | >65 | 0 | 30 | 0.013 | 0.007 | 0.000 | 0.058 |
| RAS | G12C | Thymic | <40 | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.005 |
| RAS | G12C | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Ampullary | 40-50 | 0 | 12 | 0.011 | 0.006 | 0.000 | 0.053 |
| RAS | G12C | Ampullary | 50-65 | 1 | 40 | 0.017 | 0.011 | 0.001 | 0.065 |
| RAS | G12C | Ampullary | >65 | 0 | 50 | 0.008 | 0.005 | 0.000 | 0.036 |
| RAS | G12C | SCLC | 40-50 | 0 | 22 | 0.006 | 0.005 | 0.000 | 0.024 |
| RAS | G12C | SCLC | 50-65 | 1 | 144 | 0.006 | 0.005 | 0.001 | 0.018 |
| RAS | G12C | SCLC | >65 | 1 | 224 | 0.005 | 0.005 | 0.001 | 0.015 |
| RAS | G12C | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Germ cell | <40 | 0 | 650 | 0.002 | 0.001 | 0.000 | 0.006 |
| RAS | G12C | Germ cell | 40-50 | 1 | 131 | 0.005 | 0.003 | 0.000 | 0.021 |
| RAS | G12C | Germ cell | 50-65 | 1 | 92 | 0.006 | 0.003 | 0.000 | 0.027 |
| RAS | G12C | Germ cell | >65 | 0 | 12 | 0.005 | 0.002 | 0.000 | 0.032 |
| RAS | G12C | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Nerve sheath | 40-50 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Nerve sheath | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Nerve sheath | >65 | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Penile | 50-65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.042 |
| RAS | G12C | Penile | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.043 |
| RAS | G12C | Pineal | <40 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| RAS | G12C | B cell lymphoma | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | B cell lymphoma | 40-50 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | B cell lymphoma | 50-65 | 0 | 357 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | B cell lymphoma | >65 | 0 | 413 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.052 |
| RAS | G12C | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.002 | 0.000 | 0.000 | 0.024 |
| RAS | G12C | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G12C | Hodgkin lymphoma | <40 | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.014 |
| RAS | G12C | Lung | >65 | 1 | 18 | 0.063 | 0.048 | 0.003 | 0.208 |
| RAS | G12C | Peritoneal | >65 | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.061 |
| RAS | G13 | Appendiceal | <40 | 0 | 28 | 0.038 | 0.038 | 0.003 | 0.076 |
| RAS | G13 | Appendiceal | 40-50 | 4 | 62 | 0.050 | 0.047 | 0.022 | 0.099 |
| RAS | G13 | Appendiceal | 50-65 | 5 | 161 | 0.039 | 0.039 | 0.017 | 0.067 |
| RAS | G13 | Appendiceal | >65 | 6 | 90 | 0.051 | 0.048 | 0.025 | 0.097 |
| RAS | G13 | CRC | <40 | 48 | 565 | 0.084 | 0.084 | 0.071 | 0.098 |
| RAS | G13 | CRC | 40-50 | 99 | 1280 | 0.081 | 0.082 | 0.070 | 0.092 |
| RAS | G13 | CRC | 50-65 | 231 | 2815 | 0.083 | 0.083 | 0.074 | 0.092 |
| RAS | G13 | CRC | >65 | 184 | 2055 | 0.086 | 0.086 | 0.077 | 0.097 |
| RAS | G13 | CUP | <40 | 4 | 167 | 0.025 | 0.024 | 0.015 | 0.038 |
| RAS | G13 | CUP | 40-50 | 8 | 211 | 0.027 | 0.026 | 0.017 | 0.045 |
| RAS | G13 | CUP | 50-65 | 19 | 810 | 0.024 | 0.024 | 0.017 | 0.033 |
| RAS | G13 | CUP | >65 | 17 | 797 | 0.024 | 0.023 | 0.016 | 0.032 |
| RAS | G13 | NSCLC | <40 | 2 | 161 | 0.021 | 0.021 | 0.011 | 0.028 |
| RAS | G13 | NSCLC | 40-50 | 9 | 585 | 0.020 | 0.021 | 0.012 | 0.026 |
| RAS | G13 | NSCLC | 50-65 | 89 | 3677 | 0.023 | 0.023 | 0.019 | 0.028 |
| RAS | G13 | NSCLC | >65 | 123 | 5698 | 0.022 | 0.022 | 0.018 | 0.025 |
| RAS | G13 | NSCLC | NA | 0 | 10 | 0.022 | 0.022 | 0.011 | 0.033 |
| RAS | G13 | Breast | <40 | 0 | 841 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Breast | 50-65 | 11 | 3989 | 0.003 | 0.002 | 0.001 | 0.004 |
| RAS | G13 | Breast | >65 | 1 | 2583 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | Breast | NA | 0 | 10 | 0.003 | 0.000 | 0.000 | 0.025 |
| RAS | G13 | Soft tissue sarcoma | <40 | 4 | 672 | 0.004 | 0.004 | 0.002 | 0.009 |
| RAS | G13 | Soft tissue sarcoma | 40-50 | 0 | 367 | 0.003 | 0.003 | 0.000 | 0.006 |
| RAS | G13 | Soft tissue sarcoma | 50-65 | 3 | 951 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G13 | Soft tissue sarcoma | >65 | 2 | 777 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G13 | Pancreatic | <40 | 0 | 87 | 0.008 | 0.008 | 0.002 | 0.015 |
| RAS | G13 | Pancreatic | 40-50 | 1 | 200 | 0.008 | 0.008 | 0.003 | 0.014 |
| RAS | G13 | Pancreatic | 50-65 | 8 | 1000 | 0.008 | 0.008 | 0.005 | 0.013 |
| RAS | G13 | Pancreatic | >65 | 12 | 1205 | 0.009 | 0.009 | 0.005 | 0.014 |
| RAS | G13 | Leukemia | <40 | 18 | 204 | 0.069 | 0.067 | 0.039 | 0.112 |
| RAS | G13 | Leukemia | 40-50 | 5 | 128 | 0.044 | 0.043 | 0.021 | 0.073 |
| RAS | G13 | Leukemia | 50-65 | 23 | 515 | 0.045 | 0.045 | 0.031 | 0.063 |
| RAS | G13 | Leukemia | >65 | 23 | 720 | 0.036 | 0.036 | 0.023 | 0.051 |
| RAS | G13 | Melanoma | <40 | 1 | 289 | 0.009 | 0.008 | 0.001 | 0.023 |
| RAS | G13 | Melanoma | 40-50 | 2 | 282 | 0.011 | 0.010 | 0.002 | 0.024 |
| RAS | G13 | Melanoma | 50-65 | 20 | 1016 | 0.019 | 0.019 | 0.012 | 0.028 |
| RAS | G13 | Melanoma | >65 | 39 | 1259 | 0.029 | 0.029 | 0.020 | 0.040 |
| RAS | G13 | Head and neck | <40 | 1 | 140 | 0.011 | 0.010 | 0.004 | 0.019 |
| RAS | G13 | Head and neck | 40-50 | 2 | 216 | 0.011 | 0.011 | 0.005 | 0.018 |
| RAS | G13 | Head and neck | 50-65 | 10 | 799 | 0.011 | 0.011 | 0.007 | 0.018 |
| RAS | G13 | Head and neck | >65 | 6 | 582 | 0.011 | 0.011 | 0.006 | 0.017 |
| RAS | G13 | Uterine | <40 | 2 | 57 | 0.025 | 0.024 | 0.015 | 0.044 |
| RAS | G13 | Uterine | 40-50 | 4 | 162 | 0.024 | 0.024 | 0.015 | 0.038 |
| RAS | G13 | Uterine | 50-65 | 22 | 1046 | 0.023 | 0.023 | 0.016 | 0.031 |
| RAS | G13 | Uterine | >65 | 26 | 988 | 0.025 | 0.025 | 0.018 | 0.034 |
| RAS | G13 | Non-melanoma skin | <40 | 0 | 27 | 0.006 | 0.005 | 0.000 | 0.019 |
| RAS | G13 | Non-melanoma skin | 40-50 | 0 | 20 | 0.007 | 0.005 | 0.000 | 0.021 |
| RAS | G13 | Non-melanoma skin | 50-65 | 1 | 149 | 0.007 | 0.006 | 0.001 | 0.017 |
| RAS | G13 | Non-melanoma skin | >65 | 2 | 317 | 0.006 | 0.006 | 0.001 | 0.016 |
| RAS | G13 | MDS/MPN | <40 | 5 | 87 | 0.030 | 0.025 | 0.014 | 0.073 |
| RAS | G13 | MDS/MPN | 40-50 | 1 | 83 | 0.021 | 0.021 | 0.006 | 0.038 |
| RAS | G13 | MDS/MPN | 50-65 | 6 | 373 | 0.020 | 0.020 | 0.010 | 0.032 |
| RAS | G13 | MDS/MPN | >65 | 14 | 664 | 0.022 | 0.021 | 0.013 | 0.032 |
| RAS | G13 | Adrenocortical | <40 | 0 | 27 | 0.007 | 0.004 | 0.000 | 0.033 |
| RAS | G13 | Adrenocortical | 40-50 | 0 | 30 | 0.007 | 0.004 | 0.000 | 0.032 |
| RAS | G13 | Adrenocortical | 50-65 | 0 | 51 | 0.006 | 0.003 | 0.000 | 0.029 |
| RAS | G13 | Adrenocortical | >65 | 1 | 26 | 0.019 | 0.010 | 0.001 | 0.093 |
| RAS | G13 | Ovarian | <40 | 1 | 141 | 0.006 | 0.005 | 0.002 | 0.014 |
| RAS | G13 | Ovarian | 40-50 | 3 | 253 | 0.006 | 0.006 | 0.003 | 0.016 |
| RAS | G13 | Ovarian | 50-65 | 4 | 1092 | 0.005 | 0.005 | 0.002 | 0.009 |
| RAS | G13 | Ovarian | >65 | 4 | 849 | 0.005 | 0.005 | 0.002 | 0.009 |
| RAS | G13 | Esophagogastric | <40 | 1 | 122 | 0.014 | 0.013 | 0.006 | 0.023 |
| RAS | G13 | Esophagogastric | 40-50 | 2 | 200 | 0.013 | 0.013 | 0.006 | 0.022 |
| RAS | G13 | Esophagogastric | 50-65 | 10 | 752 | 0.014 | 0.014 | 0.008 | 0.021 |
| RAS | G13 | Esophagogastric | >65 | 12 | 725 | 0.015 | 0.014 | 0.009 | 0.022 |
| RAS | G13 | Thyroid | <40 | 1 | 150 | 0.005 | 0.004 | 0.001 | 0.012 |
| RAS | G13 | Thyroid | 40-50 | 0 | 122 | 0.004 | 0.003 | 0.000 | 0.010 |
| RAS | G13 | Thyroid | 50-65 | 1 | 374 | 0.004 | 0.004 | 0.001 | 0.009 |
| RAS | G13 | Thyroid | >65 | 2 | 370 | 0.004 | 0.004 | 0.001 | 0.010 |
| RAS | G13 | Cervical | <40 | 0 | 85 | 0.008 | 0.007 | 0.000 | 0.024 |
| RAS | G13 | Cervical | 40-50 | 3 | 99 | 0.019 | 0.015 | 0.004 | 0.054 |
| RAS | G13 | Cervical | 50-65 | 1 | 144 | 0.009 | 0.008 | 0.001 | 0.025 |
| RAS | G13 | Cervical | >65 | 0 | 36 | 0.009 | 0.008 | 0.000 | 0.031 |
| RAS | G13 | Hepatobiliary | <40 | 0 | 138 | 0.008 | 0.008 | 0.000 | 0.017 |
| RAS | G13 | Hepatobiliary | 40-50 | 3 | 110 | 0.014 | 0.011 | 0.005 | 0.040 |
| RAS | G13 | Hepatobiliary | 50-65 | 6 | 525 | 0.010 | 0.010 | 0.005 | 0.019 |
| RAS | G13 | Hepatobiliary | >65 | 4 | 601 | 0.009 | 0.008 | 0.003 | 0.015 |
| RAS | G13 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | T / NK neoplasms | >65 | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | CNS | <40 | 4 | 1602 | 0.002 | 0.001 | 0.000 | 0.004 |
| RAS | G13 | CNS | 40-50 | 0 | 687 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G13 | CNS | 50-65 | 1 | 1439 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G13 | CNS | >65 | 0 | 836 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G13 | Prostate | 40-50 | 0 | 70 | 0.002 | 0.002 | 0.000 | 0.007 |
| RAS | G13 | Prostate | 50-65 | 1 | 960 | 0.002 | 0.001 | 0.000 | 0.004 |
| RAS | G13 | Prostate | >65 | 3 | 1402 | 0.002 | 0.002 | 0.000 | 0.004 |
| RAS | G13 | Anal | 40-50 | 0 | 12 | 0.016 | 0.012 | 0.000 | 0.056 |
| RAS | G13 | Anal | 50-65 | 1 | 88 | 0.015 | 0.012 | 0.002 | 0.041 |
| RAS | G13 | Anal | >65 | 1 | 45 | 0.017 | 0.014 | 0.002 | 0.052 |
| RAS | G13 | Neuroendocrine | <40 | 2 | 22 | 0.033 | 0.024 | 0.008 | 0.126 |
| RAS | G13 | Neuroendocrine | 40-50 | 1 | 55 | 0.021 | 0.019 | 0.005 | 0.049 |
| RAS | G13 | Neuroendocrine | 50-65 | 3 | 161 | 0.020 | 0.019 | 0.007 | 0.041 |
| RAS | G13 | Neuroendocrine | >65 | 1 | 121 | 0.018 | 0.017 | 0.004 | 0.037 |
| RAS | G13 | Bladder | <40 | 0 | 25 | 0.012 | 0.012 | 0.003 | 0.024 |
| RAS | G13 | Bladder | 40-50 | 1 | 78 | 0.012 | 0.012 | 0.005 | 0.024 |
| RAS | G13 | Bladder | 50-65 | 6 | 511 | 0.012 | 0.012 | 0.006 | 0.020 |
| RAS | G13 | Bladder | >65 | 12 | 962 | 0.012 | 0.012 | 0.007 | 0.019 |
| RAS | G13 | BLL/Lymphoma | <40 | 12 | 142 | 0.073 | 0.070 | 0.036 | 0.122 |
| RAS | G13 | BLL/Lymphoma | 40-50 | 1 | 16 | 0.055 | 0.048 | 0.006 | 0.159 |
| RAS | G13 | BLL/Lymphoma | 50-65 | 1 | 48 | 0.036 | 0.033 | 0.003 | 0.084 |
| RAS | G13 | BLL/Lymphoma | >65 | 0 | 42 | 0.029 | 0.025 | 0.000 | 0.078 |
| RAS | G13 | Small bowel | 40-50 | 6 | 29 | 0.150 | 0.139 | 0.046 | 0.320 |
| RAS | G13 | Small bowel | 50-65 | 4 | 96 | 0.051 | 0.049 | 0.017 | 0.098 |
| RAS | G13 | Small bowel | >65 | 3 | 78 | 0.050 | 0.048 | 0.014 | 0.101 |
| RAS | G13 | Sex cord stromal | <40 | 1 | 29 | 0.017 | 0.011 | 0.001 | 0.075 |
| RAS | G13 | Sex cord stromal | 40-50 | 0 | 15 | 0.010 | 0.006 | 0.000 | 0.045 |
| RAS | G13 | Sex cord stromal | 50-65 | 0 | 37 | 0.009 | 0.006 | 0.000 | 0.036 |
| RAS | G13 | Sex cord stromal | >65 | 0 | 27 | 0.009 | 0.006 | 0.000 | 0.039 |
| RAS | G13 | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Vaginal | 50-65 | 1 | 34 | 0.024 | 0.017 | 0.001 | 0.088 |
| RAS | G13 | Vaginal | >65 | 0 | 30 | 0.013 | 0.007 | 0.000 | 0.058 |
| RAS | G13 | Thymic | <40 | 0 | 14 | 0.008 | 0.005 | 0.000 | 0.034 |
| RAS | G13 | Thymic | 40-50 | 0 | 28 | 0.007 | 0.004 | 0.000 | 0.030 |
| RAS | G13 | Thymic | 50-65 | 1 | 72 | 0.009 | 0.007 | 0.000 | 0.033 |
| RAS | G13 | Thymic | >65 | 0 | 40 | 0.007 | 0.004 | 0.000 | 0.027 |
| RAS | G13 | Ampullary | 40-50 | 0 | 12 | 0.045 | 0.041 | 0.000 | 0.113 |
| RAS | G13 | Ampullary | 50-65 | 3 | 40 | 0.057 | 0.052 | 0.017 | 0.131 |
| RAS | G13 | Ampullary | >65 | 2 | 50 | 0.047 | 0.044 | 0.012 | 0.102 |
| RAS | G13 | SCLC | 40-50 | 0 | 22 | 0.004 | 0.002 | 0.000 | 0.019 |
| RAS | G13 | SCLC | 50-65 | 0 | 144 | 0.003 | 0.002 | 0.000 | 0.011 |
| RAS | G13 | SCLC | >65 | 1 | 224 | 0.004 | 0.003 | 0.000 | 0.013 |
| RAS | G13 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Germ cell | <40 | 5 | 650 | 0.008 | 0.008 | 0.003 | 0.015 |
| RAS | G13 | Germ cell | 40-50 | 2 | 131 | 0.010 | 0.009 | 0.003 | 0.028 |
| RAS | G13 | Germ cell | 50-65 | 0 | 92 | 0.007 | 0.007 | 0.000 | 0.017 |
| RAS | G13 | Germ cell | >65 | 0 | 12 | 0.008 | 0.007 | 0.000 | 0.026 |
| RAS | G13 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G13 | Nerve sheath | 40-50 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G13 | Nerve sheath | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G13 | Nerve sheath | >65 | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.005 |
| RAS | G13 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G13 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| RAS | G13 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| RAS | G13 | B cell lymphoma | <40 | 0 | 87 | 0.011 | 0.011 | 0.002 | 0.022 |
| RAS | G13 | B cell lymphoma | 40-50 | 1 | 105 | 0.012 | 0.012 | 0.004 | 0.024 |
| RAS | G13 | B cell lymphoma | 50-65 | 5 | 357 | 0.013 | 0.012 | 0.006 | 0.022 |
| RAS | G13 | B cell lymphoma | >65 | 6 | 413 | 0.013 | 0.013 | 0.006 | 0.023 |
| RAS | G13 | Non-hodgkin lymphoma | >65 | 1 | 14 | 0.080 | 0.062 | 0.004 | 0.254 |
| RAS | G13 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.017 |
| RAS | G13 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.007 |
| RAS | G13 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| RAS | G13 | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.024 |
| RAS | G13 | Peritoneal | >65 | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.077 |
| RAS | Q61 | Appendiceal | <40 | 1 | 28 | 0.031 | 0.029 | 0.011 | 0.064 |
| RAS | Q61 | Appendiceal | 40-50 | 2 | 62 | 0.030 | 0.029 | 0.012 | 0.059 |
| RAS | Q61 | Appendiceal | 50-65 | 5 | 161 | 0.030 | 0.029 | 0.014 | 0.054 |
| RAS | Q61 | Appendiceal | >65 | 2 | 90 | 0.029 | 0.028 | 0.011 | 0.053 |
| RAS | Q61 | CRC | <40 | 14 | 565 | 0.036 | 0.037 | 0.022 | 0.046 |
| RAS | Q61 | CRC | 40-50 | 57 | 1280 | 0.042 | 0.042 | 0.035 | 0.052 |
| RAS | Q61 | CRC | 50-65 | 121 | 2815 | 0.042 | 0.042 | 0.036 | 0.049 |
| RAS | Q61 | CRC | >65 | 83 | 2055 | 0.040 | 0.040 | 0.034 | 0.047 |
| RAS | Q61 | CUP | <40 | 4 | 167 | 0.023 | 0.023 | 0.014 | 0.036 |
| RAS | Q61 | CUP | 40-50 | 4 | 211 | 0.023 | 0.023 | 0.013 | 0.033 |
| RAS | Q61 | CUP | 50-65 | 18 | 810 | 0.023 | 0.023 | 0.016 | 0.031 |
| RAS | Q61 | CUP | >65 | 20 | 797 | 0.024 | 0.023 | 0.017 | 0.032 |
| RAS | Q61 | NSCLC | <40 | 1 | 161 | 0.022 | 0.023 | 0.010 | 0.030 |
| RAS | Q61 | NSCLC | 40-50 | 13 | 585 | 0.023 | 0.024 | 0.016 | 0.030 |
| RAS | Q61 | NSCLC | 50-65 | 94 | 3677 | 0.025 | 0.025 | 0.021 | 0.029 |
| RAS | Q61 | NSCLC | >65 | 137 | 5698 | 0.024 | 0.024 | 0.021 | 0.028 |
| RAS | Q61 | NSCLC | NA | 0 | 10 | 0.024 | 0.024 | 0.012 | 0.036 |
| RAS | Q61 | Breast | <40 | 0 | 841 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | Q61 | Breast | 40-50 | 2 | 1910 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | Q61 | Breast | 50-65 | 0 | 3989 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | Q61 | Breast | >65 | 8 | 2583 | 0.003 | 0.003 | 0.001 | 0.005 |
| RAS | Q61 | Breast | NA | 0 | 10 | 0.004 | 0.000 | 0.000 | 0.036 |
| RAS | Q61 | Soft tissue sarcoma | <40 | 18 | 672 | 0.023 | 0.023 | 0.012 | 0.037 |
| RAS | Q61 | Soft tissue sarcoma | 40-50 | 2 | 367 | 0.008 | 0.008 | 0.002 | 0.017 |
| RAS | Q61 | Soft tissue sarcoma | 50-65 | 6 | 951 | 0.008 | 0.007 | 0.003 | 0.014 |
| RAS | Q61 | Soft tissue sarcoma | >65 | 7 | 777 | 0.010 | 0.009 | 0.004 | 0.017 |
| RAS | Q61 | Pancreatic | <40 | 1 | 87 | 0.039 | 0.040 | 0.006 | 0.070 |
| RAS | Q61 | Pancreatic | 40-50 | 13 | 200 | 0.061 | 0.060 | 0.037 | 0.093 |
| RAS | Q61 | Pancreatic | 50-65 | 46 | 1000 | 0.048 | 0.048 | 0.036 | 0.063 |
| RAS | Q61 | Pancreatic | >65 | 90 | 1205 | 0.072 | 0.071 | 0.057 | 0.088 |
| RAS | Q61 | Leukemia | <40 | 8 | 204 | 0.033 | 0.032 | 0.021 | 0.054 |
| RAS | Q61 | Leukemia | 40-50 | 7 | 128 | 0.036 | 0.033 | 0.022 | 0.066 |
| RAS | Q61 | Leukemia | 50-65 | 12 | 515 | 0.029 | 0.029 | 0.018 | 0.040 |
| RAS | Q61 | Leukemia | >65 | 21 | 720 | 0.030 | 0.030 | 0.021 | 0.041 |
| RAS | Q61 | Melanoma | <40 | 38 | 289 | 0.156 | 0.155 | 0.110 | 0.204 |
| RAS | Q61 | Melanoma | 40-50 | 55 | 282 | 0.195 | 0.195 | 0.157 | 0.235 |
| RAS | Q61 | Melanoma | 50-65 | 218 | 1016 | 0.211 | 0.211 | 0.188 | 0.236 |
| RAS | Q61 | Melanoma | >65 | 273 | 1259 | 0.214 | 0.213 | 0.193 | 0.236 |
| RAS | Q61 | Head and neck | <40 | 1 | 140 | 0.013 | 0.013 | 0.004 | 0.022 |
| RAS | Q61 | Head and neck | 40-50 | 2 | 216 | 0.013 | 0.013 | 0.005 | 0.022 |
| RAS | Q61 | Head and neck | 50-65 | 15 | 799 | 0.015 | 0.015 | 0.009 | 0.024 |
| RAS | Q61 | Head and neck | >65 | 6 | 582 | 0.013 | 0.012 | 0.006 | 0.020 |
| RAS | Q61 | Uterine | <40 | 0 | 57 | 0.015 | 0.015 | 0.004 | 0.026 |
| RAS | Q61 | Uterine | 40-50 | 3 | 162 | 0.016 | 0.015 | 0.008 | 0.028 |
| RAS | Q61 | Uterine | 50-65 | 20 | 1046 | 0.017 | 0.017 | 0.011 | 0.025 |
| RAS | Q61 | Uterine | >65 | 12 | 988 | 0.014 | 0.014 | 0.008 | 0.021 |
| RAS | Q61 | Non-melanoma skin | <40 | 0 | 27 | 0.012 | 0.010 | 0.000 | 0.030 |
| RAS | Q61 | Non-melanoma skin | 40-50 | 0 | 20 | 0.012 | 0.011 | 0.000 | 0.032 |
| RAS | Q61 | Non-melanoma skin | 50-65 | 3 | 149 | 0.014 | 0.013 | 0.004 | 0.033 |
| RAS | Q61 | Non-melanoma skin | >65 | 3 | 317 | 0.011 | 0.011 | 0.003 | 0.023 |
| RAS | Q61 | MDS/MPN | <40 | 0 | 87 | 0.003 | 0.003 | 0.000 | 0.009 |
| RAS | Q61 | MDS/MPN | 40-50 | 0 | 83 | 0.003 | 0.003 | 0.000 | 0.010 |
| RAS | Q61 | MDS/MPN | 50-65 | 2 | 373 | 0.004 | 0.003 | 0.001 | 0.010 |
| RAS | Q61 | MDS/MPN | >65 | 2 | 664 | 0.003 | 0.003 | 0.001 | 0.008 |
| RAS | Q61 | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | Q61 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | Q61 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | Q61 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | Q61 | Ovarian | <40 | 4 | 141 | 0.020 | 0.019 | 0.012 | 0.037 |
| RAS | Q61 | Ovarian | 40-50 | 5 | 253 | 0.019 | 0.018 | 0.011 | 0.030 |
| RAS | Q61 | Ovarian | 50-65 | 23 | 1092 | 0.019 | 0.019 | 0.013 | 0.027 |
| RAS | Q61 | Ovarian | >65 | 11 | 849 | 0.017 | 0.017 | 0.010 | 0.024 |
| RAS | Q61 | Esophagogastric | <40 | 0 | 122 | 0.005 | 0.005 | 0.001 | 0.011 |
| RAS | Q61 | Esophagogastric | 40-50 | 1 | 200 | 0.006 | 0.005 | 0.002 | 0.012 |
| RAS | Q61 | Esophagogastric | 50-65 | 5 | 752 | 0.006 | 0.006 | 0.003 | 0.011 |
| RAS | Q61 | Esophagogastric | >65 | 4 | 725 | 0.006 | 0.005 | 0.002 | 0.010 |
| RAS | Q61 | Thyroid | <40 | 20 | 150 | 0.166 | 0.168 | 0.118 | 0.204 |
| RAS | Q61 | Thyroid | 40-50 | 22 | 122 | 0.178 | 0.178 | 0.138 | 0.221 |
| RAS | Q61 | Thyroid | 50-65 | 67 | 374 | 0.178 | 0.178 | 0.149 | 0.210 |
| RAS | Q61 | Thyroid | >65 | 73 | 370 | 0.186 | 0.185 | 0.156 | 0.223 |
| RAS | Q61 | Cervical | <40 | 1 | 85 | 0.007 | 0.006 | 0.001 | 0.022 |
| RAS | Q61 | Cervical | 40-50 | 0 | 99 | 0.005 | 0.004 | 0.000 | 0.017 |
| RAS | Q61 | Cervical | 50-65 | 1 | 144 | 0.006 | 0.005 | 0.001 | 0.018 |
| RAS | Q61 | Cervical | >65 | 0 | 36 | 0.006 | 0.005 | 0.000 | 0.020 |
| RAS | Q61 | Hepatobiliary | <40 | 0 | 138 | 0.018 | 0.020 | 0.000 | 0.034 |
| RAS | Q61 | Hepatobiliary | 40-50 | 3 | 110 | 0.025 | 0.024 | 0.009 | 0.048 |
| RAS | Q61 | Hepatobiliary | 50-65 | 14 | 525 | 0.026 | 0.025 | 0.016 | 0.038 |
| RAS | Q61 | Hepatobiliary | >65 | 18 | 601 | 0.027 | 0.027 | 0.018 | 0.040 |
| RAS | Q61 | Kidney | <40 | 1 | 191 | 0.002 | 0.002 | 0.000 | 0.010 |
| RAS | Q61 | Kidney | 40-50 | 0 | 159 | 0.002 | 0.001 | 0.000 | 0.005 |
| RAS | Q61 | Kidney | 50-65 | 1 | 628 | 0.002 | 0.001 | 0.000 | 0.005 |
| RAS | Q61 | Kidney | >65 | 0 | 440 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | Q61 | T / NK neoplasms | <40 | 1 | 28 | 0.021 | 0.018 | 0.004 | 0.060 |
| RAS | Q61 | T / NK neoplasms | 40-50 | 0 | 21 | 0.017 | 0.015 | 0.001 | 0.045 |
| RAS | Q61 | T / NK neoplasms | 50-65 | 2 | 76 | 0.020 | 0.018 | 0.005 | 0.048 |
| RAS | Q61 | T / NK neoplasms | >65 | 1 | 106 | 0.016 | 0.015 | 0.003 | 0.038 |
| RAS | Q61 | CNS | <40 | 16 | 1602 | 0.008 | 0.008 | 0.005 | 0.013 |
| RAS | Q61 | CNS | 40-50 | 5 | 687 | 0.007 | 0.007 | 0.004 | 0.012 |
| RAS | Q61 | CNS | 50-65 | 6 | 1439 | 0.006 | 0.006 | 0.003 | 0.010 |
| RAS | Q61 | CNS | >65 | 6 | 836 | 0.007 | 0.007 | 0.004 | 0.011 |
| RAS | Q61 | Prostate | 40-50 | 0 | 70 | 0.008 | 0.008 | 0.000 | 0.016 |
| RAS | Q61 | Prostate | 50-65 | 10 | 960 | 0.009 | 0.009 | 0.005 | 0.015 |
| RAS | Q61 | Prostate | >65 | 11 | 1402 | 0.008 | 0.008 | 0.005 | 0.013 |
| RAS | Q61 | Anal | 40-50 | 0 | 12 | 0.008 | 0.004 | 0.000 | 0.040 |
| RAS | Q61 | Anal | 50-65 | 1 | 88 | 0.009 | 0.007 | 0.000 | 0.033 |
| RAS | Q61 | Anal | >65 | 0 | 45 | 0.007 | 0.004 | 0.000 | 0.029 |
| RAS | Q61 | Neuroendocrine | <40 | 2 | 22 | 0.046 | 0.026 | 0.004 | 0.178 |
| RAS | Q61 | Neuroendocrine | 40-50 | 1 | 55 | 0.016 | 0.012 | 0.002 | 0.052 |
| RAS | Q61 | Neuroendocrine | 50-65 | 1 | 161 | 0.009 | 0.008 | 0.001 | 0.025 |
| RAS | Q61 | Neuroendocrine | >65 | 0 | 121 | 0.007 | 0.006 | 0.000 | 0.023 |
| RAS | Q61 | Bladder | <40 | 1 | 25 | 0.028 | 0.026 | 0.014 | 0.055 |
| RAS | Q61 | Bladder | 40-50 | 3 | 78 | 0.028 | 0.026 | 0.016 | 0.051 |
| RAS | Q61 | Bladder | 50-65 | 13 | 511 | 0.026 | 0.025 | 0.017 | 0.037 |
| RAS | Q61 | Bladder | >65 | 23 | 962 | 0.025 | 0.025 | 0.017 | 0.034 |
| RAS | Q61 | BLL/Lymphoma | <40 | 8 | 142 | 0.052 | 0.049 | 0.021 | 0.097 |
| RAS | Q61 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.011 | 0.001 | 0.000 | 0.058 |
| RAS | Q61 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.007 | 0.001 | 0.000 | 0.042 |
| RAS | Q61 | BLL/Lymphoma | >65 | 0 | 42 | 0.007 | 0.001 | 0.000 | 0.043 |
| RAS | Q61 | Small bowel | 40-50 | 2 | 29 | 0.046 | 0.041 | 0.015 | 0.109 |
| RAS | Q61 | Small bowel | 50-65 | 4 | 96 | 0.041 | 0.039 | 0.016 | 0.077 |
| RAS | Q61 | Small bowel | >65 | 2 | 78 | 0.037 | 0.036 | 0.012 | 0.073 |
| RAS | Q61 | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | Q61 | Sex cord stromal | 40-50 | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | Q61 | Sex cord stromal | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | Q61 | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | Q61 | Bone | <40 | 1 | 342 | 0.002 | 0.002 | 0.000 | 0.008 |
| RAS | Q61 | Bone | 40-50 | 0 | 61 | 0.002 | 0.001 | 0.000 | 0.009 |
| RAS | Q61 | Bone | 50-65 | 0 | 96 | 0.002 | 0.001 | 0.000 | 0.008 |
| RAS | Q61 | Bone | >65 | 0 | 67 | 0.002 | 0.001 | 0.000 | 0.009 |
| RAS | Q61 | Vaginal | 50-65 | 1 | 34 | 0.024 | 0.017 | 0.001 | 0.086 |
| RAS | Q61 | Vaginal | >65 | 0 | 30 | 0.013 | 0.007 | 0.000 | 0.058 |
| RAS | Q61 | Thymic | <40 | 0 | 14 | 0.021 | 0.016 | 0.000 | 0.077 |
| RAS | Q61 | Thymic | 40-50 | 1 | 28 | 0.031 | 0.025 | 0.002 | 0.099 |
| RAS | Q61 | Thymic | 50-65 | 0 | 72 | 0.014 | 0.011 | 0.000 | 0.048 |
| RAS | Q61 | Thymic | >65 | 3 | 40 | 0.050 | 0.041 | 0.010 | 0.140 |
| RAS | Q61 | Ampullary | 40-50 | 0 | 12 | 0.046 | 0.042 | 0.003 | 0.112 |
| RAS | Q61 | Ampullary | 50-65 | 2 | 40 | 0.050 | 0.046 | 0.013 | 0.109 |
| RAS | Q61 | Ampullary | >65 | 3 | 50 | 0.052 | 0.049 | 0.016 | 0.111 |
| RAS | Q61 | SCLC | 40-50 | 0 | 22 | 0.006 | 0.005 | 0.000 | 0.024 |
| RAS | Q61 | SCLC | 50-65 | 1 | 144 | 0.006 | 0.005 | 0.001 | 0.018 |
| RAS | Q61 | SCLC | >65 | 1 | 224 | 0.005 | 0.005 | 0.001 | 0.015 |
| RAS | Q61 | Mesothelioma | <40 | 0 | 30 | 0.003 | 0.002 | 0.000 | 0.012 |
| RAS | Q61 | Mesothelioma | 40-50 | 0 | 29 | 0.003 | 0.002 | 0.000 | 0.012 |
| RAS | Q61 | Mesothelioma | 50-65 | 0 | 122 | 0.002 | 0.001 | 0.000 | 0.009 |
| RAS | Q61 | Mesothelioma | >65 | 1 | 316 | 0.003 | 0.002 | 0.000 | 0.009 |
| RAS | Q61 | Germ cell | <40 | 4 | 650 | 0.009 | 0.008 | 0.003 | 0.018 |
| RAS | Q61 | Germ cell | 40-50 | 5 | 131 | 0.027 | 0.024 | 0.008 | 0.062 |
| RAS | Q61 | Germ cell | 50-65 | 2 | 92 | 0.019 | 0.016 | 0.005 | 0.048 |
| RAS | Q61 | Germ cell | >65 | 0 | 12 | 0.017 | 0.013 | 0.000 | 0.066 |
| RAS | Q61 | Nerve sheath | <40 | 0 | 77 | 0.010 | 0.008 | 0.000 | 0.035 |
| RAS | Q61 | Nerve sheath | 40-50 | 0 | 27 | 0.012 | 0.009 | 0.000 | 0.044 |
| RAS | Q61 | Nerve sheath | 50-65 | 1 | 37 | 0.019 | 0.014 | 0.002 | 0.068 |
| RAS | Q61 | Nerve sheath | >65 | 1 | 13 | 0.031 | 0.017 | 0.002 | 0.156 |
| RAS | Q61 | Penile | 50-65 | 0 | 11 | 0.037 | 0.021 | 0.000 | 0.161 |
| RAS | Q61 | Penile | >65 | 1 | 11 | 0.070 | 0.050 | 0.003 | 0.248 |
| RAS | Q61 | Pineal | <40 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| RAS | Q61 | B cell lymphoma | <40 | 0 | 87 | 0.022 | 0.023 | 0.002 | 0.039 |
| RAS | Q61 | B cell lymphoma | 40-50 | 5 | 105 | 0.032 | 0.029 | 0.016 | 0.065 |
| RAS | Q61 | B cell lymphoma | 50-65 | 10 | 357 | 0.027 | 0.027 | 0.016 | 0.042 |
| RAS | Q61 | B cell lymphoma | >65 | 11 | 413 | 0.027 | 0.026 | 0.016 | 0.041 |
| RAS | Q61 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.052 |
| RAS | Q61 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.002 | 0.000 | 0.000 | 0.024 |
| RAS | Q61 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | Q61 | Hodgkin lymphoma | <40 | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.014 |
| RAS | Q61 | Lung | >65 | 1 | 18 | 0.063 | 0.048 | 0.003 | 0.208 |
| RAS | Q61 | Peritoneal | >65 | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.061 |
| RAS | 12, 13, or 61 | Appendiceal | Black | 7 | 17 | 0.487 | 0.496 | 0.309 | 0.617 |
| RAS | 12, 13, or 61 | Appendiceal | NA | 21 | 33 | 0.553 | 0.541 | 0.445 | 0.712 |
| RAS | 12, 13, or 61 | Appendiceal | White | 139 | 280 | 0.501 | 0.501 | 0.446 | 0.558 |
| RAS | 12, 13, or 61 | CRC | Asian | 133 | 313 | 0.434 | 0.435 | 0.384 | 0.483 |
| RAS | 12, 13, or 61 | CRC | Black | 281 | 515 | 0.531 | 0.531 | 0.486 | 0.575 |
| RAS | 12, 13, or 61 | CRC | NA | 372 | 804 | 0.462 | 0.462 | 0.430 | 0.495 |
| RAS | 12, 13, or 61 | CRC | Native American | 10 | 17 | 0.488 | 0.482 | 0.380 | 0.626 |
| RAS | 12, 13, or 61 | CRC | Other | 62 | 139 | 0.453 | 0.453 | 0.385 | 0.520 |
| RAS | 12, 13, or 61 | CRC | White | 2057 | 4925 | 0.419 | 0.419 | 0.405 | 0.433 |
| RAS | 12, 13, or 61 | CUP | Asian | 13 | 73 | 0.200 | 0.202 | 0.146 | 0.249 |
| RAS | 12, 13, or 61 | CUP | Black | 27 | 123 | 0.210 | 0.208 | 0.167 | 0.259 |
| RAS | 12, 13, or 61 | CUP | NA | 48 | 286 | 0.191 | 0.193 | 0.149 | 0.225 |
| RAS | 12, 13, or 61 | CUP | Other | 10 | 36 | 0.216 | 0.211 | 0.166 | 0.297 |
| RAS | 12, 13, or 61 | CUP | White | 317 | 1465 | 0.213 | 0.213 | 0.194 | 0.234 |
| RAS | 12, 13, or 61 | NSCLC | Asian | 69 | 624 | 0.117 | 0.117 | 0.092 | 0.144 |
| RAS | 12, 13, or 61 | NSCLC | Black | 201 | 717 | 0.279 | 0.278 | 0.247 | 0.312 |
| RAS | 12, 13, or 61 | NSCLC | NA | 216 | 849 | 0.254 | 0.254 | 0.225 | 0.284 |
| RAS | 12, 13, or 61 | NSCLC | Native American | 4 | 17 | 0.237 | 0.231 | 0.115 | 0.390 |
| RAS | 12, 13, or 61 | NSCLC | Other | 34 | 165 | 0.210 | 0.209 | 0.155 | 0.269 |
| RAS | 12, 13, or 61 | NSCLC | Undefined | 3 | 10 | 0.260 | 0.251 | 0.122 | 0.451 |
| RAS | 12, 13, or 61 | NSCLC | White | 2480 | 7745 | 0.320 | 0.320 | 0.309 | 0.330 |
| RAS | 12, 13, or 61 | Breast | Asian | 3 | 334 | 0.010 | 0.010 | 0.006 | 0.015 |
| RAS | 12, 13, or 61 | Breast | Black | 6 | 526 | 0.011 | 0.010 | 0.007 | 0.015 |
| RAS | 12, 13, or 61 | Breast | NA | 28 | 3112 | 0.010 | 0.010 | 0.007 | 0.013 |
| RAS | 12, 13, or 61 | Breast | Native American | 0 | 11 | 0.011 | 0.010 | 0.006 | 0.016 |
| RAS | 12, 13, or 61 | Breast | Other | 2 | 176 | 0.011 | 0.010 | 0.007 | 0.016 |
| RAS | 12, 13, or 61 | Breast | White | 58 | 5174 | 0.011 | 0.011 | 0.008 | 0.013 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Asian | 1 | 143 | 0.018 | 0.018 | 0.003 | 0.034 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Black | 2 | 193 | 0.018 | 0.019 | 0.005 | 0.034 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | NA | 17 | 350 | 0.039 | 0.038 | 0.022 | 0.064 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Other | 2 | 73 | 0.026 | 0.024 | 0.008 | 0.054 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | White | 47 | 2005 | 0.024 | 0.024 | 0.018 | 0.030 |
| RAS | 12, 13, or 61 | Pancreatic | Asian | 68 | 100 | 0.721 | 0.726 | 0.653 | 0.764 |
| RAS | 12, 13, or 61 | Pancreatic | Black | 65 | 88 | 0.733 | 0.735 | 0.679 | 0.780 |
| RAS | 12, 13, or 61 | Pancreatic | NA | 164 | 231 | 0.726 | 0.728 | 0.677 | 0.762 |
| RAS | 12, 13, or 61 | Pancreatic | Other | 25 | 34 | 0.732 | 0.735 | 0.664 | 0.787 |
| RAS | 12, 13, or 61 | Pancreatic | White | 1523 | 2038 | 0.744 | 0.744 | 0.725 | 0.762 |
| RAS | 12, 13, or 61 | Leukemia | Asian | 5 | 37 | 0.151 | 0.151 | 0.106 | 0.198 |
| RAS | 12, 13, or 61 | Leukemia | Black | 10 | 69 | 0.152 | 0.151 | 0.112 | 0.195 |
| RAS | 12, 13, or 61 | Leukemia | NA | 110 | 777 | 0.147 | 0.147 | 0.125 | 0.169 |
| RAS | 12, 13, or 61 | Leukemia | Other | 3 | 13 | 0.157 | 0.153 | 0.112 | 0.226 |
| RAS | 12, 13, or 61 | Leukemia | White | 108 | 662 | 0.157 | 0.156 | 0.135 | 0.183 |
| RAS | 12, 13, or 61 | Melanoma | Asian | 6 | 33 | 0.215 | 0.219 | 0.120 | 0.296 |
| RAS | 12, 13, or 61 | Melanoma | Black | 9 | 34 | 0.239 | 0.238 | 0.157 | 0.340 |
| RAS | 12, 13, or 61 | Melanoma | NA | 83 | 398 | 0.216 | 0.216 | 0.177 | 0.256 |
| RAS | 12, 13, or 61 | Melanoma | Other | 2 | 26 | 0.192 | 0.201 | 0.072 | 0.275 |
| RAS | 12, 13, or 61 | Melanoma | White | 618 | 2348 | 0.261 | 0.261 | 0.243 | 0.279 |
| RAS | 12, 13, or 61 | Head and neck | Asian | 3 | 94 | 0.036 | 0.035 | 0.013 | 0.066 |
| RAS | 12, 13, or 61 | Head and neck | Black | 5 | 62 | 0.055 | 0.048 | 0.024 | 0.119 |
| RAS | 12, 13, or 61 | Head and neck | NA | 4 | 292 | 0.024 | 0.023 | 0.008 | 0.045 |
| RAS | 12, 13, or 61 | Head and neck | Other | 1 | 28 | 0.039 | 0.037 | 0.010 | 0.089 |
| RAS | 12, 13, or 61 | Head and neck | White | 57 | 1264 | 0.044 | 0.043 | 0.033 | 0.056 |
| RAS | 12, 13, or 61 | Uterine | Asian | 21 | 108 | 0.178 | 0.174 | 0.124 | 0.247 |
| RAS | 12, 13, or 61 | Uterine | Black | 12 | 163 | 0.103 | 0.100 | 0.054 | 0.163 |
| RAS | 12, 13, or 61 | Uterine | NA | 29 | 190 | 0.153 | 0.152 | 0.110 | 0.199 |
| RAS | 12, 13, or 61 | Uterine | Other | 5 | 37 | 0.146 | 0.145 | 0.074 | 0.228 |
| RAS | 12, 13, or 61 | Uterine | White | 317 | 1754 | 0.179 | 0.179 | 0.161 | 0.197 |
| RAS | 12, 13, or 61 | Non-melanoma skin | Asian | 0 | 11 | 0.037 | 0.034 | 0.007 | 0.083 |
| RAS | 12, 13, or 61 | Non-melanoma skin | Black | 1 | 13 | 0.043 | 0.037 | 0.015 | 0.114 |
| RAS | 12, 13, or 61 | Non-melanoma skin | NA | 3 | 53 | 0.041 | 0.038 | 0.018 | 0.087 |
| RAS | 12, 13, or 61 | Non-melanoma skin | White | 14 | 436 | 0.034 | 0.034 | 0.020 | 0.053 |
| RAS | 12, 13, or 61 | MDS/MPN | Asian | 0 | 12 | 0.045 | 0.049 | 0.000 | 0.097 |
| RAS | 12, 13, or 61 | MDS/MPN | Black | 0 | 37 | 0.039 | 0.044 | 0.000 | 0.078 |
| RAS | 12, 13, or 61 | MDS/MPN | NA | 41 | 571 | 0.067 | 0.066 | 0.049 | 0.090 |
| RAS | 12, 13, or 61 | MDS/MPN | White | 30 | 584 | 0.053 | 0.053 | 0.036 | 0.071 |
| RAS | 12, 13, or 61 | Adrenocortical | NA | 0 | 26 | 0.009 | 0.005 | 0.000 | 0.038 |
| RAS | 12, 13, or 61 | Adrenocortical | White | 1 | 103 | 0.010 | 0.007 | 0.000 | 0.034 |
| RAS | 12, 13, or 61 | Ovarian | Asian | 15 | 134 | 0.114 | 0.113 | 0.086 | 0.148 |
| RAS | 12, 13, or 61 | Ovarian | Black | 11 | 74 | 0.119 | 0.116 | 0.092 | 0.170 |
| RAS | 12, 13, or 61 | Ovarian | NA | 24 | 239 | 0.110 | 0.110 | 0.084 | 0.136 |
| RAS | 12, 13, or 61 | Ovarian | Other | 7 | 36 | 0.122 | 0.116 | 0.091 | 0.188 |
| RAS | 12, 13, or 61 | Ovarian | White | 203 | 1852 | 0.111 | 0.111 | 0.098 | 0.124 |
| RAS | 12, 13, or 61 | Esophagogastric | Asian | 6 | 115 | 0.055 | 0.055 | 0.035 | 0.076 |
| RAS | 12, 13, or 61 | Esophagogastric | Black | 2 | 68 | 0.054 | 0.054 | 0.029 | 0.074 |
| RAS | 12, 13, or 61 | Esophagogastric | NA | 10 | 191 | 0.055 | 0.055 | 0.037 | 0.075 |
| RAS | 12, 13, or 61 | Esophagogastric | Other | 3 | 46 | 0.057 | 0.056 | 0.036 | 0.084 |
| RAS | 12, 13, or 61 | Esophagogastric | White | 81 | 1379 | 0.057 | 0.057 | 0.047 | 0.069 |
| RAS | 12, 13, or 61 | Thyroid | Asian | 14 | 66 | 0.214 | 0.209 | 0.153 | 0.294 |
| RAS | 12, 13, or 61 | Thyroid | Black | 14 | 40 | 0.256 | 0.241 | 0.176 | 0.404 |
| RAS | 12, 13, or 61 | Thyroid | NA | 16 | 79 | 0.209 | 0.206 | 0.150 | 0.281 |
| RAS | 12, 13, or 61 | Thyroid | Other | 8 | 26 | 0.238 | 0.225 | 0.164 | 0.378 |
| RAS | 12, 13, or 61 | Thyroid | White | 147 | 803 | 0.189 | 0.189 | 0.163 | 0.216 |
| RAS | 12, 13, or 61 | Cervical | Asian | 5 | 27 | 0.109 | 0.100 | 0.061 | 0.212 |
| RAS | 12, 13, or 61 | Cervical | Black | 1 | 19 | 0.089 | 0.089 | 0.032 | 0.146 |
| RAS | 12, 13, or 61 | Cervical | NA | 7 | 77 | 0.092 | 0.091 | 0.053 | 0.139 |
| RAS | 12, 13, or 61 | Cervical | Other | 0 | 15 | 0.085 | 0.086 | 0.019 | 0.140 |
| RAS | 12, 13, or 61 | Cervical | White | 21 | 228 | 0.093 | 0.092 | 0.063 | 0.128 |
| RAS | 12, 13, or 61 | Hepatobiliary | Asian | 12 | 98 | 0.119 | 0.119 | 0.079 | 0.163 |
| RAS | 12, 13, or 61 | Hepatobiliary | Black | 3 | 64 | 0.101 | 0.107 | 0.038 | 0.142 |
| RAS | 12, 13, or 61 | Hepatobiliary | NA | 28 | 235 | 0.119 | 0.119 | 0.088 | 0.150 |
| RAS | 12, 13, or 61 | Hepatobiliary | Other | 1 | 25 | 0.107 | 0.112 | 0.038 | 0.152 |
| RAS | 12, 13, or 61 | Hepatobiliary | White | 126 | 948 | 0.128 | 0.127 | 0.109 | 0.149 |
| RAS | 12, 13, or 61 | Kidney | Asian | 0 | 33 | 0.010 | 0.009 | 0.001 | 0.024 |
| RAS | 12, 13, or 61 | Kidney | Black | 2 | 77 | 0.012 | 0.010 | 0.004 | 0.035 |
| RAS | 12, 13, or 61 | Kidney | NA | 2 | 169 | 0.010 | 0.009 | 0.004 | 0.022 |
| RAS | 12, 13, or 61 | Kidney | Other | 0 | 29 | 0.010 | 0.009 | 0.001 | 0.023 |
| RAS | 12, 13, or 61 | Kidney | White | 9 | 1113 | 0.009 | 0.009 | 0.005 | 0.015 |
| RAS | 12, 13, or 61 | T / NK neoplasms | Asian | 0 | 12 | 0.023 | 0.020 | 0.001 | 0.065 |
| RAS | 12, 13, or 61 | T / NK neoplasms | Black | 1 | 18 | 0.028 | 0.023 | 0.005 | 0.089 |
| RAS | 12, 13, or 61 | T / NK neoplasms | NA | 0 | 10 | 0.023 | 0.020 | 0.001 | 0.065 |
| RAS | 12, 13, or 61 | T / NK neoplasms | White | 4 | 188 | 0.022 | 0.021 | 0.007 | 0.045 |
| RAS | 12, 13, or 61 | CNS | Asian | 2 | 154 | 0.015 | 0.015 | 0.008 | 0.024 |
| RAS | 12, 13, or 61 | CNS | Black | 1 | 131 | 0.015 | 0.014 | 0.007 | 0.023 |
| RAS | 12, 13, or 61 | CNS | NA | 17 | 817 | 0.017 | 0.016 | 0.011 | 0.025 |
| RAS | 12, 13, or 61 | CNS | Other | 2 | 108 | 0.015 | 0.015 | 0.008 | 0.027 |
| RAS | 12, 13, or 61 | CNS | Undefined | 0 | 17 | 0.015 | 0.015 | 0.007 | 0.026 |
| RAS | 12, 13, or 61 | CNS | White | 45 | 3331 | 0.014 | 0.014 | 0.011 | 0.018 |
| RAS | 12, 13, or 61 | Prostate | Asian | 1 | 62 | 0.014 | 0.013 | 0.005 | 0.030 |
| RAS | 12, 13, or 61 | Prostate | Black | 5 | 175 | 0.017 | 0.015 | 0.009 | 0.036 |
| RAS | 12, 13, or 61 | Prostate | NA | 2 | 289 | 0.012 | 0.012 | 0.004 | 0.020 |
| RAS | 12, 13, or 61 | Prostate | Other | 0 | 31 | 0.013 | 0.013 | 0.003 | 0.028 |
| RAS | 12, 13, or 61 | Prostate | White | 24 | 1882 | 0.013 | 0.013 | 0.009 | 0.018 |
| RAS | 12, 13, or 61 | Anal | NA | 0 | 13 | 0.027 | 0.023 | 0.000 | 0.090 |
| RAS | 12, 13, or 61 | Anal | White | 5 | 126 | 0.038 | 0.036 | 0.013 | 0.076 |
| RAS | 12, 13, or 61 | Neuroendocrine | Black | 1 | 23 | 0.081 | 0.080 | 0.011 | 0.173 |
| RAS | 12, 13, or 61 | Neuroendocrine | NA | 10 | 45 | 0.175 | 0.168 | 0.081 | 0.310 |
| RAS | 12, 13, or 61 | Neuroendocrine | White | 23 | 283 | 0.086 | 0.085 | 0.056 | 0.121 |
| RAS | 12, 13, or 61 | Bladder | Asian | 3 | 40 | 0.085 | 0.085 | 0.044 | 0.132 |
| RAS | 12, 13, or 61 | Bladder | Black | 2 | 43 | 0.080 | 0.082 | 0.033 | 0.119 |
| RAS | 12, 13, or 61 | Bladder | NA | 12 | 169 | 0.081 | 0.082 | 0.050 | 0.110 |
| RAS | 12, 13, or 61 | Bladder | Other | 4 | 14 | 0.110 | 0.092 | 0.064 | 0.281 |
| RAS | 12, 13, or 61 | Bladder | White | 115 | 1311 | 0.087 | 0.087 | 0.073 | 0.102 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | Asian | 2 | 17 | 0.154 | 0.154 | 0.071 | 0.239 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | NA | 14 | 92 | 0.157 | 0.155 | 0.104 | 0.216 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | White | 21 | 125 | 0.161 | 0.160 | 0.112 | 0.218 |
| RAS | 12, 13, or 61 | Small bowel | Black | 16 | 25 | 0.533 | 0.525 | 0.362 | 0.747 |
| RAS | 12, 13, or 61 | Small bowel | NA | 9 | 22 | 0.422 | 0.419 | 0.267 | 0.587 |
| RAS | 12, 13, or 61 | Small bowel | White | 55 | 150 | 0.382 | 0.383 | 0.306 | 0.460 |
| RAS | 12, 13, or 61 | Sex cord stromal | NA | 1 | 23 | 0.030 | 0.023 | 0.003 | 0.102 |
| RAS | 12, 13, or 61 | Sex cord stromal | White | 1 | 69 | 0.021 | 0.018 | 0.002 | 0.061 |
| RAS | 12, 13, or 61 | Bone | Asian | 1 | 30 | 0.015 | 0.011 | 0.003 | 0.054 |
| RAS | 12, 13, or 61 | Bone | Black | 0 | 32 | 0.011 | 0.010 | 0.000 | 0.029 |
| RAS | 12, 13, or 61 | Bone | NA | 0 | 86 | 0.010 | 0.009 | 0.000 | 0.023 |
| RAS | 12, 13, or 61 | Bone | Other | 1 | 29 | 0.016 | 0.012 | 0.003 | 0.061 |
| RAS | 12, 13, or 61 | Bone | White | 4 | 391 | 0.011 | 0.010 | 0.004 | 0.021 |
| RAS | 12, 13, or 61 | Vaginal | White | 4 | 68 | 0.060 | 0.056 | 0.018 | 0.127 |
| RAS | 12, 13, or 61 | Thymic | Asian | 0 | 13 | 0.025 | 0.019 | 0.000 | 0.088 |
| RAS | 12, 13, or 61 | Thymic | NA | 0 | 23 | 0.022 | 0.017 | 0.000 | 0.076 |
| RAS | 12, 13, or 61 | Thymic | White | 6 | 108 | 0.049 | 0.047 | 0.018 | 0.097 |
| RAS | 12, 13, or 61 | Ampullary | White | 48 | 86 | 0.558 | 0.559 | 0.453 | 0.660 |
| RAS | 12, 13, or 61 | SCLC | Asian | 0 | 15 | 0.034 | 0.032 | 0.002 | 0.078 |
| RAS | 12, 13, or 61 | SCLC | NA | 1 | 30 | 0.037 | 0.034 | 0.007 | 0.084 |
| RAS | 12, 13, or 61 | SCLC | White | 13 | 337 | 0.037 | 0.036 | 0.020 | 0.059 |
| RAS | 12, 13, or 61 | Mesothelioma | Asian | 0 | 11 | 0.004 | 0.002 | 0.000 | 0.024 |
| RAS | 12, 13, or 61 | Mesothelioma | Black | 0 | 10 | 0.004 | 0.002 | 0.000 | 0.022 |
| RAS | 12, 13, or 61 | Mesothelioma | NA | 0 | 32 | 0.003 | 0.002 | 0.000 | 0.016 |
| RAS | 12, 13, or 61 | Mesothelioma | White | 1 | 434 | 0.003 | 0.002 | 0.000 | 0.009 |
| RAS | 12, 13, or 61 | Germ cell | Asian | 4 | 36 | 0.086 | 0.081 | 0.036 | 0.168 |
| RAS | 12, 13, or 61 | Germ cell | Black | 0 | 23 | 0.055 | 0.056 | 0.004 | 0.110 |
| RAS | 12, 13, or 61 | Germ cell | NA | 9 | 179 | 0.060 | 0.059 | 0.029 | 0.095 |
| RAS | 12, 13, or 61 | Germ cell | Other | 1 | 37 | 0.058 | 0.058 | 0.010 | 0.108 |
| RAS | 12, 13, or 61 | Germ cell | White | 60 | 603 | 0.094 | 0.094 | 0.072 | 0.119 |
| RAS | 12, 13, or 61 | Nerve sheath | Black | 0 | 12 | 0.016 | 0.012 | 0.000 | 0.061 |
| RAS | 12, 13, or 61 | Nerve sheath | NA | 1 | 26 | 0.021 | 0.015 | 0.002 | 0.079 |
| RAS | 12, 13, or 61 | Nerve sheath | White | 1 | 105 | 0.014 | 0.012 | 0.001 | 0.039 |
| RAS | 12, 13, or 61 | Penile | White | 1 | 20 | 0.056 | 0.042 | 0.003 | 0.185 |
| RAS | 12, 13, or 61 | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.036 |
| RAS | 12, 13, or 61 | Pineal | White | 1 | 14 | 0.078 | 0.060 | 0.003 | 0.252 |
| RAS | 12, 13, or 61 | B cell lymphoma | Asian | 0 | 21 | 0.044 | 0.047 | 0.001 | 0.098 |
| RAS | 12, 13, or 61 | B cell lymphoma | Black | 0 | 25 | 0.042 | 0.045 | 0.000 | 0.091 |
| RAS | 12, 13, or 61 | B cell lymphoma | NA | 6 | 42 | 0.093 | 0.078 | 0.042 | 0.208 |
| RAS | 12, 13, or 61 | B cell lymphoma | Other | 1 | 12 | 0.066 | 0.057 | 0.012 | 0.181 |
| RAS | 12, 13, or 61 | B cell lymphoma | White | 47 | 859 | 0.055 | 0.055 | 0.041 | 0.071 |
| RAS | 12, 13, or 61 | Non-hodgkin lymphoma | White | 2 | 19 | 0.110 | 0.097 | 0.017 | 0.276 |
| RAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.055 | 0.031 | 0.000 | 0.217 |
| RAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | White | 4 | 23 | 0.152 | 0.141 | 0.043 | 0.321 |
| RAS | 12, 13, or 61 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| RAS | 12, 13, or 61 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| RAS | 12, 13, or 61 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.017 |
| RAS | 12, 13, or 61 | Lung | White | 3 | 17 | 0.181 | 0.168 | 0.043 | 0.389 |
| RAS | 12, 13, or 61 | Peritoneal | White | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| RAS | 12, 13, or 61 | Parathyroid | White | 4 | 14 | 0.287 | 0.276 | 0.092 | 0.537 |
| RAS | G12 | Appendiceal | Black | 6 | 17 | 0.414 | 0.420 | 0.262 | 0.527 |
| RAS | G12 | Appendiceal | NA | 15 | 33 | 0.434 | 0.432 | 0.334 | 0.548 |
| RAS | G12 | Appendiceal | White | 121 | 280 | 0.431 | 0.431 | 0.377 | 0.486 |
| RAS | G12 | CRC | Asian | 100 | 313 | 0.324 | 0.323 | 0.284 | 0.365 |
| RAS | G12 | CRC | Black | 193 | 515 | 0.356 | 0.355 | 0.316 | 0.399 |
| RAS | G12 | CRC | NA | 257 | 804 | 0.322 | 0.322 | 0.294 | 0.350 |
| RAS | G12 | CRC | Native American | 9 | 17 | 0.347 | 0.338 | 0.284 | 0.460 |
| RAS | G12 | CRC | Other | 46 | 139 | 0.329 | 0.327 | 0.281 | 0.384 |
| RAS | G12 | CRC | White | 1490 | 4925 | 0.305 | 0.305 | 0.292 | 0.317 |
| RAS | G12 | CUP | Asian | 9 | 73 | 0.155 | 0.157 | 0.105 | 0.193 |
| RAS | G12 | CUP | Black | 23 | 123 | 0.167 | 0.165 | 0.133 | 0.216 |
| RAS | G12 | CUP | NA | 38 | 286 | 0.151 | 0.153 | 0.115 | 0.181 |
| RAS | G12 | CUP | Other | 7 | 36 | 0.165 | 0.163 | 0.121 | 0.227 |
| RAS | G12 | CUP | White | 247 | 1465 | 0.166 | 0.166 | 0.149 | 0.184 |
| RAS | G12 | NSCLC | Asian | 56 | 624 | 0.096 | 0.095 | 0.074 | 0.120 |
| RAS | G12 | NSCLC | Black | 173 | 717 | 0.239 | 0.239 | 0.209 | 0.271 |
| RAS | G12 | NSCLC | NA | 184 | 849 | 0.216 | 0.216 | 0.189 | 0.244 |
| RAS | G12 | NSCLC | Native American | 4 | 17 | 0.213 | 0.207 | 0.101 | 0.367 |
| RAS | G12 | NSCLC | Other | 29 | 165 | 0.178 | 0.177 | 0.128 | 0.235 |
| RAS | G12 | NSCLC | Undefined | 1 | 10 | 0.171 | 0.164 | 0.058 | 0.319 |
| RAS | G12 | NSCLC | White | 2104 | 7745 | 0.271 | 0.271 | 0.261 | 0.281 |
| RAS | G12 | Breast | Asian | 2 | 334 | 0.008 | 0.008 | 0.005 | 0.012 |
| RAS | G12 | Breast | Black | 3 | 526 | 0.008 | 0.008 | 0.004 | 0.011 |
| RAS | G12 | Breast | NA | 23 | 3112 | 0.008 | 0.008 | 0.006 | 0.010 |
| RAS | G12 | Breast | Native American | 0 | 11 | 0.008 | 0.008 | 0.004 | 0.013 |
| RAS | G12 | Breast | Other | 2 | 176 | 0.008 | 0.008 | 0.005 | 0.013 |
| RAS | G12 | Breast | White | 45 | 5174 | 0.008 | 0.008 | 0.006 | 0.011 |
| RAS | G12 | Soft tissue sarcoma | Asian | 0 | 143 | 0.010 | 0.010 | 0.002 | 0.016 |
| RAS | G12 | Soft tissue sarcoma | Black | 2 | 193 | 0.011 | 0.010 | 0.005 | 0.019 |
| RAS | G12 | Soft tissue sarcoma | NA | 5 | 350 | 0.011 | 0.011 | 0.006 | 0.020 |
| RAS | G12 | Soft tissue sarcoma | Other | 1 | 73 | 0.011 | 0.010 | 0.005 | 0.022 |
| RAS | G12 | Soft tissue sarcoma | White | 21 | 2005 | 0.011 | 0.010 | 0.007 | 0.015 |
| RAS | G12 | Pancreatic | Asian | 61 | 100 | 0.651 | 0.657 | 0.575 | 0.700 |
| RAS | G12 | Pancreatic | Black | 59 | 88 | 0.665 | 0.667 | 0.604 | 0.718 |
| RAS | G12 | Pancreatic | NA | 154 | 231 | 0.666 | 0.667 | 0.620 | 0.706 |
| RAS | G12 | Pancreatic | Other | 19 | 34 | 0.650 | 0.658 | 0.550 | 0.705 |
| RAS | G12 | Pancreatic | White | 1385 | 2038 | 0.676 | 0.676 | 0.657 | 0.696 |
| RAS | G12 | Leukemia | Asian | 3 | 37 | 0.089 | 0.089 | 0.058 | 0.122 |
| RAS | G12 | Leukemia | Black | 5 | 69 | 0.088 | 0.088 | 0.056 | 0.117 |
| RAS | G12 | Leukemia | NA | 69 | 777 | 0.089 | 0.089 | 0.073 | 0.106 |
| RAS | G12 | Leukemia | Other | 1 | 13 | 0.090 | 0.089 | 0.056 | 0.129 |
| RAS | G12 | Leukemia | White | 62 | 662 | 0.091 | 0.091 | 0.075 | 0.110 |
| RAS | G12 | Melanoma | Asian | 1 | 33 | 0.034 | 0.029 | 0.005 | 0.095 |
| RAS | G12 | Melanoma | Black | 5 | 34 | 0.098 | 0.090 | 0.025 | 0.227 |
| RAS | G12 | Melanoma | NA | 4 | 398 | 0.015 | 0.013 | 0.005 | 0.030 |
| RAS | G12 | Melanoma | Other | 1 | 26 | 0.038 | 0.031 | 0.006 | 0.114 |
| RAS | G12 | Melanoma | White | 68 | 2348 | 0.029 | 0.029 | 0.023 | 0.036 |
| RAS | G12 | Head and neck | Asian | 1 | 94 | 0.014 | 0.014 | 0.004 | 0.028 |
| RAS | G12 | Head and neck | Black | 1 | 62 | 0.015 | 0.015 | 0.004 | 0.034 |
| RAS | G12 | Head and neck | NA | 1 | 292 | 0.012 | 0.012 | 0.002 | 0.021 |
| RAS | G12 | Head and neck | Other | 1 | 28 | 0.017 | 0.015 | 0.005 | 0.047 |
| RAS | G12 | Head and neck | White | 23 | 1264 | 0.017 | 0.016 | 0.011 | 0.024 |
| RAS | G12 | Uterine | Asian | 16 | 108 | 0.133 | 0.131 | 0.091 | 0.188 |
| RAS | G12 | Uterine | Black | 10 | 163 | 0.093 | 0.092 | 0.047 | 0.137 |
| RAS | G12 | Uterine | NA | 22 | 190 | 0.118 | 0.119 | 0.082 | 0.156 |
| RAS | G12 | Uterine | Other | 4 | 37 | 0.118 | 0.118 | 0.060 | 0.180 |
| RAS | G12 | Uterine | White | 247 | 1754 | 0.138 | 0.138 | 0.123 | 0.155 |
| RAS | G12 | Non-melanoma skin | Asian | 0 | 11 | 0.021 | 0.017 | 0.002 | 0.065 |
| RAS | G12 | Non-melanoma skin | Black | 1 | 13 | 0.029 | 0.020 | 0.007 | 0.115 |
| RAS | G12 | Non-melanoma skin | NA | 2 | 53 | 0.025 | 0.020 | 0.008 | 0.067 |
| RAS | G12 | Non-melanoma skin | White | 6 | 436 | 0.017 | 0.016 | 0.007 | 0.030 |
| RAS | G12 | MDS/MPN | Asian | 0 | 12 | 0.036 | 0.038 | 0.001 | 0.069 |
| RAS | G12 | MDS/MPN | Black | 0 | 37 | 0.034 | 0.036 | 0.001 | 0.058 |
| RAS | G12 | MDS/MPN | NA | 25 | 571 | 0.042 | 0.041 | 0.029 | 0.057 |
| RAS | G12 | MDS/MPN | White | 24 | 584 | 0.041 | 0.040 | 0.028 | 0.055 |
| RAS | G12 | Adrenocortical | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12 | Ovarian | Asian | 12 | 134 | 0.092 | 0.090 | 0.063 | 0.129 |
| RAS | G12 | Ovarian | Black | 11 | 74 | 0.108 | 0.100 | 0.074 | 0.184 |
| RAS | G12 | Ovarian | NA | 16 | 239 | 0.082 | 0.083 | 0.053 | 0.107 |
| RAS | G12 | Ovarian | Other | 7 | 36 | 0.114 | 0.100 | 0.073 | 0.224 |
| RAS | G12 | Ovarian | White | 159 | 1852 | 0.087 | 0.087 | 0.075 | 0.100 |
| RAS | G12 | Esophagogastric | Asian | 3 | 115 | 0.036 | 0.036 | 0.018 | 0.052 |
| RAS | G12 | Esophagogastric | Black | 1 | 68 | 0.035 | 0.036 | 0.014 | 0.052 |
| RAS | G12 | Esophagogastric | NA | 8 | 191 | 0.038 | 0.038 | 0.024 | 0.056 |
| RAS | G12 | Esophagogastric | Other | 2 | 46 | 0.038 | 0.037 | 0.020 | 0.061 |
| RAS | G12 | Esophagogastric | White | 54 | 1379 | 0.038 | 0.038 | 0.030 | 0.048 |
| RAS | G12 | Thyroid | Asian | 0 | 66 | 0.011 | 0.011 | 0.000 | 0.023 |
| RAS | G12 | Thyroid | Black | 0 | 40 | 0.011 | 0.011 | 0.000 | 0.025 |
| RAS | G12 | Thyroid | NA | 1 | 79 | 0.013 | 0.012 | 0.003 | 0.028 |
| RAS | G12 | Thyroid | Other | 0 | 26 | 0.012 | 0.011 | 0.000 | 0.028 |
| RAS | G12 | Thyroid | White | 12 | 803 | 0.013 | 0.013 | 0.007 | 0.022 |
| RAS | G12 | Cervical | Asian | 3 | 27 | 0.080 | 0.077 | 0.041 | 0.144 |
| RAS | G12 | Cervical | Black | 1 | 19 | 0.074 | 0.073 | 0.028 | 0.124 |
| RAS | G12 | Cervical | NA | 5 | 77 | 0.074 | 0.073 | 0.039 | 0.113 |
| RAS | G12 | Cervical | Other | 0 | 15 | 0.071 | 0.071 | 0.017 | 0.118 |
| RAS | G12 | Cervical | White | 19 | 228 | 0.078 | 0.077 | 0.052 | 0.111 |
| RAS | G12 | Hepatobiliary | Asian | 10 | 98 | 0.090 | 0.088 | 0.057 | 0.134 |
| RAS | G12 | Hepatobiliary | Black | 1 | 64 | 0.069 | 0.075 | 0.015 | 0.105 |
| RAS | G12 | Hepatobiliary | NA | 20 | 235 | 0.085 | 0.085 | 0.059 | 0.113 |
| RAS | G12 | Hepatobiliary | Other | 1 | 25 | 0.078 | 0.081 | 0.024 | 0.121 |
| RAS | G12 | Hepatobiliary | White | 90 | 948 | 0.092 | 0.091 | 0.075 | 0.110 |
| RAS | G12 | Kidney | Asian | 0 | 33 | 0.009 | 0.008 | 0.001 | 0.022 |
| RAS | G12 | Kidney | Black | 2 | 77 | 0.011 | 0.009 | 0.004 | 0.034 |
| RAS | G12 | Kidney | NA | 2 | 169 | 0.009 | 0.008 | 0.003 | 0.021 |
| RAS | G12 | Kidney | Other | 0 | 29 | 0.009 | 0.008 | 0.001 | 0.022 |
| RAS | G12 | Kidney | White | 7 | 1113 | 0.007 | 0.007 | 0.003 | 0.013 |
| RAS | G12 | T / NK neoplasms | Asian | 0 | 12 | 0.007 | 0.002 | 0.000 | 0.048 |
| RAS | G12 | T / NK neoplasms | Black | 1 | 18 | 0.030 | 0.013 | 0.001 | 0.149 |
| RAS | G12 | T / NK neoplasms | NA | 0 | 10 | 0.008 | 0.002 | 0.000 | 0.056 |
| RAS | G12 | T / NK neoplasms | White | 0 | 188 | 0.003 | 0.001 | 0.000 | 0.014 |
| RAS | G12 | CNS | Asian | 0 | 154 | 0.005 | 0.006 | 0.000 | 0.011 |
| RAS | G12 | CNS | Black | 0 | 131 | 0.005 | 0.006 | 0.000 | 0.011 |
| RAS | G12 | CNS | NA | 3 | 817 | 0.005 | 0.005 | 0.002 | 0.009 |
| RAS | G12 | CNS | Other | 2 | 108 | 0.008 | 0.007 | 0.003 | 0.023 |
| RAS | G12 | CNS | Undefined | 0 | 17 | 0.006 | 0.006 | 0.000 | 0.016 |
| RAS | G12 | CNS | White | 24 | 3331 | 0.007 | 0.007 | 0.004 | 0.010 |
| RAS | G12 | Prostate | Asian | 0 | 62 | 0.003 | 0.003 | 0.000 | 0.008 |
| RAS | G12 | Prostate | Black | 1 | 175 | 0.003 | 0.003 | 0.001 | 0.010 |
| RAS | G12 | Prostate | NA | 0 | 289 | 0.003 | 0.002 | 0.000 | 0.006 |
| RAS | G12 | Prostate | Other | 0 | 31 | 0.003 | 0.003 | 0.000 | 0.009 |
| RAS | G12 | Prostate | White | 6 | 1882 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12 | Anal | NA | 0 | 13 | 0.015 | 0.010 | 0.000 | 0.063 |
| RAS | G12 | Anal | White | 2 | 126 | 0.016 | 0.014 | 0.002 | 0.042 |
| RAS | G12 | Neuroendocrine | Black | 1 | 23 | 0.064 | 0.057 | 0.007 | 0.166 |
| RAS | G12 | Neuroendocrine | NA | 10 | 45 | 0.192 | 0.188 | 0.079 | 0.326 |
| RAS | G12 | Neuroendocrine | White | 14 | 283 | 0.053 | 0.052 | 0.030 | 0.083 |
| RAS | G12 | Bladder | Asian | 2 | 40 | 0.052 | 0.051 | 0.025 | 0.086 |
| RAS | G12 | Bladder | Black | 2 | 43 | 0.051 | 0.050 | 0.024 | 0.084 |
| RAS | G12 | Bladder | NA | 5 | 169 | 0.046 | 0.047 | 0.022 | 0.066 |
| RAS | G12 | Bladder | Other | 2 | 14 | 0.059 | 0.053 | 0.031 | 0.136 |
| RAS | G12 | Bladder | White | 71 | 1311 | 0.053 | 0.053 | 0.042 | 0.065 |
| RAS | G12 | BLL/Lymphoma | Asian | 1 | 17 | 0.094 | 0.093 | 0.031 | 0.162 |
| RAS | G12 | BLL/Lymphoma | NA | 9 | 92 | 0.098 | 0.096 | 0.057 | 0.148 |
| RAS | G12 | BLL/Lymphoma | White | 13 | 125 | 0.100 | 0.099 | 0.062 | 0.148 |
| RAS | G12 | Small bowel | Black | 11 | 25 | 0.350 | 0.337 | 0.242 | 0.528 |
| RAS | G12 | Small bowel | NA | 6 | 22 | 0.305 | 0.305 | 0.183 | 0.429 |
| RAS | G12 | Small bowel | White | 44 | 150 | 0.303 | 0.303 | 0.236 | 0.373 |
| RAS | G12 | Sex cord stromal | NA | 1 | 23 | 0.031 | 0.023 | 0.003 | 0.108 |
| RAS | G12 | Sex cord stromal | White | 1 | 69 | 0.021 | 0.018 | 0.002 | 0.060 |
| RAS | G12 | Bone | Asian | 0 | 30 | 0.009 | 0.008 | 0.000 | 0.025 |
| RAS | G12 | Bone | Black | 0 | 32 | 0.009 | 0.008 | 0.000 | 0.024 |
| RAS | G12 | Bone | NA | 0 | 86 | 0.008 | 0.007 | 0.000 | 0.020 |
| RAS | G12 | Bone | Other | 1 | 29 | 0.013 | 0.009 | 0.002 | 0.051 |
| RAS | G12 | Bone | White | 4 | 391 | 0.009 | 0.009 | 0.003 | 0.019 |
| RAS | G12 | Vaginal | White | 2 | 68 | 0.032 | 0.027 | 0.004 | 0.082 |
| RAS | G12 | Thymic | Asian | 0 | 13 | 0.009 | 0.005 | 0.000 | 0.042 |
| RAS | G12 | Thymic | NA | 0 | 23 | 0.008 | 0.004 | 0.000 | 0.034 |
| RAS | G12 | Thymic | White | 1 | 108 | 0.009 | 0.006 | 0.000 | 0.030 |
| RAS | G12 | Ampullary | White | 40 | 86 | 0.465 | 0.465 | 0.361 | 0.570 |
| RAS | G12 | SCLC | Asian | 0 | 15 | 0.028 | 0.026 | 0.001 | 0.068 |
| RAS | G12 | SCLC | NA | 1 | 30 | 0.031 | 0.028 | 0.006 | 0.075 |
| RAS | G12 | SCLC | White | 10 | 337 | 0.029 | 0.028 | 0.014 | 0.049 |
| RAS | G12 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Germ cell | Asian | 4 | 36 | 0.077 | 0.069 | 0.033 | 0.165 |
| RAS | G12 | Germ cell | Black | 0 | 23 | 0.048 | 0.049 | 0.004 | 0.094 |
| RAS | G12 | Germ cell | NA | 6 | 179 | 0.046 | 0.046 | 0.019 | 0.077 |
| RAS | G12 | Germ cell | Other | 1 | 37 | 0.051 | 0.052 | 0.010 | 0.095 |
| RAS | G12 | Germ cell | White | 47 | 603 | 0.073 | 0.073 | 0.054 | 0.095 |
| RAS | G12 | Nerve sheath | Black | 0 | 12 | 0.009 | 0.005 | 0.000 | 0.041 |
| RAS | G12 | Nerve sheath | NA | 0 | 26 | 0.008 | 0.005 | 0.000 | 0.034 |
| RAS | G12 | Nerve sheath | White | 1 | 105 | 0.009 | 0.007 | 0.000 | 0.030 |
| RAS | G12 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G12 | Pheochromocytoma | White | 0 | 15 | 0.002 | 0.000 | 0.000 | 0.021 |
| RAS | G12 | Pineal | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| RAS | G12 | B cell lymphoma | Asian | 0 | 21 | 0.018 | 0.017 | 0.000 | 0.051 |
| RAS | G12 | B cell lymphoma | Black | 0 | 25 | 0.018 | 0.017 | 0.000 | 0.047 |
| RAS | G12 | B cell lymphoma | NA | 3 | 42 | 0.036 | 0.025 | 0.011 | 0.114 |
| RAS | G12 | B cell lymphoma | Other | 0 | 12 | 0.020 | 0.017 | 0.000 | 0.061 |
| RAS | G12 | B cell lymphoma | White | 15 | 859 | 0.018 | 0.018 | 0.011 | 0.028 |
| RAS | G12 | Non-hodgkin lymphoma | White | 1 | 19 | 0.061 | 0.047 | 0.003 | 0.197 |
| RAS | G12 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.054 | 0.040 | 0.000 | 0.188 |
| RAS | G12 | T-lymphoblastic leukemia/lymphoma | White | 3 | 23 | 0.111 | 0.100 | 0.025 | 0.261 |
| RAS | G12 | Retinoblastoma | NA | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.015 |
| RAS | G12 | Retinoblastoma | White | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G12 | Hodgkin lymphoma | White | 0 | 30 | 0.002 | 0.000 | 0.000 | 0.023 |
| RAS | G12 | Lung | White | 3 | 17 | 0.181 | 0.169 | 0.044 | 0.389 |
| RAS | G12 | Peritoneal | White | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.038 |
| RAS | G12 | Parathyroid | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G12C | Appendiceal | Black | 0 | 17 | 0.010 | 0.007 | 0.000 | 0.036 |
| RAS | G12C | Appendiceal | NA | 0 | 33 | 0.009 | 0.007 | 0.000 | 0.029 |
| RAS | G12C | Appendiceal | White | 3 | 280 | 0.010 | 0.009 | 0.002 | 0.024 |
| RAS | G12C | CRC | Asian | 5 | 313 | 0.013 | 0.013 | 0.008 | 0.020 |
| RAS | G12C | CRC | Black | 4 | 515 | 0.012 | 0.012 | 0.006 | 0.017 |
| RAS | G12C | CRC | NA | 10 | 804 | 0.012 | 0.012 | 0.008 | 0.017 |
| RAS | G12C | CRC | Native American | 1 | 17 | 0.013 | 0.013 | 0.007 | 0.023 |
| RAS | G12C | CRC | Other | 1 | 139 | 0.012 | 0.012 | 0.006 | 0.018 |
| RAS | G12C | CRC | White | 63 | 4925 | 0.013 | 0.013 | 0.010 | 0.016 |
| RAS | G12C | CUP | Asian | 0 | 73 | 0.009 | 0.009 | 0.001 | 0.019 |
| RAS | G12C | CUP | Black | 2 | 123 | 0.012 | 0.011 | 0.004 | 0.027 |
| RAS | G12C | CUP | NA | 1 | 286 | 0.009 | 0.009 | 0.001 | 0.016 |
| RAS | G12C | CUP | Other | 0 | 36 | 0.010 | 0.010 | 0.001 | 0.022 |
| RAS | G12C | CUP | White | 19 | 1465 | 0.012 | 0.012 | 0.007 | 0.018 |
| RAS | G12C | NSCLC | Asian | 7 | 624 | 0.014 | 0.014 | 0.006 | 0.025 |
| RAS | G12C | NSCLC | Black | 34 | 717 | 0.045 | 0.045 | 0.032 | 0.061 |
| RAS | G12C | NSCLC | NA | 19 | 849 | 0.023 | 0.023 | 0.014 | 0.034 |
| RAS | G12C | NSCLC | Native American | 0 | 17 | 0.026 | 0.022 | 0.003 | 0.069 |
| RAS | G12C | NSCLC | Other | 3 | 165 | 0.022 | 0.021 | 0.007 | 0.043 |
| RAS | G12C | NSCLC | Undefined | 0 | 10 | 0.028 | 0.024 | 0.003 | 0.081 |
| RAS | G12C | NSCLC | White | 377 | 7745 | 0.048 | 0.048 | 0.044 | 0.053 |
| RAS | G12C | Breast | Asian | 0 | 334 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | Black | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | NA | 1 | 3112 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | Native American | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Breast | Other | 0 | 176 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | White | 3 | 5174 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Soft tissue sarcoma | Asian | 0 | 143 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Soft tissue sarcoma | Black | 1 | 193 | 0.002 | 0.001 | 0.000 | 0.008 |
| RAS | G12C | Soft tissue sarcoma | NA | 0 | 350 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Soft tissue sarcoma | Other | 0 | 73 | 0.001 | 0.001 | 0.000 | 0.005 |
| RAS | G12C | Soft tissue sarcoma | White | 1 | 2005 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G12C | Pancreatic | Asian | 0 | 100 | 0.003 | 0.003 | 0.000 | 0.008 |
| RAS | G12C | Pancreatic | Black | 0 | 88 | 0.003 | 0.003 | 0.000 | 0.008 |
| RAS | G12C | Pancreatic | NA | 0 | 231 | 0.002 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Pancreatic | Other | 0 | 34 | 0.003 | 0.003 | 0.000 | 0.011 |
| RAS | G12C | Pancreatic | White | 9 | 2038 | 0.004 | 0.004 | 0.002 | 0.007 |
| RAS | G12C | Leukemia | Asian | 0 | 37 | 0.004 | 0.003 | 0.000 | 0.010 |
| RAS | G12C | Leukemia | Black | 0 | 69 | 0.003 | 0.003 | 0.000 | 0.009 |
| RAS | G12C | Leukemia | NA | 3 | 777 | 0.003 | 0.003 | 0.001 | 0.008 |
| RAS | G12C | Leukemia | Other | 0 | 13 | 0.004 | 0.003 | 0.000 | 0.012 |
| RAS | G12C | Leukemia | White | 2 | 662 | 0.003 | 0.003 | 0.001 | 0.007 |
| RAS | G12C | Melanoma | Asian | 0 | 33 | 0.003 | 0.002 | 0.000 | 0.010 |
| RAS | G12C | Melanoma | Black | 0 | 34 | 0.003 | 0.002 | 0.000 | 0.011 |
| RAS | G12C | Melanoma | NA | 0 | 398 | 0.002 | 0.002 | 0.000 | 0.005 |
| RAS | G12C | Melanoma | Other | 0 | 26 | 0.003 | 0.002 | 0.000 | 0.012 |
| RAS | G12C | Melanoma | White | 7 | 2348 | 0.003 | 0.003 | 0.001 | 0.005 |
| RAS | G12C | Head and neck | Asian | 0 | 94 | 0.001 | 0.001 | 0.000 | 0.006 |
| RAS | G12C | Head and neck | Black | 0 | 62 | 0.002 | 0.001 | 0.000 | 0.006 |
| RAS | G12C | Head and neck | NA | 1 | 292 | 0.002 | 0.001 | 0.000 | 0.006 |
| RAS | G12C | Head and neck | Other | 0 | 28 | 0.002 | 0.001 | 0.000 | 0.008 |
| RAS | G12C | Head and neck | White | 1 | 1264 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Uterine | Asian | 0 | 108 | 0.003 | 0.003 | 0.000 | 0.008 |
| RAS | G12C | Uterine | Black | 0 | 163 | 0.003 | 0.003 | 0.000 | 0.007 |
| RAS | G12C | Uterine | NA | 1 | 190 | 0.004 | 0.003 | 0.001 | 0.010 |
| RAS | G12C | Uterine | Other | 0 | 37 | 0.003 | 0.003 | 0.000 | 0.009 |
| RAS | G12C | Uterine | White | 6 | 1754 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12C | Non-melanoma skin | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-melanoma skin | Black | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-melanoma skin | NA | 0 | 53 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-melanoma skin | White | 0 | 436 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | MDS/MPN | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | Black | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | NA | 0 | 571 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | White | 0 | 584 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.007 |
| RAS | G12C | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Ovarian | Asian | 0 | 134 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Ovarian | Black | 0 | 74 | 0.001 | 0.001 | 0.000 | 0.005 |
| RAS | G12C | Ovarian | NA | 0 | 239 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Ovarian | Other | 0 | 36 | 0.001 | 0.001 | 0.000 | 0.006 |
| RAS | G12C | Ovarian | White | 3 | 1852 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Esophagogastric | Asian | 0 | 115 | 0.001 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Esophagogastric | Black | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Esophagogastric | NA | 0 | 191 | 0.001 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Esophagogastric | Other | 0 | 46 | 0.001 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Esophagogastric | White | 1 | 1379 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G12C | Thyroid | Asian | 0 | 66 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | Black | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | NA | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | Other | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | White | 0 | 803 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Cervical | Asian | 0 | 27 | 0.004 | 0.002 | 0.000 | 0.015 |
| RAS | G12C | Cervical | Black | 0 | 19 | 0.004 | 0.002 | 0.000 | 0.016 |
| RAS | G12C | Cervical | NA | 0 | 77 | 0.003 | 0.002 | 0.000 | 0.012 |
| RAS | G12C | Cervical | Other | 0 | 15 | 0.004 | 0.002 | 0.000 | 0.017 |
| RAS | G12C | Cervical | White | 1 | 228 | 0.004 | 0.003 | 0.000 | 0.012 |
| RAS | G12C | Hepatobiliary | Asian | 0 | 98 | 0.002 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Hepatobiliary | Black | 0 | 64 | 0.002 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Hepatobiliary | NA | 0 | 235 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G12C | Hepatobiliary | Other | 0 | 25 | 0.003 | 0.002 | 0.000 | 0.009 |
| RAS | G12C | Hepatobiliary | White | 3 | 948 | 0.003 | 0.002 | 0.001 | 0.006 |
| RAS | G12C | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | T / NK neoplasms | Asian | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | T / NK neoplasms | White | 0 | 188 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | CNS | Asian | 0 | 154 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | CNS | Black | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | CNS | NA | 0 | 817 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | CNS | Other | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | CNS | Undefined | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | CNS | White | 1 | 3331 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Prostate | Asian | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | Black | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | NA | 0 | 289 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | Other | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | White | 0 | 1882 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Anal | NA | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.010 |
| RAS | G12C | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Neuroendocrine | Black | 0 | 23 | 0.007 | 0.005 | 0.000 | 0.031 |
| RAS | G12C | Neuroendocrine | NA | 1 | 45 | 0.011 | 0.007 | 0.001 | 0.046 |
| RAS | G12C | Neuroendocrine | White | 1 | 283 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | G12C | Bladder | Asian | 0 | 40 | 0.003 | 0.002 | 0.000 | 0.017 |
| RAS | G12C | Bladder | Black | 0 | 43 | 0.003 | 0.002 | 0.000 | 0.016 |
| RAS | G12C | Bladder | NA | 0 | 169 | 0.002 | 0.001 | 0.000 | 0.007 |
| RAS | G12C | Bladder | Other | 1 | 14 | 0.019 | 0.004 | 0.000 | 0.135 |
| RAS | G12C | Bladder | White | 2 | 1311 | 0.002 | 0.002 | 0.000 | 0.005 |
| RAS | G12C | BLL/Lymphoma | Asian | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | BLL/Lymphoma | NA | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | BLL/Lymphoma | White | 0 | 125 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Small bowel | Black | 0 | 25 | 0.006 | 0.002 | 0.000 | 0.032 |
| RAS | G12C | Small bowel | NA | 1 | 22 | 0.027 | 0.013 | 0.001 | 0.128 |
| RAS | G12C | Small bowel | White | 0 | 150 | 0.003 | 0.001 | 0.000 | 0.016 |
| RAS | G12C | Sex cord stromal | NA | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Sex cord stromal | White | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Vaginal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12C | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Thymic | NA | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | SCLC | Asian | 0 | 15 | 0.007 | 0.004 | 0.000 | 0.028 |
| RAS | G12C | SCLC | NA | 0 | 30 | 0.006 | 0.004 | 0.000 | 0.023 |
| RAS | G12C | SCLC | White | 2 | 337 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | G12C | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Germ cell | Asian | 0 | 36 | 0.003 | 0.002 | 0.000 | 0.011 |
| RAS | G12C | Germ cell | Black | 0 | 23 | 0.003 | 0.002 | 0.000 | 0.013 |
| RAS | G12C | Germ cell | NA | 0 | 179 | 0.002 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Germ cell | Other | 0 | 37 | 0.003 | 0.002 | 0.000 | 0.011 |
| RAS | G12C | Germ cell | White | 2 | 603 | 0.003 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Nerve sheath | Black | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Nerve sheath | White | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Penile | White | 0 | 20 | 0.002 | 0.000 | 0.000 | 0.029 |
| RAS | G12C | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.040 |
| RAS | G12C | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| RAS | G12C | B cell lymphoma | Asian | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | B cell lymphoma | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | B cell lymphoma | NA | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | B cell lymphoma | Other | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | B cell lymphoma | White | 0 | 859 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.025 |
| RAS | G12C | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.033 |
| RAS | G12C | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.026 |
| RAS | G12C | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.023 |
| RAS | G12C | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.018 |
| RAS | G12C | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.009 |
| RAS | G12C | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.030 |
| RAS | G12C | Peritoneal | White | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.048 |
| RAS | G12C | Parathyroid | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.051 |
| RAS | G13 | Appendiceal | Black | 1 | 17 | 0.050 | 0.046 | 0.016 | 0.115 |
| RAS | G13 | Appendiceal | NA | 2 | 33 | 0.051 | 0.047 | 0.020 | 0.107 |
| RAS | G13 | Appendiceal | White | 12 | 280 | 0.045 | 0.044 | 0.025 | 0.070 |
| RAS | G13 | CRC | Asian | 22 | 313 | 0.080 | 0.081 | 0.056 | 0.104 |
| RAS | G13 | CRC | Black | 64 | 515 | 0.111 | 0.110 | 0.086 | 0.141 |
| RAS | G13 | CRC | NA | 79 | 804 | 0.095 | 0.095 | 0.078 | 0.115 |
| RAS | G13 | CRC | Native American | 0 | 17 | 0.084 | 0.085 | 0.040 | 0.129 |
| RAS | G13 | CRC | Other | 13 | 139 | 0.092 | 0.090 | 0.064 | 0.127 |
| RAS | G13 | CRC | White | 386 | 4925 | 0.079 | 0.079 | 0.072 | 0.087 |
| RAS | G13 | CUP | Asian | 2 | 73 | 0.025 | 0.025 | 0.014 | 0.042 |
| RAS | G13 | CUP | Black | 4 | 123 | 0.026 | 0.025 | 0.016 | 0.043 |
| RAS | G13 | CUP | NA | 7 | 286 | 0.025 | 0.024 | 0.016 | 0.037 |
| RAS | G13 | CUP | Other | 1 | 36 | 0.025 | 0.024 | 0.014 | 0.043 |
| RAS | G13 | CUP | White | 34 | 1465 | 0.024 | 0.024 | 0.018 | 0.032 |
| RAS | G13 | NSCLC | Asian | 5 | 624 | 0.013 | 0.013 | 0.005 | 0.022 |
| RAS | G13 | NSCLC | Black | 13 | 717 | 0.018 | 0.018 | 0.011 | 0.027 |
| RAS | G13 | NSCLC | NA | 12 | 849 | 0.016 | 0.015 | 0.009 | 0.023 |
| RAS | G13 | NSCLC | Native American | 0 | 17 | 0.018 | 0.017 | 0.004 | 0.039 |
| RAS | G13 | NSCLC | Other | 2 | 165 | 0.016 | 0.016 | 0.006 | 0.029 |
| RAS | G13 | NSCLC | Undefined | 1 | 10 | 0.023 | 0.019 | 0.008 | 0.067 |
| RAS | G13 | NSCLC | White | 190 | 7745 | 0.024 | 0.024 | 0.021 | 0.028 |
| RAS | G13 | Breast | Asian | 0 | 334 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G13 | Breast | Black | 3 | 526 | 0.002 | 0.002 | 0.001 | 0.008 |
| RAS | G13 | Breast | NA | 2 | 3112 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G13 | Breast | Native American | 0 | 11 | 0.002 | 0.001 | 0.000 | 0.008 |
| RAS | G13 | Breast | Other | 0 | 176 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G13 | Breast | White | 7 | 5174 | 0.001 | 0.001 | 0.001 | 0.002 |
| RAS | G13 | Soft tissue sarcoma | Asian | 0 | 143 | 0.002 | 0.001 | 0.000 | 0.010 |
| RAS | G13 | Soft tissue sarcoma | Black | 0 | 193 | 0.002 | 0.001 | 0.000 | 0.008 |
| RAS | G13 | Soft tissue sarcoma | NA | 6 | 350 | 0.015 | 0.014 | 0.004 | 0.030 |
| RAS | G13 | Soft tissue sarcoma | Other | 0 | 73 | 0.003 | 0.001 | 0.000 | 0.014 |
| RAS | G13 | Soft tissue sarcoma | White | 3 | 2005 | 0.002 | 0.002 | 0.000 | 0.004 |
| RAS | G13 | Pancreatic | Asian | 1 | 100 | 0.009 | 0.008 | 0.002 | 0.019 |
| RAS | G13 | Pancreatic | Black | 0 | 88 | 0.007 | 0.007 | 0.001 | 0.015 |
| RAS | G13 | Pancreatic | NA | 1 | 231 | 0.007 | 0.007 | 0.002 | 0.014 |
| RAS | G13 | Pancreatic | Other | 0 | 34 | 0.008 | 0.008 | 0.001 | 0.018 |
| RAS | G13 | Pancreatic | White | 19 | 2038 | 0.009 | 0.009 | 0.005 | 0.013 |
| RAS | G13 | Leukemia | Asian | 2 | 37 | 0.046 | 0.045 | 0.027 | 0.077 |
| RAS | G13 | Leukemia | Black | 4 | 69 | 0.047 | 0.045 | 0.029 | 0.076 |
| RAS | G13 | Leukemia | NA | 31 | 777 | 0.043 | 0.043 | 0.031 | 0.055 |
| RAS | G13 | Leukemia | Other | 0 | 13 | 0.044 | 0.044 | 0.021 | 0.072 |
| RAS | G13 | Leukemia | White | 32 | 662 | 0.046 | 0.046 | 0.034 | 0.060 |
| RAS | G13 | Melanoma | Asian | 1 | 33 | 0.022 | 0.021 | 0.008 | 0.045 |
| RAS | G13 | Melanoma | Black | 1 | 34 | 0.022 | 0.021 | 0.008 | 0.045 |
| RAS | G13 | Melanoma | NA | 5 | 398 | 0.018 | 0.019 | 0.008 | 0.028 |
| RAS | G13 | Melanoma | Other | 0 | 26 | 0.020 | 0.020 | 0.005 | 0.037 |
| RAS | G13 | Melanoma | White | 54 | 2348 | 0.022 | 0.022 | 0.017 | 0.028 |
| RAS | G13 | Head and neck | Asian | 2 | 94 | 0.015 | 0.012 | 0.005 | 0.039 |
| RAS | G13 | Head and neck | Black | 3 | 62 | 0.022 | 0.015 | 0.007 | 0.072 |
| RAS | G13 | Head and neck | NA | 1 | 292 | 0.009 | 0.009 | 0.001 | 0.017 |
| RAS | G13 | Head and neck | Other | 0 | 28 | 0.012 | 0.010 | 0.001 | 0.035 |
| RAS | G13 | Head and neck | White | 13 | 1264 | 0.011 | 0.011 | 0.006 | 0.017 |
| RAS | G13 | Uterine | Asian | 3 | 108 | 0.024 | 0.024 | 0.012 | 0.040 |
| RAS | G13 | Uterine | Black | 1 | 163 | 0.021 | 0.022 | 0.006 | 0.032 |
| RAS | G13 | Uterine | NA | 5 | 190 | 0.024 | 0.024 | 0.014 | 0.038 |
| RAS | G13 | Uterine | Other | 1 | 37 | 0.024 | 0.023 | 0.010 | 0.043 |
| RAS | G13 | Uterine | White | 44 | 1754 | 0.024 | 0.024 | 0.018 | 0.031 |
| RAS | G13 | Non-melanoma skin | Asian | 0 | 11 | 0.007 | 0.005 | 0.000 | 0.028 |
| RAS | G13 | Non-melanoma skin | Black | 0 | 13 | 0.007 | 0.005 | 0.000 | 0.028 |
| RAS | G13 | Non-melanoma skin | NA | 0 | 53 | 0.006 | 0.004 | 0.000 | 0.018 |
| RAS | G13 | Non-melanoma skin | White | 3 | 436 | 0.006 | 0.006 | 0.001 | 0.015 |
| RAS | G13 | MDS/MPN | Asian | 0 | 12 | 0.018 | 0.017 | 0.000 | 0.057 |
| RAS | G13 | MDS/MPN | Black | 0 | 37 | 0.015 | 0.015 | 0.000 | 0.039 |
| RAS | G13 | MDS/MPN | NA | 18 | 571 | 0.028 | 0.027 | 0.016 | 0.044 |
| RAS | G13 | MDS/MPN | White | 8 | 584 | 0.016 | 0.016 | 0.007 | 0.028 |
| RAS | G13 | Adrenocortical | NA | 0 | 26 | 0.007 | 0.003 | 0.000 | 0.036 |
| RAS | G13 | Adrenocortical | White | 1 | 103 | 0.010 | 0.007 | 0.000 | 0.033 |
| RAS | G13 | Ovarian | Asian | 2 | 134 | 0.007 | 0.006 | 0.002 | 0.021 |
| RAS | G13 | Ovarian | Black | 0 | 74 | 0.005 | 0.005 | 0.001 | 0.013 |
| RAS | G13 | Ovarian | NA | 2 | 239 | 0.006 | 0.006 | 0.002 | 0.014 |
| RAS | G13 | Ovarian | Other | 0 | 36 | 0.006 | 0.005 | 0.001 | 0.015 |
| RAS | G13 | Ovarian | White | 8 | 1852 | 0.005 | 0.005 | 0.002 | 0.008 |
| RAS | G13 | Esophagogastric | Asian | 2 | 115 | 0.015 | 0.014 | 0.007 | 0.026 |
| RAS | G13 | Esophagogastric | Black | 1 | 68 | 0.014 | 0.014 | 0.006 | 0.026 |
| RAS | G13 | Esophagogastric | NA | 2 | 191 | 0.014 | 0.013 | 0.006 | 0.023 |
| RAS | G13 | Esophagogastric | Other | 1 | 46 | 0.015 | 0.014 | 0.007 | 0.029 |
| RAS | G13 | Esophagogastric | White | 19 | 1379 | 0.014 | 0.014 | 0.009 | 0.020 |
| RAS | G13 | Thyroid | Asian | 0 | 66 | 0.004 | 0.004 | 0.000 | 0.013 |
| RAS | G13 | Thyroid | Black | 0 | 40 | 0.004 | 0.004 | 0.000 | 0.014 |
| RAS | G13 | Thyroid | NA | 1 | 79 | 0.006 | 0.004 | 0.001 | 0.020 |
| RAS | G13 | Thyroid | Other | 0 | 26 | 0.005 | 0.004 | 0.000 | 0.015 |
| RAS | G13 | Thyroid | White | 3 | 803 | 0.004 | 0.004 | 0.001 | 0.009 |
| RAS | G13 | Cervical | Asian | 2 | 27 | 0.029 | 0.017 | 0.004 | 0.122 |
| RAS | G13 | Cervical | Black | 0 | 19 | 0.012 | 0.009 | 0.000 | 0.042 |
| RAS | G13 | Cervical | NA | 1 | 77 | 0.013 | 0.011 | 0.002 | 0.037 |
| RAS | G13 | Cervical | Other | 0 | 15 | 0.013 | 0.010 | 0.000 | 0.048 |
| RAS | G13 | Cervical | White | 1 | 228 | 0.009 | 0.008 | 0.001 | 0.022 |
| RAS | G13 | Hepatobiliary | Asian | 0 | 98 | 0.009 | 0.009 | 0.001 | 0.017 |
| RAS | G13 | Hepatobiliary | Black | 1 | 64 | 0.010 | 0.009 | 0.003 | 0.024 |
| RAS | G13 | Hepatobiliary | NA | 2 | 235 | 0.009 | 0.009 | 0.003 | 0.018 |
| RAS | G13 | Hepatobiliary | Other | 0 | 25 | 0.009 | 0.009 | 0.001 | 0.021 |
| RAS | G13 | Hepatobiliary | White | 10 | 948 | 0.010 | 0.010 | 0.005 | 0.016 |
| RAS | G13 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | T / NK neoplasms | White | 0 | 188 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | CNS | Asian | 0 | 154 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G13 | CNS | Black | 0 | 131 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G13 | CNS | NA | 2 | 817 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G13 | CNS | Other | 0 | 108 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G13 | CNS | Undefined | 0 | 17 | 0.001 | 0.001 | 0.000 | 0.005 |
| RAS | G13 | CNS | White | 3 | 3331 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G13 | Prostate | Asian | 0 | 62 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G13 | Prostate | Black | 0 | 175 | 0.002 | 0.002 | 0.000 | 0.005 |
| RAS | G13 | Prostate | NA | 1 | 289 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G13 | Prostate | Other | 0 | 31 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G13 | Prostate | White | 3 | 1882 | 0.002 | 0.002 | 0.000 | 0.004 |
| RAS | G13 | Anal | NA | 0 | 13 | 0.015 | 0.010 | 0.000 | 0.063 |
| RAS | G13 | Anal | White | 2 | 126 | 0.016 | 0.014 | 0.002 | 0.042 |
| RAS | G13 | Neuroendocrine | Black | 0 | 23 | 0.014 | 0.012 | 0.000 | 0.046 |
| RAS | G13 | Neuroendocrine | NA | 0 | 45 | 0.013 | 0.011 | 0.000 | 0.039 |
| RAS | G13 | Neuroendocrine | White | 7 | 283 | 0.022 | 0.021 | 0.009 | 0.042 |
| RAS | G13 | Bladder | Asian | 0 | 40 | 0.012 | 0.011 | 0.002 | 0.026 |
| RAS | G13 | Bladder | Black | 0 | 43 | 0.012 | 0.011 | 0.002 | 0.026 |
| RAS | G13 | Bladder | NA | 3 | 169 | 0.014 | 0.013 | 0.006 | 0.029 |
| RAS | G13 | Bladder | Other | 1 | 14 | 0.018 | 0.013 | 0.005 | 0.071 |
| RAS | G13 | Bladder | White | 15 | 1311 | 0.012 | 0.012 | 0.007 | 0.018 |
| RAS | G13 | BLL/Lymphoma | Asian | 1 | 17 | 0.058 | 0.054 | 0.018 | 0.123 |
| RAS | G13 | BLL/Lymphoma | NA | 4 | 92 | 0.053 | 0.051 | 0.022 | 0.091 |
| RAS | G13 | BLL/Lymphoma | White | 8 | 125 | 0.058 | 0.057 | 0.030 | 0.097 |
| RAS | G13 | Small bowel | Black | 1 | 25 | 0.060 | 0.058 | 0.014 | 0.123 |
| RAS | G13 | Small bowel | NA | 3 | 22 | 0.080 | 0.069 | 0.031 | 0.201 |
| RAS | G13 | Small bowel | White | 8 | 150 | 0.059 | 0.057 | 0.029 | 0.098 |
| RAS | G13 | Sex cord stromal | NA | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | Sex cord stromal | White | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Vaginal | White | 1 | 68 | 0.017 | 0.013 | 0.001 | 0.058 |
| RAS | G13 | Thymic | Asian | 0 | 13 | 0.009 | 0.005 | 0.000 | 0.042 |
| RAS | G13 | Thymic | NA | 0 | 23 | 0.008 | 0.004 | 0.000 | 0.034 |
| RAS | G13 | Thymic | White | 1 | 108 | 0.009 | 0.006 | 0.000 | 0.030 |
| RAS | G13 | Ampullary | White | 4 | 86 | 0.048 | 0.044 | 0.014 | 0.101 |
| RAS | G13 | SCLC | Asian | 0 | 15 | 0.004 | 0.001 | 0.000 | 0.021 |
| RAS | G13 | SCLC | NA | 0 | 30 | 0.003 | 0.001 | 0.000 | 0.016 |
| RAS | G13 | SCLC | White | 1 | 337 | 0.003 | 0.002 | 0.000 | 0.011 |
| RAS | G13 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Germ cell | Asian | 0 | 36 | 0.008 | 0.007 | 0.001 | 0.020 |
| RAS | G13 | Germ cell | Black | 0 | 23 | 0.008 | 0.007 | 0.001 | 0.020 |
| RAS | G13 | Germ cell | NA | 2 | 179 | 0.009 | 0.008 | 0.003 | 0.019 |
| RAS | G13 | Germ cell | Other | 0 | 37 | 0.008 | 0.007 | 0.001 | 0.019 |
| RAS | G13 | Germ cell | White | 5 | 603 | 0.008 | 0.008 | 0.003 | 0.016 |
| RAS | G13 | Nerve sheath | Black | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | Nerve sheath | White | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G13 | Pheochromocytoma | White | 0 | 15 | 0.002 | 0.000 | 0.000 | 0.021 |
| RAS | G13 | Pineal | White | 1 | 14 | 0.079 | 0.061 | 0.004 | 0.258 |
| RAS | G13 | B cell lymphoma | Asian | 0 | 21 | 0.012 | 0.011 | 0.000 | 0.031 |
| RAS | G13 | B cell lymphoma | Black | 0 | 25 | 0.011 | 0.010 | 0.000 | 0.029 |
| RAS | G13 | B cell lymphoma | NA | 1 | 42 | 0.014 | 0.012 | 0.003 | 0.039 |
| RAS | G13 | B cell lymphoma | Other | 0 | 12 | 0.012 | 0.011 | 0.001 | 0.035 |
| RAS | G13 | B cell lymphoma | White | 10 | 859 | 0.012 | 0.011 | 0.006 | 0.019 |
| RAS | G13 | Non-hodgkin lymphoma | White | 0 | 19 | 0.003 | 0.000 | 0.000 | 0.036 |
| RAS | G13 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.028 | 0.016 | 0.000 | 0.118 |
| RAS | G13 | T-lymphoblastic leukemia/lymphoma | White | 1 | 23 | 0.038 | 0.028 | 0.002 | 0.128 |
| RAS | G13 | Retinoblastoma | NA | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.015 |
| RAS | G13 | Retinoblastoma | White | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G13 | Hodgkin lymphoma | White | 0 | 30 | 0.002 | 0.000 | 0.000 | 0.023 |
| RAS | G13 | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.022 |
| RAS | G13 | Peritoneal | White | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.038 |
| RAS | G13 | Parathyroid | White | 1 | 14 | 0.080 | 0.062 | 0.004 | 0.253 |
| RAS | Q61 | Appendiceal | Black | 0 | 17 | 0.025 | 0.021 | 0.000 | 0.089 |
| RAS | Q61 | Appendiceal | NA | 4 | 33 | 0.085 | 0.074 | 0.019 | 0.213 |
| RAS | Q61 | Appendiceal | White | 6 | 280 | 0.025 | 0.024 | 0.009 | 0.046 |
| RAS | Q61 | CRC | Asian | 11 | 313 | 0.041 | 0.041 | 0.030 | 0.051 |
| RAS | Q61 | CRC | Black | 25 | 515 | 0.043 | 0.042 | 0.034 | 0.055 |
| RAS | Q61 | CRC | NA | 37 | 804 | 0.043 | 0.042 | 0.035 | 0.053 |
| RAS | Q61 | CRC | Native American | 1 | 17 | 0.042 | 0.041 | 0.030 | 0.059 |
| RAS | Q61 | CRC | Other | 4 | 139 | 0.041 | 0.041 | 0.027 | 0.052 |
| RAS | Q61 | CRC | White | 197 | 4925 | 0.041 | 0.041 | 0.036 | 0.046 |
| RAS | Q61 | CUP | Asian | 2 | 73 | 0.023 | 0.022 | 0.009 | 0.046 |
| RAS | Q61 | CUP | Black | 1 | 123 | 0.019 | 0.020 | 0.005 | 0.033 |
| RAS | Q61 | CUP | NA | 3 | 286 | 0.019 | 0.019 | 0.007 | 0.030 |
| RAS | Q61 | CUP | Other | 2 | 36 | 0.026 | 0.023 | 0.011 | 0.068 |
| RAS | Q61 | CUP | White | 37 | 1465 | 0.024 | 0.024 | 0.017 | 0.032 |
| RAS | Q61 | NSCLC | Asian | 9 | 624 | 0.021 | 0.022 | 0.013 | 0.028 |
| RAS | Q61 | NSCLC | Black | 16 | 717 | 0.023 | 0.023 | 0.017 | 0.030 |
| RAS | Q61 | NSCLC | NA | 20 | 849 | 0.023 | 0.023 | 0.017 | 0.030 |
| RAS | Q61 | NSCLC | Native American | 0 | 17 | 0.023 | 0.023 | 0.013 | 0.034 |
| RAS | Q61 | NSCLC | Other | 3 | 165 | 0.023 | 0.023 | 0.014 | 0.031 |
| RAS | Q61 | NSCLC | Undefined | 1 | 10 | 0.024 | 0.024 | 0.015 | 0.038 |
| RAS | Q61 | NSCLC | White | 196 | 7745 | 0.025 | 0.025 | 0.022 | 0.028 |
| RAS | Q61 | Breast | Asian | 1 | 334 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | Q61 | Breast | Black | 0 | 526 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | Q61 | Breast | NA | 3 | 3112 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | Q61 | Breast | Native American | 0 | 11 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | Q61 | Breast | Other | 0 | 176 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | Q61 | Breast | White | 6 | 5174 | 0.001 | 0.001 | 0.001 | 0.002 |
| RAS | Q61 | Soft tissue sarcoma | Asian | 1 | 143 | 0.011 | 0.011 | 0.002 | 0.021 |
| RAS | Q61 | Soft tissue sarcoma | Black | 0 | 193 | 0.009 | 0.010 | 0.001 | 0.017 |
| RAS | Q61 | Soft tissue sarcoma | NA | 8 | 350 | 0.016 | 0.014 | 0.008 | 0.032 |
| RAS | Q61 | Soft tissue sarcoma | Other | 1 | 73 | 0.013 | 0.012 | 0.003 | 0.029 |
| RAS | Q61 | Soft tissue sarcoma | White | 23 | 2005 | 0.012 | 0.012 | 0.008 | 0.016 |
| RAS | Q61 | Pancreatic | Asian | 6 | 100 | 0.062 | 0.061 | 0.036 | 0.096 |
| RAS | Q61 | Pancreatic | Black | 7 | 88 | 0.067 | 0.063 | 0.042 | 0.114 |
| RAS | Q61 | Pancreatic | NA | 9 | 231 | 0.053 | 0.054 | 0.028 | 0.074 |
| RAS | Q61 | Pancreatic | Other | 6 | 34 | 0.085 | 0.070 | 0.048 | 0.200 |
| RAS | Q61 | Pancreatic | White | 121 | 2038 | 0.060 | 0.060 | 0.050 | 0.070 |
| RAS | Q61 | Leukemia | Asian | 1 | 37 | 0.032 | 0.031 | 0.014 | 0.055 |
| RAS | Q61 | Leukemia | Black | 1 | 69 | 0.030 | 0.030 | 0.012 | 0.048 |
| RAS | Q61 | Leukemia | NA | 21 | 777 | 0.029 | 0.029 | 0.020 | 0.040 |
| RAS | Q61 | Leukemia | Other | 2 | 13 | 0.038 | 0.032 | 0.019 | 0.107 |
| RAS | Q61 | Leukemia | White | 23 | 662 | 0.032 | 0.032 | 0.023 | 0.045 |
| RAS | Q61 | Melanoma | Asian | 4 | 33 | 0.159 | 0.163 | 0.067 | 0.234 |
| RAS | Q61 | Melanoma | Black | 4 | 34 | 0.157 | 0.161 | 0.067 | 0.232 |
| RAS | Q61 | Melanoma | NA | 74 | 398 | 0.186 | 0.186 | 0.150 | 0.221 |
| RAS | Q61 | Melanoma | Other | 1 | 26 | 0.137 | 0.143 | 0.030 | 0.220 |
| RAS | Q61 | Melanoma | White | 499 | 2348 | 0.210 | 0.210 | 0.194 | 0.227 |
| RAS | Q61 | Head and neck | Asian | 0 | 94 | 0.010 | 0.011 | 0.000 | 0.021 |
| RAS | Q61 | Head and neck | Black | 1 | 62 | 0.013 | 0.012 | 0.003 | 0.031 |
| RAS | Q61 | Head and neck | NA | 2 | 292 | 0.011 | 0.011 | 0.002 | 0.020 |
| RAS | Q61 | Head and neck | Other | 0 | 28 | 0.012 | 0.012 | 0.000 | 0.027 |
| RAS | Q61 | Head and neck | White | 21 | 1264 | 0.015 | 0.015 | 0.009 | 0.022 |
| RAS | Q61 | Uterine | Asian | 2 | 108 | 0.015 | 0.015 | 0.006 | 0.027 |
| RAS | Q61 | Uterine | Black | 1 | 163 | 0.014 | 0.014 | 0.004 | 0.023 |
| RAS | Q61 | Uterine | NA | 2 | 190 | 0.014 | 0.014 | 0.005 | 0.023 |
| RAS | Q61 | Uterine | Other | 0 | 37 | 0.014 | 0.014 | 0.003 | 0.025 |
| RAS | Q61 | Uterine | White | 30 | 1754 | 0.016 | 0.016 | 0.011 | 0.022 |
| RAS | Q61 | Non-melanoma skin | Asian | 0 | 11 | 0.013 | 0.011 | 0.000 | 0.040 |
| RAS | Q61 | Non-melanoma skin | Black | 0 | 13 | 0.013 | 0.011 | 0.001 | 0.036 |
| RAS | Q61 | Non-melanoma skin | NA | 1 | 53 | 0.014 | 0.012 | 0.003 | 0.039 |
| RAS | Q61 | Non-melanoma skin | White | 5 | 436 | 0.012 | 0.011 | 0.004 | 0.023 |
| RAS | Q61 | MDS/MPN | Asian | 0 | 12 | 0.004 | 0.003 | 0.000 | 0.017 |
| RAS | Q61 | MDS/MPN | Black | 0 | 37 | 0.004 | 0.003 | 0.000 | 0.013 |
| RAS | Q61 | MDS/MPN | NA | 1 | 571 | 0.003 | 0.003 | 0.000 | 0.007 |
| RAS | Q61 | MDS/MPN | White | 3 | 584 | 0.004 | 0.004 | 0.001 | 0.009 |
| RAS | Q61 | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.007 |
| RAS | Q61 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | Q61 | Ovarian | Asian | 1 | 134 | 0.016 | 0.017 | 0.003 | 0.027 |
| RAS | Q61 | Ovarian | Black | 0 | 74 | 0.016 | 0.017 | 0.001 | 0.028 |
| RAS | Q61 | Ovarian | NA | 6 | 239 | 0.020 | 0.019 | 0.011 | 0.036 |
| RAS | Q61 | Ovarian | Other | 0 | 36 | 0.016 | 0.017 | 0.001 | 0.030 |
| RAS | Q61 | Ovarian | White | 37 | 1852 | 0.019 | 0.019 | 0.014 | 0.026 |
| RAS | Q61 | Esophagogastric | Asian | 1 | 115 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | Q61 | Esophagogastric | Black | 0 | 68 | 0.005 | 0.005 | 0.000 | 0.012 |
| RAS | Q61 | Esophagogastric | NA | 0 | 191 | 0.005 | 0.004 | 0.000 | 0.010 |
| RAS | Q61 | Esophagogastric | Other | 0 | 46 | 0.005 | 0.005 | 0.000 | 0.013 |
| RAS | Q61 | Esophagogastric | White | 9 | 1379 | 0.006 | 0.006 | 0.003 | 0.010 |
| RAS | Q61 | Thyroid | Asian | 14 | 66 | 0.208 | 0.203 | 0.144 | 0.295 |
| RAS | Q61 | Thyroid | Black | 14 | 40 | 0.262 | 0.252 | 0.166 | 0.416 |
| RAS | Q61 | Thyroid | NA | 14 | 79 | 0.191 | 0.189 | 0.128 | 0.261 |
| RAS | Q61 | Thyroid | Other | 8 | 26 | 0.239 | 0.226 | 0.152 | 0.388 |
| RAS | Q61 | Thyroid | White | 132 | 803 | 0.170 | 0.170 | 0.145 | 0.197 |
| RAS | Q61 | Cervical | Asian | 0 | 27 | 0.006 | 0.005 | 0.000 | 0.022 |
| RAS | Q61 | Cervical | Black | 0 | 19 | 0.006 | 0.005 | 0.000 | 0.023 |
| RAS | Q61 | Cervical | NA | 1 | 77 | 0.007 | 0.006 | 0.001 | 0.024 |
| RAS | Q61 | Cervical | Other | 0 | 15 | 0.007 | 0.005 | 0.000 | 0.026 |
| RAS | Q61 | Cervical | White | 1 | 228 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | Q61 | Hepatobiliary | Asian | 2 | 98 | 0.025 | 0.024 | 0.011 | 0.039 |
| RAS | Q61 | Hepatobiliary | Black | 1 | 64 | 0.024 | 0.024 | 0.010 | 0.039 |
| RAS | Q61 | Hepatobiliary | NA | 6 | 235 | 0.025 | 0.025 | 0.014 | 0.039 |
| RAS | Q61 | Hepatobiliary | Other | 0 | 25 | 0.024 | 0.024 | 0.007 | 0.041 |
| RAS | Q61 | Hepatobiliary | White | 26 | 948 | 0.026 | 0.026 | 0.018 | 0.036 |
| RAS | Q61 | Kidney | Asian | 0 | 33 | 0.002 | 0.001 | 0.000 | 0.007 |
| RAS | Q61 | Kidney | Black | 0 | 77 | 0.002 | 0.001 | 0.000 | 0.006 |
| RAS | Q61 | Kidney | NA | 0 | 169 | 0.001 | 0.001 | 0.000 | 0.005 |
| RAS | Q61 | Kidney | Other | 0 | 29 | 0.002 | 0.001 | 0.000 | 0.007 |
| RAS | Q61 | Kidney | White | 2 | 1113 | 0.002 | 0.001 | 0.000 | 0.004 |
| RAS | Q61 | T / NK neoplasms | Asian | 0 | 12 | 0.016 | 0.013 | 0.000 | 0.054 |
| RAS | Q61 | T / NK neoplasms | Black | 0 | 18 | 0.015 | 0.012 | 0.000 | 0.049 |
| RAS | Q61 | T / NK neoplasms | NA | 0 | 10 | 0.016 | 0.013 | 0.000 | 0.057 |
| RAS | Q61 | T / NK neoplasms | White | 4 | 188 | 0.019 | 0.018 | 0.005 | 0.041 |
| RAS | Q61 | CNS | Asian | 2 | 154 | 0.009 | 0.008 | 0.003 | 0.023 |
| RAS | Q61 | CNS | Black | 1 | 131 | 0.008 | 0.008 | 0.002 | 0.019 |
| RAS | Q61 | CNS | NA | 12 | 817 | 0.011 | 0.011 | 0.006 | 0.020 |
| RAS | Q61 | CNS | Other | 0 | 108 | 0.007 | 0.007 | 0.001 | 0.016 |
| RAS | Q61 | CNS | Undefined | 0 | 17 | 0.009 | 0.007 | 0.001 | 0.025 |
| RAS | Q61 | CNS | White | 18 | 3331 | 0.006 | 0.006 | 0.004 | 0.009 |
| RAS | Q61 | Prostate | Asian | 1 | 62 | 0.011 | 0.009 | 0.003 | 0.029 |
| RAS | Q61 | Prostate | Black | 4 | 175 | 0.013 | 0.010 | 0.005 | 0.032 |
| RAS | Q61 | Prostate | NA | 1 | 289 | 0.008 | 0.008 | 0.002 | 0.015 |
| RAS | Q61 | Prostate | Other | 0 | 31 | 0.009 | 0.008 | 0.001 | 0.025 |
| RAS | Q61 | Prostate | White | 15 | 1882 | 0.008 | 0.008 | 0.005 | 0.013 |
| RAS | Q61 | Anal | NA | 0 | 13 | 0.010 | 0.005 | 0.000 | 0.052 |
| RAS | Q61 | Anal | White | 1 | 126 | 0.009 | 0.006 | 0.000 | 0.029 |
| RAS | Q61 | Neuroendocrine | Black | 0 | 23 | 0.010 | 0.008 | 0.000 | 0.035 |
| RAS | Q61 | Neuroendocrine | NA | 0 | 45 | 0.009 | 0.008 | 0.000 | 0.029 |
| RAS | Q61 | Neuroendocrine | White | 4 | 283 | 0.013 | 0.012 | 0.004 | 0.028 |
| RAS | Q61 | Bladder | Asian | 1 | 40 | 0.026 | 0.025 | 0.011 | 0.048 |
| RAS | Q61 | Bladder | Black | 0 | 43 | 0.024 | 0.024 | 0.008 | 0.041 |
| RAS | Q61 | Bladder | NA | 4 | 169 | 0.025 | 0.025 | 0.013 | 0.041 |
| RAS | Q61 | Bladder | Other | 1 | 14 | 0.028 | 0.026 | 0.013 | 0.062 |
| RAS | Q61 | Bladder | White | 34 | 1311 | 0.026 | 0.025 | 0.018 | 0.034 |
| RAS | Q61 | BLL/Lymphoma | Asian | 0 | 17 | 0.032 | 0.030 | 0.001 | 0.072 |
| RAS | Q61 | BLL/Lymphoma | NA | 4 | 92 | 0.037 | 0.035 | 0.014 | 0.074 |
| RAS | Q61 | BLL/Lymphoma | White | 4 | 125 | 0.034 | 0.032 | 0.013 | 0.063 |
| RAS | Q61 | Small bowel | Black | 4 | 25 | 0.122 | 0.110 | 0.024 | 0.289 |
| RAS | Q61 | Small bowel | NA | 0 | 22 | 0.022 | 0.015 | 0.000 | 0.085 |
| RAS | Q61 | Small bowel | White | 3 | 150 | 0.024 | 0.022 | 0.006 | 0.055 |
| RAS | Q61 | Sex cord stromal | NA | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | Q61 | Sex cord stromal | White | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | Q61 | Bone | Asian | 1 | 30 | 0.016 | 0.005 | 0.000 | 0.087 |
| RAS | Q61 | Bone | Black | 0 | 32 | 0.003 | 0.001 | 0.000 | 0.016 |
| RAS | Q61 | Bone | NA | 0 | 86 | 0.002 | 0.001 | 0.000 | 0.010 |
| RAS | Q61 | Bone | Other | 0 | 29 | 0.003 | 0.001 | 0.000 | 0.016 |
| RAS | Q61 | Bone | White | 0 | 391 | 0.001 | 0.001 | 0.000 | 0.006 |
| RAS | Q61 | Vaginal | White | 1 | 68 | 0.017 | 0.013 | 0.001 | 0.059 |
| RAS | Q61 | Thymic | Asian | 0 | 13 | 0.023 | 0.019 | 0.000 | 0.072 |
| RAS | Q61 | Thymic | NA | 0 | 23 | 0.021 | 0.018 | 0.000 | 0.065 |
| RAS | Q61 | Thymic | White | 4 | 108 | 0.032 | 0.029 | 0.009 | 0.070 |
| RAS | Q61 | Ampullary | White | 5 | 86 | 0.059 | 0.056 | 0.020 | 0.116 |
| RAS | Q61 | SCLC | Asian | 0 | 15 | 0.007 | 0.004 | 0.000 | 0.028 |
| RAS | Q61 | SCLC | NA | 0 | 30 | 0.006 | 0.004 | 0.000 | 0.023 |
| RAS | Q61 | SCLC | White | 2 | 337 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | Q61 | Mesothelioma | Asian | 0 | 11 | 0.004 | 0.002 | 0.000 | 0.020 |
| RAS | Q61 | Mesothelioma | Black | 0 | 10 | 0.004 | 0.002 | 0.000 | 0.022 |
| RAS | Q61 | Mesothelioma | NA | 0 | 32 | 0.003 | 0.002 | 0.000 | 0.015 |
| RAS | Q61 | Mesothelioma | White | 1 | 434 | 0.003 | 0.002 | 0.000 | 0.008 |
| RAS | Q61 | Germ cell | Asian | 0 | 36 | 0.011 | 0.010 | 0.001 | 0.024 |
| RAS | Q61 | Germ cell | Black | 0 | 23 | 0.011 | 0.010 | 0.001 | 0.025 |
| RAS | Q61 | Germ cell | NA | 2 | 179 | 0.011 | 0.011 | 0.004 | 0.022 |
| RAS | Q61 | Germ cell | Other | 0 | 37 | 0.011 | 0.010 | 0.001 | 0.024 |
| RAS | Q61 | Germ cell | White | 8 | 603 | 0.012 | 0.011 | 0.006 | 0.021 |
| RAS | Q61 | Nerve sheath | Black | 0 | 12 | 0.009 | 0.003 | 0.000 | 0.050 |
| RAS | Q61 | Nerve sheath | NA | 1 | 26 | 0.023 | 0.013 | 0.001 | 0.104 |
| RAS | Q61 | Nerve sheath | White | 0 | 105 | 0.005 | 0.002 | 0.000 | 0.023 |
| RAS | Q61 | Penile | White | 1 | 20 | 0.057 | 0.043 | 0.002 | 0.186 |
| RAS | Q61 | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.040 |
| RAS | Q61 | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| RAS | Q61 | B cell lymphoma | Asian | 0 | 21 | 0.026 | 0.026 | 0.002 | 0.061 |
| RAS | Q61 | B cell lymphoma | Black | 0 | 25 | 0.026 | 0.025 | 0.002 | 0.057 |
| RAS | Q61 | B cell lymphoma | NA | 3 | 42 | 0.039 | 0.032 | 0.016 | 0.103 |
| RAS | Q61 | B cell lymphoma | Other | 1 | 12 | 0.038 | 0.029 | 0.010 | 0.132 |
| RAS | Q61 | B cell lymphoma | White | 22 | 859 | 0.027 | 0.026 | 0.017 | 0.038 |
| RAS | Q61 | Non-hodgkin lymphoma | White | 1 | 19 | 0.059 | 0.044 | 0.002 | 0.197 |
| RAS | Q61 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.033 |
| RAS | Q61 | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.026 |
| RAS | Q61 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.023 |
| RAS | Q61 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.018 |
| RAS | Q61 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.009 |
| RAS | Q61 | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.030 |
| RAS | Q61 | Peritoneal | White | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.048 |
| RAS | Q61 | Parathyroid | White | 3 | 14 | 0.217 | 0.204 | 0.052 | 0.460 |
| RAS | 12, 13, or 61 | Appendiceal | Female | 81 | 174 | 0.483 | 0.485 | 0.407 | 0.552 |
| RAS | 12, 13, or 61 | Appendiceal | Male | 92 | 167 | 0.533 | 0.532 | 0.464 | 0.609 |
| RAS | 12, 13, or 61 | CRC | Female | 1425 | 3028 | 0.469 | 0.469 | 0.451 | 0.487 |
| RAS | 12, 13, or 61 | CRC | Male | 1499 | 3696 | 0.407 | 0.407 | 0.391 | 0.423 |
| RAS | 12, 13, or 61 | CUP | Female | 224 | 1000 | 0.219 | 0.219 | 0.196 | 0.246 |
| RAS | 12, 13, or 61 | CUP | Male | 192 | 989 | 0.199 | 0.199 | 0.174 | 0.223 |
| RAS | 12, 13, or 61 | NSCLC | Female | 1850 | 5722 | 0.323 | 0.323 | 0.311 | 0.335 |
| RAS | 12, 13, or 61 | NSCLC | Male | 1159 | 4406 | 0.264 | 0.264 | 0.251 | 0.277 |
| RAS | 12, 13, or 61 | Breast | Female | 96 | 9284 | 0.010 | 0.010 | 0.008 | 0.013 |
| RAS | 12, 13, or 61 | Breast | Male | 1 | 48 | 0.015 | 0.011 | 0.004 | 0.051 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Female | 32 | 1413 | 0.024 | 0.024 | 0.017 | 0.031 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Male | 37 | 1360 | 0.026 | 0.026 | 0.019 | 0.034 |
| RAS | 12, 13, or 61 | Pancreatic | Female | 855 | 1153 | 0.741 | 0.741 | 0.719 | 0.764 |
| RAS | 12, 13, or 61 | Pancreatic | Male | 993 | 1341 | 0.741 | 0.741 | 0.719 | 0.762 |
| RAS | 12, 13, or 61 | Leukemia | Female | 104 | 637 | 0.158 | 0.158 | 0.135 | 0.186 |
| RAS | 12, 13, or 61 | Leukemia | Male | 133 | 930 | 0.146 | 0.146 | 0.125 | 0.167 |
| RAS | 12, 13, or 61 | Melanoma | Female | 243 | 1104 | 0.224 | 0.223 | 0.199 | 0.249 |
| RAS | 12, 13, or 61 | Melanoma | Male | 478 | 1742 | 0.272 | 0.272 | 0.251 | 0.293 |
| RAS | 12, 13, or 61 | Head and neck | Female | 23 | 564 | 0.041 | 0.040 | 0.029 | 0.055 |
| RAS | 12, 13, or 61 | Head and neck | Male | 47 | 1179 | 0.040 | 0.040 | 0.030 | 0.051 |
| RAS | 12, 13, or 61 | Uterine | Female | 384 | 2254 | 0.170 | 0.170 | 0.155 | 0.186 |
| RAS | 12, 13, or 61 | Non-melanoma skin | Female | 1 | 183 | 0.010 | 0.007 | 0.000 | 0.033 |
| RAS | 12, 13, or 61 | Non-melanoma skin | Male | 17 | 330 | 0.050 | 0.049 | 0.028 | 0.076 |
| RAS | 12, 13, or 61 | MDS/MPN | Female | 27 | 483 | 0.058 | 0.057 | 0.041 | 0.075 |
| RAS | 12, 13, or 61 | MDS/MPN | Male | 44 | 724 | 0.060 | 0.059 | 0.046 | 0.076 |
| RAS | 12, 13, or 61 | Adrenocortical | Female | 1 | 80 | 0.011 | 0.007 | 0.000 | 0.039 |
| RAS | 12, 13, or 61 | Adrenocortical | Male | 0 | 54 | 0.006 | 0.003 | 0.000 | 0.030 |
| RAS | 12, 13, or 61 | Ovarian | Female | 260 | 2336 | 0.111 | 0.111 | 0.099 | 0.124 |
| RAS | 12, 13, or 61 | Esophagogastric | Female | 36 | 504 | 0.066 | 0.064 | 0.048 | 0.090 |
| RAS | 12, 13, or 61 | Esophagogastric | Male | 66 | 1297 | 0.053 | 0.053 | 0.042 | 0.066 |
| RAS | 12, 13, or 61 | Thyroid | Female | 105 | 537 | 0.196 | 0.195 | 0.167 | 0.226 |
| RAS | 12, 13, or 61 | Thyroid | Male | 94 | 480 | 0.196 | 0.196 | 0.166 | 0.227 |
| RAS | 12, 13, or 61 | Cervical | Female | 34 | 365 | 0.093 | 0.093 | 0.066 | 0.125 |
| RAS | 12, 13, or 61 | Hepatobiliary | Female | 80 | 636 | 0.125 | 0.125 | 0.104 | 0.149 |
| RAS | 12, 13, or 61 | Hepatobiliary | Male | 91 | 739 | 0.124 | 0.124 | 0.104 | 0.145 |
| RAS | 12, 13, or 61 | Kidney | Female | 4 | 420 | 0.010 | 0.009 | 0.004 | 0.018 |
| RAS | 12, 13, or 61 | Kidney | Male | 9 | 1002 | 0.009 | 0.009 | 0.005 | 0.015 |
| RAS | 12, 13, or 61 | T / NK neoplasms | Female | 2 | 107 | 0.022 | 0.020 | 0.006 | 0.048 |
| RAS | 12, 13, or 61 | T / NK neoplasms | Male | 3 | 124 | 0.023 | 0.021 | 0.007 | 0.050 |
| RAS | 12, 13, or 61 | CNS | Female | 24 | 1994 | 0.013 | 0.013 | 0.009 | 0.018 |
| RAS | 12, 13, or 61 | CNS | Male | 42 | 2569 | 0.015 | 0.015 | 0.011 | 0.020 |
| RAS | 12, 13, or 61 | Prostate | Male | 31 | 2436 | 0.013 | 0.013 | 0.009 | 0.018 |
| RAS | 12, 13, or 61 | Anal | Female | 3 | 102 | 0.033 | 0.031 | 0.010 | 0.069 |
| RAS | 12, 13, or 61 | Anal | Male | 2 | 47 | 0.038 | 0.034 | 0.010 | 0.088 |
| RAS | 12, 13, or 61 | Neuroendocrine | Female | 14 | 166 | 0.091 | 0.090 | 0.057 | 0.130 |
| RAS | 12, 13, or 61 | Neuroendocrine | Male | 20 | 193 | 0.099 | 0.097 | 0.066 | 0.139 |
| RAS | 12, 13, or 61 | Bladder | Female | 38 | 393 | 0.092 | 0.091 | 0.071 | 0.118 |
| RAS | 12, 13, or 61 | Bladder | Male | 100 | 1188 | 0.086 | 0.086 | 0.071 | 0.101 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | Female | 17 | 106 | 0.159 | 0.157 | 0.107 | 0.220 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | Male | 22 | 142 | 0.157 | 0.156 | 0.110 | 0.212 |
| RAS | 12, 13, or 61 | Small bowel | Female | 33 | 78 | 0.421 | 0.420 | 0.336 | 0.510 |
| RAS | 12, 13, or 61 | Small bowel | Male | 55 | 132 | 0.419 | 0.418 | 0.346 | 0.494 |
| RAS | 12, 13, or 61 | Sex cord stromal | Female | 3 | 97 | 0.030 | 0.027 | 0.007 | 0.069 |
| RAS | 12, 13, or 61 | Sex cord stromal | Male | 0 | 11 | 0.024 | 0.019 | 0.000 | 0.089 |
| RAS | 12, 13, or 61 | Bone | Female | 5 | 242 | 0.017 | 0.015 | 0.005 | 0.037 |
| RAS | 12, 13, or 61 | Bone | Male | 1 | 328 | 0.006 | 0.006 | 0.000 | 0.017 |
| RAS | 12, 13, or 61 | Vaginal | Female | 6 | 78 | 0.078 | 0.075 | 0.030 | 0.147 |
| RAS | 12, 13, or 61 | Thymic | Female | 3 | 70 | 0.041 | 0.038 | 0.013 | 0.085 |
| RAS | 12, 13, or 61 | Thymic | Male | 3 | 86 | 0.038 | 0.036 | 0.012 | 0.077 |
| RAS | 12, 13, or 61 | Ampullary | Female | 25 | 41 | 0.578 | 0.576 | 0.457 | 0.710 |
| RAS | 12, 13, or 61 | Ampullary | Male | 34 | 65 | 0.542 | 0.544 | 0.429 | 0.647 |
| RAS | 12, 13, or 61 | SCLC | Female | 8 | 193 | 0.039 | 0.038 | 0.020 | 0.066 |
| RAS | 12, 13, or 61 | SCLC | Male | 7 | 205 | 0.037 | 0.036 | 0.018 | 0.061 |
| RAS | 12, 13, or 61 | Mesothelioma | Female | 0 | 145 | 0.002 | 0.001 | 0.000 | 0.009 |
| RAS | 12, 13, or 61 | Mesothelioma | Male | 1 | 352 | 0.003 | 0.002 | 0.000 | 0.009 |
| RAS | 12, 13, or 61 | Germ cell | Female | 6 | 175 | 0.043 | 0.041 | 0.016 | 0.083 |
| RAS | 12, 13, or 61 | Germ cell | Male | 69 | 711 | 0.095 | 0.095 | 0.074 | 0.118 |
| RAS | 12, 13, or 61 | Nerve sheath | Female | 2 | 80 | 0.022 | 0.020 | 0.004 | 0.057 |
| RAS | 12, 13, or 61 | Nerve sheath | Male | 1 | 74 | 0.019 | 0.017 | 0.003 | 0.050 |
| RAS | 12, 13, or 61 | Penile | Male | 2 | 25 | 0.085 | 0.074 | 0.012 | 0.218 |
| RAS | 12, 13, or 61 | Pheochromocytoma | Male | 1 | 17 | 0.065 | 0.049 | 0.003 | 0.211 |
| RAS | 12, 13, or 61 | Pineal | Male | 1 | 12 | 0.092 | 0.071 | 0.004 | 0.302 |
| RAS | 12, 13, or 61 | B cell lymphoma | Female | 23 | 395 | 0.058 | 0.057 | 0.041 | 0.078 |
| RAS | 12, 13, or 61 | B cell lymphoma | Male | 32 | 567 | 0.057 | 0.057 | 0.041 | 0.075 |
| RAS | 12, 13, or 61 | Non-hodgkin lymphoma | Female | 1 | 12 | 0.122 | 0.110 | 0.017 | 0.294 |
| RAS | 12, 13, or 61 | Non-hodgkin lymphoma | Male | 2 | 11 | 0.148 | 0.133 | 0.031 | 0.355 |
| RAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Female | 1 | 12 | 0.100 | 0.091 | 0.017 | 0.240 |
| RAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Male | 3 | 28 | 0.104 | 0.097 | 0.029 | 0.221 |
| RAS | 12, 13, or 61 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | 12, 13, or 61 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | 12, 13, or 61 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.011 |
| RAS | 12, 13, or 61 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.010 |
| RAS | 12, 13, or 61 | Lung | Male | 3 | 16 | 0.191 | 0.178 | 0.045 | 0.407 |
| RAS | 12, 13, or 61 | Blastic plasmacytoid dendritic cell neoplasm | Male | 4 | 11 | 0.367 | 0.357 | 0.128 | 0.651 |
| RAS | 12, 13, or 61 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.033 |
| RAS | G12 | Appendiceal | Female | 72 | 174 | 0.424 | 0.425 | 0.358 | 0.488 |
| RAS | G12 | Appendiceal | Male | 76 | 167 | 0.445 | 0.444 | 0.380 | 0.514 |
| RAS | G12 | CRC | Female | 1022 | 3028 | 0.336 | 0.336 | 0.319 | 0.353 |
| RAS | G12 | CRC | Male | 1081 | 3696 | 0.294 | 0.294 | 0.279 | 0.309 |
| RAS | G12 | CUP | Female | 178 | 1000 | 0.174 | 0.173 | 0.152 | 0.198 |
| RAS | G12 | CUP | Male | 146 | 989 | 0.152 | 0.152 | 0.130 | 0.174 |
| RAS | G12 | NSCLC | Female | 1572 | 5722 | 0.274 | 0.274 | 0.262 | 0.286 |
| RAS | G12 | NSCLC | Male | 981 | 4406 | 0.224 | 0.224 | 0.211 | 0.236 |
| RAS | G12 | Breast | Female | 75 | 9284 | 0.008 | 0.008 | 0.006 | 0.010 |
| RAS | G12 | Breast | Male | 0 | 48 | 0.007 | 0.007 | 0.000 | 0.023 |
| RAS | G12 | Soft tissue sarcoma | Female | 18 | 1413 | 0.012 | 0.011 | 0.007 | 0.017 |
| RAS | G12 | Soft tissue sarcoma | Male | 11 | 1360 | 0.009 | 0.009 | 0.005 | 0.014 |
| RAS | G12 | Pancreatic | Female | 780 | 1153 | 0.675 | 0.675 | 0.651 | 0.700 |
| RAS | G12 | Pancreatic | Male | 900 | 1341 | 0.672 | 0.672 | 0.649 | 0.695 |
| RAS | G12 | Leukemia | Female | 63 | 637 | 0.095 | 0.094 | 0.076 | 0.117 |
| RAS | G12 | Leukemia | Male | 78 | 930 | 0.087 | 0.087 | 0.070 | 0.104 |
| RAS | G12 | Melanoma | Female | 30 | 1104 | 0.028 | 0.027 | 0.020 | 0.036 |
| RAS | G12 | Melanoma | Male | 49 | 1742 | 0.028 | 0.028 | 0.022 | 0.035 |
| RAS | G12 | Head and neck | Female | 11 | 564 | 0.017 | 0.017 | 0.010 | 0.028 |
| RAS | G12 | Head and neck | Male | 16 | 1179 | 0.015 | 0.015 | 0.009 | 0.022 |
| RAS | G12 | Uterine | Female | 299 | 2254 | 0.133 | 0.133 | 0.119 | 0.147 |
| RAS | G12 | Non-melanoma skin | Female | 1 | 183 | 0.012 | 0.011 | 0.001 | 0.029 |
| RAS | G12 | Non-melanoma skin | Male | 8 | 330 | 0.021 | 0.020 | 0.009 | 0.039 |
| RAS | G12 | MDS/MPN | Female | 18 | 483 | 0.039 | 0.039 | 0.026 | 0.054 |
| RAS | G12 | MDS/MPN | Male | 31 | 724 | 0.042 | 0.041 | 0.030 | 0.056 |
| RAS | G12 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12 | Ovarian | Female | 205 | 2336 | 0.088 | 0.088 | 0.077 | 0.100 |
| RAS | G12 | Esophagogastric | Female | 24 | 504 | 0.043 | 0.042 | 0.030 | 0.062 |
| RAS | G12 | Esophagogastric | Male | 44 | 1297 | 0.036 | 0.036 | 0.027 | 0.046 |
| RAS | G12 | Thyroid | Female | 4 | 537 | 0.010 | 0.010 | 0.003 | 0.019 |
| RAS | G12 | Thyroid | Male | 9 | 480 | 0.016 | 0.015 | 0.008 | 0.029 |
| RAS | G12 | Cervical | Female | 28 | 365 | 0.077 | 0.076 | 0.052 | 0.106 |
| RAS | G12 | Hepatobiliary | Female | 56 | 636 | 0.089 | 0.089 | 0.071 | 0.108 |
| RAS | G12 | Hepatobiliary | Male | 67 | 739 | 0.090 | 0.090 | 0.073 | 0.109 |
| RAS | G12 | Kidney | Female | 2 | 420 | 0.007 | 0.007 | 0.002 | 0.014 |
| RAS | G12 | Kidney | Male | 9 | 1002 | 0.008 | 0.008 | 0.004 | 0.014 |
| RAS | G12 | T / NK neoplasms | Female | 1 | 107 | 0.007 | 0.005 | 0.000 | 0.028 |
| RAS | G12 | T / NK neoplasms | Male | 0 | 124 | 0.003 | 0.002 | 0.000 | 0.016 |
| RAS | G12 | CNS | Female | 14 | 1994 | 0.007 | 0.006 | 0.004 | 0.010 |
| RAS | G12 | CNS | Male | 14 | 2569 | 0.006 | 0.006 | 0.004 | 0.009 |
| RAS | G12 | Prostate | Male | 6 | 2436 | 0.003 | 0.002 | 0.001 | 0.005 |
| RAS | G12 | Anal | Female | 0 | 102 | 0.005 | 0.001 | 0.000 | 0.027 |
| RAS | G12 | Anal | Male | 2 | 47 | 0.035 | 0.027 | 0.004 | 0.106 |
| RAS | G12 | Neuroendocrine | Female | 11 | 166 | 0.069 | 0.068 | 0.041 | 0.103 |
| RAS | G12 | Neuroendocrine | Male | 14 | 193 | 0.071 | 0.070 | 0.044 | 0.106 |
| RAS | G12 | Bladder | Female | 22 | 393 | 0.055 | 0.054 | 0.039 | 0.074 |
| RAS | G12 | Bladder | Male | 62 | 1188 | 0.053 | 0.053 | 0.042 | 0.065 |
| RAS | G12 | BLL/Lymphoma | Female | 11 | 106 | 0.100 | 0.098 | 0.060 | 0.152 |
| RAS | G12 | BLL/Lymphoma | Male | 13 | 142 | 0.096 | 0.094 | 0.058 | 0.140 |
| RAS | G12 | Small bowel | Female | 25 | 78 | 0.320 | 0.318 | 0.241 | 0.406 |
| RAS | G12 | Small bowel | Male | 42 | 132 | 0.319 | 0.318 | 0.251 | 0.390 |
| RAS | G12 | Sex cord stromal | Female | 2 | 97 | 0.021 | 0.018 | 0.003 | 0.056 |
| RAS | G12 | Sex cord stromal | Male | 0 | 11 | 0.019 | 0.012 | 0.000 | 0.076 |
| RAS | G12 | Bone | Female | 4 | 242 | 0.013 | 0.011 | 0.004 | 0.031 |
| RAS | G12 | Bone | Male | 1 | 328 | 0.006 | 0.006 | 0.001 | 0.016 |
| RAS | G12 | Vaginal | Female | 4 | 78 | 0.053 | 0.050 | 0.016 | 0.112 |
| RAS | G12 | Thymic | Female | 0 | 70 | 0.006 | 0.003 | 0.000 | 0.025 |
| RAS | G12 | Thymic | Male | 1 | 86 | 0.010 | 0.007 | 0.000 | 0.035 |
| RAS | G12 | Ampullary | Female | 19 | 41 | 0.469 | 0.469 | 0.351 | 0.586 |
| RAS | G12 | Ampullary | Male | 31 | 65 | 0.474 | 0.474 | 0.369 | 0.581 |
| RAS | G12 | SCLC | Female | 7 | 193 | 0.033 | 0.031 | 0.016 | 0.058 |
| RAS | G12 | SCLC | Male | 5 | 205 | 0.029 | 0.028 | 0.012 | 0.050 |
| RAS | G12 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Germ cell | Female | 4 | 175 | 0.031 | 0.028 | 0.009 | 0.067 |
| RAS | G12 | Germ cell | Male | 54 | 711 | 0.074 | 0.074 | 0.056 | 0.095 |
| RAS | G12 | Nerve sheath | Female | 1 | 80 | 0.010 | 0.007 | 0.000 | 0.036 |
| RAS | G12 | Nerve sheath | Male | 0 | 74 | 0.006 | 0.003 | 0.000 | 0.024 |
| RAS | G12 | Penile | Male | 1 | 25 | 0.045 | 0.034 | 0.002 | 0.153 |
| RAS | G12 | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.038 |
| RAS | G12 | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.036 |
| RAS | G12 | B cell lymphoma | Female | 7 | 395 | 0.019 | 0.018 | 0.009 | 0.030 |
| RAS | G12 | B cell lymphoma | Male | 11 | 567 | 0.019 | 0.019 | 0.011 | 0.030 |
| RAS | G12 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.034 | 0.019 | 0.000 | 0.149 |
| RAS | G12 | Non-hodgkin lymphoma | Male | 1 | 11 | 0.066 | 0.047 | 0.003 | 0.241 |
| RAS | G12 | T-lymphoblastic leukemia/lymphoma | Female | 1 | 12 | 0.083 | 0.072 | 0.011 | 0.221 |
| RAS | G12 | T-lymphoblastic leukemia/lymphoma | Male | 2 | 28 | 0.077 | 0.070 | 0.015 | 0.181 |
| RAS | G12 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.015 |
| RAS | G12 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.013 |
| RAS | G12 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G12 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G12 | Lung | Male | 2 | 16 | 0.131 | 0.116 | 0.020 | 0.323 |
| RAS | G12 | Blastic plasmacytoid dendritic cell neoplasm | Male | 3 | 11 | 0.278 | 0.264 | 0.071 | 0.556 |
| RAS | G12 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G12C | Appendiceal | Female | 3 | 174 | 0.014 | 0.013 | 0.004 | 0.034 |
| RAS | G12C | Appendiceal | Male | 1 | 167 | 0.011 | 0.009 | 0.001 | 0.026 |
| RAS | G12C | CRC | Female | 41 | 3028 | 0.013 | 0.013 | 0.010 | 0.017 |
| RAS | G12C | CRC | Male | 43 | 3696 | 0.012 | 0.012 | 0.009 | 0.015 |
| RAS | G12C | CUP | Female | 15 | 1000 | 0.013 | 0.013 | 0.008 | 0.021 |
| RAS | G12C | CUP | Male | 7 | 989 | 0.009 | 0.009 | 0.004 | 0.015 |
| RAS | G12C | NSCLC | Female | 287 | 5722 | 0.050 | 0.050 | 0.044 | 0.056 |
| RAS | G12C | NSCLC | Male | 154 | 4406 | 0.036 | 0.036 | 0.030 | 0.042 |
| RAS | G12C | Breast | Female | 4 | 9284 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Breast | Male | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.011 |
| RAS | G12C | Soft tissue sarcoma | Female | 1 | 1413 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G12C | Soft tissue sarcoma | Male | 1 | 1360 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G12C | Pancreatic | Female | 4 | 1153 | 0.004 | 0.004 | 0.001 | 0.007 |
| RAS | G12C | Pancreatic | Male | 5 | 1341 | 0.004 | 0.004 | 0.002 | 0.007 |
| RAS | G12C | Leukemia | Female | 2 | 637 | 0.003 | 0.003 | 0.001 | 0.008 |
| RAS | G12C | Leukemia | Male | 3 | 930 | 0.003 | 0.003 | 0.001 | 0.007 |
| RAS | G12C | Melanoma | Female | 5 | 1104 | 0.004 | 0.003 | 0.001 | 0.008 |
| RAS | G12C | Melanoma | Male | 2 | 1742 | 0.002 | 0.002 | 0.000 | 0.004 |
| RAS | G12C | Head and neck | Female | 1 | 564 | 0.002 | 0.001 | 0.000 | 0.005 |
| RAS | G12C | Head and neck | Male | 1 | 1179 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Uterine | Female | 7 | 2254 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12C | Non-melanoma skin | Female | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-melanoma skin | Male | 0 | 330 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | MDS/MPN | Female | 0 | 483 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | MDS/MPN | Male | 0 | 724 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Ovarian | Female | 3 | 2336 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Esophagogastric | Female | 1 | 504 | 0.002 | 0.001 | 0.000 | 0.006 |
| RAS | G12C | Esophagogastric | Male | 0 | 1297 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Thyroid | Female | 0 | 537 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | Male | 0 | 480 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Cervical | Female | 1 | 365 | 0.003 | 0.002 | 0.000 | 0.011 |
| RAS | G12C | Hepatobiliary | Female | 2 | 636 | 0.003 | 0.002 | 0.001 | 0.007 |
| RAS | G12C | Hepatobiliary | Male | 1 | 739 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G12C | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | T / NK neoplasms | Male | 0 | 124 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | CNS | Female | 1 | 1994 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | CNS | Male | 0 | 2569 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Prostate | Male | 0 | 2436 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12C | Neuroendocrine | Female | 1 | 166 | 0.006 | 0.005 | 0.001 | 0.019 |
| RAS | G12C | Neuroendocrine | Male | 1 | 193 | 0.006 | 0.005 | 0.001 | 0.018 |
| RAS | G12C | Bladder | Female | 1 | 393 | 0.003 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Bladder | Male | 3 | 1188 | 0.003 | 0.002 | 0.001 | 0.006 |
| RAS | G12C | BLL/Lymphoma | Female | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | BLL/Lymphoma | Male | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Small bowel | Female | 2 | 78 | 0.019 | 0.016 | 0.003 | 0.053 |
| RAS | G12C | Small bowel | Male | 1 | 132 | 0.013 | 0.011 | 0.001 | 0.034 |
| RAS | G12C | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Sex cord stromal | Male | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.006 |
| RAS | G12C | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Vaginal | Female | 1 | 78 | 0.015 | 0.011 | 0.001 | 0.050 |
| RAS | G12C | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Ampullary | Female | 0 | 41 | 0.008 | 0.004 | 0.000 | 0.037 |
| RAS | G12C | Ampullary | Male | 1 | 65 | 0.014 | 0.010 | 0.001 | 0.048 |
| RAS | G12C | SCLC | Female | 1 | 193 | 0.006 | 0.005 | 0.001 | 0.017 |
| RAS | G12C | SCLC | Male | 1 | 205 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | G12C | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Germ cell | Female | 0 | 175 | 0.002 | 0.001 | 0.000 | 0.007 |
| RAS | G12C | Germ cell | Male | 2 | 711 | 0.003 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Nerve sheath | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Nerve sheath | Male | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.023 |
| RAS | G12C | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G12C | Pineal | Male | 0 | 12 | 0.004 | 0.000 | 0.000 | 0.045 |
| RAS | G12C | B cell lymphoma | Female | 0 | 395 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | B cell lymphoma | Male | 0 | 567 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Non-hodgkin lymphoma | Female | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.031 |
| RAS | G12C | Non-hodgkin lymphoma | Male | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G12C | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.023 |
| RAS | G12C | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.002 | 0.000 | 0.000 | 0.019 |
| RAS | G12C | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G12C | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G12C | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.015 |
| RAS | G12C | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.013 |
| RAS | G12C | Lung | Male | 1 | 16 | 0.070 | 0.053 | 0.003 | 0.229 |
| RAS | G12C | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.056 |
| RAS | G12C | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.040 |
| RAS | G13 | Appendiceal | Female | 7 | 174 | 0.043 | 0.042 | 0.022 | 0.072 |
| RAS | G13 | Appendiceal | Male | 8 | 167 | 0.046 | 0.044 | 0.024 | 0.076 |
| RAS | G13 | CRC | Female | 274 | 3028 | 0.089 | 0.089 | 0.079 | 0.099 |
| RAS | G13 | CRC | Male | 291 | 3696 | 0.080 | 0.080 | 0.071 | 0.089 |
| RAS | G13 | CUP | Female | 24 | 1000 | 0.024 | 0.024 | 0.017 | 0.033 |
| RAS | G13 | CUP | Male | 24 | 989 | 0.024 | 0.024 | 0.017 | 0.033 |
| RAS | G13 | NSCLC | Female | 134 | 5722 | 0.023 | 0.023 | 0.019 | 0.027 |
| RAS | G13 | NSCLC | Male | 89 | 4406 | 0.021 | 0.021 | 0.017 | 0.025 |
| RAS | G13 | Breast | Female | 11 | 9284 | 0.001 | 0.001 | 0.001 | 0.002 |
| RAS | G13 | Breast | Male | 1 | 48 | 0.010 | 0.003 | 0.001 | 0.053 |
| RAS | G13 | Soft tissue sarcoma | Female | 2 | 1413 | 0.002 | 0.002 | 0.000 | 0.005 |
| RAS | G13 | Soft tissue sarcoma | Male | 7 | 1360 | 0.004 | 0.004 | 0.002 | 0.008 |
| RAS | G13 | Pancreatic | Female | 9 | 1153 | 0.008 | 0.008 | 0.005 | 0.013 |
| RAS | G13 | Pancreatic | Male | 12 | 1341 | 0.009 | 0.009 | 0.005 | 0.013 |
| RAS | G13 | Leukemia | Female | 29 | 637 | 0.045 | 0.044 | 0.033 | 0.059 |
| RAS | G13 | Leukemia | Male | 40 | 930 | 0.044 | 0.044 | 0.033 | 0.056 |
| RAS | G13 | Melanoma | Female | 15 | 1104 | 0.016 | 0.015 | 0.009 | 0.024 |
| RAS | G13 | Melanoma | Male | 47 | 1742 | 0.026 | 0.026 | 0.019 | 0.034 |
| RAS | G13 | Head and neck | Female | 7 | 564 | 0.012 | 0.011 | 0.006 | 0.020 |
| RAS | G13 | Head and neck | Male | 12 | 1179 | 0.011 | 0.011 | 0.006 | 0.017 |
| RAS | G13 | Uterine | Female | 54 | 2254 | 0.024 | 0.024 | 0.018 | 0.031 |
| RAS | G13 | Non-melanoma skin | Female | 0 | 183 | 0.003 | 0.002 | 0.000 | 0.013 |
| RAS | G13 | Non-melanoma skin | Male | 3 | 330 | 0.008 | 0.007 | 0.002 | 0.020 |
| RAS | G13 | MDS/MPN | Female | 12 | 483 | 0.023 | 0.022 | 0.014 | 0.036 |
| RAS | G13 | MDS/MPN | Male | 14 | 724 | 0.021 | 0.021 | 0.013 | 0.031 |
| RAS | G13 | Adrenocortical | Female | 1 | 80 | 0.011 | 0.008 | 0.000 | 0.038 |
| RAS | G13 | Adrenocortical | Male | 0 | 54 | 0.007 | 0.004 | 0.000 | 0.030 |
| RAS | G13 | Ovarian | Female | 12 | 2336 | 0.005 | 0.005 | 0.003 | 0.009 |
| RAS | G13 | Esophagogastric | Female | 10 | 504 | 0.017 | 0.016 | 0.009 | 0.029 |
| RAS | G13 | Esophagogastric | Male | 15 | 1297 | 0.013 | 0.013 | 0.008 | 0.019 |
| RAS | G13 | Thyroid | Female | 2 | 537 | 0.004 | 0.004 | 0.001 | 0.010 |
| RAS | G13 | Thyroid | Male | 2 | 480 | 0.004 | 0.004 | 0.001 | 0.010 |
| RAS | G13 | Cervical | Female | 4 | 365 | 0.011 | 0.010 | 0.003 | 0.024 |
| RAS | G13 | Hepatobiliary | Female | 5 | 636 | 0.009 | 0.009 | 0.004 | 0.016 |
| RAS | G13 | Hepatobiliary | Male | 8 | 739 | 0.010 | 0.010 | 0.005 | 0.017 |
| RAS | G13 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | T / NK neoplasms | Male | 0 | 124 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | CNS | Female | 0 | 1994 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | CNS | Male | 5 | 2569 | 0.002 | 0.002 | 0.001 | 0.004 |
| RAS | G13 | Prostate | Male | 4 | 2436 | 0.002 | 0.002 | 0.000 | 0.004 |
| RAS | G13 | Anal | Female | 2 | 102 | 0.017 | 0.014 | 0.002 | 0.047 |
| RAS | G13 | Anal | Male | 0 | 47 | 0.010 | 0.006 | 0.000 | 0.039 |
| RAS | G13 | Neuroendocrine | Female | 3 | 166 | 0.020 | 0.019 | 0.007 | 0.039 |
| RAS | G13 | Neuroendocrine | Male | 4 | 193 | 0.020 | 0.019 | 0.008 | 0.040 |
| RAS | G13 | Bladder | Female | 4 | 393 | 0.012 | 0.011 | 0.005 | 0.020 |
| RAS | G13 | Bladder | Male | 15 | 1188 | 0.012 | 0.012 | 0.007 | 0.019 |
| RAS | G13 | BLL/Lymphoma | Female | 4 | 106 | 0.049 | 0.048 | 0.018 | 0.087 |
| RAS | G13 | BLL/Lymphoma | Male | 10 | 142 | 0.063 | 0.060 | 0.033 | 0.105 |
| RAS | G13 | Small bowel | Female | 3 | 78 | 0.054 | 0.053 | 0.017 | 0.098 |
| RAS | G13 | Small bowel | Male | 10 | 132 | 0.068 | 0.065 | 0.035 | 0.112 |
| RAS | G13 | Sex cord stromal | Female | 1 | 97 | 0.011 | 0.008 | 0.001 | 0.039 |
| RAS | G13 | Sex cord stromal | Male | 0 | 11 | 0.012 | 0.006 | 0.000 | 0.062 |
| RAS | G13 | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Vaginal | Female | 1 | 78 | 0.015 | 0.011 | 0.001 | 0.052 |
| RAS | G13 | Thymic | Female | 1 | 70 | 0.011 | 0.008 | 0.000 | 0.043 |
| RAS | G13 | Thymic | Male | 0 | 86 | 0.005 | 0.003 | 0.000 | 0.023 |
| RAS | G13 | Ampullary | Female | 3 | 41 | 0.058 | 0.052 | 0.017 | 0.133 |
| RAS | G13 | Ampullary | Male | 2 | 65 | 0.043 | 0.040 | 0.010 | 0.094 |
| RAS | G13 | SCLC | Female | 1 | 193 | 0.004 | 0.003 | 0.000 | 0.016 |
| RAS | G13 | SCLC | Male | 0 | 205 | 0.002 | 0.001 | 0.000 | 0.009 |
| RAS | G13 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Germ cell | Female | 1 | 175 | 0.008 | 0.007 | 0.001 | 0.018 |
| RAS | G13 | Germ cell | Male | 6 | 711 | 0.008 | 0.008 | 0.003 | 0.016 |
| RAS | G13 | Nerve sheath | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G13 | Nerve sheath | Male | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G13 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| RAS | G13 | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.038 |
| RAS | G13 | Pineal | Male | 1 | 12 | 0.092 | 0.071 | 0.005 | 0.300 |
| RAS | G13 | B cell lymphoma | Female | 7 | 395 | 0.015 | 0.014 | 0.007 | 0.028 |
| RAS | G13 | B cell lymphoma | Male | 5 | 567 | 0.011 | 0.011 | 0.004 | 0.020 |
| RAS | G13 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.034 | 0.019 | 0.000 | 0.149 |
| RAS | G13 | Non-hodgkin lymphoma | Male | 1 | 11 | 0.066 | 0.047 | 0.003 | 0.241 |
| RAS | G13 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.025 | 0.015 | 0.000 | 0.106 |
| RAS | G13 | T-lymphoblastic leukemia/lymphoma | Male | 1 | 28 | 0.032 | 0.024 | 0.001 | 0.107 |
| RAS | G13 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.015 |
| RAS | G13 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.013 |
| RAS | G13 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G13 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G13 | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.039 |
| RAS | G13 | Blastic plasmacytoid dendritic cell neoplasm | Male | 1 | 11 | 0.101 | 0.078 | 0.005 | 0.319 |
| RAS | G13 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | Q61 | Appendiceal | Female | 2 | 174 | 0.019 | 0.018 | 0.003 | 0.043 |
| RAS | Q61 | Appendiceal | Male | 8 | 167 | 0.041 | 0.039 | 0.017 | 0.077 |
| RAS | Q61 | CRC | Female | 139 | 3028 | 0.045 | 0.044 | 0.038 | 0.052 |
| RAS | Q61 | CRC | Male | 136 | 3696 | 0.038 | 0.038 | 0.032 | 0.044 |
| RAS | Q61 | CUP | Female | 23 | 1000 | 0.023 | 0.023 | 0.016 | 0.032 |
| RAS | Q61 | CUP | Male | 23 | 989 | 0.023 | 0.023 | 0.016 | 0.032 |
| RAS | Q61 | NSCLC | Female | 148 | 5722 | 0.025 | 0.025 | 0.022 | 0.029 |
| RAS | Q61 | NSCLC | Male | 97 | 4406 | 0.023 | 0.023 | 0.019 | 0.027 |
| RAS | Q61 | Breast | Female | 10 | 9284 | 0.001 | 0.001 | 0.001 | 0.002 |
| RAS | Q61 | Breast | Male | 0 | 48 | 0.002 | 0.001 | 0.000 | 0.012 |
| RAS | Q61 | Soft tissue sarcoma | Female | 13 | 1413 | 0.011 | 0.011 | 0.006 | 0.016 |
| RAS | Q61 | Soft tissue sarcoma | Male | 20 | 1360 | 0.013 | 0.013 | 0.009 | 0.020 |
| RAS | Q61 | Pancreatic | Female | 69 | 1153 | 0.060 | 0.060 | 0.049 | 0.072 |
| RAS | Q61 | Pancreatic | Male | 81 | 1341 | 0.060 | 0.060 | 0.050 | 0.072 |
| RAS | Q61 | Leukemia | Female | 19 | 637 | 0.031 | 0.030 | 0.021 | 0.042 |
| RAS | Q61 | Leukemia | Male | 29 | 930 | 0.031 | 0.031 | 0.022 | 0.042 |
| RAS | Q61 | Melanoma | Female | 199 | 1104 | 0.184 | 0.184 | 0.161 | 0.209 |
| RAS | Q61 | Melanoma | Male | 385 | 1742 | 0.219 | 0.219 | 0.199 | 0.239 |
| RAS | Q61 | Head and neck | Female | 5 | 564 | 0.012 | 0.012 | 0.005 | 0.020 |
| RAS | Q61 | Head and neck | Male | 19 | 1179 | 0.015 | 0.015 | 0.009 | 0.022 |
| RAS | Q61 | Uterine | Female | 35 | 2254 | 0.016 | 0.015 | 0.011 | 0.021 |
| RAS | Q61 | Non-melanoma skin | Female | 0 | 183 | 0.003 | 0.000 | 0.000 | 0.016 |
| RAS | Q61 | Non-melanoma skin | Male | 6 | 330 | 0.017 | 0.016 | 0.006 | 0.034 |
| RAS | Q61 | MDS/MPN | Female | 1 | 483 | 0.003 | 0.003 | 0.000 | 0.008 |
| RAS | Q61 | MDS/MPN | Male | 3 | 724 | 0.004 | 0.003 | 0.001 | 0.009 |
| RAS | Q61 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | Q61 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | Q61 | Ovarian | Female | 44 | 2336 | 0.019 | 0.019 | 0.014 | 0.025 |
| RAS | Q61 | Esophagogastric | Female | 2 | 504 | 0.005 | 0.005 | 0.001 | 0.011 |
| RAS | Q61 | Esophagogastric | Male | 8 | 1297 | 0.006 | 0.006 | 0.003 | 0.010 |
| RAS | Q61 | Thyroid | Female | 99 | 537 | 0.182 | 0.181 | 0.155 | 0.212 |
| RAS | Q61 | Thyroid | Male | 83 | 480 | 0.176 | 0.176 | 0.147 | 0.206 |
| RAS | Q61 | Cervical | Female | 2 | 365 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | Q61 | Hepatobiliary | Female | 19 | 636 | 0.028 | 0.027 | 0.018 | 0.041 |
| RAS | Q61 | Hepatobiliary | Male | 16 | 739 | 0.024 | 0.024 | 0.015 | 0.034 |
| RAS | Q61 | Kidney | Female | 2 | 420 | 0.004 | 0.003 | 0.000 | 0.012 |
| RAS | Q61 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | Q61 | T / NK neoplasms | Female | 1 | 107 | 0.016 | 0.014 | 0.002 | 0.039 |
| RAS | Q61 | T / NK neoplasms | Male | 3 | 124 | 0.021 | 0.019 | 0.005 | 0.048 |
| RAS | Q61 | CNS | Female | 10 | 1994 | 0.006 | 0.006 | 0.003 | 0.010 |
| RAS | Q61 | CNS | Male | 23 | 2569 | 0.008 | 0.008 | 0.005 | 0.012 |
| RAS | Q61 | Prostate | Male | 21 | 2436 | 0.009 | 0.009 | 0.005 | 0.013 |
| RAS | Q61 | Anal | Female | 1 | 102 | 0.009 | 0.006 | 0.000 | 0.031 |
| RAS | Q61 | Anal | Male | 0 | 47 | 0.007 | 0.004 | 0.000 | 0.029 |
| RAS | Q61 | Neuroendocrine | Female | 0 | 166 | 0.004 | 0.001 | 0.000 | 0.018 |
| RAS | Q61 | Neuroendocrine | Male | 4 | 193 | 0.019 | 0.017 | 0.005 | 0.042 |
| RAS | Q61 | Bladder | Female | 12 | 393 | 0.028 | 0.027 | 0.017 | 0.043 |
| RAS | Q61 | Bladder | Male | 28 | 1188 | 0.025 | 0.024 | 0.017 | 0.034 |
| RAS | Q61 | BLL/Lymphoma | Female | 4 | 106 | 0.035 | 0.033 | 0.014 | 0.068 |
| RAS | Q61 | BLL/Lymphoma | Male | 4 | 142 | 0.032 | 0.030 | 0.012 | 0.060 |
| RAS | Q61 | Small bowel | Female | 5 | 78 | 0.051 | 0.046 | 0.018 | 0.108 |
| RAS | Q61 | Small bowel | Male | 3 | 132 | 0.032 | 0.030 | 0.009 | 0.064 |
| RAS | Q61 | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | Q61 | Sex cord stromal | Male | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.006 |
| RAS | Q61 | Bone | Female | 1 | 242 | 0.003 | 0.002 | 0.000 | 0.013 |
| RAS | Q61 | Bone | Male | 0 | 328 | 0.001 | 0.001 | 0.000 | 0.006 |
| RAS | Q61 | Vaginal | Female | 1 | 78 | 0.015 | 0.011 | 0.001 | 0.050 |
| RAS | Q61 | Thymic | Female | 2 | 70 | 0.028 | 0.025 | 0.007 | 0.066 |
| RAS | Q61 | Thymic | Male | 2 | 86 | 0.027 | 0.024 | 0.006 | 0.061 |
| RAS | Q61 | Ampullary | Female | 3 | 41 | 0.057 | 0.052 | 0.016 | 0.133 |
| RAS | Q61 | Ampullary | Male | 2 | 65 | 0.043 | 0.040 | 0.010 | 0.094 |
| RAS | Q61 | SCLC | Female | 0 | 193 | 0.003 | 0.002 | 0.000 | 0.013 |
| RAS | Q61 | SCLC | Male | 2 | 205 | 0.008 | 0.006 | 0.001 | 0.023 |
| RAS | Q61 | Mesothelioma | Female | 0 | 145 | 0.002 | 0.001 | 0.000 | 0.009 |
| RAS | Q61 | Mesothelioma | Male | 1 | 352 | 0.003 | 0.002 | 0.000 | 0.009 |
| RAS | Q61 | Germ cell | Female | 2 | 175 | 0.013 | 0.012 | 0.004 | 0.026 |
| RAS | Q61 | Germ cell | Male | 9 | 711 | 0.013 | 0.012 | 0.006 | 0.021 |
| RAS | Q61 | Nerve sheath | Female | 1 | 80 | 0.014 | 0.012 | 0.002 | 0.041 |
| RAS | Q61 | Nerve sheath | Male | 1 | 74 | 0.015 | 0.012 | 0.002 | 0.043 |
| RAS | Q61 | Penile | Male | 1 | 25 | 0.046 | 0.034 | 0.002 | 0.155 |
| RAS | Q61 | Pheochromocytoma | Male | 1 | 17 | 0.065 | 0.049 | 0.003 | 0.214 |
| RAS | Q61 | Pineal | Male | 0 | 12 | 0.004 | 0.000 | 0.000 | 0.045 |
| RAS | Q61 | B cell lymphoma | Female | 9 | 395 | 0.026 | 0.025 | 0.013 | 0.039 |
| RAS | Q61 | B cell lymphoma | Male | 17 | 567 | 0.028 | 0.028 | 0.018 | 0.042 |
| RAS | Q61 | Non-hodgkin lymphoma | Female | 1 | 12 | 0.063 | 0.045 | 0.003 | 0.224 |
| RAS | Q61 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.035 | 0.021 | 0.000 | 0.154 |
| RAS | Q61 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.023 |
| RAS | Q61 | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.002 | 0.000 | 0.000 | 0.019 |
| RAS | Q61 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | Q61 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | Q61 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.015 |
| RAS | Q61 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.013 |
| RAS | Q61 | Lung | Male | 1 | 16 | 0.070 | 0.053 | 0.003 | 0.229 |
| RAS | Q61 | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.056 |
| RAS | Q61 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.040 |
| RAS | 12, 13, or 61 | Appendiceal | Metastasis | 82 | 174 | 0.485 | 0.486 | 0.413 | 0.552 |
| RAS | 12, 13, or 61 | Appendiceal | Not Applicable or Heme | 3 | 10 | 0.455 | 0.479 | 0.202 | 0.597 |
| RAS | 12, 13, or 61 | Appendiceal | Primary | 85 | 151 | 0.537 | 0.536 | 0.465 | 0.618 |
| RAS | 12, 13, or 61 | CRC | Metastasis | 1051 | 2354 | 0.443 | 0.443 | 0.425 | 0.462 |
| RAS | 12, 13, or 61 | CRC | Not Applicable or Heme | 96 | 224 | 0.434 | 0.434 | 0.393 | 0.472 |
| RAS | 12, 13, or 61 | CRC | Primary | 1763 | 4115 | 0.430 | 0.430 | 0.415 | 0.445 |
| RAS | 12, 13, or 61 | CRC | Unspecified | 14 | 31 | 0.437 | 0.436 | 0.381 | 0.498 |
| RAS | 12, 13, or 61 | CUP | Metastasis | 288 | 1389 | 0.208 | 0.208 | 0.188 | 0.229 |
| RAS | 12, 13, or 61 | CUP | Not Applicable or Heme | 62 | 229 | 0.245 | 0.243 | 0.198 | 0.307 |
| RAS | 12, 13, or 61 | CUP | Primary | 52 | 311 | 0.186 | 0.186 | 0.143 | 0.225 |
| RAS | 12, 13, or 61 | CUP | Unspecified | 14 | 60 | 0.221 | 0.217 | 0.159 | 0.300 |
| RAS | 12, 13, or 61 | NSCLC | Metastasis | 1008 | 3750 | 0.269 | 0.269 | 0.255 | 0.283 |
| RAS | 12, 13, or 61 | NSCLC | Not Applicable or Heme | 56 | 223 | 0.254 | 0.254 | 0.203 | 0.307 |
| RAS | 12, 13, or 61 | NSCLC | Primary | 1930 | 6059 | 0.318 | 0.318 | 0.306 | 0.330 |
| RAS | 12, 13, or 61 | NSCLC | Unspecified | 15 | 99 | 0.193 | 0.192 | 0.115 | 0.274 |
| RAS | 12, 13, or 61 | Breast | Metastasis | 45 | 3094 | 0.014 | 0.014 | 0.011 | 0.019 |
| RAS | 12, 13, or 61 | Breast | Not Applicable or Heme | 5 | 105 | 0.035 | 0.031 | 0.010 | 0.081 |
| RAS | 12, 13, or 61 | Breast | Primary | 46 | 6125 | 0.008 | 0.008 | 0.006 | 0.010 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Metastasis | 20 | 939 | 0.024 | 0.023 | 0.016 | 0.031 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Not Applicable or Heme | 3 | 119 | 0.025 | 0.024 | 0.014 | 0.039 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Primary | 46 | 1686 | 0.026 | 0.026 | 0.020 | 0.033 |
| RAS | 12, 13, or 61 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.024 | 0.024 | 0.009 | 0.038 |
| RAS | 12, 13, or 61 | Pancreatic | Metastasis | 710 | 981 | 0.729 | 0.730 | 0.701 | 0.754 |
| RAS | 12, 13, or 61 | Pancreatic | Not Applicable or Heme | 53 | 75 | 0.730 | 0.734 | 0.654 | 0.782 |
| RAS | 12, 13, or 61 | Pancreatic | Primary | 1081 | 1429 | 0.751 | 0.751 | 0.730 | 0.773 |
| RAS | 12, 13, or 61 | Leukemia | Metastasis | 5 | 15 | 0.173 | 0.160 | 0.123 | 0.321 |
| RAS | 12, 13, or 61 | Leukemia | Not Applicable or Heme | 139 | 923 | 0.152 | 0.151 | 0.131 | 0.173 |
| RAS | 12, 13, or 61 | Leukemia | Primary | 55 | 412 | 0.145 | 0.145 | 0.115 | 0.171 |
| RAS | 12, 13, or 61 | Leukemia | Unspecified | 38 | 217 | 0.162 | 0.159 | 0.131 | 0.208 |
| RAS | 12, 13, or 61 | Melanoma | Metastasis | 468 | 1738 | 0.267 | 0.267 | 0.246 | 0.289 |
| RAS | 12, 13, or 61 | Melanoma | Not Applicable or Heme | 39 | 188 | 0.214 | 0.215 | 0.158 | 0.268 |
| RAS | 12, 13, or 61 | Melanoma | Primary | 214 | 898 | 0.239 | 0.239 | 0.211 | 0.266 |
| RAS | 12, 13, or 61 | Melanoma | Unspecified | 0 | 22 | 0.127 | 0.121 | 0.001 | 0.265 |
| RAS | 12, 13, or 61 | Head and neck | Metastasis | 20 | 731 | 0.032 | 0.032 | 0.020 | 0.046 |
| RAS | 12, 13, or 61 | Head and neck | Not Applicable or Heme | 4 | 67 | 0.047 | 0.043 | 0.023 | 0.094 |
| RAS | 12, 13, or 61 | Head and neck | Primary | 46 | 938 | 0.046 | 0.046 | 0.034 | 0.061 |
| RAS | 12, 13, or 61 | Uterine | Metastasis | 90 | 586 | 0.163 | 0.163 | 0.136 | 0.187 |
| RAS | 12, 13, or 61 | Uterine | Not Applicable or Heme | 13 | 76 | 0.171 | 0.170 | 0.129 | 0.218 |
| RAS | 12, 13, or 61 | Uterine | Primary | 270 | 1541 | 0.173 | 0.173 | 0.156 | 0.191 |
| RAS | 12, 13, or 61 | Uterine | Unspecified | 11 | 51 | 0.176 | 0.173 | 0.137 | 0.238 |
| RAS | 12, 13, or 61 | Non-melanoma skin | Metastasis | 8 | 203 | 0.038 | 0.036 | 0.020 | 0.062 |
| RAS | 12, 13, or 61 | Non-melanoma skin | Not Applicable or Heme | 2 | 22 | 0.045 | 0.038 | 0.019 | 0.123 |
| RAS | 12, 13, or 61 | Non-melanoma skin | Primary | 8 | 287 | 0.033 | 0.033 | 0.017 | 0.053 |
| RAS | 12, 13, or 61 | MDS/MPN | Metastasis | 1 | 11 | 0.072 | 0.064 | 0.025 | 0.170 |
| RAS | 12, 13, or 61 | MDS/MPN | Not Applicable or Heme | 45 | 915 | 0.053 | 0.053 | 0.039 | 0.068 |
| RAS | 12, 13, or 61 | MDS/MPN | Primary | 23 | 250 | 0.079 | 0.078 | 0.051 | 0.118 |
| RAS | 12, 13, or 61 | MDS/MPN | Unspecified | 2 | 31 | 0.066 | 0.063 | 0.026 | 0.130 |
| RAS | 12, 13, or 61 | Adrenocortical | Metastasis | 1 | 55 | 0.014 | 0.010 | 0.001 | 0.055 |
| RAS | 12, 13, or 61 | Adrenocortical | Primary | 0 | 72 | 0.006 | 0.003 | 0.000 | 0.027 |
| RAS | 12, 13, or 61 | Ovarian | Metastasis | 106 | 1088 | 0.103 | 0.103 | 0.085 | 0.120 |
| RAS | 12, 13, or 61 | Ovarian | Not Applicable or Heme | 16 | 160 | 0.108 | 0.109 | 0.076 | 0.140 |
| RAS | 12, 13, or 61 | Ovarian | Primary | 133 | 1060 | 0.120 | 0.120 | 0.103 | 0.141 |
| RAS | 12, 13, or 61 | Ovarian | Unspecified | 5 | 28 | 0.121 | 0.115 | 0.081 | 0.197 |
| RAS | 12, 13, or 61 | Esophagogastric | Metastasis | 25 | 462 | 0.056 | 0.056 | 0.041 | 0.072 |
| RAS | 12, 13, or 61 | Esophagogastric | Not Applicable or Heme | 2 | 43 | 0.056 | 0.056 | 0.031 | 0.083 |
| RAS | 12, 13, or 61 | Esophagogastric | Primary | 74 | 1283 | 0.057 | 0.057 | 0.046 | 0.069 |
| RAS | 12, 13, or 61 | Esophagogastric | Unspecified | 1 | 14 | 0.058 | 0.056 | 0.031 | 0.096 |
| RAS | 12, 13, or 61 | Thyroid | Metastasis | 63 | 402 | 0.169 | 0.169 | 0.131 | 0.207 |
| RAS | 12, 13, or 61 | Thyroid | Not Applicable or Heme | 7 | 28 | 0.213 | 0.203 | 0.134 | 0.337 |
| RAS | 12, 13, or 61 | Thyroid | Primary | 127 | 582 | 0.212 | 0.211 | 0.180 | 0.247 |
| RAS | 12, 13, or 61 | Cervical | Metastasis | 17 | 136 | 0.107 | 0.104 | 0.066 | 0.165 |
| RAS | 12, 13, or 61 | Cervical | Not Applicable or Heme | 1 | 12 | 0.093 | 0.088 | 0.027 | 0.197 |
| RAS | 12, 13, or 61 | Cervical | Primary | 14 | 211 | 0.078 | 0.077 | 0.045 | 0.115 |
| RAS | 12, 13, or 61 | Hepatobiliary | Metastasis | 62 | 438 | 0.134 | 0.132 | 0.109 | 0.165 |
| RAS | 12, 13, or 61 | Hepatobiliary | Not Applicable or Heme | 5 | 34 | 0.131 | 0.128 | 0.087 | 0.201 |
| RAS | 12, 13, or 61 | Hepatobiliary | Primary | 103 | 895 | 0.120 | 0.120 | 0.100 | 0.140 |
| RAS | 12, 13, or 61 | Kidney | Metastasis | 5 | 445 | 0.010 | 0.009 | 0.005 | 0.019 |
| RAS | 12, 13, or 61 | Kidney | Not Applicable or Heme | 0 | 24 | 0.010 | 0.009 | 0.000 | 0.024 |
| RAS | 12, 13, or 61 | Kidney | Primary | 8 | 944 | 0.009 | 0.009 | 0.005 | 0.015 |
| RAS | 12, 13, or 61 | T / NK neoplasms | Metastasis | 0 | 10 | 0.020 | 0.017 | 0.000 | 0.068 |
| RAS | 12, 13, or 61 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.017 | 0.015 | 0.000 | 0.050 |
| RAS | 12, 13, or 61 | T / NK neoplasms | Primary | 5 | 187 | 0.024 | 0.022 | 0.008 | 0.049 |
| RAS | 12, 13, or 61 | CNS | Metastasis | 8 | 409 | 0.016 | 0.015 | 0.010 | 0.026 |
| RAS | 12, 13, or 61 | CNS | Not Applicable or Heme | 6 | 526 | 0.014 | 0.014 | 0.008 | 0.021 |
| RAS | 12, 13, or 61 | CNS | Primary | 50 | 3522 | 0.015 | 0.014 | 0.011 | 0.018 |
| RAS | 12, 13, or 61 | CNS | Unspecified | 3 | 108 | 0.017 | 0.015 | 0.010 | 0.033 |
| RAS | 12, 13, or 61 | Prostate | Metastasis | 11 | 901 | 0.013 | 0.013 | 0.008 | 0.019 |
| RAS | 12, 13, or 61 | Prostate | Not Applicable or Heme | 0 | 57 | 0.013 | 0.012 | 0.001 | 0.024 |
| RAS | 12, 13, or 61 | Prostate | Primary | 20 | 1468 | 0.013 | 0.013 | 0.009 | 0.019 |
| RAS | 12, 13, or 61 | Prostate | Unspecified | 1 | 12 | 0.020 | 0.014 | 0.007 | 0.092 |
| RAS | 12, 13, or 61 | Anal | Metastasis | 2 | 59 | 0.036 | 0.033 | 0.009 | 0.079 |
| RAS | 12, 13, or 61 | Anal | Primary | 3 | 84 | 0.036 | 0.033 | 0.011 | 0.078 |
| RAS | 12, 13, or 61 | Neuroendocrine | Metastasis | 11 | 143 | 0.090 | 0.089 | 0.054 | 0.129 |
| RAS | 12, 13, or 61 | Neuroendocrine | Not Applicable or Heme | 3 | 20 | 0.105 | 0.098 | 0.056 | 0.205 |
| RAS | 12, 13, or 61 | Neuroendocrine | Primary | 20 | 196 | 0.098 | 0.097 | 0.066 | 0.136 |
| RAS | 12, 13, or 61 | Bladder | Metastasis | 28 | 390 | 0.080 | 0.081 | 0.056 | 0.102 |
| RAS | 12, 13, or 61 | Bladder | Not Applicable or Heme | 3 | 25 | 0.092 | 0.088 | 0.053 | 0.164 |
| RAS | 12, 13, or 61 | Bladder | Primary | 107 | 1164 | 0.090 | 0.089 | 0.075 | 0.106 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.096 | 0.093 | 0.001 | 0.222 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | Not Applicable or Heme | 21 | 109 | 0.183 | 0.180 | 0.121 | 0.259 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | Primary | 10 | 101 | 0.115 | 0.112 | 0.058 | 0.183 |
| RAS | 12, 13, or 61 | BLL/Lymphoma | Unspecified | 8 | 25 | 0.252 | 0.239 | 0.123 | 0.452 |
| RAS | 12, 13, or 61 | Small bowel | Metastasis | 34 | 78 | 0.428 | 0.427 | 0.342 | 0.520 |
| RAS | 12, 13, or 61 | Small bowel | Primary | 53 | 128 | 0.419 | 0.419 | 0.344 | 0.495 |
| RAS | 12, 13, or 61 | Sex cord stromal | Metastasis | 1 | 49 | 0.029 | 0.025 | 0.004 | 0.074 |
| RAS | 12, 13, or 61 | Sex cord stromal | Primary | 2 | 54 | 0.033 | 0.029 | 0.006 | 0.082 |
| RAS | 12, 13, or 61 | Bone | Metastasis | 2 | 203 | 0.011 | 0.010 | 0.003 | 0.023 |
| RAS | 12, 13, or 61 | Bone | Not Applicable or Heme | 0 | 25 | 0.010 | 0.009 | 0.000 | 0.027 |
| RAS | 12, 13, or 61 | Bone | Primary | 4 | 326 | 0.011 | 0.010 | 0.004 | 0.022 |
| RAS | 12, 13, or 61 | Bone | Unspecified | 0 | 16 | 0.011 | 0.010 | 0.000 | 0.029 |
| RAS | 12, 13, or 61 | Vaginal | Metastasis | 2 | 16 | 0.095 | 0.084 | 0.027 | 0.230 |
| RAS | 12, 13, or 61 | Vaginal | Primary | 4 | 60 | 0.077 | 0.073 | 0.027 | 0.149 |
| RAS | 12, 13, or 61 | Thymic | Metastasis | 3 | 61 | 0.045 | 0.042 | 0.015 | 0.095 |
| RAS | 12, 13, or 61 | Thymic | Primary | 3 | 84 | 0.041 | 0.038 | 0.013 | 0.082 |
| RAS | 12, 13, or 61 | Ampullary | Metastasis | 15 | 23 | 0.591 | 0.584 | 0.446 | 0.769 |
| RAS | 12, 13, or 61 | Ampullary | Primary | 43 | 82 | 0.540 | 0.541 | 0.437 | 0.639 |
| RAS | 12, 13, or 61 | SCLC | Metastasis | 10 | 207 | 0.043 | 0.041 | 0.023 | 0.072 |
| RAS | 12, 13, or 61 | SCLC | Primary | 5 | 183 | 0.035 | 0.034 | 0.014 | 0.059 |
| RAS | 12, 13, or 61 | Mesothelioma | Metastasis | 0 | 82 | 0.002 | 0.001 | 0.000 | 0.011 |
| RAS | 12, 13, or 61 | Mesothelioma | Primary | 1 | 408 | 0.003 | 0.002 | 0.000 | 0.009 |
| RAS | 12, 13, or 61 | Germ cell | Metastasis | 24 | 274 | 0.084 | 0.083 | 0.058 | 0.115 |
| RAS | 12, 13, or 61 | Germ cell | Not Applicable or Heme | 2 | 81 | 0.058 | 0.060 | 0.012 | 0.100 |
| RAS | 12, 13, or 61 | Germ cell | Primary | 49 | 517 | 0.090 | 0.089 | 0.068 | 0.116 |
| RAS | 12, 13, or 61 | Germ cell | Unspecified | 0 | 14 | 0.064 | 0.069 | 0.003 | 0.120 |
| RAS | 12, 13, or 61 | Nerve sheath | Metastasis | 1 | 16 | 0.034 | 0.024 | 0.004 | 0.134 |
| RAS | 12, 13, or 61 | Nerve sheath | Not Applicable or Heme | 1 | 17 | 0.033 | 0.024 | 0.004 | 0.125 |
| RAS | 12, 13, or 61 | Nerve sheath | Primary | 1 | 117 | 0.018 | 0.016 | 0.002 | 0.046 |
| RAS | 12, 13, or 61 | Penile | Metastasis | 1 | 11 | 0.091 | 0.076 | 0.010 | 0.257 |
| RAS | 12, 13, or 61 | Penile | Primary | 1 | 13 | 0.087 | 0.074 | 0.010 | 0.240 |
| RAS | 12, 13, or 61 | Pheochromocytoma | Primary | 1 | 18 | 0.061 | 0.047 | 0.002 | 0.200 |
| RAS | 12, 13, or 61 | Pineal | Primary | 1 | 14 | 0.078 | 0.060 | 0.003 | 0.258 |
| RAS | 12, 13, or 61 | B cell lymphoma | Metastasis | 4 | 57 | 0.060 | 0.058 | 0.037 | 0.094 |
| RAS | 12, 13, or 61 | B cell lymphoma | Not Applicable or Heme | 10 | 145 | 0.060 | 0.059 | 0.040 | 0.089 |
| RAS | 12, 13, or 61 | B cell lymphoma | Primary | 39 | 709 | 0.057 | 0.056 | 0.042 | 0.073 |
| RAS | 12, 13, or 61 | B cell lymphoma | Unspecified | 2 | 51 | 0.057 | 0.056 | 0.031 | 0.086 |
| RAS | 12, 13, or 61 | Non-hodgkin lymphoma | Primary | 1 | 14 | 0.080 | 0.061 | 0.003 | 0.259 |
| RAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 3 | 25 | 0.102 | 0.092 | 0.021 | 0.240 |
| RAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.052 | 0.039 | 0.000 | 0.182 |
| RAS | 12, 13, or 61 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| RAS | 12, 13, or 61 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.015 |
| RAS | 12, 13, or 61 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.015 |
| RAS | 12, 13, or 61 | Lung | Primary | 2 | 17 | 0.123 | 0.108 | 0.018 | 0.309 |
| RAS | 12, 13, or 61 | Parathyroid | Primary | 2 | 13 | 0.164 | 0.146 | 0.025 | 0.398 |
| RAS | G12 | Appendiceal | Metastasis | 67 | 174 | 0.397 | 0.397 | 0.324 | 0.468 |
| RAS | G12 | Appendiceal | Not Applicable or Heme | 2 | 10 | 0.351 | 0.374 | 0.104 | 0.519 |
| RAS | G12 | Appendiceal | Primary | 76 | 151 | 0.480 | 0.479 | 0.401 | 0.564 |
| RAS | G12 | CRC | Metastasis | 757 | 2354 | 0.319 | 0.318 | 0.302 | 0.336 |
| RAS | G12 | CRC | Not Applicable or Heme | 70 | 224 | 0.313 | 0.313 | 0.277 | 0.350 |
| RAS | G12 | CRC | Primary | 1267 | 4115 | 0.309 | 0.309 | 0.296 | 0.323 |
| RAS | G12 | CRC | Unspecified | 9 | 31 | 0.313 | 0.313 | 0.260 | 0.365 |
| RAS | G12 | CUP | Metastasis | 224 | 1389 | 0.161 | 0.161 | 0.143 | 0.181 |
| RAS | G12 | CUP | Not Applicable or Heme | 56 | 229 | 0.228 | 0.228 | 0.172 | 0.287 |
| RAS | G12 | CUP | Primary | 34 | 311 | 0.120 | 0.119 | 0.085 | 0.161 |
| RAS | G12 | CUP | Unspecified | 10 | 60 | 0.166 | 0.164 | 0.099 | 0.250 |
| RAS | G12 | NSCLC | Metastasis | 820 | 3750 | 0.219 | 0.219 | 0.206 | 0.232 |
| RAS | G12 | NSCLC | Not Applicable or Heme | 46 | 223 | 0.212 | 0.212 | 0.164 | 0.260 |
| RAS | G12 | NSCLC | Primary | 1673 | 6059 | 0.275 | 0.275 | 0.264 | 0.286 |
| RAS | G12 | NSCLC | Unspecified | 14 | 99 | 0.178 | 0.179 | 0.110 | 0.246 |
| RAS | G12 | Breast | Metastasis | 36 | 3094 | 0.011 | 0.011 | 0.008 | 0.015 |
| RAS | G12 | Breast | Not Applicable or Heme | 3 | 105 | 0.018 | 0.015 | 0.006 | 0.050 |
| RAS | G12 | Breast | Primary | 35 | 6125 | 0.006 | 0.006 | 0.004 | 0.008 |
| RAS | G12 | Soft tissue sarcoma | Metastasis | 9 | 939 | 0.010 | 0.010 | 0.006 | 0.015 |
| RAS | G12 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.010 | 0.010 | 0.004 | 0.019 |
| RAS | G12 | Soft tissue sarcoma | Primary | 19 | 1686 | 0.011 | 0.011 | 0.007 | 0.015 |
| RAS | G12 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.010 | 0.010 | 0.003 | 0.019 |
| RAS | G12 | Pancreatic | Metastasis | 645 | 981 | 0.664 | 0.665 | 0.635 | 0.691 |
| RAS | G12 | Pancreatic | Not Applicable or Heme | 53 | 75 | 0.682 | 0.680 | 0.626 | 0.748 |
| RAS | G12 | Pancreatic | Primary | 979 | 1429 | 0.682 | 0.682 | 0.659 | 0.705 |
| RAS | G12 | Leukemia | Metastasis | 2 | 15 | 0.092 | 0.090 | 0.062 | 0.135 |
| RAS | G12 | Leukemia | Not Applicable or Heme | 86 | 923 | 0.091 | 0.091 | 0.076 | 0.108 |
| RAS | G12 | Leukemia | Primary | 33 | 412 | 0.087 | 0.087 | 0.067 | 0.107 |
| RAS | G12 | Leukemia | Unspecified | 20 | 217 | 0.091 | 0.090 | 0.068 | 0.116 |
| RAS | G12 | Melanoma | Metastasis | 40 | 1738 | 0.023 | 0.023 | 0.017 | 0.031 |
| RAS | G12 | Melanoma | Not Applicable or Heme | 1 | 188 | 0.013 | 0.012 | 0.001 | 0.032 |
| RAS | G12 | Melanoma | Primary | 38 | 898 | 0.040 | 0.040 | 0.027 | 0.054 |
| RAS | G12 | Melanoma | Unspecified | 0 | 22 | 0.020 | 0.018 | 0.000 | 0.061 |
| RAS | G12 | Head and neck | Metastasis | 9 | 731 | 0.015 | 0.015 | 0.008 | 0.022 |
| RAS | G12 | Head and neck | Not Applicable or Heme | 2 | 67 | 0.018 | 0.016 | 0.008 | 0.041 |
| RAS | G12 | Head and neck | Primary | 16 | 938 | 0.016 | 0.016 | 0.010 | 0.024 |
| RAS | G12 | Uterine | Metastasis | 69 | 586 | 0.126 | 0.127 | 0.102 | 0.148 |
| RAS | G12 | Uterine | Not Applicable or Heme | 11 | 76 | 0.136 | 0.134 | 0.101 | 0.186 |
| RAS | G12 | Uterine | Primary | 209 | 1541 | 0.135 | 0.135 | 0.119 | 0.151 |
| RAS | G12 | Uterine | Unspecified | 10 | 51 | 0.144 | 0.138 | 0.108 | 0.220 |
| RAS | G12 | Non-melanoma skin | Metastasis | 4 | 203 | 0.019 | 0.018 | 0.008 | 0.036 |
| RAS | G12 | Non-melanoma skin | Not Applicable or Heme | 1 | 22 | 0.022 | 0.018 | 0.007 | 0.065 |
| RAS | G12 | Non-melanoma skin | Primary | 4 | 287 | 0.017 | 0.016 | 0.007 | 0.031 |
| RAS | G12 | MDS/MPN | Metastasis | 0 | 11 | 0.038 | 0.038 | 0.002 | 0.076 |
| RAS | G12 | MDS/MPN | Not Applicable or Heme | 35 | 915 | 0.039 | 0.039 | 0.028 | 0.052 |
| RAS | G12 | MDS/MPN | Primary | 14 | 250 | 0.047 | 0.045 | 0.030 | 0.075 |
| RAS | G12 | MDS/MPN | Unspecified | 0 | 31 | 0.035 | 0.037 | 0.002 | 0.063 |
| RAS | G12 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12 | Ovarian | Metastasis | 83 | 1088 | 0.079 | 0.079 | 0.064 | 0.095 |
| RAS | G12 | Ovarian | Not Applicable or Heme | 9 | 160 | 0.075 | 0.077 | 0.041 | 0.104 |
| RAS | G12 | Ovarian | Primary | 109 | 1060 | 0.098 | 0.098 | 0.081 | 0.117 |
| RAS | G12 | Ovarian | Unspecified | 4 | 28 | 0.098 | 0.091 | 0.056 | 0.176 |
| RAS | G12 | Esophagogastric | Metastasis | 17 | 462 | 0.038 | 0.037 | 0.026 | 0.052 |
| RAS | G12 | Esophagogastric | Not Applicable or Heme | 2 | 43 | 0.040 | 0.038 | 0.022 | 0.069 |
| RAS | G12 | Esophagogastric | Primary | 48 | 1283 | 0.038 | 0.038 | 0.029 | 0.048 |
| RAS | G12 | Esophagogastric | Unspecified | 1 | 14 | 0.041 | 0.038 | 0.021 | 0.084 |
| RAS | G12 | Thyroid | Metastasis | 7 | 402 | 0.015 | 0.014 | 0.007 | 0.027 |
| RAS | G12 | Thyroid | Not Applicable or Heme | 1 | 28 | 0.018 | 0.014 | 0.005 | 0.062 |
| RAS | G12 | Thyroid | Primary | 5 | 582 | 0.011 | 0.011 | 0.005 | 0.020 |
| RAS | G12 | Cervical | Metastasis | 13 | 136 | 0.082 | 0.080 | 0.049 | 0.131 |
| RAS | G12 | Cervical | Not Applicable or Heme | 1 | 12 | 0.079 | 0.073 | 0.028 | 0.174 |
| RAS | G12 | Cervical | Primary | 12 | 211 | 0.066 | 0.066 | 0.038 | 0.098 |
| RAS | G12 | Hepatobiliary | Metastasis | 45 | 438 | 0.097 | 0.096 | 0.076 | 0.125 |
| RAS | G12 | Hepatobiliary | Not Applicable or Heme | 5 | 34 | 0.104 | 0.096 | 0.066 | 0.192 |
| RAS | G12 | Hepatobiliary | Primary | 72 | 895 | 0.085 | 0.085 | 0.068 | 0.103 |
| RAS | G12 | Kidney | Metastasis | 5 | 445 | 0.009 | 0.009 | 0.004 | 0.018 |
| RAS | G12 | Kidney | Not Applicable or Heme | 0 | 24 | 0.009 | 0.007 | 0.000 | 0.025 |
| RAS | G12 | Kidney | Primary | 6 | 944 | 0.007 | 0.007 | 0.003 | 0.013 |
| RAS | G12 | T / NK neoplasms | Metastasis | 0 | 10 | 0.007 | 0.003 | 0.000 | 0.035 |
| RAS | G12 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.006 | 0.003 | 0.000 | 0.024 |
| RAS | G12 | T / NK neoplasms | Primary | 1 | 187 | 0.005 | 0.004 | 0.000 | 0.019 |
| RAS | G12 | CNS | Metastasis | 3 | 409 | 0.007 | 0.006 | 0.003 | 0.011 |
| RAS | G12 | CNS | Not Applicable or Heme | 2 | 526 | 0.006 | 0.006 | 0.003 | 0.010 |
| RAS | G12 | CNS | Primary | 23 | 3522 | 0.006 | 0.006 | 0.004 | 0.009 |
| RAS | G12 | CNS | Unspecified | 1 | 108 | 0.007 | 0.006 | 0.003 | 0.014 |
| RAS | G12 | Prostate | Metastasis | 1 | 901 | 0.002 | 0.002 | 0.000 | 0.005 |
| RAS | G12 | Prostate | Not Applicable or Heme | 0 | 57 | 0.003 | 0.002 | 0.000 | 0.010 |
| RAS | G12 | Prostate | Primary | 6 | 1468 | 0.003 | 0.003 | 0.001 | 0.007 |
| RAS | G12 | Prostate | Unspecified | 0 | 12 | 0.004 | 0.003 | 0.000 | 0.015 |
| RAS | G12 | Anal | Metastasis | 1 | 59 | 0.016 | 0.013 | 0.002 | 0.049 |
| RAS | G12 | Anal | Primary | 1 | 84 | 0.015 | 0.012 | 0.002 | 0.043 |
| RAS | G12 | Neuroendocrine | Metastasis | 9 | 143 | 0.069 | 0.068 | 0.039 | 0.103 |
| RAS | G12 | Neuroendocrine | Not Applicable or Heme | 3 | 20 | 0.085 | 0.075 | 0.041 | 0.197 |
| RAS | G12 | Neuroendocrine | Primary | 13 | 196 | 0.069 | 0.068 | 0.043 | 0.102 |
| RAS | G12 | Bladder | Metastasis | 18 | 390 | 0.051 | 0.051 | 0.034 | 0.067 |
| RAS | G12 | Bladder | Not Applicable or Heme | 2 | 25 | 0.057 | 0.054 | 0.032 | 0.107 |
| RAS | G12 | Bladder | Primary | 64 | 1164 | 0.054 | 0.054 | 0.043 | 0.067 |
| RAS | G12 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.064 | 0.061 | 0.001 | 0.154 |
| RAS | G12 | BLL/Lymphoma | Not Applicable or Heme | 17 | 109 | 0.135 | 0.132 | 0.076 | 0.211 |
| RAS | G12 | BLL/Lymphoma | Primary | 5 | 101 | 0.064 | 0.062 | 0.023 | 0.118 |
| RAS | G12 | BLL/Lymphoma | Unspecified | 2 | 25 | 0.085 | 0.082 | 0.022 | 0.178 |
| RAS | G12 | Small bowel | Metastasis | 29 | 78 | 0.347 | 0.344 | 0.264 | 0.451 |
| RAS | G12 | Small bowel | Primary | 38 | 128 | 0.311 | 0.312 | 0.237 | 0.386 |
| RAS | G12 | Sex cord stromal | Metastasis | 1 | 49 | 0.021 | 0.018 | 0.002 | 0.061 |
| RAS | G12 | Sex cord stromal | Primary | 1 | 54 | 0.021 | 0.018 | 0.002 | 0.060 |
| RAS | G12 | Bone | Metastasis | 1 | 203 | 0.008 | 0.007 | 0.001 | 0.019 |
| RAS | G12 | Bone | Not Applicable or Heme | 0 | 25 | 0.009 | 0.008 | 0.000 | 0.025 |
| RAS | G12 | Bone | Primary | 4 | 326 | 0.010 | 0.009 | 0.003 | 0.021 |
| RAS | G12 | Bone | Unspecified | 0 | 16 | 0.009 | 0.008 | 0.000 | 0.028 |
| RAS | G12 | Vaginal | Metastasis | 1 | 16 | 0.059 | 0.051 | 0.010 | 0.157 |
| RAS | G12 | Vaginal | Primary | 3 | 60 | 0.053 | 0.049 | 0.015 | 0.113 |
| RAS | G12 | Thymic | Metastasis | 0 | 61 | 0.006 | 0.003 | 0.000 | 0.027 |
| RAS | G12 | Thymic | Primary | 1 | 84 | 0.010 | 0.007 | 0.000 | 0.036 |
| RAS | G12 | Ampullary | Metastasis | 15 | 23 | 0.577 | 0.570 | 0.397 | 0.787 |
| RAS | G12 | Ampullary | Primary | 34 | 82 | 0.436 | 0.436 | 0.328 | 0.544 |
| RAS | G12 | SCLC | Metastasis | 8 | 207 | 0.034 | 0.033 | 0.017 | 0.060 |
| RAS | G12 | SCLC | Primary | 4 | 183 | 0.028 | 0.027 | 0.011 | 0.050 |
| RAS | G12 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12 | Germ cell | Metastasis | 19 | 274 | 0.067 | 0.066 | 0.042 | 0.100 |
| RAS | G12 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.014 | 0.006 | 0.000 | 0.067 |
| RAS | G12 | Germ cell | Primary | 39 | 517 | 0.074 | 0.073 | 0.053 | 0.098 |
| RAS | G12 | Germ cell | Unspecified | 0 | 14 | 0.026 | 0.014 | 0.000 | 0.097 |
| RAS | G12 | Nerve sheath | Metastasis | 1 | 16 | 0.036 | 0.018 | 0.001 | 0.169 |
| RAS | G12 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.008 | 0.003 | 0.000 | 0.046 |
| RAS | G12 | Nerve sheath | Primary | 0 | 117 | 0.004 | 0.002 | 0.000 | 0.021 |
| RAS | G12 | Penile | Metastasis | 1 | 11 | 0.068 | 0.048 | 0.003 | 0.247 |
| RAS | G12 | Penile | Primary | 0 | 13 | 0.032 | 0.017 | 0.000 | 0.144 |
| RAS | G12 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.034 |
| RAS | G12 | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.045 |
| RAS | G12 | B cell lymphoma | Metastasis | 2 | 57 | 0.022 | 0.020 | 0.010 | 0.050 |
| RAS | G12 | B cell lymphoma | Not Applicable or Heme | 4 | 145 | 0.022 | 0.020 | 0.011 | 0.041 |
| RAS | G12 | B cell lymphoma | Primary | 11 | 709 | 0.018 | 0.018 | 0.010 | 0.028 |
| RAS | G12 | B cell lymphoma | Unspecified | 1 | 51 | 0.020 | 0.019 | 0.008 | 0.041 |
| RAS | G12 | Non-hodgkin lymphoma | Primary | 1 | 14 | 0.080 | 0.060 | 0.004 | 0.262 |
| RAS | G12 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 2 | 25 | 0.068 | 0.058 | 0.009 | 0.185 |
| RAS | G12 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.040 | 0.029 | 0.000 | 0.150 |
| RAS | G12 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| RAS | G12 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.014 |
| RAS | G12 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G12 | Lung | Primary | 1 | 17 | 0.066 | 0.050 | 0.003 | 0.219 |
| RAS | G12 | Parathyroid | Primary | 0 | 13 | 0.004 | 0.000 | 0.000 | 0.044 |
| RAS | G12C | Appendiceal | Metastasis | 2 | 174 | 0.012 | 0.011 | 0.003 | 0.028 |
| RAS | G12C | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.014 | 0.011 | 0.001 | 0.043 |
| RAS | G12C | Appendiceal | Primary | 2 | 151 | 0.013 | 0.012 | 0.003 | 0.030 |
| RAS | G12C | CRC | Metastasis | 33 | 2354 | 0.013 | 0.013 | 0.010 | 0.017 |
| RAS | G12C | CRC | Not Applicable or Heme | 3 | 224 | 0.013 | 0.013 | 0.008 | 0.020 |
| RAS | G12C | CRC | Primary | 48 | 4115 | 0.012 | 0.012 | 0.009 | 0.015 |
| RAS | G12C | CRC | Unspecified | 0 | 31 | 0.013 | 0.012 | 0.006 | 0.020 |
| RAS | G12C | CUP | Metastasis | 19 | 1389 | 0.012 | 0.012 | 0.007 | 0.019 |
| RAS | G12C | CUP | Not Applicable or Heme | 1 | 229 | 0.009 | 0.009 | 0.002 | 0.017 |
| RAS | G12C | CUP | Primary | 1 | 311 | 0.008 | 0.008 | 0.001 | 0.016 |
| RAS | G12C | CUP | Unspecified | 1 | 60 | 0.012 | 0.010 | 0.003 | 0.031 |
| RAS | G12C | NSCLC | Metastasis | 145 | 3750 | 0.039 | 0.039 | 0.033 | 0.045 |
| RAS | G12C | NSCLC | Not Applicable or Heme | 5 | 223 | 0.032 | 0.033 | 0.013 | 0.049 |
| RAS | G12C | NSCLC | Primary | 290 | 6059 | 0.047 | 0.047 | 0.042 | 0.053 |
| RAS | G12C | NSCLC | Unspecified | 1 | 99 | 0.031 | 0.032 | 0.007 | 0.051 |
| RAS | G12C | Breast | Metastasis | 3 | 3094 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G12C | Breast | Not Applicable or Heme | 0 | 105 | 0.001 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Breast | Primary | 1 | 6125 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Soft tissue sarcoma | Metastasis | 0 | 939 | 0.001 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.003 | 0.001 | 0.000 | 0.018 |
| RAS | G12C | Soft tissue sarcoma | Primary | 1 | 1686 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G12C | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.002 | 0.001 | 0.000 | 0.013 |
| RAS | G12C | Pancreatic | Metastasis | 3 | 981 | 0.004 | 0.003 | 0.001 | 0.007 |
| RAS | G12C | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.004 | 0.003 | 0.000 | 0.009 |
| RAS | G12C | Pancreatic | Primary | 6 | 1429 | 0.004 | 0.004 | 0.002 | 0.007 |
| RAS | G12C | Leukemia | Metastasis | 0 | 15 | 0.004 | 0.003 | 0.001 | 0.011 |
| RAS | G12C | Leukemia | Not Applicable or Heme | 3 | 923 | 0.003 | 0.003 | 0.001 | 0.007 |
| RAS | G12C | Leukemia | Primary | 1 | 412 | 0.003 | 0.003 | 0.001 | 0.008 |
| RAS | G12C | Leukemia | Unspecified | 1 | 217 | 0.004 | 0.003 | 0.001 | 0.009 |
| RAS | G12C | Melanoma | Metastasis | 4 | 1738 | 0.002 | 0.002 | 0.001 | 0.005 |
| RAS | G12C | Melanoma | Not Applicable or Heme | 0 | 188 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | G12C | Melanoma | Primary | 3 | 898 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12C | Melanoma | Unspecified | 0 | 22 | 0.003 | 0.002 | 0.000 | 0.008 |
| RAS | G12C | Head and neck | Metastasis | 1 | 731 | 0.001 | 0.001 | 0.000 | 0.005 |
| RAS | G12C | Head and neck | Not Applicable or Heme | 1 | 67 | 0.008 | 0.003 | 0.000 | 0.041 |
| RAS | G12C | Head and neck | Primary | 0 | 938 | 0.001 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Uterine | Metastasis | 2 | 586 | 0.003 | 0.003 | 0.001 | 0.007 |
| RAS | G12C | Uterine | Not Applicable or Heme | 0 | 76 | 0.003 | 0.003 | 0.000 | 0.008 |
| RAS | G12C | Uterine | Primary | 5 | 1541 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G12C | Uterine | Unspecified | 0 | 51 | 0.003 | 0.003 | 0.000 | 0.009 |
| RAS | G12C | Non-melanoma skin | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Non-melanoma skin | Primary | 0 | 287 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | MDS/MPN | Metastasis | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | Not Applicable or Heme | 0 | 915 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | Primary | 0 | 250 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | MDS/MPN | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Adrenocortical | Metastasis | 0 | 55 | 0.001 | 0.000 | 0.000 | 0.006 |
| RAS | G12C | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | G12C | Ovarian | Metastasis | 2 | 1088 | 0.002 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Ovarian | Not Applicable or Heme | 0 | 160 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | G12C | Ovarian | Primary | 1 | 1060 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Ovarian | Unspecified | 0 | 28 | 0.002 | 0.001 | 0.000 | 0.006 |
| RAS | G12C | Esophagogastric | Metastasis | 0 | 462 | 0.001 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.001 | 0.000 | 0.000 | 0.005 |
| RAS | G12C | Esophagogastric | Primary | 1 | 1283 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G12C | Esophagogastric | Unspecified | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.008 |
| RAS | G12C | Thyroid | Metastasis | 0 | 402 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Thyroid | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Thyroid | Primary | 0 | 582 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Cervical | Metastasis | 1 | 136 | 0.005 | 0.003 | 0.000 | 0.020 |
| RAS | G12C | Cervical | Not Applicable or Heme | 0 | 12 | 0.005 | 0.002 | 0.000 | 0.034 |
| RAS | G12C | Cervical | Primary | 0 | 211 | 0.002 | 0.001 | 0.000 | 0.011 |
| RAS | G12C | Hepatobiliary | Metastasis | 3 | 438 | 0.006 | 0.005 | 0.001 | 0.015 |
| RAS | G12C | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.003 | 0.000 | 0.000 | 0.020 |
| RAS | G12C | Hepatobiliary | Primary | 0 | 895 | 0.001 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | T / NK neoplasms | Metastasis | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | CNS | Metastasis | 0 | 409 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | CNS | Not Applicable or Heme | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | CNS | Primary | 1 | 3522 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | CNS | Unspecified | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Prostate | Metastasis | 0 | 901 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | Not Applicable or Heme | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | Primary | 0 | 1468 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Prostate | Unspecified | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G12C | Neuroendocrine | Metastasis | 1 | 143 | 0.006 | 0.005 | 0.001 | 0.019 |
| RAS | G12C | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.007 | 0.005 | 0.000 | 0.025 |
| RAS | G12C | Neuroendocrine | Primary | 1 | 196 | 0.006 | 0.005 | 0.001 | 0.017 |
| RAS | G12C | Bladder | Metastasis | 1 | 390 | 0.003 | 0.002 | 0.000 | 0.007 |
| RAS | G12C | Bladder | Not Applicable or Heme | 0 | 25 | 0.003 | 0.002 | 0.000 | 0.013 |
| RAS | G12C | Bladder | Primary | 3 | 1164 | 0.003 | 0.002 | 0.001 | 0.006 |
| RAS | G12C | BLL/Lymphoma | Metastasis | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | BLL/Lymphoma | Not Applicable or Heme | 0 | 109 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | BLL/Lymphoma | Primary | 0 | 101 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | BLL/Lymphoma | Unspecified | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Small bowel | Metastasis | 2 | 78 | 0.020 | 0.016 | 0.004 | 0.054 |
| RAS | G12C | Small bowel | Primary | 1 | 128 | 0.013 | 0.012 | 0.001 | 0.035 |
| RAS | G12C | Sex cord stromal | Metastasis | 0 | 49 | 0.000 | 0.000 | 0.000 | 0.006 |
| RAS | G12C | Sex cord stromal | Primary | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.006 |
| RAS | G12C | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Vaginal | Metastasis | 0 | 16 | 0.015 | 0.008 | 0.000 | 0.064 |
| RAS | G12C | Vaginal | Primary | 1 | 60 | 0.017 | 0.012 | 0.001 | 0.057 |
| RAS | G12C | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G12C | Ampullary | Metastasis | 1 | 23 | 0.031 | 0.018 | 0.001 | 0.130 |
| RAS | G12C | Ampullary | Primary | 0 | 82 | 0.006 | 0.002 | 0.000 | 0.030 |
| RAS | G12C | SCLC | Metastasis | 1 | 207 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | G12C | SCLC | Primary | 1 | 183 | 0.006 | 0.005 | 0.001 | 0.017 |
| RAS | G12C | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G12C | Germ cell | Metastasis | 2 | 274 | 0.005 | 0.004 | 0.001 | 0.017 |
| RAS | G12C | Germ cell | Not Applicable or Heme | 0 | 81 | 0.002 | 0.001 | 0.000 | 0.010 |
| RAS | G12C | Germ cell | Primary | 0 | 517 | 0.001 | 0.001 | 0.000 | 0.005 |
| RAS | G12C | Germ cell | Unspecified | 0 | 14 | 0.004 | 0.001 | 0.000 | 0.027 |
| RAS | G12C | Nerve sheath | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.006 |
| RAS | G12C | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.006 |
| RAS | G12C | Nerve sheath | Primary | 0 | 117 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G12C | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.035 |
| RAS | G12C | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G12C | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.033 |
| RAS | G12C | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.049 |
| RAS | G12C | B cell lymphoma | Metastasis | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | B cell lymphoma | Primary | 0 | 709 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | B cell lymphoma | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G12C | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.034 |
| RAS | G12C | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.017 |
| RAS | G12C | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| RAS | G12C | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.020 |
| RAS | G12C | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.013 |
| RAS | G12C | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.016 |
| RAS | G12C | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.038 |
| RAS | G12C | Parathyroid | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.040 |
| RAS | G13 | Appendiceal | Metastasis | 7 | 174 | 0.044 | 0.043 | 0.022 | 0.071 |
| RAS | G13 | Appendiceal | Not Applicable or Heme | 1 | 10 | 0.053 | 0.046 | 0.019 | 0.143 |
| RAS | G13 | Appendiceal | Primary | 7 | 151 | 0.046 | 0.045 | 0.024 | 0.076 |
| RAS | G13 | CRC | Metastasis | 197 | 2354 | 0.084 | 0.084 | 0.075 | 0.094 |
| RAS | G13 | CRC | Not Applicable or Heme | 20 | 224 | 0.085 | 0.084 | 0.068 | 0.106 |
| RAS | G13 | CRC | Primary | 346 | 4115 | 0.084 | 0.084 | 0.077 | 0.092 |
| RAS | G13 | CRC | Unspecified | 2 | 31 | 0.084 | 0.083 | 0.058 | 0.108 |
| RAS | G13 | CUP | Metastasis | 36 | 1389 | 0.025 | 0.025 | 0.018 | 0.033 |
| RAS | G13 | CUP | Not Applicable or Heme | 2 | 229 | 0.020 | 0.021 | 0.007 | 0.032 |
| RAS | G13 | CUP | Primary | 8 | 311 | 0.024 | 0.024 | 0.014 | 0.037 |
| RAS | G13 | CUP | Unspecified | 2 | 60 | 0.025 | 0.024 | 0.011 | 0.047 |
| RAS | G13 | NSCLC | Metastasis | 96 | 3750 | 0.024 | 0.024 | 0.020 | 0.029 |
| RAS | G13 | NSCLC | Not Applicable or Heme | 4 | 223 | 0.021 | 0.021 | 0.010 | 0.031 |
| RAS | G13 | NSCLC | Primary | 123 | 6059 | 0.021 | 0.021 | 0.017 | 0.024 |
| RAS | G13 | NSCLC | Unspecified | 0 | 99 | 0.019 | 0.020 | 0.003 | 0.029 |
| RAS | G13 | Breast | Metastasis | 6 | 3094 | 0.002 | 0.002 | 0.001 | 0.003 |
| RAS | G13 | Breast | Not Applicable or Heme | 1 | 105 | 0.003 | 0.002 | 0.001 | 0.016 |
| RAS | G13 | Breast | Primary | 5 | 6125 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G13 | Soft tissue sarcoma | Metastasis | 2 | 939 | 0.003 | 0.003 | 0.001 | 0.006 |
| RAS | G13 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.004 | 0.003 | 0.001 | 0.012 |
| RAS | G13 | Soft tissue sarcoma | Primary | 6 | 1686 | 0.003 | 0.003 | 0.002 | 0.006 |
| RAS | G13 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.004 | 0.003 | 0.001 | 0.010 |
| RAS | G13 | Pancreatic | Metastasis | 5 | 981 | 0.007 | 0.007 | 0.002 | 0.012 |
| RAS | G13 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.007 | 0.007 | 0.000 | 0.017 |
| RAS | G13 | Pancreatic | Primary | 16 | 1429 | 0.010 | 0.010 | 0.006 | 0.016 |
| RAS | G13 | Leukemia | Metastasis | 4 | 15 | 0.104 | 0.061 | 0.035 | 0.348 |
| RAS | G13 | Leukemia | Not Applicable or Heme | 39 | 923 | 0.044 | 0.043 | 0.032 | 0.056 |
| RAS | G13 | Leukemia | Primary | 15 | 412 | 0.041 | 0.041 | 0.025 | 0.058 |
| RAS | G13 | Leukemia | Unspecified | 11 | 217 | 0.049 | 0.047 | 0.030 | 0.077 |
| RAS | G13 | Melanoma | Metastasis | 42 | 1738 | 0.023 | 0.023 | 0.017 | 0.030 |
| RAS | G13 | Melanoma | Not Applicable or Heme | 3 | 188 | 0.021 | 0.021 | 0.010 | 0.031 |
| RAS | G13 | Melanoma | Primary | 17 | 898 | 0.021 | 0.021 | 0.013 | 0.028 |
| RAS | G13 | Melanoma | Unspecified | 0 | 22 | 0.021 | 0.021 | 0.007 | 0.036 |
| RAS | G13 | Head and neck | Metastasis | 4 | 731 | 0.008 | 0.008 | 0.003 | 0.015 |
| RAS | G13 | Head and neck | Not Applicable or Heme | 1 | 67 | 0.013 | 0.011 | 0.003 | 0.033 |
| RAS | G13 | Head and neck | Primary | 14 | 938 | 0.013 | 0.013 | 0.007 | 0.021 |
| RAS | G13 | Uterine | Metastasis | 11 | 586 | 0.022 | 0.022 | 0.012 | 0.031 |
| RAS | G13 | Uterine | Not Applicable or Heme | 2 | 76 | 0.024 | 0.023 | 0.010 | 0.044 |
| RAS | G13 | Uterine | Primary | 41 | 1541 | 0.025 | 0.025 | 0.019 | 0.033 |
| RAS | G13 | Uterine | Unspecified | 0 | 51 | 0.021 | 0.022 | 0.003 | 0.036 |
| RAS | G13 | Non-melanoma skin | Metastasis | 1 | 203 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | G13 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.007 | 0.005 | 0.000 | 0.023 |
| RAS | G13 | Non-melanoma skin | Primary | 2 | 287 | 0.007 | 0.006 | 0.001 | 0.016 |
| RAS | G13 | MDS/MPN | Metastasis | 1 | 11 | 0.037 | 0.026 | 0.008 | 0.140 |
| RAS | G13 | MDS/MPN | Not Applicable or Heme | 15 | 915 | 0.019 | 0.018 | 0.011 | 0.028 |
| RAS | G13 | MDS/MPN | Primary | 10 | 250 | 0.032 | 0.030 | 0.016 | 0.059 |
| RAS | G13 | MDS/MPN | Unspecified | 0 | 31 | 0.021 | 0.020 | 0.001 | 0.054 |
| RAS | G13 | Adrenocortical | Metastasis | 1 | 55 | 0.014 | 0.010 | 0.000 | 0.054 |
| RAS | G13 | Adrenocortical | Primary | 0 | 72 | 0.006 | 0.003 | 0.000 | 0.028 |
| RAS | G13 | Ovarian | Metastasis | 3 | 1088 | 0.004 | 0.004 | 0.001 | 0.008 |
| RAS | G13 | Ovarian | Not Applicable or Heme | 3 | 160 | 0.009 | 0.007 | 0.003 | 0.029 |
| RAS | G13 | Ovarian | Primary | 6 | 1060 | 0.006 | 0.005 | 0.003 | 0.010 |
| RAS | G13 | Ovarian | Unspecified | 0 | 28 | 0.006 | 0.005 | 0.001 | 0.022 |
| RAS | G13 | Esophagogastric | Metastasis | 6 | 462 | 0.014 | 0.013 | 0.007 | 0.022 |
| RAS | G13 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.013 | 0.013 | 0.001 | 0.025 |
| RAS | G13 | Esophagogastric | Primary | 19 | 1283 | 0.014 | 0.014 | 0.009 | 0.021 |
| RAS | G13 | Esophagogastric | Unspecified | 0 | 14 | 0.014 | 0.013 | 0.001 | 0.028 |
| RAS | G13 | Thyroid | Metastasis | 2 | 402 | 0.004 | 0.004 | 0.001 | 0.011 |
| RAS | G13 | Thyroid | Not Applicable or Heme | 0 | 28 | 0.004 | 0.004 | 0.000 | 0.015 |
| RAS | G13 | Thyroid | Primary | 2 | 582 | 0.004 | 0.004 | 0.001 | 0.009 |
| RAS | G13 | Cervical | Metastasis | 3 | 136 | 0.016 | 0.013 | 0.004 | 0.040 |
| RAS | G13 | Cervical | Not Applicable or Heme | 0 | 12 | 0.013 | 0.010 | 0.000 | 0.051 |
| RAS | G13 | Cervical | Primary | 1 | 211 | 0.009 | 0.008 | 0.001 | 0.023 |
| RAS | G13 | Hepatobiliary | Metastasis | 5 | 438 | 0.010 | 0.010 | 0.005 | 0.018 |
| RAS | G13 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.010 | 0.009 | 0.001 | 0.023 |
| RAS | G13 | Hepatobiliary | Primary | 8 | 895 | 0.009 | 0.009 | 0.005 | 0.016 |
| RAS | G13 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | CNS | Metastasis | 0 | 409 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G13 | CNS | Not Applicable or Heme | 2 | 526 | 0.002 | 0.001 | 0.000 | 0.006 |
| RAS | G13 | CNS | Primary | 3 | 3522 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | G13 | CNS | Unspecified | 0 | 108 | 0.001 | 0.001 | 0.000 | 0.005 |
| RAS | G13 | Prostate | Metastasis | 0 | 901 | 0.001 | 0.001 | 0.000 | 0.003 |
| RAS | G13 | Prostate | Not Applicable or Heme | 0 | 57 | 0.002 | 0.001 | 0.000 | 0.009 |
| RAS | G13 | Prostate | Primary | 4 | 1468 | 0.002 | 0.002 | 0.001 | 0.005 |
| RAS | G13 | Prostate | Unspecified | 0 | 12 | 0.003 | 0.001 | 0.000 | 0.019 |
| RAS | G13 | Anal | Metastasis | 0 | 59 | 0.010 | 0.006 | 0.000 | 0.038 |
| RAS | G13 | Anal | Primary | 2 | 84 | 0.020 | 0.016 | 0.002 | 0.055 |
| RAS | G13 | Neuroendocrine | Metastasis | 1 | 143 | 0.014 | 0.013 | 0.001 | 0.034 |
| RAS | G13 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.017 | 0.015 | 0.000 | 0.050 |
| RAS | G13 | Neuroendocrine | Primary | 6 | 196 | 0.025 | 0.023 | 0.009 | 0.050 |
| RAS | G13 | Bladder | Metastasis | 2 | 390 | 0.009 | 0.009 | 0.002 | 0.018 |
| RAS | G13 | Bladder | Not Applicable or Heme | 1 | 25 | 0.018 | 0.013 | 0.004 | 0.072 |
| RAS | G13 | Bladder | Primary | 16 | 1164 | 0.013 | 0.013 | 0.008 | 0.020 |
| RAS | G13 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.053 | 0.052 | 0.009 | 0.100 |
| RAS | G13 | BLL/Lymphoma | Not Applicable or Heme | 7 | 109 | 0.059 | 0.057 | 0.031 | 0.097 |
| RAS | G13 | BLL/Lymphoma | Primary | 5 | 101 | 0.055 | 0.054 | 0.027 | 0.091 |
| RAS | G13 | BLL/Lymphoma | Unspecified | 2 | 25 | 0.060 | 0.057 | 0.025 | 0.120 |
| RAS | G13 | Small bowel | Metastasis | 1 | 78 | 0.027 | 0.021 | 0.001 | 0.078 |
| RAS | G13 | Small bowel | Primary | 12 | 128 | 0.087 | 0.084 | 0.044 | 0.143 |
| RAS | G13 | Sex cord stromal | Metastasis | 0 | 49 | 0.009 | 0.005 | 0.000 | 0.037 |
| RAS | G13 | Sex cord stromal | Primary | 1 | 54 | 0.015 | 0.010 | 0.001 | 0.054 |
| RAS | G13 | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.000 |
| RAS | G13 | Vaginal | Metastasis | 0 | 16 | 0.014 | 0.008 | 0.000 | 0.061 |
| RAS | G13 | Vaginal | Primary | 1 | 60 | 0.016 | 0.012 | 0.001 | 0.055 |
| RAS | G13 | Thymic | Metastasis | 0 | 61 | 0.006 | 0.003 | 0.000 | 0.027 |
| RAS | G13 | Thymic | Primary | 1 | 84 | 0.010 | 0.007 | 0.000 | 0.036 |
| RAS | G13 | Ampullary | Metastasis | 1 | 23 | 0.049 | 0.044 | 0.008 | 0.122 |
| RAS | G13 | Ampullary | Primary | 4 | 82 | 0.049 | 0.046 | 0.016 | 0.100 |
| RAS | G13 | SCLC | Metastasis | 1 | 207 | 0.004 | 0.003 | 0.000 | 0.014 |
| RAS | G13 | SCLC | Primary | 0 | 183 | 0.002 | 0.001 | 0.000 | 0.010 |
| RAS | G13 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| RAS | G13 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| RAS | G13 | Germ cell | Metastasis | 0 | 274 | 0.005 | 0.004 | 0.000 | 0.014 |
| RAS | G13 | Germ cell | Not Applicable or Heme | 2 | 81 | 0.015 | 0.010 | 0.003 | 0.049 |
| RAS | G13 | Germ cell | Primary | 5 | 517 | 0.009 | 0.008 | 0.003 | 0.018 |
| RAS | G13 | Germ cell | Unspecified | 0 | 14 | 0.009 | 0.006 | 0.000 | 0.038 |
| RAS | G13 | Nerve sheath | Metastasis | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G13 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.004 |
| RAS | G13 | Nerve sheath | Primary | 0 | 117 | 0.000 | 0.000 | 0.000 | 0.003 |
| RAS | G13 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.035 |
| RAS | G13 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.034 |
| RAS | G13 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.034 |
| RAS | G13 | Pineal | Primary | 1 | 14 | 0.080 | 0.062 | 0.003 | 0.259 |
| RAS | G13 | B cell lymphoma | Metastasis | 0 | 57 | 0.010 | 0.010 | 0.000 | 0.024 |
| RAS | G13 | B cell lymphoma | Not Applicable or Heme | 1 | 145 | 0.011 | 0.010 | 0.001 | 0.022 |
| RAS | G13 | B cell lymphoma | Primary | 11 | 709 | 0.014 | 0.013 | 0.007 | 0.023 |
| RAS | G13 | B cell lymphoma | Unspecified | 0 | 51 | 0.010 | 0.010 | 0.000 | 0.024 |
| RAS | G13 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G13 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 1 | 25 | 0.035 | 0.026 | 0.001 | 0.120 |
| RAS | G13 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.027 | 0.016 | 0.000 | 0.114 |
| RAS | G13 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| RAS | G13 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.014 |
| RAS | G13 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.012 |
| RAS | G13 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| RAS | G13 | Parathyroid | Primary | 1 | 13 | 0.085 | 0.066 | 0.004 | 0.273 |
| RAS | Q61 | Appendiceal | Metastasis | 8 | 174 | 0.038 | 0.036 | 0.016 | 0.071 |
| RAS | Q61 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.028 | 0.025 | 0.000 | 0.084 |
| RAS | Q61 | Appendiceal | Primary | 2 | 151 | 0.022 | 0.021 | 0.004 | 0.046 |
| RAS | Q61 | CRC | Metastasis | 101 | 2354 | 0.042 | 0.042 | 0.036 | 0.049 |
| RAS | Q61 | CRC | Not Applicable or Heme | 7 | 224 | 0.040 | 0.040 | 0.025 | 0.053 |
| RAS | Q61 | CRC | Primary | 164 | 4115 | 0.040 | 0.040 | 0.035 | 0.046 |
| RAS | Q61 | CRC | Unspecified | 3 | 31 | 0.045 | 0.042 | 0.030 | 0.086 |
| RAS | Q61 | CUP | Metastasis | 30 | 1389 | 0.023 | 0.023 | 0.016 | 0.030 |
| RAS | Q61 | CUP | Not Applicable or Heme | 4 | 229 | 0.023 | 0.022 | 0.012 | 0.034 |
| RAS | Q61 | CUP | Primary | 10 | 311 | 0.026 | 0.025 | 0.016 | 0.041 |
| RAS | Q61 | CUP | Unspecified | 2 | 60 | 0.025 | 0.024 | 0.013 | 0.046 |
| RAS | Q61 | NSCLC | Metastasis | 95 | 3750 | 0.025 | 0.025 | 0.021 | 0.029 |
| RAS | Q61 | NSCLC | Not Applicable or Heme | 6 | 223 | 0.025 | 0.024 | 0.017 | 0.035 |
| RAS | Q61 | NSCLC | Primary | 143 | 6059 | 0.024 | 0.024 | 0.021 | 0.027 |
| RAS | Q61 | NSCLC | Unspecified | 1 | 99 | 0.024 | 0.024 | 0.013 | 0.033 |
| RAS | Q61 | Breast | Metastasis | 3 | 3094 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | Q61 | Breast | Not Applicable or Heme | 1 | 105 | 0.003 | 0.001 | 0.000 | 0.015 |
| RAS | Q61 | Breast | Primary | 6 | 6125 | 0.001 | 0.001 | 0.000 | 0.002 |
| RAS | Q61 | Soft tissue sarcoma | Metastasis | 9 | 939 | 0.011 | 0.011 | 0.006 | 0.016 |
| RAS | Q61 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.012 | 0.011 | 0.004 | 0.020 |
| RAS | Q61 | Soft tissue sarcoma | Primary | 23 | 1686 | 0.013 | 0.012 | 0.008 | 0.018 |
| RAS | Q61 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.012 | 0.011 | 0.003 | 0.023 |
| RAS | Q61 | Pancreatic | Metastasis | 61 | 981 | 0.061 | 0.061 | 0.048 | 0.077 |
| RAS | Q61 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.023 | 0.012 | 0.000 | 0.067 |
| RAS | Q61 | Pancreatic | Primary | 88 | 1429 | 0.061 | 0.061 | 0.050 | 0.074 |
| RAS | Q61 | Leukemia | Metastasis | 1 | 15 | 0.033 | 0.031 | 0.018 | 0.065 |
| RAS | Q61 | Leukemia | Not Applicable or Heme | 25 | 923 | 0.030 | 0.029 | 0.021 | 0.040 |
| RAS | Q61 | Leukemia | Primary | 13 | 412 | 0.031 | 0.031 | 0.021 | 0.045 |
| RAS | Q61 | Leukemia | Unspecified | 9 | 217 | 0.034 | 0.032 | 0.022 | 0.054 |
| RAS | Q61 | Melanoma | Metastasis | 386 | 1738 | 0.219 | 0.219 | 0.200 | 0.239 |
| RAS | Q61 | Melanoma | Not Applicable or Heme | 35 | 188 | 0.188 | 0.188 | 0.140 | 0.235 |
| RAS | Q61 | Melanoma | Primary | 163 | 898 | 0.184 | 0.184 | 0.159 | 0.209 |
| RAS | Q61 | Melanoma | Unspecified | 0 | 22 | 0.129 | 0.144 | 0.004 | 0.225 |
| RAS | Q61 | Head and neck | Metastasis | 7 | 731 | 0.012 | 0.012 | 0.006 | 0.020 |
| RAS | Q61 | Head and neck | Not Applicable or Heme | 1 | 67 | 0.015 | 0.014 | 0.005 | 0.031 |
| RAS | Q61 | Head and neck | Primary | 16 | 938 | 0.015 | 0.015 | 0.009 | 0.023 |
| RAS | Q61 | Uterine | Metastasis | 11 | 586 | 0.017 | 0.016 | 0.010 | 0.025 |
| RAS | Q61 | Uterine | Not Applicable or Heme | 0 | 76 | 0.015 | 0.015 | 0.004 | 0.025 |
| RAS | Q61 | Uterine | Primary | 23 | 1541 | 0.015 | 0.015 | 0.010 | 0.021 |
| RAS | Q61 | Uterine | Unspecified | 1 | 51 | 0.016 | 0.016 | 0.007 | 0.032 |
| RAS | Q61 | Non-melanoma skin | Metastasis | 3 | 203 | 0.013 | 0.012 | 0.004 | 0.029 |
| RAS | Q61 | Non-melanoma skin | Not Applicable or Heme | 1 | 22 | 0.019 | 0.013 | 0.004 | 0.075 |
| RAS | Q61 | Non-melanoma skin | Primary | 2 | 287 | 0.011 | 0.010 | 0.003 | 0.023 |
| RAS | Q61 | MDS/MPN | Metastasis | 0 | 11 | 0.010 | 0.004 | 0.000 | 0.066 |
| RAS | Q61 | MDS/MPN | Not Applicable or Heme | 1 | 915 | 0.002 | 0.002 | 0.000 | 0.006 |
| RAS | Q61 | MDS/MPN | Primary | 1 | 250 | 0.005 | 0.004 | 0.000 | 0.015 |
| RAS | Q61 | MDS/MPN | Unspecified | 2 | 31 | 0.037 | 0.026 | 0.002 | 0.133 |
| RAS | Q61 | Adrenocortical | Metastasis | 0 | 55 | 0.001 | 0.000 | 0.000 | 0.006 |
| RAS | Q61 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.005 |
| RAS | Q61 | Ovarian | Metastasis | 20 | 1088 | 0.019 | 0.019 | 0.013 | 0.026 |
| RAS | Q61 | Ovarian | Not Applicable or Heme | 4 | 160 | 0.020 | 0.019 | 0.012 | 0.034 |
| RAS | Q61 | Ovarian | Primary | 19 | 1060 | 0.019 | 0.019 | 0.013 | 0.026 |
| RAS | Q61 | Ovarian | Unspecified | 1 | 28 | 0.021 | 0.019 | 0.011 | 0.041 |
| RAS | Q61 | Esophagogastric | Metastasis | 2 | 462 | 0.005 | 0.005 | 0.002 | 0.011 |
| RAS | Q61 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.006 | 0.005 | 0.000 | 0.014 |
| RAS | Q61 | Esophagogastric | Primary | 8 | 1283 | 0.006 | 0.006 | 0.003 | 0.010 |
| RAS | Q61 | Esophagogastric | Unspecified | 0 | 14 | 0.006 | 0.005 | 0.000 | 0.017 |
| RAS | Q61 | Thyroid | Metastasis | 54 | 402 | 0.145 | 0.144 | 0.110 | 0.183 |
| RAS | Q61 | Thyroid | Not Applicable or Heme | 6 | 28 | 0.190 | 0.184 | 0.109 | 0.312 |
| RAS | Q61 | Thyroid | Primary | 120 | 582 | 0.200 | 0.200 | 0.168 | 0.234 |
| RAS | Q61 | Cervical | Metastasis | 1 | 136 | 0.007 | 0.005 | 0.001 | 0.020 |
| RAS | Q61 | Cervical | Not Applicable or Heme | 0 | 12 | 0.007 | 0.005 | 0.000 | 0.026 |
| RAS | Q61 | Cervical | Primary | 1 | 211 | 0.006 | 0.005 | 0.001 | 0.017 |
| RAS | Q61 | Hepatobiliary | Metastasis | 12 | 438 | 0.026 | 0.026 | 0.016 | 0.040 |
| RAS | Q61 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.021 | 0.023 | 0.000 | 0.042 |
| RAS | Q61 | Hepatobiliary | Primary | 23 | 895 | 0.026 | 0.025 | 0.017 | 0.036 |
| RAS | Q61 | Kidney | Metastasis | 0 | 445 | 0.001 | 0.001 | 0.000 | 0.004 |
| RAS | Q61 | Kidney | Not Applicable or Heme | 0 | 24 | 0.002 | 0.001 | 0.000 | 0.012 |
| RAS | Q61 | Kidney | Primary | 2 | 944 | 0.002 | 0.001 | 0.000 | 0.005 |
| RAS | Q61 | T / NK neoplasms | Metastasis | 0 | 10 | 0.018 | 0.014 | 0.000 | 0.065 |
| RAS | Q61 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.015 | 0.012 | 0.000 | 0.045 |
| RAS | Q61 | T / NK neoplasms | Primary | 4 | 187 | 0.019 | 0.018 | 0.005 | 0.042 |
| RAS | Q61 | CNS | Metastasis | 5 | 409 | 0.009 | 0.008 | 0.005 | 0.017 |
| RAS | Q61 | CNS | Not Applicable or Heme | 2 | 526 | 0.007 | 0.007 | 0.002 | 0.011 |
| RAS | Q61 | CNS | Primary | 24 | 3522 | 0.007 | 0.007 | 0.005 | 0.010 |
| RAS | Q61 | CNS | Unspecified | 2 | 108 | 0.009 | 0.008 | 0.004 | 0.024 |
| RAS | Q61 | Prostate | Metastasis | 10 | 901 | 0.010 | 0.009 | 0.005 | 0.016 |
| RAS | Q61 | Prostate | Not Applicable or Heme | 0 | 57 | 0.009 | 0.008 | 0.001 | 0.021 |
| RAS | Q61 | Prostate | Primary | 10 | 1468 | 0.008 | 0.008 | 0.004 | 0.012 |
| RAS | Q61 | Prostate | Unspecified | 1 | 12 | 0.017 | 0.010 | 0.004 | 0.092 |
| RAS | Q61 | Anal | Metastasis | 1 | 59 | 0.013 | 0.008 | 0.000 | 0.049 |
| RAS | Q61 | Anal | Primary | 0 | 84 | 0.005 | 0.003 | 0.000 | 0.025 |
| RAS | Q61 | Neuroendocrine | Metastasis | 1 | 143 | 0.011 | 0.009 | 0.001 | 0.026 |
| RAS | Q61 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.012 | 0.010 | 0.000 | 0.036 |
| RAS | Q61 | Neuroendocrine | Primary | 3 | 196 | 0.013 | 0.011 | 0.003 | 0.029 |
| RAS | Q61 | Bladder | Metastasis | 8 | 390 | 0.023 | 0.023 | 0.012 | 0.035 |
| RAS | Q61 | Bladder | Not Applicable or Heme | 0 | 25 | 0.023 | 0.023 | 0.001 | 0.045 |
| RAS | Q61 | Bladder | Primary | 32 | 1164 | 0.026 | 0.026 | 0.018 | 0.036 |
| RAS | Q61 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.028 | 0.021 | 0.000 | 0.105 |
| RAS | Q61 | BLL/Lymphoma | Not Applicable or Heme | 3 | 109 | 0.030 | 0.028 | 0.008 | 0.064 |
| RAS | Q61 | BLL/Lymphoma | Primary | 1 | 101 | 0.019 | 0.016 | 0.001 | 0.051 |
| RAS | Q61 | BLL/Lymphoma | Unspecified | 4 | 25 | 0.106 | 0.092 | 0.021 | 0.272 |
| RAS | Q61 | Small bowel | Metastasis | 4 | 78 | 0.042 | 0.038 | 0.014 | 0.090 |
| RAS | Q61 | Small bowel | Primary | 3 | 128 | 0.031 | 0.029 | 0.009 | 0.063 |
| RAS | Q61 | Sex cord stromal | Metastasis | 0 | 49 | 0.000 | 0.000 | 0.000 | 0.006 |
| RAS | Q61 | Sex cord stromal | Primary | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.006 |
| RAS | Q61 | Bone | Metastasis | 1 | 203 | 0.003 | 0.002 | 0.000 | 0.013 |
| RAS | Q61 | Bone | Not Applicable or Heme | 0 | 25 | 0.002 | 0.001 | 0.000 | 0.013 |
| RAS | Q61 | Bone | Primary | 0 | 326 | 0.001 | 0.001 | 0.000 | 0.006 |
| RAS | Q61 | Bone | Unspecified | 0 | 16 | 0.003 | 0.001 | 0.000 | 0.015 |
| RAS | Q61 | Vaginal | Metastasis | 1 | 16 | 0.046 | 0.027 | 0.001 | 0.190 |
| RAS | Q61 | Vaginal | Primary | 0 | 60 | 0.007 | 0.001 | 0.000 | 0.040 |
| RAS | Q61 | Thymic | Metastasis | 3 | 61 | 0.037 | 0.032 | 0.009 | 0.093 |
| RAS | Q61 | Thymic | Primary | 1 | 84 | 0.023 | 0.020 | 0.002 | 0.057 |
| RAS | Q61 | Ampullary | Metastasis | 0 | 23 | 0.028 | 0.022 | 0.000 | 0.092 |
| RAS | Q61 | Ampullary | Primary | 5 | 82 | 0.055 | 0.052 | 0.018 | 0.112 |
| RAS | Q61 | SCLC | Metastasis | 1 | 207 | 0.006 | 0.005 | 0.001 | 0.016 |
| RAS | Q61 | SCLC | Primary | 1 | 183 | 0.006 | 0.005 | 0.001 | 0.017 |
| RAS | Q61 | Mesothelioma | Metastasis | 0 | 82 | 0.002 | 0.001 | 0.000 | 0.011 |
| RAS | Q61 | Mesothelioma | Primary | 1 | 408 | 0.002 | 0.002 | 0.000 | 0.009 |
| RAS | Q61 | Germ cell | Metastasis | 6 | 274 | 0.016 | 0.015 | 0.007 | 0.033 |
| RAS | Q61 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.010 | 0.010 | 0.000 | 0.024 |
| RAS | Q61 | Germ cell | Primary | 5 | 517 | 0.011 | 0.011 | 0.004 | 0.021 |
| RAS | Q61 | Germ cell | Unspecified | 0 | 14 | 0.013 | 0.011 | 0.000 | 0.037 |
| RAS | Q61 | Nerve sheath | Metastasis | 0 | 16 | 0.015 | 0.011 | 0.000 | 0.058 |
| RAS | Q61 | Nerve sheath | Not Applicable or Heme | 1 | 17 | 0.026 | 0.016 | 0.002 | 0.115 |
| RAS | Q61 | Nerve sheath | Primary | 1 | 117 | 0.013 | 0.011 | 0.001 | 0.037 |
| RAS | Q61 | Penile | Metastasis | 0 | 11 | 0.037 | 0.023 | 0.000 | 0.153 |
| RAS | Q61 | Penile | Primary | 1 | 13 | 0.059 | 0.042 | 0.003 | 0.208 |
| RAS | Q61 | Pheochromocytoma | Primary | 1 | 18 | 0.063 | 0.048 | 0.002 | 0.208 |
| RAS | Q61 | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.049 |
| RAS | Q61 | B cell lymphoma | Metastasis | 2 | 57 | 0.029 | 0.027 | 0.014 | 0.054 |
| RAS | Q61 | B cell lymphoma | Not Applicable or Heme | 5 | 145 | 0.029 | 0.028 | 0.016 | 0.050 |
| RAS | Q61 | B cell lymphoma | Primary | 18 | 709 | 0.027 | 0.026 | 0.017 | 0.038 |
| RAS | Q61 | B cell lymphoma | Unspecified | 1 | 51 | 0.027 | 0.026 | 0.011 | 0.048 |
| RAS | Q61 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.034 |
| RAS | Q61 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.017 |
| RAS | Q61 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| RAS | Q61 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.020 |
| RAS | Q61 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.013 |
| RAS | Q61 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.016 |
| RAS | Q61 | Lung | Primary | 1 | 17 | 0.067 | 0.051 | 0.003 | 0.218 |
| RAS | Q61 | Parathyroid | Primary | 1 | 13 | 0.087 | 0.067 | 0.004 | 0.277 |
| KRAS | 12, 13, or 61 | Appendiceal | <40 | 20 | 28 | 0.567 | 0.547 | 0.443 | 0.769 |
| KRAS | 12, 13, or 61 | Appendiceal | 40-50 | 29 | 62 | 0.485 | 0.486 | 0.389 | 0.575 |
| KRAS | 12, 13, or 61 | Appendiceal | 50-65 | 72 | 161 | 0.468 | 0.469 | 0.394 | 0.535 |
| KRAS | 12, 13, or 61 | Appendiceal | >65 | 45 | 90 | 0.498 | 0.496 | 0.417 | 0.583 |
| KRAS | 12, 13, or 61 | CRC | <40 | 207 | 565 | 0.384 | 0.385 | 0.349 | 0.410 |
| KRAS | 12, 13, or 61 | CRC | 40-50 | 509 | 1280 | 0.396 | 0.396 | 0.375 | 0.417 |
| KRAS | 12, 13, or 61 | CRC | 50-65 | 1142 | 2815 | 0.402 | 0.402 | 0.386 | 0.419 |
| KRAS | 12, 13, or 61 | CRC | >65 | 801 | 2055 | 0.391 | 0.392 | 0.373 | 0.410 |
| KRAS | 12, 13, or 61 | CUP | <40 | 8 | 167 | 0.061 | 0.059 | 0.028 | 0.105 |
| KRAS | 12, 13, or 61 | CUP | 40-50 | 33 | 211 | 0.156 | 0.155 | 0.111 | 0.206 |
| KRAS | 12, 13, or 61 | CUP | 50-65 | 159 | 810 | 0.195 | 0.195 | 0.169 | 0.223 |
| KRAS | 12, 13, or 61 | CUP | >65 | 174 | 797 | 0.217 | 0.217 | 0.189 | 0.246 |
| KRAS | 12, 13, or 61 | NSCLC | <40 | 12 | 161 | 0.087 | 0.085 | 0.048 | 0.136 |
| KRAS | 12, 13, or 61 | NSCLC | 40-50 | 104 | 585 | 0.178 | 0.178 | 0.149 | 0.210 |
| KRAS | 12, 13, or 61 | NSCLC | 50-65 | 1056 | 3677 | 0.287 | 0.287 | 0.272 | 0.301 |
| KRAS | 12, 13, or 61 | NSCLC | >65 | 1744 | 5698 | 0.306 | 0.306 | 0.294 | 0.318 |
| KRAS | 12, 13, or 61 | NSCLC | NA | 1 | 10 | 0.155 | 0.145 | 0.031 | 0.338 |
| KRAS | 12, 13, or 61 | Breast | <40 | 3 | 841 | 0.005 | 0.005 | 0.002 | 0.010 |
| KRAS | 12, 13, or 61 | Breast | 40-50 | 6 | 1910 | 0.005 | 0.004 | 0.002 | 0.008 |
| KRAS | 12, 13, or 61 | Breast | 50-65 | 35 | 3989 | 0.009 | 0.008 | 0.006 | 0.011 |
| KRAS | 12, 13, or 61 | Breast | >65 | 27 | 2583 | 0.010 | 0.010 | 0.006 | 0.014 |
| KRAS | 12, 13, or 61 | Breast | NA | 1 | 10 | 0.019 | 0.009 | 0.003 | 0.112 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | <40 | 8 | 672 | 0.010 | 0.009 | 0.006 | 0.016 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | 40-50 | 1 | 367 | 0.008 | 0.008 | 0.002 | 0.013 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | 50-65 | 7 | 951 | 0.009 | 0.008 | 0.004 | 0.013 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | >65 | 9 | 777 | 0.010 | 0.009 | 0.006 | 0.016 |
| KRAS | 12, 13, or 61 | Pancreatic | <40 | 22 | 87 | 0.268 | 0.266 | 0.180 | 0.368 |
| KRAS | 12, 13, or 61 | Pancreatic | 40-50 | 117 | 200 | 0.585 | 0.585 | 0.518 | 0.651 |
| KRAS | 12, 13, or 61 | Pancreatic | 50-65 | 717 | 1000 | 0.717 | 0.717 | 0.688 | 0.744 |
| KRAS | 12, 13, or 61 | Pancreatic | >65 | 977 | 1205 | 0.810 | 0.810 | 0.787 | 0.832 |
| KRAS | 12, 13, or 61 | Leukemia | <40 | 15 | 204 | 0.055 | 0.052 | 0.037 | 0.088 |
| KRAS | 12, 13, or 61 | Leukemia | 40-50 | 4 | 128 | 0.044 | 0.044 | 0.022 | 0.065 |
| KRAS | 12, 13, or 61 | Leukemia | 50-65 | 26 | 515 | 0.049 | 0.048 | 0.035 | 0.065 |
| KRAS | 12, 13, or 61 | Leukemia | >65 | 28 | 720 | 0.043 | 0.043 | 0.030 | 0.057 |
| KRAS | 12, 13, or 61 | Melanoma | <40 | 0 | 289 | 0.002 | 0.001 | 0.000 | 0.009 |
| KRAS | 12, 13, or 61 | Melanoma | 40-50 | 0 | 282 | 0.002 | 0.001 | 0.000 | 0.009 |
| KRAS | 12, 13, or 61 | Melanoma | 50-65 | 9 | 1016 | 0.009 | 0.008 | 0.004 | 0.015 |
| KRAS | 12, 13, or 61 | Melanoma | >65 | 28 | 1259 | 0.022 | 0.022 | 0.014 | 0.031 |
| KRAS | 12, 13, or 61 | Head and neck | <40 | 1 | 140 | 0.007 | 0.007 | 0.003 | 0.014 |
| KRAS | 12, 13, or 61 | Head and neck | 40-50 | 1 | 216 | 0.007 | 0.007 | 0.002 | 0.013 |
| KRAS | 12, 13, or 61 | Head and neck | 50-65 | 6 | 799 | 0.007 | 0.007 | 0.003 | 0.012 |
| KRAS | 12, 13, or 61 | Head and neck | >65 | 4 | 582 | 0.007 | 0.007 | 0.003 | 0.012 |
| KRAS | 12, 13, or 61 | Uterine | <40 | 2 | 57 | 0.103 | 0.108 | 0.024 | 0.166 |
| KRAS | 12, 13, or 61 | Uterine | 40-50 | 29 | 162 | 0.165 | 0.161 | 0.123 | 0.223 |
| KRAS | 12, 13, or 61 | Uterine | 50-65 | 172 | 1046 | 0.161 | 0.161 | 0.140 | 0.184 |
| KRAS | 12, 13, or 61 | Uterine | >65 | 136 | 988 | 0.140 | 0.140 | 0.119 | 0.161 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | <40 | 0 | 27 | 0.005 | 0.003 | 0.000 | 0.016 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | 40-50 | 0 | 20 | 0.005 | 0.003 | 0.000 | 0.017 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | 50-65 | 1 | 149 | 0.005 | 0.004 | 0.000 | 0.015 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | >65 | 1 | 317 | 0.004 | 0.003 | 0.000 | 0.012 |
| KRAS | 12, 13, or 61 | MDS/MPN | <40 | 3 | 87 | 0.018 | 0.016 | 0.008 | 0.046 |
| KRAS | 12, 13, or 61 | MDS/MPN | 40-50 | 0 | 83 | 0.014 | 0.013 | 0.002 | 0.025 |
| KRAS | 12, 13, or 61 | MDS/MPN | 50-65 | 5 | 373 | 0.015 | 0.014 | 0.007 | 0.025 |
| KRAS | 12, 13, or 61 | MDS/MPN | >65 | 10 | 664 | 0.015 | 0.015 | 0.008 | 0.024 |
| KRAS | 12, 13, or 61 | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Ovarian | <40 | 36 | 141 | 0.240 | 0.239 | 0.173 | 0.315 |
| KRAS | 12, 13, or 61 | Ovarian | 40-50 | 34 | 253 | 0.133 | 0.132 | 0.096 | 0.176 |
| KRAS | 12, 13, or 61 | Ovarian | 50-65 | 92 | 1092 | 0.085 | 0.085 | 0.070 | 0.103 |
| KRAS | 12, 13, or 61 | Ovarian | >65 | 63 | 849 | 0.076 | 0.076 | 0.059 | 0.094 |
| KRAS | 12, 13, or 61 | Esophagogastric | <40 | 5 | 122 | 0.049 | 0.049 | 0.028 | 0.069 |
| KRAS | 12, 13, or 61 | Esophagogastric | 40-50 | 9 | 200 | 0.050 | 0.049 | 0.032 | 0.068 |
| KRAS | 12, 13, or 61 | Esophagogastric | 50-65 | 33 | 752 | 0.048 | 0.048 | 0.035 | 0.061 |
| KRAS | 12, 13, or 61 | Esophagogastric | >65 | 45 | 725 | 0.056 | 0.055 | 0.043 | 0.072 |
| KRAS | 12, 13, or 61 | Thyroid | <40 | 3 | 150 | 0.026 | 0.025 | 0.011 | 0.042 |
| KRAS | 12, 13, or 61 | Thyroid | 40-50 | 2 | 122 | 0.025 | 0.025 | 0.009 | 0.042 |
| KRAS | 12, 13, or 61 | Thyroid | 50-65 | 15 | 374 | 0.032 | 0.030 | 0.019 | 0.051 |
| KRAS | 12, 13, or 61 | Thyroid | >65 | 8 | 370 | 0.025 | 0.025 | 0.014 | 0.038 |
| KRAS | 12, 13, or 61 | Cervical | <40 | 3 | 85 | 0.069 | 0.070 | 0.024 | 0.112 |
| KRAS | 12, 13, or 61 | Cervical | 40-50 | 8 | 99 | 0.083 | 0.082 | 0.047 | 0.126 |
| KRAS | 12, 13, or 61 | Cervical | 50-65 | 16 | 144 | 0.095 | 0.093 | 0.060 | 0.144 |
| KRAS | 12, 13, or 61 | Cervical | >65 | 4 | 36 | 0.091 | 0.087 | 0.046 | 0.164 |
| KRAS | 12, 13, or 61 | Hepatobiliary | <40 | 6 | 138 | 0.080 | 0.083 | 0.033 | 0.116 |
| KRAS | 12, 13, or 61 | Hepatobiliary | 40-50 | 13 | 110 | 0.106 | 0.104 | 0.072 | 0.155 |
| KRAS | 12, 13, or 61 | Hepatobiliary | 50-65 | 54 | 525 | 0.102 | 0.102 | 0.081 | 0.125 |
| KRAS | 12, 13, or 61 | Hepatobiliary | >65 | 68 | 601 | 0.108 | 0.107 | 0.088 | 0.133 |
| KRAS | 12, 13, or 61 | Kidney | <40 | 1 | 191 | 0.009 | 0.009 | 0.003 | 0.016 |
| KRAS | 12, 13, or 61 | Kidney | 40-50 | 2 | 159 | 0.010 | 0.009 | 0.004 | 0.019 |
| KRAS | 12, 13, or 61 | Kidney | 50-65 | 5 | 628 | 0.009 | 0.009 | 0.004 | 0.015 |
| KRAS | 12, 13, or 61 | Kidney | >65 | 5 | 440 | 0.010 | 0.009 | 0.005 | 0.017 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | <40 | 1 | 28 | 0.019 | 0.014 | 0.003 | 0.071 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | 40-50 | 1 | 21 | 0.021 | 0.015 | 0.003 | 0.085 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | 50-65 | 0 | 76 | 0.011 | 0.010 | 0.000 | 0.032 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | >65 | 1 | 106 | 0.013 | 0.011 | 0.002 | 0.034 |
| KRAS | 12, 13, or 61 | CNS | <40 | 16 | 1602 | 0.009 | 0.009 | 0.006 | 0.013 |
| KRAS | 12, 13, or 61 | CNS | 40-50 | 9 | 687 | 0.010 | 0.009 | 0.006 | 0.017 |
| KRAS | 12, 13, or 61 | CNS | 50-65 | 7 | 1439 | 0.007 | 0.007 | 0.003 | 0.011 |
| KRAS | 12, 13, or 61 | CNS | >65 | 5 | 836 | 0.008 | 0.008 | 0.004 | 0.012 |
| KRAS | 12, 13, or 61 | Prostate | 40-50 | 0 | 70 | 0.005 | 0.005 | 0.001 | 0.012 |
| KRAS | 12, 13, or 61 | Prostate | 50-65 | 5 | 960 | 0.005 | 0.005 | 0.002 | 0.009 |
| KRAS | 12, 13, or 61 | Prostate | >65 | 7 | 1402 | 0.005 | 0.005 | 0.002 | 0.009 |
| KRAS | 12, 13, or 61 | Anal | 40-50 | 0 | 12 | 0.033 | 0.030 | 0.001 | 0.085 |
| KRAS | 12, 13, or 61 | Anal | 50-65 | 4 | 88 | 0.038 | 0.035 | 0.012 | 0.079 |
| KRAS | 12, 13, or 61 | Anal | >65 | 1 | 45 | 0.033 | 0.030 | 0.005 | 0.075 |
| KRAS | 12, 13, or 61 | Neuroendocrine | <40 | 2 | 22 | 0.091 | 0.085 | 0.030 | 0.189 |
| KRAS | 12, 13, or 61 | Neuroendocrine | 40-50 | 10 | 55 | 0.134 | 0.126 | 0.066 | 0.245 |
| KRAS | 12, 13, or 61 | Neuroendocrine | 50-65 | 13 | 161 | 0.083 | 0.082 | 0.049 | 0.124 |
| KRAS | 12, 13, or 61 | Neuroendocrine | >65 | 5 | 121 | 0.061 | 0.060 | 0.023 | 0.106 |
| KRAS | 12, 13, or 61 | Bladder | <40 | 1 | 25 | 0.047 | 0.047 | 0.016 | 0.082 |
| KRAS | 12, 13, or 61 | Bladder | 40-50 | 1 | 78 | 0.041 | 0.043 | 0.010 | 0.063 |
| KRAS | 12, 13, or 61 | Bladder | 50-65 | 28 | 511 | 0.051 | 0.050 | 0.037 | 0.069 |
| KRAS | 12, 13, or 61 | Bladder | >65 | 46 | 962 | 0.048 | 0.048 | 0.036 | 0.060 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | <40 | 16 | 142 | 0.099 | 0.096 | 0.055 | 0.155 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.045 | 0.041 | 0.000 | 0.117 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | 50-65 | 1 | 48 | 0.044 | 0.040 | 0.004 | 0.101 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | >65 | 2 | 42 | 0.056 | 0.054 | 0.012 | 0.118 |
| KRAS | 12, 13, or 61 | Small bowel | 40-50 | 13 | 29 | 0.425 | 0.423 | 0.319 | 0.549 |
| KRAS | 12, 13, or 61 | Small bowel | 50-65 | 44 | 96 | 0.435 | 0.433 | 0.356 | 0.524 |
| KRAS | 12, 13, or 61 | Small bowel | >65 | 28 | 78 | 0.397 | 0.399 | 0.299 | 0.482 |
| KRAS | 12, 13, or 61 | Sex cord stromal | <40 | 1 | 29 | 0.023 | 0.019 | 0.003 | 0.073 |
| KRAS | 12, 13, or 61 | Sex cord stromal | 40-50 | 0 | 15 | 0.019 | 0.015 | 0.000 | 0.061 |
| KRAS | 12, 13, or 61 | Sex cord stromal | 50-65 | 1 | 37 | 0.022 | 0.018 | 0.003 | 0.067 |
| KRAS | 12, 13, or 61 | Sex cord stromal | >65 | 0 | 27 | 0.018 | 0.015 | 0.000 | 0.056 |
| KRAS | 12, 13, or 61 | Bone | <40 | 2 | 342 | 0.010 | 0.009 | 0.003 | 0.020 |
| KRAS | 12, 13, or 61 | Bone | 40-50 | 1 | 61 | 0.013 | 0.011 | 0.003 | 0.034 |
| KRAS | 12, 13, or 61 | Bone | 50-65 | 1 | 96 | 0.012 | 0.010 | 0.003 | 0.028 |
| KRAS | 12, 13, or 61 | Bone | >65 | 2 | 67 | 0.015 | 0.012 | 0.004 | 0.044 |
| KRAS | 12, 13, or 61 | Vaginal | 50-65 | 2 | 34 | 0.064 | 0.059 | 0.016 | 0.141 |
| KRAS | 12, 13, or 61 | Vaginal | >65 | 2 | 30 | 0.066 | 0.061 | 0.016 | 0.151 |
| KRAS | 12, 13, or 61 | Thymic | <40 | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | 12, 13, or 61 | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | 12, 13, or 61 | Ampullary | 40-50 | 3 | 12 | 0.431 | 0.456 | 0.132 | 0.653 |
| KRAS | 12, 13, or 61 | Ampullary | 50-65 | 26 | 40 | 0.612 | 0.609 | 0.481 | 0.753 |
| KRAS | 12, 13, or 61 | Ampullary | >65 | 30 | 50 | 0.586 | 0.586 | 0.466 | 0.709 |
| KRAS | 12, 13, or 61 | SCLC | 40-50 | 0 | 22 | 0.027 | 0.026 | 0.003 | 0.057 |
| KRAS | 12, 13, or 61 | SCLC | 50-65 | 4 | 144 | 0.028 | 0.027 | 0.012 | 0.052 |
| KRAS | 12, 13, or 61 | SCLC | >65 | 7 | 224 | 0.029 | 0.028 | 0.014 | 0.051 |
| KRAS | 12, 13, or 61 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Germ cell | <40 | 29 | 650 | 0.047 | 0.047 | 0.032 | 0.065 |
| KRAS | 12, 13, or 61 | Germ cell | 40-50 | 19 | 131 | 0.128 | 0.126 | 0.072 | 0.194 |
| KRAS | 12, 13, or 61 | Germ cell | 50-65 | 5 | 92 | 0.061 | 0.059 | 0.025 | 0.109 |
| KRAS | 12, 13, or 61 | Germ cell | >65 | 1 | 12 | 0.082 | 0.071 | 0.017 | 0.210 |
| KRAS | 12, 13, or 61 | Nerve sheath | <40 | 0 | 77 | 0.006 | 0.003 | 0.000 | 0.024 |
| KRAS | 12, 13, or 61 | Nerve sheath | 40-50 | 1 | 27 | 0.018 | 0.009 | 0.000 | 0.089 |
| KRAS | 12, 13, or 61 | Nerve sheath | 50-65 | 0 | 37 | 0.007 | 0.004 | 0.000 | 0.030 |
| KRAS | 12, 13, or 61 | Nerve sheath | >65 | 0 | 13 | 0.008 | 0.004 | 0.000 | 0.041 |
| KRAS | 12, 13, or 61 | Penile | 50-65 | 0 | 11 | 0.037 | 0.021 | 0.000 | 0.162 |
| KRAS | 12, 13, or 61 | Penile | >65 | 1 | 11 | 0.070 | 0.050 | 0.003 | 0.248 |
| KRAS | 12, 13, or 61 | Pineal | <40 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.044 |
| KRAS | 12, 13, or 61 | B cell lymphoma | <40 | 0 | 87 | 0.027 | 0.029 | 0.001 | 0.050 |
| KRAS | 12, 13, or 61 | B cell lymphoma | 40-50 | 6 | 105 | 0.044 | 0.040 | 0.023 | 0.084 |
| KRAS | 12, 13, or 61 | B cell lymphoma | 50-65 | 12 | 357 | 0.035 | 0.035 | 0.020 | 0.052 |
| KRAS | 12, 13, or 61 | B cell lymphoma | >65 | 18 | 413 | 0.040 | 0.039 | 0.026 | 0.059 |
| KRAS | 12, 13, or 61 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | <40 | 1 | 27 | 0.041 | 0.031 | 0.002 | 0.139 |
| KRAS | 12, 13, or 61 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.011 |
| KRAS | 12, 13, or 61 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| KRAS | 12, 13, or 61 | Lung | >65 | 2 | 18 | 0.116 | 0.102 | 0.017 | 0.295 |
| KRAS | 12, 13, or 61 | Peritoneal | >65 | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.059 |
| KRAS | G12 | Appendiceal | <40 | 19 | 28 | 0.522 | 0.500 | 0.389 | 0.742 |
| KRAS | G12 | Appendiceal | 40-50 | 25 | 62 | 0.423 | 0.424 | 0.325 | 0.517 |
| KRAS | G12 | Appendiceal | 50-65 | 65 | 161 | 0.418 | 0.418 | 0.347 | 0.484 |
| KRAS | G12 | Appendiceal | >65 | 38 | 90 | 0.431 | 0.430 | 0.348 | 0.514 |
| KRAS | G12 | CRC | <40 | 156 | 565 | 0.290 | 0.291 | 0.259 | 0.316 |
| KRAS | G12 | CRC | 40-50 | 389 | 1280 | 0.301 | 0.301 | 0.281 | 0.323 |
| KRAS | G12 | CRC | 50-65 | 879 | 2815 | 0.308 | 0.308 | 0.293 | 0.325 |
| KRAS | G12 | CRC | >65 | 593 | 2055 | 0.292 | 0.292 | 0.274 | 0.309 |
| KRAS | G12 | CUP | <40 | 5 | 167 | 0.041 | 0.039 | 0.015 | 0.080 |
| KRAS | G12 | CUP | 40-50 | 26 | 211 | 0.123 | 0.121 | 0.083 | 0.168 |
| KRAS | G12 | CUP | 50-65 | 134 | 810 | 0.164 | 0.164 | 0.140 | 0.190 |
| KRAS | G12 | CUP | >65 | 148 | 797 | 0.184 | 0.184 | 0.158 | 0.212 |
| KRAS | G12 | NSCLC | <40 | 10 | 161 | 0.075 | 0.073 | 0.039 | 0.121 |
| KRAS | G12 | NSCLC | 40-50 | 87 | 585 | 0.150 | 0.149 | 0.122 | 0.179 |
| KRAS | G12 | NSCLC | 50-65 | 903 | 3677 | 0.245 | 0.245 | 0.232 | 0.259 |
| KRAS | G12 | NSCLC | >65 | 1534 | 5698 | 0.269 | 0.269 | 0.258 | 0.281 |
| KRAS | G12 | NSCLC | NA | 1 | 10 | 0.147 | 0.138 | 0.031 | 0.324 |
| KRAS | G12 | Breast | <40 | 3 | 841 | 0.005 | 0.005 | 0.002 | 0.009 |
| KRAS | G12 | Breast | 40-50 | 6 | 1910 | 0.005 | 0.005 | 0.002 | 0.008 |
| KRAS | G12 | Breast | 50-65 | 30 | 3989 | 0.007 | 0.007 | 0.005 | 0.010 |
| KRAS | G12 | Breast | >65 | 25 | 2583 | 0.009 | 0.008 | 0.006 | 0.013 |
| KRAS | G12 | Breast | NA | 1 | 10 | 0.016 | 0.008 | 0.003 | 0.094 |
| KRAS | G12 | Soft tissue sarcoma | <40 | 8 | 672 | 0.009 | 0.009 | 0.005 | 0.016 |
| KRAS | G12 | Soft tissue sarcoma | 40-50 | 1 | 367 | 0.007 | 0.007 | 0.002 | 0.013 |
| KRAS | G12 | Soft tissue sarcoma | 50-65 | 6 | 951 | 0.008 | 0.008 | 0.004 | 0.012 |
| KRAS | G12 | Soft tissue sarcoma | >65 | 8 | 777 | 0.009 | 0.009 | 0.005 | 0.015 |
| KRAS | G12 | Pancreatic | <40 | 22 | 87 | 0.271 | 0.269 | 0.182 | 0.372 |
| KRAS | G12 | Pancreatic | 40-50 | 105 | 200 | 0.526 | 0.526 | 0.457 | 0.594 |
| KRAS | G12 | Pancreatic | 50-65 | 669 | 1000 | 0.668 | 0.668 | 0.639 | 0.697 |
| KRAS | G12 | Pancreatic | >65 | 881 | 1205 | 0.730 | 0.730 | 0.705 | 0.755 |
| KRAS | G12 | Leukemia | <40 | 6 | 204 | 0.028 | 0.028 | 0.015 | 0.045 |
| KRAS | G12 | Leukemia | 40-50 | 0 | 128 | 0.021 | 0.023 | 0.001 | 0.037 |
| KRAS | G12 | Leukemia | 50-65 | 17 | 515 | 0.030 | 0.029 | 0.020 | 0.044 |
| KRAS | G12 | Leukemia | >65 | 21 | 720 | 0.028 | 0.028 | 0.019 | 0.040 |
| KRAS | G12 | Melanoma | <40 | 0 | 289 | 0.002 | 0.001 | 0.000 | 0.010 |
| KRAS | G12 | Melanoma | 40-50 | 0 | 282 | 0.002 | 0.001 | 0.000 | 0.010 |
| KRAS | G12 | Melanoma | 50-65 | 6 | 1016 | 0.006 | 0.006 | 0.002 | 0.011 |
| KRAS | G12 | Melanoma | >65 | 17 | 1259 | 0.013 | 0.012 | 0.007 | 0.020 |
| KRAS | G12 | Head and neck | <40 | 1 | 140 | 0.006 | 0.005 | 0.002 | 0.013 |
| KRAS | G12 | Head and neck | 40-50 | 1 | 216 | 0.005 | 0.005 | 0.002 | 0.011 |
| KRAS | G12 | Head and neck | 50-65 | 4 | 799 | 0.005 | 0.005 | 0.002 | 0.010 |
| KRAS | G12 | Head and neck | >65 | 3 | 582 | 0.005 | 0.005 | 0.002 | 0.010 |
| KRAS | G12 | Uterine | <40 | 1 | 57 | 0.070 | 0.069 | 0.008 | 0.136 |
| KRAS | G12 | Uterine | 40-50 | 26 | 162 | 0.147 | 0.144 | 0.104 | 0.206 |
| KRAS | G12 | Uterine | 50-65 | 146 | 1046 | 0.137 | 0.137 | 0.117 | 0.159 |
| KRAS | G12 | Uterine | >65 | 106 | 988 | 0.109 | 0.109 | 0.090 | 0.129 |
| KRAS | G12 | Non-melanoma skin | <40 | 0 | 27 | 0.005 | 0.003 | 0.000 | 0.016 |
| KRAS | G12 | Non-melanoma skin | 40-50 | 0 | 20 | 0.005 | 0.004 | 0.000 | 0.018 |
| KRAS | G12 | Non-melanoma skin | 50-65 | 1 | 149 | 0.005 | 0.004 | 0.001 | 0.015 |
| KRAS | G12 | Non-melanoma skin | >65 | 1 | 317 | 0.004 | 0.003 | 0.000 | 0.012 |
| KRAS | G12 | MDS/MPN | <40 | 1 | 87 | 0.010 | 0.009 | 0.003 | 0.022 |
| KRAS | G12 | MDS/MPN | 40-50 | 0 | 83 | 0.009 | 0.008 | 0.001 | 0.018 |
| KRAS | G12 | MDS/MPN | 50-65 | 4 | 373 | 0.010 | 0.009 | 0.004 | 0.018 |
| KRAS | G12 | MDS/MPN | >65 | 6 | 664 | 0.009 | 0.009 | 0.004 | 0.016 |
| KRAS | G12 | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12 | Ovarian | <40 | 33 | 141 | 0.218 | 0.217 | 0.151 | 0.292 |
| KRAS | G12 | Ovarian | 40-50 | 29 | 253 | 0.114 | 0.113 | 0.079 | 0.154 |
| KRAS | G12 | Ovarian | 50-65 | 83 | 1092 | 0.077 | 0.077 | 0.062 | 0.093 |
| KRAS | G12 | Ovarian | >65 | 57 | 849 | 0.069 | 0.068 | 0.053 | 0.087 |
| KRAS | G12 | Esophagogastric | <40 | 4 | 122 | 0.036 | 0.036 | 0.021 | 0.054 |
| KRAS | G12 | Esophagogastric | 40-50 | 7 | 200 | 0.036 | 0.036 | 0.023 | 0.052 |
| KRAS | G12 | Esophagogastric | 50-65 | 23 | 752 | 0.034 | 0.034 | 0.024 | 0.045 |
| KRAS | G12 | Esophagogastric | >65 | 32 | 725 | 0.039 | 0.039 | 0.029 | 0.053 |
| KRAS | G12 | Thyroid | <40 | 1 | 150 | 0.010 | 0.010 | 0.001 | 0.022 |
| KRAS | G12 | Thyroid | 40-50 | 0 | 122 | 0.009 | 0.009 | 0.000 | 0.020 |
| KRAS | G12 | Thyroid | 50-65 | 8 | 374 | 0.016 | 0.015 | 0.007 | 0.031 |
| KRAS | G12 | Thyroid | >65 | 3 | 370 | 0.010 | 0.010 | 0.003 | 0.019 |
| KRAS | G12 | Cervical | <40 | 3 | 85 | 0.061 | 0.062 | 0.021 | 0.101 |
| KRAS | G12 | Cervical | 40-50 | 5 | 99 | 0.065 | 0.065 | 0.028 | 0.104 |
| KRAS | G12 | Cervical | 50-65 | 15 | 144 | 0.087 | 0.084 | 0.053 | 0.137 |
| KRAS | G12 | Cervical | >65 | 4 | 36 | 0.083 | 0.078 | 0.040 | 0.163 |
| KRAS | G12 | Hepatobiliary | <40 | 6 | 138 | 0.073 | 0.075 | 0.038 | 0.099 |
| KRAS | G12 | Hepatobiliary | 40-50 | 10 | 110 | 0.084 | 0.083 | 0.057 | 0.117 |
| KRAS | G12 | Hepatobiliary | 50-65 | 43 | 525 | 0.082 | 0.081 | 0.064 | 0.102 |
| KRAS | G12 | Hepatobiliary | >65 | 55 | 601 | 0.086 | 0.086 | 0.069 | 0.108 |
| KRAS | G12 | Kidney | <40 | 0 | 191 | 0.007 | 0.007 | 0.001 | 0.014 |
| KRAS | G12 | Kidney | 40-50 | 2 | 159 | 0.009 | 0.008 | 0.003 | 0.020 |
| KRAS | G12 | Kidney | 50-65 | 4 | 628 | 0.007 | 0.007 | 0.003 | 0.013 |
| KRAS | G12 | Kidney | >65 | 5 | 440 | 0.009 | 0.008 | 0.004 | 0.017 |
| KRAS | G12 | T / NK neoplasms | <40 | 0 | 28 | 0.005 | 0.002 | 0.000 | 0.024 |
| KRAS | G12 | T / NK neoplasms | 40-50 | 1 | 21 | 0.023 | 0.010 | 0.000 | 0.123 |
| KRAS | G12 | T / NK neoplasms | 50-65 | 0 | 76 | 0.004 | 0.002 | 0.000 | 0.017 |
| KRAS | G12 | T / NK neoplasms | >65 | 0 | 106 | 0.003 | 0.002 | 0.000 | 0.016 |
| KRAS | G12 | CNS | <40 | 10 | 1602 | 0.006 | 0.006 | 0.003 | 0.009 |
| KRAS | G12 | CNS | 40-50 | 7 | 687 | 0.007 | 0.006 | 0.003 | 0.014 |
| KRAS | G12 | CNS | 50-65 | 5 | 1439 | 0.005 | 0.005 | 0.002 | 0.008 |
| KRAS | G12 | CNS | >65 | 2 | 836 | 0.005 | 0.005 | 0.001 | 0.008 |
| KRAS | G12 | Prostate | 40-50 | 0 | 70 | 0.003 | 0.003 | 0.000 | 0.009 |
| KRAS | G12 | Prostate | 50-65 | 3 | 960 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | G12 | Prostate | >65 | 4 | 1402 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | G12 | Anal | 40-50 | 0 | 12 | 0.014 | 0.009 | 0.000 | 0.055 |
| KRAS | G12 | Anal | 50-65 | 2 | 88 | 0.018 | 0.015 | 0.002 | 0.050 |
| KRAS | G12 | Anal | >65 | 0 | 45 | 0.011 | 0.008 | 0.000 | 0.039 |
| KRAS | G12 | Neuroendocrine | <40 | 0 | 22 | 0.037 | 0.031 | 0.000 | 0.109 |
| KRAS | G12 | Neuroendocrine | 40-50 | 10 | 55 | 0.151 | 0.147 | 0.062 | 0.266 |
| KRAS | G12 | Neuroendocrine | 50-65 | 10 | 161 | 0.063 | 0.061 | 0.032 | 0.102 |
| KRAS | G12 | Neuroendocrine | >65 | 4 | 121 | 0.041 | 0.038 | 0.013 | 0.081 |
| KRAS | G12 | Bladder | <40 | 1 | 25 | 0.041 | 0.040 | 0.009 | 0.089 |
| KRAS | G12 | Bladder | 40-50 | 0 | 78 | 0.030 | 0.034 | 0.001 | 0.054 |
| KRAS | G12 | Bladder | 50-65 | 25 | 511 | 0.045 | 0.045 | 0.032 | 0.063 |
| KRAS | G12 | Bladder | >65 | 41 | 962 | 0.042 | 0.042 | 0.031 | 0.055 |
| KRAS | G12 | BLL/Lymphoma | <40 | 7 | 142 | 0.043 | 0.041 | 0.020 | 0.075 |
| KRAS | G12 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.038 | 0.036 | 0.005 | 0.079 |
| KRAS | G12 | BLL/Lymphoma | 50-65 | 1 | 48 | 0.037 | 0.036 | 0.009 | 0.073 |
| KRAS | G12 | BLL/Lymphoma | >65 | 2 | 42 | 0.042 | 0.039 | 0.014 | 0.084 |
| KRAS | G12 | Small bowel | 40-50 | 5 | 29 | 0.264 | 0.273 | 0.112 | 0.383 |
| KRAS | G12 | Small bowel | 50-65 | 37 | 96 | 0.356 | 0.352 | 0.272 | 0.455 |
| KRAS | G12 | Small bowel | >65 | 24 | 78 | 0.312 | 0.312 | 0.227 | 0.399 |
| KRAS | G12 | Sex cord stromal | <40 | 1 | 29 | 0.023 | 0.018 | 0.002 | 0.075 |
| KRAS | G12 | Sex cord stromal | 40-50 | 0 | 15 | 0.018 | 0.014 | 0.000 | 0.060 |
| KRAS | G12 | Sex cord stromal | 50-65 | 1 | 37 | 0.022 | 0.017 | 0.002 | 0.065 |
| KRAS | G12 | Sex cord stromal | >65 | 0 | 27 | 0.017 | 0.014 | 0.000 | 0.054 |
| KRAS | G12 | Bone | <40 | 1 | 342 | 0.007 | 0.007 | 0.001 | 0.017 |
| KRAS | G12 | Bone | 40-50 | 1 | 61 | 0.012 | 0.010 | 0.002 | 0.035 |
| KRAS | G12 | Bone | 50-65 | 1 | 96 | 0.010 | 0.009 | 0.002 | 0.027 |
| KRAS | G12 | Bone | >65 | 2 | 67 | 0.015 | 0.011 | 0.003 | 0.047 |
| KRAS | G12 | Vaginal | 50-65 | 1 | 34 | 0.044 | 0.039 | 0.006 | 0.115 |
| KRAS | G12 | Vaginal | >65 | 2 | 30 | 0.055 | 0.047 | 0.011 | 0.139 |
| KRAS | G12 | Thymic | <40 | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12 | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12 | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12 | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12 | Ampullary | 40-50 | 3 | 12 | 0.420 | 0.443 | 0.157 | 0.589 |
| KRAS | G12 | Ampullary | 50-65 | 22 | 40 | 0.512 | 0.509 | 0.392 | 0.648 |
| KRAS | G12 | Ampullary | >65 | 25 | 50 | 0.491 | 0.490 | 0.377 | 0.607 |
| KRAS | G12 | SCLC | 40-50 | 0 | 22 | 0.026 | 0.025 | 0.001 | 0.057 |
| KRAS | G12 | SCLC | 50-65 | 4 | 144 | 0.028 | 0.027 | 0.012 | 0.052 |
| KRAS | G12 | SCLC | >65 | 7 | 224 | 0.029 | 0.028 | 0.014 | 0.051 |
| KRAS | G12 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12 | Germ cell | <40 | 27 | 650 | 0.045 | 0.044 | 0.030 | 0.062 |
| KRAS | G12 | Germ cell | 40-50 | 18 | 131 | 0.120 | 0.118 | 0.065 | 0.185 |
| KRAS | G12 | Germ cell | 50-65 | 5 | 92 | 0.060 | 0.058 | 0.025 | 0.108 |
| KRAS | G12 | Germ cell | >65 | 1 | 12 | 0.079 | 0.069 | 0.017 | 0.203 |
| KRAS | G12 | Nerve sheath | <40 | 0 | 77 | 0.006 | 0.003 | 0.000 | 0.025 |
| KRAS | G12 | Nerve sheath | 40-50 | 1 | 27 | 0.018 | 0.009 | 0.001 | 0.084 |
| KRAS | G12 | Nerve sheath | 50-65 | 0 | 37 | 0.006 | 0.004 | 0.000 | 0.030 |
| KRAS | G12 | Nerve sheath | >65 | 0 | 13 | 0.008 | 0.004 | 0.000 | 0.040 |
| KRAS | G12 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.031 |
| KRAS | G12 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| KRAS | G12 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| KRAS | G12 | B cell lymphoma | <40 | 0 | 87 | 0.013 | 0.013 | 0.001 | 0.025 |
| KRAS | G12 | B cell lymphoma | 40-50 | 1 | 105 | 0.014 | 0.013 | 0.003 | 0.027 |
| KRAS | G12 | B cell lymphoma | 50-65 | 6 | 357 | 0.015 | 0.014 | 0.007 | 0.026 |
| KRAS | G12 | B cell lymphoma | >65 | 7 | 413 | 0.015 | 0.015 | 0.008 | 0.026 |
| KRAS | G12 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.005 | 0.000 | 0.000 | 0.052 |
| KRAS | G12 | T-lymphoblastic leukemia/lymphoma | <40 | 1 | 27 | 0.042 | 0.031 | 0.002 | 0.142 |
| KRAS | G12 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.010 |
| KRAS | G12 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| KRAS | G12 | Lung | >65 | 2 | 18 | 0.117 | 0.102 | 0.017 | 0.296 |
| KRAS | G12 | Peritoneal | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.049 |
| KRAS | G12C | Appendiceal | <40 | 1 | 28 | 0.030 | 0.027 | 0.007 | 0.076 |
| KRAS | G12C | Appendiceal | 40-50 | 1 | 62 | 0.025 | 0.024 | 0.005 | 0.053 |
| KRAS | G12C | Appendiceal | 50-65 | 2 | 161 | 0.022 | 0.021 | 0.006 | 0.044 |
| KRAS | G12C | Appendiceal | >65 | 5 | 90 | 0.036 | 0.032 | 0.014 | 0.081 |
| KRAS | G12C | CRC | <40 | 16 | 565 | 0.030 | 0.030 | 0.022 | 0.039 |
| KRAS | G12C | CRC | 40-50 | 34 | 1280 | 0.029 | 0.029 | 0.022 | 0.036 |
| KRAS | G12C | CRC | 50-65 | 102 | 2815 | 0.034 | 0.033 | 0.028 | 0.040 |
| KRAS | G12C | CRC | >65 | 58 | 2055 | 0.030 | 0.030 | 0.024 | 0.036 |
| KRAS | G12C | CUP | <40 | 0 | 167 | 0.010 | 0.008 | 0.000 | 0.033 |
| KRAS | G12C | CUP | 40-50 | 3 | 211 | 0.018 | 0.017 | 0.005 | 0.036 |
| KRAS | G12C | CUP | 50-65 | 28 | 810 | 0.033 | 0.033 | 0.023 | 0.047 |
| KRAS | G12C | CUP | >65 | 30 | 797 | 0.036 | 0.035 | 0.024 | 0.050 |
| KRAS | G12C | NSCLC | <40 | 1 | 161 | 0.017 | 0.014 | 0.002 | 0.044 |
| KRAS | G12C | NSCLC | 40-50 | 41 | 585 | 0.070 | 0.070 | 0.051 | 0.093 |
| KRAS | G12C | NSCLC | 50-65 | 439 | 3677 | 0.119 | 0.119 | 0.109 | 0.130 |
| KRAS | G12C | NSCLC | >65 | 731 | 5698 | 0.128 | 0.128 | 0.120 | 0.137 |
| KRAS | G12C | NSCLC | NA | 1 | 10 | 0.094 | 0.077 | 0.011 | 0.271 |
| KRAS | G12C | Breast | <40 | 0 | 841 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Breast | 40-50 | 0 | 1910 | 0.001 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Breast | 50-65 | 3 | 3989 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Breast | >65 | 5 | 2583 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | Breast | NA | 0 | 10 | 0.002 | 0.001 | 0.000 | 0.013 |
| KRAS | G12C | Soft tissue sarcoma | <40 | 2 | 672 | 0.002 | 0.002 | 0.001 | 0.005 |
| KRAS | G12C | Soft tissue sarcoma | 40-50 | 0 | 367 | 0.002 | 0.002 | 0.000 | 0.004 |
| KRAS | G12C | Soft tissue sarcoma | 50-65 | 1 | 951 | 0.002 | 0.002 | 0.000 | 0.004 |
| KRAS | G12C | Soft tissue sarcoma | >65 | 2 | 777 | 0.002 | 0.002 | 0.001 | 0.005 |
| KRAS | G12C | Pancreatic | <40 | 0 | 87 | 0.008 | 0.008 | 0.001 | 0.016 |
| KRAS | G12C | Pancreatic | 40-50 | 1 | 200 | 0.008 | 0.008 | 0.002 | 0.015 |
| KRAS | G12C | Pancreatic | 50-65 | 6 | 1000 | 0.008 | 0.007 | 0.003 | 0.012 |
| KRAS | G12C | Pancreatic | >65 | 15 | 1205 | 0.010 | 0.010 | 0.006 | 0.017 |
| KRAS | G12C | Leukemia | <40 | 0 | 204 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | 40-50 | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | 50-65 | 0 | 515 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | >65 | 0 | 720 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Melanoma | <40 | 0 | 289 | 0.001 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Melanoma | 40-50 | 0 | 282 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Melanoma | 50-65 | 0 | 1016 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Melanoma | >65 | 2 | 1259 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | G12C | Head and neck | <40 | 0 | 140 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | Head and neck | 40-50 | 1 | 216 | 0.002 | 0.001 | 0.000 | 0.009 |
| KRAS | G12C | Head and neck | 50-65 | 1 | 799 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | G12C | Head and neck | >65 | 0 | 582 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | Uterine | <40 | 0 | 57 | 0.010 | 0.010 | 0.000 | 0.020 |
| KRAS | G12C | Uterine | 40-50 | 0 | 162 | 0.009 | 0.009 | 0.000 | 0.017 |
| KRAS | G12C | Uterine | 50-65 | 13 | 1046 | 0.012 | 0.012 | 0.007 | 0.018 |
| KRAS | G12C | Uterine | >65 | 13 | 988 | 0.012 | 0.012 | 0.007 | 0.019 |
| KRAS | G12C | Non-melanoma skin | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Non-melanoma skin | 40-50 | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Non-melanoma skin | 50-65 | 0 | 149 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Non-melanoma skin | >65 | 0 | 317 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | 40-50 | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | 50-65 | 0 | 373 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | >65 | 0 | 664 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Ovarian | <40 | 4 | 141 | 0.019 | 0.016 | 0.003 | 0.050 |
| KRAS | G12C | Ovarian | 40-50 | 0 | 253 | 0.003 | 0.002 | 0.000 | 0.009 |
| KRAS | G12C | Ovarian | 50-65 | 3 | 1092 | 0.003 | 0.003 | 0.001 | 0.007 |
| KRAS | G12C | Ovarian | >65 | 3 | 849 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | G12C | Esophagogastric | <40 | 1 | 122 | 0.004 | 0.003 | 0.001 | 0.012 |
| KRAS | G12C | Esophagogastric | 40-50 | 0 | 200 | 0.003 | 0.003 | 0.000 | 0.007 |
| KRAS | G12C | Esophagogastric | 50-65 | 2 | 752 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | G12C | Esophagogastric | >65 | 2 | 725 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | G12C | Thyroid | <40 | 0 | 150 | 0.002 | 0.002 | 0.000 | 0.007 |
| KRAS | G12C | Thyroid | 40-50 | 0 | 122 | 0.002 | 0.002 | 0.000 | 0.007 |
| KRAS | G12C | Thyroid | 50-65 | 1 | 374 | 0.002 | 0.002 | 0.000 | 0.007 |
| KRAS | G12C | Thyroid | >65 | 1 | 370 | 0.002 | 0.002 | 0.000 | 0.007 |
| KRAS | G12C | Cervical | <40 | 0 | 85 | 0.003 | 0.002 | 0.000 | 0.012 |
| KRAS | G12C | Cervical | 40-50 | 0 | 99 | 0.003 | 0.002 | 0.000 | 0.012 |
| KRAS | G12C | Cervical | 50-65 | 1 | 144 | 0.004 | 0.003 | 0.000 | 0.017 |
| KRAS | G12C | Cervical | >65 | 0 | 36 | 0.003 | 0.002 | 0.000 | 0.015 |
| KRAS | G12C | Hepatobiliary | <40 | 0 | 138 | 0.006 | 0.006 | 0.000 | 0.013 |
| KRAS | G12C | Hepatobiliary | 40-50 | 0 | 110 | 0.006 | 0.006 | 0.000 | 0.014 |
| KRAS | G12C | Hepatobiliary | 50-65 | 5 | 525 | 0.008 | 0.007 | 0.003 | 0.015 |
| KRAS | G12C | Hepatobiliary | >65 | 5 | 601 | 0.008 | 0.007 | 0.003 | 0.014 |
| KRAS | G12C | Kidney | <40 | 0 | 191 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Kidney | 40-50 | 0 | 159 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Kidney | 50-65 | 0 | 628 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Kidney | >65 | 1 | 440 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | T / NK neoplasms | >65 | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | CNS | <40 | 0 | 1602 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | 40-50 | 0 | 687 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | 50-65 | 0 | 1439 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | 40-50 | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | 50-65 | 0 | 960 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | >65 | 0 | 1402 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Neuroendocrine | <40 | 0 | 22 | 0.006 | 0.005 | 0.000 | 0.024 |
| KRAS | G12C | Neuroendocrine | 40-50 | 1 | 55 | 0.009 | 0.006 | 0.001 | 0.033 |
| KRAS | G12C | Neuroendocrine | 50-65 | 1 | 161 | 0.006 | 0.005 | 0.001 | 0.018 |
| KRAS | G12C | Neuroendocrine | >65 | 0 | 121 | 0.005 | 0.004 | 0.000 | 0.016 |
| KRAS | G12C | Bladder | <40 | 0 | 25 | 0.006 | 0.005 | 0.001 | 0.013 |
| KRAS | G12C | Bladder | 40-50 | 0 | 78 | 0.005 | 0.005 | 0.001 | 0.011 |
| KRAS | G12C | Bladder | 50-65 | 3 | 511 | 0.005 | 0.005 | 0.002 | 0.011 |
| KRAS | G12C | Bladder | >65 | 5 | 962 | 0.005 | 0.005 | 0.002 | 0.010 |
| KRAS | G12C | BLL/Lymphoma | <40 | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | BLL/Lymphoma | 40-50 | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | BLL/Lymphoma | 50-65 | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | BLL/Lymphoma | >65 | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Small bowel | 40-50 | 0 | 29 | 0.022 | 0.018 | 0.000 | 0.070 |
| KRAS | G12C | Small bowel | 50-65 | 7 | 96 | 0.060 | 0.056 | 0.023 | 0.119 |
| KRAS | G12C | Small bowel | >65 | 1 | 78 | 0.023 | 0.020 | 0.001 | 0.062 |
| KRAS | G12C | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G12C | Sex cord stromal | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.006 |
| KRAS | G12C | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Vaginal | 50-65 | 1 | 34 | 0.024 | 0.017 | 0.001 | 0.087 |
| KRAS | G12C | Vaginal | >65 | 0 | 30 | 0.013 | 0.008 | 0.000 | 0.058 |
| KRAS | G12C | Thymic | <40 | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Ampullary | 40-50 | 0 | 12 | 0.035 | 0.030 | 0.000 | 0.100 |
| KRAS | G12C | Ampullary | 50-65 | 3 | 40 | 0.052 | 0.046 | 0.013 | 0.130 |
| KRAS | G12C | Ampullary | >65 | 1 | 50 | 0.034 | 0.030 | 0.004 | 0.085 |
| KRAS | G12C | SCLC | 40-50 | 0 | 22 | 0.008 | 0.007 | 0.000 | 0.026 |
| KRAS | G12C | SCLC | 50-65 | 1 | 144 | 0.008 | 0.007 | 0.001 | 0.021 |
| KRAS | G12C | SCLC | >65 | 2 | 224 | 0.008 | 0.007 | 0.002 | 0.021 |
| KRAS | G12C | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Germ cell | <40 | 0 | 650 | 0.001 | 0.001 | 0.000 | 0.006 |
| KRAS | G12C | Germ cell | 40-50 | 3 | 131 | 0.019 | 0.016 | 0.003 | 0.049 |
| KRAS | G12C | Germ cell | 50-65 | 1 | 92 | 0.009 | 0.007 | 0.000 | 0.034 |
| KRAS | G12C | Germ cell | >65 | 0 | 12 | 0.009 | 0.003 | 0.000 | 0.060 |
| KRAS | G12C | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Nerve sheath | 40-50 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Nerve sheath | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Nerve sheath | >65 | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.031 |
| KRAS | G12C | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| KRAS | G12C | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| KRAS | G12C | B cell lymphoma | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | 40-50 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | 50-65 | 0 | 357 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | >65 | 0 | 413 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.005 | 0.000 | 0.000 | 0.052 |
| KRAS | G12C | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.018 |
| KRAS | G12C | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.010 |
| KRAS | G12C | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| KRAS | G12C | Lung | >65 | 2 | 18 | 0.117 | 0.102 | 0.017 | 0.296 |
| KRAS | G12C | Peritoneal | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.049 |
| KRAS | G13 | Appendiceal | <40 | 0 | 28 | 0.035 | 0.035 | 0.002 | 0.074 |
| KRAS | G13 | Appendiceal | 40-50 | 4 | 62 | 0.049 | 0.044 | 0.021 | 0.102 |
| KRAS | G13 | Appendiceal | 50-65 | 4 | 161 | 0.035 | 0.034 | 0.013 | 0.062 |
| KRAS | G13 | Appendiceal | >65 | 6 | 90 | 0.050 | 0.046 | 0.023 | 0.099 |
| KRAS | G13 | CRC | <40 | 47 | 565 | 0.080 | 0.079 | 0.068 | 0.095 |
| KRAS | G13 | CRC | 40-50 | 95 | 1280 | 0.077 | 0.077 | 0.066 | 0.088 |
| KRAS | G13 | CRC | 50-65 | 214 | 2815 | 0.077 | 0.077 | 0.069 | 0.086 |
| KRAS | G13 | CRC | >65 | 171 | 2055 | 0.081 | 0.080 | 0.072 | 0.091 |
| KRAS | G13 | CUP | <40 | 3 | 167 | 0.020 | 0.019 | 0.011 | 0.032 |
| KRAS | G13 | CUP | 40-50 | 7 | 211 | 0.022 | 0.021 | 0.014 | 0.040 |
| KRAS | G13 | CUP | 50-65 | 16 | 810 | 0.020 | 0.020 | 0.013 | 0.028 |
| KRAS | G13 | CUP | >65 | 13 | 797 | 0.019 | 0.019 | 0.012 | 0.026 |
| KRAS | G13 | NSCLC | <40 | 2 | 161 | 0.020 | 0.020 | 0.010 | 0.027 |
| KRAS | G13 | NSCLC | 40-50 | 9 | 585 | 0.019 | 0.020 | 0.012 | 0.025 |
| KRAS | G13 | NSCLC | 50-65 | 87 | 3677 | 0.022 | 0.022 | 0.018 | 0.027 |
| KRAS | G13 | NSCLC | >65 | 111 | 5698 | 0.020 | 0.020 | 0.017 | 0.023 |
| KRAS | G13 | NSCLC | NA | 0 | 10 | 0.020 | 0.020 | 0.010 | 0.032 |
| KRAS | G13 | Breast | <40 | 0 | 841 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Breast | 50-65 | 5 | 3989 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G13 | Breast | >65 | 0 | 2583 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Breast | NA | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.016 |
| KRAS | G13 | Soft tissue sarcoma | <40 | 0 | 672 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Soft tissue sarcoma | 40-50 | 0 | 367 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Soft tissue sarcoma | 50-65 | 0 | 951 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Soft tissue sarcoma | >65 | 1 | 777 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Pancreatic | <40 | 0 | 87 | 0.007 | 0.007 | 0.001 | 0.013 |
| KRAS | G13 | Pancreatic | 40-50 | 1 | 200 | 0.007 | 0.007 | 0.002 | 0.013 |
| KRAS | G13 | Pancreatic | 50-65 | 6 | 1000 | 0.007 | 0.007 | 0.003 | 0.011 |
| KRAS | G13 | Pancreatic | >65 | 11 | 1205 | 0.008 | 0.008 | 0.004 | 0.013 |
| KRAS | G13 | Leukemia | <40 | 10 | 204 | 0.040 | 0.039 | 0.016 | 0.073 |
| KRAS | G13 | Leukemia | 40-50 | 3 | 128 | 0.022 | 0.020 | 0.007 | 0.048 |
| KRAS | G13 | Leukemia | 50-65 | 8 | 515 | 0.016 | 0.016 | 0.008 | 0.028 |
| KRAS | G13 | Leukemia | >65 | 5 | 720 | 0.009 | 0.009 | 0.003 | 0.018 |
| KRAS | G13 | Melanoma | <40 | 0 | 289 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | Melanoma | 40-50 | 0 | 282 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | Melanoma | 50-65 | 1 | 1016 | 0.002 | 0.002 | 0.000 | 0.004 |
| KRAS | G13 | Melanoma | >65 | 6 | 1259 | 0.004 | 0.003 | 0.001 | 0.008 |
| KRAS | G13 | Head and neck | <40 | 0 | 140 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | G13 | Head and neck | 40-50 | 0 | 216 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | G13 | Head and neck | 50-65 | 2 | 799 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | Head and neck | >65 | 1 | 582 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | Uterine | <40 | 1 | 57 | 0.023 | 0.023 | 0.012 | 0.038 |
| KRAS | G13 | Uterine | 40-50 | 4 | 162 | 0.024 | 0.023 | 0.014 | 0.036 |
| KRAS | G13 | Uterine | 50-65 | 21 | 1046 | 0.022 | 0.022 | 0.015 | 0.030 |
| KRAS | G13 | Uterine | >65 | 26 | 988 | 0.024 | 0.024 | 0.017 | 0.033 |
| KRAS | G13 | Non-melanoma skin | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Non-melanoma skin | 40-50 | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Non-melanoma skin | 50-65 | 0 | 149 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Non-melanoma skin | >65 | 0 | 317 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | MDS/MPN | <40 | 2 | 87 | 0.010 | 0.007 | 0.002 | 0.037 |
| KRAS | G13 | MDS/MPN | 40-50 | 0 | 83 | 0.006 | 0.005 | 0.000 | 0.015 |
| KRAS | G13 | MDS/MPN | 50-65 | 1 | 373 | 0.005 | 0.005 | 0.001 | 0.011 |
| KRAS | G13 | MDS/MPN | >65 | 4 | 664 | 0.006 | 0.006 | 0.002 | 0.012 |
| KRAS | G13 | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Ovarian | <40 | 1 | 141 | 0.005 | 0.005 | 0.002 | 0.014 |
| KRAS | G13 | Ovarian | 40-50 | 3 | 253 | 0.006 | 0.005 | 0.002 | 0.016 |
| KRAS | G13 | Ovarian | 50-65 | 3 | 1092 | 0.004 | 0.004 | 0.002 | 0.008 |
| KRAS | G13 | Ovarian | >65 | 4 | 849 | 0.005 | 0.005 | 0.002 | 0.009 |
| KRAS | G13 | Esophagogastric | <40 | 1 | 122 | 0.012 | 0.012 | 0.005 | 0.022 |
| KRAS | G13 | Esophagogastric | 40-50 | 2 | 200 | 0.012 | 0.012 | 0.006 | 0.021 |
| KRAS | G13 | Esophagogastric | 50-65 | 8 | 752 | 0.012 | 0.012 | 0.007 | 0.019 |
| KRAS | G13 | Esophagogastric | >65 | 12 | 725 | 0.014 | 0.013 | 0.008 | 0.022 |
| KRAS | G13 | Thyroid | <40 | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | 40-50 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | 50-65 | 0 | 374 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | >65 | 0 | 370 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Cervical | <40 | 0 | 85 | 0.008 | 0.007 | 0.000 | 0.024 |
| KRAS | G13 | Cervical | 40-50 | 3 | 99 | 0.018 | 0.015 | 0.004 | 0.053 |
| KRAS | G13 | Cervical | 50-65 | 1 | 144 | 0.010 | 0.008 | 0.001 | 0.025 |
| KRAS | G13 | Cervical | >65 | 0 | 36 | 0.009 | 0.008 | 0.000 | 0.030 |
| KRAS | G13 | Hepatobiliary | <40 | 0 | 138 | 0.006 | 0.006 | 0.001 | 0.013 |
| KRAS | G13 | Hepatobiliary | 40-50 | 2 | 110 | 0.009 | 0.007 | 0.003 | 0.024 |
| KRAS | G13 | Hepatobiliary | 50-65 | 4 | 525 | 0.007 | 0.007 | 0.003 | 0.014 |
| KRAS | G13 | Hepatobiliary | >65 | 3 | 601 | 0.006 | 0.006 | 0.002 | 0.012 |
| KRAS | G13 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | T / NK neoplasms | >65 | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | CNS | <40 | 1 | 1602 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | CNS | 40-50 | 0 | 687 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | 50-65 | 0 | 1439 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Prostate | 40-50 | 0 | 70 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | Prostate | 50-65 | 0 | 960 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Prostate | >65 | 1 | 1402 | 0.001 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Anal | 40-50 | 0 | 12 | 0.016 | 0.012 | 0.000 | 0.056 |
| KRAS | G13 | Anal | 50-65 | 1 | 88 | 0.014 | 0.012 | 0.002 | 0.041 |
| KRAS | G13 | Anal | >65 | 1 | 45 | 0.017 | 0.013 | 0.002 | 0.051 |
| KRAS | G13 | Neuroendocrine | <40 | 2 | 22 | 0.032 | 0.021 | 0.007 | 0.127 |
| KRAS | G13 | Neuroendocrine | 40-50 | 1 | 55 | 0.019 | 0.017 | 0.004 | 0.047 |
| KRAS | G13 | Neuroendocrine | 50-65 | 2 | 161 | 0.016 | 0.015 | 0.004 | 0.034 |
| KRAS | G13 | Neuroendocrine | >65 | 1 | 121 | 0.015 | 0.014 | 0.003 | 0.035 |
| KRAS | G13 | Bladder | <40 | 0 | 25 | 0.004 | 0.002 | 0.000 | 0.018 |
| KRAS | G13 | Bladder | 40-50 | 1 | 78 | 0.006 | 0.003 | 0.001 | 0.028 |
| KRAS | G13 | Bladder | 50-65 | 0 | 511 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | G13 | Bladder | >65 | 3 | 962 | 0.003 | 0.003 | 0.001 | 0.007 |
| KRAS | G13 | BLL/Lymphoma | <40 | 8 | 142 | 0.051 | 0.049 | 0.020 | 0.095 |
| KRAS | G13 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.012 | 0.004 | 0.000 | 0.063 |
| KRAS | G13 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.009 | 0.002 | 0.000 | 0.044 |
| KRAS | G13 | BLL/Lymphoma | >65 | 0 | 42 | 0.009 | 0.002 | 0.000 | 0.046 |
| KRAS | G13 | Small bowel | 40-50 | 6 | 29 | 0.147 | 0.136 | 0.046 | 0.317 |
| KRAS | G13 | Small bowel | 50-65 | 4 | 96 | 0.051 | 0.049 | 0.017 | 0.097 |
| KRAS | G13 | Small bowel | >65 | 3 | 78 | 0.050 | 0.048 | 0.013 | 0.100 |
| KRAS | G13 | Sex cord stromal | <40 | 0 | 29 | 0.001 | 0.000 | 0.000 | 0.007 |
| KRAS | G13 | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | G13 | Sex cord stromal | 50-65 | 0 | 37 | 0.001 | 0.000 | 0.000 | 0.007 |
| KRAS | G13 | Sex cord stromal | >65 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.007 |
| KRAS | G13 | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Vaginal | 50-65 | 1 | 34 | 0.023 | 0.017 | 0.001 | 0.086 |
| KRAS | G13 | Vaginal | >65 | 0 | 30 | 0.013 | 0.008 | 0.000 | 0.057 |
| KRAS | G13 | Thymic | <40 | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Ampullary | 40-50 | 0 | 12 | 0.044 | 0.040 | 0.000 | 0.112 |
| KRAS | G13 | Ampullary | 50-65 | 3 | 40 | 0.057 | 0.051 | 0.017 | 0.131 |
| KRAS | G13 | Ampullary | >65 | 2 | 50 | 0.047 | 0.044 | 0.012 | 0.101 |
| KRAS | G13 | SCLC | 40-50 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | SCLC | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | SCLC | >65 | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Germ cell | <40 | 2 | 650 | 0.004 | 0.003 | 0.001 | 0.009 |
| KRAS | G13 | Germ cell | 40-50 | 1 | 131 | 0.005 | 0.004 | 0.001 | 0.015 |
| KRAS | G13 | Germ cell | 50-65 | 0 | 92 | 0.004 | 0.003 | 0.000 | 0.011 |
| KRAS | G13 | Germ cell | >65 | 0 | 12 | 0.005 | 0.003 | 0.000 | 0.019 |
| KRAS | G13 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Nerve sheath | 40-50 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Nerve sheath | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Nerve sheath | >65 | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Penile | 50-65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.040 |
| KRAS | G13 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.040 |
| KRAS | G13 | Pineal | <40 | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.031 |
| KRAS | G13 | B cell lymphoma | <40 | 0 | 87 | 0.008 | 0.007 | 0.001 | 0.017 |
| KRAS | G13 | B cell lymphoma | 40-50 | 1 | 105 | 0.009 | 0.008 | 0.002 | 0.020 |
| KRAS | G13 | B cell lymphoma | 50-65 | 2 | 357 | 0.008 | 0.007 | 0.002 | 0.015 |
| KRAS | G13 | B cell lymphoma | >65 | 5 | 413 | 0.009 | 0.009 | 0.004 | 0.019 |
| KRAS | G13 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.034 |
| KRAS | G13 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.016 |
| KRAS | G13 | Retinoblastoma | <40 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.006 |
| KRAS | G13 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G13 | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.029 |
| KRAS | G13 | Peritoneal | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.049 |
| KRAS | Q61 | Appendiceal | <40 | 1 | 28 | 0.018 | 0.015 | 0.004 | 0.054 |
| KRAS | Q61 | Appendiceal | 40-50 | 0 | 62 | 0.013 | 0.012 | 0.001 | 0.032 |
| KRAS | Q61 | Appendiceal | 50-65 | 3 | 161 | 0.016 | 0.015 | 0.005 | 0.034 |
| KRAS | Q61 | Appendiceal | >65 | 1 | 90 | 0.015 | 0.013 | 0.003 | 0.033 |
| KRAS | Q61 | CRC | <40 | 4 | 565 | 0.016 | 0.016 | 0.006 | 0.022 |
| KRAS | Q61 | CRC | 40-50 | 25 | 1280 | 0.019 | 0.019 | 0.014 | 0.025 |
| KRAS | Q61 | CRC | 50-65 | 55 | 2815 | 0.019 | 0.019 | 0.015 | 0.023 |
| KRAS | Q61 | CRC | >65 | 41 | 2055 | 0.019 | 0.019 | 0.015 | 0.024 |
| KRAS | Q61 | CUP | <40 | 0 | 167 | 0.005 | 0.003 | 0.000 | 0.015 |
| KRAS | Q61 | CUP | 40-50 | 0 | 211 | 0.004 | 0.003 | 0.000 | 0.015 |
| KRAS | Q61 | CUP | 50-65 | 9 | 810 | 0.011 | 0.011 | 0.005 | 0.018 |
| KRAS | Q61 | CUP | >65 | 14 | 797 | 0.016 | 0.015 | 0.009 | 0.026 |
| KRAS | Q61 | NSCLC | <40 | 0 | 161 | 0.015 | 0.016 | 0.003 | 0.022 |
| KRAS | Q61 | NSCLC | 40-50 | 8 | 585 | 0.016 | 0.017 | 0.009 | 0.022 |
| KRAS | Q61 | NSCLC | 50-65 | 69 | 3677 | 0.018 | 0.018 | 0.015 | 0.022 |
| KRAS | Q61 | NSCLC | >65 | 102 | 5698 | 0.018 | 0.018 | 0.015 | 0.021 |
| KRAS | Q61 | NSCLC | NA | 0 | 10 | 0.017 | 0.017 | 0.005 | 0.028 |
| KRAS | Q61 | Breast | <40 | 0 | 841 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | 50-65 | 0 | 3989 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | >65 | 2 | 2583 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Breast | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | Q61 | Soft tissue sarcoma | <40 | 0 | 672 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Soft tissue sarcoma | 40-50 | 0 | 367 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Soft tissue sarcoma | 50-65 | 1 | 951 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Soft tissue sarcoma | >65 | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Pancreatic | <40 | 0 | 87 | 0.023 | 0.020 | 0.000 | 0.060 |
| KRAS | Q61 | Pancreatic | 40-50 | 11 | 200 | 0.053 | 0.052 | 0.029 | 0.084 |
| KRAS | Q61 | Pancreatic | 50-65 | 42 | 1000 | 0.043 | 0.042 | 0.031 | 0.057 |
| KRAS | Q61 | Pancreatic | >65 | 86 | 1205 | 0.069 | 0.069 | 0.055 | 0.085 |
| KRAS | Q61 | Leukemia | <40 | 1 | 204 | 0.004 | 0.004 | 0.001 | 0.010 |
| KRAS | Q61 | Leukemia | 40-50 | 1 | 128 | 0.005 | 0.004 | 0.001 | 0.013 |
| KRAS | Q61 | Leukemia | 50-65 | 1 | 515 | 0.004 | 0.003 | 0.001 | 0.008 |
| KRAS | Q61 | Leukemia | >65 | 3 | 720 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | Q61 | Melanoma | <40 | 0 | 289 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | Q61 | Melanoma | 40-50 | 0 | 282 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | Q61 | Melanoma | 50-65 | 3 | 1016 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | Q61 | Melanoma | >65 | 5 | 1259 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | Q61 | Head and neck | <40 | 0 | 140 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | 40-50 | 0 | 216 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | 50-65 | 0 | 799 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | >65 | 0 | 582 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Uterine | <40 | 0 | 57 | 0.004 | 0.004 | 0.000 | 0.009 |
| KRAS | Q61 | Uterine | 40-50 | 0 | 162 | 0.004 | 0.004 | 0.000 | 0.008 |
| KRAS | Q61 | Uterine | 50-65 | 5 | 1046 | 0.004 | 0.004 | 0.002 | 0.008 |
| KRAS | Q61 | Uterine | >65 | 4 | 988 | 0.004 | 0.004 | 0.002 | 0.008 |
| KRAS | Q61 | Non-melanoma skin | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Non-melanoma skin | 40-50 | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Non-melanoma skin | 50-65 | 0 | 149 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Non-melanoma skin | >65 | 0 | 317 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | 40-50 | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | 50-65 | 0 | 373 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | >65 | 0 | 664 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Ovarian | <40 | 2 | 141 | 0.007 | 0.006 | 0.002 | 0.020 |
| KRAS | Q61 | Ovarian | 40-50 | 2 | 253 | 0.006 | 0.005 | 0.002 | 0.014 |
| KRAS | Q61 | Ovarian | 50-65 | 6 | 1092 | 0.005 | 0.005 | 0.003 | 0.009 |
| KRAS | Q61 | Ovarian | >65 | 2 | 849 | 0.005 | 0.004 | 0.001 | 0.008 |
| KRAS | Q61 | Esophagogastric | <40 | 0 | 122 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | Q61 | Esophagogastric | 40-50 | 0 | 200 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | Q61 | Esophagogastric | 50-65 | 2 | 752 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | Q61 | Esophagogastric | >65 | 1 | 725 | 0.002 | 0.001 | 0.000 | 0.004 |
| KRAS | Q61 | Thyroid | <40 | 2 | 150 | 0.016 | 0.015 | 0.007 | 0.027 |
| KRAS | Q61 | Thyroid | 40-50 | 2 | 122 | 0.016 | 0.016 | 0.008 | 0.029 |
| KRAS | Q61 | Thyroid | 50-65 | 7 | 374 | 0.017 | 0.016 | 0.009 | 0.027 |
| KRAS | Q61 | Thyroid | >65 | 5 | 370 | 0.016 | 0.015 | 0.008 | 0.025 |
| KRAS | Q61 | Cervical | <40 | 0 | 85 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Cervical | 40-50 | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Cervical | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Cervical | >65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Hepatobiliary | <40 | 0 | 138 | 0.011 | 0.011 | 0.001 | 0.021 |
| KRAS | Q61 | Hepatobiliary | 40-50 | 1 | 110 | 0.012 | 0.012 | 0.003 | 0.024 |
| KRAS | Q61 | Hepatobiliary | 50-65 | 7 | 525 | 0.013 | 0.013 | 0.007 | 0.022 |
| KRAS | Q61 | Hepatobiliary | >65 | 10 | 601 | 0.014 | 0.014 | 0.008 | 0.024 |
| KRAS | Q61 | Kidney | <40 | 1 | 191 | 0.002 | 0.002 | 0.000 | 0.009 |
| KRAS | Q61 | Kidney | 40-50 | 0 | 159 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | Q61 | Kidney | 50-65 | 1 | 628 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | Q61 | Kidney | >65 | 0 | 440 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | Q61 | T / NK neoplasms | <40 | 1 | 28 | 0.015 | 0.010 | 0.001 | 0.064 |
| KRAS | Q61 | T / NK neoplasms | 40-50 | 0 | 21 | 0.010 | 0.007 | 0.000 | 0.034 |
| KRAS | Q61 | T / NK neoplasms | 50-65 | 0 | 76 | 0.008 | 0.006 | 0.000 | 0.025 |
| KRAS | Q61 | T / NK neoplasms | >65 | 1 | 106 | 0.010 | 0.008 | 0.001 | 0.028 |
| KRAS | Q61 | CNS | <40 | 5 | 1602 | 0.003 | 0.003 | 0.001 | 0.005 |
| KRAS | Q61 | CNS | 40-50 | 2 | 687 | 0.003 | 0.003 | 0.001 | 0.005 |
| KRAS | Q61 | CNS | 50-65 | 2 | 1439 | 0.002 | 0.002 | 0.001 | 0.004 |
| KRAS | Q61 | CNS | >65 | 3 | 836 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | Q61 | Prostate | 40-50 | 0 | 70 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | Q61 | Prostate | 50-65 | 2 | 960 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | Q61 | Prostate | >65 | 2 | 1402 | 0.002 | 0.002 | 0.000 | 0.004 |
| KRAS | Q61 | Anal | 40-50 | 0 | 12 | 0.009 | 0.005 | 0.000 | 0.041 |
| KRAS | Q61 | Anal | 50-65 | 1 | 88 | 0.009 | 0.007 | 0.000 | 0.033 |
| KRAS | Q61 | Anal | >65 | 0 | 45 | 0.007 | 0.004 | 0.000 | 0.030 |
| KRAS | Q61 | Neuroendocrine | <40 | 0 | 22 | 0.006 | 0.005 | 0.000 | 0.024 |
| KRAS | Q61 | Neuroendocrine | 40-50 | 1 | 55 | 0.009 | 0.006 | 0.001 | 0.033 |
| KRAS | Q61 | Neuroendocrine | 50-65 | 1 | 161 | 0.006 | 0.005 | 0.001 | 0.018 |
| KRAS | Q61 | Neuroendocrine | >65 | 0 | 121 | 0.005 | 0.004 | 0.000 | 0.016 |
| KRAS | Q61 | Bladder | <40 | 0 | 25 | 0.004 | 0.003 | 0.000 | 0.013 |
| KRAS | Q61 | Bladder | 40-50 | 0 | 78 | 0.003 | 0.003 | 0.000 | 0.010 |
| KRAS | Q61 | Bladder | 50-65 | 3 | 511 | 0.004 | 0.004 | 0.001 | 0.010 |
| KRAS | Q61 | Bladder | >65 | 2 | 962 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | Q61 | BLL/Lymphoma | <40 | 3 | 142 | 0.016 | 0.014 | 0.003 | 0.040 |
| KRAS | Q61 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.011 | 0.008 | 0.000 | 0.040 |
| KRAS | Q61 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.009 | 0.007 | 0.000 | 0.031 |
| KRAS | Q61 | BLL/Lymphoma | >65 | 0 | 42 | 0.009 | 0.007 | 0.000 | 0.032 |
| KRAS | Q61 | Small bowel | 40-50 | 2 | 29 | 0.040 | 0.033 | 0.011 | 0.111 |
| KRAS | Q61 | Small bowel | 50-65 | 3 | 96 | 0.031 | 0.029 | 0.010 | 0.064 |
| KRAS | Q61 | Small bowel | >65 | 1 | 78 | 0.027 | 0.025 | 0.005 | 0.057 |
| KRAS | Q61 | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | Q61 | Sex cord stromal | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.006 |
| KRAS | Q61 | Bone | <40 | 1 | 342 | 0.002 | 0.002 | 0.000 | 0.008 |
| KRAS | Q61 | Bone | 40-50 | 0 | 61 | 0.002 | 0.001 | 0.000 | 0.010 |
| KRAS | Q61 | Bone | 50-65 | 0 | 96 | 0.002 | 0.001 | 0.000 | 0.009 |
| KRAS | Q61 | Bone | >65 | 0 | 67 | 0.002 | 0.001 | 0.000 | 0.010 |
| KRAS | Q61 | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.011 |
| KRAS | Q61 | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | Q61 | Thymic | <40 | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Ampullary | 40-50 | 0 | 12 | 0.045 | 0.041 | 0.001 | 0.112 |
| KRAS | Q61 | Ampullary | 50-65 | 2 | 40 | 0.050 | 0.046 | 0.013 | 0.109 |
| KRAS | Q61 | Ampullary | >65 | 3 | 50 | 0.053 | 0.049 | 0.016 | 0.111 |
| KRAS | Q61 | SCLC | 40-50 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | SCLC | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | SCLC | >65 | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | <40 | 0 | 650 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | 40-50 | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | 50-65 | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | >65 | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Nerve sheath | 40-50 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Nerve sheath | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Nerve sheath | >65 | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Penile | 50-65 | 0 | 11 | 0.039 | 0.022 | 0.000 | 0.166 |
| KRAS | Q61 | Penile | >65 | 1 | 11 | 0.068 | 0.048 | 0.003 | 0.244 |
| KRAS | Q61 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| KRAS | Q61 | B cell lymphoma | <40 | 0 | 87 | 0.013 | 0.013 | 0.001 | 0.026 |
| KRAS | Q61 | B cell lymphoma | 40-50 | 4 | 105 | 0.021 | 0.017 | 0.008 | 0.053 |
| KRAS | Q61 | B cell lymphoma | 50-65 | 4 | 357 | 0.014 | 0.013 | 0.005 | 0.024 |
| KRAS | Q61 | B cell lymphoma | >65 | 6 | 413 | 0.015 | 0.014 | 0.007 | 0.026 |
| KRAS | Q61 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.005 | 0.000 | 0.000 | 0.052 |
| KRAS | Q61 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.018 |
| KRAS | Q61 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.010 |
| KRAS | Q61 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| KRAS | Q61 | Lung | >65 | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.037 |
| KRAS | Q61 | Peritoneal | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.049 |
| KRAS | 12, 13, or 61 | Appendiceal | Black | 7 | 17 | 0.472 | 0.479 | 0.302 | 0.601 |
| KRAS | 12, 13, or 61 | Appendiceal | NA | 20 | 33 | 0.526 | 0.515 | 0.421 | 0.681 |
| KRAS | 12, 13, or 61 | Appendiceal | White | 133 | 280 | 0.481 | 0.481 | 0.424 | 0.536 |
| KRAS | 12, 13, or 61 | CRC | Asian | 124 | 313 | 0.404 | 0.404 | 0.356 | 0.451 |
| KRAS | 12, 13, or 61 | CRC | Black | 256 | 515 | 0.482 | 0.481 | 0.438 | 0.526 |
| KRAS | 12, 13, or 61 | CRC | NA | 343 | 804 | 0.426 | 0.426 | 0.394 | 0.458 |
| KRAS | 12, 13, or 61 | CRC | Native American | 9 | 17 | 0.442 | 0.436 | 0.346 | 0.566 |
| KRAS | 12, 13, or 61 | CRC | Other | 56 | 139 | 0.412 | 0.412 | 0.348 | 0.476 |
| KRAS | 12, 13, or 61 | CRC | White | 1868 | 4925 | 0.381 | 0.381 | 0.367 | 0.394 |
| KRAS | 12, 13, or 61 | CUP | Asian | 13 | 73 | 0.185 | 0.185 | 0.142 | 0.230 |
| KRAS | 12, 13, or 61 | CUP | Black | 25 | 123 | 0.190 | 0.189 | 0.153 | 0.236 |
| KRAS | 12, 13, or 61 | CUP | NA | 44 | 286 | 0.176 | 0.177 | 0.137 | 0.206 |
| KRAS | 12, 13, or 61 | CUP | Other | 8 | 36 | 0.190 | 0.188 | 0.144 | 0.250 |
| KRAS | 12, 13, or 61 | CUP | White | 284 | 1465 | 0.191 | 0.191 | 0.173 | 0.211 |
| KRAS | 12, 13, or 61 | NSCLC | Asian | 64 | 624 | 0.109 | 0.108 | 0.085 | 0.134 |
| KRAS | 12, 13, or 61 | NSCLC | Black | 196 | 717 | 0.272 | 0.271 | 0.240 | 0.305 |
| KRAS | 12, 13, or 61 | NSCLC | NA | 204 | 849 | 0.240 | 0.240 | 0.212 | 0.269 |
| KRAS | 12, 13, or 61 | NSCLC | Native American | 4 | 17 | 0.233 | 0.226 | 0.114 | 0.391 |
| KRAS | 12, 13, or 61 | NSCLC | Other | 34 | 165 | 0.208 | 0.207 | 0.153 | 0.270 |
| KRAS | 12, 13, or 61 | NSCLC | Undefined | 3 | 10 | 0.256 | 0.245 | 0.116 | 0.455 |
| KRAS | 12, 13, or 61 | NSCLC | White | 2410 | 7745 | 0.311 | 0.311 | 0.301 | 0.321 |
| KRAS | 12, 13, or 61 | Breast | Asian | 1 | 334 | 0.007 | 0.007 | 0.004 | 0.011 |
| KRAS | 12, 13, or 61 | Breast | Black | 4 | 526 | 0.008 | 0.008 | 0.005 | 0.011 |
| KRAS | 12, 13, or 61 | Breast | NA | 23 | 3112 | 0.008 | 0.008 | 0.005 | 0.010 |
| KRAS | 12, 13, or 61 | Breast | Native American | 0 | 11 | 0.008 | 0.008 | 0.004 | 0.013 |
| KRAS | 12, 13, or 61 | Breast | Other | 2 | 176 | 0.008 | 0.008 | 0.005 | 0.013 |
| KRAS | 12, 13, or 61 | Breast | White | 42 | 5174 | 0.008 | 0.008 | 0.006 | 0.010 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Asian | 0 | 143 | 0.008 | 0.008 | 0.001 | 0.015 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Black | 1 | 193 | 0.009 | 0.009 | 0.003 | 0.016 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | NA | 4 | 350 | 0.010 | 0.009 | 0.005 | 0.018 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Other | 2 | 73 | 0.011 | 0.010 | 0.005 | 0.030 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | White | 18 | 2005 | 0.009 | 0.009 | 0.006 | 0.013 |
| KRAS | 12, 13, or 61 | Pancreatic | Asian | 67 | 100 | 0.713 | 0.719 | 0.641 | 0.758 |
| KRAS | 12, 13, or 61 | Pancreatic | Black | 64 | 88 | 0.726 | 0.728 | 0.667 | 0.772 |
| KRAS | 12, 13, or 61 | Pancreatic | NA | 164 | 231 | 0.721 | 0.723 | 0.672 | 0.758 |
| KRAS | 12, 13, or 61 | Pancreatic | Other | 24 | 34 | 0.723 | 0.727 | 0.650 | 0.777 |
| KRAS | 12, 13, or 61 | Pancreatic | White | 1513 | 2038 | 0.739 | 0.739 | 0.720 | 0.757 |
| KRAS | 12, 13, or 61 | Leukemia | Asian | 2 | 37 | 0.048 | 0.047 | 0.028 | 0.075 |
| KRAS | 12, 13, or 61 | Leukemia | Black | 2 | 69 | 0.046 | 0.046 | 0.025 | 0.066 |
| KRAS | 12, 13, or 61 | Leukemia | NA | 38 | 777 | 0.048 | 0.047 | 0.036 | 0.061 |
| KRAS | 12, 13, or 61 | Leukemia | Other | 1 | 13 | 0.049 | 0.047 | 0.027 | 0.081 |
| KRAS | 12, 13, or 61 | Leukemia | White | 30 | 662 | 0.046 | 0.046 | 0.034 | 0.059 |
| KRAS | 12, 13, or 61 | Melanoma | Asian | 0 | 33 | 0.007 | 0.003 | 0.000 | 0.035 |
| KRAS | 12, 13, or 61 | Melanoma | Black | 2 | 34 | 0.043 | 0.033 | 0.005 | 0.133 |
| KRAS | 12, 13, or 61 | Melanoma | NA | 0 | 398 | 0.002 | 0.001 | 0.000 | 0.012 |
| KRAS | 12, 13, or 61 | Melanoma | Other | 0 | 26 | 0.008 | 0.003 | 0.000 | 0.040 |
| KRAS | 12, 13, or 61 | Melanoma | White | 34 | 2348 | 0.014 | 0.014 | 0.010 | 0.019 |
| KRAS | 12, 13, or 61 | Head and neck | Asian | 0 | 94 | 0.006 | 0.006 | 0.001 | 0.014 |
| KRAS | 12, 13, or 61 | Head and neck | Black | 1 | 62 | 0.008 | 0.007 | 0.002 | 0.020 |
| KRAS | 12, 13, or 61 | Head and neck | NA | 1 | 292 | 0.006 | 0.006 | 0.001 | 0.012 |
| KRAS | 12, 13, or 61 | Head and neck | Other | 0 | 28 | 0.007 | 0.006 | 0.001 | 0.015 |
| KRAS | 12, 13, or 61 | Head and neck | White | 10 | 1264 | 0.007 | 0.007 | 0.004 | 0.012 |
| KRAS | 12, 13, or 61 | Uterine | Asian | 19 | 108 | 0.158 | 0.154 | 0.111 | 0.222 |
| KRAS | 12, 13, or 61 | Uterine | Black | 11 | 163 | 0.102 | 0.100 | 0.052 | 0.154 |
| KRAS | 12, 13, or 61 | Uterine | NA | 28 | 190 | 0.145 | 0.144 | 0.105 | 0.189 |
| KRAS | 12, 13, or 61 | Uterine | Other | 5 | 37 | 0.139 | 0.139 | 0.075 | 0.212 |
| KRAS | 12, 13, or 61 | Uterine | White | 276 | 1754 | 0.156 | 0.155 | 0.139 | 0.173 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | Asian | 0 | 11 | 0.007 | 0.004 | 0.000 | 0.034 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | Black | 0 | 13 | 0.007 | 0.004 | 0.000 | 0.035 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | NA | 1 | 53 | 0.008 | 0.005 | 0.001 | 0.038 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | White | 1 | 436 | 0.004 | 0.003 | 0.000 | 0.011 |
| KRAS | 12, 13, or 61 | MDS/MPN | Asian | 0 | 12 | 0.015 | 0.014 | 0.001 | 0.038 |
| KRAS | 12, 13, or 61 | MDS/MPN | Black | 0 | 37 | 0.014 | 0.014 | 0.001 | 0.029 |
| KRAS | 12, 13, or 61 | MDS/MPN | NA | 11 | 571 | 0.017 | 0.016 | 0.009 | 0.027 |
| KRAS | 12, 13, or 61 | MDS/MPN | White | 7 | 584 | 0.014 | 0.014 | 0.006 | 0.022 |
| KRAS | 12, 13, or 61 | Adrenocortical | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | 12, 13, or 61 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Ovarian | Asian | 14 | 134 | 0.102 | 0.100 | 0.075 | 0.139 |
| KRAS | 12, 13, or 61 | Ovarian | Black | 11 | 74 | 0.111 | 0.105 | 0.081 | 0.175 |
| KRAS | 12, 13, or 61 | Ovarian | NA | 21 | 239 | 0.097 | 0.097 | 0.071 | 0.123 |
| KRAS | 12, 13, or 61 | Ovarian | Other | 7 | 36 | 0.115 | 0.105 | 0.081 | 0.203 |
| KRAS | 12, 13, or 61 | Ovarian | White | 173 | 1852 | 0.096 | 0.095 | 0.083 | 0.108 |
| KRAS | 12, 13, or 61 | Esophagogastric | Asian | 4 | 115 | 0.048 | 0.048 | 0.026 | 0.067 |
| KRAS | 12, 13, or 61 | Esophagogastric | Black | 2 | 68 | 0.048 | 0.048 | 0.024 | 0.068 |
| KRAS | 12, 13, or 61 | Esophagogastric | NA | 9 | 191 | 0.049 | 0.049 | 0.032 | 0.069 |
| KRAS | 12, 13, or 61 | Esophagogastric | Other | 3 | 46 | 0.052 | 0.050 | 0.031 | 0.081 |
| KRAS | 12, 13, or 61 | Esophagogastric | White | 74 | 1379 | 0.052 | 0.052 | 0.042 | 0.064 |
| KRAS | 12, 13, or 61 | Thyroid | Asian | 0 | 66 | 0.022 | 0.023 | 0.001 | 0.042 |
| KRAS | 12, 13, or 61 | Thyroid | Black | 1 | 40 | 0.027 | 0.026 | 0.006 | 0.059 |
| KRAS | 12, 13, or 61 | Thyroid | NA | 4 | 79 | 0.034 | 0.030 | 0.015 | 0.075 |
| KRAS | 12, 13, or 61 | Thyroid | Other | 0 | 26 | 0.024 | 0.024 | 0.001 | 0.050 |
| KRAS | 12, 13, or 61 | Thyroid | White | 23 | 803 | 0.028 | 0.028 | 0.018 | 0.040 |
| KRAS | 12, 13, or 61 | Cervical | Asian | 5 | 27 | 0.103 | 0.093 | 0.055 | 0.217 |
| KRAS | 12, 13, or 61 | Cervical | Black | 1 | 19 | 0.083 | 0.081 | 0.028 | 0.143 |
| KRAS | 12, 13, or 61 | Cervical | NA | 6 | 77 | 0.084 | 0.083 | 0.045 | 0.129 |
| KRAS | 12, 13, or 61 | Cervical | Other | 0 | 15 | 0.078 | 0.079 | 0.016 | 0.131 |
| KRAS | 12, 13, or 61 | Cervical | White | 19 | 228 | 0.084 | 0.083 | 0.056 | 0.118 |
| KRAS | 12, 13, or 61 | Hepatobiliary | Asian | 9 | 98 | 0.094 | 0.095 | 0.056 | 0.132 |
| KRAS | 12, 13, or 61 | Hepatobiliary | Black | 2 | 64 | 0.080 | 0.085 | 0.025 | 0.120 |
| KRAS | 12, 13, or 61 | Hepatobiliary | NA | 22 | 235 | 0.095 | 0.096 | 0.066 | 0.124 |
| KRAS | 12, 13, or 61 | Hepatobiliary | Other | 1 | 25 | 0.087 | 0.092 | 0.028 | 0.131 |
| KRAS | 12, 13, or 61 | Hepatobiliary | White | 107 | 948 | 0.108 | 0.107 | 0.090 | 0.128 |
| KRAS | 12, 13, or 61 | Kidney | Asian | 0 | 33 | 0.010 | 0.009 | 0.002 | 0.022 |
| KRAS | 12, 13, or 61 | Kidney | Black | 2 | 77 | 0.012 | 0.010 | 0.004 | 0.033 |
| KRAS | 12, 13, or 61 | Kidney | NA | 2 | 169 | 0.010 | 0.009 | 0.004 | 0.021 |
| KRAS | 12, 13, or 61 | Kidney | Other | 0 | 29 | 0.010 | 0.009 | 0.002 | 0.023 |
| KRAS | 12, 13, or 61 | Kidney | White | 9 | 1113 | 0.009 | 0.009 | 0.005 | 0.015 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | Asian | 0 | 12 | 0.015 | 0.012 | 0.000 | 0.052 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | Black | 1 | 18 | 0.023 | 0.015 | 0.003 | 0.096 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | NA | 0 | 10 | 0.015 | 0.012 | 0.000 | 0.055 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | White | 2 | 188 | 0.013 | 0.012 | 0.003 | 0.032 |
| KRAS | 12, 13, or 61 | CNS | Asian | 0 | 154 | 0.007 | 0.007 | 0.001 | 0.012 |
| KRAS | 12, 13, or 61 | CNS | Black | 0 | 131 | 0.007 | 0.007 | 0.001 | 0.012 |
| KRAS | 12, 13, or 61 | CNS | NA | 7 | 817 | 0.008 | 0.008 | 0.004 | 0.013 |
| KRAS | 12, 13, or 61 | CNS | Other | 1 | 108 | 0.008 | 0.008 | 0.002 | 0.015 |
| KRAS | 12, 13, or 61 | CNS | Undefined | 0 | 17 | 0.008 | 0.008 | 0.001 | 0.016 |
| KRAS | 12, 13, or 61 | CNS | White | 29 | 3331 | 0.008 | 0.008 | 0.006 | 0.011 |
| KRAS | 12, 13, or 61 | Prostate | Asian | 0 | 62 | 0.005 | 0.004 | 0.000 | 0.013 |
| KRAS | 12, 13, or 61 | Prostate | Black | 2 | 175 | 0.007 | 0.005 | 0.002 | 0.019 |
| KRAS | 12, 13, or 61 | Prostate | NA | 0 | 289 | 0.004 | 0.004 | 0.000 | 0.009 |
| KRAS | 12, 13, or 61 | Prostate | Other | 0 | 31 | 0.005 | 0.004 | 0.000 | 0.015 |
| KRAS | 12, 13, or 61 | Prostate | White | 10 | 1882 | 0.005 | 0.005 | 0.003 | 0.009 |
| KRAS | 12, 13, or 61 | Anal | NA | 0 | 13 | 0.028 | 0.024 | 0.000 | 0.094 |
| KRAS | 12, 13, or 61 | Anal | White | 5 | 126 | 0.038 | 0.036 | 0.013 | 0.077 |
| KRAS | 12, 13, or 61 | Neuroendocrine | Black | 1 | 23 | 0.073 | 0.069 | 0.009 | 0.169 |
| KRAS | 12, 13, or 61 | Neuroendocrine | NA | 10 | 45 | 0.183 | 0.179 | 0.078 | 0.321 |
| KRAS | 12, 13, or 61 | Neuroendocrine | White | 19 | 283 | 0.071 | 0.070 | 0.044 | 0.105 |
| KRAS | 12, 13, or 61 | Bladder | Asian | 0 | 40 | 0.035 | 0.038 | 0.002 | 0.065 |
| KRAS | 12, 13, or 61 | Bladder | Black | 2 | 43 | 0.045 | 0.044 | 0.015 | 0.087 |
| KRAS | 12, 13, or 61 | Bladder | NA | 4 | 169 | 0.036 | 0.037 | 0.013 | 0.059 |
| KRAS | 12, 13, or 61 | Bladder | Other | 2 | 14 | 0.061 | 0.049 | 0.021 | 0.183 |
| KRAS | 12, 13, or 61 | Bladder | White | 66 | 1311 | 0.049 | 0.049 | 0.038 | 0.061 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | Asian | 1 | 17 | 0.081 | 0.078 | 0.030 | 0.143 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | NA | 7 | 92 | 0.080 | 0.079 | 0.042 | 0.124 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | White | 11 | 125 | 0.083 | 0.082 | 0.049 | 0.127 |
| KRAS | 12, 13, or 61 | Small bowel | Black | 14 | 25 | 0.459 | 0.443 | 0.334 | 0.659 |
| KRAS | 12, 13, or 61 | Small bowel | NA | 9 | 22 | 0.412 | 0.407 | 0.284 | 0.560 |
| KRAS | 12, 13, or 61 | Small bowel | White | 55 | 150 | 0.383 | 0.383 | 0.310 | 0.457 |
| KRAS | 12, 13, or 61 | Sex cord stromal | NA | 1 | 23 | 0.031 | 0.023 | 0.003 | 0.107 |
| KRAS | 12, 13, or 61 | Sex cord stromal | White | 1 | 69 | 0.022 | 0.018 | 0.002 | 0.061 |
| KRAS | 12, 13, or 61 | Bone | Asian | 1 | 30 | 0.014 | 0.011 | 0.003 | 0.048 |
| KRAS | 12, 13, or 61 | Bone | Black | 0 | 32 | 0.011 | 0.010 | 0.001 | 0.028 |
| KRAS | 12, 13, or 61 | Bone | NA | 0 | 86 | 0.010 | 0.009 | 0.000 | 0.023 |
| KRAS | 12, 13, or 61 | Bone | Other | 1 | 29 | 0.015 | 0.011 | 0.003 | 0.050 |
| KRAS | 12, 13, or 61 | Bone | White | 4 | 391 | 0.011 | 0.010 | 0.004 | 0.022 |
| KRAS | 12, 13, or 61 | Vaginal | White | 2 | 68 | 0.031 | 0.026 | 0.004 | 0.082 |
| KRAS | 12, 13, or 61 | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.007 |
| KRAS | 12, 13, or 61 | Thymic | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | 12, 13, or 61 | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | 12, 13, or 61 | Ampullary | White | 48 | 86 | 0.558 | 0.559 | 0.453 | 0.660 |
| KRAS | 12, 13, or 61 | SCLC | Asian | 0 | 15 | 0.026 | 0.024 | 0.001 | 0.065 |
| KRAS | 12, 13, or 61 | SCLC | NA | 1 | 30 | 0.029 | 0.026 | 0.006 | 0.074 |
| KRAS | 12, 13, or 61 | SCLC | White | 9 | 337 | 0.027 | 0.026 | 0.013 | 0.045 |
| KRAS | 12, 13, or 61 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | 12, 13, or 61 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | 12, 13, or 61 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Germ cell | Asian | 2 | 36 | 0.053 | 0.051 | 0.014 | 0.111 |
| KRAS | 12, 13, or 61 | Germ cell | Black | 0 | 23 | 0.040 | 0.039 | 0.003 | 0.086 |
| KRAS | 12, 13, or 61 | Germ cell | NA | 5 | 179 | 0.038 | 0.036 | 0.014 | 0.069 |
| KRAS | 12, 13, or 61 | Germ cell | Other | 1 | 37 | 0.044 | 0.042 | 0.008 | 0.089 |
| KRAS | 12, 13, or 61 | Germ cell | White | 46 | 603 | 0.071 | 0.071 | 0.052 | 0.094 |
| KRAS | 12, 13, or 61 | Nerve sheath | Black | 0 | 12 | 0.009 | 0.005 | 0.000 | 0.042 |
| KRAS | 12, 13, or 61 | Nerve sheath | NA | 0 | 26 | 0.008 | 0.005 | 0.000 | 0.034 |
| KRAS | 12, 13, or 61 | Nerve sheath | White | 1 | 105 | 0.009 | 0.006 | 0.000 | 0.030 |
| KRAS | 12, 13, or 61 | Penile | White | 1 | 20 | 0.057 | 0.043 | 0.003 | 0.189 |
| KRAS | 12, 13, or 61 | Pheochromocytoma | White | 0 | 15 | 0.004 | 0.000 | 0.000 | 0.042 |
| KRAS | 12, 13, or 61 | Pineal | White | 1 | 14 | 0.079 | 0.060 | 0.003 | 0.258 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Asian | 0 | 21 | 0.031 | 0.033 | 0.000 | 0.064 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Black | 0 | 25 | 0.031 | 0.032 | 0.000 | 0.062 |
| KRAS | 12, 13, or 61 | B cell lymphoma | NA | 3 | 42 | 0.045 | 0.040 | 0.018 | 0.109 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Other | 0 | 12 | 0.033 | 0.034 | 0.000 | 0.074 |
| KRAS | 12, 13, or 61 | B cell lymphoma | White | 33 | 859 | 0.038 | 0.037 | 0.027 | 0.051 |
| KRAS | 12, 13, or 61 | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.027 |
| KRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.027 | 0.016 | 0.000 | 0.118 |
| KRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | White | 1 | 23 | 0.038 | 0.027 | 0.002 | 0.130 |
| KRAS | 12, 13, or 61 | Retinoblastoma | NA | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.031 |
| KRAS | 12, 13, or 61 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.024 |
| KRAS | 12, 13, or 61 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.011 |
| KRAS | 12, 13, or 61 | Lung | White | 3 | 17 | 0.181 | 0.168 | 0.043 | 0.388 |
| KRAS | 12, 13, or 61 | Peritoneal | White | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.027 |
| KRAS | 12, 13, or 61 | Parathyroid | White | 1 | 14 | 0.079 | 0.059 | 0.004 | 0.258 |
| KRAS | G12 | Appendiceal | Black | 6 | 17 | 0.415 | 0.419 | 0.274 | 0.523 |
| KRAS | G12 | Appendiceal | NA | 15 | 33 | 0.433 | 0.430 | 0.334 | 0.547 |
| KRAS | G12 | Appendiceal | White | 120 | 280 | 0.428 | 0.428 | 0.373 | 0.483 |
| KRAS | G12 | CRC | Asian | 97 | 313 | 0.313 | 0.313 | 0.274 | 0.355 |
| KRAS | G12 | CRC | Black | 188 | 515 | 0.347 | 0.346 | 0.308 | 0.391 |
| KRAS | G12 | CRC | NA | 249 | 804 | 0.311 | 0.311 | 0.283 | 0.340 |
| KRAS | G12 | CRC | Native American | 9 | 17 | 0.339 | 0.329 | 0.273 | 0.466 |
| KRAS | G12 | CRC | Other | 43 | 139 | 0.314 | 0.313 | 0.263 | 0.369 |
| KRAS | G12 | CRC | White | 1426 | 4925 | 0.292 | 0.292 | 0.279 | 0.304 |
| KRAS | G12 | CUP | Asian | 9 | 73 | 0.151 | 0.152 | 0.106 | 0.190 |
| KRAS | G12 | CUP | Black | 23 | 123 | 0.164 | 0.161 | 0.131 | 0.213 |
| KRAS | G12 | CUP | NA | 37 | 286 | 0.147 | 0.148 | 0.112 | 0.176 |
| KRAS | G12 | CUP | Other | 7 | 36 | 0.161 | 0.158 | 0.118 | 0.222 |
| KRAS | G12 | CUP | White | 237 | 1465 | 0.160 | 0.160 | 0.143 | 0.178 |
| KRAS | G12 | NSCLC | Asian | 54 | 624 | 0.092 | 0.092 | 0.070 | 0.117 |
| KRAS | G12 | NSCLC | Black | 172 | 717 | 0.238 | 0.238 | 0.208 | 0.269 |
| KRAS | G12 | NSCLC | NA | 181 | 849 | 0.212 | 0.212 | 0.186 | 0.240 |
| KRAS | G12 | NSCLC | Native American | 4 | 17 | 0.213 | 0.205 | 0.100 | 0.367 |
| KRAS | G12 | NSCLC | Other | 29 | 165 | 0.178 | 0.177 | 0.127 | 0.236 |
| KRAS | G12 | NSCLC | Undefined | 1 | 10 | 0.168 | 0.162 | 0.055 | 0.321 |
| KRAS | G12 | NSCLC | White | 2092 | 7745 | 0.270 | 0.270 | 0.260 | 0.280 |
| KRAS | G12 | Breast | Asian | 1 | 334 | 0.007 | 0.007 | 0.003 | 0.010 |
| KRAS | G12 | Breast | Black | 3 | 526 | 0.007 | 0.007 | 0.004 | 0.010 |
| KRAS | G12 | Breast | NA | 21 | 3112 | 0.007 | 0.007 | 0.005 | 0.009 |
| KRAS | G12 | Breast | Native American | 0 | 11 | 0.007 | 0.007 | 0.004 | 0.011 |
| KRAS | G12 | Breast | Other | 2 | 176 | 0.007 | 0.007 | 0.004 | 0.012 |
| KRAS | G12 | Breast | White | 38 | 5174 | 0.007 | 0.007 | 0.005 | 0.009 |
| KRAS | G12 | Soft tissue sarcoma | Asian | 0 | 143 | 0.008 | 0.008 | 0.002 | 0.014 |
| KRAS | G12 | Soft tissue sarcoma | Black | 1 | 193 | 0.008 | 0.008 | 0.003 | 0.014 |
| KRAS | G12 | Soft tissue sarcoma | NA | 4 | 350 | 0.009 | 0.009 | 0.005 | 0.016 |
| KRAS | G12 | Soft tissue sarcoma | Other | 1 | 73 | 0.009 | 0.008 | 0.003 | 0.019 |
| KRAS | G12 | Soft tissue sarcoma | White | 17 | 2005 | 0.008 | 0.008 | 0.005 | 0.012 |
| KRAS | G12 | Pancreatic | Asian | 61 | 100 | 0.652 | 0.657 | 0.578 | 0.699 |
| KRAS | G12 | Pancreatic | Black | 59 | 88 | 0.665 | 0.667 | 0.604 | 0.715 |
| KRAS | G12 | Pancreatic | NA | 154 | 231 | 0.666 | 0.666 | 0.620 | 0.705 |
| KRAS | G12 | Pancreatic | Other | 19 | 34 | 0.651 | 0.659 | 0.553 | 0.706 |
| KRAS | G12 | Pancreatic | White | 1383 | 2038 | 0.675 | 0.675 | 0.656 | 0.695 |
| KRAS | G12 | Leukemia | Asian | 2 | 37 | 0.033 | 0.029 | 0.013 | 0.079 |
| KRAS | G12 | Leukemia | Black | 0 | 69 | 0.023 | 0.024 | 0.002 | 0.041 |
| KRAS | G12 | Leukemia | NA | 27 | 777 | 0.031 | 0.031 | 0.021 | 0.044 |
| KRAS | G12 | Leukemia | Other | 0 | 13 | 0.027 | 0.026 | 0.003 | 0.057 |
| KRAS | G12 | Leukemia | White | 15 | 662 | 0.025 | 0.025 | 0.015 | 0.036 |
| KRAS | G12 | Melanoma | Asian | 0 | 33 | 0.006 | 0.005 | 0.000 | 0.025 |
| KRAS | G12 | Melanoma | Black | 1 | 34 | 0.016 | 0.009 | 0.001 | 0.069 |
| KRAS | G12 | Melanoma | NA | 0 | 398 | 0.003 | 0.002 | 0.000 | 0.011 |
| KRAS | G12 | Melanoma | Other | 0 | 26 | 0.006 | 0.005 | 0.000 | 0.029 |
| KRAS | G12 | Melanoma | White | 22 | 2348 | 0.009 | 0.009 | 0.006 | 0.013 |
| KRAS | G12 | Head and neck | Asian | 0 | 94 | 0.005 | 0.005 | 0.001 | 0.012 |
| KRAS | G12 | Head and neck | Black | 1 | 62 | 0.006 | 0.005 | 0.002 | 0.020 |
| KRAS | G12 | Head and neck | NA | 1 | 292 | 0.005 | 0.005 | 0.001 | 0.011 |
| KRAS | G12 | Head and neck | Other | 0 | 28 | 0.006 | 0.005 | 0.001 | 0.015 |
| KRAS | G12 | Head and neck | White | 7 | 1264 | 0.005 | 0.005 | 0.002 | 0.010 |
| KRAS | G12 | Uterine | Asian | 15 | 108 | 0.125 | 0.123 | 0.087 | 0.174 |
| KRAS | G12 | Uterine | Black | 10 | 163 | 0.096 | 0.097 | 0.049 | 0.133 |
| KRAS | G12 | Uterine | NA | 22 | 190 | 0.117 | 0.117 | 0.084 | 0.152 |
| KRAS | G12 | Uterine | Other | 4 | 37 | 0.116 | 0.116 | 0.065 | 0.171 |
| KRAS | G12 | Uterine | White | 228 | 1754 | 0.128 | 0.127 | 0.113 | 0.143 |
| KRAS | G12 | Non-melanoma skin | Asian | 0 | 11 | 0.006 | 0.004 | 0.000 | 0.030 |
| KRAS | G12 | Non-melanoma skin | Black | 0 | 13 | 0.006 | 0.004 | 0.000 | 0.029 |
| KRAS | G12 | Non-melanoma skin | NA | 1 | 53 | 0.008 | 0.005 | 0.001 | 0.037 |
| KRAS | G12 | Non-melanoma skin | White | 1 | 436 | 0.004 | 0.003 | 0.000 | 0.011 |
| KRAS | G12 | MDS/MPN | Asian | 0 | 12 | 0.010 | 0.009 | 0.002 | 0.024 |
| KRAS | G12 | MDS/MPN | Black | 0 | 37 | 0.009 | 0.009 | 0.002 | 0.021 |
| KRAS | G12 | MDS/MPN | NA | 5 | 571 | 0.009 | 0.009 | 0.004 | 0.016 |
| KRAS | G12 | MDS/MPN | White | 6 | 584 | 0.010 | 0.009 | 0.004 | 0.017 |
| KRAS | G12 | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G12 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12 | Ovarian | Asian | 12 | 134 | 0.091 | 0.089 | 0.061 | 0.130 |
| KRAS | G12 | Ovarian | Black | 11 | 74 | 0.109 | 0.101 | 0.073 | 0.186 |
| KRAS | G12 | Ovarian | NA | 16 | 239 | 0.081 | 0.082 | 0.052 | 0.107 |
| KRAS | G12 | Ovarian | Other | 7 | 36 | 0.115 | 0.101 | 0.071 | 0.224 |
| KRAS | G12 | Ovarian | White | 156 | 1852 | 0.086 | 0.085 | 0.074 | 0.098 |
| KRAS | G12 | Esophagogastric | Asian | 3 | 115 | 0.035 | 0.035 | 0.018 | 0.051 |
| KRAS | G12 | Esophagogastric | Black | 1 | 68 | 0.035 | 0.035 | 0.016 | 0.052 |
| KRAS | G12 | Esophagogastric | NA | 8 | 191 | 0.037 | 0.037 | 0.024 | 0.055 |
| KRAS | G12 | Esophagogastric | Other | 2 | 46 | 0.037 | 0.036 | 0.021 | 0.058 |
| KRAS | G12 | Esophagogastric | White | 52 | 1379 | 0.037 | 0.037 | 0.028 | 0.047 |
| KRAS | G12 | Thyroid | Asian | 0 | 66 | 0.004 | 0.001 | 0.000 | 0.019 |
| KRAS | G12 | Thyroid | Black | 0 | 40 | 0.005 | 0.001 | 0.000 | 0.021 |
| KRAS | G12 | Thyroid | NA | 0 | 79 | 0.004 | 0.001 | 0.000 | 0.018 |
| KRAS | G12 | Thyroid | Other | 0 | 26 | 0.005 | 0.001 | 0.000 | 0.023 |
| KRAS | G12 | Thyroid | White | 12 | 803 | 0.014 | 0.013 | 0.007 | 0.023 |
| KRAS | G12 | Cervical | Asian | 3 | 27 | 0.079 | 0.075 | 0.041 | 0.144 |
| KRAS | G12 | Cervical | Black | 1 | 19 | 0.072 | 0.071 | 0.030 | 0.120 |
| KRAS | G12 | Cervical | NA | 5 | 77 | 0.072 | 0.071 | 0.038 | 0.110 |
| KRAS | G12 | Cervical | Other | 0 | 15 | 0.069 | 0.069 | 0.016 | 0.116 |
| KRAS | G12 | Cervical | White | 18 | 228 | 0.075 | 0.074 | 0.049 | 0.107 |
| KRAS | G12 | Hepatobiliary | Asian | 9 | 98 | 0.084 | 0.082 | 0.048 | 0.133 |
| KRAS | G12 | Hepatobiliary | Black | 0 | 64 | 0.049 | 0.051 | 0.001 | 0.095 |
| KRAS | G12 | Hepatobiliary | NA | 19 | 235 | 0.079 | 0.079 | 0.052 | 0.110 |
| KRAS | G12 | Hepatobiliary | Other | 1 | 25 | 0.067 | 0.070 | 0.012 | 0.120 |
| KRAS | G12 | Hepatobiliary | White | 85 | 948 | 0.087 | 0.087 | 0.071 | 0.105 |
| KRAS | G12 | Kidney | Asian | 0 | 33 | 0.009 | 0.008 | 0.001 | 0.022 |
| KRAS | G12 | Kidney | Black | 2 | 77 | 0.011 | 0.009 | 0.004 | 0.035 |
| KRAS | G12 | Kidney | NA | 2 | 169 | 0.009 | 0.008 | 0.003 | 0.021 |
| KRAS | G12 | Kidney | Other | 0 | 29 | 0.009 | 0.008 | 0.001 | 0.023 |
| KRAS | G12 | Kidney | White | 7 | 1113 | 0.007 | 0.007 | 0.003 | 0.013 |
| KRAS | G12 | T / NK neoplasms | Asian | 0 | 12 | 0.008 | 0.002 | 0.000 | 0.052 |
| KRAS | G12 | T / NK neoplasms | Black | 1 | 18 | 0.029 | 0.012 | 0.000 | 0.144 |
| KRAS | G12 | T / NK neoplasms | NA | 0 | 10 | 0.008 | 0.003 | 0.000 | 0.055 |
| KRAS | G12 | T / NK neoplasms | White | 0 | 188 | 0.003 | 0.001 | 0.000 | 0.015 |
| KRAS | G12 | CNS | Asian | 0 | 154 | 0.004 | 0.004 | 0.000 | 0.009 |
| KRAS | G12 | CNS | Black | 0 | 131 | 0.004 | 0.004 | 0.000 | 0.009 |
| KRAS | G12 | CNS | NA | 2 | 817 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | G12 | CNS | Other | 1 | 108 | 0.006 | 0.005 | 0.001 | 0.015 |
| KRAS | G12 | CNS | Undefined | 0 | 17 | 0.005 | 0.005 | 0.000 | 0.015 |
| KRAS | G12 | CNS | White | 21 | 3331 | 0.006 | 0.006 | 0.004 | 0.008 |
| KRAS | G12 | Prostate | Asian | 0 | 62 | 0.003 | 0.003 | 0.000 | 0.008 |
| KRAS | G12 | Prostate | Black | 1 | 175 | 0.004 | 0.003 | 0.001 | 0.011 |
| KRAS | G12 | Prostate | NA | 0 | 289 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | G12 | Prostate | Other | 0 | 31 | 0.003 | 0.003 | 0.000 | 0.010 |
| KRAS | G12 | Prostate | White | 6 | 1882 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | G12 | Anal | NA | 0 | 13 | 0.015 | 0.010 | 0.000 | 0.063 |
| KRAS | G12 | Anal | White | 2 | 126 | 0.016 | 0.014 | 0.002 | 0.044 |
| KRAS | G12 | Neuroendocrine | Black | 1 | 23 | 0.063 | 0.056 | 0.007 | 0.165 |
| KRAS | G12 | Neuroendocrine | NA | 10 | 45 | 0.194 | 0.190 | 0.083 | 0.326 |
| KRAS | G12 | Neuroendocrine | White | 13 | 283 | 0.049 | 0.048 | 0.027 | 0.078 |
| KRAS | G12 | Bladder | Asian | 0 | 40 | 0.031 | 0.032 | 0.004 | 0.057 |
| KRAS | G12 | Bladder | Black | 2 | 43 | 0.040 | 0.038 | 0.013 | 0.082 |
| KRAS | G12 | Bladder | NA | 3 | 169 | 0.030 | 0.031 | 0.009 | 0.051 |
| KRAS | G12 | Bladder | Other | 1 | 14 | 0.042 | 0.039 | 0.011 | 0.108 |
| KRAS | G12 | Bladder | White | 59 | 1311 | 0.043 | 0.043 | 0.033 | 0.055 |
| KRAS | G12 | BLL/Lymphoma | Asian | 1 | 17 | 0.047 | 0.043 | 0.015 | 0.113 |
| KRAS | G12 | BLL/Lymphoma | NA | 5 | 92 | 0.046 | 0.044 | 0.021 | 0.086 |
| KRAS | G12 | BLL/Lymphoma | White | 4 | 125 | 0.040 | 0.039 | 0.016 | 0.072 |
| KRAS | G12 | Small bowel | Black | 11 | 25 | 0.351 | 0.338 | 0.245 | 0.530 |
| KRAS | G12 | Small bowel | NA | 6 | 22 | 0.306 | 0.306 | 0.181 | 0.431 |
| KRAS | G12 | Small bowel | White | 44 | 150 | 0.304 | 0.303 | 0.238 | 0.372 |
| KRAS | G12 | Sex cord stromal | NA | 1 | 23 | 0.030 | 0.023 | 0.003 | 0.102 |
| KRAS | G12 | Sex cord stromal | White | 1 | 69 | 0.021 | 0.018 | 0.002 | 0.061 |
| KRAS | G12 | Bone | Asian | 0 | 30 | 0.008 | 0.007 | 0.000 | 0.025 |
| KRAS | G12 | Bone | Black | 0 | 32 | 0.008 | 0.007 | 0.000 | 0.024 |
| KRAS | G12 | Bone | NA | 0 | 86 | 0.007 | 0.007 | 0.000 | 0.020 |
| KRAS | G12 | Bone | Other | 1 | 29 | 0.015 | 0.010 | 0.002 | 0.065 |
| KRAS | G12 | Bone | White | 4 | 391 | 0.009 | 0.009 | 0.003 | 0.020 |
| KRAS | G12 | Vaginal | White | 1 | 68 | 0.017 | 0.013 | 0.001 | 0.057 |
| KRAS | G12 | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | G12 | Thymic | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | G12 | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12 | Ampullary | White | 40 | 86 | 0.465 | 0.465 | 0.362 | 0.569 |
| KRAS | G12 | SCLC | Asian | 0 | 15 | 0.025 | 0.023 | 0.001 | 0.063 |
| KRAS | G12 | SCLC | NA | 1 | 30 | 0.028 | 0.025 | 0.006 | 0.071 |
| KRAS | G12 | SCLC | White | 9 | 337 | 0.026 | 0.025 | 0.013 | 0.045 |
| KRAS | G12 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12 | Germ cell | Asian | 2 | 36 | 0.052 | 0.050 | 0.015 | 0.104 |
| KRAS | G12 | Germ cell | Black | 0 | 23 | 0.040 | 0.041 | 0.003 | 0.083 |
| KRAS | G12 | Germ cell | NA | 5 | 179 | 0.039 | 0.038 | 0.014 | 0.068 |
| KRAS | G12 | Germ cell | Other | 1 | 37 | 0.044 | 0.044 | 0.008 | 0.085 |
| KRAS | G12 | Germ cell | White | 43 | 603 | 0.066 | 0.066 | 0.048 | 0.088 |
| KRAS | G12 | Nerve sheath | Black | 0 | 12 | 0.009 | 0.005 | 0.000 | 0.040 |
| KRAS | G12 | Nerve sheath | NA | 0 | 26 | 0.008 | 0.005 | 0.000 | 0.034 |
| KRAS | G12 | Nerve sheath | White | 1 | 105 | 0.009 | 0.006 | 0.000 | 0.030 |
| KRAS | G12 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.039 |
| KRAS | G12 | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.036 |
| KRAS | G12 | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.039 |
| KRAS | G12 | B cell lymphoma | Asian | 0 | 21 | 0.014 | 0.013 | 0.000 | 0.038 |
| KRAS | G12 | B cell lymphoma | Black | 0 | 25 | 0.014 | 0.013 | 0.000 | 0.037 |
| KRAS | G12 | B cell lymphoma | NA | 2 | 42 | 0.022 | 0.017 | 0.007 | 0.073 |
| KRAS | G12 | B cell lymphoma | Other | 0 | 12 | 0.015 | 0.014 | 0.000 | 0.046 |
| KRAS | G12 | B cell lymphoma | White | 12 | 859 | 0.014 | 0.014 | 0.008 | 0.023 |
| KRAS | G12 | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.027 |
| KRAS | G12 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.026 | 0.015 | 0.000 | 0.117 |
| KRAS | G12 | T-lymphoblastic leukemia/lymphoma | White | 1 | 23 | 0.038 | 0.027 | 0.002 | 0.133 |
| KRAS | G12 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G12 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | G12 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.017 |
| KRAS | G12 | Lung | White | 3 | 17 | 0.181 | 0.168 | 0.043 | 0.389 |
| KRAS | G12 | Peritoneal | White | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| KRAS | G12 | Parathyroid | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| KRAS | G12C | Appendiceal | Black | 0 | 17 | 0.017 | 0.015 | 0.000 | 0.053 |
| KRAS | G12C | Appendiceal | NA | 0 | 33 | 0.015 | 0.013 | 0.000 | 0.044 |
| KRAS | G12C | Appendiceal | White | 7 | 280 | 0.023 | 0.022 | 0.009 | 0.043 |
| KRAS | G12C | CRC | Asian | 8 | 313 | 0.031 | 0.031 | 0.022 | 0.040 |
| KRAS | G12C | CRC | Black | 15 | 515 | 0.031 | 0.031 | 0.023 | 0.040 |
| KRAS | G12C | CRC | NA | 30 | 804 | 0.033 | 0.033 | 0.026 | 0.043 |
| KRAS | G12C | CRC | Native American | 2 | 17 | 0.034 | 0.032 | 0.024 | 0.055 |
| KRAS | G12C | CRC | Other | 4 | 139 | 0.032 | 0.031 | 0.022 | 0.043 |
| KRAS | G12C | CRC | White | 152 | 4925 | 0.031 | 0.031 | 0.027 | 0.036 |
| KRAS | G12C | CUP | Asian | 1 | 73 | 0.029 | 0.029 | 0.012 | 0.044 |
| KRAS | G12C | CUP | Black | 5 | 123 | 0.032 | 0.031 | 0.019 | 0.051 |
| KRAS | G12C | CUP | NA | 7 | 286 | 0.029 | 0.029 | 0.017 | 0.041 |
| KRAS | G12C | CUP | Other | 0 | 36 | 0.029 | 0.029 | 0.010 | 0.045 |
| KRAS | G12C | CUP | White | 48 | 1465 | 0.031 | 0.031 | 0.024 | 0.040 |
| KRAS | G12C | NSCLC | Asian | 21 | 624 | 0.038 | 0.037 | 0.024 | 0.055 |
| KRAS | G12C | NSCLC | Black | 78 | 717 | 0.107 | 0.107 | 0.086 | 0.130 |
| KRAS | G12C | NSCLC | NA | 76 | 849 | 0.089 | 0.089 | 0.071 | 0.108 |
| KRAS | G12C | NSCLC | Native American | 1 | 17 | 0.074 | 0.069 | 0.018 | 0.163 |
| KRAS | G12C | NSCLC | Other | 10 | 165 | 0.064 | 0.063 | 0.035 | 0.102 |
| KRAS | G12C | NSCLC | Undefined | 0 | 10 | 0.065 | 0.060 | 0.010 | 0.156 |
| KRAS | G12C | NSCLC | White | 1026 | 7745 | 0.132 | 0.132 | 0.125 | 0.140 |
| KRAS | G12C | Breast | Asian | 0 | 334 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Breast | Black | 0 | 526 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Breast | NA | 2 | 3112 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Breast | Native American | 0 | 11 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | Breast | Other | 0 | 176 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Breast | White | 6 | 5174 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Soft tissue sarcoma | Asian | 0 | 143 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G12C | Soft tissue sarcoma | Black | 1 | 193 | 0.002 | 0.002 | 0.001 | 0.008 |
| KRAS | G12C | Soft tissue sarcoma | NA | 1 | 350 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | G12C | Soft tissue sarcoma | Other | 0 | 73 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | G12C | Soft tissue sarcoma | White | 3 | 2005 | 0.002 | 0.002 | 0.001 | 0.004 |
| KRAS | G12C | Pancreatic | Asian | 0 | 100 | 0.008 | 0.008 | 0.002 | 0.016 |
| KRAS | G12C | Pancreatic | Black | 1 | 88 | 0.009 | 0.009 | 0.003 | 0.020 |
| KRAS | G12C | Pancreatic | NA | 3 | 231 | 0.010 | 0.009 | 0.005 | 0.019 |
| KRAS | G12C | Pancreatic | Other | 0 | 34 | 0.009 | 0.008 | 0.002 | 0.019 |
| KRAS | G12C | Pancreatic | White | 18 | 2038 | 0.009 | 0.009 | 0.005 | 0.013 |
| KRAS | G12C | Leukemia | Asian | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | Black | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | NA | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | Other | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | White | 0 | 662 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Melanoma | Asian | 0 | 33 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | Melanoma | Black | 0 | 34 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | Melanoma | NA | 0 | 398 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | Melanoma | Other | 0 | 26 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | Melanoma | White | 2 | 2348 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Head and neck | Asian | 0 | 94 | 0.002 | 0.001 | 0.000 | 0.009 |
| KRAS | G12C | Head and neck | Black | 1 | 62 | 0.007 | 0.003 | 0.000 | 0.039 |
| KRAS | G12C | Head and neck | NA | 1 | 292 | 0.002 | 0.002 | 0.000 | 0.009 |
| KRAS | G12C | Head and neck | Other | 0 | 28 | 0.003 | 0.001 | 0.000 | 0.017 |
| KRAS | G12C | Head and neck | White | 0 | 1264 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Uterine | Asian | 2 | 108 | 0.013 | 0.012 | 0.006 | 0.025 |
| KRAS | G12C | Uterine | Black | 1 | 163 | 0.011 | 0.011 | 0.004 | 0.020 |
| KRAS | G12C | Uterine | NA | 1 | 190 | 0.011 | 0.011 | 0.004 | 0.019 |
| KRAS | G12C | Uterine | Other | 1 | 37 | 0.013 | 0.012 | 0.005 | 0.028 |
| KRAS | G12C | Uterine | White | 21 | 1754 | 0.012 | 0.012 | 0.008 | 0.017 |
| KRAS | G12C | Non-melanoma skin | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Non-melanoma skin | Black | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Non-melanoma skin | NA | 0 | 53 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Non-melanoma skin | White | 0 | 436 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | MDS/MPN | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | Black | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | NA | 0 | 571 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | White | 0 | 584 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G12C | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Ovarian | Asian | 1 | 134 | 0.005 | 0.004 | 0.001 | 0.013 |
| KRAS | G12C | Ovarian | Black | 0 | 74 | 0.005 | 0.004 | 0.001 | 0.011 |
| KRAS | G12C | Ovarian | NA | 2 | 239 | 0.005 | 0.005 | 0.002 | 0.013 |
| KRAS | G12C | Ovarian | Other | 0 | 36 | 0.005 | 0.004 | 0.001 | 0.013 |
| KRAS | G12C | Ovarian | White | 7 | 1852 | 0.004 | 0.004 | 0.002 | 0.007 |
| KRAS | G12C | Esophagogastric | Asian | 0 | 115 | 0.003 | 0.003 | 0.000 | 0.007 |
| KRAS | G12C | Esophagogastric | Black | 0 | 68 | 0.003 | 0.003 | 0.000 | 0.009 |
| KRAS | G12C | Esophagogastric | NA | 1 | 191 | 0.003 | 0.003 | 0.001 | 0.009 |
| KRAS | G12C | Esophagogastric | Other | 0 | 46 | 0.003 | 0.003 | 0.000 | 0.008 |
| KRAS | G12C | Esophagogastric | White | 4 | 1379 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | G12C | Thyroid | Asian | 0 | 66 | 0.002 | 0.002 | 0.000 | 0.008 |
| KRAS | G12C | Thyroid | Black | 0 | 40 | 0.002 | 0.002 | 0.000 | 0.008 |
| KRAS | G12C | Thyroid | NA | 0 | 79 | 0.002 | 0.002 | 0.000 | 0.007 |
| KRAS | G12C | Thyroid | Other | 0 | 26 | 0.002 | 0.002 | 0.000 | 0.009 |
| KRAS | G12C | Thyroid | White | 2 | 803 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | G12C | Cervical | Asian | 0 | 27 | 0.003 | 0.002 | 0.000 | 0.015 |
| KRAS | G12C | Cervical | Black | 0 | 19 | 0.004 | 0.002 | 0.000 | 0.016 |
| KRAS | G12C | Cervical | NA | 0 | 77 | 0.003 | 0.002 | 0.000 | 0.013 |
| KRAS | G12C | Cervical | Other | 0 | 15 | 0.004 | 0.002 | 0.000 | 0.017 |
| KRAS | G12C | Cervical | White | 1 | 228 | 0.004 | 0.003 | 0.000 | 0.012 |
| KRAS | G12C | Hepatobiliary | Asian | 0 | 98 | 0.006 | 0.006 | 0.000 | 0.014 |
| KRAS | G12C | Hepatobiliary | Black | 0 | 64 | 0.006 | 0.006 | 0.000 | 0.015 |
| KRAS | G12C | Hepatobiliary | NA | 1 | 235 | 0.006 | 0.006 | 0.001 | 0.013 |
| KRAS | G12C | Hepatobiliary | Other | 0 | 25 | 0.007 | 0.006 | 0.000 | 0.020 |
| KRAS | G12C | Hepatobiliary | White | 9 | 948 | 0.008 | 0.008 | 0.004 | 0.014 |
| KRAS | G12C | Kidney | Asian | 0 | 33 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Kidney | Black | 0 | 77 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Kidney | NA | 0 | 169 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Kidney | Other | 0 | 29 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Kidney | White | 1 | 1113 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | T / NK neoplasms | White | 0 | 188 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | CNS | Asian | 0 | 154 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | Black | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | NA | 0 | 817 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | Other | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | Undefined | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | White | 0 | 3331 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | Asian | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | Black | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | NA | 0 | 289 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | Other | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | White | 0 | 1882 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Anal | NA | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Neuroendocrine | Black | 0 | 23 | 0.007 | 0.005 | 0.000 | 0.031 |
| KRAS | G12C | Neuroendocrine | NA | 1 | 45 | 0.011 | 0.007 | 0.001 | 0.047 |
| KRAS | G12C | Neuroendocrine | White | 1 | 283 | 0.006 | 0.005 | 0.000 | 0.016 |
| KRAS | G12C | Bladder | Asian | 0 | 40 | 0.004 | 0.004 | 0.000 | 0.012 |
| KRAS | G12C | Bladder | Black | 0 | 43 | 0.004 | 0.004 | 0.000 | 0.012 |
| KRAS | G12C | Bladder | NA | 0 | 169 | 0.003 | 0.003 | 0.000 | 0.009 |
| KRAS | G12C | Bladder | Other | 0 | 14 | 0.005 | 0.004 | 0.000 | 0.016 |
| KRAS | G12C | Bladder | White | 7 | 1311 | 0.005 | 0.005 | 0.002 | 0.009 |
| KRAS | G12C | BLL/Lymphoma | Asian | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | BLL/Lymphoma | NA | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | BLL/Lymphoma | White | 0 | 125 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Small bowel | Black | 3 | 25 | 0.076 | 0.060 | 0.015 | 0.214 |
| KRAS | G12C | Small bowel | NA | 1 | 22 | 0.044 | 0.035 | 0.006 | 0.134 |
| KRAS | G12C | Small bowel | White | 2 | 150 | 0.022 | 0.020 | 0.004 | 0.052 |
| KRAS | G12C | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | G12C | Sex cord stromal | White | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Vaginal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | G12C | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | G12C | Thymic | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | G12C | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Ampullary | White | 2 | 86 | 0.025 | 0.022 | 0.004 | 0.066 |
| KRAS | G12C | SCLC | Asian | 0 | 15 | 0.009 | 0.006 | 0.000 | 0.033 |
| KRAS | G12C | SCLC | NA | 0 | 30 | 0.008 | 0.006 | 0.000 | 0.027 |
| KRAS | G12C | SCLC | White | 3 | 337 | 0.008 | 0.008 | 0.002 | 0.020 |
| KRAS | G12C | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Germ cell | Asian | 0 | 36 | 0.004 | 0.003 | 0.000 | 0.014 |
| KRAS | G12C | Germ cell | Black | 0 | 23 | 0.004 | 0.003 | 0.000 | 0.015 |
| KRAS | G12C | Germ cell | NA | 0 | 179 | 0.003 | 0.002 | 0.000 | 0.010 |
| KRAS | G12C | Germ cell | Other | 0 | 37 | 0.004 | 0.003 | 0.000 | 0.014 |
| KRAS | G12C | Germ cell | White | 4 | 603 | 0.006 | 0.005 | 0.002 | 0.012 |
| KRAS | G12C | Nerve sheath | Black | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Nerve sheath | White | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.039 |
| KRAS | G12C | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.036 |
| KRAS | G12C | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.039 |
| KRAS | G12C | B cell lymphoma | Asian | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | NA | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | Other | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | White | 0 | 859 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.027 |
| KRAS | G12C | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.029 |
| KRAS | G12C | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| KRAS | G12C | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G12C | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | G12C | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.017 |
| KRAS | G12C | Lung | White | 1 | 17 | 0.066 | 0.050 | 0.003 | 0.218 |
| KRAS | G12C | Peritoneal | White | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| KRAS | G12C | Parathyroid | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| KRAS | G13 | Appendiceal | Black | 1 | 17 | 0.049 | 0.044 | 0.016 | 0.116 |
| KRAS | G13 | Appendiceal | NA | 2 | 33 | 0.048 | 0.044 | 0.019 | 0.104 |
| KRAS | G13 | Appendiceal | White | 11 | 280 | 0.042 | 0.041 | 0.023 | 0.067 |
| KRAS | G13 | CRC | Asian | 22 | 313 | 0.078 | 0.078 | 0.055 | 0.102 |
| KRAS | G13 | CRC | Black | 63 | 515 | 0.109 | 0.109 | 0.083 | 0.140 |
| KRAS | G13 | CRC | NA | 73 | 804 | 0.089 | 0.089 | 0.073 | 0.108 |
| KRAS | G13 | CRC | Native American | 0 | 17 | 0.079 | 0.080 | 0.033 | 0.125 |
| KRAS | G13 | CRC | Other | 13 | 139 | 0.089 | 0.087 | 0.061 | 0.126 |
| KRAS | G13 | CRC | White | 358 | 4925 | 0.074 | 0.074 | 0.066 | 0.081 |
| KRAS | G13 | CUP | Asian | 2 | 73 | 0.021 | 0.020 | 0.011 | 0.037 |
| KRAS | G13 | CUP | Black | 2 | 123 | 0.020 | 0.019 | 0.010 | 0.032 |
| KRAS | G13 | CUP | NA | 6 | 286 | 0.020 | 0.020 | 0.012 | 0.031 |
| KRAS | G13 | CUP | Other | 1 | 36 | 0.021 | 0.020 | 0.011 | 0.037 |
| KRAS | G13 | CUP | White | 28 | 1465 | 0.020 | 0.019 | 0.014 | 0.026 |
| KRAS | G13 | NSCLC | Asian | 4 | 624 | 0.012 | 0.011 | 0.004 | 0.020 |
| KRAS | G13 | NSCLC | Black | 12 | 717 | 0.017 | 0.017 | 0.010 | 0.025 |
| KRAS | G13 | NSCLC | NA | 12 | 849 | 0.015 | 0.015 | 0.009 | 0.023 |
| KRAS | G13 | NSCLC | Native American | 0 | 17 | 0.017 | 0.016 | 0.004 | 0.036 |
| KRAS | G13 | NSCLC | Other | 2 | 165 | 0.016 | 0.015 | 0.006 | 0.028 |
| KRAS | G13 | NSCLC | Undefined | 1 | 10 | 0.022 | 0.018 | 0.007 | 0.064 |
| KRAS | G13 | NSCLC | White | 178 | 7745 | 0.022 | 0.022 | 0.019 | 0.026 |
| KRAS | G13 | Breast | Asian | 0 | 334 | 0.001 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Breast | Black | 1 | 526 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G13 | Breast | NA | 1 | 3112 | 0.001 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Breast | Native American | 0 | 11 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G13 | Breast | Other | 0 | 176 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G13 | Breast | White | 3 | 5174 | 0.001 | 0.001 | 0.000 | 0.001 |
| KRAS | G13 | Soft tissue sarcoma | Asian | 0 | 143 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Soft tissue sarcoma | Black | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Soft tissue sarcoma | NA | 0 | 350 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Soft tissue sarcoma | Other | 0 | 73 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Soft tissue sarcoma | White | 1 | 2005 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Pancreatic | Asian | 1 | 100 | 0.008 | 0.007 | 0.002 | 0.017 |
| KRAS | G13 | Pancreatic | Black | 0 | 88 | 0.007 | 0.007 | 0.001 | 0.013 |
| KRAS | G13 | Pancreatic | NA | 1 | 231 | 0.007 | 0.007 | 0.002 | 0.013 |
| KRAS | G13 | Pancreatic | Other | 0 | 34 | 0.007 | 0.007 | 0.001 | 0.016 |
| KRAS | G13 | Pancreatic | White | 16 | 2038 | 0.007 | 0.007 | 0.004 | 0.011 |
| KRAS | G13 | Leukemia | Asian | 1 | 37 | 0.019 | 0.017 | 0.008 | 0.041 |
| KRAS | G13 | Leukemia | Black | 2 | 69 | 0.019 | 0.017 | 0.009 | 0.041 |
| KRAS | G13 | Leukemia | NA | 10 | 777 | 0.016 | 0.015 | 0.009 | 0.023 |
| KRAS | G13 | Leukemia | Other | 0 | 13 | 0.018 | 0.016 | 0.005 | 0.037 |
| KRAS | G13 | Leukemia | White | 13 | 662 | 0.018 | 0.017 | 0.011 | 0.027 |
| KRAS | G13 | Melanoma | Asian | 0 | 33 | 0.002 | 0.002 | 0.000 | 0.009 |
| KRAS | G13 | Melanoma | Black | 0 | 34 | 0.002 | 0.002 | 0.000 | 0.009 |
| KRAS | G13 | Melanoma | NA | 0 | 398 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | G13 | Melanoma | Other | 0 | 26 | 0.002 | 0.002 | 0.000 | 0.010 |
| KRAS | G13 | Melanoma | White | 6 | 2348 | 0.002 | 0.002 | 0.001 | 0.005 |
| KRAS | G13 | Head and neck | Asian | 0 | 94 | 0.002 | 0.001 | 0.000 | 0.006 |
| KRAS | G13 | Head and neck | Black | 0 | 62 | 0.002 | 0.001 | 0.000 | 0.006 |
| KRAS | G13 | Head and neck | NA | 0 | 292 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | G13 | Head and neck | Other | 0 | 28 | 0.002 | 0.001 | 0.000 | 0.008 |
| KRAS | G13 | Head and neck | White | 3 | 1264 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | Uterine | Asian | 3 | 108 | 0.024 | 0.023 | 0.010 | 0.044 |
| KRAS | G13 | Uterine | Black | 0 | 163 | 0.017 | 0.018 | 0.001 | 0.030 |
| KRAS | G13 | Uterine | NA | 5 | 190 | 0.024 | 0.023 | 0.012 | 0.041 |
| KRAS | G13 | Uterine | Other | 1 | 37 | 0.023 | 0.022 | 0.007 | 0.050 |
| KRAS | G13 | Uterine | White | 43 | 1754 | 0.024 | 0.023 | 0.017 | 0.031 |
| KRAS | G13 | Non-melanoma skin | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Non-melanoma skin | Black | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Non-melanoma skin | NA | 0 | 53 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Non-melanoma skin | White | 0 | 436 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | MDS/MPN | Asian | 0 | 12 | 0.007 | 0.005 | 0.000 | 0.032 |
| KRAS | G13 | MDS/MPN | Black | 0 | 37 | 0.006 | 0.004 | 0.000 | 0.020 |
| KRAS | G13 | MDS/MPN | NA | 6 | 571 | 0.008 | 0.007 | 0.003 | 0.017 |
| KRAS | G13 | MDS/MPN | White | 1 | 584 | 0.004 | 0.003 | 0.000 | 0.010 |
| KRAS | G13 | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G13 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Ovarian | Asian | 2 | 134 | 0.007 | 0.005 | 0.002 | 0.021 |
| KRAS | G13 | Ovarian | Black | 0 | 74 | 0.005 | 0.005 | 0.001 | 0.013 |
| KRAS | G13 | Ovarian | NA | 2 | 239 | 0.006 | 0.005 | 0.002 | 0.015 |
| KRAS | G13 | Ovarian | Other | 0 | 36 | 0.005 | 0.005 | 0.001 | 0.015 |
| KRAS | G13 | Ovarian | White | 7 | 1852 | 0.005 | 0.004 | 0.002 | 0.008 |
| KRAS | G13 | Esophagogastric | Asian | 1 | 115 | 0.012 | 0.012 | 0.004 | 0.022 |
| KRAS | G13 | Esophagogastric | Black | 1 | 68 | 0.013 | 0.012 | 0.005 | 0.026 |
| KRAS | G13 | Esophagogastric | NA | 1 | 191 | 0.012 | 0.012 | 0.004 | 0.020 |
| KRAS | G13 | Esophagogastric | Other | 1 | 46 | 0.013 | 0.013 | 0.005 | 0.028 |
| KRAS | G13 | Esophagogastric | White | 19 | 1379 | 0.013 | 0.013 | 0.008 | 0.019 |
| KRAS | G13 | Thyroid | Asian | 0 | 66 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | Black | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | NA | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | Other | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | White | 0 | 803 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Cervical | Asian | 2 | 27 | 0.032 | 0.019 | 0.004 | 0.128 |
| KRAS | G13 | Cervical | Black | 0 | 19 | 0.012 | 0.009 | 0.000 | 0.047 |
| KRAS | G13 | Cervical | NA | 1 | 77 | 0.013 | 0.011 | 0.002 | 0.038 |
| KRAS | G13 | Cervical | Other | 0 | 15 | 0.013 | 0.010 | 0.000 | 0.052 |
| KRAS | G13 | Cervical | White | 1 | 228 | 0.009 | 0.008 | 0.001 | 0.022 |
| KRAS | G13 | Hepatobiliary | Asian | 0 | 98 | 0.006 | 0.006 | 0.000 | 0.014 |
| KRAS | G13 | Hepatobiliary | Black | 1 | 64 | 0.008 | 0.007 | 0.002 | 0.022 |
| KRAS | G13 | Hepatobiliary | NA | 1 | 235 | 0.006 | 0.006 | 0.001 | 0.013 |
| KRAS | G13 | Hepatobiliary | Other | 0 | 25 | 0.007 | 0.006 | 0.001 | 0.018 |
| KRAS | G13 | Hepatobiliary | White | 7 | 948 | 0.007 | 0.007 | 0.003 | 0.012 |
| KRAS | G13 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | T / NK neoplasms | Asian | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | T / NK neoplasms | Black | 0 | 18 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | T / NK neoplasms | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | T / NK neoplasms | White | 0 | 188 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | CNS | Asian | 0 | 154 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | Black | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | CNS | NA | 0 | 817 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | Other | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | Undefined | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | CNS | White | 1 | 3331 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Prostate | Asian | 0 | 62 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Prostate | Black | 0 | 175 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Prostate | NA | 0 | 289 | 0.001 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Prostate | Other | 0 | 31 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Prostate | White | 1 | 1882 | 0.001 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Anal | NA | 0 | 13 | 0.015 | 0.010 | 0.000 | 0.063 |
| KRAS | G13 | Anal | White | 2 | 126 | 0.016 | 0.013 | 0.002 | 0.042 |
| KRAS | G13 | Neuroendocrine | Black | 0 | 23 | 0.013 | 0.012 | 0.000 | 0.044 |
| KRAS | G13 | Neuroendocrine | NA | 0 | 45 | 0.012 | 0.011 | 0.000 | 0.036 |
| KRAS | G13 | Neuroendocrine | White | 6 | 283 | 0.019 | 0.018 | 0.007 | 0.037 |
| KRAS | G13 | Bladder | Asian | 0 | 40 | 0.004 | 0.003 | 0.000 | 0.019 |
| KRAS | G13 | Bladder | Black | 0 | 43 | 0.004 | 0.003 | 0.000 | 0.018 |
| KRAS | G13 | Bladder | NA | 1 | 169 | 0.004 | 0.003 | 0.001 | 0.016 |
| KRAS | G13 | Bladder | Other | 1 | 14 | 0.016 | 0.004 | 0.001 | 0.114 |
| KRAS | G13 | Bladder | White | 2 | 1311 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | BLL/Lymphoma | Asian | 0 | 17 | 0.031 | 0.029 | 0.000 | 0.075 |
| KRAS | G13 | BLL/Lymphoma | NA | 2 | 92 | 0.030 | 0.029 | 0.007 | 0.061 |
| KRAS | G13 | BLL/Lymphoma | White | 6 | 125 | 0.039 | 0.037 | 0.016 | 0.076 |
| KRAS | G13 | Small bowel | Black | 1 | 25 | 0.060 | 0.058 | 0.014 | 0.122 |
| KRAS | G13 | Small bowel | NA | 3 | 22 | 0.081 | 0.070 | 0.031 | 0.203 |
| KRAS | G13 | Small bowel | White | 8 | 150 | 0.059 | 0.058 | 0.029 | 0.098 |
| KRAS | G13 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.013 |
| KRAS | G13 | Sex cord stromal | White | 0 | 69 | 0.001 | 0.000 | 0.000 | 0.009 |
| KRAS | G13 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Vaginal | White | 1 | 68 | 0.017 | 0.013 | 0.001 | 0.058 |
| KRAS | G13 | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | Thymic | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G13 | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Ampullary | White | 4 | 86 | 0.048 | 0.045 | 0.014 | 0.100 |
| KRAS | G13 | SCLC | Asian | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | SCLC | NA | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | SCLC | White | 0 | 337 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Germ cell | Asian | 0 | 36 | 0.003 | 0.003 | 0.000 | 0.012 |
| KRAS | G13 | Germ cell | Black | 0 | 23 | 0.004 | 0.003 | 0.000 | 0.014 |
| KRAS | G13 | Germ cell | NA | 0 | 179 | 0.003 | 0.002 | 0.000 | 0.009 |
| KRAS | G13 | Germ cell | Other | 0 | 37 | 0.003 | 0.002 | 0.000 | 0.012 |
| KRAS | G13 | Germ cell | White | 3 | 603 | 0.004 | 0.004 | 0.001 | 0.010 |
| KRAS | G13 | Nerve sheath | Black | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Nerve sheath | White | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Penile | White | 0 | 20 | 0.002 | 0.000 | 0.000 | 0.030 |
| KRAS | G13 | Pheochromocytoma | White | 0 | 15 | 0.004 | 0.000 | 0.000 | 0.046 |
| KRAS | G13 | Pineal | White | 1 | 14 | 0.079 | 0.060 | 0.004 | 0.256 |
| KRAS | G13 | B cell lymphoma | Asian | 0 | 21 | 0.008 | 0.007 | 0.000 | 0.023 |
| KRAS | G13 | B cell lymphoma | Black | 0 | 25 | 0.008 | 0.007 | 0.000 | 0.023 |
| KRAS | G13 | B cell lymphoma | NA | 0 | 42 | 0.007 | 0.007 | 0.000 | 0.020 |
| KRAS | G13 | B cell lymphoma | Other | 0 | 12 | 0.008 | 0.007 | 0.000 | 0.026 |
| KRAS | G13 | B cell lymphoma | White | 8 | 859 | 0.009 | 0.008 | 0.004 | 0.016 |
| KRAS | G13 | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.023 |
| KRAS | G13 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| KRAS | G13 | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.023 |
| KRAS | G13 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | G13 | Retinoblastoma | White | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.016 |
| KRAS | G13 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.017 |
| KRAS | G13 | Lung | White | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.035 |
| KRAS | G13 | Peritoneal | White | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.059 |
| KRAS | G13 | Parathyroid | White | 1 | 14 | 0.080 | 0.062 | 0.004 | 0.261 |
| KRAS | Q61 | Appendiceal | Black | 0 | 17 | 0.016 | 0.010 | 0.000 | 0.075 |
| KRAS | Q61 | Appendiceal | NA | 3 | 33 | 0.065 | 0.054 | 0.009 | 0.179 |
| KRAS | Q61 | Appendiceal | White | 2 | 280 | 0.010 | 0.009 | 0.002 | 0.026 |
| KRAS | Q61 | CRC | Asian | 5 | 313 | 0.018 | 0.018 | 0.009 | 0.027 |
| KRAS | Q61 | CRC | Black | 5 | 515 | 0.016 | 0.016 | 0.007 | 0.023 |
| KRAS | Q61 | CRC | NA | 22 | 804 | 0.022 | 0.021 | 0.015 | 0.033 |
| KRAS | Q61 | CRC | Native American | 0 | 17 | 0.018 | 0.018 | 0.006 | 0.033 |
| KRAS | Q61 | CRC | Other | 1 | 139 | 0.017 | 0.017 | 0.006 | 0.026 |
| KRAS | Q61 | CRC | White | 92 | 4925 | 0.019 | 0.019 | 0.015 | 0.022 |
| KRAS | Q61 | CUP | Asian | 2 | 73 | 0.015 | 0.012 | 0.004 | 0.046 |
| KRAS | Q61 | CUP | Black | 0 | 123 | 0.008 | 0.008 | 0.000 | 0.018 |
| KRAS | Q61 | CUP | NA | 1 | 286 | 0.008 | 0.008 | 0.001 | 0.016 |
| KRAS | Q61 | CUP | Other | 0 | 36 | 0.010 | 0.009 | 0.000 | 0.024 |
| KRAS | Q61 | CUP | White | 20 | 1465 | 0.013 | 0.012 | 0.008 | 0.019 |
| KRAS | Q61 | NSCLC | Asian | 7 | 624 | 0.016 | 0.016 | 0.010 | 0.021 |
| KRAS | Q61 | NSCLC | Black | 13 | 717 | 0.017 | 0.017 | 0.012 | 0.023 |
| KRAS | Q61 | NSCLC | NA | 11 | 849 | 0.016 | 0.016 | 0.010 | 0.021 |
| KRAS | Q61 | NSCLC | Native American | 0 | 17 | 0.017 | 0.017 | 0.009 | 0.026 |
| KRAS | Q61 | NSCLC | Other | 3 | 165 | 0.017 | 0.017 | 0.010 | 0.025 |
| KRAS | Q61 | NSCLC | Undefined | 1 | 10 | 0.018 | 0.017 | 0.011 | 0.029 |
| KRAS | Q61 | NSCLC | White | 144 | 7745 | 0.018 | 0.018 | 0.015 | 0.021 |
| KRAS | Q61 | Breast | Asian | 0 | 334 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | Black | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | NA | 1 | 3112 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | Native American | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | Other | 0 | 176 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | White | 1 | 5174 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Soft tissue sarcoma | Asian | 0 | 143 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Soft tissue sarcoma | Black | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Soft tissue sarcoma | NA | 0 | 350 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Soft tissue sarcoma | Other | 1 | 73 | 0.008 | 0.003 | 0.000 | 0.038 |
| KRAS | Q61 | Soft tissue sarcoma | White | 0 | 2005 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Pancreatic | Asian | 5 | 100 | 0.055 | 0.055 | 0.033 | 0.081 |
| KRAS | Q61 | Pancreatic | Black | 5 | 88 | 0.057 | 0.056 | 0.035 | 0.087 |
| KRAS | Q61 | Pancreatic | NA | 9 | 231 | 0.051 | 0.052 | 0.030 | 0.069 |
| KRAS | Q61 | Pancreatic | Other | 5 | 34 | 0.067 | 0.060 | 0.042 | 0.143 |
| KRAS | Q61 | Pancreatic | White | 115 | 2038 | 0.056 | 0.056 | 0.047 | 0.066 |
| KRAS | Q61 | Leukemia | Asian | 0 | 37 | 0.005 | 0.004 | 0.000 | 0.014 |
| KRAS | Q61 | Leukemia | Black | 0 | 69 | 0.004 | 0.004 | 0.000 | 0.012 |
| KRAS | Q61 | Leukemia | NA | 3 | 777 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | Q61 | Leukemia | Other | 1 | 13 | 0.010 | 0.004 | 0.001 | 0.069 |
| KRAS | Q61 | Leukemia | White | 2 | 662 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | Q61 | Melanoma | Asian | 0 | 33 | 0.003 | 0.003 | 0.000 | 0.015 |
| KRAS | Q61 | Melanoma | Black | 1 | 34 | 0.008 | 0.004 | 0.001 | 0.051 |
| KRAS | Q61 | Melanoma | NA | 0 | 398 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | Q61 | Melanoma | Other | 0 | 26 | 0.004 | 0.003 | 0.000 | 0.016 |
| KRAS | Q61 | Melanoma | White | 7 | 2348 | 0.003 | 0.003 | 0.001 | 0.005 |
| KRAS | Q61 | Head and neck | Asian | 0 | 94 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | Black | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | NA | 0 | 292 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | Other | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | White | 0 | 1264 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Uterine | Asian | 1 | 108 | 0.005 | 0.004 | 0.002 | 0.013 |
| KRAS | Q61 | Uterine | Black | 1 | 163 | 0.005 | 0.004 | 0.002 | 0.011 |
| KRAS | Q61 | Uterine | NA | 1 | 190 | 0.005 | 0.004 | 0.002 | 0.011 |
| KRAS | Q61 | Uterine | Other | 0 | 37 | 0.005 | 0.004 | 0.001 | 0.012 |
| KRAS | Q61 | Uterine | White | 6 | 1754 | 0.004 | 0.004 | 0.002 | 0.007 |
| KRAS | Q61 | Non-melanoma skin | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Non-melanoma skin | Black | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Non-melanoma skin | NA | 0 | 53 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Non-melanoma skin | White | 0 | 436 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | MDS/MPN | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | Black | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | NA | 0 | 571 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | White | 0 | 584 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | Q61 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Ovarian | Asian | 0 | 134 | 0.005 | 0.005 | 0.000 | 0.011 |
| KRAS | Q61 | Ovarian | Black | 0 | 74 | 0.005 | 0.005 | 0.000 | 0.013 |
| KRAS | Q61 | Ovarian | NA | 3 | 239 | 0.007 | 0.006 | 0.003 | 0.019 |
| KRAS | Q61 | Ovarian | Other | 0 | 36 | 0.006 | 0.005 | 0.000 | 0.016 |
| KRAS | Q61 | Ovarian | White | 10 | 1852 | 0.006 | 0.005 | 0.003 | 0.009 |
| KRAS | Q61 | Esophagogastric | Asian | 0 | 115 | 0.002 | 0.001 | 0.000 | 0.006 |
| KRAS | Q61 | Esophagogastric | Black | 0 | 68 | 0.002 | 0.001 | 0.000 | 0.006 |
| KRAS | Q61 | Esophagogastric | NA | 0 | 191 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | Q61 | Esophagogastric | Other | 0 | 46 | 0.002 | 0.001 | 0.000 | 0.007 |
| KRAS | Q61 | Esophagogastric | White | 3 | 1379 | 0.002 | 0.002 | 0.000 | 0.004 |
| KRAS | Q61 | Thyroid | Asian | 0 | 66 | 0.013 | 0.013 | 0.000 | 0.031 |
| KRAS | Q61 | Thyroid | Black | 1 | 40 | 0.019 | 0.017 | 0.004 | 0.054 |
| KRAS | Q61 | Thyroid | NA | 4 | 79 | 0.028 | 0.022 | 0.010 | 0.076 |
| KRAS | Q61 | Thyroid | Other | 0 | 26 | 0.016 | 0.014 | 0.000 | 0.042 |
| KRAS | Q61 | Thyroid | White | 11 | 803 | 0.015 | 0.014 | 0.008 | 0.024 |
| KRAS | Q61 | Cervical | Asian | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Cervical | Black | 0 | 19 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Cervical | NA | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Cervical | Other | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Cervical | White | 0 | 228 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Hepatobiliary | Asian | 0 | 98 | 0.011 | 0.011 | 0.000 | 0.021 |
| KRAS | Q61 | Hepatobiliary | Black | 1 | 64 | 0.013 | 0.012 | 0.003 | 0.029 |
| KRAS | Q61 | Hepatobiliary | NA | 2 | 235 | 0.012 | 0.011 | 0.003 | 0.021 |
| KRAS | Q61 | Hepatobiliary | Other | 0 | 25 | 0.012 | 0.012 | 0.001 | 0.026 |
| KRAS | Q61 | Hepatobiliary | White | 15 | 948 | 0.014 | 0.014 | 0.008 | 0.022 |
| KRAS | Q61 | Kidney | Asian | 0 | 33 | 0.002 | 0.001 | 0.000 | 0.007 |
| KRAS | Q61 | Kidney | Black | 0 | 77 | 0.002 | 0.001 | 0.000 | 0.006 |
| KRAS | Q61 | Kidney | NA | 0 | 169 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | Q61 | Kidney | Other | 0 | 29 | 0.002 | 0.001 | 0.000 | 0.007 |
| KRAS | Q61 | Kidney | White | 2 | 1113 | 0.002 | 0.001 | 0.000 | 0.004 |
| KRAS | Q61 | T / NK neoplasms | Asian | 0 | 12 | 0.010 | 0.007 | 0.000 | 0.039 |
| KRAS | Q61 | T / NK neoplasms | Black | 0 | 18 | 0.009 | 0.006 | 0.000 | 0.035 |
| KRAS | Q61 | T / NK neoplasms | NA | 0 | 10 | 0.010 | 0.007 | 0.000 | 0.039 |
| KRAS | Q61 | T / NK neoplasms | White | 2 | 188 | 0.010 | 0.008 | 0.001 | 0.027 |
| KRAS | Q61 | CNS | Asian | 0 | 154 | 0.003 | 0.002 | 0.000 | 0.006 |
| KRAS | Q61 | CNS | Black | 0 | 131 | 0.003 | 0.002 | 0.000 | 0.007 |
| KRAS | Q61 | CNS | NA | 5 | 817 | 0.004 | 0.003 | 0.001 | 0.009 |
| KRAS | Q61 | CNS | Other | 0 | 108 | 0.003 | 0.002 | 0.000 | 0.007 |
| KRAS | Q61 | CNS | Undefined | 0 | 17 | 0.003 | 0.003 | 0.000 | 0.012 |
| KRAS | Q61 | CNS | White | 7 | 3331 | 0.002 | 0.002 | 0.001 | 0.004 |
| KRAS | Q61 | Prostate | Asian | 0 | 62 | 0.002 | 0.002 | 0.000 | 0.007 |
| KRAS | Q61 | Prostate | Black | 1 | 175 | 0.002 | 0.002 | 0.000 | 0.009 |
| KRAS | Q61 | Prostate | NA | 0 | 289 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | Q61 | Prostate | Other | 0 | 31 | 0.002 | 0.002 | 0.000 | 0.008 |
| KRAS | Q61 | Prostate | White | 3 | 1882 | 0.002 | 0.002 | 0.000 | 0.004 |
| KRAS | Q61 | Anal | NA | 0 | 13 | 0.010 | 0.005 | 0.000 | 0.052 |
| KRAS | Q61 | Anal | White | 1 | 126 | 0.009 | 0.006 | 0.000 | 0.030 |
| KRAS | Q61 | Neuroendocrine | Black | 0 | 23 | 0.006 | 0.004 | 0.000 | 0.025 |
| KRAS | Q61 | Neuroendocrine | NA | 0 | 45 | 0.005 | 0.004 | 0.000 | 0.020 |
| KRAS | Q61 | Neuroendocrine | White | 2 | 283 | 0.007 | 0.006 | 0.001 | 0.018 |
| KRAS | Q61 | Bladder | Asian | 0 | 40 | 0.003 | 0.003 | 0.000 | 0.010 |
| KRAS | Q61 | Bladder | Black | 0 | 43 | 0.003 | 0.003 | 0.000 | 0.010 |
| KRAS | Q61 | Bladder | NA | 0 | 169 | 0.003 | 0.002 | 0.000 | 0.008 |
| KRAS | Q61 | Bladder | Other | 0 | 14 | 0.004 | 0.003 | 0.000 | 0.013 |
| KRAS | Q61 | Bladder | White | 5 | 1311 | 0.003 | 0.003 | 0.001 | 0.007 |
| KRAS | Q61 | BLL/Lymphoma | Asian | 0 | 17 | 0.013 | 0.011 | 0.000 | 0.043 |
| KRAS | Q61 | BLL/Lymphoma | NA | 2 | 92 | 0.016 | 0.013 | 0.003 | 0.043 |
| KRAS | Q61 | BLL/Lymphoma | White | 1 | 125 | 0.012 | 0.011 | 0.002 | 0.031 |
| KRAS | Q61 | Small bowel | Black | 2 | 25 | 0.041 | 0.031 | 0.009 | 0.136 |
| KRAS | Q61 | Small bowel | NA | 0 | 22 | 0.023 | 0.021 | 0.000 | 0.064 |
| KRAS | Q61 | Small bowel | White | 3 | 150 | 0.024 | 0.022 | 0.007 | 0.051 |
| KRAS | Q61 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | Q61 | Sex cord stromal | White | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Bone | Asian | 1 | 30 | 0.016 | 0.006 | 0.000 | 0.085 |
| KRAS | Q61 | Bone | Black | 0 | 32 | 0.003 | 0.001 | 0.000 | 0.017 |
| KRAS | Q61 | Bone | NA | 0 | 86 | 0.002 | 0.001 | 0.000 | 0.010 |
| KRAS | Q61 | Bone | Other | 0 | 29 | 0.003 | 0.001 | 0.000 | 0.018 |
| KRAS | Q61 | Bone | White | 0 | 391 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | Q61 | Vaginal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | Q61 | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | Q61 | Thymic | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | Q61 | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Ampullary | White | 5 | 86 | 0.059 | 0.056 | 0.021 | 0.118 |
| KRAS | Q61 | SCLC | Asian | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | SCLC | NA | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | SCLC | White | 0 | 337 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Germ cell | Asian | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Germ cell | Black | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Germ cell | NA | 0 | 179 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | Other | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | White | 0 | 603 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Nerve sheath | Black | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Nerve sheath | White | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Penile | White | 1 | 20 | 0.056 | 0.042 | 0.003 | 0.185 |
| KRAS | Q61 | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.036 |
| KRAS | Q61 | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.039 |
| KRAS | Q61 | B cell lymphoma | Asian | 0 | 21 | 0.014 | 0.013 | 0.000 | 0.034 |
| KRAS | Q61 | B cell lymphoma | Black | 0 | 25 | 0.014 | 0.013 | 0.001 | 0.033 |
| KRAS | Q61 | B cell lymphoma | NA | 1 | 42 | 0.016 | 0.014 | 0.004 | 0.042 |
| KRAS | Q61 | B cell lymphoma | Other | 0 | 12 | 0.015 | 0.014 | 0.000 | 0.038 |
| KRAS | Q61 | B cell lymphoma | White | 13 | 859 | 0.015 | 0.014 | 0.008 | 0.024 |
| KRAS | Q61 | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.027 |
| KRAS | Q61 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.029 |
| KRAS | Q61 | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| KRAS | Q61 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | Q61 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | Q61 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.017 |
| KRAS | Q61 | Lung | White | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.039 |
| KRAS | Q61 | Peritoneal | White | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| KRAS | Q61 | Parathyroid | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| KRAS | 12, 13, or 61 | Appendiceal | Female | 77 | 174 | 0.459 | 0.461 | 0.385 | 0.527 |
| KRAS | 12, 13, or 61 | Appendiceal | Male | 89 | 167 | 0.515 | 0.514 | 0.445 | 0.592 |
| KRAS | 12, 13, or 61 | CRC | Female | 1295 | 3028 | 0.426 | 0.426 | 0.409 | 0.444 |
| KRAS | 12, 13, or 61 | CRC | Male | 1370 | 3696 | 0.372 | 0.372 | 0.356 | 0.388 |
| KRAS | 12, 13, or 61 | CUP | Female | 203 | 1000 | 0.199 | 0.198 | 0.175 | 0.225 |
| KRAS | 12, 13, or 61 | CUP | Male | 171 | 989 | 0.177 | 0.177 | 0.154 | 0.200 |
| KRAS | 12, 13, or 61 | NSCLC | Female | 1800 | 5722 | 0.314 | 0.314 | 0.302 | 0.326 |
| KRAS | 12, 13, or 61 | NSCLC | Male | 1117 | 4406 | 0.254 | 0.254 | 0.242 | 0.268 |
| KRAS | 12, 13, or 61 | Breast | Female | 71 | 9284 | 0.008 | 0.008 | 0.006 | 0.010 |
| KRAS | 12, 13, or 61 | Breast | Male | 1 | 48 | 0.012 | 0.008 | 0.002 | 0.043 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Female | 16 | 1413 | 0.010 | 0.010 | 0.006 | 0.016 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Male | 9 | 1360 | 0.008 | 0.008 | 0.004 | 0.013 |
| KRAS | 12, 13, or 61 | Pancreatic | Female | 848 | 1153 | 0.735 | 0.736 | 0.712 | 0.758 |
| KRAS | 12, 13, or 61 | Pancreatic | Male | 986 | 1341 | 0.735 | 0.735 | 0.713 | 0.756 |
| KRAS | 12, 13, or 61 | Leukemia | Female | 31 | 637 | 0.048 | 0.047 | 0.035 | 0.062 |
| KRAS | 12, 13, or 61 | Leukemia | Male | 42 | 930 | 0.046 | 0.046 | 0.035 | 0.059 |
| KRAS | 12, 13, or 61 | Melanoma | Female | 14 | 1104 | 0.013 | 0.013 | 0.008 | 0.019 |
| KRAS | 12, 13, or 61 | Melanoma | Male | 23 | 1742 | 0.013 | 0.013 | 0.009 | 0.018 |
| KRAS | 12, 13, or 61 | Head and neck | Female | 5 | 564 | 0.008 | 0.007 | 0.003 | 0.015 |
| KRAS | 12, 13, or 61 | Head and neck | Male | 7 | 1179 | 0.007 | 0.006 | 0.003 | 0.011 |
| KRAS | 12, 13, or 61 | Uterine | Female | 339 | 2254 | 0.150 | 0.150 | 0.136 | 0.165 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | Female | 0 | 183 | 0.003 | 0.002 | 0.000 | 0.011 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | Male | 2 | 330 | 0.005 | 0.004 | 0.001 | 0.015 |
| KRAS | 12, 13, or 61 | MDS/MPN | Female | 9 | 483 | 0.016 | 0.016 | 0.009 | 0.028 |
| KRAS | 12, 13, or 61 | MDS/MPN | Male | 9 | 724 | 0.014 | 0.014 | 0.007 | 0.022 |
| KRAS | 12, 13, or 61 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | 12, 13, or 61 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.006 |
| KRAS | 12, 13, or 61 | Ovarian | Female | 226 | 2336 | 0.097 | 0.097 | 0.085 | 0.109 |
| KRAS | 12, 13, or 61 | Esophagogastric | Female | 34 | 504 | 0.062 | 0.060 | 0.044 | 0.085 |
| KRAS | 12, 13, or 61 | Esophagogastric | Male | 58 | 1297 | 0.047 | 0.047 | 0.036 | 0.059 |
| KRAS | 12, 13, or 61 | Thyroid | Female | 13 | 537 | 0.026 | 0.026 | 0.015 | 0.039 |
| KRAS | 12, 13, or 61 | Thyroid | Male | 15 | 480 | 0.029 | 0.029 | 0.018 | 0.044 |
| KRAS | 12, 13, or 61 | Cervical | Female | 31 | 365 | 0.085 | 0.085 | 0.059 | 0.116 |
| KRAS | 12, 13, or 61 | Hepatobiliary | Female | 67 | 636 | 0.104 | 0.104 | 0.085 | 0.126 |
| KRAS | 12, 13, or 61 | Hepatobiliary | Male | 74 | 739 | 0.101 | 0.101 | 0.083 | 0.121 |
| KRAS | 12, 13, or 61 | Kidney | Female | 4 | 420 | 0.009 | 0.009 | 0.004 | 0.017 |
| KRAS | 12, 13, or 61 | Kidney | Male | 9 | 1002 | 0.009 | 0.009 | 0.005 | 0.015 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | Female | 2 | 107 | 0.016 | 0.013 | 0.003 | 0.041 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | Male | 1 | 124 | 0.012 | 0.011 | 0.001 | 0.033 |
| KRAS | 12, 13, or 61 | CNS | Female | 16 | 1994 | 0.008 | 0.008 | 0.005 | 0.012 |
| KRAS | 12, 13, or 61 | CNS | Male | 21 | 2569 | 0.008 | 0.008 | 0.005 | 0.011 |
| KRAS | 12, 13, or 61 | Prostate | Male | 11 | 2436 | 0.005 | 0.004 | 0.002 | 0.008 |
| KRAS | 12, 13, or 61 | Anal | Female | 3 | 102 | 0.033 | 0.031 | 0.010 | 0.069 |
| KRAS | 12, 13, or 61 | Anal | Male | 2 | 47 | 0.038 | 0.034 | 0.010 | 0.089 |
| KRAS | 12, 13, or 61 | Neuroendocrine | Female | 12 | 166 | 0.079 | 0.079 | 0.047 | 0.115 |
| KRAS | 12, 13, or 61 | Neuroendocrine | Male | 18 | 193 | 0.088 | 0.086 | 0.058 | 0.127 |
| KRAS | 12, 13, or 61 | Bladder | Female | 23 | 393 | 0.053 | 0.052 | 0.038 | 0.076 |
| KRAS | 12, 13, or 61 | Bladder | Male | 53 | 1188 | 0.046 | 0.046 | 0.036 | 0.058 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | Female | 11 | 106 | 0.089 | 0.086 | 0.049 | 0.148 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | Male | 8 | 142 | 0.068 | 0.067 | 0.033 | 0.108 |
| KRAS | 12, 13, or 61 | Small bowel | Female | 32 | 78 | 0.409 | 0.409 | 0.324 | 0.499 |
| KRAS | 12, 13, or 61 | Small bowel | Male | 54 | 132 | 0.410 | 0.410 | 0.337 | 0.484 |
| KRAS | 12, 13, or 61 | Sex cord stromal | Female | 2 | 97 | 0.020 | 0.017 | 0.003 | 0.054 |
| KRAS | 12, 13, or 61 | Sex cord stromal | Male | 0 | 11 | 0.020 | 0.014 | 0.000 | 0.077 |
| KRAS | 12, 13, or 61 | Bone | Female | 5 | 242 | 0.017 | 0.015 | 0.005 | 0.038 |
| KRAS | 12, 13, or 61 | Bone | Male | 1 | 328 | 0.006 | 0.005 | 0.000 | 0.017 |
| KRAS | 12, 13, or 61 | Vaginal | Female | 4 | 78 | 0.053 | 0.049 | 0.015 | 0.111 |
| KRAS | 12, 13, or 61 | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Ampullary | Female | 25 | 41 | 0.578 | 0.576 | 0.459 | 0.711 |
| KRAS | 12, 13, or 61 | Ampullary | Male | 34 | 65 | 0.543 | 0.544 | 0.431 | 0.647 |
| KRAS | 12, 13, or 61 | SCLC | Female | 6 | 193 | 0.029 | 0.028 | 0.013 | 0.052 |
| KRAS | 12, 13, or 61 | SCLC | Male | 5 | 205 | 0.027 | 0.026 | 0.012 | 0.048 |
| KRAS | 12, 13, or 61 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Germ cell | Female | 3 | 175 | 0.024 | 0.021 | 0.005 | 0.058 |
| KRAS | 12, 13, or 61 | Germ cell | Male | 51 | 711 | 0.070 | 0.070 | 0.052 | 0.090 |
| KRAS | 12, 13, or 61 | Nerve sheath | Female | 1 | 80 | 0.010 | 0.007 | 0.000 | 0.037 |
| KRAS | 12, 13, or 61 | Nerve sheath | Male | 0 | 74 | 0.005 | 0.003 | 0.000 | 0.025 |
| KRAS | 12, 13, or 61 | Penile | Male | 2 | 25 | 0.085 | 0.074 | 0.012 | 0.215 |
| KRAS | 12, 13, or 61 | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.034 |
| KRAS | 12, 13, or 61 | Pineal | Male | 1 | 12 | 0.092 | 0.072 | 0.004 | 0.294 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Female | 17 | 395 | 0.040 | 0.039 | 0.026 | 0.059 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Male | 19 | 567 | 0.036 | 0.036 | 0.023 | 0.050 |
| KRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| KRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.024 | 0.014 | 0.000 | 0.101 |
| KRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Male | 1 | 28 | 0.032 | 0.023 | 0.001 | 0.109 |
| KRAS | 12, 13, or 61 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.016 |
| KRAS | 12, 13, or 61 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.014 |
| KRAS | 12, 13, or 61 | Hodgkin lymphoma | Female | 0 | 16 | 0.002 | 0.000 | 0.000 | 0.022 |
| KRAS | 12, 13, or 61 | Hodgkin lymphoma | Male | 0 | 24 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | 12, 13, or 61 | Lung | Male | 2 | 16 | 0.132 | 0.116 | 0.020 | 0.329 |
| KRAS | 12, 13, or 61 | Blastic plasmacytoid dendritic cell neoplasm | Male | 1 | 11 | 0.101 | 0.077 | 0.004 | 0.324 |
| KRAS | 12, 13, or 61 | Peritoneal | Female | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.022 |
| KRAS | G12 | Appendiceal | Female | 71 | 174 | 0.420 | 0.421 | 0.353 | 0.485 |
| KRAS | G12 | Appendiceal | Male | 76 | 167 | 0.443 | 0.442 | 0.378 | 0.514 |
| KRAS | G12 | CRC | Female | 983 | 3028 | 0.323 | 0.323 | 0.306 | 0.340 |
| KRAS | G12 | CRC | Male | 1037 | 3696 | 0.282 | 0.282 | 0.267 | 0.297 |
| KRAS | G12 | CUP | Female | 173 | 1000 | 0.169 | 0.168 | 0.147 | 0.193 |
| KRAS | G12 | CUP | Male | 140 | 989 | 0.146 | 0.146 | 0.124 | 0.168 |
| KRAS | G12 | NSCLC | Female | 1562 | 5722 | 0.272 | 0.272 | 0.261 | 0.284 |
| KRAS | G12 | NSCLC | Male | 973 | 4406 | 0.222 | 0.222 | 0.210 | 0.234 |
| KRAS | G12 | Breast | Female | 65 | 9284 | 0.007 | 0.007 | 0.005 | 0.009 |
| KRAS | G12 | Breast | Male | 0 | 48 | 0.006 | 0.006 | 0.000 | 0.020 |
| KRAS | G12 | Soft tissue sarcoma | Female | 15 | 1413 | 0.009 | 0.009 | 0.006 | 0.015 |
| KRAS | G12 | Soft tissue sarcoma | Male | 8 | 1360 | 0.007 | 0.007 | 0.003 | 0.012 |
| KRAS | G12 | Pancreatic | Female | 779 | 1153 | 0.675 | 0.675 | 0.650 | 0.700 |
| KRAS | G12 | Pancreatic | Male | 899 | 1341 | 0.671 | 0.671 | 0.648 | 0.694 |
| KRAS | G12 | Leukemia | Female | 20 | 637 | 0.030 | 0.029 | 0.020 | 0.042 |
| KRAS | G12 | Leukemia | Male | 24 | 930 | 0.027 | 0.027 | 0.019 | 0.037 |
| KRAS | G12 | Melanoma | Female | 8 | 1104 | 0.008 | 0.008 | 0.004 | 0.012 |
| KRAS | G12 | Melanoma | Male | 15 | 1742 | 0.008 | 0.008 | 0.005 | 0.013 |
| KRAS | G12 | Head and neck | Female | 4 | 564 | 0.006 | 0.006 | 0.002 | 0.013 |
| KRAS | G12 | Head and neck | Male | 5 | 1179 | 0.005 | 0.005 | 0.002 | 0.009 |
| KRAS | G12 | Uterine | Female | 279 | 2254 | 0.124 | 0.124 | 0.110 | 0.138 |
| KRAS | G12 | Non-melanoma skin | Female | 0 | 183 | 0.003 | 0.002 | 0.000 | 0.011 |
| KRAS | G12 | Non-melanoma skin | Male | 2 | 330 | 0.005 | 0.004 | 0.001 | 0.015 |
| KRAS | G12 | MDS/MPN | Female | 5 | 483 | 0.010 | 0.009 | 0.004 | 0.018 |
| KRAS | G12 | MDS/MPN | Male | 6 | 724 | 0.009 | 0.009 | 0.004 | 0.016 |
| KRAS | G12 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12 | Ovarian | Female | 202 | 2336 | 0.087 | 0.086 | 0.075 | 0.098 |
| KRAS | G12 | Esophagogastric | Female | 24 | 504 | 0.043 | 0.042 | 0.029 | 0.062 |
| KRAS | G12 | Esophagogastric | Male | 42 | 1297 | 0.034 | 0.034 | 0.025 | 0.045 |
| KRAS | G12 | Thyroid | Female | 3 | 537 | 0.009 | 0.008 | 0.002 | 0.017 |
| KRAS | G12 | Thyroid | Male | 9 | 480 | 0.016 | 0.015 | 0.007 | 0.029 |
| KRAS | G12 | Cervical | Female | 27 | 365 | 0.074 | 0.073 | 0.050 | 0.103 |
| KRAS | G12 | Hepatobiliary | Female | 54 | 636 | 0.084 | 0.084 | 0.067 | 0.104 |
| KRAS | G12 | Hepatobiliary | Male | 60 | 739 | 0.082 | 0.082 | 0.066 | 0.100 |
| KRAS | G12 | Kidney | Female | 2 | 420 | 0.007 | 0.007 | 0.002 | 0.014 |
| KRAS | G12 | Kidney | Male | 9 | 1002 | 0.008 | 0.008 | 0.004 | 0.014 |
| KRAS | G12 | T / NK neoplasms | Female | 1 | 107 | 0.007 | 0.005 | 0.000 | 0.028 |
| KRAS | G12 | T / NK neoplasms | Male | 0 | 124 | 0.003 | 0.002 | 0.000 | 0.016 |
| KRAS | G12 | CNS | Female | 13 | 1994 | 0.006 | 0.006 | 0.003 | 0.009 |
| KRAS | G12 | CNS | Male | 11 | 2569 | 0.005 | 0.005 | 0.003 | 0.007 |
| KRAS | G12 | Prostate | Male | 6 | 2436 | 0.003 | 0.002 | 0.001 | 0.005 |
| KRAS | G12 | Anal | Female | 0 | 102 | 0.005 | 0.001 | 0.000 | 0.027 |
| KRAS | G12 | Anal | Male | 2 | 47 | 0.035 | 0.028 | 0.004 | 0.106 |
| KRAS | G12 | Neuroendocrine | Female | 10 | 166 | 0.065 | 0.064 | 0.037 | 0.097 |
| KRAS | G12 | Neuroendocrine | Male | 14 | 193 | 0.070 | 0.068 | 0.043 | 0.103 |
| KRAS | G12 | Bladder | Female | 18 | 393 | 0.044 | 0.043 | 0.030 | 0.062 |
| KRAS | G12 | Bladder | Male | 49 | 1188 | 0.042 | 0.042 | 0.032 | 0.053 |
| KRAS | G12 | BLL/Lymphoma | Female | 8 | 106 | 0.066 | 0.062 | 0.027 | 0.123 |
| KRAS | G12 | BLL/Lymphoma | Male | 2 | 142 | 0.023 | 0.020 | 0.003 | 0.056 |
| KRAS | G12 | Small bowel | Female | 25 | 78 | 0.320 | 0.319 | 0.242 | 0.405 |
| KRAS | G12 | Small bowel | Male | 42 | 132 | 0.318 | 0.318 | 0.252 | 0.390 |
| KRAS | G12 | Sex cord stromal | Female | 2 | 97 | 0.021 | 0.018 | 0.003 | 0.055 |
| KRAS | G12 | Sex cord stromal | Male | 0 | 11 | 0.020 | 0.014 | 0.000 | 0.077 |
| KRAS | G12 | Bone | Female | 4 | 242 | 0.013 | 0.011 | 0.004 | 0.031 |
| KRAS | G12 | Bone | Male | 1 | 328 | 0.006 | 0.006 | 0.000 | 0.016 |
| KRAS | G12 | Vaginal | Female | 3 | 78 | 0.040 | 0.036 | 0.009 | 0.093 |
| KRAS | G12 | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12 | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12 | Ampullary | Female | 19 | 41 | 0.469 | 0.470 | 0.348 | 0.586 |
| KRAS | G12 | Ampullary | Male | 31 | 65 | 0.474 | 0.474 | 0.370 | 0.580 |
| KRAS | G12 | SCLC | Female | 6 | 193 | 0.029 | 0.028 | 0.014 | 0.053 |
| KRAS | G12 | SCLC | Male | 5 | 205 | 0.027 | 0.026 | 0.012 | 0.048 |
| KRAS | G12 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12 | Germ cell | Female | 3 | 175 | 0.025 | 0.022 | 0.006 | 0.058 |
| KRAS | G12 | Germ cell | Male | 48 | 711 | 0.066 | 0.066 | 0.049 | 0.086 |
| KRAS | G12 | Nerve sheath | Female | 1 | 80 | 0.011 | 0.007 | 0.000 | 0.040 |
| KRAS | G12 | Nerve sheath | Male | 0 | 74 | 0.004 | 0.001 | 0.000 | 0.022 |
| KRAS | G12 | Penile | Male | 1 | 25 | 0.046 | 0.034 | 0.002 | 0.156 |
| KRAS | G12 | Pheochromocytoma | Male | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.017 |
| KRAS | G12 | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.034 |
| KRAS | G12 | B cell lymphoma | Female | 6 | 395 | 0.015 | 0.015 | 0.007 | 0.026 |
| KRAS | G12 | B cell lymphoma | Male | 8 | 567 | 0.015 | 0.014 | 0.007 | 0.024 |
| KRAS | G12 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.025 |
| KRAS | G12 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.023 |
| KRAS | G12 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.025 | 0.015 | 0.000 | 0.103 |
| KRAS | G12 | T-lymphoblastic leukemia/lymphoma | Male | 1 | 28 | 0.032 | 0.024 | 0.002 | 0.109 |
| KRAS | G12 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | G12 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | G12 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.011 |
| KRAS | G12 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.010 |
| KRAS | G12 | Lung | Male | 2 | 16 | 0.130 | 0.115 | 0.019 | 0.325 |
| KRAS | G12 | Blastic plasmacytoid dendritic cell neoplasm | Male | 1 | 11 | 0.101 | 0.078 | 0.004 | 0.326 |
| KRAS | G12 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.033 |
| KRAS | G12C | Appendiceal | Female | 6 | 174 | 0.030 | 0.028 | 0.013 | 0.057 |
| KRAS | G12C | Appendiceal | Male | 3 | 167 | 0.024 | 0.023 | 0.008 | 0.046 |
| KRAS | G12C | CRC | Female | 110 | 3028 | 0.035 | 0.035 | 0.029 | 0.042 |
| KRAS | G12C | CRC | Male | 102 | 3696 | 0.029 | 0.029 | 0.023 | 0.034 |
| KRAS | G12C | CUP | Female | 39 | 1000 | 0.037 | 0.036 | 0.026 | 0.050 |
| KRAS | G12C | CUP | Male | 22 | 989 | 0.025 | 0.025 | 0.016 | 0.035 |
| KRAS | G12C | NSCLC | Female | 755 | 5722 | 0.131 | 0.131 | 0.122 | 0.140 |
| KRAS | G12C | NSCLC | Male | 458 | 4406 | 0.105 | 0.105 | 0.096 | 0.114 |
| KRAS | G12C | Breast | Female | 8 | 9284 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Breast | Male | 0 | 48 | 0.002 | 0.001 | 0.000 | 0.010 |
| KRAS | G12C | Soft tissue sarcoma | Female | 4 | 1413 | 0.002 | 0.002 | 0.001 | 0.005 |
| KRAS | G12C | Soft tissue sarcoma | Male | 1 | 1360 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | G12C | Pancreatic | Female | 8 | 1153 | 0.008 | 0.008 | 0.004 | 0.013 |
| KRAS | G12C | Pancreatic | Male | 14 | 1341 | 0.010 | 0.009 | 0.006 | 0.015 |
| KRAS | G12C | Leukemia | Female | 0 | 637 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | Male | 0 | 930 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Melanoma | Female | 1 | 1104 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | Melanoma | Male | 1 | 1742 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Head and neck | Female | 1 | 564 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | Head and neck | Male | 1 | 1179 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | Uterine | Female | 26 | 2254 | 0.012 | 0.011 | 0.008 | 0.016 |
| KRAS | G12C | Non-melanoma skin | Female | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Non-melanoma skin | Male | 0 | 330 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | MDS/MPN | Female | 0 | 483 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | Male | 0 | 724 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Ovarian | Female | 10 | 2336 | 0.004 | 0.004 | 0.002 | 0.007 |
| KRAS | G12C | Esophagogastric | Female | 2 | 504 | 0.003 | 0.003 | 0.001 | 0.008 |
| KRAS | G12C | Esophagogastric | Male | 3 | 1297 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | G12C | Thyroid | Female | 1 | 537 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | G12C | Thyroid | Male | 1 | 480 | 0.002 | 0.002 | 0.000 | 0.007 |
| KRAS | G12C | Cervical | Female | 1 | 365 | 0.003 | 0.002 | 0.000 | 0.011 |
| KRAS | G12C | Hepatobiliary | Female | 4 | 636 | 0.007 | 0.007 | 0.003 | 0.013 |
| KRAS | G12C | Hepatobiliary | Male | 6 | 739 | 0.008 | 0.007 | 0.003 | 0.014 |
| KRAS | G12C | Kidney | Female | 0 | 420 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Kidney | Male | 1 | 1002 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | T / NK neoplasms | Male | 0 | 124 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | CNS | Female | 0 | 1994 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | Male | 0 | 2569 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | Male | 0 | 2436 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Neuroendocrine | Female | 1 | 166 | 0.006 | 0.005 | 0.001 | 0.019 |
| KRAS | G12C | Neuroendocrine | Male | 1 | 193 | 0.006 | 0.005 | 0.001 | 0.018 |
| KRAS | G12C | Bladder | Female | 1 | 393 | 0.004 | 0.004 | 0.001 | 0.010 |
| KRAS | G12C | Bladder | Male | 7 | 1188 | 0.005 | 0.005 | 0.002 | 0.010 |
| KRAS | G12C | BLL/Lymphoma | Female | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | BLL/Lymphoma | Male | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Small bowel | Female | 2 | 78 | 0.035 | 0.034 | 0.009 | 0.071 |
| KRAS | G12C | Small bowel | Male | 6 | 132 | 0.041 | 0.039 | 0.018 | 0.076 |
| KRAS | G12C | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Sex cord stromal | Male | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G12C | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Vaginal | Female | 1 | 78 | 0.015 | 0.011 | 0.001 | 0.051 |
| KRAS | G12C | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Ampullary | Female | 1 | 41 | 0.036 | 0.032 | 0.005 | 0.088 |
| KRAS | G12C | Ampullary | Male | 3 | 65 | 0.042 | 0.038 | 0.011 | 0.094 |
| KRAS | G12C | SCLC | Female | 2 | 193 | 0.009 | 0.008 | 0.002 | 0.023 |
| KRAS | G12C | SCLC | Male | 1 | 205 | 0.007 | 0.006 | 0.001 | 0.019 |
| KRAS | G12C | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Germ cell | Female | 0 | 175 | 0.002 | 0.001 | 0.000 | 0.009 |
| KRAS | G12C | Germ cell | Male | 4 | 711 | 0.005 | 0.005 | 0.001 | 0.012 |
| KRAS | G12C | Nerve sheath | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Nerve sheath | Male | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | G12C | Pheochromocytoma | Male | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.017 |
| KRAS | G12C | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.034 |
| KRAS | G12C | B cell lymphoma | Female | 0 | 395 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | Male | 0 | 567 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.025 |
| KRAS | G12C | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.023 |
| KRAS | G12C | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | G12C | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.009 |
| KRAS | G12C | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | G12C | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | G12C | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.011 |
| KRAS | G12C | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.010 |
| KRAS | G12C | Lung | Male | 1 | 16 | 0.070 | 0.053 | 0.003 | 0.231 |
| KRAS | G12C | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.082 |
| KRAS | G12C | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.033 |
| KRAS | G13 | Appendiceal | Female | 6 | 174 | 0.039 | 0.038 | 0.018 | 0.066 |
| KRAS | G13 | Appendiceal | Male | 8 | 167 | 0.044 | 0.042 | 0.023 | 0.074 |
| KRAS | G13 | CRC | Female | 253 | 3028 | 0.082 | 0.082 | 0.073 | 0.092 |
| KRAS | G13 | CRC | Male | 277 | 3696 | 0.076 | 0.076 | 0.068 | 0.084 |
| KRAS | G13 | CUP | Female | 18 | 1000 | 0.019 | 0.019 | 0.012 | 0.027 |
| KRAS | G13 | CUP | Male | 21 | 989 | 0.020 | 0.020 | 0.014 | 0.029 |
| KRAS | G13 | NSCLC | Female | 125 | 5722 | 0.021 | 0.021 | 0.018 | 0.025 |
| KRAS | G13 | NSCLC | Male | 84 | 4406 | 0.020 | 0.020 | 0.016 | 0.023 |
| KRAS | G13 | Breast | Female | 4 | 9284 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Breast | Male | 1 | 48 | 0.014 | 0.008 | 0.000 | 0.065 |
| KRAS | G13 | Soft tissue sarcoma | Female | 0 | 1413 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Soft tissue sarcoma | Male | 1 | 1360 | 0.001 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Pancreatic | Female | 7 | 1153 | 0.007 | 0.007 | 0.003 | 0.011 |
| KRAS | G13 | Pancreatic | Male | 11 | 1341 | 0.008 | 0.007 | 0.004 | 0.012 |
| KRAS | G13 | Leukemia | Female | 11 | 637 | 0.017 | 0.017 | 0.010 | 0.026 |
| KRAS | G13 | Leukemia | Male | 15 | 930 | 0.017 | 0.016 | 0.010 | 0.024 |
| KRAS | G13 | Melanoma | Female | 2 | 1104 | 0.002 | 0.002 | 0.001 | 0.005 |
| KRAS | G13 | Melanoma | Male | 5 | 1742 | 0.003 | 0.003 | 0.001 | 0.005 |
| KRAS | G13 | Head and neck | Female | 1 | 564 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | Head and neck | Male | 2 | 1179 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | Uterine | Female | 52 | 2254 | 0.023 | 0.023 | 0.017 | 0.030 |
| KRAS | G13 | Non-melanoma skin | Female | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Non-melanoma skin | Male | 0 | 330 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | MDS/MPN | Female | 4 | 483 | 0.007 | 0.006 | 0.002 | 0.015 |
| KRAS | G13 | MDS/MPN | Male | 3 | 724 | 0.005 | 0.005 | 0.002 | 0.011 |
| KRAS | G13 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.006 |
| KRAS | G13 | Adrenocortical | Male | 0 | 54 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G13 | Ovarian | Female | 11 | 2336 | 0.005 | 0.005 | 0.002 | 0.008 |
| KRAS | G13 | Esophagogastric | Female | 8 | 504 | 0.014 | 0.013 | 0.008 | 0.024 |
| KRAS | G13 | Esophagogastric | Male | 15 | 1297 | 0.012 | 0.012 | 0.008 | 0.018 |
| KRAS | G13 | Thyroid | Female | 0 | 537 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | Male | 0 | 480 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Cervical | Female | 4 | 365 | 0.012 | 0.011 | 0.003 | 0.025 |
| KRAS | G13 | Hepatobiliary | Female | 3 | 636 | 0.006 | 0.006 | 0.002 | 0.012 |
| KRAS | G13 | Hepatobiliary | Male | 6 | 739 | 0.007 | 0.007 | 0.003 | 0.014 |
| KRAS | G13 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | T / NK neoplasms | Male | 0 | 124 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | CNS | Female | 0 | 1994 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | Male | 1 | 2569 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Prostate | Male | 1 | 2436 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Anal | Female | 2 | 102 | 0.017 | 0.014 | 0.002 | 0.047 |
| KRAS | G13 | Anal | Male | 0 | 47 | 0.010 | 0.007 | 0.000 | 0.038 |
| KRAS | G13 | Neuroendocrine | Female | 2 | 166 | 0.016 | 0.015 | 0.004 | 0.034 |
| KRAS | G13 | Neuroendocrine | Male | 4 | 193 | 0.018 | 0.017 | 0.006 | 0.038 |
| KRAS | G13 | Bladder | Female | 2 | 393 | 0.004 | 0.003 | 0.001 | 0.011 |
| KRAS | G13 | Bladder | Male | 2 | 1188 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | BLL/Lymphoma | Female | 2 | 106 | 0.028 | 0.027 | 0.007 | 0.057 |
| KRAS | G13 | BLL/Lymphoma | Male | 6 | 142 | 0.036 | 0.034 | 0.015 | 0.069 |
| KRAS | G13 | Small bowel | Female | 3 | 78 | 0.053 | 0.052 | 0.016 | 0.097 |
| KRAS | G13 | Small bowel | Male | 10 | 132 | 0.068 | 0.066 | 0.035 | 0.114 |
| KRAS | G13 | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Sex cord stromal | Male | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Vaginal | Female | 1 | 78 | 0.015 | 0.011 | 0.001 | 0.051 |
| KRAS | G13 | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Ampullary | Female | 3 | 41 | 0.058 | 0.052 | 0.016 | 0.134 |
| KRAS | G13 | Ampullary | Male | 2 | 65 | 0.043 | 0.040 | 0.009 | 0.093 |
| KRAS | G13 | SCLC | Female | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | SCLC | Male | 0 | 205 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Germ cell | Female | 0 | 175 | 0.002 | 0.002 | 0.000 | 0.009 |
| KRAS | G13 | Germ cell | Male | 3 | 711 | 0.004 | 0.003 | 0.001 | 0.010 |
| KRAS | G13 | Nerve sheath | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Nerve sheath | Male | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.023 |
| KRAS | G13 | Pheochromocytoma | Male | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.028 |
| KRAS | G13 | Pineal | Male | 1 | 12 | 0.093 | 0.072 | 0.004 | 0.300 |
| KRAS | G13 | B cell lymphoma | Female | 6 | 395 | 0.013 | 0.012 | 0.004 | 0.027 |
| KRAS | G13 | B cell lymphoma | Male | 2 | 567 | 0.006 | 0.005 | 0.001 | 0.013 |
| KRAS | G13 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.027 |
| KRAS | G13 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.029 |
| KRAS | G13 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.019 |
| KRAS | G13 | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | G13 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.011 |
| KRAS | G13 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.010 |
| KRAS | G13 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.016 |
| KRAS | G13 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | G13 | Lung | Male | 0 | 16 | 0.004 | 0.000 | 0.000 | 0.041 |
| KRAS | G13 | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.059 |
| KRAS | G13 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.031 |
| KRAS | Q61 | Appendiceal | Female | 0 | 174 | 0.003 | 0.000 | 0.000 | 0.019 |
| KRAS | Q61 | Appendiceal | Male | 5 | 167 | 0.028 | 0.026 | 0.008 | 0.058 |
| KRAS | Q61 | CRC | Female | 64 | 3028 | 0.020 | 0.020 | 0.016 | 0.025 |
| KRAS | Q61 | CRC | Male | 61 | 3696 | 0.017 | 0.017 | 0.014 | 0.021 |
| KRAS | Q61 | CUP | Female | 13 | 1000 | 0.012 | 0.012 | 0.007 | 0.019 |
| KRAS | Q61 | CUP | Male | 10 | 989 | 0.011 | 0.011 | 0.006 | 0.017 |
| KRAS | Q61 | NSCLC | Female | 115 | 5722 | 0.019 | 0.019 | 0.016 | 0.023 |
| KRAS | Q61 | NSCLC | Male | 64 | 4406 | 0.015 | 0.015 | 0.012 | 0.019 |
| KRAS | Q61 | Breast | Female | 2 | 9284 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | Male | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.008 |
| KRAS | Q61 | Soft tissue sarcoma | Female | 1 | 1413 | 0.001 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Soft tissue sarcoma | Male | 0 | 1360 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Pancreatic | Female | 63 | 1153 | 0.055 | 0.055 | 0.044 | 0.067 |
| KRAS | Q61 | Pancreatic | Male | 76 | 1341 | 0.056 | 0.056 | 0.046 | 0.068 |
| KRAS | Q61 | Leukemia | Female | 2 | 637 | 0.004 | 0.003 | 0.001 | 0.008 |
| KRAS | Q61 | Leukemia | Male | 4 | 930 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | Q61 | Melanoma | Female | 4 | 1104 | 0.003 | 0.003 | 0.001 | 0.007 |
| KRAS | Q61 | Melanoma | Male | 4 | 1742 | 0.003 | 0.003 | 0.001 | 0.005 |
| KRAS | Q61 | Head and neck | Female | 0 | 564 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | Male | 0 | 1179 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Uterine | Female | 9 | 2254 | 0.004 | 0.004 | 0.002 | 0.007 |
| KRAS | Q61 | Non-melanoma skin | Female | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Non-melanoma skin | Male | 0 | 330 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | MDS/MPN | Female | 0 | 483 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | Male | 0 | 724 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Ovarian | Female | 13 | 2336 | 0.006 | 0.005 | 0.003 | 0.009 |
| KRAS | Q61 | Esophagogastric | Female | 2 | 504 | 0.003 | 0.002 | 0.000 | 0.009 |
| KRAS | Q61 | Esophagogastric | Male | 1 | 1297 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | Q61 | Thyroid | Female | 10 | 537 | 0.017 | 0.016 | 0.009 | 0.028 |
| KRAS | Q61 | Thyroid | Male | 6 | 480 | 0.015 | 0.014 | 0.007 | 0.025 |
| KRAS | Q61 | Cervical | Female | 0 | 365 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Hepatobiliary | Female | 10 | 636 | 0.014 | 0.014 | 0.008 | 0.023 |
| KRAS | Q61 | Hepatobiliary | Male | 8 | 739 | 0.012 | 0.012 | 0.006 | 0.020 |
| KRAS | Q61 | Kidney | Female | 2 | 420 | 0.004 | 0.003 | 0.000 | 0.012 |
| KRAS | Q61 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | T / NK neoplasms | Female | 1 | 107 | 0.010 | 0.008 | 0.001 | 0.030 |
| KRAS | Q61 | T / NK neoplasms | Male | 1 | 124 | 0.010 | 0.008 | 0.001 | 0.028 |
| KRAS | Q61 | CNS | Female | 3 | 1994 | 0.002 | 0.002 | 0.001 | 0.004 |
| KRAS | Q61 | CNS | Male | 9 | 2569 | 0.003 | 0.003 | 0.001 | 0.005 |
| KRAS | Q61 | Prostate | Male | 4 | 2436 | 0.002 | 0.002 | 0.000 | 0.004 |
| KRAS | Q61 | Anal | Female | 1 | 102 | 0.009 | 0.007 | 0.000 | 0.031 |
| KRAS | Q61 | Anal | Male | 0 | 47 | 0.006 | 0.004 | 0.000 | 0.028 |
| KRAS | Q61 | Neuroendocrine | Female | 0 | 166 | 0.003 | 0.002 | 0.000 | 0.014 |
| KRAS | Q61 | Neuroendocrine | Male | 2 | 193 | 0.009 | 0.007 | 0.001 | 0.025 |
| KRAS | Q61 | Bladder | Female | 3 | 393 | 0.005 | 0.004 | 0.001 | 0.015 |
| KRAS | Q61 | Bladder | Male | 2 | 1188 | 0.003 | 0.002 | 0.000 | 0.006 |
| KRAS | Q61 | BLL/Lymphoma | Female | 1 | 106 | 0.012 | 0.011 | 0.002 | 0.032 |
| KRAS | Q61 | BLL/Lymphoma | Male | 2 | 142 | 0.013 | 0.012 | 0.003 | 0.033 |
| KRAS | Q61 | Small bowel | Female | 4 | 78 | 0.039 | 0.035 | 0.012 | 0.091 |
| KRAS | Q61 | Small bowel | Male | 2 | 132 | 0.024 | 0.022 | 0.005 | 0.052 |
| KRAS | Q61 | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Sex cord stromal | Male | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | Q61 | Bone | Female | 1 | 242 | 0.003 | 0.002 | 0.000 | 0.013 |
| KRAS | Q61 | Bone | Male | 0 | 328 | 0.001 | 0.001 | 0.000 | 0.006 |
| KRAS | Q61 | Vaginal | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Ampullary | Female | 3 | 41 | 0.057 | 0.051 | 0.016 | 0.135 |
| KRAS | Q61 | Ampullary | Male | 2 | 65 | 0.043 | 0.040 | 0.010 | 0.094 |
| KRAS | Q61 | SCLC | Female | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | SCLC | Male | 0 | 205 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Germ cell | Female | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | Male | 0 | 711 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Nerve sheath | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Nerve sheath | Male | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Penile | Male | 1 | 25 | 0.046 | 0.034 | 0.002 | 0.156 |
| KRAS | Q61 | Pheochromocytoma | Male | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.017 |
| KRAS | Q61 | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.034 |
| KRAS | Q61 | B cell lymphoma | Female | 5 | 395 | 0.014 | 0.014 | 0.006 | 0.025 |
| KRAS | Q61 | B cell lymphoma | Male | 9 | 567 | 0.015 | 0.015 | 0.008 | 0.025 |
| KRAS | Q61 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.025 |
| KRAS | Q61 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.023 |
| KRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.009 |
| KRAS | Q61 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | Q61 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | Q61 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.011 |
| KRAS | Q61 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.010 |
| KRAS | Q61 | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.034 |
| KRAS | Q61 | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.082 |
| KRAS | Q61 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.033 |
| KRAS | 12, 13, or 61 | Appendiceal | Metastasis | 78 | 174 | 0.462 | 0.463 | 0.390 | 0.530 |
| KRAS | 12, 13, or 61 | Appendiceal | Not Applicable or Heme | 3 | 10 | 0.441 | 0.461 | 0.203 | 0.586 |
| KRAS | 12, 13, or 61 | Appendiceal | Primary | 82 | 151 | 0.518 | 0.516 | 0.445 | 0.600 |
| KRAS | 12, 13, or 61 | CRC | Metastasis | 952 | 2354 | 0.402 | 0.402 | 0.384 | 0.420 |
| KRAS | 12, 13, or 61 | CRC | Not Applicable or Heme | 88 | 224 | 0.396 | 0.396 | 0.358 | 0.434 |
| KRAS | 12, 13, or 61 | CRC | Primary | 1613 | 4115 | 0.393 | 0.393 | 0.379 | 0.407 |
| KRAS | 12, 13, or 61 | CRC | Unspecified | 12 | 31 | 0.396 | 0.397 | 0.340 | 0.450 |
| KRAS | 12, 13, or 61 | CUP | Metastasis | 264 | 1389 | 0.190 | 0.190 | 0.170 | 0.210 |
| KRAS | 12, 13, or 61 | CUP | Not Applicable or Heme | 56 | 229 | 0.223 | 0.221 | 0.176 | 0.282 |
| KRAS | 12, 13, or 61 | CUP | Primary | 43 | 311 | 0.156 | 0.156 | 0.115 | 0.197 |
| KRAS | 12, 13, or 61 | CUP | Unspecified | 11 | 60 | 0.187 | 0.185 | 0.123 | 0.261 |
| KRAS | 12, 13, or 61 | NSCLC | Metastasis | 971 | 3750 | 0.259 | 0.259 | 0.245 | 0.273 |
| KRAS | 12, 13, or 61 | NSCLC | Not Applicable or Heme | 52 | 223 | 0.237 | 0.236 | 0.186 | 0.289 |
| KRAS | 12, 13, or 61 | NSCLC | Primary | 1880 | 6059 | 0.310 | 0.310 | 0.298 | 0.321 |
| KRAS | 12, 13, or 61 | NSCLC | Unspecified | 14 | 99 | 0.181 | 0.180 | 0.106 | 0.260 |
| KRAS | 12, 13, or 61 | Breast | Metastasis | 37 | 3094 | 0.012 | 0.012 | 0.008 | 0.016 |
| KRAS | 12, 13, or 61 | Breast | Not Applicable or Heme | 5 | 105 | 0.038 | 0.035 | 0.010 | 0.084 |
| KRAS | 12, 13, or 61 | Breast | Primary | 29 | 6125 | 0.005 | 0.005 | 0.003 | 0.007 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Metastasis | 8 | 939 | 0.009 | 0.009 | 0.005 | 0.014 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.009 | 0.009 | 0.004 | 0.017 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Primary | 16 | 1686 | 0.009 | 0.009 | 0.006 | 0.013 |
| KRAS | 12, 13, or 61 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.009 | 0.009 | 0.003 | 0.018 |
| KRAS | 12, 13, or 61 | Pancreatic | Metastasis | 704 | 981 | 0.723 | 0.724 | 0.695 | 0.749 |
| KRAS | 12, 13, or 61 | Pancreatic | Not Applicable or Heme | 53 | 75 | 0.726 | 0.730 | 0.655 | 0.780 |
| KRAS | 12, 13, or 61 | Pancreatic | Primary | 1073 | 1429 | 0.746 | 0.746 | 0.724 | 0.769 |
| KRAS | 12, 13, or 61 | Leukemia | Metastasis | 3 | 15 | 0.063 | 0.050 | 0.034 | 0.186 |
| KRAS | 12, 13, or 61 | Leukemia | Not Applicable or Heme | 42 | 923 | 0.046 | 0.046 | 0.035 | 0.059 |
| KRAS | 12, 13, or 61 | Leukemia | Primary | 20 | 412 | 0.048 | 0.047 | 0.034 | 0.065 |
| KRAS | 12, 13, or 61 | Leukemia | Unspecified | 8 | 217 | 0.045 | 0.045 | 0.026 | 0.063 |
| KRAS | 12, 13, or 61 | Melanoma | Metastasis | 21 | 1738 | 0.012 | 0.012 | 0.008 | 0.018 |
| KRAS | 12, 13, or 61 | Melanoma | Not Applicable or Heme | 0 | 188 | 0.009 | 0.010 | 0.000 | 0.018 |
| KRAS | 12, 13, or 61 | Melanoma | Primary | 16 | 898 | 0.015 | 0.015 | 0.009 | 0.024 |
| KRAS | 12, 13, or 61 | Melanoma | Unspecified | 0 | 22 | 0.012 | 0.012 | 0.000 | 0.030 |
| KRAS | 12, 13, or 61 | Head and neck | Metastasis | 3 | 731 | 0.006 | 0.005 | 0.002 | 0.011 |
| KRAS | 12, 13, or 61 | Head and neck | Not Applicable or Heme | 3 | 67 | 0.025 | 0.017 | 0.004 | 0.081 |
| KRAS | 12, 13, or 61 | Head and neck | Primary | 6 | 938 | 0.007 | 0.007 | 0.003 | 0.012 |
| KRAS | 12, 13, or 61 | Uterine | Metastasis | 79 | 586 | 0.144 | 0.144 | 0.118 | 0.167 |
| KRAS | 12, 13, or 61 | Uterine | Not Applicable or Heme | 13 | 76 | 0.154 | 0.152 | 0.119 | 0.205 |
| KRAS | 12, 13, or 61 | Uterine | Primary | 237 | 1541 | 0.153 | 0.152 | 0.136 | 0.170 |
| KRAS | 12, 13, or 61 | Uterine | Unspecified | 10 | 51 | 0.158 | 0.154 | 0.121 | 0.222 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | Metastasis | 1 | 203 | 0.005 | 0.004 | 0.000 | 0.016 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | Not Applicable or Heme | 1 | 22 | 0.020 | 0.008 | 0.001 | 0.111 |
| KRAS | 12, 13, or 61 | Non-melanoma skin | Primary | 0 | 287 | 0.003 | 0.002 | 0.000 | 0.010 |
| KRAS | 12, 13, or 61 | MDS/MPN | Metastasis | 1 | 11 | 0.031 | 0.018 | 0.006 | 0.141 |
| KRAS | 12, 13, or 61 | MDS/MPN | Not Applicable or Heme | 10 | 915 | 0.013 | 0.013 | 0.007 | 0.021 |
| KRAS | 12, 13, or 61 | MDS/MPN | Primary | 7 | 250 | 0.022 | 0.020 | 0.010 | 0.044 |
| KRAS | 12, 13, or 61 | MDS/MPN | Unspecified | 0 | 31 | 0.016 | 0.014 | 0.001 | 0.044 |
| KRAS | 12, 13, or 61 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | 12, 13, or 61 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | 12, 13, or 61 | Ovarian | Metastasis | 91 | 1088 | 0.088 | 0.088 | 0.072 | 0.105 |
| KRAS | 12, 13, or 61 | Ovarian | Not Applicable or Heme | 13 | 160 | 0.092 | 0.093 | 0.061 | 0.123 |
| KRAS | 12, 13, or 61 | Ovarian | Primary | 117 | 1060 | 0.106 | 0.105 | 0.089 | 0.125 |
| KRAS | 12, 13, or 61 | Ovarian | Unspecified | 5 | 28 | 0.111 | 0.103 | 0.071 | 0.204 |
| KRAS | 12, 13, or 61 | Esophagogastric | Metastasis | 23 | 462 | 0.051 | 0.050 | 0.037 | 0.066 |
| KRAS | 12, 13, or 61 | Esophagogastric | Not Applicable or Heme | 2 | 43 | 0.051 | 0.050 | 0.029 | 0.079 |
| KRAS | 12, 13, or 61 | Esophagogastric | Primary | 66 | 1283 | 0.051 | 0.051 | 0.041 | 0.063 |
| KRAS | 12, 13, or 61 | Esophagogastric | Unspecified | 1 | 14 | 0.054 | 0.051 | 0.031 | 0.091 |
| KRAS | 12, 13, or 61 | Thyroid | Metastasis | 10 | 402 | 0.027 | 0.027 | 0.015 | 0.042 |
| KRAS | 12, 13, or 61 | Thyroid | Not Applicable or Heme | 3 | 28 | 0.046 | 0.033 | 0.018 | 0.149 |
| KRAS | 12, 13, or 61 | Thyroid | Primary | 15 | 582 | 0.027 | 0.027 | 0.017 | 0.040 |
| KRAS | 12, 13, or 61 | Cervical | Metastasis | 15 | 136 | 0.094 | 0.091 | 0.058 | 0.147 |
| KRAS | 12, 13, or 61 | Cervical | Not Applicable or Heme | 1 | 12 | 0.086 | 0.080 | 0.026 | 0.183 |
| KRAS | 12, 13, or 61 | Cervical | Primary | 13 | 211 | 0.072 | 0.072 | 0.042 | 0.107 |
| KRAS | 12, 13, or 61 | Hepatobiliary | Metastasis | 53 | 438 | 0.114 | 0.112 | 0.090 | 0.144 |
| KRAS | 12, 13, or 61 | Hepatobiliary | Not Applicable or Heme | 5 | 34 | 0.116 | 0.109 | 0.072 | 0.201 |
| KRAS | 12, 13, or 61 | Hepatobiliary | Primary | 82 | 895 | 0.097 | 0.097 | 0.078 | 0.116 |
| KRAS | 12, 13, or 61 | Kidney | Metastasis | 5 | 445 | 0.010 | 0.009 | 0.004 | 0.019 |
| KRAS | 12, 13, or 61 | Kidney | Not Applicable or Heme | 0 | 24 | 0.009 | 0.009 | 0.000 | 0.024 |
| KRAS | 12, 13, or 61 | Kidney | Primary | 8 | 944 | 0.009 | 0.009 | 0.004 | 0.015 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | Metastasis | 0 | 10 | 0.014 | 0.010 | 0.000 | 0.053 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.011 | 0.009 | 0.000 | 0.038 |
| KRAS | 12, 13, or 61 | T / NK neoplasms | Primary | 3 | 187 | 0.015 | 0.013 | 0.003 | 0.035 |
| KRAS | 12, 13, or 61 | CNS | Metastasis | 4 | 409 | 0.009 | 0.008 | 0.005 | 0.016 |
| KRAS | 12, 13, or 61 | CNS | Not Applicable or Heme | 2 | 526 | 0.007 | 0.007 | 0.003 | 0.012 |
| KRAS | 12, 13, or 61 | CNS | Primary | 29 | 3522 | 0.008 | 0.008 | 0.006 | 0.011 |
| KRAS | 12, 13, or 61 | CNS | Unspecified | 2 | 108 | 0.010 | 0.009 | 0.005 | 0.023 |
| KRAS | 12, 13, or 61 | Prostate | Metastasis | 3 | 901 | 0.005 | 0.004 | 0.001 | 0.008 |
| KRAS | 12, 13, or 61 | Prostate | Not Applicable or Heme | 0 | 57 | 0.005 | 0.005 | 0.000 | 0.016 |
| KRAS | 12, 13, or 61 | Prostate | Primary | 8 | 1468 | 0.005 | 0.005 | 0.003 | 0.009 |
| KRAS | 12, 13, or 61 | Prostate | Unspecified | 1 | 12 | 0.015 | 0.006 | 0.002 | 0.103 |
| KRAS | 12, 13, or 61 | Anal | Metastasis | 2 | 59 | 0.036 | 0.033 | 0.009 | 0.081 |
| KRAS | 12, 13, or 61 | Anal | Primary | 3 | 84 | 0.036 | 0.034 | 0.011 | 0.077 |
| KRAS | 12, 13, or 61 | Neuroendocrine | Metastasis | 9 | 143 | 0.077 | 0.077 | 0.043 | 0.115 |
| KRAS | 12, 13, or 61 | Neuroendocrine | Not Applicable or Heme | 3 | 20 | 0.097 | 0.088 | 0.049 | 0.205 |
| KRAS | 12, 13, or 61 | Neuroendocrine | Primary | 18 | 196 | 0.087 | 0.086 | 0.057 | 0.125 |
| KRAS | 12, 13, or 61 | Bladder | Metastasis | 15 | 390 | 0.044 | 0.044 | 0.027 | 0.060 |
| KRAS | 12, 13, or 61 | Bladder | Not Applicable or Heme | 1 | 25 | 0.048 | 0.047 | 0.020 | 0.090 |
| KRAS | 12, 13, or 61 | Bladder | Primary | 60 | 1164 | 0.050 | 0.049 | 0.039 | 0.062 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.072 | 0.071 | 0.016 | 0.127 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | Not Applicable or Heme | 9 | 109 | 0.078 | 0.076 | 0.044 | 0.122 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | Primary | 7 | 101 | 0.075 | 0.073 | 0.041 | 0.116 |
| KRAS | 12, 13, or 61 | BLL/Lymphoma | Unspecified | 3 | 25 | 0.083 | 0.078 | 0.040 | 0.160 |
| KRAS | 12, 13, or 61 | Small bowel | Metastasis | 33 | 78 | 0.420 | 0.419 | 0.334 | 0.508 |
| KRAS | 12, 13, or 61 | Small bowel | Primary | 53 | 128 | 0.416 | 0.416 | 0.342 | 0.493 |
| KRAS | 12, 13, or 61 | Sex cord stromal | Metastasis | 1 | 49 | 0.022 | 0.018 | 0.002 | 0.063 |
| KRAS | 12, 13, or 61 | Sex cord stromal | Primary | 1 | 54 | 0.021 | 0.018 | 0.002 | 0.060 |
| KRAS | 12, 13, or 61 | Bone | Metastasis | 2 | 203 | 0.011 | 0.010 | 0.003 | 0.023 |
| KRAS | 12, 13, or 61 | Bone | Not Applicable or Heme | 0 | 25 | 0.011 | 0.009 | 0.000 | 0.027 |
| KRAS | 12, 13, or 61 | Bone | Primary | 4 | 326 | 0.011 | 0.010 | 0.004 | 0.022 |
| KRAS | 12, 13, or 61 | Bone | Unspecified | 0 | 16 | 0.011 | 0.010 | 0.000 | 0.031 |
| KRAS | 12, 13, or 61 | Vaginal | Metastasis | 1 | 16 | 0.058 | 0.050 | 0.009 | 0.154 |
| KRAS | 12, 13, or 61 | Vaginal | Primary | 3 | 60 | 0.053 | 0.049 | 0.014 | 0.115 |
| KRAS | 12, 13, or 61 | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | 12, 13, or 61 | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | 12, 13, or 61 | Ampullary | Metastasis | 15 | 23 | 0.595 | 0.588 | 0.448 | 0.774 |
| KRAS | 12, 13, or 61 | Ampullary | Primary | 43 | 82 | 0.540 | 0.541 | 0.437 | 0.639 |
| KRAS | 12, 13, or 61 | SCLC | Metastasis | 7 | 207 | 0.031 | 0.029 | 0.014 | 0.055 |
| KRAS | 12, 13, or 61 | SCLC | Primary | 4 | 183 | 0.026 | 0.026 | 0.010 | 0.048 |
| KRAS | 12, 13, or 61 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | 12, 13, or 61 | Germ cell | Metastasis | 18 | 274 | 0.064 | 0.063 | 0.039 | 0.095 |
| KRAS | 12, 13, or 61 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.017 | 0.008 | 0.000 | 0.065 |
| KRAS | 12, 13, or 61 | Germ cell | Primary | 36 | 517 | 0.068 | 0.067 | 0.048 | 0.091 |
| KRAS | 12, 13, or 61 | Germ cell | Unspecified | 0 | 14 | 0.029 | 0.020 | 0.000 | 0.099 |
| KRAS | 12, 13, or 61 | Nerve sheath | Metastasis | 1 | 16 | 0.040 | 0.019 | 0.001 | 0.180 |
| KRAS | 12, 13, or 61 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.007 | 0.002 | 0.000 | 0.043 |
| KRAS | 12, 13, or 61 | Nerve sheath | Primary | 0 | 117 | 0.004 | 0.001 | 0.000 | 0.020 |
| KRAS | 12, 13, or 61 | Penile | Metastasis | 1 | 11 | 0.092 | 0.076 | 0.010 | 0.257 |
| KRAS | 12, 13, or 61 | Penile | Primary | 1 | 13 | 0.087 | 0.074 | 0.010 | 0.240 |
| KRAS | 12, 13, or 61 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.033 |
| KRAS | 12, 13, or 61 | Pineal | Primary | 1 | 14 | 0.082 | 0.063 | 0.003 | 0.266 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Metastasis | 2 | 57 | 0.038 | 0.037 | 0.020 | 0.064 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Not Applicable or Heme | 7 | 145 | 0.040 | 0.039 | 0.025 | 0.065 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Primary | 25 | 709 | 0.037 | 0.037 | 0.026 | 0.050 |
| KRAS | 12, 13, or 61 | B cell lymphoma | Unspecified | 2 | 51 | 0.039 | 0.038 | 0.020 | 0.066 |
| KRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.047 |
| KRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.016 |
| KRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | 12, 13, or 61 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.019 |
| KRAS | 12, 13, or 61 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.011 |
| KRAS | 12, 13, or 61 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | 12, 13, or 61 | Lung | Primary | 1 | 17 | 0.066 | 0.051 | 0.003 | 0.216 |
| KRAS | 12, 13, or 61 | Parathyroid | Primary | 1 | 13 | 0.086 | 0.066 | 0.004 | 0.274 |
| KRAS | G12 | Appendiceal | Metastasis | 67 | 174 | 0.397 | 0.398 | 0.324 | 0.467 |
| KRAS | G12 | Appendiceal | Not Applicable or Heme | 2 | 10 | 0.356 | 0.381 | 0.110 | 0.517 |
| KRAS | G12 | Appendiceal | Primary | 75 | 151 | 0.473 | 0.471 | 0.396 | 0.556 |
| KRAS | G12 | CRC | Metastasis | 726 | 2354 | 0.306 | 0.306 | 0.290 | 0.323 |
| KRAS | G12 | CRC | Not Applicable or Heme | 69 | 224 | 0.304 | 0.303 | 0.270 | 0.342 |
| KRAS | G12 | CRC | Primary | 1216 | 4115 | 0.297 | 0.297 | 0.284 | 0.310 |
| KRAS | G12 | CRC | Unspecified | 9 | 31 | 0.302 | 0.301 | 0.253 | 0.353 |
| KRAS | G12 | CUP | Metastasis | 219 | 1389 | 0.158 | 0.157 | 0.139 | 0.177 |
| KRAS | G12 | CUP | Not Applicable or Heme | 53 | 229 | 0.216 | 0.215 | 0.162 | 0.274 |
| KRAS | G12 | CUP | Primary | 32 | 311 | 0.114 | 0.113 | 0.080 | 0.153 |
| KRAS | G12 | CUP | Unspecified | 9 | 60 | 0.154 | 0.152 | 0.090 | 0.231 |
| KRAS | G12 | NSCLC | Metastasis | 815 | 3750 | 0.217 | 0.217 | 0.204 | 0.231 |
| KRAS | G12 | NSCLC | Not Applicable or Heme | 43 | 223 | 0.200 | 0.200 | 0.153 | 0.247 |
| KRAS | G12 | NSCLC | Primary | 1663 | 6059 | 0.274 | 0.274 | 0.262 | 0.285 |
| KRAS | G12 | NSCLC | Unspecified | 14 | 99 | 0.174 | 0.174 | 0.105 | 0.242 |
| KRAS | G12 | Breast | Metastasis | 34 | 3094 | 0.011 | 0.011 | 0.007 | 0.015 |
| KRAS | G12 | Breast | Not Applicable or Heme | 3 | 105 | 0.020 | 0.016 | 0.005 | 0.054 |
| KRAS | G12 | Breast | Primary | 27 | 6125 | 0.005 | 0.005 | 0.003 | 0.007 |
| KRAS | G12 | Soft tissue sarcoma | Metastasis | 7 | 939 | 0.008 | 0.008 | 0.004 | 0.013 |
| KRAS | G12 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.009 | 0.008 | 0.003 | 0.016 |
| KRAS | G12 | Soft tissue sarcoma | Primary | 15 | 1686 | 0.009 | 0.008 | 0.005 | 0.013 |
| KRAS | G12 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.009 | 0.008 | 0.003 | 0.017 |
| KRAS | G12 | Pancreatic | Metastasis | 643 | 981 | 0.662 | 0.663 | 0.633 | 0.689 |
| KRAS | G12 | Pancreatic | Not Applicable or Heme | 53 | 75 | 0.681 | 0.679 | 0.625 | 0.750 |
| KRAS | G12 | Pancreatic | Primary | 979 | 1429 | 0.682 | 0.682 | 0.659 | 0.705 |
| KRAS | G12 | Leukemia | Metastasis | 2 | 15 | 0.040 | 0.031 | 0.017 | 0.135 |
| KRAS | G12 | Leukemia | Not Applicable or Heme | 25 | 923 | 0.028 | 0.028 | 0.019 | 0.038 |
| KRAS | G12 | Leukemia | Primary | 14 | 412 | 0.031 | 0.030 | 0.020 | 0.047 |
| KRAS | G12 | Leukemia | Unspecified | 3 | 217 | 0.024 | 0.025 | 0.009 | 0.038 |
| KRAS | G12 | Melanoma | Metastasis | 13 | 1738 | 0.008 | 0.008 | 0.005 | 0.012 |
| KRAS | G12 | Melanoma | Not Applicable or Heme | 0 | 188 | 0.007 | 0.007 | 0.000 | 0.013 |
| KRAS | G12 | Melanoma | Primary | 10 | 898 | 0.009 | 0.009 | 0.005 | 0.016 |
| KRAS | G12 | Melanoma | Unspecified | 0 | 22 | 0.008 | 0.008 | 0.000 | 0.021 |
| KRAS | G12 | Head and neck | Metastasis | 3 | 731 | 0.005 | 0.005 | 0.002 | 0.010 |
| KRAS | G12 | Head and neck | Not Applicable or Heme | 2 | 67 | 0.012 | 0.007 | 0.003 | 0.049 |
| KRAS | G12 | Head and neck | Primary | 4 | 938 | 0.005 | 0.005 | 0.002 | 0.009 |
| KRAS | G12 | Uterine | Metastasis | 64 | 586 | 0.118 | 0.118 | 0.094 | 0.139 |
| KRAS | G12 | Uterine | Not Applicable or Heme | 11 | 76 | 0.130 | 0.127 | 0.097 | 0.183 |
| KRAS | G12 | Uterine | Primary | 194 | 1541 | 0.125 | 0.125 | 0.111 | 0.141 |
| KRAS | G12 | Uterine | Unspecified | 10 | 51 | 0.138 | 0.130 | 0.103 | 0.218 |
| KRAS | G12 | Non-melanoma skin | Metastasis | 1 | 203 | 0.005 | 0.004 | 0.000 | 0.016 |
| KRAS | G12 | Non-melanoma skin | Not Applicable or Heme | 1 | 22 | 0.021 | 0.008 | 0.001 | 0.113 |
| KRAS | G12 | Non-melanoma skin | Primary | 0 | 287 | 0.003 | 0.002 | 0.000 | 0.010 |
| KRAS | G12 | MDS/MPN | Metastasis | 0 | 11 | 0.010 | 0.009 | 0.001 | 0.031 |
| KRAS | G12 | MDS/MPN | Not Applicable or Heme | 7 | 915 | 0.009 | 0.009 | 0.004 | 0.015 |
| KRAS | G12 | MDS/MPN | Primary | 4 | 250 | 0.011 | 0.010 | 0.005 | 0.025 |
| KRAS | G12 | MDS/MPN | Unspecified | 0 | 31 | 0.010 | 0.009 | 0.001 | 0.025 |
| KRAS | G12 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12 | Ovarian | Metastasis | 82 | 1088 | 0.079 | 0.079 | 0.063 | 0.094 |
| KRAS | G12 | Ovarian | Not Applicable or Heme | 9 | 160 | 0.075 | 0.077 | 0.042 | 0.103 |
| KRAS | G12 | Ovarian | Primary | 107 | 1060 | 0.096 | 0.096 | 0.080 | 0.115 |
| KRAS | G12 | Ovarian | Unspecified | 4 | 28 | 0.095 | 0.089 | 0.057 | 0.172 |
| KRAS | G12 | Esophagogastric | Metastasis | 17 | 462 | 0.037 | 0.037 | 0.026 | 0.051 |
| KRAS | G12 | Esophagogastric | Not Applicable or Heme | 2 | 43 | 0.038 | 0.037 | 0.022 | 0.065 |
| KRAS | G12 | Esophagogastric | Primary | 46 | 1283 | 0.036 | 0.036 | 0.028 | 0.046 |
| KRAS | G12 | Esophagogastric | Unspecified | 1 | 14 | 0.040 | 0.037 | 0.022 | 0.074 |
| KRAS | G12 | Thyroid | Metastasis | 7 | 402 | 0.014 | 0.013 | 0.006 | 0.026 |
| KRAS | G12 | Thyroid | Not Applicable or Heme | 0 | 28 | 0.012 | 0.011 | 0.000 | 0.031 |
| KRAS | G12 | Thyroid | Primary | 5 | 582 | 0.011 | 0.010 | 0.004 | 0.019 |
| KRAS | G12 | Cervical | Metastasis | 12 | 136 | 0.077 | 0.074 | 0.046 | 0.121 |
| KRAS | G12 | Cervical | Not Applicable or Heme | 1 | 12 | 0.075 | 0.070 | 0.027 | 0.158 |
| KRAS | G12 | Cervical | Primary | 12 | 211 | 0.065 | 0.065 | 0.038 | 0.097 |
| KRAS | G12 | Hepatobiliary | Metastasis | 43 | 438 | 0.092 | 0.091 | 0.071 | 0.121 |
| KRAS | G12 | Hepatobiliary | Not Applicable or Heme | 5 | 34 | 0.101 | 0.091 | 0.061 | 0.193 |
| KRAS | G12 | Hepatobiliary | Primary | 65 | 895 | 0.077 | 0.077 | 0.061 | 0.095 |
| KRAS | G12 | Kidney | Metastasis | 5 | 445 | 0.009 | 0.008 | 0.004 | 0.018 |
| KRAS | G12 | Kidney | Not Applicable or Heme | 0 | 24 | 0.008 | 0.007 | 0.000 | 0.024 |
| KRAS | G12 | Kidney | Primary | 6 | 944 | 0.007 | 0.007 | 0.003 | 0.013 |
| KRAS | G12 | T / NK neoplasms | Metastasis | 0 | 10 | 0.007 | 0.003 | 0.000 | 0.036 |
| KRAS | G12 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.006 | 0.003 | 0.000 | 0.025 |
| KRAS | G12 | T / NK neoplasms | Primary | 1 | 187 | 0.005 | 0.004 | 0.000 | 0.018 |
| KRAS | G12 | CNS | Metastasis | 3 | 409 | 0.006 | 0.005 | 0.003 | 0.011 |
| KRAS | G12 | CNS | Not Applicable or Heme | 1 | 526 | 0.005 | 0.005 | 0.001 | 0.008 |
| KRAS | G12 | CNS | Primary | 19 | 3522 | 0.005 | 0.005 | 0.003 | 0.008 |
| KRAS | G12 | CNS | Unspecified | 1 | 108 | 0.006 | 0.005 | 0.002 | 0.014 |
| KRAS | G12 | Prostate | Metastasis | 1 | 901 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G12 | Prostate | Not Applicable or Heme | 0 | 57 | 0.003 | 0.003 | 0.000 | 0.010 |
| KRAS | G12 | Prostate | Primary | 6 | 1468 | 0.003 | 0.003 | 0.001 | 0.007 |
| KRAS | G12 | Prostate | Unspecified | 0 | 12 | 0.004 | 0.003 | 0.000 | 0.015 |
| KRAS | G12 | Anal | Metastasis | 1 | 59 | 0.016 | 0.013 | 0.002 | 0.049 |
| KRAS | G12 | Anal | Primary | 1 | 84 | 0.015 | 0.012 | 0.001 | 0.042 |
| KRAS | G12 | Neuroendocrine | Metastasis | 8 | 143 | 0.065 | 0.064 | 0.036 | 0.098 |
| KRAS | G12 | Neuroendocrine | Not Applicable or Heme | 3 | 20 | 0.083 | 0.073 | 0.040 | 0.198 |
| KRAS | G12 | Neuroendocrine | Primary | 13 | 196 | 0.068 | 0.067 | 0.041 | 0.100 |
| KRAS | G12 | Bladder | Metastasis | 15 | 390 | 0.040 | 0.040 | 0.026 | 0.056 |
| KRAS | G12 | Bladder | Not Applicable or Heme | 0 | 25 | 0.037 | 0.039 | 0.001 | 0.064 |
| KRAS | G12 | Bladder | Primary | 52 | 1164 | 0.043 | 0.043 | 0.033 | 0.055 |
| KRAS | G12 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.039 | 0.037 | 0.004 | 0.083 |
| KRAS | G12 | BLL/Lymphoma | Not Applicable or Heme | 6 | 109 | 0.045 | 0.042 | 0.020 | 0.082 |
| KRAS | G12 | BLL/Lymphoma | Primary | 3 | 101 | 0.038 | 0.037 | 0.013 | 0.070 |
| KRAS | G12 | BLL/Lymphoma | Unspecified | 1 | 25 | 0.041 | 0.038 | 0.011 | 0.087 |
| KRAS | G12 | Small bowel | Metastasis | 29 | 78 | 0.347 | 0.344 | 0.264 | 0.447 |
| KRAS | G12 | Small bowel | Primary | 38 | 128 | 0.312 | 0.312 | 0.238 | 0.387 |
| KRAS | G12 | Sex cord stromal | Metastasis | 1 | 49 | 0.022 | 0.018 | 0.002 | 0.064 |
| KRAS | G12 | Sex cord stromal | Primary | 1 | 54 | 0.021 | 0.017 | 0.002 | 0.061 |
| KRAS | G12 | Bone | Metastasis | 1 | 203 | 0.008 | 0.007 | 0.001 | 0.018 |
| KRAS | G12 | Bone | Not Applicable or Heme | 0 | 25 | 0.009 | 0.008 | 0.000 | 0.026 |
| KRAS | G12 | Bone | Primary | 4 | 326 | 0.010 | 0.009 | 0.003 | 0.021 |
| KRAS | G12 | Bone | Unspecified | 0 | 16 | 0.009 | 0.008 | 0.000 | 0.029 |
| KRAS | G12 | Vaginal | Metastasis | 1 | 16 | 0.050 | 0.040 | 0.007 | 0.152 |
| KRAS | G12 | Vaginal | Primary | 2 | 60 | 0.040 | 0.035 | 0.008 | 0.094 |
| KRAS | G12 | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12 | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12 | Ampullary | Metastasis | 15 | 23 | 0.576 | 0.570 | 0.395 | 0.784 |
| KRAS | G12 | Ampullary | Primary | 34 | 82 | 0.436 | 0.436 | 0.329 | 0.543 |
| KRAS | G12 | SCLC | Metastasis | 7 | 207 | 0.031 | 0.029 | 0.015 | 0.054 |
| KRAS | G12 | SCLC | Primary | 4 | 183 | 0.027 | 0.026 | 0.010 | 0.048 |
| KRAS | G12 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12 | Germ cell | Metastasis | 18 | 274 | 0.063 | 0.062 | 0.039 | 0.094 |
| KRAS | G12 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.018 | 0.010 | 0.000 | 0.065 |
| KRAS | G12 | Germ cell | Primary | 33 | 517 | 0.062 | 0.061 | 0.044 | 0.084 |
| KRAS | G12 | Germ cell | Unspecified | 0 | 14 | 0.029 | 0.021 | 0.000 | 0.094 |
| KRAS | G12 | Nerve sheath | Metastasis | 1 | 16 | 0.039 | 0.019 | 0.001 | 0.182 |
| KRAS | G12 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.007 | 0.002 | 0.000 | 0.046 |
| KRAS | G12 | Nerve sheath | Primary | 0 | 117 | 0.004 | 0.001 | 0.000 | 0.021 |
| KRAS | G12 | Penile | Metastasis | 1 | 11 | 0.066 | 0.046 | 0.002 | 0.243 |
| KRAS | G12 | Penile | Primary | 0 | 13 | 0.033 | 0.019 | 0.000 | 0.142 |
| KRAS | G12 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.032 |
| KRAS | G12 | Pineal | Primary | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G12 | B cell lymphoma | Metastasis | 0 | 57 | 0.014 | 0.013 | 0.002 | 0.029 |
| KRAS | G12 | B cell lymphoma | Not Applicable or Heme | 4 | 145 | 0.018 | 0.016 | 0.008 | 0.039 |
| KRAS | G12 | B cell lymphoma | Primary | 9 | 709 | 0.014 | 0.014 | 0.007 | 0.023 |
| KRAS | G12 | B cell lymphoma | Unspecified | 1 | 51 | 0.016 | 0.015 | 0.005 | 0.038 |
| KRAS | G12 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.049 |
| KRAS | G12 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | G12 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G12 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| KRAS | G12 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | G12 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | G12 | Lung | Primary | 1 | 17 | 0.065 | 0.049 | 0.003 | 0.217 |
| KRAS | G12 | Parathyroid | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.041 |
| KRAS | G12C | Appendiceal | Metastasis | 6 | 174 | 0.029 | 0.028 | 0.013 | 0.055 |
| KRAS | G12C | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.027 | 0.024 | 0.001 | 0.071 |
| KRAS | G12C | Appendiceal | Primary | 3 | 151 | 0.025 | 0.024 | 0.009 | 0.048 |
| KRAS | G12C | CRC | Metastasis | 108 | 2354 | 0.045 | 0.045 | 0.037 | 0.054 |
| KRAS | G12C | CRC | Not Applicable or Heme | 9 | 224 | 0.037 | 0.036 | 0.020 | 0.062 |
| KRAS | G12C | CRC | Primary | 95 | 4115 | 0.024 | 0.024 | 0.019 | 0.029 |
| KRAS | G12C | CRC | Unspecified | 0 | 31 | 0.028 | 0.027 | 0.003 | 0.062 |
| KRAS | G12C | CUP | Metastasis | 47 | 1389 | 0.032 | 0.032 | 0.024 | 0.041 |
| KRAS | G12C | CUP | Not Applicable or Heme | 5 | 229 | 0.028 | 0.028 | 0.014 | 0.041 |
| KRAS | G12C | CUP | Primary | 6 | 311 | 0.027 | 0.027 | 0.013 | 0.039 |
| KRAS | G12C | CUP | Unspecified | 3 | 60 | 0.033 | 0.031 | 0.017 | 0.063 |
| KRAS | G12C | NSCLC | Metastasis | 407 | 3750 | 0.109 | 0.109 | 0.100 | 0.119 |
| KRAS | G12C | NSCLC | Not Applicable or Heme | 19 | 223 | 0.101 | 0.102 | 0.067 | 0.129 |
| KRAS | G12C | NSCLC | Primary | 779 | 6059 | 0.127 | 0.127 | 0.119 | 0.136 |
| KRAS | G12C | NSCLC | Unspecified | 8 | 99 | 0.103 | 0.105 | 0.061 | 0.138 |
| KRAS | G12C | Breast | Metastasis | 6 | 3094 | 0.002 | 0.001 | 0.001 | 0.003 |
| KRAS | G12C | Breast | Not Applicable or Heme | 0 | 105 | 0.001 | 0.001 | 0.000 | 0.007 |
| KRAS | G12C | Breast | Primary | 2 | 6125 | 0.001 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Soft tissue sarcoma | Metastasis | 0 | 939 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | G12C | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.004 | 0.002 | 0.000 | 0.018 |
| KRAS | G12C | Soft tissue sarcoma | Primary | 4 | 1686 | 0.002 | 0.002 | 0.001 | 0.005 |
| KRAS | G12C | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.003 | 0.002 | 0.000 | 0.013 |
| KRAS | G12C | Pancreatic | Metastasis | 7 | 981 | 0.008 | 0.008 | 0.004 | 0.013 |
| KRAS | G12C | Pancreatic | Not Applicable or Heme | 1 | 75 | 0.010 | 0.009 | 0.003 | 0.022 |
| KRAS | G12C | Pancreatic | Primary | 14 | 1429 | 0.009 | 0.009 | 0.006 | 0.014 |
| KRAS | G12C | Leukemia | Metastasis | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | Not Applicable or Heme | 0 | 923 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | Primary | 0 | 412 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Leukemia | Unspecified | 0 | 217 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Melanoma | Metastasis | 1 | 1738 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G12C | Melanoma | Not Applicable or Heme | 0 | 188 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | Melanoma | Primary | 1 | 898 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | Melanoma | Unspecified | 0 | 22 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | Head and neck | Metastasis | 1 | 731 | 0.001 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | Head and neck | Not Applicable or Heme | 1 | 67 | 0.008 | 0.003 | 0.000 | 0.041 |
| KRAS | G12C | Head and neck | Primary | 0 | 938 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Uterine | Metastasis | 5 | 586 | 0.010 | 0.010 | 0.004 | 0.017 |
| KRAS | G12C | Uterine | Not Applicable or Heme | 0 | 76 | 0.009 | 0.010 | 0.000 | 0.019 |
| KRAS | G12C | Uterine | Primary | 21 | 1541 | 0.012 | 0.012 | 0.008 | 0.018 |
| KRAS | G12C | Uterine | Unspecified | 0 | 51 | 0.010 | 0.010 | 0.000 | 0.021 |
| KRAS | G12C | Non-melanoma skin | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Non-melanoma skin | Primary | 0 | 287 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | MDS/MPN | Metastasis | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | Not Applicable or Heme | 0 | 915 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | Primary | 0 | 250 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | MDS/MPN | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Ovarian | Metastasis | 5 | 1088 | 0.005 | 0.004 | 0.002 | 0.008 |
| KRAS | G12C | Ovarian | Not Applicable or Heme | 1 | 160 | 0.005 | 0.004 | 0.002 | 0.013 |
| KRAS | G12C | Ovarian | Primary | 3 | 1060 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | G12C | Ovarian | Unspecified | 1 | 28 | 0.007 | 0.005 | 0.002 | 0.033 |
| KRAS | G12C | Esophagogastric | Metastasis | 0 | 462 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | G12C | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.002 | 0.002 | 0.000 | 0.011 |
| KRAS | G12C | Esophagogastric | Primary | 5 | 1283 | 0.003 | 0.003 | 0.001 | 0.007 |
| KRAS | G12C | Esophagogastric | Unspecified | 0 | 14 | 0.004 | 0.002 | 0.000 | 0.021 |
| KRAS | G12C | Thyroid | Metastasis | 1 | 402 | 0.002 | 0.002 | 0.000 | 0.007 |
| KRAS | G12C | Thyroid | Not Applicable or Heme | 0 | 28 | 0.003 | 0.002 | 0.000 | 0.012 |
| KRAS | G12C | Thyroid | Primary | 1 | 582 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | G12C | Cervical | Metastasis | 1 | 136 | 0.005 | 0.003 | 0.000 | 0.020 |
| KRAS | G12C | Cervical | Not Applicable or Heme | 0 | 12 | 0.005 | 0.002 | 0.000 | 0.032 |
| KRAS | G12C | Cervical | Primary | 0 | 211 | 0.002 | 0.001 | 0.000 | 0.010 |
| KRAS | G12C | Hepatobiliary | Metastasis | 6 | 438 | 0.010 | 0.009 | 0.004 | 0.022 |
| KRAS | G12C | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.008 | 0.007 | 0.000 | 0.024 |
| KRAS | G12C | Hepatobiliary | Primary | 4 | 895 | 0.006 | 0.006 | 0.002 | 0.012 |
| KRAS | G12C | Kidney | Metastasis | 0 | 445 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Kidney | Not Applicable or Heme | 0 | 24 | 0.002 | 0.001 | 0.000 | 0.010 |
| KRAS | G12C | Kidney | Primary | 1 | 944 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | G12C | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | CNS | Metastasis | 0 | 409 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | Not Applicable or Heme | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | Primary | 0 | 3522 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | CNS | Unspecified | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | Metastasis | 0 | 901 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | Not Applicable or Heme | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | Primary | 0 | 1468 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Prostate | Unspecified | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G12C | Neuroendocrine | Metastasis | 1 | 143 | 0.007 | 0.005 | 0.001 | 0.019 |
| KRAS | G12C | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.007 | 0.005 | 0.000 | 0.026 |
| KRAS | G12C | Neuroendocrine | Primary | 1 | 196 | 0.006 | 0.005 | 0.001 | 0.017 |
| KRAS | G12C | Bladder | Metastasis | 4 | 390 | 0.007 | 0.006 | 0.002 | 0.017 |
| KRAS | G12C | Bladder | Not Applicable or Heme | 0 | 25 | 0.006 | 0.005 | 0.000 | 0.023 |
| KRAS | G12C | Bladder | Primary | 4 | 1164 | 0.005 | 0.004 | 0.002 | 0.009 |
| KRAS | G12C | BLL/Lymphoma | Metastasis | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | BLL/Lymphoma | Not Applicable or Heme | 0 | 109 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | BLL/Lymphoma | Primary | 0 | 101 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | BLL/Lymphoma | Unspecified | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Small bowel | Metastasis | 3 | 78 | 0.040 | 0.038 | 0.014 | 0.079 |
| KRAS | G12C | Small bowel | Primary | 5 | 128 | 0.040 | 0.038 | 0.016 | 0.073 |
| KRAS | G12C | Sex cord stromal | Metastasis | 0 | 49 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Sex cord stromal | Primary | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Vaginal | Metastasis | 0 | 16 | 0.014 | 0.008 | 0.000 | 0.062 |
| KRAS | G12C | Vaginal | Primary | 1 | 60 | 0.017 | 0.012 | 0.001 | 0.056 |
| KRAS | G12C | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Ampullary | Metastasis | 1 | 23 | 0.042 | 0.037 | 0.007 | 0.112 |
| KRAS | G12C | Ampullary | Primary | 3 | 82 | 0.039 | 0.036 | 0.010 | 0.085 |
| KRAS | G12C | SCLC | Metastasis | 2 | 207 | 0.009 | 0.008 | 0.002 | 0.022 |
| KRAS | G12C | SCLC | Primary | 1 | 183 | 0.008 | 0.007 | 0.001 | 0.020 |
| KRAS | G12C | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G12C | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G12C | Germ cell | Metastasis | 3 | 274 | 0.007 | 0.006 | 0.002 | 0.019 |
| KRAS | G12C | Germ cell | Not Applicable or Heme | 0 | 81 | 0.004 | 0.004 | 0.000 | 0.013 |
| KRAS | G12C | Germ cell | Primary | 1 | 517 | 0.004 | 0.003 | 0.000 | 0.010 |
| KRAS | G12C | Germ cell | Unspecified | 0 | 14 | 0.006 | 0.004 | 0.000 | 0.025 |
| KRAS | G12C | Nerve sheath | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G12C | Nerve sheath | Primary | 0 | 117 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G12C | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| KRAS | G12C | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.033 |
| KRAS | G12C | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.032 |
| KRAS | G12C | Pineal | Primary | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G12C | B cell lymphoma | Metastasis | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | Primary | 0 | 709 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | B cell lymphoma | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G12C | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.049 |
| KRAS | G12C | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | G12C | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G12C | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| KRAS | G12C | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | G12C | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | G12C | Lung | Primary | 1 | 17 | 0.065 | 0.049 | 0.003 | 0.217 |
| KRAS | G12C | Parathyroid | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.041 |
| KRAS | G13 | Appendiceal | Metastasis | 6 | 174 | 0.040 | 0.040 | 0.019 | 0.067 |
| KRAS | G13 | Appendiceal | Not Applicable or Heme | 1 | 10 | 0.051 | 0.044 | 0.018 | 0.144 |
| KRAS | G13 | Appendiceal | Primary | 7 | 151 | 0.044 | 0.043 | 0.023 | 0.074 |
| KRAS | G13 | CRC | Metastasis | 181 | 2354 | 0.078 | 0.078 | 0.069 | 0.087 |
| KRAS | G13 | CRC | Not Applicable or Heme | 19 | 224 | 0.080 | 0.079 | 0.064 | 0.100 |
| KRAS | G13 | CRC | Primary | 328 | 4115 | 0.079 | 0.079 | 0.072 | 0.087 |
| KRAS | G13 | CRC | Unspecified | 2 | 31 | 0.079 | 0.079 | 0.057 | 0.103 |
| KRAS | G13 | CUP | Metastasis | 30 | 1389 | 0.021 | 0.021 | 0.014 | 0.029 |
| KRAS | G13 | CUP | Not Applicable or Heme | 0 | 229 | 0.010 | 0.010 | 0.000 | 0.025 |
| KRAS | G13 | CUP | Primary | 7 | 311 | 0.021 | 0.020 | 0.010 | 0.037 |
| KRAS | G13 | CUP | Unspecified | 2 | 60 | 0.024 | 0.020 | 0.006 | 0.065 |
| KRAS | G13 | NSCLC | Metastasis | 89 | 3750 | 0.022 | 0.022 | 0.018 | 0.027 |
| KRAS | G13 | NSCLC | Not Applicable or Heme | 4 | 223 | 0.020 | 0.020 | 0.010 | 0.030 |
| KRAS | G13 | NSCLC | Primary | 116 | 6059 | 0.020 | 0.020 | 0.016 | 0.023 |
| KRAS | G13 | NSCLC | Unspecified | 0 | 99 | 0.018 | 0.019 | 0.003 | 0.028 |
| KRAS | G13 | Breast | Metastasis | 2 | 3094 | 0.001 | 0.001 | 0.000 | 0.002 |
| KRAS | G13 | Breast | Not Applicable or Heme | 1 | 105 | 0.003 | 0.001 | 0.000 | 0.018 |
| KRAS | G13 | Breast | Primary | 2 | 6125 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Soft tissue sarcoma | Metastasis | 0 | 939 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Soft tissue sarcoma | Not Applicable or Heme | 0 | 119 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | Soft tissue sarcoma | Primary | 1 | 1686 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Pancreatic | Metastasis | 4 | 981 | 0.006 | 0.006 | 0.002 | 0.010 |
| KRAS | G13 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.006 | 0.006 | 0.000 | 0.016 |
| KRAS | G13 | Pancreatic | Primary | 14 | 1429 | 0.009 | 0.008 | 0.005 | 0.014 |
| KRAS | G13 | Leukemia | Metastasis | 2 | 15 | 0.033 | 0.020 | 0.010 | 0.149 |
| KRAS | G13 | Leukemia | Not Applicable or Heme | 14 | 923 | 0.016 | 0.016 | 0.010 | 0.024 |
| KRAS | G13 | Leukemia | Primary | 5 | 412 | 0.016 | 0.015 | 0.007 | 0.025 |
| KRAS | G13 | Leukemia | Unspecified | 5 | 217 | 0.019 | 0.018 | 0.010 | 0.037 |
| KRAS | G13 | Melanoma | Metastasis | 5 | 1738 | 0.003 | 0.002 | 0.001 | 0.005 |
| KRAS | G13 | Melanoma | Not Applicable or Heme | 0 | 188 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | G13 | Melanoma | Primary | 2 | 898 | 0.002 | 0.002 | 0.001 | 0.005 |
| KRAS | G13 | Melanoma | Unspecified | 0 | 22 | 0.003 | 0.002 | 0.000 | 0.009 |
| KRAS | G13 | Head and neck | Metastasis | 0 | 731 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | G13 | Head and neck | Not Applicable or Heme | 1 | 67 | 0.007 | 0.003 | 0.000 | 0.038 |
| KRAS | G13 | Head and neck | Primary | 2 | 938 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | G13 | Uterine | Metastasis | 10 | 586 | 0.021 | 0.021 | 0.011 | 0.030 |
| KRAS | G13 | Uterine | Not Applicable or Heme | 2 | 76 | 0.023 | 0.022 | 0.009 | 0.042 |
| KRAS | G13 | Uterine | Primary | 40 | 1541 | 0.024 | 0.024 | 0.018 | 0.032 |
| KRAS | G13 | Uterine | Unspecified | 0 | 51 | 0.020 | 0.021 | 0.002 | 0.035 |
| KRAS | G13 | Non-melanoma skin | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Non-melanoma skin | Primary | 0 | 287 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | MDS/MPN | Metastasis | 1 | 11 | 0.025 | 0.009 | 0.002 | 0.155 |
| KRAS | G13 | MDS/MPN | Not Applicable or Heme | 3 | 915 | 0.005 | 0.005 | 0.001 | 0.010 |
| KRAS | G13 | MDS/MPN | Primary | 3 | 250 | 0.009 | 0.008 | 0.003 | 0.024 |
| KRAS | G13 | MDS/MPN | Unspecified | 0 | 31 | 0.008 | 0.006 | 0.000 | 0.031 |
| KRAS | G13 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Ovarian | Metastasis | 3 | 1088 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | G13 | Ovarian | Not Applicable or Heme | 3 | 160 | 0.009 | 0.007 | 0.003 | 0.029 |
| KRAS | G13 | Ovarian | Primary | 5 | 1060 | 0.005 | 0.005 | 0.002 | 0.009 |
| KRAS | G13 | Ovarian | Unspecified | 0 | 28 | 0.006 | 0.005 | 0.000 | 0.021 |
| KRAS | G13 | Esophagogastric | Metastasis | 6 | 462 | 0.013 | 0.012 | 0.007 | 0.021 |
| KRAS | G13 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.012 | 0.012 | 0.002 | 0.023 |
| KRAS | G13 | Esophagogastric | Primary | 17 | 1283 | 0.013 | 0.013 | 0.008 | 0.019 |
| KRAS | G13 | Esophagogastric | Unspecified | 0 | 14 | 0.013 | 0.012 | 0.003 | 0.028 |
| KRAS | G13 | Thyroid | Metastasis | 0 | 402 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Thyroid | Primary | 0 | 582 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Cervical | Metastasis | 3 | 136 | 0.016 | 0.013 | 0.004 | 0.041 |
| KRAS | G13 | Cervical | Not Applicable or Heme | 0 | 12 | 0.013 | 0.010 | 0.000 | 0.049 |
| KRAS | G13 | Cervical | Primary | 1 | 211 | 0.009 | 0.008 | 0.001 | 0.023 |
| KRAS | G13 | Hepatobiliary | Metastasis | 3 | 438 | 0.007 | 0.006 | 0.003 | 0.013 |
| KRAS | G13 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.007 | 0.006 | 0.000 | 0.018 |
| KRAS | G13 | Hepatobiliary | Primary | 6 | 895 | 0.007 | 0.006 | 0.003 | 0.012 |
| KRAS | G13 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G13 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | G13 | CNS | Metastasis | 0 | 409 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | Not Applicable or Heme | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | Primary | 1 | 3522 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | CNS | Unspecified | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Prostate | Metastasis | 0 | 901 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Prostate | Not Applicable or Heme | 0 | 57 | 0.001 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Prostate | Primary | 1 | 1468 | 0.001 | 0.000 | 0.000 | 0.002 |
| KRAS | G13 | Prostate | Unspecified | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.007 |
| KRAS | G13 | Anal | Metastasis | 0 | 59 | 0.009 | 0.005 | 0.000 | 0.035 |
| KRAS | G13 | Anal | Primary | 2 | 84 | 0.020 | 0.016 | 0.003 | 0.057 |
| KRAS | G13 | Neuroendocrine | Metastasis | 1 | 143 | 0.013 | 0.012 | 0.001 | 0.032 |
| KRAS | G13 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.016 | 0.013 | 0.000 | 0.046 |
| KRAS | G13 | Neuroendocrine | Primary | 5 | 196 | 0.020 | 0.019 | 0.007 | 0.043 |
| KRAS | G13 | Bladder | Metastasis | 0 | 390 | 0.002 | 0.001 | 0.000 | 0.006 |
| KRAS | G13 | Bladder | Not Applicable or Heme | 1 | 25 | 0.017 | 0.005 | 0.001 | 0.097 |
| KRAS | G13 | Bladder | Primary | 3 | 1164 | 0.003 | 0.002 | 0.001 | 0.006 |
| KRAS | G13 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.030 | 0.028 | 0.000 | 0.069 |
| KRAS | G13 | BLL/Lymphoma | Not Applicable or Heme | 4 | 109 | 0.033 | 0.032 | 0.013 | 0.064 |
| KRAS | G13 | BLL/Lymphoma | Primary | 4 | 101 | 0.034 | 0.032 | 0.013 | 0.066 |
| KRAS | G13 | BLL/Lymphoma | Unspecified | 0 | 25 | 0.028 | 0.027 | 0.000 | 0.063 |
| KRAS | G13 | Small bowel | Metastasis | 1 | 78 | 0.027 | 0.021 | 0.001 | 0.078 |
| KRAS | G13 | Small bowel | Primary | 12 | 128 | 0.086 | 0.084 | 0.044 | 0.143 |
| KRAS | G13 | Sex cord stromal | Metastasis | 0 | 49 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | Sex cord stromal | Primary | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Vaginal | Metastasis | 0 | 16 | 0.014 | 0.008 | 0.000 | 0.063 |
| KRAS | G13 | Vaginal | Primary | 1 | 60 | 0.017 | 0.012 | 0.001 | 0.056 |
| KRAS | G13 | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Ampullary | Metastasis | 1 | 23 | 0.050 | 0.044 | 0.008 | 0.123 |
| KRAS | G13 | Ampullary | Primary | 4 | 82 | 0.049 | 0.046 | 0.016 | 0.100 |
| KRAS | G13 | SCLC | Metastasis | 0 | 207 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | SCLC | Primary | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | G13 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | G13 | Germ cell | Metastasis | 0 | 274 | 0.002 | 0.002 | 0.000 | 0.008 |
| KRAS | G13 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.003 | 0.002 | 0.000 | 0.011 |
| KRAS | G13 | Germ cell | Primary | 3 | 517 | 0.004 | 0.004 | 0.001 | 0.011 |
| KRAS | G13 | Germ cell | Unspecified | 0 | 14 | 0.004 | 0.002 | 0.000 | 0.020 |
| KRAS | G13 | Nerve sheath | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | G13 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | G13 | Nerve sheath | Primary | 0 | 117 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | G13 | Penile | Metastasis | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G13 | Penile | Primary | 0 | 13 | 0.002 | 0.000 | 0.000 | 0.025 |
| KRAS | G13 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.033 |
| KRAS | G13 | Pineal | Primary | 1 | 14 | 0.080 | 0.062 | 0.004 | 0.258 |
| KRAS | G13 | B cell lymphoma | Metastasis | 0 | 57 | 0.005 | 0.004 | 0.000 | 0.017 |
| KRAS | G13 | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.004 | 0.003 | 0.000 | 0.014 |
| KRAS | G13 | B cell lymphoma | Primary | 8 | 709 | 0.010 | 0.009 | 0.004 | 0.018 |
| KRAS | G13 | B cell lymphoma | Unspecified | 0 | 51 | 0.005 | 0.004 | 0.000 | 0.019 |
| KRAS | G13 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| KRAS | G13 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.019 |
| KRAS | G13 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | G13 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | G13 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.012 |
| KRAS | G13 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.016 |
| KRAS | G13 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.040 |
| KRAS | G13 | Parathyroid | Primary | 1 | 13 | 0.086 | 0.066 | 0.004 | 0.279 |
| KRAS | Q61 | Appendiceal | Metastasis | 5 | 174 | 0.026 | 0.024 | 0.008 | 0.055 |
| KRAS | Q61 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.009 | 0.001 | 0.000 | 0.065 |
| KRAS | Q61 | Appendiceal | Primary | 0 | 151 | 0.004 | 0.000 | 0.000 | 0.021 |
| KRAS | Q61 | CRC | Metastasis | 48 | 2354 | 0.019 | 0.019 | 0.015 | 0.025 |
| KRAS | Q61 | CRC | Not Applicable or Heme | 1 | 224 | 0.016 | 0.017 | 0.004 | 0.024 |
| KRAS | Q61 | CRC | Primary | 75 | 4115 | 0.018 | 0.018 | 0.015 | 0.022 |
| KRAS | Q61 | CRC | Unspecified | 1 | 31 | 0.020 | 0.019 | 0.008 | 0.042 |
| KRAS | Q61 | CUP | Metastasis | 16 | 1389 | 0.012 | 0.011 | 0.007 | 0.017 |
| KRAS | Q61 | CUP | Not Applicable or Heme | 3 | 229 | 0.012 | 0.012 | 0.006 | 0.021 |
| KRAS | Q61 | CUP | Primary | 4 | 311 | 0.012 | 0.012 | 0.006 | 0.020 |
| KRAS | Q61 | CUP | Unspecified | 0 | 60 | 0.011 | 0.011 | 0.003 | 0.020 |
| KRAS | Q61 | NSCLC | Metastasis | 70 | 3750 | 0.018 | 0.018 | 0.015 | 0.022 |
| KRAS | Q61 | NSCLC | Not Applicable or Heme | 5 | 223 | 0.018 | 0.018 | 0.012 | 0.028 |
| KRAS | Q61 | NSCLC | Primary | 104 | 6059 | 0.017 | 0.017 | 0.015 | 0.020 |
| KRAS | Q61 | NSCLC | Unspecified | 0 | 99 | 0.017 | 0.017 | 0.006 | 0.024 |
| KRAS | Q61 | Breast | Metastasis | 1 | 3094 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Breast | Not Applicable or Heme | 1 | 105 | 0.006 | 0.003 | 0.000 | 0.030 |
| KRAS | Q61 | Breast | Primary | 0 | 6125 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Soft tissue sarcoma | Metastasis | 1 | 939 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Soft tissue sarcoma | Not Applicable or Heme | 0 | 119 | 0.001 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Soft tissue sarcoma | Primary | 0 | 1686 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.001 | 0.000 | 0.000 | 0.006 |
| KRAS | Q61 | Pancreatic | Metastasis | 57 | 981 | 0.057 | 0.057 | 0.045 | 0.072 |
| KRAS | Q61 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.029 | 0.028 | 0.000 | 0.065 |
| KRAS | Q61 | Pancreatic | Primary | 81 | 1429 | 0.056 | 0.056 | 0.045 | 0.068 |
| KRAS | Q61 | Leukemia | Metastasis | 0 | 15 | 0.004 | 0.004 | 0.001 | 0.012 |
| KRAS | Q61 | Leukemia | Not Applicable or Heme | 4 | 923 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | Q61 | Leukemia | Primary | 1 | 412 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | Q61 | Leukemia | Unspecified | 1 | 217 | 0.004 | 0.004 | 0.001 | 0.010 |
| KRAS | Q61 | Melanoma | Metastasis | 3 | 1738 | 0.002 | 0.002 | 0.001 | 0.005 |
| KRAS | Q61 | Melanoma | Not Applicable or Heme | 0 | 188 | 0.003 | 0.002 | 0.000 | 0.007 |
| KRAS | Q61 | Melanoma | Primary | 5 | 898 | 0.004 | 0.004 | 0.001 | 0.009 |
| KRAS | Q61 | Melanoma | Unspecified | 0 | 22 | 0.004 | 0.003 | 0.000 | 0.015 |
| KRAS | Q61 | Head and neck | Metastasis | 0 | 731 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | Not Applicable or Heme | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Head and neck | Primary | 0 | 938 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Uterine | Metastasis | 5 | 586 | 0.006 | 0.005 | 0.002 | 0.014 |
| KRAS | Q61 | Uterine | Not Applicable or Heme | 0 | 76 | 0.004 | 0.004 | 0.000 | 0.012 |
| KRAS | Q61 | Uterine | Primary | 4 | 1541 | 0.003 | 0.003 | 0.001 | 0.007 |
| KRAS | Q61 | Uterine | Unspecified | 0 | 51 | 0.004 | 0.004 | 0.000 | 0.014 |
| KRAS | Q61 | Non-melanoma skin | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Non-melanoma skin | Primary | 0 | 287 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | MDS/MPN | Metastasis | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | Not Applicable or Heme | 0 | 915 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | Primary | 0 | 250 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | MDS/MPN | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| KRAS | Q61 | Ovarian | Metastasis | 6 | 1088 | 0.006 | 0.006 | 0.003 | 0.010 |
| KRAS | Q61 | Ovarian | Not Applicable or Heme | 1 | 160 | 0.006 | 0.006 | 0.002 | 0.013 |
| KRAS | Q61 | Ovarian | Primary | 5 | 1060 | 0.005 | 0.005 | 0.003 | 0.009 |
| KRAS | Q61 | Ovarian | Unspecified | 1 | 28 | 0.008 | 0.006 | 0.002 | 0.027 |
| KRAS | Q61 | Esophagogastric | Metastasis | 0 | 462 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | Q61 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.002 | 0.001 | 0.000 | 0.008 |
| KRAS | Q61 | Esophagogastric | Primary | 3 | 1283 | 0.002 | 0.002 | 0.000 | 0.005 |
| KRAS | Q61 | Esophagogastric | Unspecified | 0 | 14 | 0.003 | 0.001 | 0.000 | 0.014 |
| KRAS | Q61 | Thyroid | Metastasis | 3 | 402 | 0.011 | 0.010 | 0.003 | 0.022 |
| KRAS | Q61 | Thyroid | Not Applicable or Heme | 3 | 28 | 0.065 | 0.050 | 0.011 | 0.195 |
| KRAS | Q61 | Thyroid | Primary | 10 | 582 | 0.017 | 0.017 | 0.009 | 0.028 |
| KRAS | Q61 | Cervical | Metastasis | 0 | 136 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Cervical | Not Applicable or Heme | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Cervical | Primary | 0 | 211 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Hepatobiliary | Metastasis | 7 | 438 | 0.014 | 0.014 | 0.007 | 0.024 |
| KRAS | Q61 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.013 | 0.012 | 0.000 | 0.028 |
| KRAS | Q61 | Hepatobiliary | Primary | 11 | 895 | 0.013 | 0.013 | 0.007 | 0.020 |
| KRAS | Q61 | Kidney | Metastasis | 0 | 445 | 0.001 | 0.001 | 0.000 | 0.004 |
| KRAS | Q61 | Kidney | Not Applicable or Heme | 0 | 24 | 0.002 | 0.001 | 0.000 | 0.013 |
| KRAS | Q61 | Kidney | Primary | 2 | 944 | 0.002 | 0.001 | 0.000 | 0.005 |
| KRAS | Q61 | T / NK neoplasms | Metastasis | 0 | 10 | 0.010 | 0.006 | 0.000 | 0.048 |
| KRAS | Q61 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.008 | 0.006 | 0.000 | 0.033 |
| KRAS | Q61 | T / NK neoplasms | Primary | 2 | 187 | 0.010 | 0.009 | 0.001 | 0.028 |
| KRAS | Q61 | CNS | Metastasis | 1 | 409 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | Q61 | CNS | Not Applicable or Heme | 1 | 526 | 0.003 | 0.003 | 0.001 | 0.006 |
| KRAS | Q61 | CNS | Primary | 9 | 3522 | 0.003 | 0.003 | 0.001 | 0.004 |
| KRAS | Q61 | CNS | Unspecified | 1 | 108 | 0.003 | 0.003 | 0.001 | 0.010 |
| KRAS | Q61 | Prostate | Metastasis | 2 | 901 | 0.002 | 0.002 | 0.000 | 0.006 |
| KRAS | Q61 | Prostate | Not Applicable or Heme | 0 | 57 | 0.003 | 0.002 | 0.000 | 0.015 |
| KRAS | Q61 | Prostate | Primary | 1 | 1468 | 0.001 | 0.001 | 0.000 | 0.003 |
| KRAS | Q61 | Prostate | Unspecified | 1 | 12 | 0.025 | 0.004 | 0.001 | 0.172 |
| KRAS | Q61 | Anal | Metastasis | 1 | 59 | 0.013 | 0.009 | 0.000 | 0.050 |
| KRAS | Q61 | Anal | Primary | 0 | 84 | 0.005 | 0.002 | 0.000 | 0.024 |
| KRAS | Q61 | Neuroendocrine | Metastasis | 0 | 143 | 0.004 | 0.002 | 0.000 | 0.014 |
| KRAS | Q61 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.006 | 0.003 | 0.000 | 0.029 |
| KRAS | Q61 | Neuroendocrine | Primary | 2 | 196 | 0.008 | 0.007 | 0.001 | 0.024 |
| KRAS | Q61 | Bladder | Metastasis | 0 | 390 | 0.002 | 0.001 | 0.000 | 0.006 |
| KRAS | Q61 | Bladder | Not Applicable or Heme | 0 | 25 | 0.003 | 0.002 | 0.000 | 0.017 |
| KRAS | Q61 | Bladder | Primary | 5 | 1164 | 0.004 | 0.004 | 0.001 | 0.008 |
| KRAS | Q61 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.013 | 0.008 | 0.000 | 0.064 |
| KRAS | Q61 | BLL/Lymphoma | Not Applicable or Heme | 1 | 109 | 0.011 | 0.009 | 0.001 | 0.033 |
| KRAS | Q61 | BLL/Lymphoma | Primary | 0 | 101 | 0.007 | 0.005 | 0.000 | 0.026 |
| KRAS | Q61 | BLL/Lymphoma | Unspecified | 2 | 25 | 0.045 | 0.029 | 0.004 | 0.163 |
| KRAS | Q61 | Small bowel | Metastasis | 3 | 78 | 0.033 | 0.030 | 0.010 | 0.072 |
| KRAS | Q61 | Small bowel | Primary | 3 | 128 | 0.028 | 0.027 | 0.009 | 0.057 |
| KRAS | Q61 | Sex cord stromal | Metastasis | 0 | 49 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Sex cord stromal | Primary | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Bone | Metastasis | 1 | 203 | 0.003 | 0.002 | 0.000 | 0.012 |
| KRAS | Q61 | Bone | Not Applicable or Heme | 0 | 25 | 0.003 | 0.001 | 0.000 | 0.015 |
| KRAS | Q61 | Bone | Primary | 0 | 326 | 0.002 | 0.001 | 0.000 | 0.007 |
| KRAS | Q61 | Bone | Unspecified | 0 | 16 | 0.003 | 0.001 | 0.000 | 0.019 |
| KRAS | Q61 | Vaginal | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.010 |
| KRAS | Q61 | Vaginal | Primary | 0 | 60 | 0.001 | 0.000 | 0.000 | 0.007 |
| KRAS | Q61 | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Ampullary | Metastasis | 0 | 23 | 0.026 | 0.019 | 0.000 | 0.094 |
| KRAS | Q61 | Ampullary | Primary | 5 | 82 | 0.056 | 0.052 | 0.019 | 0.113 |
| KRAS | Q61 | SCLC | Metastasis | 0 | 207 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | SCLC | Primary | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| KRAS | Q61 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| KRAS | Q61 | Germ cell | Metastasis | 0 | 274 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | Primary | 0 | 517 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Germ cell | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.000 |
| KRAS | Q61 | Nerve sheath | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.005 |
| KRAS | Q61 | Nerve sheath | Primary | 0 | 117 | 0.000 | 0.000 | 0.000 | 0.003 |
| KRAS | Q61 | Penile | Metastasis | 0 | 11 | 0.036 | 0.021 | 0.000 | 0.152 |
| KRAS | Q61 | Penile | Primary | 1 | 13 | 0.058 | 0.042 | 0.002 | 0.208 |
| KRAS | Q61 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.032 |
| KRAS | Q61 | Pineal | Primary | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | Q61 | B cell lymphoma | Metastasis | 2 | 57 | 0.019 | 0.016 | 0.007 | 0.048 |
| KRAS | Q61 | B cell lymphoma | Not Applicable or Heme | 3 | 145 | 0.017 | 0.016 | 0.007 | 0.034 |
| KRAS | Q61 | B cell lymphoma | Primary | 8 | 709 | 0.014 | 0.014 | 0.007 | 0.023 |
| KRAS | Q61 | B cell lymphoma | Unspecified | 1 | 51 | 0.017 | 0.015 | 0.006 | 0.040 |
| KRAS | Q61 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.049 |
| KRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| KRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| KRAS | Q61 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| KRAS | Q61 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | Q61 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.015 |
| KRAS | Q61 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.034 |
| KRAS | Q61 | Parathyroid | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.041 |
| HRAS | 12, 13, or 61 | Appendiceal | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Appendiceal | 40-50 | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Appendiceal | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Appendiceal | >65 | 0 | 90 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | CRC | <40 | 0 | 565 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | CRC | 40-50 | 0 | 1280 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | CRC | 50-65 | 1 | 2814 | 0.001 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | CRC | >65 | 4 | 2052 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | CUP | <40 | 1 | 166 | 0.006 | 0.005 | 0.002 | 0.012 |
| HRAS | 12, 13, or 61 | CUP | 40-50 | 2 | 211 | 0.006 | 0.005 | 0.002 | 0.014 |
| HRAS | 12, 13, or 61 | CUP | 50-65 | 2 | 809 | 0.005 | 0.004 | 0.001 | 0.009 |
| HRAS | 12, 13, or 61 | CUP | >65 | 5 | 795 | 0.005 | 0.005 | 0.002 | 0.010 |
| HRAS | 12, 13, or 61 | NSCLC | <40 | 0 | 161 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | NSCLC | 40-50 | 0 | 585 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | NSCLC | 50-65 | 3 | 3677 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | NSCLC | >65 | 15 | 5698 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | 12, 13, or 61 | NSCLC | NA | 0 | 10 | 0.003 | 0.001 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Breast | <40 | 1 | 840 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | 12, 13, or 61 | Breast | 40-50 | 2 | 1910 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | 12, 13, or 61 | Breast | 50-65 | 11 | 3989 | 0.003 | 0.002 | 0.002 | 0.004 |
| HRAS | 12, 13, or 61 | Breast | >65 | 9 | 2583 | 0.003 | 0.003 | 0.002 | 0.005 |
| HRAS | 12, 13, or 61 | Breast | NA | 0 | 10 | 0.003 | 0.002 | 0.001 | 0.006 |
| HRAS | 12, 13, or 61 | Pancreatic | <40 | 0 | 87 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Pancreatic | 40-50 | 0 | 200 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Pancreatic | 50-65 | 2 | 999 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Pancreatic | >65 | 1 | 1205 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Leukemia | <40 | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | 40-50 | 0 | 127 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | 50-65 | 0 | 511 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | >65 | 0 | 719 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Melanoma | <40 | 1 | 289 | 0.010 | 0.011 | 0.002 | 0.018 |
| HRAS | 12, 13, or 61 | Melanoma | 40-50 | 2 | 282 | 0.011 | 0.011 | 0.003 | 0.019 |
| HRAS | 12, 13, or 61 | Melanoma | 50-65 | 13 | 1016 | 0.013 | 0.012 | 0.008 | 0.019 |
| HRAS | 12, 13, or 61 | Melanoma | >65 | 21 | 1259 | 0.014 | 0.014 | 0.009 | 0.022 |
| HRAS | 12, 13, or 61 | Head and neck | <40 | 3 | 140 | 0.027 | 0.027 | 0.015 | 0.040 |
| HRAS | 12, 13, or 61 | Head and neck | 40-50 | 5 | 216 | 0.027 | 0.027 | 0.016 | 0.039 |
| HRAS | 12, 13, or 61 | Head and neck | 50-65 | 25 | 799 | 0.029 | 0.028 | 0.020 | 0.039 |
| HRAS | 12, 13, or 61 | Head and neck | >65 | 15 | 582 | 0.027 | 0.027 | 0.018 | 0.037 |
| HRAS | 12, 13, or 61 | Uterine | <40 | 0 | 56 | 0.003 | 0.003 | 0.001 | 0.009 |
| HRAS | 12, 13, or 61 | Uterine | 40-50 | 1 | 162 | 0.003 | 0.003 | 0.001 | 0.010 |
| HRAS | 12, 13, or 61 | Uterine | 50-65 | 3 | 1043 | 0.003 | 0.003 | 0.001 | 0.006 |
| HRAS | 12, 13, or 61 | Uterine | >65 | 2 | 986 | 0.003 | 0.002 | 0.001 | 0.006 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | <40 | 1 | 27 | 0.031 | 0.029 | 0.012 | 0.065 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | 40-50 | 1 | 20 | 0.033 | 0.030 | 0.013 | 0.074 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | 50-65 | 5 | 149 | 0.031 | 0.030 | 0.015 | 0.054 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | >65 | 8 | 317 | 0.028 | 0.028 | 0.015 | 0.046 |
| HRAS | 12, 13, or 61 | MDS/MPN | <40 | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | 40-50 | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | 50-65 | 0 | 373 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | >65 | 0 | 664 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Adrenocortical | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | <40 | 7 | 667 | 0.007 | 0.007 | 0.003 | 0.016 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | 40-50 | 0 | 363 | 0.003 | 0.003 | 0.000 | 0.007 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | 50-65 | 3 | 936 | 0.004 | 0.004 | 0.001 | 0.007 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | >65 | 2 | 766 | 0.004 | 0.003 | 0.001 | 0.007 |
| HRAS | 12, 13, or 61 | Ovarian | <40 | 0 | 141 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Ovarian | 40-50 | 0 | 253 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Ovarian | 50-65 | 1 | 1092 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Ovarian | >65 | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Esophagogastric | <40 | 0 | 122 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Esophagogastric | 40-50 | 0 | 200 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Esophagogastric | 50-65 | 2 | 752 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Esophagogastric | >65 | 1 | 725 | 0.002 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Thyroid | <40 | 8 | 150 | 0.046 | 0.045 | 0.030 | 0.069 |
| HRAS | 12, 13, or 61 | Thyroid | 40-50 | 3 | 122 | 0.041 | 0.042 | 0.021 | 0.060 |
| HRAS | 12, 13, or 61 | Thyroid | 50-65 | 16 | 374 | 0.044 | 0.043 | 0.030 | 0.060 |
| HRAS | 12, 13, or 61 | Thyroid | >65 | 18 | 370 | 0.045 | 0.045 | 0.031 | 0.063 |
| HRAS | 12, 13, or 61 | Cervical | <40 | 0 | 85 | 0.003 | 0.002 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Cervical | 40-50 | 0 | 99 | 0.003 | 0.002 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Cervical | 50-65 | 1 | 144 | 0.004 | 0.003 | 0.000 | 0.016 |
| HRAS | 12, 13, or 61 | Cervical | >65 | 0 | 36 | 0.003 | 0.002 | 0.000 | 0.015 |
| HRAS | 12, 13, or 61 | Hepatobiliary | <40 | 0 | 137 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Hepatobiliary | 40-50 | 1 | 110 | 0.005 | 0.002 | 0.000 | 0.026 |
| HRAS | 12, 13, or 61 | Hepatobiliary | 50-65 | 0 | 525 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Hepatobiliary | >65 | 0 | 601 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | CNS | <40 | 3 | 1602 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CNS | 40-50 | 0 | 687 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | CNS | 50-65 | 1 | 1438 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | CNS | >65 | 0 | 836 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Prostate | 40-50 | 0 | 70 | 0.006 | 0.006 | 0.000 | 0.014 |
| HRAS | 12, 13, or 61 | Prostate | 50-65 | 9 | 960 | 0.008 | 0.007 | 0.004 | 0.014 |
| HRAS | 12, 13, or 61 | Prostate | >65 | 7 | 1402 | 0.006 | 0.006 | 0.003 | 0.010 |
| HRAS | 12, 13, or 61 | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Neuroendocrine | <40 | 1 | 22 | 0.022 | 0.008 | 0.000 | 0.116 |
| HRAS | 12, 13, or 61 | Neuroendocrine | 40-50 | 0 | 55 | 0.003 | 0.001 | 0.000 | 0.015 |
| HRAS | 12, 13, or 61 | Neuroendocrine | 50-65 | 0 | 161 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | 12, 13, or 61 | Neuroendocrine | >65 | 0 | 121 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | 12, 13, or 61 | Bladder | <40 | 3 | 25 | 0.051 | 0.041 | 0.026 | 0.143 |
| HRAS | 12, 13, or 61 | Bladder | 40-50 | 5 | 78 | 0.045 | 0.040 | 0.026 | 0.091 |
| HRAS | 12, 13, or 61 | Bladder | 50-65 | 16 | 511 | 0.035 | 0.035 | 0.023 | 0.049 |
| HRAS | 12, 13, or 61 | Bladder | >65 | 33 | 961 | 0.036 | 0.036 | 0.026 | 0.047 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | <40 | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | >65 | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Small bowel | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Small bowel | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Small bowel | >65 | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Sex cord stromal | 50-65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Bone | <40 | 0 | 335 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | 40-50 | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | 50-65 | 0 | 93 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | >65 | 0 | 63 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Vaginal | 50-65 | 1 | 34 | 0.024 | 0.017 | 0.001 | 0.088 |
| HRAS | 12, 13, or 61 | Vaginal | >65 | 0 | 30 | 0.013 | 0.007 | 0.000 | 0.058 |
| HRAS | 12, 13, or 61 | Thymic | <40 | 0 | 14 | 0.031 | 0.028 | 0.001 | 0.082 |
| HRAS | 12, 13, or 61 | Thymic | 40-50 | 1 | 28 | 0.035 | 0.031 | 0.006 | 0.087 |
| HRAS | 12, 13, or 61 | Thymic | 50-65 | 1 | 71 | 0.028 | 0.026 | 0.004 | 0.065 |
| HRAS | 12, 13, or 61 | Thymic | >65 | 3 | 39 | 0.045 | 0.038 | 0.012 | 0.117 |
| HRAS | 12, 13, or 61 | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Ampullary | 50-65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Ampullary | >65 | 0 | 50 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | SCLC | 40-50 | 0 | 22 | 0.006 | 0.004 | 0.000 | 0.023 |
| HRAS | 12, 13, or 61 | SCLC | 50-65 | 0 | 144 | 0.004 | 0.003 | 0.000 | 0.015 |
| HRAS | 12, 13, or 61 | SCLC | >65 | 2 | 224 | 0.007 | 0.006 | 0.001 | 0.020 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | >65 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Germ cell | <40 | 1 | 649 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Germ cell | 40-50 | 0 | 131 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Germ cell | 50-65 | 0 | 92 | 0.001 | 0.001 | 0.000 | 0.007 |
| HRAS | 12, 13, or 61 | Germ cell | >65 | 0 | 12 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | 12, 13, or 61 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Nerve sheath | 40-50 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Nerve sheath | 50-65 | 0 | 35 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Nerve sheath | >65 | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | 12, 13, or 61 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | 12, 13, or 61 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| HRAS | 12, 13, or 61 | B cell lymphoma | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | 40-50 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | 50-65 | 0 | 356 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | >65 | 0 | 413 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.051 |
| HRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.017 |
| HRAS | 12, 13, or 61 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | 12, 13, or 61 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | 12, 13, or 61 | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | 12, 13, or 61 | Peritoneal | >65 | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.077 |
| HRAS | G12 | Appendiceal | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Appendiceal | 40-50 | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Appendiceal | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Appendiceal | >65 | 0 | 90 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | CRC | <40 | 0 | 565 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | CRC | 40-50 | 0 | 1280 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | CRC | 50-65 | 1 | 2814 | 0.001 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | CRC | >65 | 3 | 2052 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | CUP | <40 | 0 | 166 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | CUP | 40-50 | 1 | 211 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | G12 | CUP | 50-65 | 0 | 809 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | CUP | >65 | 1 | 795 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | NSCLC | <40 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | 40-50 | 0 | 585 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | 50-65 | 0 | 3677 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | NSCLC | >65 | 1 | 5698 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | NSCLC | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Breast | <40 | 1 | 840 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Breast | 40-50 | 0 | 1910 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Breast | 50-65 | 6 | 3989 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Breast | >65 | 2 | 2583 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Breast | NA | 0 | 10 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G12 | Pancreatic | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | 40-50 | 0 | 200 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | 50-65 | 0 | 999 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | >65 | 0 | 1205 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | <40 | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | 40-50 | 0 | 127 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | 50-65 | 0 | 511 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | >65 | 0 | 719 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Melanoma | <40 | 0 | 289 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | G12 | Melanoma | 40-50 | 1 | 282 | 0.003 | 0.003 | 0.001 | 0.008 |
| HRAS | G12 | Melanoma | 50-65 | 1 | 1016 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | G12 | Melanoma | >65 | 6 | 1259 | 0.004 | 0.003 | 0.001 | 0.007 |
| HRAS | G12 | Head and neck | <40 | 1 | 140 | 0.008 | 0.008 | 0.003 | 0.016 |
| HRAS | G12 | Head and neck | 40-50 | 2 | 216 | 0.008 | 0.008 | 0.004 | 0.016 |
| HRAS | G12 | Head and neck | 50-65 | 6 | 799 | 0.008 | 0.008 | 0.004 | 0.013 |
| HRAS | G12 | Head and neck | >65 | 5 | 582 | 0.008 | 0.008 | 0.004 | 0.014 |
| HRAS | G12 | Uterine | <40 | 0 | 56 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G12 | Uterine | 40-50 | 1 | 162 | 0.003 | 0.002 | 0.000 | 0.010 |
| HRAS | G12 | Uterine | 50-65 | 1 | 1043 | 0.002 | 0.002 | 0.000 | 0.004 |
| HRAS | G12 | Uterine | >65 | 2 | 986 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | G12 | Non-melanoma skin | <40 | 1 | 27 | 0.017 | 0.013 | 0.004 | 0.059 |
| HRAS | G12 | Non-melanoma skin | 40-50 | 1 | 20 | 0.018 | 0.013 | 0.004 | 0.071 |
| HRAS | G12 | Non-melanoma skin | 50-65 | 1 | 149 | 0.012 | 0.011 | 0.002 | 0.026 |
| HRAS | G12 | Non-melanoma skin | >65 | 3 | 317 | 0.012 | 0.011 | 0.004 | 0.023 |
| HRAS | G12 | MDS/MPN | <40 | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | 40-50 | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | 50-65 | 0 | 373 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | >65 | 0 | 664 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Adrenocortical | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12 | Adrenocortical | 40-50 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Adrenocortical | >65 | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12 | Soft tissue sarcoma | <40 | 2 | 667 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Soft tissue sarcoma | 40-50 | 0 | 363 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Soft tissue sarcoma | 50-65 | 0 | 936 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Soft tissue sarcoma | >65 | 1 | 766 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | Ovarian | <40 | 0 | 141 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Ovarian | 40-50 | 0 | 253 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Ovarian | 50-65 | 1 | 1092 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Ovarian | >65 | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Esophagogastric | <40 | 0 | 122 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Esophagogastric | 40-50 | 0 | 200 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Esophagogastric | 50-65 | 0 | 752 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Esophagogastric | >65 | 1 | 725 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Thyroid | <40 | 0 | 150 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Thyroid | 40-50 | 0 | 122 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Thyroid | 50-65 | 1 | 374 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G12 | Thyroid | >65 | 0 | 370 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | Cervical | <40 | 0 | 85 | 0.003 | 0.002 | 0.000 | 0.012 |
| HRAS | G12 | Cervical | 40-50 | 0 | 99 | 0.003 | 0.002 | 0.000 | 0.012 |
| HRAS | G12 | Cervical | 50-65 | 1 | 144 | 0.004 | 0.003 | 0.000 | 0.017 |
| HRAS | G12 | Cervical | >65 | 0 | 36 | 0.003 | 0.002 | 0.000 | 0.015 |
| HRAS | G12 | Hepatobiliary | <40 | 0 | 137 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | 40-50 | 0 | 110 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | 50-65 | 0 | 525 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | >65 | 0 | 601 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | <40 | 0 | 1602 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | 40-50 | 0 | 687 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | 50-65 | 0 | 1438 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | 40-50 | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | 50-65 | 0 | 960 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | >65 | 0 | 1402 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Anal | 40-50 | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Neuroendocrine | <40 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Neuroendocrine | 40-50 | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Neuroendocrine | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Neuroendocrine | >65 | 0 | 121 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bladder | <40 | 2 | 25 | 0.037 | 0.023 | 0.006 | 0.137 |
| HRAS | G12 | Bladder | 40-50 | 3 | 78 | 0.025 | 0.020 | 0.006 | 0.070 |
| HRAS | G12 | Bladder | 50-65 | 3 | 511 | 0.008 | 0.008 | 0.002 | 0.016 |
| HRAS | G12 | Bladder | >65 | 8 | 961 | 0.009 | 0.009 | 0.004 | 0.016 |
| HRAS | G12 | BLL/Lymphoma | <40 | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | BLL/Lymphoma | >65 | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Small bowel | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Small bowel | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Small bowel | >65 | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12 | Sex cord stromal | 50-65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Bone | <40 | 0 | 335 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | 40-50 | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | 50-65 | 0 | 93 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | >65 | 0 | 63 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G12 | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.010 |
| HRAS | G12 | Thymic | <40 | 0 | 14 | 0.008 | 0.004 | 0.000 | 0.037 |
| HRAS | G12 | Thymic | 40-50 | 0 | 28 | 0.007 | 0.004 | 0.000 | 0.031 |
| HRAS | G12 | Thymic | 50-65 | 0 | 71 | 0.006 | 0.003 | 0.000 | 0.025 |
| HRAS | G12 | Thymic | >65 | 1 | 39 | 0.014 | 0.009 | 0.000 | 0.063 |
| HRAS | G12 | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Ampullary | 50-65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Ampullary | >65 | 0 | 50 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | SCLC | 40-50 | 0 | 22 | 0.004 | 0.002 | 0.000 | 0.018 |
| HRAS | G12 | SCLC | 50-65 | 0 | 144 | 0.003 | 0.002 | 0.000 | 0.010 |
| HRAS | G12 | SCLC | >65 | 1 | 224 | 0.004 | 0.003 | 0.000 | 0.013 |
| HRAS | G12 | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | T / NK neoplasms | >65 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Germ cell | <40 | 0 | 649 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | 40-50 | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | 50-65 | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | >65 | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Nerve sheath | 40-50 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Nerve sheath | 50-65 | 0 | 35 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Nerve sheath | >65 | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | G12 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | G12 | Pineal | <40 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.044 |
| HRAS | G12 | B cell lymphoma | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | 40-50 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | 50-65 | 0 | 356 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | >65 | 0 | 413 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.022 |
| HRAS | G12 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.002 | 0.000 | 0.000 | 0.020 |
| HRAS | G12 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G12 | Hodgkin lymphoma | <40 | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.016 |
| HRAS | G12 | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.028 |
| HRAS | G12 | Peritoneal | >65 | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.056 |
| HRAS | G12C | Appendiceal | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Appendiceal | 40-50 | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Appendiceal | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Appendiceal | >65 | 0 | 90 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | CRC | <40 | 0 | 565 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | 40-50 | 0 | 1280 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | 50-65 | 0 | 2814 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | >65 | 0 | 2052 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | <40 | 0 | 166 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | 40-50 | 0 | 211 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | 50-65 | 0 | 809 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | >65 | 0 | 795 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | <40 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | 40-50 | 0 | 585 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | 50-65 | 0 | 3677 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | >65 | 0 | 5698 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Breast | <40 | 0 | 840 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | 50-65 | 2 | 3989 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | >65 | 0 | 2583 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Pancreatic | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | 40-50 | 0 | 200 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | 50-65 | 0 | 999 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | >65 | 0 | 1205 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | <40 | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | 40-50 | 0 | 127 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | 50-65 | 0 | 511 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | >65 | 0 | 719 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | <40 | 0 | 289 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | 40-50 | 0 | 282 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | 50-65 | 0 | 1016 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | >65 | 0 | 1259 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | <40 | 0 | 140 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | 40-50 | 0 | 216 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | 50-65 | 0 | 799 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | >65 | 0 | 582 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | <40 | 0 | 56 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | 40-50 | 0 | 162 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | 50-65 | 0 | 1043 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | >65 | 0 | 986 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Non-melanoma skin | <40 | 0 | 27 | 0.003 | 0.001 | 0.000 | 0.014 |
| HRAS | G12C | Non-melanoma skin | 40-50 | 0 | 20 | 0.003 | 0.001 | 0.000 | 0.017 |
| HRAS | G12C | Non-melanoma skin | 50-65 | 1 | 149 | 0.004 | 0.003 | 0.000 | 0.017 |
| HRAS | G12C | Non-melanoma skin | >65 | 0 | 317 | 0.002 | 0.001 | 0.000 | 0.007 |
| HRAS | G12C | MDS/MPN | <40 | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | 40-50 | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | 50-65 | 0 | 373 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | >65 | 0 | 664 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Soft tissue sarcoma | <40 | 0 | 667 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | 40-50 | 0 | 363 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | 50-65 | 0 | 936 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | >65 | 0 | 766 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | <40 | 0 | 141 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | 40-50 | 0 | 253 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | 50-65 | 0 | 1092 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | >65 | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | <40 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | 40-50 | 0 | 200 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | 50-65 | 0 | 752 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | >65 | 0 | 725 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | <40 | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | 40-50 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | 50-65 | 0 | 374 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | >65 | 0 | 370 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Cervical | <40 | 0 | 85 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Cervical | 40-50 | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Cervical | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Cervical | >65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Hepatobiliary | <40 | 0 | 137 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | 40-50 | 0 | 110 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | 50-65 | 0 | 525 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | >65 | 0 | 601 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | <40 | 0 | 1602 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | 40-50 | 0 | 687 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | 50-65 | 0 | 1438 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | 40-50 | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | 50-65 | 0 | 960 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | >65 | 0 | 1402 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Neuroendocrine | <40 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Neuroendocrine | 40-50 | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Neuroendocrine | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Neuroendocrine | >65 | 0 | 121 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Bladder | <40 | 0 | 25 | 0.003 | 0.002 | 0.000 | 0.011 |
| HRAS | G12C | Bladder | 40-50 | 0 | 78 | 0.002 | 0.002 | 0.000 | 0.008 |
| HRAS | G12C | Bladder | 50-65 | 2 | 511 | 0.003 | 0.002 | 0.000 | 0.007 |
| HRAS | G12C | Bladder | >65 | 1 | 961 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | G12C | BLL/Lymphoma | <40 | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | BLL/Lymphoma | 40-50 | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | BLL/Lymphoma | 50-65 | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | BLL/Lymphoma | >65 | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Small bowel | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Small bowel | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Small bowel | >65 | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Sex cord stromal | 50-65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Bone | <40 | 0 | 335 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Bone | 40-50 | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Bone | 50-65 | 0 | 93 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Bone | >65 | 0 | 63 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.011 |
| HRAS | G12C | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G12C | Thymic | <40 | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Thymic | 50-65 | 0 | 71 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Thymic | >65 | 0 | 39 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | G12C | Ampullary | 50-65 | 0 | 40 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12C | Ampullary | >65 | 0 | 50 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12C | SCLC | 40-50 | 0 | 22 | 0.004 | 0.002 | 0.000 | 0.018 |
| HRAS | G12C | SCLC | 50-65 | 0 | 144 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | G12C | SCLC | >65 | 1 | 224 | 0.004 | 0.003 | 0.000 | 0.013 |
| HRAS | G12C | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | T / NK neoplasms | >65 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | <40 | 0 | 649 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | 40-50 | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | 50-65 | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Germ cell | >65 | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Nerve sheath | 40-50 | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12C | Nerve sheath | 50-65 | 0 | 35 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Nerve sheath | >65 | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12C | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.031 |
| HRAS | G12C | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| HRAS | G12C | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| HRAS | G12C | B cell lymphoma | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | 40-50 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | 50-65 | 0 | 356 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | >65 | 0 | 413 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.005 | 0.000 | 0.000 | 0.052 |
| HRAS | G12C | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.018 |
| HRAS | G12C | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.010 |
| HRAS | G12C | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | G12C | Lung | >65 | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.037 |
| HRAS | G12C | Peritoneal | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.049 |
| HRAS | G13 | Appendiceal | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Appendiceal | 40-50 | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Appendiceal | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Appendiceal | >65 | 0 | 90 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | CRC | <40 | 0 | 565 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | 40-50 | 0 | 1280 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | 50-65 | 0 | 2814 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | >65 | 1 | 2052 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CUP | <40 | 0 | 166 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | G13 | CUP | 40-50 | 0 | 211 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | G13 | CUP | 50-65 | 1 | 809 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | G13 | CUP | >65 | 3 | 795 | 0.003 | 0.002 | 0.001 | 0.006 |
| HRAS | G13 | NSCLC | <40 | 0 | 161 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | NSCLC | 40-50 | 0 | 585 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | NSCLC | 50-65 | 1 | 3677 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | G13 | NSCLC | >65 | 9 | 5698 | 0.001 | 0.001 | 0.001 | 0.002 |
| HRAS | G13 | NSCLC | NA | 0 | 10 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | G13 | Breast | <40 | 0 | 840 | 0.001 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Breast | 50-65 | 5 | 3989 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | Breast | >65 | 1 | 2583 | 0.001 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Breast | NA | 0 | 10 | 0.001 | 0.001 | 0.000 | 0.007 |
| HRAS | G13 | Pancreatic | <40 | 0 | 87 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Pancreatic | 40-50 | 0 | 200 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Pancreatic | 50-65 | 1 | 999 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Pancreatic | >65 | 0 | 1205 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Leukemia | <40 | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | 40-50 | 0 | 127 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | 50-65 | 0 | 511 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | >65 | 0 | 719 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Melanoma | <40 | 0 | 289 | 0.003 | 0.003 | 0.000 | 0.009 |
| HRAS | G13 | Melanoma | 40-50 | 0 | 282 | 0.003 | 0.003 | 0.000 | 0.009 |
| HRAS | G13 | Melanoma | 50-65 | 5 | 1016 | 0.005 | 0.005 | 0.002 | 0.009 |
| HRAS | G13 | Melanoma | >65 | 11 | 1259 | 0.007 | 0.007 | 0.004 | 0.013 |
| HRAS | G13 | Head and neck | <40 | 1 | 140 | 0.008 | 0.008 | 0.003 | 0.015 |
| HRAS | G13 | Head and neck | 40-50 | 2 | 216 | 0.008 | 0.008 | 0.004 | 0.016 |
| HRAS | G13 | Head and neck | 50-65 | 7 | 799 | 0.008 | 0.008 | 0.004 | 0.014 |
| HRAS | G13 | Head and neck | >65 | 4 | 582 | 0.008 | 0.008 | 0.004 | 0.013 |
| HRAS | G13 | Uterine | <40 | 0 | 56 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Uterine | 40-50 | 0 | 162 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Uterine | 50-65 | 1 | 1043 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Uterine | >65 | 0 | 986 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Non-melanoma skin | <40 | 0 | 27 | 0.006 | 0.005 | 0.000 | 0.020 |
| HRAS | G13 | Non-melanoma skin | 40-50 | 0 | 20 | 0.007 | 0.005 | 0.000 | 0.022 |
| HRAS | G13 | Non-melanoma skin | 50-65 | 1 | 149 | 0.007 | 0.006 | 0.001 | 0.018 |
| HRAS | G13 | Non-melanoma skin | >65 | 2 | 317 | 0.006 | 0.006 | 0.001 | 0.015 |
| HRAS | G13 | MDS/MPN | <40 | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | 40-50 | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | 50-65 | 0 | 373 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | >65 | 0 | 664 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Soft tissue sarcoma | <40 | 2 | 667 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | G13 | Soft tissue sarcoma | 40-50 | 0 | 363 | 0.002 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | Soft tissue sarcoma | 50-65 | 3 | 936 | 0.002 | 0.002 | 0.001 | 0.006 |
| HRAS | G13 | Soft tissue sarcoma | >65 | 0 | 766 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | Ovarian | <40 | 0 | 141 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Ovarian | 40-50 | 0 | 253 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Ovarian | 50-65 | 1 | 1092 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Ovarian | >65 | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Esophagogastric | <40 | 0 | 122 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Esophagogastric | 40-50 | 0 | 200 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Esophagogastric | 50-65 | 1 | 752 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Esophagogastric | >65 | 0 | 725 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Thyroid | <40 | 1 | 150 | 0.003 | 0.002 | 0.000 | 0.015 |
| HRAS | G13 | Thyroid | 40-50 | 0 | 122 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G13 | Thyroid | 50-65 | 1 | 374 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G13 | Thyroid | >65 | 0 | 370 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Cervical | <40 | 0 | 85 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Cervical | 40-50 | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Cervical | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Cervical | >65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Hepatobiliary | <40 | 0 | 137 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | 40-50 | 0 | 110 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | 50-65 | 0 | 525 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | >65 | 0 | 601 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | CNS | <40 | 3 | 1602 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | CNS | 40-50 | 0 | 687 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | CNS | 50-65 | 0 | 1438 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Prostate | 40-50 | 0 | 70 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Prostate | 50-65 | 1 | 960 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Prostate | >65 | 2 | 1402 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Neuroendocrine | <40 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Neuroendocrine | 40-50 | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Neuroendocrine | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Neuroendocrine | >65 | 0 | 121 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bladder | <40 | 0 | 25 | 0.008 | 0.008 | 0.000 | 0.020 |
| HRAS | G13 | Bladder | 40-50 | 0 | 78 | 0.008 | 0.007 | 0.000 | 0.016 |
| HRAS | G13 | Bladder | 50-65 | 6 | 511 | 0.009 | 0.009 | 0.004 | 0.018 |
| HRAS | G13 | Bladder | >65 | 7 | 961 | 0.008 | 0.008 | 0.004 | 0.013 |
| HRAS | G13 | BLL/Lymphoma | <40 | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | BLL/Lymphoma | >65 | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Small bowel | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Small bowel | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Small bowel | >65 | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Sex cord stromal | 40-50 | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Sex cord stromal | 50-65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Bone | <40 | 0 | 335 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Bone | 40-50 | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bone | 50-65 | 0 | 93 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Bone | >65 | 0 | 63 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G13 | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.010 |
| HRAS | G13 | Thymic | <40 | 0 | 14 | 0.007 | 0.004 | 0.000 | 0.034 |
| HRAS | G13 | Thymic | 40-50 | 0 | 28 | 0.007 | 0.004 | 0.000 | 0.031 |
| HRAS | G13 | Thymic | 50-65 | 1 | 71 | 0.010 | 0.007 | 0.000 | 0.036 |
| HRAS | G13 | Thymic | >65 | 0 | 39 | 0.007 | 0.004 | 0.000 | 0.029 |
| HRAS | G13 | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G13 | Ampullary | 50-65 | 0 | 40 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G13 | Ampullary | >65 | 0 | 50 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G13 | SCLC | 40-50 | 0 | 22 | 0.004 | 0.002 | 0.000 | 0.021 |
| HRAS | G13 | SCLC | 50-65 | 0 | 144 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | G13 | SCLC | >65 | 1 | 224 | 0.004 | 0.003 | 0.000 | 0.014 |
| HRAS | G13 | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | T / NK neoplasms | >65 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Germ cell | <40 | 1 | 649 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G13 | Germ cell | 40-50 | 0 | 131 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Germ cell | 50-65 | 0 | 92 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Germ cell | >65 | 0 | 12 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | G13 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Nerve sheath | 40-50 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Nerve sheath | 50-65 | 0 | 35 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Nerve sheath | >65 | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Penile | 50-65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.042 |
| HRAS | G13 | Penile | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.043 |
| HRAS | G13 | Pineal | <40 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| HRAS | G13 | B cell lymphoma | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | B cell lymphoma | 40-50 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | B cell lymphoma | 50-65 | 0 | 356 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | B cell lymphoma | >65 | 0 | 413 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.052 |
| HRAS | G13 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | G13 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G13 | Hodgkin lymphoma | <40 | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.014 |
| HRAS | G13 | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.026 |
| HRAS | G13 | Peritoneal | >65 | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.061 |
| HRAS | Q61 | Appendiceal | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Appendiceal | 40-50 | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Appendiceal | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Appendiceal | >65 | 0 | 90 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CRC | <40 | 0 | 565 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | 40-50 | 0 | 1280 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | 50-65 | 0 | 2814 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | >65 | 0 | 2052 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CUP | <40 | 1 | 166 | 0.003 | 0.002 | 0.001 | 0.010 |
| HRAS | Q61 | CUP | 40-50 | 1 | 211 | 0.003 | 0.002 | 0.001 | 0.008 |
| HRAS | Q61 | CUP | 50-65 | 1 | 809 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | Q61 | CUP | >65 | 1 | 795 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | Q61 | NSCLC | <40 | 0 | 161 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | NSCLC | 40-50 | 0 | 585 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | NSCLC | 50-65 | 2 | 3677 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | Q61 | NSCLC | >65 | 5 | 5698 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | Q61 | NSCLC | NA | 0 | 10 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Breast | <40 | 0 | 840 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Breast | 40-50 | 2 | 1910 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Breast | 50-65 | 0 | 3989 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Breast | >65 | 6 | 2583 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | Q61 | Breast | NA | 0 | 10 | 0.003 | 0.000 | 0.000 | 0.024 |
| HRAS | Q61 | Pancreatic | <40 | 0 | 87 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Pancreatic | 40-50 | 0 | 200 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Pancreatic | 50-65 | 1 | 999 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Pancreatic | >65 | 1 | 1205 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Leukemia | <40 | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | 40-50 | 0 | 127 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | 50-65 | 0 | 511 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | >65 | 0 | 719 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Melanoma | <40 | 1 | 289 | 0.005 | 0.004 | 0.001 | 0.009 |
| HRAS | Q61 | Melanoma | 40-50 | 1 | 282 | 0.005 | 0.004 | 0.001 | 0.009 |
| HRAS | Q61 | Melanoma | 50-65 | 7 | 1016 | 0.005 | 0.005 | 0.003 | 0.010 |
| HRAS | Q61 | Melanoma | >65 | 4 | 1259 | 0.004 | 0.004 | 0.002 | 0.007 |
| HRAS | Q61 | Head and neck | <40 | 1 | 140 | 0.011 | 0.011 | 0.003 | 0.020 |
| HRAS | Q61 | Head and neck | 40-50 | 1 | 216 | 0.010 | 0.010 | 0.003 | 0.018 |
| HRAS | Q61 | Head and neck | 50-65 | 12 | 799 | 0.013 | 0.012 | 0.007 | 0.020 |
| HRAS | Q61 | Head and neck | >65 | 6 | 582 | 0.011 | 0.011 | 0.006 | 0.018 |
| HRAS | Q61 | Uterine | <40 | 0 | 56 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Uterine | 40-50 | 0 | 162 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Uterine | 50-65 | 1 | 1043 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Uterine | >65 | 0 | 986 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Non-melanoma skin | <40 | 0 | 27 | 0.012 | 0.011 | 0.001 | 0.030 |
| HRAS | Q61 | Non-melanoma skin | 40-50 | 0 | 20 | 0.012 | 0.011 | 0.001 | 0.034 |
| HRAS | Q61 | Non-melanoma skin | 50-65 | 3 | 149 | 0.014 | 0.013 | 0.004 | 0.032 |
| HRAS | Q61 | Non-melanoma skin | >65 | 3 | 317 | 0.011 | 0.011 | 0.004 | 0.023 |
| HRAS | Q61 | MDS/MPN | <40 | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | 40-50 | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | 50-65 | 0 | 373 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | >65 | 0 | 664 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Adrenocortical | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Soft tissue sarcoma | <40 | 3 | 667 | 0.003 | 0.002 | 0.001 | 0.009 |
| HRAS | Q61 | Soft tissue sarcoma | 40-50 | 0 | 363 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Soft tissue sarcoma | 50-65 | 0 | 936 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Soft tissue sarcoma | >65 | 1 | 766 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Ovarian | <40 | 0 | 141 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | 40-50 | 0 | 253 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | 50-65 | 0 | 1092 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | >65 | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Esophagogastric | <40 | 0 | 122 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Esophagogastric | 40-50 | 0 | 200 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Esophagogastric | 50-65 | 1 | 752 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Esophagogastric | >65 | 0 | 725 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Thyroid | <40 | 7 | 150 | 0.042 | 0.041 | 0.026 | 0.064 |
| HRAS | Q61 | Thyroid | 40-50 | 3 | 122 | 0.039 | 0.039 | 0.019 | 0.057 |
| HRAS | Q61 | Thyroid | 50-65 | 14 | 374 | 0.040 | 0.040 | 0.026 | 0.056 |
| HRAS | Q61 | Thyroid | >65 | 18 | 370 | 0.043 | 0.043 | 0.030 | 0.062 |
| HRAS | Q61 | Cervical | <40 | 0 | 85 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Cervical | 40-50 | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Cervical | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Cervical | >65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Hepatobiliary | <40 | 0 | 137 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Hepatobiliary | 40-50 | 1 | 110 | 0.005 | 0.002 | 0.000 | 0.026 |
| HRAS | Q61 | Hepatobiliary | 50-65 | 0 | 525 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Hepatobiliary | >65 | 0 | 601 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CNS | <40 | 0 | 1602 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CNS | 40-50 | 0 | 687 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CNS | 50-65 | 1 | 1438 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Prostate | 40-50 | 0 | 70 | 0.005 | 0.005 | 0.000 | 0.014 |
| HRAS | Q61 | Prostate | 50-65 | 8 | 960 | 0.007 | 0.006 | 0.003 | 0.013 |
| HRAS | Q61 | Prostate | >65 | 5 | 1402 | 0.005 | 0.004 | 0.002 | 0.008 |
| HRAS | Q61 | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Neuroendocrine | <40 | 1 | 22 | 0.022 | 0.008 | 0.000 | 0.116 |
| HRAS | Q61 | Neuroendocrine | 40-50 | 0 | 55 | 0.003 | 0.001 | 0.000 | 0.015 |
| HRAS | Q61 | Neuroendocrine | 50-65 | 0 | 161 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | Q61 | Neuroendocrine | >65 | 0 | 121 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | Q61 | Bladder | <40 | 1 | 25 | 0.021 | 0.019 | 0.009 | 0.047 |
| HRAS | Q61 | Bladder | 40-50 | 2 | 78 | 0.020 | 0.019 | 0.010 | 0.038 |
| HRAS | Q61 | Bladder | 50-65 | 7 | 511 | 0.017 | 0.017 | 0.009 | 0.026 |
| HRAS | Q61 | Bladder | >65 | 19 | 961 | 0.019 | 0.019 | 0.012 | 0.027 |
| HRAS | Q61 | BLL/Lymphoma | <40 | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | BLL/Lymphoma | >65 | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Small bowel | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Small bowel | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Small bowel | >65 | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Sex cord stromal | 50-65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Bone | <40 | 0 | 335 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | 40-50 | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | 50-65 | 0 | 93 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | >65 | 0 | 63 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Vaginal | 50-65 | 1 | 34 | 0.024 | 0.017 | 0.001 | 0.088 |
| HRAS | Q61 | Vaginal | >65 | 0 | 30 | 0.013 | 0.007 | 0.000 | 0.058 |
| HRAS | Q61 | Thymic | <40 | 0 | 14 | 0.019 | 0.015 | 0.000 | 0.063 |
| HRAS | Q61 | Thymic | 40-50 | 1 | 28 | 0.026 | 0.020 | 0.003 | 0.087 |
| HRAS | Q61 | Thymic | 50-65 | 0 | 71 | 0.014 | 0.012 | 0.000 | 0.044 |
| HRAS | Q61 | Thymic | >65 | 2 | 39 | 0.031 | 0.025 | 0.005 | 0.097 |
| HRAS | Q61 | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | Ampullary | 50-65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Ampullary | >65 | 0 | 50 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | SCLC | 40-50 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | SCLC | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | SCLC | >65 | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | T / NK neoplasms | >65 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Germ cell | <40 | 0 | 649 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | 40-50 | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | 50-65 | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | >65 | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Nerve sheath | 40-50 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Nerve sheath | 50-65 | 0 | 35 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Nerve sheath | >65 | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | Q61 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | Q61 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| HRAS | Q61 | B cell lymphoma | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | 40-50 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | 50-65 | 0 | 356 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | >65 | 0 | 413 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.051 |
| HRAS | Q61 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.017 |
| HRAS | Q61 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | Q61 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | Q61 | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | Q61 | Peritoneal | >65 | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.077 |
| HRAS | 12, 13, or 61 | Appendiceal | Black | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Appendiceal | NA | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Appendiceal | White | 0 | 280 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | CRC | Asian | 0 | 313 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CRC | Black | 2 | 514 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | CRC | NA | 1 | 804 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CRC | Native American | 0 | 17 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | CRC | Other | 0 | 139 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | CRC | White | 2 | 4922 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | CUP | Asian | 0 | 73 | 0.005 | 0.004 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | CUP | Black | 1 | 123 | 0.006 | 0.005 | 0.001 | 0.016 |
| HRAS | 12, 13, or 61 | CUP | NA | 0 | 286 | 0.004 | 0.004 | 0.000 | 0.009 |
| HRAS | 12, 13, or 61 | CUP | Other | 0 | 36 | 0.005 | 0.004 | 0.000 | 0.014 |
| HRAS | 12, 13, or 61 | CUP | White | 9 | 1461 | 0.005 | 0.005 | 0.003 | 0.010 |
| HRAS | 12, 13, or 61 | NSCLC | Asian | 0 | 624 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | NSCLC | Black | 0 | 717 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | NSCLC | NA | 3 | 849 | 0.003 | 0.002 | 0.001 | 0.007 |
| HRAS | 12, 13, or 61 | NSCLC | Native American | 0 | 17 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | NSCLC | Other | 0 | 165 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | NSCLC | Undefined | 0 | 10 | 0.002 | 0.001 | 0.000 | 0.013 |
| HRAS | 12, 13, or 61 | NSCLC | White | 15 | 7745 | 0.002 | 0.002 | 0.001 | 0.003 |
| HRAS | 12, 13, or 61 | Breast | Asian | 2 | 334 | 0.003 | 0.003 | 0.001 | 0.008 |
| HRAS | 12, 13, or 61 | Breast | Black | 1 | 525 | 0.002 | 0.002 | 0.001 | 0.005 |
| HRAS | 12, 13, or 61 | Breast | NA | 4 | 3112 | 0.002 | 0.002 | 0.001 | 0.003 |
| HRAS | 12, 13, or 61 | Breast | Native American | 0 | 11 | 0.003 | 0.002 | 0.001 | 0.007 |
| HRAS | 12, 13, or 61 | Breast | Other | 0 | 176 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Breast | White | 16 | 5174 | 0.003 | 0.003 | 0.002 | 0.004 |
| HRAS | 12, 13, or 61 | Pancreatic | Asian | 0 | 100 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Pancreatic | Black | 0 | 88 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Pancreatic | NA | 0 | 231 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Pancreatic | Other | 0 | 34 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Pancreatic | White | 2 | 2037 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Leukemia | Asian | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | Black | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | NA | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | Other | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | White | 0 | 655 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Melanoma | Asian | 1 | 33 | 0.017 | 0.013 | 0.003 | 0.056 |
| HRAS | 12, 13, or 61 | Melanoma | Black | 1 | 34 | 0.017 | 0.013 | 0.003 | 0.056 |
| HRAS | 12, 13, or 61 | Melanoma | NA | 1 | 398 | 0.008 | 0.008 | 0.001 | 0.017 |
| HRAS | 12, 13, or 61 | Melanoma | Other | 0 | 26 | 0.012 | 0.011 | 0.001 | 0.035 |
| HRAS | 12, 13, or 61 | Melanoma | White | 34 | 2348 | 0.014 | 0.014 | 0.010 | 0.019 |
| HRAS | 12, 13, or 61 | Head and neck | Asian | 2 | 94 | 0.026 | 0.026 | 0.009 | 0.048 |
| HRAS | 12, 13, or 61 | Head and neck | Black | 4 | 62 | 0.036 | 0.031 | 0.017 | 0.086 |
| HRAS | 12, 13, or 61 | Head and neck | NA | 3 | 292 | 0.021 | 0.021 | 0.007 | 0.035 |
| HRAS | 12, 13, or 61 | Head and neck | Other | 1 | 28 | 0.029 | 0.027 | 0.009 | 0.068 |
| HRAS | 12, 13, or 61 | Head and neck | White | 38 | 1264 | 0.029 | 0.029 | 0.021 | 0.039 |
| HRAS | 12, 13, or 61 | Uterine | Asian | 0 | 108 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | 12, 13, or 61 | Uterine | Black | 0 | 162 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Uterine | NA | 0 | 189 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Uterine | Other | 0 | 37 | 0.003 | 0.002 | 0.000 | 0.010 |
| HRAS | 12, 13, or 61 | Uterine | White | 6 | 1750 | 0.003 | 0.003 | 0.001 | 0.006 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | Asian | 0 | 11 | 0.030 | 0.028 | 0.005 | 0.071 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | Black | 1 | 13 | 0.036 | 0.030 | 0.012 | 0.103 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | NA | 2 | 53 | 0.032 | 0.030 | 0.013 | 0.066 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | White | 12 | 436 | 0.029 | 0.028 | 0.016 | 0.045 |
| HRAS | 12, 13, or 61 | MDS/MPN | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | Black | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | NA | 0 | 571 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | White | 0 | 584 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Asian | 0 | 143 | 0.004 | 0.003 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Black | 1 | 190 | 0.005 | 0.004 | 0.001 | 0.015 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | NA | 6 | 347 | 0.012 | 0.011 | 0.003 | 0.028 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Other | 0 | 73 | 0.004 | 0.003 | 0.000 | 0.015 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | White | 5 | 1976 | 0.003 | 0.003 | 0.001 | 0.006 |
| HRAS | 12, 13, or 61 | Ovarian | Asian | 0 | 134 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Ovarian | Black | 0 | 74 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Ovarian | NA | 0 | 239 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Ovarian | Other | 0 | 36 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Ovarian | White | 1 | 1852 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Esophagogastric | Asian | 1 | 115 | 0.003 | 0.002 | 0.000 | 0.013 |
| HRAS | 12, 13, or 61 | Esophagogastric | Black | 0 | 68 | 0.002 | 0.002 | 0.000 | 0.008 |
| HRAS | 12, 13, or 61 | Esophagogastric | NA | 0 | 191 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Esophagogastric | Other | 0 | 46 | 0.002 | 0.002 | 0.000 | 0.008 |
| HRAS | 12, 13, or 61 | Esophagogastric | White | 2 | 1379 | 0.002 | 0.002 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Thyroid | Asian | 4 | 66 | 0.047 | 0.045 | 0.028 | 0.078 |
| HRAS | 12, 13, or 61 | Thyroid | Black | 1 | 40 | 0.044 | 0.044 | 0.021 | 0.070 |
| HRAS | 12, 13, or 61 | Thyroid | NA | 3 | 79 | 0.044 | 0.044 | 0.024 | 0.069 |
| HRAS | 12, 13, or 61 | Thyroid | Other | 2 | 26 | 0.048 | 0.046 | 0.027 | 0.086 |
| HRAS | 12, 13, or 61 | Thyroid | White | 35 | 803 | 0.044 | 0.044 | 0.032 | 0.058 |
| HRAS | 12, 13, or 61 | Cervical | Asian | 0 | 27 | 0.003 | 0.002 | 0.000 | 0.015 |
| HRAS | 12, 13, or 61 | Cervical | Black | 0 | 19 | 0.004 | 0.002 | 0.000 | 0.017 |
| HRAS | 12, 13, or 61 | Cervical | NA | 0 | 77 | 0.003 | 0.002 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Cervical | Other | 0 | 15 | 0.004 | 0.002 | 0.000 | 0.018 |
| HRAS | 12, 13, or 61 | Cervical | White | 1 | 228 | 0.004 | 0.003 | 0.000 | 0.013 |
| HRAS | 12, 13, or 61 | Hepatobiliary | Asian | 0 | 97 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Hepatobiliary | Black | 0 | 64 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Hepatobiliary | NA | 0 | 235 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Hepatobiliary | Other | 0 | 25 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Hepatobiliary | White | 1 | 948 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | CNS | Asian | 0 | 154 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CNS | Black | 0 | 131 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CNS | NA | 1 | 817 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CNS | Other | 0 | 108 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CNS | Undefined | 0 | 17 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CNS | White | 3 | 3330 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Prostate | Asian | 1 | 62 | 0.009 | 0.007 | 0.003 | 0.024 |
| HRAS | 12, 13, or 61 | Prostate | Black | 3 | 175 | 0.009 | 0.008 | 0.004 | 0.024 |
| HRAS | 12, 13, or 61 | Prostate | NA | 2 | 289 | 0.007 | 0.007 | 0.003 | 0.015 |
| HRAS | 12, 13, or 61 | Prostate | Other | 0 | 31 | 0.008 | 0.007 | 0.002 | 0.019 |
| HRAS | 12, 13, or 61 | Prostate | White | 10 | 1882 | 0.006 | 0.006 | 0.003 | 0.010 |
| HRAS | 12, 13, or 61 | Anal | NA | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Neuroendocrine | Black | 0 | 23 | 0.004 | 0.002 | 0.000 | 0.020 |
| HRAS | 12, 13, or 61 | Neuroendocrine | NA | 0 | 45 | 0.003 | 0.002 | 0.000 | 0.016 |
| HRAS | 12, 13, or 61 | Neuroendocrine | White | 1 | 283 | 0.003 | 0.003 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Bladder | Asian | 3 | 40 | 0.045 | 0.039 | 0.022 | 0.102 |
| HRAS | 12, 13, or 61 | Bladder | Black | 0 | 43 | 0.033 | 0.034 | 0.005 | 0.059 |
| HRAS | 12, 13, or 61 | Bladder | NA | 6 | 169 | 0.037 | 0.036 | 0.021 | 0.059 |
| HRAS | 12, 13, or 61 | Bladder | Other | 2 | 14 | 0.051 | 0.040 | 0.022 | 0.159 |
| HRAS | 12, 13, or 61 | Bladder | White | 46 | 1310 | 0.036 | 0.036 | 0.027 | 0.046 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | Asian | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | NA | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | White | 0 | 125 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Small bowel | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Small bowel | NA | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Small bowel | White | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | 12, 13, or 61 | Sex cord stromal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | Black | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | White | 0 | 379 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Vaginal | White | 2 | 68 | 0.032 | 0.027 | 0.004 | 0.082 |
| HRAS | 12, 13, or 61 | Thymic | Asian | 0 | 13 | 0.026 | 0.022 | 0.000 | 0.083 |
| HRAS | 12, 13, or 61 | Thymic | NA | 0 | 23 | 0.024 | 0.021 | 0.000 | 0.074 |
| HRAS | 12, 13, or 61 | Thymic | White | 5 | 106 | 0.041 | 0.038 | 0.014 | 0.084 |
| HRAS | 12, 13, or 61 | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | SCLC | Asian | 0 | 15 | 0.007 | 0.004 | 0.000 | 0.034 |
| HRAS | 12, 13, or 61 | SCLC | NA | 0 | 30 | 0.006 | 0.004 | 0.000 | 0.023 |
| HRAS | 12, 13, or 61 | SCLC | White | 2 | 337 | 0.006 | 0.005 | 0.001 | 0.016 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | White | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Germ cell | Asian | 0 | 36 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | 12, 13, or 61 | Germ cell | Black | 0 | 23 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | 12, 13, or 61 | Germ cell | NA | 1 | 179 | 0.003 | 0.002 | 0.000 | 0.013 |
| HRAS | 12, 13, or 61 | Germ cell | Other | 0 | 36 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | 12, 13, or 61 | Germ cell | White | 0 | 603 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Nerve sheath | Black | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Nerve sheath | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | 12, 13, or 61 | Pheochromocytoma | White | 0 | 15 | 0.002 | 0.000 | 0.000 | 0.021 |
| HRAS | 12, 13, or 61 | Pineal | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Asian | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | NA | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Other | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | White | 0 | 858 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Non-hodgkin lymphoma | White | 0 | 19 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.028 |
| HRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | 12, 13, or 61 | Retinoblastoma | NA | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | 12, 13, or 61 | Retinoblastoma | White | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Hodgkin lymphoma | White | 0 | 30 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | 12, 13, or 61 | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.022 |
| HRAS | 12, 13, or 61 | Peritoneal | White | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.038 |
| HRAS | 12, 13, or 61 | Parathyroid | White | 1 | 14 | 0.080 | 0.062 | 0.004 | 0.253 |
| HRAS | G12 | Appendiceal | Black | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Appendiceal | NA | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Appendiceal | White | 0 | 280 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | CRC | Asian | 0 | 313 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | CRC | Black | 2 | 514 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | G12 | CRC | NA | 0 | 804 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | CRC | Native American | 0 | 17 | 0.002 | 0.001 | 0.000 | 0.008 |
| HRAS | G12 | CRC | Other | 0 | 139 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | CRC | White | 2 | 4922 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | G12 | CUP | Asian | 0 | 73 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | CUP | Black | 0 | 123 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | CUP | NA | 0 | 286 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | CUP | Other | 0 | 36 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | G12 | CUP | White | 2 | 1461 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | NSCLC | Asian | 0 | 624 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | Black | 0 | 717 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | NA | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | Native American | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | Other | 0 | 165 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | Undefined | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | White | 1 | 7745 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Breast | Asian | 1 | 334 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Breast | Black | 0 | 525 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Breast | NA | 1 | 3112 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Breast | Native American | 0 | 11 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | Breast | Other | 0 | 176 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Breast | White | 7 | 5174 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Pancreatic | Asian | 0 | 100 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | Black | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | NA | 0 | 231 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | Other | 0 | 34 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | White | 0 | 2037 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Asian | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Black | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | NA | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Other | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | White | 0 | 655 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Melanoma | Asian | 0 | 33 | 0.004 | 0.003 | 0.000 | 0.016 |
| HRAS | G12 | Melanoma | Black | 1 | 34 | 0.009 | 0.004 | 0.001 | 0.051 |
| HRAS | G12 | Melanoma | NA | 0 | 398 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | G12 | Melanoma | Other | 0 | 26 | 0.004 | 0.003 | 0.000 | 0.018 |
| HRAS | G12 | Melanoma | White | 7 | 2348 | 0.003 | 0.003 | 0.001 | 0.005 |
| HRAS | G12 | Head and neck | Asian | 0 | 94 | 0.005 | 0.004 | 0.000 | 0.015 |
| HRAS | G12 | Head and neck | Black | 0 | 62 | 0.005 | 0.004 | 0.000 | 0.017 |
| HRAS | G12 | Head and neck | NA | 0 | 292 | 0.004 | 0.003 | 0.000 | 0.012 |
| HRAS | G12 | Head and neck | Other | 1 | 28 | 0.017 | 0.009 | 0.001 | 0.082 |
| HRAS | G12 | Head and neck | White | 13 | 1264 | 0.009 | 0.009 | 0.005 | 0.015 |
| HRAS | G12 | Uterine | Asian | 0 | 108 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Uterine | Black | 0 | 162 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Uterine | NA | 0 | 189 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Uterine | Other | 0 | 37 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G12 | Uterine | White | 4 | 1750 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | G12 | Non-melanoma skin | Asian | 0 | 11 | 0.015 | 0.012 | 0.001 | 0.054 |
| HRAS | G12 | Non-melanoma skin | Black | 1 | 13 | 0.023 | 0.014 | 0.004 | 0.115 |
| HRAS | G12 | Non-melanoma skin | NA | 1 | 53 | 0.015 | 0.012 | 0.003 | 0.045 |
| HRAS | G12 | Non-melanoma skin | White | 4 | 436 | 0.011 | 0.011 | 0.004 | 0.022 |
| HRAS | G12 | MDS/MPN | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | Black | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | NA | 0 | 571 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | White | 0 | 584 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Adrenocortical | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Soft tissue sarcoma | Asian | 0 | 143 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | Soft tissue sarcoma | Black | 1 | 190 | 0.002 | 0.001 | 0.000 | 0.008 |
| HRAS | G12 | Soft tissue sarcoma | NA | 0 | 347 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Soft tissue sarcoma | Other | 0 | 73 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Soft tissue sarcoma | White | 2 | 1976 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Ovarian | Asian | 0 | 134 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Ovarian | Black | 0 | 74 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Ovarian | NA | 0 | 239 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Ovarian | Other | 0 | 36 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Ovarian | White | 1 | 1852 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Esophagogastric | Asian | 0 | 115 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Esophagogastric | Black | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Esophagogastric | NA | 0 | 191 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Esophagogastric | Other | 0 | 46 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Esophagogastric | White | 1 | 1379 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Thyroid | Asian | 0 | 66 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G12 | Thyroid | Black | 0 | 40 | 0.001 | 0.000 | 0.000 | 0.011 |
| HRAS | G12 | Thyroid | NA | 1 | 79 | 0.007 | 0.003 | 0.000 | 0.037 |
| HRAS | G12 | Thyroid | Other | 0 | 26 | 0.002 | 0.000 | 0.000 | 0.014 |
| HRAS | G12 | Thyroid | White | 0 | 803 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Cervical | Asian | 0 | 27 | 0.004 | 0.002 | 0.000 | 0.016 |
| HRAS | G12 | Cervical | Black | 0 | 19 | 0.004 | 0.002 | 0.000 | 0.017 |
| HRAS | G12 | Cervical | NA | 0 | 77 | 0.003 | 0.002 | 0.000 | 0.013 |
| HRAS | G12 | Cervical | Other | 0 | 15 | 0.004 | 0.002 | 0.000 | 0.017 |
| HRAS | G12 | Cervical | White | 1 | 228 | 0.004 | 0.003 | 0.000 | 0.012 |
| HRAS | G12 | Hepatobiliary | Asian | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | Black | 0 | 64 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | NA | 0 | 235 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | Other | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | White | 0 | 948 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Asian | 0 | 154 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Black | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | NA | 0 | 817 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Other | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Undefined | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | White | 0 | 3330 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | Asian | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | Black | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | NA | 0 | 289 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | Other | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | White | 0 | 1882 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Anal | NA | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12 | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Neuroendocrine | Black | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Neuroendocrine | NA | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Neuroendocrine | White | 0 | 283 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bladder | Asian | 2 | 40 | 0.020 | 0.013 | 0.006 | 0.075 |
| HRAS | G12 | Bladder | Black | 0 | 43 | 0.011 | 0.010 | 0.001 | 0.030 |
| HRAS | G12 | Bladder | NA | 2 | 169 | 0.012 | 0.011 | 0.004 | 0.026 |
| HRAS | G12 | Bladder | Other | 1 | 14 | 0.021 | 0.012 | 0.005 | 0.099 |
| HRAS | G12 | Bladder | White | 11 | 1310 | 0.010 | 0.009 | 0.005 | 0.015 |
| HRAS | G12 | BLL/Lymphoma | Asian | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | BLL/Lymphoma | NA | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | BLL/Lymphoma | White | 0 | 125 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Small bowel | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Small bowel | NA | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Small bowel | White | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G12 | Sex cord stromal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | Black | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | White | 0 | 379 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Vaginal | White | 1 | 68 | 0.017 | 0.013 | 0.001 | 0.057 |
| HRAS | G12 | Thymic | Asian | 0 | 13 | 0.009 | 0.005 | 0.000 | 0.043 |
| HRAS | G12 | Thymic | NA | 0 | 23 | 0.008 | 0.005 | 0.000 | 0.037 |
| HRAS | G12 | Thymic | White | 1 | 106 | 0.009 | 0.007 | 0.000 | 0.030 |
| HRAS | G12 | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | SCLC | Asian | 0 | 15 | 0.004 | 0.002 | 0.000 | 0.025 |
| HRAS | G12 | SCLC | NA | 0 | 30 | 0.004 | 0.002 | 0.000 | 0.019 |
| HRAS | G12 | SCLC | White | 1 | 337 | 0.003 | 0.002 | 0.000 | 0.011 |
| HRAS | G12 | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | T / NK neoplasms | White | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Germ cell | Asian | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | Black | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | NA | 0 | 179 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | Other | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | White | 0 | 603 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Nerve sheath | Black | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Nerve sheath | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.031 |
| HRAS | G12 | Pheochromocytoma | White | 0 | 15 | 0.004 | 0.000 | 0.000 | 0.047 |
| HRAS | G12 | Pineal | White | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.030 |
| HRAS | G12 | B cell lymphoma | Asian | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | B cell lymphoma | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | B cell lymphoma | NA | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | Other | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | White | 0 | 858 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.029 |
| HRAS | G12 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.031 |
| HRAS | G12 | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | G12 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | G12 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.019 |
| HRAS | G12 | Hodgkin lymphoma | White | 0 | 30 | 0.002 | 0.000 | 0.000 | 0.022 |
| HRAS | G12 | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.020 |
| HRAS | G12 | Peritoneal | White | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.058 |
| HRAS | G12 | Parathyroid | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.043 |
| HRAS | G12C | Appendiceal | Black | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Appendiceal | NA | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Appendiceal | White | 0 | 280 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | CRC | Asian | 0 | 313 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | Black | 0 | 514 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | NA | 0 | 804 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | Native American | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | Other | 0 | 139 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | White | 0 | 4922 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Asian | 0 | 73 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Black | 0 | 123 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | NA | 0 | 286 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Other | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | White | 0 | 1461 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Asian | 0 | 624 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Black | 0 | 717 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | NA | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Native American | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Other | 0 | 165 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Undefined | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | White | 0 | 7745 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Breast | Asian | 0 | 334 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | Black | 0 | 525 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | NA | 0 | 3112 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | Native American | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Breast | Other | 0 | 176 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | White | 2 | 5174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Pancreatic | Asian | 0 | 100 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | Black | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | NA | 0 | 231 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | Other | 0 | 34 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | White | 0 | 2037 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Asian | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Black | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | NA | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Other | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | White | 0 | 655 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Black | 0 | 34 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | NA | 0 | 398 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Other | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | White | 0 | 2348 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | Asian | 0 | 94 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | Black | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | NA | 0 | 292 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | Other | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | White | 0 | 1264 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | Asian | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | Black | 0 | 162 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | NA | 0 | 189 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | Other | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | White | 0 | 1750 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Non-melanoma skin | Asian | 0 | 11 | 0.003 | 0.002 | 0.000 | 0.019 |
| HRAS | G12C | Non-melanoma skin | Black | 0 | 13 | 0.003 | 0.001 | 0.000 | 0.018 |
| HRAS | G12C | Non-melanoma skin | NA | 0 | 53 | 0.002 | 0.001 | 0.000 | 0.012 |
| HRAS | G12C | Non-melanoma skin | White | 1 | 436 | 0.002 | 0.002 | 0.000 | 0.008 |
| HRAS | G12C | MDS/MPN | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | Black | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | NA | 0 | 571 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | White | 0 | 584 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Adrenocortical | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Soft tissue sarcoma | Asian | 0 | 143 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | Black | 0 | 190 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | NA | 0 | 347 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | Other | 0 | 73 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | White | 0 | 1976 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | Asian | 0 | 134 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | Black | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | NA | 0 | 239 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | Other | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | White | 0 | 1852 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Asian | 0 | 115 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Black | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | NA | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Other | 0 | 46 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | White | 0 | 1379 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | Asian | 0 | 66 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | Black | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | NA | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | Other | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | White | 0 | 803 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Cervical | Asian | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Cervical | Black | 0 | 19 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Cervical | NA | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Cervical | Other | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Cervical | White | 0 | 228 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | Asian | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | Black | 0 | 64 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | NA | 0 | 235 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | Other | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | White | 0 | 948 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Asian | 0 | 154 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Black | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | NA | 0 | 817 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Other | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Undefined | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | White | 0 | 3330 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | Asian | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | Black | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | NA | 0 | 289 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | Other | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | White | 0 | 1882 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Anal | NA | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Neuroendocrine | Black | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Neuroendocrine | NA | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Neuroendocrine | White | 0 | 283 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Bladder | Asian | 0 | 40 | 0.004 | 0.002 | 0.000 | 0.019 |
| HRAS | G12C | Bladder | Black | 0 | 43 | 0.003 | 0.002 | 0.000 | 0.018 |
| HRAS | G12C | Bladder | NA | 1 | 169 | 0.004 | 0.003 | 0.000 | 0.016 |
| HRAS | G12C | Bladder | Other | 1 | 14 | 0.019 | 0.004 | 0.001 | 0.126 |
| HRAS | G12C | Bladder | White | 1 | 1310 | 0.002 | 0.001 | 0.000 | 0.004 |
| HRAS | G12C | BLL/Lymphoma | Asian | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | BLL/Lymphoma | NA | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | BLL/Lymphoma | White | 0 | 125 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Small bowel | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Small bowel | NA | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Small bowel | White | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.010 |
| HRAS | G12C | Sex cord stromal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12C | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Bone | Black | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Bone | White | 0 | 379 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Vaginal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | G12C | Thymic | Asian | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Thymic | NA | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Thymic | White | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | SCLC | Asian | 0 | 15 | 0.004 | 0.002 | 0.000 | 0.023 |
| HRAS | G12C | SCLC | NA | 0 | 30 | 0.004 | 0.002 | 0.000 | 0.018 |
| HRAS | G12C | SCLC | White | 1 | 337 | 0.003 | 0.002 | 0.000 | 0.011 |
| HRAS | G12C | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | T / NK neoplasms | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | T / NK neoplasms | White | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Germ cell | Asian | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Germ cell | Black | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Germ cell | NA | 0 | 179 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | Other | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | White | 0 | 603 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Nerve sheath | Black | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12C | Nerve sheath | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Nerve sheath | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.039 |
| HRAS | G12C | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | G12C | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.039 |
| HRAS | G12C | B cell lymphoma | Asian | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | NA | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | Other | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | White | 0 | 858 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.027 |
| HRAS | G12C | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.029 |
| HRAS | G12C | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | G12C | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| HRAS | G12C | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| HRAS | G12C | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.017 |
| HRAS | G12C | Lung | White | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.039 |
| HRAS | G12C | Peritoneal | White | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| HRAS | G12C | Parathyroid | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| HRAS | G13 | Appendiceal | Black | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Appendiceal | NA | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Appendiceal | White | 0 | 280 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | Asian | 0 | 313 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | Black | 0 | 514 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | NA | 1 | 804 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | CRC | Native American | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | CRC | Other | 0 | 139 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | CRC | White | 0 | 4922 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CUP | Asian | 0 | 73 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G13 | CUP | Black | 1 | 123 | 0.003 | 0.002 | 0.000 | 0.012 |
| HRAS | G13 | CUP | NA | 0 | 286 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | G13 | CUP | Other | 0 | 36 | 0.002 | 0.002 | 0.000 | 0.008 |
| HRAS | G13 | CUP | White | 3 | 1461 | 0.002 | 0.002 | 0.001 | 0.005 |
| HRAS | G13 | NSCLC | Asian | 0 | 624 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | NSCLC | Black | 0 | 717 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | NSCLC | NA | 0 | 849 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | NSCLC | Native American | 0 | 17 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | NSCLC | Other | 0 | 165 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | NSCLC | Undefined | 0 | 10 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | NSCLC | White | 10 | 7745 | 0.001 | 0.001 | 0.001 | 0.002 |
| HRAS | G13 | Breast | Asian | 0 | 334 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | Breast | Black | 1 | 525 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Breast | NA | 1 | 3112 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | G13 | Breast | Native American | 0 | 11 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Breast | Other | 0 | 176 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | Breast | White | 4 | 5174 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | G13 | Pancreatic | Asian | 0 | 100 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Pancreatic | Black | 0 | 88 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Pancreatic | NA | 0 | 231 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Pancreatic | Other | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Pancreatic | White | 1 | 2037 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Leukemia | Asian | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | Black | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | NA | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | Other | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | White | 0 | 655 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Melanoma | Asian | 1 | 33 | 0.009 | 0.006 | 0.002 | 0.036 |
| HRAS | G13 | Melanoma | Black | 0 | 34 | 0.006 | 0.005 | 0.001 | 0.018 |
| HRAS | G13 | Melanoma | NA | 1 | 398 | 0.005 | 0.005 | 0.001 | 0.010 |
| HRAS | G13 | Melanoma | Other | 0 | 26 | 0.006 | 0.005 | 0.001 | 0.018 |
| HRAS | G13 | Melanoma | White | 14 | 2348 | 0.006 | 0.006 | 0.003 | 0.009 |
| HRAS | G13 | Head and neck | Asian | 2 | 94 | 0.014 | 0.011 | 0.004 | 0.041 |
| HRAS | G13 | Head and neck | Black | 3 | 62 | 0.023 | 0.015 | 0.005 | 0.077 |
| HRAS | G13 | Head and neck | NA | 1 | 292 | 0.007 | 0.007 | 0.001 | 0.015 |
| HRAS | G13 | Head and neck | Other | 0 | 28 | 0.010 | 0.008 | 0.000 | 0.035 |
| HRAS | G13 | Head and neck | White | 8 | 1264 | 0.007 | 0.007 | 0.003 | 0.012 |
| HRAS | G13 | Uterine | Asian | 0 | 108 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Uterine | Black | 0 | 162 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Uterine | NA | 0 | 189 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Uterine | Other | 0 | 37 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Uterine | White | 1 | 1750 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Non-melanoma skin | Asian | 0 | 11 | 0.007 | 0.005 | 0.000 | 0.027 |
| HRAS | G13 | Non-melanoma skin | Black | 0 | 13 | 0.007 | 0.005 | 0.000 | 0.023 |
| HRAS | G13 | Non-melanoma skin | NA | 0 | 53 | 0.006 | 0.005 | 0.000 | 0.018 |
| HRAS | G13 | Non-melanoma skin | White | 3 | 436 | 0.006 | 0.006 | 0.001 | 0.015 |
| HRAS | G13 | MDS/MPN | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | Black | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | NA | 0 | 571 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | White | 0 | 584 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G13 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Soft tissue sarcoma | Asian | 0 | 143 | 0.002 | 0.001 | 0.000 | 0.007 |
| HRAS | G13 | Soft tissue sarcoma | Black | 0 | 190 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Soft tissue sarcoma | NA | 3 | 347 | 0.005 | 0.004 | 0.001 | 0.016 |
| HRAS | G13 | Soft tissue sarcoma | Other | 0 | 73 | 0.002 | 0.001 | 0.000 | 0.009 |
| HRAS | G13 | Soft tissue sarcoma | White | 2 | 1976 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Ovarian | Asian | 0 | 134 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Ovarian | Black | 0 | 74 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Ovarian | NA | 0 | 239 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Ovarian | Other | 0 | 36 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Ovarian | White | 1 | 1852 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Esophagogastric | Asian | 1 | 115 | 0.004 | 0.002 | 0.000 | 0.023 |
| HRAS | G13 | Esophagogastric | Black | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G13 | Esophagogastric | NA | 0 | 191 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Esophagogastric | Other | 0 | 46 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G13 | Esophagogastric | White | 0 | 1379 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Thyroid | Asian | 0 | 66 | 0.002 | 0.002 | 0.000 | 0.008 |
| HRAS | G13 | Thyroid | Black | 0 | 40 | 0.002 | 0.002 | 0.000 | 0.009 |
| HRAS | G13 | Thyroid | NA | 0 | 79 | 0.002 | 0.002 | 0.000 | 0.008 |
| HRAS | G13 | Thyroid | Other | 0 | 26 | 0.002 | 0.002 | 0.000 | 0.009 |
| HRAS | G13 | Thyroid | White | 2 | 803 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | G13 | Cervical | Asian | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Cervical | Black | 0 | 19 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Cervical | NA | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Cervical | Other | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Cervical | White | 0 | 228 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Hepatobiliary | Asian | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | Black | 0 | 64 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | NA | 0 | 235 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | Other | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | White | 0 | 948 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | CNS | Asian | 0 | 154 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | CNS | Black | 0 | 131 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | CNS | NA | 1 | 817 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | CNS | Other | 0 | 108 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | CNS | Undefined | 0 | 17 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | CNS | White | 2 | 3330 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | Prostate | Asian | 0 | 62 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | G13 | Prostate | Black | 0 | 175 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | Prostate | NA | 1 | 289 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Prostate | Other | 0 | 31 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Prostate | White | 2 | 1882 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Anal | NA | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.010 |
| HRAS | G13 | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Neuroendocrine | Black | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Neuroendocrine | NA | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Neuroendocrine | White | 0 | 283 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bladder | Asian | 0 | 40 | 0.008 | 0.008 | 0.001 | 0.019 |
| HRAS | G13 | Bladder | Black | 0 | 43 | 0.008 | 0.008 | 0.001 | 0.020 |
| HRAS | G13 | Bladder | NA | 2 | 169 | 0.009 | 0.008 | 0.003 | 0.020 |
| HRAS | G13 | Bladder | Other | 0 | 14 | 0.009 | 0.008 | 0.001 | 0.022 |
| HRAS | G13 | Bladder | White | 11 | 1310 | 0.008 | 0.008 | 0.004 | 0.014 |
| HRAS | G13 | BLL/Lymphoma | Asian | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | BLL/Lymphoma | NA | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | BLL/Lymphoma | White | 0 | 125 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Small bowel | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Small bowel | NA | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Small bowel | White | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G13 | Sex cord stromal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bone | Black | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bone | White | 0 | 379 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Vaginal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Thymic | Asian | 0 | 13 | 0.009 | 0.005 | 0.000 | 0.041 |
| HRAS | G13 | Thymic | NA | 0 | 23 | 0.008 | 0.005 | 0.000 | 0.034 |
| HRAS | G13 | Thymic | White | 1 | 106 | 0.009 | 0.006 | 0.000 | 0.030 |
| HRAS | G13 | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | SCLC | Asian | 0 | 15 | 0.004 | 0.002 | 0.000 | 0.022 |
| HRAS | G13 | SCLC | NA | 0 | 30 | 0.004 | 0.002 | 0.000 | 0.018 |
| HRAS | G13 | SCLC | White | 1 | 337 | 0.003 | 0.002 | 0.000 | 0.011 |
| HRAS | G13 | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | T / NK neoplasms | White | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Germ cell | Asian | 0 | 36 | 0.002 | 0.001 | 0.000 | 0.009 |
| HRAS | G13 | Germ cell | Black | 0 | 23 | 0.002 | 0.001 | 0.000 | 0.012 |
| HRAS | G13 | Germ cell | NA | 1 | 179 | 0.003 | 0.002 | 0.000 | 0.012 |
| HRAS | G13 | Germ cell | Other | 0 | 36 | 0.002 | 0.001 | 0.000 | 0.009 |
| HRAS | G13 | Germ cell | White | 0 | 603 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | Nerve sheath | Black | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Nerve sheath | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Penile | White | 0 | 20 | 0.002 | 0.000 | 0.000 | 0.029 |
| HRAS | G13 | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.040 |
| HRAS | G13 | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| HRAS | G13 | B cell lymphoma | Asian | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | B cell lymphoma | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | B cell lymphoma | NA | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | B cell lymphoma | Other | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | B cell lymphoma | White | 0 | 858 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.025 |
| HRAS | G13 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.033 |
| HRAS | G13 | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.026 |
| HRAS | G13 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | G13 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.018 |
| HRAS | G13 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G13 | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.030 |
| HRAS | G13 | Peritoneal | White | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.048 |
| HRAS | G13 | Parathyroid | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.051 |
| HRAS | Q61 | Appendiceal | Black | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Appendiceal | NA | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Appendiceal | White | 0 | 280 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CRC | Asian | 0 | 313 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | Black | 0 | 514 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | NA | 0 | 804 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | Native American | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | Other | 0 | 139 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | White | 0 | 4922 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CUP | Asian | 0 | 73 | 0.002 | 0.001 | 0.000 | 0.007 |
| HRAS | Q61 | CUP | Black | 0 | 123 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | Q61 | CUP | NA | 0 | 286 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | Q61 | CUP | Other | 0 | 36 | 0.002 | 0.002 | 0.000 | 0.008 |
| HRAS | Q61 | CUP | White | 4 | 1461 | 0.002 | 0.002 | 0.001 | 0.005 |
| HRAS | Q61 | NSCLC | Asian | 0 | 624 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | NSCLC | Black | 0 | 717 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | NSCLC | NA | 3 | 849 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | Q61 | NSCLC | Native American | 0 | 17 | 0.001 | 0.001 | 0.000 | 0.007 |
| HRAS | Q61 | NSCLC | Other | 0 | 165 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | NSCLC | Undefined | 0 | 10 | 0.002 | 0.001 | 0.000 | 0.009 |
| HRAS | Q61 | NSCLC | White | 4 | 7745 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | Q61 | Breast | Asian | 1 | 334 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Breast | Black | 0 | 525 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Breast | NA | 2 | 3112 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Breast | Native American | 0 | 11 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Breast | Other | 0 | 176 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Breast | White | 5 | 5174 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Pancreatic | Asian | 0 | 100 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Pancreatic | Black | 0 | 88 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Pancreatic | NA | 0 | 231 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Pancreatic | Other | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Pancreatic | White | 1 | 2037 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Leukemia | Asian | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | Black | 0 | 69 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | NA | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | Other | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | White | 0 | 655 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Melanoma | Asian | 0 | 33 | 0.003 | 0.002 | 0.000 | 0.014 |
| HRAS | Q61 | Melanoma | Black | 0 | 34 | 0.003 | 0.002 | 0.000 | 0.014 |
| HRAS | Q61 | Melanoma | NA | 0 | 398 | 0.002 | 0.001 | 0.000 | 0.007 |
| HRAS | Q61 | Melanoma | Other | 0 | 26 | 0.003 | 0.002 | 0.000 | 0.015 |
| HRAS | Q61 | Melanoma | White | 13 | 2348 | 0.005 | 0.005 | 0.003 | 0.009 |
| HRAS | Q61 | Head and neck | Asian | 0 | 94 | 0.010 | 0.010 | 0.001 | 0.019 |
| HRAS | Q61 | Head and neck | Black | 1 | 62 | 0.012 | 0.011 | 0.003 | 0.028 |
| HRAS | Q61 | Head and neck | NA | 2 | 292 | 0.010 | 0.010 | 0.003 | 0.018 |
| HRAS | Q61 | Head and neck | Other | 0 | 28 | 0.011 | 0.010 | 0.001 | 0.024 |
| HRAS | Q61 | Head and neck | White | 17 | 1264 | 0.012 | 0.012 | 0.007 | 0.019 |
| HRAS | Q61 | Uterine | Asian | 0 | 108 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Uterine | Black | 0 | 162 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Uterine | NA | 0 | 189 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Uterine | Other | 0 | 37 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Uterine | White | 1 | 1750 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Non-melanoma skin | Asian | 0 | 11 | 0.013 | 0.011 | 0.000 | 0.039 |
| HRAS | Q61 | Non-melanoma skin | Black | 0 | 13 | 0.013 | 0.011 | 0.000 | 0.040 |
| HRAS | Q61 | Non-melanoma skin | NA | 1 | 53 | 0.014 | 0.012 | 0.003 | 0.040 |
| HRAS | Q61 | Non-melanoma skin | White | 5 | 436 | 0.012 | 0.011 | 0.004 | 0.023 |
| HRAS | Q61 | MDS/MPN | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | Black | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | NA | 0 | 571 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | White | 0 | 584 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Soft tissue sarcoma | Asian | 0 | 143 | 0.001 | 0.001 | 0.000 | 0.007 |
| HRAS | Q61 | Soft tissue sarcoma | Black | 0 | 190 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | Q61 | Soft tissue sarcoma | NA | 3 | 347 | 0.005 | 0.004 | 0.001 | 0.017 |
| HRAS | Q61 | Soft tissue sarcoma | Other | 0 | 73 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | Q61 | Soft tissue sarcoma | White | 1 | 1976 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Ovarian | Asian | 0 | 134 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | Black | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | NA | 0 | 239 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | Other | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | White | 0 | 1852 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Esophagogastric | Asian | 0 | 115 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Esophagogastric | Black | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Esophagogastric | NA | 0 | 191 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Esophagogastric | Other | 0 | 46 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Esophagogastric | White | 1 | 1379 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Thyroid | Asian | 4 | 66 | 0.044 | 0.043 | 0.025 | 0.077 |
| HRAS | Q61 | Thyroid | Black | 1 | 40 | 0.041 | 0.040 | 0.018 | 0.067 |
| HRAS | Q61 | Thyroid | NA | 2 | 79 | 0.040 | 0.040 | 0.018 | 0.061 |
| HRAS | Q61 | Thyroid | Other | 2 | 26 | 0.045 | 0.042 | 0.023 | 0.085 |
| HRAS | Q61 | Thyroid | White | 33 | 803 | 0.041 | 0.041 | 0.030 | 0.055 |
| HRAS | Q61 | Cervical | Asian | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Cervical | Black | 0 | 19 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Cervical | NA | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Cervical | Other | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Cervical | White | 0 | 228 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Hepatobiliary | Asian | 0 | 97 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Hepatobiliary | Black | 0 | 64 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Hepatobiliary | NA | 0 | 235 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Hepatobiliary | Other | 0 | 25 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | Q61 | Hepatobiliary | White | 1 | 948 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CNS | Asian | 0 | 154 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | CNS | Black | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | CNS | NA | 0 | 817 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CNS | Other | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | CNS | Undefined | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | CNS | White | 1 | 3330 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Prostate | Asian | 1 | 62 | 0.008 | 0.006 | 0.002 | 0.025 |
| HRAS | Q61 | Prostate | Black | 3 | 175 | 0.009 | 0.007 | 0.003 | 0.025 |
| HRAS | Q61 | Prostate | NA | 1 | 289 | 0.006 | 0.005 | 0.001 | 0.012 |
| HRAS | Q61 | Prostate | Other | 0 | 31 | 0.007 | 0.005 | 0.001 | 0.019 |
| HRAS | Q61 | Prostate | White | 8 | 1882 | 0.005 | 0.005 | 0.002 | 0.008 |
| HRAS | Q61 | Anal | NA | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Neuroendocrine | Black | 0 | 23 | 0.004 | 0.002 | 0.000 | 0.020 |
| HRAS | Q61 | Neuroendocrine | NA | 0 | 45 | 0.003 | 0.002 | 0.000 | 0.016 |
| HRAS | Q61 | Neuroendocrine | White | 1 | 283 | 0.003 | 0.003 | 0.000 | 0.012 |
| HRAS | Q61 | Bladder | Asian | 1 | 40 | 0.019 | 0.018 | 0.007 | 0.042 |
| HRAS | Q61 | Bladder | Black | 0 | 43 | 0.017 | 0.017 | 0.003 | 0.032 |
| HRAS | Q61 | Bladder | NA | 2 | 169 | 0.017 | 0.017 | 0.006 | 0.030 |
| HRAS | Q61 | Bladder | Other | 1 | 14 | 0.023 | 0.019 | 0.008 | 0.070 |
| HRAS | Q61 | Bladder | White | 25 | 1310 | 0.019 | 0.018 | 0.013 | 0.026 |
| HRAS | Q61 | BLL/Lymphoma | Asian | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | BLL/Lymphoma | NA | 0 | 92 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | BLL/Lymphoma | White | 0 | 125 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Small bowel | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Small bowel | NA | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Small bowel | White | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | Q61 | Sex cord stromal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | Black | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | White | 0 | 379 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Vaginal | White | 1 | 68 | 0.017 | 0.013 | 0.001 | 0.058 |
| HRAS | Q61 | Thymic | Asian | 0 | 13 | 0.019 | 0.015 | 0.000 | 0.063 |
| HRAS | Q61 | Thymic | NA | 0 | 23 | 0.018 | 0.014 | 0.000 | 0.057 |
| HRAS | Q61 | Thymic | White | 3 | 106 | 0.024 | 0.022 | 0.005 | 0.058 |
| HRAS | Q61 | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | SCLC | Asian | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | SCLC | NA | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | SCLC | White | 0 | 337 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | T / NK neoplasms | White | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Germ cell | Asian | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | Black | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | NA | 0 | 179 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | Other | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | White | 0 | 603 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Nerve sheath | Black | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Nerve sheath | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | Q61 | Pheochromocytoma | White | 0 | 15 | 0.002 | 0.000 | 0.000 | 0.021 |
| HRAS | Q61 | Pineal | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| HRAS | Q61 | B cell lymphoma | Asian | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | NA | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | Other | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | White | 0 | 858 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Non-hodgkin lymphoma | White | 0 | 19 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | Q61 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.028 |
| HRAS | Q61 | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | Q61 | Retinoblastoma | NA | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | Q61 | Retinoblastoma | White | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | Q61 | Hodgkin lymphoma | White | 0 | 30 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | Q61 | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.022 |
| HRAS | Q61 | Peritoneal | White | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.038 |
| HRAS | Q61 | Parathyroid | White | 1 | 14 | 0.080 | 0.062 | 0.004 | 0.253 |
| HRAS | 12, 13, or 61 | Appendiceal | Female | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Appendiceal | Male | 0 | 167 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | CRC | Female | 3 | 3026 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | CRC | Male | 2 | 3694 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | CUP | Female | 7 | 999 | 0.006 | 0.006 | 0.003 | 0.011 |
| HRAS | 12, 13, or 61 | CUP | Male | 3 | 986 | 0.004 | 0.004 | 0.001 | 0.008 |
| HRAS | 12, 13, or 61 | NSCLC | Female | 10 | 5722 | 0.002 | 0.002 | 0.001 | 0.003 |
| HRAS | 12, 13, or 61 | NSCLC | Male | 8 | 4406 | 0.002 | 0.002 | 0.001 | 0.003 |
| HRAS | 12, 13, or 61 | Breast | Female | 23 | 9283 | 0.002 | 0.002 | 0.002 | 0.004 |
| HRAS | 12, 13, or 61 | Breast | Male | 0 | 48 | 0.003 | 0.002 | 0.000 | 0.014 |
| HRAS | 12, 13, or 61 | Pancreatic | Female | 1 | 1153 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Pancreatic | Male | 2 | 1340 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Leukemia | Female | 0 | 635 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | Male | 0 | 925 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Melanoma | Female | 12 | 1104 | 0.012 | 0.012 | 0.007 | 0.018 |
| HRAS | 12, 13, or 61 | Melanoma | Male | 25 | 1742 | 0.014 | 0.013 | 0.009 | 0.019 |
| HRAS | 12, 13, or 61 | Head and neck | Female | 15 | 564 | 0.027 | 0.027 | 0.018 | 0.039 |
| HRAS | 12, 13, or 61 | Head and neck | Male | 33 | 1179 | 0.028 | 0.028 | 0.020 | 0.037 |
| HRAS | 12, 13, or 61 | Uterine | Female | 6 | 2248 | 0.003 | 0.003 | 0.001 | 0.005 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | Female | 1 | 183 | 0.011 | 0.009 | 0.001 | 0.034 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | Male | 14 | 330 | 0.040 | 0.039 | 0.021 | 0.064 |
| HRAS | 12, 13, or 61 | MDS/MPN | Female | 0 | 482 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | Male | 0 | 724 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Female | 4 | 1400 | 0.004 | 0.004 | 0.001 | 0.007 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Male | 8 | 1338 | 0.005 | 0.005 | 0.002 | 0.009 |
| HRAS | 12, 13, or 61 | Ovarian | Female | 1 | 2336 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Esophagogastric | Female | 1 | 504 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Esophagogastric | Male | 2 | 1297 | 0.002 | 0.002 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Thyroid | Female | 27 | 537 | 0.047 | 0.046 | 0.033 | 0.065 |
| HRAS | 12, 13, or 61 | Thyroid | Male | 18 | 480 | 0.041 | 0.041 | 0.027 | 0.058 |
| HRAS | 12, 13, or 61 | Cervical | Female | 1 | 365 | 0.003 | 0.002 | 0.000 | 0.011 |
| HRAS | 12, 13, or 61 | Hepatobiliary | Female | 0 | 636 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Hepatobiliary | Male | 1 | 738 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | CNS | Female | 0 | 1993 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | CNS | Male | 4 | 2569 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Prostate | Male | 16 | 2436 | 0.007 | 0.006 | 0.004 | 0.010 |
| HRAS | 12, 13, or 61 | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Neuroendocrine | Female | 0 | 166 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | 12, 13, or 61 | Neuroendocrine | Male | 1 | 193 | 0.004 | 0.003 | 0.000 | 0.016 |
| HRAS | 12, 13, or 61 | Bladder | Female | 12 | 393 | 0.034 | 0.034 | 0.020 | 0.048 |
| HRAS | 12, 13, or 61 | Bladder | Male | 45 | 1187 | 0.037 | 0.037 | 0.028 | 0.048 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | Female | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | Male | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Small bowel | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Small bowel | Male | 0 | 132 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Sex cord stromal | Female | 0 | 97 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Sex cord stromal | Male | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.014 |
| HRAS | 12, 13, or 61 | Bone | Female | 0 | 237 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | Male | 0 | 318 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Vaginal | Female | 2 | 78 | 0.028 | 0.024 | 0.004 | 0.072 |
| HRAS | 12, 13, or 61 | Thymic | Female | 2 | 68 | 0.033 | 0.031 | 0.009 | 0.072 |
| HRAS | 12, 13, or 61 | Thymic | Male | 3 | 86 | 0.034 | 0.032 | 0.010 | 0.074 |
| HRAS | 12, 13, or 61 | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | SCLC | Female | 2 | 193 | 0.009 | 0.007 | 0.001 | 0.025 |
| HRAS | 12, 13, or 61 | SCLC | Male | 0 | 205 | 0.003 | 0.001 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | Male | 0 | 123 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Germ cell | Female | 0 | 175 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Germ cell | Male | 1 | 710 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Nerve sheath | Female | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Nerve sheath | Male | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| HRAS | 12, 13, or 61 | Pheochromocytoma | Male | 1 | 17 | 0.066 | 0.050 | 0.003 | 0.217 |
| HRAS | 12, 13, or 61 | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Female | 0 | 395 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Male | 0 | 566 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.028 |
| HRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.028 |
| HRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | 12, 13, or 61 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.013 |
| HRAS | 12, 13, or 61 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.039 |
| HRAS | 12, 13, or 61 | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.054 |
| HRAS | 12, 13, or 61 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | G12 | Appendiceal | Female | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Appendiceal | Male | 0 | 167 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | CRC | Female | 2 | 3026 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | CRC | Male | 2 | 3694 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | G12 | CUP | Female | 1 | 999 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | CUP | Male | 1 | 986 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | NSCLC | Female | 1 | 5722 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | Male | 0 | 4406 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Breast | Female | 9 | 9283 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Breast | Male | 0 | 48 | 0.001 | 0.001 | 0.000 | 0.009 |
| HRAS | G12 | Pancreatic | Female | 0 | 1153 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | Male | 0 | 1340 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Female | 0 | 635 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Male | 0 | 925 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Melanoma | Female | 3 | 1104 | 0.003 | 0.003 | 0.001 | 0.006 |
| HRAS | G12 | Melanoma | Male | 5 | 1742 | 0.003 | 0.003 | 0.001 | 0.005 |
| HRAS | G12 | Head and neck | Female | 6 | 564 | 0.009 | 0.009 | 0.004 | 0.017 |
| HRAS | G12 | Head and neck | Male | 8 | 1179 | 0.008 | 0.007 | 0.004 | 0.013 |
| HRAS | G12 | Uterine | Female | 4 | 2248 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | G12 | Non-melanoma skin | Female | 1 | 183 | 0.010 | 0.009 | 0.001 | 0.023 |
| HRAS | G12 | Non-melanoma skin | Male | 5 | 330 | 0.013 | 0.012 | 0.005 | 0.027 |
| HRAS | G12 | MDS/MPN | Female | 0 | 482 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | Male | 0 | 724 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Soft tissue sarcoma | Female | 1 | 1400 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Soft tissue sarcoma | Male | 2 | 1338 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Ovarian | Female | 1 | 2336 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Esophagogastric | Female | 0 | 504 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Esophagogastric | Male | 1 | 1297 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Thyroid | Female | 1 | 537 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G12 | Thyroid | Male | 0 | 480 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Cervical | Female | 1 | 365 | 0.003 | 0.002 | 0.000 | 0.011 |
| HRAS | G12 | Hepatobiliary | Female | 0 | 636 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | Male | 0 | 738 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Female | 0 | 1993 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Male | 0 | 2569 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | Male | 0 | 2436 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Neuroendocrine | Female | 0 | 166 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Neuroendocrine | Male | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bladder | Female | 3 | 393 | 0.009 | 0.009 | 0.003 | 0.017 |
| HRAS | G12 | Bladder | Male | 13 | 1187 | 0.011 | 0.010 | 0.006 | 0.016 |
| HRAS | G12 | BLL/Lymphoma | Female | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | BLL/Lymphoma | Male | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Small bowel | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Small bowel | Male | 0 | 132 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Sex cord stromal | Male | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G12 | Bone | Female | 0 | 237 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Bone | Male | 0 | 318 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Vaginal | Female | 1 | 78 | 0.015 | 0.011 | 0.001 | 0.051 |
| HRAS | G12 | Thymic | Female | 0 | 68 | 0.006 | 0.003 | 0.000 | 0.025 |
| HRAS | G12 | Thymic | Male | 1 | 86 | 0.009 | 0.007 | 0.000 | 0.034 |
| HRAS | G12 | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | SCLC | Female | 1 | 193 | 0.004 | 0.003 | 0.000 | 0.016 |
| HRAS | G12 | SCLC | Male | 0 | 205 | 0.002 | 0.001 | 0.000 | 0.009 |
| HRAS | G12 | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | T / NK neoplasms | Male | 0 | 123 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | Female | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | Male | 0 | 710 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Nerve sheath | Female | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Nerve sheath | Male | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.022 |
| HRAS | G12 | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.039 |
| HRAS | G12 | Pineal | Male | 0 | 12 | 0.005 | 0.000 | 0.000 | 0.057 |
| HRAS | G12 | B cell lymphoma | Female | 0 | 395 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | Male | 0 | 566 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.035 |
| HRAS | G12 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | G12 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.021 |
| HRAS | G12 | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.002 | 0.000 | 0.000 | 0.018 |
| HRAS | G12 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.011 |
| HRAS | G12 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.010 |
| HRAS | G12 | Hodgkin lymphoma | Female | 0 | 16 | 0.002 | 0.000 | 0.000 | 0.018 |
| HRAS | G12 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | G12 | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.033 |
| HRAS | G12 | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.056 |
| HRAS | G12 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | G12C | Appendiceal | Female | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Appendiceal | Male | 0 | 167 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | CRC | Female | 0 | 3026 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | Male | 0 | 3694 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Female | 0 | 999 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Male | 0 | 986 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Female | 0 | 5722 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Male | 0 | 4406 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Breast | Female | 2 | 9283 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | Male | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G12C | Pancreatic | Female | 0 | 1153 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | Male | 0 | 1340 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Female | 0 | 635 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Male | 0 | 925 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Female | 0 | 1104 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Male | 0 | 1742 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | Female | 0 | 564 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | Male | 0 | 1179 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | Female | 0 | 2248 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Non-melanoma skin | Female | 0 | 183 | 0.002 | 0.001 | 0.000 | 0.008 |
| HRAS | G12C | Non-melanoma skin | Male | 1 | 330 | 0.003 | 0.002 | 0.000 | 0.010 |
| HRAS | G12C | MDS/MPN | Female | 0 | 482 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | Male | 0 | 724 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Soft tissue sarcoma | Female | 0 | 1400 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | Male | 0 | 1338 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | Female | 0 | 2336 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Female | 0 | 504 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Male | 0 | 1297 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | Female | 0 | 537 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | Male | 0 | 480 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Cervical | Female | 0 | 365 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | Female | 0 | 636 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | Male | 0 | 738 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Female | 0 | 1993 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Male | 0 | 2569 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | Male | 0 | 2436 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Neuroendocrine | Female | 0 | 166 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Neuroendocrine | Male | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Bladder | Female | 1 | 393 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G12C | Bladder | Male | 2 | 1187 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | G12C | BLL/Lymphoma | Female | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | BLL/Lymphoma | Male | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Small bowel | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Small bowel | Male | 0 | 132 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Sex cord stromal | Male | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12C | Bone | Female | 0 | 237 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Bone | Male | 0 | 318 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Vaginal | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12C | Thymic | Female | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | SCLC | Female | 1 | 193 | 0.004 | 0.003 | 0.000 | 0.016 |
| HRAS | G12C | SCLC | Male | 0 | 205 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | G12C | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | T / NK neoplasms | Male | 0 | 123 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Germ cell | Female | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | Male | 0 | 710 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Nerve sheath | Female | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Nerve sheath | Male | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| HRAS | G12C | Pheochromocytoma | Male | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.017 |
| HRAS | G12C | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | G12C | B cell lymphoma | Female | 0 | 395 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | Male | 0 | 566 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.025 |
| HRAS | G12C | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | G12C | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G12C | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G12C | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G12C | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G12C | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.011 |
| HRAS | G12C | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.010 |
| HRAS | G12C | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | G12C | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.082 |
| HRAS | G12C | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.033 |
| HRAS | G13 | Appendiceal | Female | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Appendiceal | Male | 0 | 167 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | Female | 1 | 3026 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | Male | 0 | 3694 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CUP | Female | 4 | 999 | 0.004 | 0.003 | 0.001 | 0.008 |
| HRAS | G13 | CUP | Male | 0 | 986 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | NSCLC | Female | 7 | 5722 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | NSCLC | Male | 3 | 4406 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | Breast | Female | 6 | 9283 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | G13 | Breast | Male | 0 | 48 | 0.001 | 0.001 | 0.000 | 0.011 |
| HRAS | G13 | Pancreatic | Female | 0 | 1153 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Pancreatic | Male | 1 | 1340 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Leukemia | Female | 0 | 635 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | Male | 0 | 925 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Melanoma | Female | 5 | 1104 | 0.005 | 0.005 | 0.002 | 0.009 |
| HRAS | G13 | Melanoma | Male | 11 | 1742 | 0.006 | 0.006 | 0.003 | 0.010 |
| HRAS | G13 | Head and neck | Female | 4 | 564 | 0.008 | 0.008 | 0.003 | 0.014 |
| HRAS | G13 | Head and neck | Male | 10 | 1179 | 0.008 | 0.008 | 0.004 | 0.014 |
| HRAS | G13 | Uterine | Female | 1 | 2248 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Non-melanoma skin | Female | 0 | 183 | 0.003 | 0.001 | 0.000 | 0.013 |
| HRAS | G13 | Non-melanoma skin | Male | 3 | 330 | 0.008 | 0.007 | 0.002 | 0.020 |
| HRAS | G13 | MDS/MPN | Female | 0 | 482 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | Male | 0 | 724 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Soft tissue sarcoma | Female | 1 | 1400 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | Soft tissue sarcoma | Male | 4 | 1338 | 0.002 | 0.002 | 0.001 | 0.006 |
| HRAS | G13 | Ovarian | Female | 1 | 2336 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Esophagogastric | Female | 1 | 504 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Esophagogastric | Male | 0 | 1297 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Thyroid | Female | 1 | 537 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | G13 | Thyroid | Male | 1 | 480 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G13 | Cervical | Female | 0 | 365 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | Female | 0 | 636 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | Male | 0 | 738 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | CNS | Female | 0 | 1993 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CNS | Male | 3 | 2569 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Prostate | Male | 3 | 2436 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Neuroendocrine | Female | 0 | 166 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Neuroendocrine | Male | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bladder | Female | 2 | 393 | 0.007 | 0.007 | 0.002 | 0.014 |
| HRAS | G13 | Bladder | Male | 11 | 1187 | 0.009 | 0.008 | 0.005 | 0.014 |
| HRAS | G13 | BLL/Lymphoma | Female | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | BLL/Lymphoma | Male | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Small bowel | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Small bowel | Male | 0 | 132 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Sex cord stromal | Male | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | G13 | Bone | Female | 0 | 237 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bone | Male | 0 | 318 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Vaginal | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Thymic | Female | 1 | 68 | 0.011 | 0.008 | 0.000 | 0.042 |
| HRAS | G13 | Thymic | Male | 0 | 86 | 0.005 | 0.003 | 0.000 | 0.023 |
| HRAS | G13 | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | SCLC | Female | 1 | 193 | 0.004 | 0.003 | 0.000 | 0.016 |
| HRAS | G13 | SCLC | Male | 0 | 205 | 0.002 | 0.001 | 0.000 | 0.009 |
| HRAS | G13 | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | T / NK neoplasms | Male | 0 | 123 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Germ cell | Female | 0 | 175 | 0.001 | 0.001 | 0.000 | 0.006 |
| HRAS | G13 | Germ cell | Male | 1 | 710 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G13 | Nerve sheath | Female | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Nerve sheath | Male | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | G13 | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | G13 | Pineal | Male | 0 | 12 | 0.004 | 0.000 | 0.000 | 0.045 |
| HRAS | G13 | B cell lymphoma | Female | 0 | 395 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | B cell lymphoma | Male | 0 | 566 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.031 |
| HRAS | G13 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | G13 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.023 |
| HRAS | G13 | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.002 | 0.000 | 0.000 | 0.019 |
| HRAS | G13 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G13 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G13 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | G13 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.013 |
| HRAS | G13 | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.037 |
| HRAS | G13 | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.056 |
| HRAS | G13 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.040 |
| HRAS | Q61 | Appendiceal | Female | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Appendiceal | Male | 0 | 167 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CRC | Female | 0 | 3026 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | Male | 0 | 3694 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CUP | Female | 2 | 999 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | Q61 | CUP | Male | 2 | 986 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | Q61 | NSCLC | Female | 2 | 5722 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | Q61 | NSCLC | Male | 5 | 4406 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Breast | Female | 8 | 9283 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Breast | Male | 0 | 48 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | Q61 | Pancreatic | Female | 1 | 1153 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Pancreatic | Male | 1 | 1340 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Leukemia | Female | 0 | 635 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | Male | 0 | 925 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Melanoma | Female | 4 | 1104 | 0.004 | 0.004 | 0.002 | 0.008 |
| HRAS | Q61 | Melanoma | Male | 9 | 1742 | 0.005 | 0.005 | 0.002 | 0.008 |
| HRAS | Q61 | Head and neck | Female | 5 | 564 | 0.011 | 0.011 | 0.005 | 0.018 |
| HRAS | Q61 | Head and neck | Male | 15 | 1179 | 0.012 | 0.012 | 0.007 | 0.018 |
| HRAS | Q61 | Uterine | Female | 1 | 2248 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Non-melanoma skin | Female | 0 | 183 | 0.003 | 0.000 | 0.000 | 0.016 |
| HRAS | Q61 | Non-melanoma skin | Male | 6 | 330 | 0.017 | 0.016 | 0.006 | 0.034 |
| HRAS | Q61 | MDS/MPN | Female | 0 | 482 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | Male | 0 | 724 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Soft tissue sarcoma | Female | 2 | 1400 | 0.002 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Soft tissue sarcoma | Male | 2 | 1338 | 0.002 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Ovarian | Female | 0 | 2336 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Esophagogastric | Female | 0 | 504 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Esophagogastric | Male | 1 | 1297 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Thyroid | Female | 25 | 537 | 0.044 | 0.043 | 0.030 | 0.061 |
| HRAS | Q61 | Thyroid | Male | 17 | 480 | 0.039 | 0.039 | 0.025 | 0.055 |
| HRAS | Q61 | Cervical | Female | 0 | 365 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Hepatobiliary | Female | 0 | 636 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Hepatobiliary | Male | 1 | 738 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CNS | Female | 0 | 1993 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CNS | Male | 1 | 2569 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Prostate | Male | 13 | 2436 | 0.005 | 0.005 | 0.003 | 0.009 |
| HRAS | Q61 | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Neuroendocrine | Female | 0 | 166 | 0.002 | 0.001 | 0.000 | 0.011 |
| HRAS | Q61 | Neuroendocrine | Male | 1 | 193 | 0.004 | 0.003 | 0.000 | 0.016 |
| HRAS | Q61 | Bladder | Female | 7 | 393 | 0.018 | 0.018 | 0.010 | 0.029 |
| HRAS | Q61 | Bladder | Male | 22 | 1187 | 0.018 | 0.018 | 0.012 | 0.026 |
| HRAS | Q61 | BLL/Lymphoma | Female | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | BLL/Lymphoma | Male | 0 | 142 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Small bowel | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Small bowel | Male | 0 | 132 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Sex cord stromal | Female | 0 | 97 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | Q61 | Sex cord stromal | Male | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.014 |
| HRAS | Q61 | Bone | Female | 0 | 237 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | Male | 0 | 318 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Vaginal | Female | 1 | 78 | 0.015 | 0.011 | 0.001 | 0.052 |
| HRAS | Q61 | Thymic | Female | 1 | 68 | 0.020 | 0.017 | 0.003 | 0.051 |
| HRAS | Q61 | Thymic | Male | 2 | 86 | 0.022 | 0.019 | 0.004 | 0.054 |
| HRAS | Q61 | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | SCLC | Female | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | SCLC | Male | 0 | 205 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | T / NK neoplasms | Male | 0 | 123 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Germ cell | Female | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | Male | 0 | 710 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Nerve sheath | Female | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Nerve sheath | Male | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| HRAS | Q61 | Pheochromocytoma | Male | 1 | 17 | 0.066 | 0.050 | 0.003 | 0.217 |
| HRAS | Q61 | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | Q61 | B cell lymphoma | Female | 0 | 395 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | Male | 0 | 566 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.028 |
| HRAS | Q61 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.028 |
| HRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | Q61 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | Q61 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.013 |
| HRAS | Q61 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | Q61 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | Q61 | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.039 |
| HRAS | Q61 | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.054 |
| HRAS | Q61 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | 12, 13, or 61 | Appendiceal | Metastasis | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Appendiceal | Primary | 0 | 151 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | CRC | Metastasis | 0 | 2352 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | CRC | Not Applicable or Heme | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CRC | Primary | 5 | 4113 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | CRC | Unspecified | 0 | 31 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | 12, 13, or 61 | CUP | Metastasis | 6 | 1388 | 0.005 | 0.005 | 0.002 | 0.009 |
| HRAS | 12, 13, or 61 | CUP | Not Applicable or Heme | 1 | 229 | 0.005 | 0.005 | 0.001 | 0.011 |
| HRAS | 12, 13, or 61 | CUP | Primary | 3 | 311 | 0.006 | 0.006 | 0.002 | 0.015 |
| HRAS | 12, 13, or 61 | CUP | Unspecified | 0 | 57 | 0.005 | 0.005 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | NSCLC | Metastasis | 11 | 3750 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | 12, 13, or 61 | NSCLC | Not Applicable or Heme | 0 | 223 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | NSCLC | Primary | 7 | 6059 | 0.001 | 0.001 | 0.001 | 0.002 |
| HRAS | 12, 13, or 61 | NSCLC | Unspecified | 0 | 99 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Breast | Metastasis | 7 | 3094 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | 12, 13, or 61 | Breast | Not Applicable or Heme | 0 | 105 | 0.003 | 0.002 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Breast | Primary | 16 | 6124 | 0.003 | 0.002 | 0.002 | 0.004 |
| HRAS | 12, 13, or 61 | Pancreatic | Metastasis | 1 | 981 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | 12, 13, or 61 | Pancreatic | Primary | 2 | 1428 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Leukemia | Metastasis | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | Not Applicable or Heme | 0 | 923 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | Primary | 0 | 407 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Leukemia | Unspecified | 0 | 215 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Melanoma | Metastasis | 25 | 1738 | 0.013 | 0.013 | 0.009 | 0.019 |
| HRAS | 12, 13, or 61 | Melanoma | Not Applicable or Heme | 1 | 188 | 0.012 | 0.012 | 0.003 | 0.019 |
| HRAS | 12, 13, or 61 | Melanoma | Primary | 11 | 898 | 0.013 | 0.012 | 0.008 | 0.019 |
| HRAS | 12, 13, or 61 | Melanoma | Unspecified | 0 | 22 | 0.013 | 0.012 | 0.002 | 0.024 |
| HRAS | 12, 13, or 61 | Head and neck | Metastasis | 13 | 731 | 0.021 | 0.021 | 0.011 | 0.033 |
| HRAS | 12, 13, or 61 | Head and neck | Not Applicable or Heme | 1 | 67 | 0.024 | 0.024 | 0.005 | 0.048 |
| HRAS | 12, 13, or 61 | Head and neck | Primary | 34 | 938 | 0.033 | 0.033 | 0.023 | 0.046 |
| HRAS | 12, 13, or 61 | Uterine | Metastasis | 2 | 583 | 0.003 | 0.003 | 0.001 | 0.007 |
| HRAS | 12, 13, or 61 | Uterine | Not Applicable or Heme | 0 | 76 | 0.003 | 0.002 | 0.000 | 0.008 |
| HRAS | 12, 13, or 61 | Uterine | Primary | 4 | 1538 | 0.003 | 0.003 | 0.001 | 0.005 |
| HRAS | 12, 13, or 61 | Uterine | Unspecified | 0 | 51 | 0.003 | 0.003 | 0.000 | 0.008 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | Metastasis | 6 | 203 | 0.030 | 0.029 | 0.015 | 0.050 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | Not Applicable or Heme | 1 | 22 | 0.033 | 0.030 | 0.012 | 0.079 |
| HRAS | 12, 13, or 61 | Non-melanoma skin | Primary | 8 | 287 | 0.029 | 0.029 | 0.015 | 0.048 |
| HRAS | 12, 13, or 61 | MDS/MPN | Metastasis | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | Not Applicable or Heme | 0 | 914 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | Primary | 0 | 250 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | MDS/MPN | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Metastasis | 4 | 928 | 0.005 | 0.004 | 0.002 | 0.008 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.005 | 0.004 | 0.002 | 0.013 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Primary | 7 | 1668 | 0.004 | 0.004 | 0.002 | 0.007 |
| HRAS | 12, 13, or 61 | Soft tissue sarcoma | Unspecified | 0 | 23 | 0.005 | 0.004 | 0.001 | 0.012 |
| HRAS | 12, 13, or 61 | Ovarian | Metastasis | 0 | 1088 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Ovarian | Not Applicable or Heme | 0 | 160 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Ovarian | Primary | 1 | 1060 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Ovarian | Unspecified | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Esophagogastric | Metastasis | 0 | 462 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | 12, 13, or 61 | Esophagogastric | Primary | 3 | 1283 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Esophagogastric | Unspecified | 0 | 14 | 0.003 | 0.001 | 0.000 | 0.019 |
| HRAS | 12, 13, or 61 | Thyroid | Metastasis | 10 | 402 | 0.032 | 0.031 | 0.015 | 0.052 |
| HRAS | 12, 13, or 61 | Thyroid | Not Applicable or Heme | 3 | 28 | 0.069 | 0.056 | 0.026 | 0.177 |
| HRAS | 12, 13, or 61 | Thyroid | Primary | 32 | 582 | 0.052 | 0.052 | 0.036 | 0.072 |
| HRAS | 12, 13, or 61 | Cervical | Metastasis | 1 | 136 | 0.005 | 0.003 | 0.000 | 0.020 |
| HRAS | 12, 13, or 61 | Cervical | Not Applicable or Heme | 0 | 12 | 0.005 | 0.002 | 0.000 | 0.033 |
| HRAS | 12, 13, or 61 | Cervical | Primary | 0 | 211 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | 12, 13, or 61 | Hepatobiliary | Metastasis | 0 | 438 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.001 | 0.001 | 0.000 | 0.008 |
| HRAS | 12, 13, or 61 | Hepatobiliary | Primary | 1 | 894 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | CNS | Metastasis | 0 | 409 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | CNS | Not Applicable or Heme | 1 | 526 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | CNS | Primary | 3 | 3521 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | CNS | Unspecified | 0 | 108 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Prostate | Metastasis | 7 | 901 | 0.007 | 0.007 | 0.004 | 0.012 |
| HRAS | 12, 13, or 61 | Prostate | Not Applicable or Heme | 0 | 57 | 0.007 | 0.006 | 0.001 | 0.014 |
| HRAS | 12, 13, or 61 | Prostate | Primary | 9 | 1468 | 0.006 | 0.006 | 0.003 | 0.010 |
| HRAS | 12, 13, or 61 | Prostate | Unspecified | 0 | 12 | 0.007 | 0.006 | 0.001 | 0.017 |
| HRAS | 12, 13, or 61 | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Neuroendocrine | Metastasis | 1 | 143 | 0.005 | 0.003 | 0.000 | 0.017 |
| HRAS | 12, 13, or 61 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.004 | 0.002 | 0.000 | 0.023 |
| HRAS | 12, 13, or 61 | Neuroendocrine | Primary | 0 | 196 | 0.003 | 0.002 | 0.000 | 0.011 |
| HRAS | 12, 13, or 61 | Bladder | Metastasis | 11 | 389 | 0.033 | 0.033 | 0.019 | 0.047 |
| HRAS | 12, 13, or 61 | Bladder | Not Applicable or Heme | 2 | 25 | 0.043 | 0.038 | 0.021 | 0.110 |
| HRAS | 12, 13, or 61 | Bladder | Primary | 44 | 1164 | 0.037 | 0.037 | 0.028 | 0.048 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | Not Applicable or Heme | 0 | 109 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | Primary | 0 | 101 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | BLL/Lymphoma | Unspecified | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Small bowel | Metastasis | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Small bowel | Primary | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Sex cord stromal | Metastasis | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | 12, 13, or 61 | Sex cord stromal | Primary | 0 | 54 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | 12, 13, or 61 | Bone | Metastasis | 0 | 197 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Bone | Primary | 0 | 319 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Bone | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Vaginal | Metastasis | 1 | 16 | 0.040 | 0.029 | 0.004 | 0.145 |
| HRAS | 12, 13, or 61 | Vaginal | Primary | 1 | 60 | 0.026 | 0.022 | 0.002 | 0.072 |
| HRAS | 12, 13, or 61 | Thymic | Metastasis | 3 | 60 | 0.041 | 0.037 | 0.012 | 0.093 |
| HRAS | 12, 13, or 61 | Thymic | Primary | 2 | 83 | 0.033 | 0.030 | 0.008 | 0.071 |
| HRAS | 12, 13, or 61 | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | 12, 13, or 61 | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | SCLC | Metastasis | 2 | 207 | 0.008 | 0.007 | 0.001 | 0.024 |
| HRAS | 12, 13, or 61 | SCLC | Primary | 0 | 183 | 0.003 | 0.001 | 0.000 | 0.013 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | 12, 13, or 61 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | 12, 13, or 61 | Germ cell | Metastasis | 0 | 274 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Germ cell | Not Applicable or Heme | 1 | 81 | 0.006 | 0.002 | 0.000 | 0.031 |
| HRAS | 12, 13, or 61 | Germ cell | Primary | 0 | 516 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | 12, 13, or 61 | Germ cell | Unspecified | 0 | 14 | 0.003 | 0.001 | 0.000 | 0.023 |
| HRAS | 12, 13, or 61 | Nerve sheath | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | 12, 13, or 61 | Nerve sheath | Primary | 0 | 115 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | 12, 13, or 61 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.035 |
| HRAS | 12, 13, or 61 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | 12, 13, or 61 | Pheochromocytoma | Primary | 1 | 18 | 0.062 | 0.047 | 0.002 | 0.204 |
| HRAS | 12, 13, or 61 | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.045 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Metastasis | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Primary | 0 | 708 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | B cell lymphoma | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| HRAS | 12, 13, or 61 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| HRAS | 12, 13, or 61 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.014 |
| HRAS | 12, 13, or 61 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | 12, 13, or 61 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | 12, 13, or 61 | Parathyroid | Primary | 0 | 13 | 0.004 | 0.000 | 0.000 | 0.044 |
| HRAS | G12 | Appendiceal | Metastasis | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Appendiceal | Primary | 0 | 151 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | CRC | Metastasis | 0 | 2352 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | CRC | Not Applicable or Heme | 0 | 224 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | CRC | Primary | 4 | 4113 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | CRC | Unspecified | 0 | 31 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12 | CUP | Metastasis | 2 | 1388 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | CUP | Not Applicable or Heme | 0 | 229 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | CUP | Primary | 0 | 311 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | CUP | Unspecified | 0 | 57 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | NSCLC | Metastasis | 1 | 3750 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | Not Applicable or Heme | 0 | 223 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | NSCLC | Primary | 0 | 6059 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | NSCLC | Unspecified | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Breast | Metastasis | 2 | 3094 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Breast | Not Applicable or Heme | 0 | 105 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Breast | Primary | 7 | 6124 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Pancreatic | Metastasis | 0 | 981 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Pancreatic | Primary | 0 | 1428 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Metastasis | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Not Applicable or Heme | 0 | 923 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Primary | 0 | 407 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Leukemia | Unspecified | 0 | 215 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Melanoma | Metastasis | 6 | 1738 | 0.003 | 0.003 | 0.001 | 0.006 |
| HRAS | G12 | Melanoma | Not Applicable or Heme | 0 | 188 | 0.003 | 0.003 | 0.000 | 0.006 |
| HRAS | G12 | Melanoma | Primary | 2 | 898 | 0.003 | 0.003 | 0.001 | 0.006 |
| HRAS | G12 | Melanoma | Unspecified | 0 | 22 | 0.003 | 0.003 | 0.000 | 0.009 |
| HRAS | G12 | Head and neck | Metastasis | 2 | 731 | 0.004 | 0.004 | 0.001 | 0.011 |
| HRAS | G12 | Head and neck | Not Applicable or Heme | 0 | 67 | 0.006 | 0.005 | 0.000 | 0.019 |
| HRAS | G12 | Head and neck | Primary | 12 | 938 | 0.011 | 0.011 | 0.005 | 0.019 |
| HRAS | G12 | Uterine | Metastasis | 1 | 583 | 0.002 | 0.002 | 0.000 | 0.005 |
| HRAS | G12 | Uterine | Not Applicable or Heme | 0 | 76 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | G12 | Uterine | Primary | 3 | 1538 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | G12 | Uterine | Unspecified | 0 | 51 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G12 | Non-melanoma skin | Metastasis | 2 | 203 | 0.011 | 0.011 | 0.003 | 0.025 |
| HRAS | G12 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.010 | 0.009 | 0.000 | 0.030 |
| HRAS | G12 | Non-melanoma skin | Primary | 4 | 287 | 0.013 | 0.012 | 0.005 | 0.026 |
| HRAS | G12 | MDS/MPN | Metastasis | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | Not Applicable or Heme | 0 | 914 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | Primary | 0 | 250 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | MDS/MPN | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Soft tissue sarcoma | Metastasis | 2 | 928 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G12 | Soft tissue sarcoma | Not Applicable or Heme | 0 | 119 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G12 | Soft tissue sarcoma | Primary | 1 | 1668 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G12 | Soft tissue sarcoma | Unspecified | 0 | 23 | 0.002 | 0.001 | 0.000 | 0.007 |
| HRAS | G12 | Ovarian | Metastasis | 0 | 1088 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Ovarian | Not Applicable or Heme | 0 | 160 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Ovarian | Primary | 1 | 1060 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Ovarian | Unspecified | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12 | Esophagogastric | Metastasis | 0 | 462 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Esophagogastric | Primary | 1 | 1283 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G12 | Esophagogastric | Unspecified | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12 | Thyroid | Metastasis | 0 | 402 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Thyroid | Not Applicable or Heme | 1 | 28 | 0.029 | 0.018 | 0.000 | 0.119 |
| HRAS | G12 | Thyroid | Primary | 0 | 582 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Cervical | Metastasis | 1 | 136 | 0.005 | 0.003 | 0.000 | 0.020 |
| HRAS | G12 | Cervical | Not Applicable or Heme | 0 | 12 | 0.005 | 0.002 | 0.000 | 0.029 |
| HRAS | G12 | Cervical | Primary | 0 | 211 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | G12 | Hepatobiliary | Metastasis | 0 | 438 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Hepatobiliary | Primary | 0 | 894 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Metastasis | 0 | 409 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Not Applicable or Heme | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Primary | 0 | 3521 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | CNS | Unspecified | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | Metastasis | 0 | 901 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | Not Applicable or Heme | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | Primary | 0 | 1468 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Prostate | Unspecified | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G12 | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Neuroendocrine | Metastasis | 0 | 143 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Neuroendocrine | Primary | 0 | 196 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bladder | Metastasis | 3 | 389 | 0.010 | 0.009 | 0.003 | 0.019 |
| HRAS | G12 | Bladder | Not Applicable or Heme | 2 | 25 | 0.032 | 0.015 | 0.006 | 0.139 |
| HRAS | G12 | Bladder | Primary | 11 | 1164 | 0.010 | 0.010 | 0.005 | 0.016 |
| HRAS | G12 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | BLL/Lymphoma | Not Applicable or Heme | 0 | 109 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | BLL/Lymphoma | Primary | 0 | 101 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | BLL/Lymphoma | Unspecified | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Small bowel | Metastasis | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Small bowel | Primary | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Sex cord stromal | Metastasis | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12 | Sex cord stromal | Primary | 0 | 54 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12 | Bone | Metastasis | 0 | 197 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Bone | Primary | 0 | 319 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Bone | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Vaginal | Metastasis | 0 | 16 | 0.014 | 0.008 | 0.000 | 0.063 |
| HRAS | G12 | Vaginal | Primary | 1 | 60 | 0.016 | 0.012 | 0.001 | 0.055 |
| HRAS | G12 | Thymic | Metastasis | 0 | 60 | 0.006 | 0.003 | 0.000 | 0.027 |
| HRAS | G12 | Thymic | Primary | 1 | 83 | 0.010 | 0.007 | 0.000 | 0.037 |
| HRAS | G12 | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G12 | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | SCLC | Metastasis | 1 | 207 | 0.004 | 0.003 | 0.000 | 0.015 |
| HRAS | G12 | SCLC | Primary | 0 | 183 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | G12 | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | T / NK neoplasms | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12 | Germ cell | Metastasis | 0 | 274 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | Primary | 0 | 516 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Germ cell | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Nerve sheath | Metastasis | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12 | Nerve sheath | Primary | 0 | 115 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.036 |
| HRAS | G12 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.033 |
| HRAS | G12 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | G12 | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.046 |
| HRAS | G12 | B cell lymphoma | Metastasis | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | Primary | 0 | 708 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | B cell lymphoma | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | G12 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.018 |
| HRAS | G12 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | G12 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | G12 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.009 |
| HRAS | G12 | Hodgkin lymphoma | Primary | 0 | 35 | 0.002 | 0.000 | 0.000 | 0.019 |
| HRAS | G12 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.039 |
| HRAS | G12 | Parathyroid | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.035 |
| HRAS | G12C | Appendiceal | Metastasis | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Appendiceal | Primary | 0 | 151 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | CRC | Metastasis | 0 | 2352 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | Not Applicable or Heme | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | Primary | 0 | 4113 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CRC | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Metastasis | 0 | 1388 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Not Applicable or Heme | 0 | 229 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Primary | 0 | 311 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CUP | Unspecified | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Metastasis | 0 | 3750 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Not Applicable or Heme | 0 | 223 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Primary | 0 | 6059 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | NSCLC | Unspecified | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Breast | Metastasis | 0 | 3094 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Breast | Not Applicable or Heme | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Breast | Primary | 2 | 6124 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Pancreatic | Metastasis | 0 | 981 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Pancreatic | Primary | 0 | 1428 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Metastasis | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Not Applicable or Heme | 0 | 923 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Primary | 0 | 407 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Leukemia | Unspecified | 0 | 215 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Metastasis | 0 | 1738 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Not Applicable or Heme | 0 | 188 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Primary | 0 | 898 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Melanoma | Unspecified | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | Metastasis | 0 | 731 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | Not Applicable or Heme | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Head and neck | Primary | 0 | 938 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | Metastasis | 0 | 583 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | Not Applicable or Heme | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | Primary | 0 | 1538 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Uterine | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Non-melanoma skin | Metastasis | 0 | 203 | 0.002 | 0.001 | 0.000 | 0.008 |
| HRAS | G12C | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.003 | 0.001 | 0.000 | 0.015 |
| HRAS | G12C | Non-melanoma skin | Primary | 1 | 287 | 0.003 | 0.002 | 0.000 | 0.010 |
| HRAS | G12C | MDS/MPN | Metastasis | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | Not Applicable or Heme | 0 | 914 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | Primary | 0 | 250 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | MDS/MPN | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Soft tissue sarcoma | Metastasis | 0 | 928 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | Not Applicable or Heme | 0 | 119 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | Primary | 0 | 1668 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Soft tissue sarcoma | Unspecified | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | Metastasis | 0 | 1088 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | Not Applicable or Heme | 0 | 160 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | Primary | 0 | 1060 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Ovarian | Unspecified | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Metastasis | 0 | 462 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Primary | 0 | 1283 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Esophagogastric | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | Metastasis | 0 | 402 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Thyroid | Primary | 0 | 582 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Cervical | Metastasis | 0 | 136 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Cervical | Not Applicable or Heme | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Cervical | Primary | 0 | 211 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Hepatobiliary | Metastasis | 0 | 438 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Hepatobiliary | Primary | 0 | 894 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Metastasis | 0 | 409 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Not Applicable or Heme | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Primary | 0 | 3521 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | CNS | Unspecified | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | Metastasis | 0 | 901 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | Not Applicable or Heme | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | Primary | 0 | 1468 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Prostate | Unspecified | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Neuroendocrine | Metastasis | 0 | 143 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Neuroendocrine | Primary | 0 | 196 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Bladder | Metastasis | 1 | 389 | 0.003 | 0.002 | 0.000 | 0.008 |
| HRAS | G12C | Bladder | Not Applicable or Heme | 1 | 25 | 0.013 | 0.004 | 0.001 | 0.083 |
| HRAS | G12C | Bladder | Primary | 1 | 1164 | 0.002 | 0.001 | 0.000 | 0.004 |
| HRAS | G12C | BLL/Lymphoma | Metastasis | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | BLL/Lymphoma | Not Applicable or Heme | 0 | 109 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | BLL/Lymphoma | Primary | 0 | 101 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | BLL/Lymphoma | Unspecified | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Small bowel | Metastasis | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Small bowel | Primary | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Sex cord stromal | Metastasis | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | G12C | Sex cord stromal | Primary | 0 | 54 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12C | Bone | Metastasis | 0 | 197 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Bone | Primary | 0 | 319 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Bone | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Vaginal | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.010 |
| HRAS | G12C | Vaginal | Primary | 0 | 60 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12C | Thymic | Metastasis | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Thymic | Primary | 0 | 83 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G12C | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | SCLC | Metastasis | 1 | 207 | 0.004 | 0.003 | 0.000 | 0.015 |
| HRAS | G12C | SCLC | Primary | 0 | 183 | 0.002 | 0.001 | 0.000 | 0.010 |
| HRAS | G12C | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | T / NK neoplasms | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G12C | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Germ cell | Metastasis | 0 | 274 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | Not Applicable or Heme | 0 | 81 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | Primary | 0 | 516 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Germ cell | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | Nerve sheath | Metastasis | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G12C | Nerve sheath | Primary | 0 | 115 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G12C | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | G12C | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.033 |
| HRAS | G12C | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | G12C | Pineal | Primary | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.026 |
| HRAS | G12C | B cell lymphoma | Metastasis | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | Primary | 0 | 708 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G12C | B cell lymphoma | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G12C | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.049 |
| HRAS | G12C | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| HRAS | G12C | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| HRAS | G12C | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| HRAS | G12C | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | G12C | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.015 |
| HRAS | G12C | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | G12C | Parathyroid | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.041 |
| HRAS | G13 | Appendiceal | Metastasis | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Appendiceal | Primary | 0 | 151 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | Metastasis | 0 | 2352 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | Not Applicable or Heme | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | Primary | 1 | 4113 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | CRC | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | CUP | Metastasis | 2 | 1388 | 0.002 | 0.002 | 0.000 | 0.004 |
| HRAS | G13 | CUP | Not Applicable or Heme | 1 | 229 | 0.003 | 0.002 | 0.001 | 0.008 |
| HRAS | G13 | CUP | Primary | 1 | 311 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G13 | CUP | Unspecified | 0 | 57 | 0.002 | 0.002 | 0.000 | 0.007 |
| HRAS | G13 | NSCLC | Metastasis | 6 | 3750 | 0.001 | 0.001 | 0.001 | 0.002 |
| HRAS | G13 | NSCLC | Not Applicable or Heme | 0 | 223 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | NSCLC | Primary | 4 | 6059 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | NSCLC | Unspecified | 0 | 99 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | Breast | Metastasis | 3 | 3094 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | Breast | Not Applicable or Heme | 0 | 105 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Breast | Primary | 3 | 6124 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | G13 | Pancreatic | Metastasis | 0 | 981 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Pancreatic | Primary | 1 | 1428 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Leukemia | Metastasis | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | Not Applicable or Heme | 0 | 923 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | Primary | 0 | 407 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Leukemia | Unspecified | 0 | 215 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Melanoma | Metastasis | 12 | 1738 | 0.006 | 0.006 | 0.003 | 0.010 |
| HRAS | G13 | Melanoma | Not Applicable or Heme | 1 | 188 | 0.006 | 0.005 | 0.002 | 0.012 |
| HRAS | G13 | Melanoma | Primary | 3 | 898 | 0.005 | 0.005 | 0.002 | 0.009 |
| HRAS | G13 | Melanoma | Unspecified | 0 | 22 | 0.006 | 0.005 | 0.001 | 0.015 |
| HRAS | G13 | Head and neck | Metastasis | 4 | 731 | 0.007 | 0.007 | 0.003 | 0.012 |
| HRAS | G13 | Head and neck | Not Applicable or Heme | 0 | 67 | 0.007 | 0.007 | 0.000 | 0.017 |
| HRAS | G13 | Head and neck | Primary | 10 | 938 | 0.009 | 0.009 | 0.005 | 0.016 |
| HRAS | G13 | Uterine | Metastasis | 1 | 583 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G13 | Uterine | Not Applicable or Heme | 0 | 76 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Uterine | Primary | 0 | 1538 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Uterine | Unspecified | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G13 | Non-melanoma skin | Metastasis | 1 | 203 | 0.006 | 0.005 | 0.001 | 0.016 |
| HRAS | G13 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.007 | 0.005 | 0.000 | 0.023 |
| HRAS | G13 | Non-melanoma skin | Primary | 2 | 287 | 0.007 | 0.006 | 0.001 | 0.016 |
| HRAS | G13 | MDS/MPN | Metastasis | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | Not Applicable or Heme | 0 | 914 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | Primary | 0 | 250 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | MDS/MPN | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Adrenocortical | Metastasis | 0 | 55 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G13 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Soft tissue sarcoma | Metastasis | 1 | 928 | 0.002 | 0.002 | 0.000 | 0.004 |
| HRAS | G13 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.003 | 0.002 | 0.001 | 0.012 |
| HRAS | G13 | Soft tissue sarcoma | Primary | 3 | 1668 | 0.002 | 0.002 | 0.001 | 0.004 |
| HRAS | G13 | Soft tissue sarcoma | Unspecified | 0 | 23 | 0.003 | 0.002 | 0.000 | 0.010 |
| HRAS | G13 | Ovarian | Metastasis | 0 | 1088 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Ovarian | Not Applicable or Heme | 0 | 160 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Ovarian | Primary | 1 | 1060 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Ovarian | Unspecified | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Esophagogastric | Metastasis | 0 | 462 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Esophagogastric | Primary | 1 | 1283 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | G13 | Esophagogastric | Unspecified | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | G13 | Thyroid | Metastasis | 0 | 402 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | G13 | Thyroid | Not Applicable or Heme | 0 | 28 | 0.003 | 0.001 | 0.000 | 0.017 |
| HRAS | G13 | Thyroid | Primary | 2 | 582 | 0.003 | 0.002 | 0.000 | 0.008 |
| HRAS | G13 | Cervical | Metastasis | 0 | 136 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Cervical | Not Applicable or Heme | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Cervical | Primary | 0 | 211 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | Metastasis | 0 | 438 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Hepatobiliary | Primary | 0 | 894 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | CNS | Metastasis | 0 | 409 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | CNS | Not Applicable or Heme | 1 | 526 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | CNS | Primary | 2 | 3521 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | G13 | CNS | Unspecified | 0 | 108 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | Prostate | Metastasis | 0 | 901 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Prostate | Not Applicable or Heme | 0 | 57 | 0.001 | 0.001 | 0.000 | 0.007 |
| HRAS | G13 | Prostate | Primary | 3 | 1468 | 0.002 | 0.001 | 0.000 | 0.004 |
| HRAS | G13 | Prostate | Unspecified | 0 | 12 | 0.002 | 0.001 | 0.000 | 0.015 |
| HRAS | G13 | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Neuroendocrine | Metastasis | 0 | 143 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Neuroendocrine | Primary | 0 | 196 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bladder | Metastasis | 2 | 389 | 0.007 | 0.007 | 0.001 | 0.014 |
| HRAS | G13 | Bladder | Not Applicable or Heme | 0 | 25 | 0.008 | 0.007 | 0.000 | 0.022 |
| HRAS | G13 | Bladder | Primary | 11 | 1164 | 0.009 | 0.008 | 0.005 | 0.014 |
| HRAS | G13 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | BLL/Lymphoma | Not Applicable or Heme | 0 | 109 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | BLL/Lymphoma | Primary | 0 | 101 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | BLL/Lymphoma | Unspecified | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Small bowel | Metastasis | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Small bowel | Primary | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Sex cord stromal | Metastasis | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Sex cord stromal | Primary | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | Bone | Metastasis | 0 | 197 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Bone | Primary | 0 | 319 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Bone | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Vaginal | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | G13 | Vaginal | Primary | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | G13 | Thymic | Metastasis | 0 | 60 | 0.006 | 0.003 | 0.000 | 0.027 |
| HRAS | G13 | Thymic | Primary | 1 | 83 | 0.010 | 0.007 | 0.000 | 0.035 |
| HRAS | G13 | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | G13 | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.006 |
| HRAS | G13 | SCLC | Metastasis | 1 | 207 | 0.004 | 0.003 | 0.000 | 0.015 |
| HRAS | G13 | SCLC | Primary | 0 | 183 | 0.002 | 0.001 | 0.000 | 0.009 |
| HRAS | G13 | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | T / NK neoplasms | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | G13 | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | G13 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | G13 | Germ cell | Metastasis | 0 | 274 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Germ cell | Not Applicable or Heme | 1 | 81 | 0.008 | 0.004 | 0.000 | 0.037 |
| HRAS | G13 | Germ cell | Primary | 0 | 516 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Germ cell | Unspecified | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.026 |
| HRAS | G13 | Nerve sheath | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G13 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.006 |
| HRAS | G13 | Nerve sheath | Primary | 0 | 115 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | G13 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.035 |
| HRAS | G13 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | G13 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.033 |
| HRAS | G13 | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.049 |
| HRAS | G13 | B cell lymphoma | Metastasis | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | B cell lymphoma | Primary | 0 | 708 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | B cell lymphoma | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | G13 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | G13 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.017 |
| HRAS | G13 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| HRAS | G13 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.020 |
| HRAS | G13 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.013 |
| HRAS | G13 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.016 |
| HRAS | G13 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.038 |
| HRAS | G13 | Parathyroid | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.040 |
| HRAS | Q61 | Appendiceal | Metastasis | 0 | 174 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Appendiceal | Primary | 0 | 151 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CRC | Metastasis | 0 | 2352 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | Not Applicable or Heme | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | Primary | 0 | 4113 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CRC | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CUP | Metastasis | 2 | 1388 | 0.002 | 0.002 | 0.000 | 0.004 |
| HRAS | Q61 | CUP | Not Applicable or Heme | 0 | 229 | 0.002 | 0.002 | 0.000 | 0.006 |
| HRAS | Q61 | CUP | Primary | 2 | 311 | 0.004 | 0.003 | 0.001 | 0.012 |
| HRAS | Q61 | CUP | Unspecified | 0 | 57 | 0.002 | 0.002 | 0.000 | 0.009 |
| HRAS | Q61 | NSCLC | Metastasis | 4 | 3750 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | NSCLC | Not Applicable or Heme | 0 | 223 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | NSCLC | Primary | 3 | 6059 | 0.001 | 0.001 | 0.000 | 0.001 |
| HRAS | Q61 | NSCLC | Unspecified | 0 | 99 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Breast | Metastasis | 2 | 3094 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Breast | Not Applicable or Heme | 0 | 105 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Breast | Primary | 6 | 6124 | 0.001 | 0.001 | 0.000 | 0.002 |
| HRAS | Q61 | Pancreatic | Metastasis | 1 | 981 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.001 | 0.001 | 0.000 | 0.005 |
| HRAS | Q61 | Pancreatic | Primary | 1 | 1428 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Leukemia | Metastasis | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | Not Applicable or Heme | 0 | 923 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | Primary | 0 | 407 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Leukemia | Unspecified | 0 | 215 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Melanoma | Metastasis | 7 | 1738 | 0.004 | 0.004 | 0.002 | 0.007 |
| HRAS | Q61 | Melanoma | Not Applicable or Heme | 0 | 188 | 0.004 | 0.004 | 0.000 | 0.009 |
| HRAS | Q61 | Melanoma | Primary | 6 | 898 | 0.005 | 0.005 | 0.002 | 0.010 |
| HRAS | Q61 | Melanoma | Unspecified | 0 | 22 | 0.005 | 0.004 | 0.000 | 0.015 |
| HRAS | Q61 | Head and neck | Metastasis | 7 | 731 | 0.011 | 0.011 | 0.006 | 0.018 |
| HRAS | Q61 | Head and neck | Not Applicable or Heme | 1 | 67 | 0.012 | 0.011 | 0.004 | 0.027 |
| HRAS | Q61 | Head and neck | Primary | 12 | 938 | 0.012 | 0.012 | 0.007 | 0.019 |
| HRAS | Q61 | Uterine | Metastasis | 0 | 583 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Uterine | Not Applicable or Heme | 0 | 76 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Uterine | Primary | 1 | 1538 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Uterine | Unspecified | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Non-melanoma skin | Metastasis | 3 | 203 | 0.013 | 0.012 | 0.004 | 0.028 |
| HRAS | Q61 | Non-melanoma skin | Not Applicable or Heme | 1 | 22 | 0.019 | 0.013 | 0.004 | 0.078 |
| HRAS | Q61 | Non-melanoma skin | Primary | 2 | 287 | 0.011 | 0.010 | 0.003 | 0.022 |
| HRAS | Q61 | MDS/MPN | Metastasis | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | Not Applicable or Heme | 0 | 914 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | Primary | 0 | 250 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | MDS/MPN | Unspecified | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Soft tissue sarcoma | Metastasis | 1 | 928 | 0.001 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Soft tissue sarcoma | Not Applicable or Heme | 0 | 119 | 0.002 | 0.001 | 0.000 | 0.005 |
| HRAS | Q61 | Soft tissue sarcoma | Primary | 3 | 1668 | 0.002 | 0.001 | 0.000 | 0.004 |
| HRAS | Q61 | Soft tissue sarcoma | Unspecified | 0 | 23 | 0.002 | 0.001 | 0.000 | 0.006 |
| HRAS | Q61 | Ovarian | Metastasis | 0 | 1088 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | Not Applicable or Heme | 0 | 160 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | Primary | 0 | 1060 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Ovarian | Unspecified | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Esophagogastric | Metastasis | 0 | 462 | 0.001 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | Esophagogastric | Primary | 1 | 1283 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Esophagogastric | Unspecified | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | Q61 | Thyroid | Metastasis | 10 | 402 | 0.032 | 0.032 | 0.016 | 0.050 |
| HRAS | Q61 | Thyroid | Not Applicable or Heme | 2 | 28 | 0.051 | 0.044 | 0.019 | 0.126 |
| HRAS | Q61 | Thyroid | Primary | 30 | 582 | 0.048 | 0.047 | 0.033 | 0.067 |
| HRAS | Q61 | Cervical | Metastasis | 0 | 136 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Cervical | Not Applicable or Heme | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Cervical | Primary | 0 | 211 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Hepatobiliary | Metastasis | 0 | 438 | 0.001 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.001 | 0.001 | 0.000 | 0.008 |
| HRAS | Q61 | Hepatobiliary | Primary | 1 | 894 | 0.001 | 0.001 | 0.000 | 0.003 |
| HRAS | Q61 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | CNS | Metastasis | 0 | 409 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CNS | Not Applicable or Heme | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CNS | Primary | 1 | 3521 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | CNS | Unspecified | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Prostate | Metastasis | 7 | 901 | 0.006 | 0.006 | 0.003 | 0.012 |
| HRAS | Q61 | Prostate | Not Applicable or Heme | 0 | 57 | 0.005 | 0.005 | 0.000 | 0.013 |
| HRAS | Q61 | Prostate | Primary | 6 | 1468 | 0.005 | 0.005 | 0.002 | 0.008 |
| HRAS | Q61 | Prostate | Unspecified | 0 | 12 | 0.006 | 0.005 | 0.000 | 0.018 |
| HRAS | Q61 | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | Neuroendocrine | Metastasis | 1 | 143 | 0.005 | 0.003 | 0.000 | 0.017 |
| HRAS | Q61 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.004 | 0.002 | 0.000 | 0.023 |
| HRAS | Q61 | Neuroendocrine | Primary | 0 | 196 | 0.003 | 0.002 | 0.000 | 0.011 |
| HRAS | Q61 | Bladder | Metastasis | 6 | 389 | 0.017 | 0.017 | 0.008 | 0.027 |
| HRAS | Q61 | Bladder | Not Applicable or Heme | 0 | 25 | 0.017 | 0.017 | 0.001 | 0.035 |
| HRAS | Q61 | Bladder | Primary | 23 | 1164 | 0.019 | 0.019 | 0.012 | 0.027 |
| HRAS | Q61 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | BLL/Lymphoma | Not Applicable or Heme | 0 | 109 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | BLL/Lymphoma | Primary | 0 | 101 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | BLL/Lymphoma | Unspecified | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Small bowel | Metastasis | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Small bowel | Primary | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Sex cord stromal | Metastasis | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.008 |
| HRAS | Q61 | Sex cord stromal | Primary | 0 | 54 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | Q61 | Bone | Metastasis | 0 | 197 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Bone | Primary | 0 | 319 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Bone | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Vaginal | Metastasis | 1 | 16 | 0.043 | 0.025 | 0.001 | 0.181 |
| HRAS | Q61 | Vaginal | Primary | 0 | 60 | 0.008 | 0.003 | 0.000 | 0.041 |
| HRAS | Q61 | Thymic | Metastasis | 3 | 60 | 0.043 | 0.037 | 0.008 | 0.109 |
| HRAS | Q61 | Thymic | Primary | 0 | 83 | 0.007 | 0.002 | 0.000 | 0.037 |
| HRAS | Q61 | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.007 |
| HRAS | Q61 | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | SCLC | Metastasis | 0 | 207 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | SCLC | Primary | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | T / NK neoplasms | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.004 |
| HRAS | Q61 | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| HRAS | Q61 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| HRAS | Q61 | Germ cell | Metastasis | 0 | 274 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | Primary | 0 | 516 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Germ cell | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Nerve sheath | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.005 |
| HRAS | Q61 | Nerve sheath | Primary | 0 | 115 | 0.000 | 0.000 | 0.000 | 0.003 |
| HRAS | Q61 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.035 |
| HRAS | Q61 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.034 |
| HRAS | Q61 | Pheochromocytoma | Primary | 1 | 18 | 0.062 | 0.047 | 0.002 | 0.204 |
| HRAS | Q61 | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.045 |
| HRAS | Q61 | B cell lymphoma | Metastasis | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | Primary | 0 | 708 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | B cell lymphoma | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.000 |
| HRAS | Q61 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.024 |
| HRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| HRAS | Q61 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| HRAS | Q61 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.014 |
| HRAS | Q61 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.012 |
| HRAS | Q61 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| HRAS | Q61 | Parathyroid | Primary | 0 | 13 | 0.004 | 0.000 | 0.000 | 0.044 |
| NRAS | 12, 13, or 61 | Appendiceal | <40 | 0 | 28 | 0.019 | 0.018 | 0.001 | 0.045 |
| NRAS | 12, 13, or 61 | Appendiceal | 40-50 | 2 | 62 | 0.023 | 0.021 | 0.007 | 0.054 |
| NRAS | 12, 13, or 61 | Appendiceal | 50-65 | 4 | 161 | 0.022 | 0.021 | 0.008 | 0.043 |
| NRAS | 12, 13, or 61 | Appendiceal | >65 | 1 | 90 | 0.019 | 0.018 | 0.004 | 0.040 |
| NRAS | 12, 13, or 61 | CRC | <40 | 18 | 565 | 0.038 | 0.038 | 0.028 | 0.047 |
| NRAS | 12, 13, or 61 | CRC | 40-50 | 53 | 1280 | 0.040 | 0.040 | 0.033 | 0.049 |
| NRAS | 12, 13, or 61 | CRC | 50-65 | 104 | 2814 | 0.038 | 0.038 | 0.032 | 0.044 |
| NRAS | 12, 13, or 61 | CRC | >65 | 91 | 2052 | 0.042 | 0.041 | 0.035 | 0.050 |
| NRAS | 12, 13, or 61 | CUP | <40 | 5 | 167 | 0.019 | 0.018 | 0.011 | 0.036 |
| NRAS | 12, 13, or 61 | CUP | 40-50 | 4 | 211 | 0.017 | 0.017 | 0.010 | 0.029 |
| NRAS | 12, 13, or 61 | CUP | 50-65 | 14 | 810 | 0.017 | 0.017 | 0.011 | 0.025 |
| NRAS | 12, 13, or 61 | CUP | >65 | 10 | 796 | 0.016 | 0.015 | 0.009 | 0.023 |
| NRAS | 12, 13, or 61 | NSCLC | <40 | 1 | 161 | 0.008 | 0.008 | 0.004 | 0.012 |
| NRAS | 12, 13, or 61 | NSCLC | 40-50 | 5 | 585 | 0.008 | 0.008 | 0.005 | 0.012 |
| NRAS | 12, 13, or 61 | NSCLC | 50-65 | 31 | 3677 | 0.008 | 0.008 | 0.006 | 0.011 |
| NRAS | 12, 13, or 61 | NSCLC | >65 | 44 | 5698 | 0.008 | 0.008 | 0.006 | 0.010 |
| NRAS | 12, 13, or 61 | NSCLC | NA | 0 | 10 | 0.008 | 0.008 | 0.004 | 0.013 |
| NRAS | 12, 13, or 61 | Breast | <40 | 0 | 840 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Breast | 50-65 | 2 | 3989 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Breast | >65 | 0 | 2583 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Breast | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | <40 | 17 | 672 | 0.022 | 0.021 | 0.011 | 0.035 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | 40-50 | 2 | 367 | 0.008 | 0.007 | 0.002 | 0.016 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | 50-65 | 5 | 951 | 0.007 | 0.006 | 0.003 | 0.013 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | >65 | 8 | 777 | 0.011 | 0.010 | 0.005 | 0.018 |
| NRAS | 12, 13, or 61 | Pancreatic | <40 | 1 | 87 | 0.006 | 0.005 | 0.002 | 0.015 |
| NRAS | 12, 13, or 61 | Pancreatic | 40-50 | 2 | 200 | 0.006 | 0.005 | 0.003 | 0.014 |
| NRAS | 12, 13, or 61 | Pancreatic | 50-65 | 4 | 999 | 0.005 | 0.005 | 0.002 | 0.009 |
| NRAS | 12, 13, or 61 | Pancreatic | >65 | 6 | 1205 | 0.005 | 0.005 | 0.003 | 0.009 |
| NRAS | 12, 13, or 61 | Leukemia | <40 | 26 | 204 | 0.120 | 0.119 | 0.095 | 0.153 |
| NRAS | 12, 13, or 61 | Leukemia | 40-50 | 20 | 128 | 0.126 | 0.122 | 0.099 | 0.175 |
| NRAS | 12, 13, or 61 | Leukemia | 50-65 | 55 | 515 | 0.114 | 0.114 | 0.092 | 0.135 |
| NRAS | 12, 13, or 61 | Leukemia | >65 | 81 | 720 | 0.115 | 0.115 | 0.097 | 0.135 |
| NRAS | 12, 13, or 61 | Melanoma | <40 | 38 | 289 | 0.148 | 0.147 | 0.107 | 0.198 |
| NRAS | 12, 13, or 61 | Melanoma | 40-50 | 61 | 282 | 0.215 | 0.215 | 0.173 | 0.261 |
| NRAS | 12, 13, or 61 | Melanoma | 50-65 | 236 | 1016 | 0.231 | 0.230 | 0.206 | 0.256 |
| NRAS | 12, 13, or 61 | Melanoma | >65 | 314 | 1259 | 0.247 | 0.247 | 0.224 | 0.271 |
| NRAS | 12, 13, or 61 | Head and neck | <40 | 0 | 140 | 0.006 | 0.006 | 0.001 | 0.012 |
| NRAS | 12, 13, or 61 | Head and neck | 40-50 | 1 | 216 | 0.006 | 0.006 | 0.002 | 0.012 |
| NRAS | 12, 13, or 61 | Head and neck | 50-65 | 7 | 799 | 0.007 | 0.007 | 0.003 | 0.013 |
| NRAS | 12, 13, or 61 | Head and neck | >65 | 3 | 582 | 0.006 | 0.006 | 0.002 | 0.011 |
| NRAS | 12, 13, or 61 | Uterine | <40 | 1 | 57 | 0.020 | 0.019 | 0.006 | 0.043 |
| NRAS | 12, 13, or 61 | Uterine | 40-50 | 5 | 162 | 0.023 | 0.021 | 0.012 | 0.046 |
| NRAS | 12, 13, or 61 | Uterine | 50-65 | 26 | 1046 | 0.023 | 0.022 | 0.015 | 0.032 |
| NRAS | 12, 13, or 61 | Uterine | >65 | 11 | 987 | 0.015 | 0.015 | 0.008 | 0.023 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | <40 | 0 | 27 | 0.003 | 0.001 | 0.000 | 0.013 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | 40-50 | 0 | 20 | 0.003 | 0.001 | 0.000 | 0.015 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | 50-65 | 0 | 149 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | >65 | 1 | 317 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | MDS/MPN | <40 | 5 | 87 | 0.051 | 0.049 | 0.028 | 0.083 |
| NRAS | 12, 13, or 61 | MDS/MPN | 40-50 | 1 | 83 | 0.042 | 0.043 | 0.011 | 0.065 |
| NRAS | 12, 13, or 61 | MDS/MPN | 50-65 | 16 | 373 | 0.046 | 0.046 | 0.030 | 0.064 |
| NRAS | 12, 13, or 61 | MDS/MPN | >65 | 38 | 664 | 0.053 | 0.052 | 0.039 | 0.070 |
| NRAS | 12, 13, or 61 | Adrenocortical | <40 | 0 | 27 | 0.007 | 0.004 | 0.000 | 0.034 |
| NRAS | 12, 13, or 61 | Adrenocortical | 40-50 | 0 | 30 | 0.007 | 0.004 | 0.000 | 0.034 |
| NRAS | 12, 13, or 61 | Adrenocortical | 50-65 | 0 | 51 | 0.006 | 0.004 | 0.000 | 0.028 |
| NRAS | 12, 13, or 61 | Adrenocortical | >65 | 1 | 26 | 0.018 | 0.010 | 0.001 | 0.091 |
| NRAS | 12, 13, or 61 | Ovarian | <40 | 2 | 141 | 0.014 | 0.014 | 0.007 | 0.025 |
| NRAS | 12, 13, or 61 | Ovarian | 40-50 | 4 | 253 | 0.015 | 0.014 | 0.008 | 0.024 |
| NRAS | 12, 13, or 61 | Ovarian | 50-65 | 18 | 1092 | 0.015 | 0.015 | 0.010 | 0.022 |
| NRAS | 12, 13, or 61 | Ovarian | >65 | 9 | 849 | 0.013 | 0.013 | 0.008 | 0.019 |
| NRAS | 12, 13, or 61 | Esophagogastric | <40 | 0 | 122 | 0.005 | 0.005 | 0.001 | 0.011 |
| NRAS | 12, 13, or 61 | Esophagogastric | 40-50 | 2 | 200 | 0.006 | 0.005 | 0.002 | 0.014 |
| NRAS | 12, 13, or 61 | Esophagogastric | 50-65 | 4 | 752 | 0.005 | 0.005 | 0.002 | 0.010 |
| NRAS | 12, 13, or 61 | Esophagogastric | >65 | 3 | 725 | 0.005 | 0.005 | 0.002 | 0.009 |
| NRAS | 12, 13, or 61 | Thyroid | <40 | 11 | 150 | 0.107 | 0.110 | 0.061 | 0.143 |
| NRAS | 12, 13, or 61 | Thyroid | 40-50 | 17 | 122 | 0.128 | 0.126 | 0.093 | 0.174 |
| NRAS | 12, 13, or 61 | Thyroid | 50-65 | 46 | 374 | 0.123 | 0.123 | 0.097 | 0.152 |
| NRAS | 12, 13, or 61 | Thyroid | >65 | 52 | 370 | 0.131 | 0.130 | 0.105 | 0.165 |
| NRAS | 12, 13, or 61 | Cervical | <40 | 1 | 85 | 0.007 | 0.006 | 0.001 | 0.024 |
| NRAS | 12, 13, or 61 | Cervical | 40-50 | 0 | 99 | 0.005 | 0.004 | 0.000 | 0.017 |
| NRAS | 12, 13, or 61 | Cervical | 50-65 | 1 | 144 | 0.006 | 0.005 | 0.001 | 0.019 |
| NRAS | 12, 13, or 61 | Cervical | >65 | 0 | 36 | 0.006 | 0.005 | 0.000 | 0.020 |
| NRAS | 12, 13, or 61 | Hepatobiliary | <40 | 0 | 137 | 0.016 | 0.017 | 0.001 | 0.029 |
| NRAS | 12, 13, or 61 | Hepatobiliary | 40-50 | 2 | 110 | 0.020 | 0.020 | 0.006 | 0.037 |
| NRAS | 12, 13, or 61 | Hepatobiliary | 50-65 | 11 | 525 | 0.021 | 0.020 | 0.012 | 0.032 |
| NRAS | 12, 13, or 61 | Hepatobiliary | >65 | 16 | 601 | 0.023 | 0.023 | 0.014 | 0.036 |
| NRAS | 12, 13, or 61 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | <40 | 0 | 28 | 0.007 | 0.003 | 0.000 | 0.031 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | 40-50 | 0 | 21 | 0.007 | 0.004 | 0.000 | 0.033 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | 50-65 | 2 | 76 | 0.018 | 0.013 | 0.002 | 0.058 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | >65 | 0 | 106 | 0.005 | 0.003 | 0.000 | 0.021 |
| NRAS | 12, 13, or 61 | CNS | <40 | 14 | 1602 | 0.007 | 0.007 | 0.004 | 0.011 |
| NRAS | 12, 13, or 61 | CNS | 40-50 | 4 | 687 | 0.006 | 0.006 | 0.003 | 0.010 |
| NRAS | 12, 13, or 61 | CNS | 50-65 | 5 | 1439 | 0.005 | 0.005 | 0.002 | 0.008 |
| NRAS | 12, 13, or 61 | CNS | >65 | 3 | 836 | 0.005 | 0.005 | 0.002 | 0.008 |
| NRAS | 12, 13, or 61 | Prostate | 40-50 | 0 | 70 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Prostate | 50-65 | 0 | 960 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | 12, 13, or 61 | Prostate | >65 | 4 | 1402 | 0.002 | 0.002 | 0.001 | 0.006 |
| NRAS | 12, 13, or 61 | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | 12, 13, or 61 | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | 12, 13, or 61 | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | 12, 13, or 61 | Neuroendocrine | <40 | 1 | 22 | 0.017 | 0.010 | 0.002 | 0.083 |
| NRAS | 12, 13, or 61 | Neuroendocrine | 40-50 | 0 | 55 | 0.008 | 0.006 | 0.000 | 0.025 |
| NRAS | 12, 13, or 61 | Neuroendocrine | 50-65 | 2 | 161 | 0.010 | 0.009 | 0.002 | 0.026 |
| NRAS | 12, 13, or 61 | Neuroendocrine | >65 | 0 | 121 | 0.007 | 0.006 | 0.000 | 0.020 |
| NRAS | 12, 13, or 61 | Bladder | <40 | 0 | 25 | 0.007 | 0.006 | 0.001 | 0.018 |
| NRAS | 12, 13, or 61 | Bladder | 40-50 | 1 | 78 | 0.007 | 0.007 | 0.002 | 0.019 |
| NRAS | 12, 13, or 61 | Bladder | 50-65 | 4 | 511 | 0.007 | 0.007 | 0.003 | 0.014 |
| NRAS | 12, 13, or 61 | Bladder | >65 | 5 | 961 | 0.006 | 0.006 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | <40 | 26 | 142 | 0.177 | 0.176 | 0.118 | 0.243 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | 40-50 | 1 | 16 | 0.064 | 0.050 | 0.004 | 0.202 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | 50-65 | 1 | 48 | 0.028 | 0.023 | 0.002 | 0.086 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | >65 | 0 | 42 | 0.016 | 0.009 | 0.000 | 0.069 |
| NRAS | 12, 13, or 61 | Small bowel | 40-50 | 0 | 29 | 0.010 | 0.008 | 0.000 | 0.033 |
| NRAS | 12, 13, or 61 | Small bowel | 50-65 | 1 | 96 | 0.011 | 0.009 | 0.001 | 0.031 |
| NRAS | 12, 13, or 61 | Small bowel | >65 | 1 | 78 | 0.011 | 0.009 | 0.001 | 0.033 |
| NRAS | 12, 13, or 61 | Sex cord stromal | <40 | 1 | 29 | 0.018 | 0.011 | 0.001 | 0.080 |
| NRAS | 12, 13, or 61 | Sex cord stromal | 40-50 | 0 | 15 | 0.010 | 0.005 | 0.000 | 0.045 |
| NRAS | 12, 13, or 61 | Sex cord stromal | 50-65 | 0 | 36 | 0.008 | 0.005 | 0.000 | 0.036 |
| NRAS | 12, 13, or 61 | Sex cord stromal | >65 | 0 | 27 | 0.009 | 0.005 | 0.000 | 0.039 |
| NRAS | 12, 13, or 61 | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.011 |
| NRAS | 12, 13, or 61 | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | 12, 13, or 61 | Thymic | <40 | 0 | 14 | 0.008 | 0.004 | 0.000 | 0.038 |
| NRAS | 12, 13, or 61 | Thymic | 40-50 | 0 | 28 | 0.007 | 0.004 | 0.000 | 0.030 |
| NRAS | 12, 13, or 61 | Thymic | 50-65 | 0 | 72 | 0.005 | 0.003 | 0.000 | 0.024 |
| NRAS | 12, 13, or 61 | Thymic | >65 | 1 | 40 | 0.014 | 0.008 | 0.000 | 0.061 |
| NRAS | 12, 13, or 61 | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | 12, 13, or 61 | Ampullary | 50-65 | 0 | 40 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | 12, 13, or 61 | Ampullary | >65 | 0 | 50 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | 12, 13, or 61 | SCLC | 40-50 | 0 | 22 | 0.007 | 0.005 | 0.000 | 0.024 |
| NRAS | 12, 13, or 61 | SCLC | 50-65 | 1 | 144 | 0.006 | 0.005 | 0.001 | 0.018 |
| NRAS | 12, 13, or 61 | SCLC | >65 | 1 | 224 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | 12, 13, or 61 | Mesothelioma | <40 | 0 | 30 | 0.003 | 0.001 | 0.000 | 0.013 |
| NRAS | 12, 13, or 61 | Mesothelioma | 40-50 | 0 | 29 | 0.003 | 0.001 | 0.000 | 0.013 |
| NRAS | 12, 13, or 61 | Mesothelioma | 50-65 | 0 | 122 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Mesothelioma | >65 | 1 | 316 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Germ cell | <40 | 10 | 650 | 0.018 | 0.018 | 0.009 | 0.030 |
| NRAS | 12, 13, or 61 | Germ cell | 40-50 | 8 | 131 | 0.045 | 0.042 | 0.017 | 0.092 |
| NRAS | 12, 13, or 61 | Germ cell | 50-65 | 2 | 92 | 0.024 | 0.022 | 0.006 | 0.053 |
| NRAS | 12, 13, or 61 | Germ cell | >65 | 0 | 12 | 0.025 | 0.021 | 0.001 | 0.079 |
| NRAS | 12, 13, or 61 | Nerve sheath | <40 | 0 | 77 | 0.010 | 0.008 | 0.000 | 0.035 |
| NRAS | 12, 13, or 61 | Nerve sheath | 40-50 | 0 | 27 | 0.012 | 0.009 | 0.000 | 0.044 |
| NRAS | 12, 13, or 61 | Nerve sheath | 50-65 | 1 | 37 | 0.019 | 0.014 | 0.002 | 0.067 |
| NRAS | 12, 13, or 61 | Nerve sheath | >65 | 1 | 13 | 0.030 | 0.017 | 0.002 | 0.149 |
| NRAS | 12, 13, or 61 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.031 |
| NRAS | 12, 13, or 61 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| NRAS | 12, 13, or 61 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| NRAS | 12, 13, or 61 | B cell lymphoma | <40 | 0 | 87 | 0.016 | 0.016 | 0.001 | 0.032 |
| NRAS | 12, 13, or 61 | B cell lymphoma | 40-50 | 1 | 105 | 0.017 | 0.018 | 0.003 | 0.033 |
| NRAS | 12, 13, or 61 | B cell lymphoma | 50-65 | 11 | 357 | 0.025 | 0.023 | 0.013 | 0.043 |
| NRAS | 12, 13, or 61 | B cell lymphoma | >65 | 8 | 413 | 0.020 | 0.019 | 0.010 | 0.032 |
| NRAS | 12, 13, or 61 | Non-hodgkin lymphoma | >65 | 2 | 14 | 0.148 | 0.131 | 0.022 | 0.366 |
| NRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | <40 | 2 | 27 | 0.078 | 0.068 | 0.012 | 0.201 |
| NRAS | 12, 13, or 61 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | 12, 13, or 61 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | 12, 13, or 61 | Lung | >65 | 1 | 18 | 0.063 | 0.048 | 0.003 | 0.206 |
| NRAS | 12, 13, or 61 | Peritoneal | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.049 |
| NRAS | G12 | Appendiceal | <40 | 0 | 28 | 0.003 | 0.002 | 0.000 | 0.016 |
| NRAS | G12 | Appendiceal | 40-50 | 0 | 62 | 0.003 | 0.002 | 0.000 | 0.013 |
| NRAS | G12 | Appendiceal | 50-65 | 1 | 161 | 0.004 | 0.003 | 0.000 | 0.016 |
| NRAS | G12 | Appendiceal | >65 | 0 | 90 | 0.003 | 0.002 | 0.000 | 0.012 |
| NRAS | G12 | CRC | <40 | 7 | 565 | 0.012 | 0.012 | 0.007 | 0.020 |
| NRAS | G12 | CRC | 40-50 | 17 | 1280 | 0.013 | 0.013 | 0.008 | 0.019 |
| NRAS | G12 | CRC | 50-65 | 21 | 2814 | 0.009 | 0.009 | 0.005 | 0.013 |
| NRAS | G12 | CRC | >65 | 37 | 2052 | 0.016 | 0.016 | 0.011 | 0.023 |
| NRAS | G12 | CUP | <40 | 1 | 167 | 0.005 | 0.004 | 0.001 | 0.011 |
| NRAS | G12 | CUP | 40-50 | 0 | 211 | 0.004 | 0.004 | 0.001 | 0.009 |
| NRAS | G12 | CUP | 50-65 | 4 | 810 | 0.005 | 0.004 | 0.002 | 0.009 |
| NRAS | G12 | CUP | >65 | 4 | 796 | 0.005 | 0.004 | 0.002 | 0.009 |
| NRAS | G12 | NSCLC | <40 | 0 | 161 | 0.002 | 0.002 | 0.000 | 0.004 |
| NRAS | G12 | NSCLC | 40-50 | 0 | 585 | 0.002 | 0.002 | 0.000 | 0.003 |
| NRAS | G12 | NSCLC | 50-65 | 7 | 3677 | 0.002 | 0.002 | 0.001 | 0.003 |
| NRAS | G12 | NSCLC | >65 | 11 | 5698 | 0.002 | 0.002 | 0.001 | 0.003 |
| NRAS | G12 | NSCLC | NA | 0 | 10 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | G12 | Breast | <40 | 0 | 840 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Breast | 50-65 | 1 | 3989 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Breast | >65 | 0 | 2583 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Breast | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Soft tissue sarcoma | <40 | 1 | 672 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Soft tissue sarcoma | 40-50 | 0 | 367 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Soft tissue sarcoma | 50-65 | 0 | 951 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Soft tissue sarcoma | >65 | 2 | 777 | 0.002 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Pancreatic | <40 | 0 | 87 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Pancreatic | 40-50 | 0 | 200 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Pancreatic | 50-65 | 0 | 999 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Pancreatic | >65 | 2 | 1205 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Leukemia | <40 | 12 | 204 | 0.065 | 0.065 | 0.045 | 0.087 |
| NRAS | G12 | Leukemia | 40-50 | 13 | 128 | 0.074 | 0.071 | 0.053 | 0.115 |
| NRAS | G12 | Leukemia | 50-65 | 29 | 515 | 0.063 | 0.063 | 0.046 | 0.079 |
| NRAS | G12 | Leukemia | >65 | 50 | 720 | 0.068 | 0.068 | 0.054 | 0.084 |
| NRAS | G12 | Melanoma | <40 | 0 | 289 | 0.008 | 0.008 | 0.000 | 0.020 |
| NRAS | G12 | Melanoma | 40-50 | 5 | 282 | 0.017 | 0.016 | 0.007 | 0.032 |
| NRAS | G12 | Melanoma | 50-65 | 15 | 1016 | 0.015 | 0.015 | 0.009 | 0.022 |
| NRAS | G12 | Melanoma | >65 | 28 | 1259 | 0.020 | 0.020 | 0.014 | 0.029 |
| NRAS | G12 | Head and neck | <40 | 0 | 140 | 0.003 | 0.003 | 0.000 | 0.007 |
| NRAS | G12 | Head and neck | 40-50 | 0 | 216 | 0.003 | 0.002 | 0.000 | 0.007 |
| NRAS | G12 | Head and neck | 50-65 | 3 | 799 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | G12 | Head and neck | >65 | 2 | 582 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | G12 | Uterine | <40 | 0 | 57 | 0.007 | 0.006 | 0.000 | 0.020 |
| NRAS | G12 | Uterine | 40-50 | 2 | 162 | 0.009 | 0.008 | 0.003 | 0.023 |
| NRAS | G12 | Uterine | 50-65 | 12 | 1046 | 0.010 | 0.009 | 0.005 | 0.017 |
| NRAS | G12 | Uterine | >65 | 3 | 987 | 0.005 | 0.005 | 0.001 | 0.010 |
| NRAS | G12 | Non-melanoma skin | <40 | 0 | 27 | 0.003 | 0.001 | 0.000 | 0.014 |
| NRAS | G12 | Non-melanoma skin | 40-50 | 0 | 20 | 0.003 | 0.001 | 0.000 | 0.016 |
| NRAS | G12 | Non-melanoma skin | 50-65 | 0 | 149 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | G12 | Non-melanoma skin | >65 | 1 | 317 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | G12 | MDS/MPN | <40 | 3 | 87 | 0.033 | 0.032 | 0.013 | 0.061 |
| NRAS | G12 | MDS/MPN | 40-50 | 0 | 83 | 0.024 | 0.025 | 0.001 | 0.045 |
| NRAS | G12 | MDS/MPN | 50-65 | 10 | 373 | 0.030 | 0.029 | 0.015 | 0.045 |
| NRAS | G12 | MDS/MPN | >65 | 28 | 664 | 0.038 | 0.037 | 0.026 | 0.054 |
| NRAS | G12 | Adrenocortical | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Ovarian | <40 | 0 | 141 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Ovarian | 40-50 | 1 | 253 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | G12 | Ovarian | 50-65 | 1 | 1092 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Ovarian | >65 | 0 | 849 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Esophagogastric | <40 | 0 | 122 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Esophagogastric | 40-50 | 1 | 200 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | G12 | Esophagogastric | 50-65 | 1 | 752 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Esophagogastric | >65 | 0 | 725 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Thyroid | <40 | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | 40-50 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | 50-65 | 0 | 374 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | >65 | 0 | 370 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Cervical | <40 | 0 | 85 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Cervical | 40-50 | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Cervical | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Cervical | >65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Hepatobiliary | <40 | 0 | 137 | 0.005 | 0.005 | 0.000 | 0.013 |
| NRAS | G12 | Hepatobiliary | 40-50 | 0 | 110 | 0.005 | 0.005 | 0.000 | 0.013 |
| NRAS | G12 | Hepatobiliary | 50-65 | 2 | 525 | 0.005 | 0.005 | 0.001 | 0.011 |
| NRAS | G12 | Hepatobiliary | >65 | 7 | 601 | 0.009 | 0.008 | 0.003 | 0.018 |
| NRAS | G12 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | T / NK neoplasms | >65 | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | CNS | <40 | 3 | 1602 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | CNS | 40-50 | 1 | 687 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | CNS | 50-65 | 1 | 1439 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G12 | CNS | >65 | 0 | 836 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G12 | Prostate | 40-50 | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | 50-65 | 0 | 960 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | >65 | 0 | 1402 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Neuroendocrine | <40 | 0 | 22 | 0.004 | 0.002 | 0.000 | 0.016 |
| NRAS | G12 | Neuroendocrine | 40-50 | 0 | 55 | 0.003 | 0.002 | 0.000 | 0.014 |
| NRAS | G12 | Neuroendocrine | 50-65 | 1 | 161 | 0.004 | 0.003 | 0.000 | 0.015 |
| NRAS | G12 | Neuroendocrine | >65 | 0 | 121 | 0.003 | 0.002 | 0.000 | 0.012 |
| NRAS | G12 | Bladder | <40 | 0 | 25 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | G12 | Bladder | 40-50 | 0 | 78 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G12 | Bladder | 50-65 | 1 | 511 | 0.002 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Bladder | >65 | 1 | 961 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | BLL/Lymphoma | <40 | 16 | 142 | 0.110 | 0.109 | 0.064 | 0.167 |
| NRAS | G12 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.008 | 0.000 | 0.000 | 0.067 |
| NRAS | G12 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.004 | 0.000 | 0.000 | 0.033 |
| NRAS | G12 | BLL/Lymphoma | >65 | 0 | 42 | 0.005 | 0.000 | 0.000 | 0.035 |
| NRAS | G12 | Small bowel | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Small bowel | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Small bowel | >65 | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Sex cord stromal | 50-65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12 | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12 | Thymic | <40 | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Ampullary | 50-65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Ampullary | >65 | 0 | 50 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | SCLC | 40-50 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | SCLC | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | SCLC | >65 | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Germ cell | <40 | 5 | 650 | 0.008 | 0.008 | 0.003 | 0.015 |
| NRAS | G12 | Germ cell | 40-50 | 2 | 131 | 0.010 | 0.009 | 0.003 | 0.028 |
| NRAS | G12 | Germ cell | 50-65 | 0 | 92 | 0.007 | 0.007 | 0.000 | 0.017 |
| NRAS | G12 | Germ cell | >65 | 0 | 12 | 0.008 | 0.007 | 0.000 | 0.026 |
| NRAS | G12 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Nerve sheath | 40-50 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Nerve sheath | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Nerve sheath | >65 | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G12 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | G12 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| NRAS | G12 | B cell lymphoma | <40 | 0 | 87 | 0.005 | 0.004 | 0.000 | 0.013 |
| NRAS | G12 | B cell lymphoma | 40-50 | 0 | 105 | 0.005 | 0.004 | 0.000 | 0.012 |
| NRAS | G12 | B cell lymphoma | 50-65 | 3 | 357 | 0.006 | 0.005 | 0.002 | 0.014 |
| NRAS | G12 | B cell lymphoma | >65 | 2 | 413 | 0.005 | 0.005 | 0.001 | 0.012 |
| NRAS | G12 | Non-hodgkin lymphoma | >65 | 1 | 14 | 0.080 | 0.062 | 0.004 | 0.254 |
| NRAS | G12 | T-lymphoblastic leukemia/lymphoma | <40 | 2 | 27 | 0.079 | 0.068 | 0.011 | 0.202 |
| NRAS | G12 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | G12 | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | G12 | Peritoneal | >65 | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.077 |
| NRAS | G12C | Appendiceal | <40 | 0 | 28 | 0.003 | 0.002 | 0.000 | 0.016 |
| NRAS | G12C | Appendiceal | 40-50 | 0 | 62 | 0.003 | 0.002 | 0.000 | 0.013 |
| NRAS | G12C | Appendiceal | 50-65 | 1 | 161 | 0.004 | 0.003 | 0.000 | 0.016 |
| NRAS | G12C | Appendiceal | >65 | 0 | 90 | 0.003 | 0.002 | 0.000 | 0.012 |
| NRAS | G12C | CRC | <40 | 1 | 565 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12C | CRC | 40-50 | 3 | 1280 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12C | CRC | 50-65 | 3 | 2814 | 0.002 | 0.002 | 0.001 | 0.003 |
| NRAS | G12C | CRC | >65 | 9 | 2052 | 0.003 | 0.003 | 0.002 | 0.006 |
| NRAS | G12C | CUP | <40 | 1 | 167 | 0.002 | 0.001 | 0.000 | 0.012 |
| NRAS | G12C | CUP | 40-50 | 0 | 211 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | CUP | 50-65 | 1 | 810 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | CUP | >65 | 0 | 796 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12C | NSCLC | <40 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | 40-50 | 0 | 585 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | 50-65 | 1 | 3677 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | >65 | 2 | 5698 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Breast | <40 | 0 | 840 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | 50-65 | 0 | 3989 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | >65 | 0 | 2583 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | <40 | 0 | 672 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | 40-50 | 0 | 367 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | 50-65 | 0 | 951 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | >65 | 0 | 777 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Pancreatic | <40 | 0 | 87 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Pancreatic | 40-50 | 0 | 200 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Pancreatic | 50-65 | 0 | 999 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Pancreatic | >65 | 1 | 1205 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Leukemia | <40 | 3 | 204 | 0.009 | 0.007 | 0.002 | 0.026 |
| NRAS | G12C | Leukemia | 40-50 | 1 | 128 | 0.006 | 0.005 | 0.001 | 0.020 |
| NRAS | G12C | Leukemia | 50-65 | 0 | 515 | 0.003 | 0.003 | 0.000 | 0.008 |
| NRAS | G12C | Leukemia | >65 | 4 | 720 | 0.005 | 0.005 | 0.002 | 0.011 |
| NRAS | G12C | Melanoma | <40 | 0 | 289 | 0.004 | 0.004 | 0.000 | 0.007 |
| NRAS | G12C | Melanoma | 40-50 | 1 | 282 | 0.004 | 0.004 | 0.001 | 0.009 |
| NRAS | G12C | Melanoma | 50-65 | 3 | 1016 | 0.004 | 0.004 | 0.001 | 0.007 |
| NRAS | G12C | Melanoma | >65 | 8 | 1259 | 0.005 | 0.005 | 0.002 | 0.009 |
| NRAS | G12C | Head and neck | <40 | 0 | 140 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Head and neck | 40-50 | 0 | 216 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Head and neck | 50-65 | 0 | 799 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Head and neck | >65 | 1 | 582 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Uterine | <40 | 0 | 57 | 0.003 | 0.002 | 0.000 | 0.008 |
| NRAS | G12C | Uterine | 40-50 | 1 | 162 | 0.003 | 0.002 | 0.001 | 0.010 |
| NRAS | G12C | Uterine | 50-65 | 3 | 1046 | 0.003 | 0.002 | 0.001 | 0.006 |
| NRAS | G12C | Uterine | >65 | 1 | 987 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | G12C | Non-melanoma skin | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-melanoma skin | 40-50 | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-melanoma skin | 50-65 | 0 | 149 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-melanoma skin | >65 | 0 | 317 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | MDS/MPN | <40 | 0 | 87 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | MDS/MPN | 40-50 | 0 | 83 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | MDS/MPN | 50-65 | 0 | 373 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | MDS/MPN | >65 | 1 | 664 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Adrenocortical | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Ovarian | <40 | 0 | 141 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | 40-50 | 0 | 253 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | 50-65 | 0 | 1092 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | >65 | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | <40 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | 40-50 | 0 | 200 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | 50-65 | 0 | 752 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | >65 | 0 | 725 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | <40 | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | 40-50 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | 50-65 | 0 | 374 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | >65 | 0 | 370 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Cervical | <40 | 0 | 85 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Cervical | 40-50 | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Cervical | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Cervical | >65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Hepatobiliary | <40 | 0 | 137 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | Hepatobiliary | 40-50 | 0 | 110 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G12C | Hepatobiliary | 50-65 | 0 | 525 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Hepatobiliary | >65 | 2 | 601 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | G12C | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | T / NK neoplasms | >65 | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | CNS | <40 | 0 | 1602 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | CNS | 40-50 | 1 | 687 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | CNS | 50-65 | 1 | 1439 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Prostate | 40-50 | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | 50-65 | 0 | 960 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | >65 | 0 | 1402 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Neuroendocrine | <40 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Neuroendocrine | 40-50 | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Neuroendocrine | 50-65 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Neuroendocrine | >65 | 0 | 121 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Bladder | <40 | 0 | 25 | 0.001 | 0.001 | 0.000 | 0.007 |
| NRAS | G12C | Bladder | 40-50 | 0 | 78 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | Bladder | 50-65 | 0 | 511 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Bladder | >65 | 1 | 961 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12C | BLL/Lymphoma | <40 | 1 | 142 | 0.005 | 0.004 | 0.000 | 0.019 |
| NRAS | G12C | BLL/Lymphoma | 40-50 | 0 | 16 | 0.005 | 0.003 | 0.000 | 0.023 |
| NRAS | G12C | BLL/Lymphoma | 50-65 | 0 | 48 | 0.004 | 0.003 | 0.000 | 0.018 |
| NRAS | G12C | BLL/Lymphoma | >65 | 0 | 42 | 0.005 | 0.003 | 0.000 | 0.019 |
| NRAS | G12C | Small bowel | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Small bowel | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Small bowel | >65 | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Sex cord stromal | 50-65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12C | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12C | Thymic | <40 | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Ampullary | 50-65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Ampullary | >65 | 0 | 50 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | SCLC | 40-50 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | SCLC | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | SCLC | >65 | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Germ cell | <40 | 1 | 650 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | Germ cell | 40-50 | 0 | 131 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G12C | Germ cell | 50-65 | 0 | 92 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G12C | Germ cell | >65 | 0 | 12 | 0.002 | 0.001 | 0.000 | 0.012 |
| NRAS | G12C | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Nerve sheath | 40-50 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Nerve sheath | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Nerve sheath | >65 | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G12C | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | G12C | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.041 |
| NRAS | G12C | B cell lymphoma | <40 | 0 | 87 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | 40-50 | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | 50-65 | 0 | 357 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | >65 | 0 | 413 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.051 |
| NRAS | G12C | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.017 |
| NRAS | G12C | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12C | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | G12C | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | G12C | Peritoneal | >65 | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.077 |
| NRAS | G13 | Appendiceal | <40 | 0 | 28 | 0.004 | 0.002 | 0.000 | 0.017 |
| NRAS | G13 | Appendiceal | 40-50 | 0 | 62 | 0.003 | 0.002 | 0.000 | 0.014 |
| NRAS | G13 | Appendiceal | 50-65 | 1 | 161 | 0.004 | 0.003 | 0.000 | 0.015 |
| NRAS | G13 | Appendiceal | >65 | 0 | 90 | 0.003 | 0.002 | 0.000 | 0.013 |
| NRAS | G13 | CRC | <40 | 1 | 565 | 0.005 | 0.005 | 0.001 | 0.007 |
| NRAS | G13 | CRC | 40-50 | 4 | 1280 | 0.005 | 0.005 | 0.002 | 0.007 |
| NRAS | G13 | CRC | 50-65 | 17 | 2814 | 0.005 | 0.005 | 0.003 | 0.008 |
| NRAS | G13 | CRC | >65 | 12 | 2052 | 0.005 | 0.005 | 0.003 | 0.008 |
| NRAS | G13 | CUP | <40 | 1 | 167 | 0.003 | 0.003 | 0.001 | 0.010 |
| NRAS | G13 | CUP | 40-50 | 1 | 211 | 0.003 | 0.003 | 0.001 | 0.009 |
| NRAS | G13 | CUP | 50-65 | 2 | 810 | 0.003 | 0.002 | 0.001 | 0.006 |
| NRAS | G13 | CUP | >65 | 1 | 796 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G13 | NSCLC | <40 | 0 | 161 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | NSCLC | 40-50 | 0 | 585 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | NSCLC | 50-65 | 1 | 3677 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | NSCLC | >65 | 3 | 5698 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | NSCLC | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Breast | <40 | 0 | 840 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Breast | 50-65 | 1 | 3989 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Breast | >65 | 0 | 2583 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Breast | NA | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Soft tissue sarcoma | <40 | 2 | 672 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G13 | Soft tissue sarcoma | 40-50 | 0 | 367 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Soft tissue sarcoma | 50-65 | 0 | 951 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Soft tissue sarcoma | >65 | 1 | 777 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Pancreatic | <40 | 0 | 87 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Pancreatic | 40-50 | 0 | 200 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Pancreatic | 50-65 | 1 | 999 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Pancreatic | >65 | 1 | 1205 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Leukemia | <40 | 8 | 204 | 0.030 | 0.029 | 0.019 | 0.049 |
| NRAS | G13 | Leukemia | 40-50 | 2 | 128 | 0.027 | 0.027 | 0.012 | 0.040 |
| NRAS | G13 | Leukemia | 50-65 | 16 | 515 | 0.029 | 0.029 | 0.020 | 0.041 |
| NRAS | G13 | Leukemia | >65 | 18 | 720 | 0.027 | 0.027 | 0.018 | 0.037 |
| NRAS | G13 | Melanoma | <40 | 1 | 289 | 0.011 | 0.011 | 0.002 | 0.018 |
| NRAS | G13 | Melanoma | 40-50 | 2 | 282 | 0.012 | 0.012 | 0.004 | 0.019 |
| NRAS | G13 | Melanoma | 50-65 | 14 | 1016 | 0.013 | 0.013 | 0.008 | 0.020 |
| NRAS | G13 | Melanoma | >65 | 22 | 1259 | 0.015 | 0.015 | 0.010 | 0.022 |
| NRAS | G13 | Head and neck | <40 | 0 | 140 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Head and neck | 40-50 | 0 | 216 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Head and neck | 50-65 | 1 | 799 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Head and neck | >65 | 1 | 582 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Uterine | <40 | 1 | 57 | 0.012 | 0.005 | 0.000 | 0.055 |
| NRAS | G13 | Uterine | 40-50 | 0 | 162 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Uterine | 50-65 | 0 | 1046 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Uterine | >65 | 0 | 987 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | 40-50 | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | 50-65 | 0 | 149 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Non-melanoma skin | >65 | 0 | 317 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | MDS/MPN | <40 | 3 | 87 | 0.019 | 0.018 | 0.009 | 0.042 |
| NRAS | G13 | MDS/MPN | 40-50 | 1 | 83 | 0.017 | 0.016 | 0.006 | 0.031 |
| NRAS | G13 | MDS/MPN | 50-65 | 5 | 373 | 0.016 | 0.016 | 0.008 | 0.026 |
| NRAS | G13 | MDS/MPN | >65 | 11 | 664 | 0.017 | 0.016 | 0.010 | 0.026 |
| NRAS | G13 | Adrenocortical | <40 | 0 | 27 | 0.008 | 0.004 | 0.000 | 0.035 |
| NRAS | G13 | Adrenocortical | 40-50 | 0 | 30 | 0.007 | 0.004 | 0.000 | 0.033 |
| NRAS | G13 | Adrenocortical | 50-65 | 0 | 51 | 0.007 | 0.004 | 0.000 | 0.029 |
| NRAS | G13 | Adrenocortical | >65 | 1 | 26 | 0.018 | 0.010 | 0.000 | 0.087 |
| NRAS | G13 | Ovarian | <40 | 0 | 141 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | 40-50 | 0 | 253 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | 50-65 | 0 | 1092 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | >65 | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Esophagogastric | <40 | 0 | 122 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Esophagogastric | 40-50 | 0 | 200 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Esophagogastric | 50-65 | 1 | 752 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Esophagogastric | >65 | 0 | 725 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Thyroid | <40 | 0 | 150 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G13 | Thyroid | 40-50 | 0 | 122 | 0.002 | 0.001 | 0.000 | 0.007 |
| NRAS | G13 | Thyroid | 50-65 | 0 | 374 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Thyroid | >65 | 2 | 370 | 0.004 | 0.003 | 0.000 | 0.012 |
| NRAS | G13 | Cervical | <40 | 0 | 85 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Cervical | 40-50 | 0 | 99 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Cervical | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Cervical | >65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Hepatobiliary | <40 | 0 | 137 | 0.003 | 0.003 | 0.000 | 0.008 |
| NRAS | G13 | Hepatobiliary | 40-50 | 1 | 110 | 0.004 | 0.003 | 0.001 | 0.015 |
| NRAS | G13 | Hepatobiliary | 50-65 | 2 | 525 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | G13 | Hepatobiliary | >65 | 1 | 601 | 0.003 | 0.003 | 0.000 | 0.007 |
| NRAS | G13 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | T / NK neoplasms | <40 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | T / NK neoplasms | 40-50 | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | T / NK neoplasms | 50-65 | 0 | 76 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | T / NK neoplasms | >65 | 0 | 106 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | CNS | <40 | 0 | 1602 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | CNS | 40-50 | 0 | 687 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | CNS | 50-65 | 1 | 1439 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | CNS | >65 | 0 | 836 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Prostate | 40-50 | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | 50-65 | 0 | 960 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | >65 | 0 | 1402 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Anal | 40-50 | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Neuroendocrine | <40 | 0 | 22 | 0.003 | 0.001 | 0.000 | 0.016 |
| NRAS | G13 | Neuroendocrine | 40-50 | 0 | 55 | 0.003 | 0.001 | 0.000 | 0.013 |
| NRAS | G13 | Neuroendocrine | 50-65 | 1 | 161 | 0.005 | 0.003 | 0.000 | 0.018 |
| NRAS | G13 | Neuroendocrine | >65 | 0 | 121 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G13 | Bladder | <40 | 0 | 25 | 0.002 | 0.001 | 0.000 | 0.007 |
| NRAS | G13 | Bladder | 40-50 | 0 | 78 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G13 | Bladder | 50-65 | 0 | 511 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Bladder | >65 | 2 | 961 | 0.002 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | BLL/Lymphoma | <40 | 6 | 142 | 0.036 | 0.034 | 0.015 | 0.066 |
| NRAS | G13 | BLL/Lymphoma | 40-50 | 1 | 16 | 0.038 | 0.032 | 0.010 | 0.106 |
| NRAS | G13 | BLL/Lymphoma | 50-65 | 1 | 48 | 0.030 | 0.029 | 0.006 | 0.064 |
| NRAS | G13 | BLL/Lymphoma | >65 | 0 | 42 | 0.027 | 0.026 | 0.002 | 0.059 |
| NRAS | G13 | Small bowel | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Small bowel | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Small bowel | >65 | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Sex cord stromal | <40 | 1 | 29 | 0.017 | 0.011 | 0.001 | 0.071 |
| NRAS | G13 | Sex cord stromal | 40-50 | 0 | 15 | 0.011 | 0.006 | 0.000 | 0.046 |
| NRAS | G13 | Sex cord stromal | 50-65 | 0 | 36 | 0.009 | 0.006 | 0.000 | 0.038 |
| NRAS | G13 | Sex cord stromal | >65 | 0 | 27 | 0.010 | 0.006 | 0.000 | 0.041 |
| NRAS | G13 | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.009 |
| NRAS | G13 | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | G13 | Thymic | <40 | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Thymic | 40-50 | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Thymic | 50-65 | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Thymic | >65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Ampullary | 50-65 | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Ampullary | >65 | 0 | 50 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | SCLC | 40-50 | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | SCLC | 50-65 | 0 | 144 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | SCLC | >65 | 0 | 224 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | <40 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | 40-50 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | 50-65 | 0 | 122 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | >65 | 0 | 316 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Germ cell | <40 | 2 | 650 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | G13 | Germ cell | 40-50 | 1 | 131 | 0.004 | 0.003 | 0.001 | 0.015 |
| NRAS | G13 | Germ cell | 50-65 | 0 | 92 | 0.004 | 0.003 | 0.000 | 0.011 |
| NRAS | G13 | Germ cell | >65 | 0 | 12 | 0.004 | 0.003 | 0.000 | 0.017 |
| NRAS | G13 | Nerve sheath | <40 | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Nerve sheath | 40-50 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Nerve sheath | 50-65 | 0 | 37 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Nerve sheath | >65 | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | G13 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | G13 | Pineal | <40 | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.044 |
| NRAS | G13 | B cell lymphoma | <40 | 0 | 87 | 0.004 | 0.003 | 0.000 | 0.011 |
| NRAS | G13 | B cell lymphoma | 40-50 | 0 | 105 | 0.004 | 0.003 | 0.000 | 0.011 |
| NRAS | G13 | B cell lymphoma | 50-65 | 3 | 357 | 0.006 | 0.005 | 0.001 | 0.014 |
| NRAS | G13 | B cell lymphoma | >65 | 1 | 413 | 0.004 | 0.003 | 0.000 | 0.009 |
| NRAS | G13 | Non-hodgkin lymphoma | >65 | 1 | 14 | 0.079 | 0.060 | 0.004 | 0.256 |
| NRAS | G13 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | G13 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.009 |
| NRAS | G13 | Hodgkin lymphoma | <40 | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.016 |
| NRAS | G13 | Lung | >65 | 0 | 18 | 0.002 | 0.000 | 0.000 | 0.028 |
| NRAS | G13 | Peritoneal | >65 | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.056 |
| NRAS | Q61 | Appendiceal | <40 | 0 | 28 | 0.015 | 0.013 | 0.001 | 0.037 |
| NRAS | Q61 | Appendiceal | 40-50 | 2 | 62 | 0.019 | 0.016 | 0.005 | 0.050 |
| NRAS | Q61 | Appendiceal | 50-65 | 2 | 161 | 0.015 | 0.013 | 0.004 | 0.031 |
| NRAS | Q61 | Appendiceal | >65 | 1 | 90 | 0.015 | 0.013 | 0.003 | 0.034 |
| NRAS | Q61 | CRC | <40 | 10 | 565 | 0.022 | 0.022 | 0.015 | 0.028 |
| NRAS | Q61 | CRC | 40-50 | 32 | 1280 | 0.023 | 0.023 | 0.018 | 0.029 |
| NRAS | Q61 | CRC | 50-65 | 66 | 2814 | 0.023 | 0.023 | 0.019 | 0.027 |
| NRAS | Q61 | CRC | >65 | 42 | 2052 | 0.022 | 0.022 | 0.017 | 0.026 |
| NRAS | Q61 | CUP | <40 | 3 | 167 | 0.011 | 0.010 | 0.005 | 0.024 |
| NRAS | Q61 | CUP | 40-50 | 3 | 211 | 0.011 | 0.010 | 0.005 | 0.021 |
| NRAS | Q61 | CUP | 50-65 | 8 | 810 | 0.010 | 0.010 | 0.005 | 0.016 |
| NRAS | Q61 | CUP | >65 | 5 | 796 | 0.009 | 0.009 | 0.004 | 0.014 |
| NRAS | Q61 | NSCLC | <40 | 1 | 161 | 0.006 | 0.006 | 0.003 | 0.010 |
| NRAS | Q61 | NSCLC | 40-50 | 5 | 585 | 0.006 | 0.006 | 0.004 | 0.011 |
| NRAS | Q61 | NSCLC | 50-65 | 23 | 3677 | 0.006 | 0.006 | 0.004 | 0.008 |
| NRAS | Q61 | NSCLC | >65 | 30 | 5698 | 0.006 | 0.006 | 0.004 | 0.007 |
| NRAS | Q61 | NSCLC | NA | 0 | 10 | 0.006 | 0.006 | 0.003 | 0.011 |
| NRAS | Q61 | Breast | <40 | 0 | 840 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | 40-50 | 0 | 1910 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | 50-65 | 0 | 3989 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | >65 | 0 | 2583 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Soft tissue sarcoma | <40 | 15 | 672 | 0.018 | 0.018 | 0.009 | 0.031 |
| NRAS | Q61 | Soft tissue sarcoma | 40-50 | 2 | 367 | 0.008 | 0.007 | 0.002 | 0.016 |
| NRAS | Q61 | Soft tissue sarcoma | 50-65 | 5 | 951 | 0.007 | 0.007 | 0.003 | 0.013 |
| NRAS | Q61 | Soft tissue sarcoma | >65 | 6 | 777 | 0.009 | 0.008 | 0.004 | 0.015 |
| NRAS | Q61 | Pancreatic | <40 | 1 | 87 | 0.005 | 0.004 | 0.001 | 0.017 |
| NRAS | Q61 | Pancreatic | 40-50 | 2 | 200 | 0.005 | 0.004 | 0.002 | 0.015 |
| NRAS | Q61 | Pancreatic | 50-65 | 3 | 999 | 0.004 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Pancreatic | >65 | 3 | 1205 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Leukemia | <40 | 7 | 204 | 0.029 | 0.029 | 0.018 | 0.046 |
| NRAS | Q61 | Leukemia | 40-50 | 6 | 128 | 0.031 | 0.029 | 0.019 | 0.056 |
| NRAS | Q61 | Leukemia | 50-65 | 12 | 515 | 0.027 | 0.027 | 0.017 | 0.037 |
| NRAS | Q61 | Leukemia | >65 | 18 | 720 | 0.027 | 0.027 | 0.018 | 0.037 |
| NRAS | Q61 | Melanoma | <40 | 37 | 289 | 0.154 | 0.153 | 0.108 | 0.200 |
| NRAS | Q61 | Melanoma | 40-50 | 54 | 282 | 0.191 | 0.191 | 0.153 | 0.230 |
| NRAS | Q61 | Melanoma | 50-65 | 209 | 1016 | 0.203 | 0.202 | 0.180 | 0.227 |
| NRAS | Q61 | Melanoma | >65 | 264 | 1259 | 0.206 | 0.206 | 0.185 | 0.229 |
| NRAS | Q61 | Head and neck | <40 | 0 | 140 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | Q61 | Head and neck | 40-50 | 1 | 216 | 0.003 | 0.002 | 0.000 | 0.010 |
| NRAS | Q61 | Head and neck | 50-65 | 3 | 799 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Head and neck | >65 | 0 | 582 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | Q61 | Uterine | <40 | 0 | 57 | 0.011 | 0.010 | 0.001 | 0.021 |
| NRAS | Q61 | Uterine | 40-50 | 3 | 162 | 0.013 | 0.012 | 0.006 | 0.027 |
| NRAS | Q61 | Uterine | 50-65 | 14 | 1046 | 0.012 | 0.012 | 0.007 | 0.019 |
| NRAS | Q61 | Uterine | >65 | 8 | 987 | 0.010 | 0.010 | 0.005 | 0.016 |
| NRAS | Q61 | Non-melanoma skin | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Non-melanoma skin | 40-50 | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Non-melanoma skin | 50-65 | 0 | 149 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Non-melanoma skin | >65 | 0 | 317 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | MDS/MPN | <40 | 0 | 87 | 0.003 | 0.003 | 0.000 | 0.009 |
| NRAS | Q61 | MDS/MPN | 40-50 | 0 | 83 | 0.003 | 0.003 | 0.000 | 0.009 |
| NRAS | Q61 | MDS/MPN | 50-65 | 2 | 373 | 0.004 | 0.003 | 0.001 | 0.010 |
| NRAS | Q61 | MDS/MPN | >65 | 2 | 664 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | Q61 | Adrenocortical | <40 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Adrenocortical | 40-50 | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Adrenocortical | 50-65 | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Adrenocortical | >65 | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Ovarian | <40 | 2 | 141 | 0.013 | 0.013 | 0.007 | 0.023 |
| NRAS | Q61 | Ovarian | 40-50 | 3 | 253 | 0.013 | 0.013 | 0.007 | 0.021 |
| NRAS | Q61 | Ovarian | 50-65 | 17 | 1092 | 0.014 | 0.014 | 0.009 | 0.020 |
| NRAS | Q61 | Ovarian | >65 | 9 | 849 | 0.013 | 0.012 | 0.007 | 0.019 |
| NRAS | Q61 | Esophagogastric | <40 | 0 | 122 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | Q61 | Esophagogastric | 40-50 | 1 | 200 | 0.004 | 0.003 | 0.001 | 0.009 |
| NRAS | Q61 | Esophagogastric | 50-65 | 2 | 752 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Esophagogastric | >65 | 3 | 725 | 0.004 | 0.003 | 0.001 | 0.008 |
| NRAS | Q61 | Thyroid | <40 | 11 | 150 | 0.107 | 0.109 | 0.062 | 0.141 |
| NRAS | Q61 | Thyroid | 40-50 | 17 | 122 | 0.126 | 0.124 | 0.092 | 0.173 |
| NRAS | Q61 | Thyroid | 50-65 | 46 | 374 | 0.122 | 0.122 | 0.097 | 0.150 |
| NRAS | Q61 | Thyroid | >65 | 50 | 370 | 0.127 | 0.126 | 0.102 | 0.159 |
| NRAS | Q61 | Cervical | <40 | 1 | 85 | 0.007 | 0.006 | 0.001 | 0.024 |
| NRAS | Q61 | Cervical | 40-50 | 0 | 99 | 0.005 | 0.004 | 0.000 | 0.017 |
| NRAS | Q61 | Cervical | 50-65 | 1 | 144 | 0.006 | 0.005 | 0.001 | 0.019 |
| NRAS | Q61 | Cervical | >65 | 0 | 36 | 0.006 | 0.005 | 0.000 | 0.020 |
| NRAS | Q61 | Hepatobiliary | <40 | 0 | 137 | 0.010 | 0.010 | 0.001 | 0.019 |
| NRAS | Q61 | Hepatobiliary | 40-50 | 1 | 110 | 0.011 | 0.011 | 0.003 | 0.022 |
| NRAS | Q61 | Hepatobiliary | 50-65 | 7 | 525 | 0.012 | 0.012 | 0.006 | 0.020 |
| NRAS | Q61 | Hepatobiliary | >65 | 8 | 601 | 0.012 | 0.012 | 0.006 | 0.020 |
| NRAS | Q61 | Kidney | <40 | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | 40-50 | 0 | 159 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | 50-65 | 0 | 628 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | >65 | 0 | 440 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | T / NK neoplasms | <40 | 0 | 28 | 0.007 | 0.003 | 0.000 | 0.031 |
| NRAS | Q61 | T / NK neoplasms | 40-50 | 0 | 21 | 0.007 | 0.004 | 0.000 | 0.033 |
| NRAS | Q61 | T / NK neoplasms | 50-65 | 2 | 76 | 0.018 | 0.013 | 0.002 | 0.058 |
| NRAS | Q61 | T / NK neoplasms | >65 | 0 | 106 | 0.005 | 0.003 | 0.000 | 0.021 |
| NRAS | Q61 | CNS | <40 | 11 | 1602 | 0.005 | 0.005 | 0.003 | 0.009 |
| NRAS | Q61 | CNS | 40-50 | 3 | 687 | 0.004 | 0.004 | 0.002 | 0.008 |
| NRAS | Q61 | CNS | 50-65 | 3 | 1439 | 0.004 | 0.004 | 0.001 | 0.006 |
| NRAS | Q61 | CNS | >65 | 3 | 836 | 0.004 | 0.004 | 0.002 | 0.007 |
| NRAS | Q61 | Prostate | 40-50 | 0 | 70 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | Q61 | Prostate | 50-65 | 0 | 960 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Prostate | >65 | 4 | 1402 | 0.002 | 0.002 | 0.001 | 0.006 |
| NRAS | Q61 | Anal | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | Q61 | Anal | 50-65 | 0 | 88 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Anal | >65 | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Neuroendocrine | <40 | 1 | 22 | 0.024 | 0.009 | 0.000 | 0.127 |
| NRAS | Q61 | Neuroendocrine | 40-50 | 0 | 55 | 0.003 | 0.001 | 0.000 | 0.014 |
| NRAS | Q61 | Neuroendocrine | 50-65 | 0 | 161 | 0.002 | 0.001 | 0.000 | 0.010 |
| NRAS | Q61 | Neuroendocrine | >65 | 0 | 121 | 0.002 | 0.001 | 0.000 | 0.010 |
| NRAS | Q61 | Bladder | <40 | 0 | 25 | 0.005 | 0.004 | 0.000 | 0.016 |
| NRAS | Q61 | Bladder | 40-50 | 1 | 78 | 0.006 | 0.004 | 0.001 | 0.021 |
| NRAS | Q61 | Bladder | 50-65 | 3 | 511 | 0.005 | 0.004 | 0.001 | 0.011 |
| NRAS | Q61 | Bladder | >65 | 2 | 961 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | BLL/Lymphoma | <40 | 6 | 142 | 0.036 | 0.034 | 0.012 | 0.075 |
| NRAS | Q61 | BLL/Lymphoma | 40-50 | 0 | 16 | 0.011 | 0.004 | 0.000 | 0.052 |
| NRAS | Q61 | BLL/Lymphoma | 50-65 | 0 | 48 | 0.009 | 0.003 | 0.000 | 0.039 |
| NRAS | Q61 | BLL/Lymphoma | >65 | 0 | 42 | 0.009 | 0.002 | 0.000 | 0.040 |
| NRAS | Q61 | Small bowel | 40-50 | 0 | 29 | 0.010 | 0.008 | 0.000 | 0.033 |
| NRAS | Q61 | Small bowel | 50-65 | 1 | 96 | 0.011 | 0.009 | 0.001 | 0.031 |
| NRAS | Q61 | Small bowel | >65 | 1 | 78 | 0.011 | 0.009 | 0.001 | 0.033 |
| NRAS | Q61 | Sex cord stromal | <40 | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Sex cord stromal | 40-50 | 0 | 15 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | Q61 | Sex cord stromal | 50-65 | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | Q61 | Sex cord stromal | >65 | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | Q61 | Bone | <40 | 0 | 342 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Bone | 40-50 | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Bone | 50-65 | 0 | 96 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Bone | >65 | 0 | 67 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Vaginal | 50-65 | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.011 |
| NRAS | Q61 | Vaginal | >65 | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | Q61 | Thymic | <40 | 0 | 14 | 0.008 | 0.004 | 0.000 | 0.038 |
| NRAS | Q61 | Thymic | 40-50 | 0 | 28 | 0.007 | 0.004 | 0.000 | 0.030 |
| NRAS | Q61 | Thymic | 50-65 | 0 | 72 | 0.005 | 0.003 | 0.000 | 0.024 |
| NRAS | Q61 | Thymic | >65 | 1 | 40 | 0.014 | 0.008 | 0.000 | 0.061 |
| NRAS | Q61 | Ampullary | 40-50 | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | Q61 | Ampullary | 50-65 | 0 | 40 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | Q61 | Ampullary | >65 | 0 | 50 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | Q61 | SCLC | 40-50 | 0 | 22 | 0.007 | 0.005 | 0.000 | 0.024 |
| NRAS | Q61 | SCLC | 50-65 | 1 | 144 | 0.006 | 0.005 | 0.001 | 0.018 |
| NRAS | Q61 | SCLC | >65 | 1 | 224 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | Q61 | Mesothelioma | <40 | 0 | 30 | 0.003 | 0.001 | 0.000 | 0.013 |
| NRAS | Q61 | Mesothelioma | 40-50 | 0 | 29 | 0.003 | 0.001 | 0.000 | 0.013 |
| NRAS | Q61 | Mesothelioma | 50-65 | 0 | 122 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | Q61 | Mesothelioma | >65 | 1 | 316 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | Q61 | Germ cell | <40 | 4 | 650 | 0.009 | 0.008 | 0.003 | 0.018 |
| NRAS | Q61 | Germ cell | 40-50 | 5 | 131 | 0.027 | 0.023 | 0.008 | 0.064 |
| NRAS | Q61 | Germ cell | 50-65 | 2 | 92 | 0.018 | 0.015 | 0.005 | 0.048 |
| NRAS | Q61 | Germ cell | >65 | 0 | 12 | 0.017 | 0.012 | 0.000 | 0.068 |
| NRAS | Q61 | Nerve sheath | <40 | 0 | 77 | 0.010 | 0.008 | 0.000 | 0.035 |
| NRAS | Q61 | Nerve sheath | 40-50 | 0 | 27 | 0.012 | 0.009 | 0.000 | 0.044 |
| NRAS | Q61 | Nerve sheath | 50-65 | 1 | 37 | 0.019 | 0.014 | 0.002 | 0.067 |
| NRAS | Q61 | Nerve sheath | >65 | 1 | 13 | 0.030 | 0.017 | 0.002 | 0.149 |
| NRAS | Q61 | Penile | 50-65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.031 |
| NRAS | Q61 | Penile | >65 | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| NRAS | Q61 | Pineal | <40 | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.037 |
| NRAS | Q61 | B cell lymphoma | <40 | 0 | 87 | 0.011 | 0.011 | 0.002 | 0.023 |
| NRAS | Q61 | B cell lymphoma | 40-50 | 1 | 105 | 0.012 | 0.012 | 0.004 | 0.024 |
| NRAS | Q61 | B cell lymphoma | 50-65 | 6 | 357 | 0.014 | 0.013 | 0.006 | 0.024 |
| NRAS | Q61 | B cell lymphoma | >65 | 5 | 413 | 0.012 | 0.012 | 0.006 | 0.022 |
| NRAS | Q61 | Non-hodgkin lymphoma | >65 | 0 | 14 | 0.005 | 0.000 | 0.000 | 0.052 |
| NRAS | Q61 | T-lymphoblastic leukemia/lymphoma | <40 | 0 | 27 | 0.001 | 0.000 | 0.000 | 0.018 |
| NRAS | Q61 | Retinoblastoma | <40 | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | Q61 | Hodgkin lymphoma | <40 | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | Q61 | Lung | >65 | 1 | 18 | 0.063 | 0.048 | 0.003 | 0.206 |
| NRAS | Q61 | Peritoneal | >65 | 0 | 11 | 0.004 | 0.000 | 0.000 | 0.049 |
| NRAS | 12, 13, or 61 | Appendiceal | Black | 0 | 17 | 0.021 | 0.019 | 0.000 | 0.054 |
| NRAS | 12, 13, or 61 | Appendiceal | NA | 1 | 33 | 0.024 | 0.021 | 0.005 | 0.066 |
| NRAS | 12, 13, or 61 | Appendiceal | White | 6 | 280 | 0.022 | 0.021 | 0.009 | 0.041 |
| NRAS | 12, 13, or 61 | CRC | Asian | 9 | 313 | 0.038 | 0.038 | 0.026 | 0.048 |
| NRAS | 12, 13, or 61 | CRC | Black | 25 | 514 | 0.042 | 0.041 | 0.033 | 0.055 |
| NRAS | 12, 13, or 61 | CRC | NA | 29 | 804 | 0.039 | 0.039 | 0.030 | 0.047 |
| NRAS | 12, 13, or 61 | CRC | Native American | 1 | 17 | 0.040 | 0.040 | 0.028 | 0.058 |
| NRAS | 12, 13, or 61 | CRC | Other | 6 | 139 | 0.040 | 0.040 | 0.029 | 0.054 |
| NRAS | 12, 13, or 61 | CRC | White | 196 | 4922 | 0.040 | 0.040 | 0.035 | 0.045 |
| NRAS | 12, 13, or 61 | CUP | Asian | 0 | 73 | 0.015 | 0.015 | 0.004 | 0.026 |
| NRAS | 12, 13, or 61 | CUP | Black | 2 | 123 | 0.017 | 0.016 | 0.008 | 0.029 |
| NRAS | 12, 13, or 61 | CUP | NA | 4 | 286 | 0.016 | 0.016 | 0.008 | 0.025 |
| NRAS | 12, 13, or 61 | CUP | Other | 2 | 36 | 0.020 | 0.017 | 0.009 | 0.050 |
| NRAS | 12, 13, or 61 | CUP | White | 24 | 1464 | 0.016 | 0.016 | 0.011 | 0.023 |
| NRAS | 12, 13, or 61 | NSCLC | Asian | 5 | 624 | 0.008 | 0.008 | 0.005 | 0.012 |
| NRAS | 12, 13, or 61 | NSCLC | Black | 5 | 717 | 0.008 | 0.008 | 0.005 | 0.011 |
| NRAS | 12, 13, or 61 | NSCLC | NA | 9 | 849 | 0.008 | 0.008 | 0.006 | 0.013 |
| NRAS | 12, 13, or 61 | NSCLC | Native American | 0 | 17 | 0.008 | 0.008 | 0.004 | 0.013 |
| NRAS | 12, 13, or 61 | NSCLC | Other | 0 | 165 | 0.008 | 0.008 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | NSCLC | Undefined | 0 | 10 | 0.008 | 0.008 | 0.004 | 0.013 |
| NRAS | 12, 13, or 61 | NSCLC | White | 62 | 7745 | 0.008 | 0.008 | 0.006 | 0.010 |
| NRAS | 12, 13, or 61 | Breast | Asian | 0 | 334 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Breast | Black | 1 | 525 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | Breast | NA | 1 | 3112 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Breast | Native American | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | 12, 13, or 61 | Breast | Other | 0 | 176 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | 12, 13, or 61 | Breast | White | 0 | 5174 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Asian | 1 | 143 | 0.010 | 0.010 | 0.001 | 0.020 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Black | 0 | 193 | 0.008 | 0.009 | 0.000 | 0.016 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | NA | 7 | 350 | 0.015 | 0.013 | 0.007 | 0.030 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Other | 0 | 73 | 0.009 | 0.010 | 0.000 | 0.020 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | White | 24 | 2005 | 0.012 | 0.012 | 0.008 | 0.016 |
| NRAS | 12, 13, or 61 | Pancreatic | Asian | 1 | 100 | 0.007 | 0.006 | 0.002 | 0.023 |
| NRAS | 12, 13, or 61 | Pancreatic | Black | 2 | 88 | 0.011 | 0.007 | 0.003 | 0.038 |
| NRAS | 12, 13, or 61 | Pancreatic | NA | 0 | 231 | 0.005 | 0.005 | 0.000 | 0.011 |
| NRAS | 12, 13, or 61 | Pancreatic | Other | 1 | 34 | 0.011 | 0.007 | 0.002 | 0.048 |
| NRAS | 12, 13, or 61 | Pancreatic | White | 9 | 2037 | 0.005 | 0.005 | 0.002 | 0.008 |
| NRAS | 12, 13, or 61 | Leukemia | Asian | 3 | 37 | 0.113 | 0.113 | 0.067 | 0.155 |
| NRAS | 12, 13, or 61 | Leukemia | Black | 8 | 69 | 0.117 | 0.116 | 0.079 | 0.160 |
| NRAS | 12, 13, or 61 | Leukemia | NA | 80 | 777 | 0.109 | 0.109 | 0.089 | 0.129 |
| NRAS | 12, 13, or 61 | Leukemia | Other | 2 | 13 | 0.119 | 0.116 | 0.073 | 0.178 |
| NRAS | 12, 13, or 61 | Leukemia | White | 88 | 662 | 0.125 | 0.124 | 0.104 | 0.151 |
| NRAS | 12, 13, or 61 | Melanoma | Asian | 5 | 33 | 0.197 | 0.204 | 0.106 | 0.262 |
| NRAS | 12, 13, or 61 | Melanoma | Black | 6 | 34 | 0.202 | 0.208 | 0.116 | 0.269 |
| NRAS | 12, 13, or 61 | Melanoma | NA | 82 | 398 | 0.209 | 0.210 | 0.173 | 0.243 |
| NRAS | 12, 13, or 61 | Melanoma | Other | 2 | 26 | 0.185 | 0.196 | 0.071 | 0.251 |
| NRAS | 12, 13, or 61 | Melanoma | White | 552 | 2348 | 0.232 | 0.232 | 0.216 | 0.250 |
| NRAS | 12, 13, or 61 | Head and neck | Asian | 1 | 94 | 0.007 | 0.006 | 0.001 | 0.023 |
| NRAS | 12, 13, or 61 | Head and neck | Black | 0 | 62 | 0.005 | 0.005 | 0.000 | 0.015 |
| NRAS | 12, 13, or 61 | Head and neck | NA | 0 | 292 | 0.004 | 0.004 | 0.000 | 0.010 |
| NRAS | 12, 13, or 61 | Head and neck | Other | 0 | 28 | 0.006 | 0.005 | 0.000 | 0.019 |
| NRAS | 12, 13, or 61 | Head and neck | White | 10 | 1264 | 0.007 | 0.007 | 0.003 | 0.012 |
| NRAS | 12, 13, or 61 | Uterine | Asian | 2 | 108 | 0.017 | 0.017 | 0.005 | 0.035 |
| NRAS | 12, 13, or 61 | Uterine | Black | 1 | 163 | 0.013 | 0.014 | 0.002 | 0.026 |
| NRAS | 12, 13, or 61 | Uterine | NA | 1 | 190 | 0.013 | 0.013 | 0.002 | 0.025 |
| NRAS | 12, 13, or 61 | Uterine | Other | 0 | 37 | 0.014 | 0.015 | 0.001 | 0.031 |
| NRAS | 12, 13, or 61 | Uterine | White | 39 | 1753 | 0.021 | 0.020 | 0.015 | 0.028 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | Asian | 0 | 11 | 0.003 | 0.002 | 0.000 | 0.019 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | Black | 0 | 13 | 0.003 | 0.001 | 0.000 | 0.018 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | NA | 0 | 53 | 0.002 | 0.001 | 0.000 | 0.012 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | White | 1 | 436 | 0.002 | 0.002 | 0.000 | 0.008 |
| NRAS | 12, 13, or 61 | MDS/MPN | Asian | 0 | 12 | 0.041 | 0.044 | 0.001 | 0.086 |
| NRAS | 12, 13, or 61 | MDS/MPN | Black | 0 | 37 | 0.037 | 0.041 | 0.001 | 0.069 |
| NRAS | 12, 13, or 61 | MDS/MPN | NA | 35 | 571 | 0.056 | 0.055 | 0.040 | 0.077 |
| NRAS | 12, 13, or 61 | MDS/MPN | White | 25 | 584 | 0.045 | 0.045 | 0.030 | 0.061 |
| NRAS | 12, 13, or 61 | Adrenocortical | NA | 0 | 26 | 0.009 | 0.005 | 0.000 | 0.038 |
| NRAS | 12, 13, or 61 | Adrenocortical | White | 1 | 103 | 0.010 | 0.007 | 0.000 | 0.034 |
| NRAS | 12, 13, or 61 | Ovarian | Asian | 1 | 134 | 0.012 | 0.013 | 0.003 | 0.022 |
| NRAS | 12, 13, or 61 | Ovarian | Black | 0 | 74 | 0.012 | 0.012 | 0.001 | 0.022 |
| NRAS | 12, 13, or 61 | Ovarian | NA | 3 | 239 | 0.013 | 0.013 | 0.005 | 0.023 |
| NRAS | 12, 13, or 61 | Ovarian | Other | 0 | 36 | 0.013 | 0.013 | 0.001 | 0.024 |
| NRAS | 12, 13, or 61 | Ovarian | White | 29 | 1852 | 0.015 | 0.014 | 0.010 | 0.020 |
| NRAS | 12, 13, or 61 | Esophagogastric | Asian | 1 | 115 | 0.006 | 0.005 | 0.002 | 0.013 |
| NRAS | 12, 13, or 61 | Esophagogastric | Black | 0 | 68 | 0.005 | 0.005 | 0.001 | 0.011 |
| NRAS | 12, 13, or 61 | Esophagogastric | NA | 1 | 191 | 0.005 | 0.005 | 0.002 | 0.012 |
| NRAS | 12, 13, or 61 | Esophagogastric | Other | 0 | 46 | 0.005 | 0.005 | 0.001 | 0.012 |
| NRAS | 12, 13, or 61 | Esophagogastric | White | 7 | 1379 | 0.005 | 0.005 | 0.002 | 0.009 |
| NRAS | 12, 13, or 61 | Thyroid | Asian | 10 | 66 | 0.151 | 0.147 | 0.091 | 0.231 |
| NRAS | 12, 13, or 61 | Thyroid | Black | 12 | 40 | 0.222 | 0.214 | 0.119 | 0.373 |
| NRAS | 12, 13, or 61 | Thyroid | NA | 9 | 79 | 0.130 | 0.128 | 0.074 | 0.195 |
| NRAS | 12, 13, or 61 | Thyroid | Other | 6 | 26 | 0.185 | 0.174 | 0.100 | 0.328 |
| NRAS | 12, 13, or 61 | Thyroid | White | 89 | 803 | 0.115 | 0.115 | 0.094 | 0.138 |
| NRAS | 12, 13, or 61 | Cervical | Asian | 0 | 27 | 0.006 | 0.005 | 0.000 | 0.021 |
| NRAS | 12, 13, or 61 | Cervical | Black | 0 | 19 | 0.007 | 0.005 | 0.000 | 0.023 |
| NRAS | 12, 13, or 61 | Cervical | NA | 1 | 77 | 0.007 | 0.006 | 0.001 | 0.025 |
| NRAS | 12, 13, or 61 | Cervical | Other | 0 | 15 | 0.007 | 0.005 | 0.000 | 0.024 |
| NRAS | 12, 13, or 61 | Cervical | White | 1 | 228 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | 12, 13, or 61 | Hepatobiliary | Asian | 3 | 97 | 0.022 | 0.021 | 0.012 | 0.041 |
| NRAS | 12, 13, or 61 | Hepatobiliary | Black | 1 | 64 | 0.021 | 0.020 | 0.009 | 0.036 |
| NRAS | 12, 13, or 61 | Hepatobiliary | NA | 6 | 235 | 0.022 | 0.021 | 0.013 | 0.036 |
| NRAS | 12, 13, or 61 | Hepatobiliary | Other | 0 | 25 | 0.021 | 0.020 | 0.008 | 0.037 |
| NRAS | 12, 13, or 61 | Hepatobiliary | White | 18 | 948 | 0.020 | 0.020 | 0.013 | 0.029 |
| NRAS | 12, 13, or 61 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | Asian | 0 | 12 | 0.010 | 0.007 | 0.000 | 0.039 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | Black | 0 | 18 | 0.009 | 0.006 | 0.000 | 0.035 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | NA | 0 | 10 | 0.010 | 0.007 | 0.000 | 0.039 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | White | 2 | 188 | 0.010 | 0.008 | 0.001 | 0.027 |
| NRAS | 12, 13, or 61 | CNS | Asian | 2 | 154 | 0.008 | 0.007 | 0.003 | 0.020 |
| NRAS | 12, 13, or 61 | CNS | Black | 1 | 131 | 0.007 | 0.006 | 0.002 | 0.017 |
| NRAS | 12, 13, or 61 | CNS | NA | 9 | 817 | 0.008 | 0.008 | 0.004 | 0.015 |
| NRAS | 12, 13, or 61 | CNS | Other | 1 | 108 | 0.007 | 0.006 | 0.002 | 0.019 |
| NRAS | 12, 13, or 61 | CNS | Undefined | 0 | 17 | 0.007 | 0.006 | 0.002 | 0.021 |
| NRAS | 12, 13, or 61 | CNS | White | 13 | 3331 | 0.005 | 0.005 | 0.003 | 0.008 |
| NRAS | 12, 13, or 61 | Prostate | Asian | 0 | 62 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | 12, 13, or 61 | Prostate | Black | 0 | 175 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | 12, 13, or 61 | Prostate | NA | 0 | 289 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | Prostate | Other | 0 | 31 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | 12, 13, or 61 | Prostate | White | 4 | 1882 | 0.002 | 0.002 | 0.001 | 0.004 |
| NRAS | 12, 13, or 61 | Anal | NA | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | 12, 13, or 61 | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | 12, 13, or 61 | Neuroendocrine | Black | 0 | 23 | 0.009 | 0.006 | 0.000 | 0.032 |
| NRAS | 12, 13, or 61 | Neuroendocrine | NA | 0 | 45 | 0.008 | 0.006 | 0.000 | 0.025 |
| NRAS | 12, 13, or 61 | Neuroendocrine | White | 3 | 283 | 0.010 | 0.009 | 0.002 | 0.023 |
| NRAS | 12, 13, or 61 | Bladder | Asian | 0 | 40 | 0.006 | 0.006 | 0.000 | 0.016 |
| NRAS | 12, 13, or 61 | Bladder | Black | 0 | 43 | 0.006 | 0.006 | 0.000 | 0.016 |
| NRAS | 12, 13, or 61 | Bladder | NA | 2 | 169 | 0.007 | 0.007 | 0.002 | 0.018 |
| NRAS | 12, 13, or 61 | Bladder | Other | 0 | 14 | 0.007 | 0.006 | 0.001 | 0.020 |
| NRAS | 12, 13, or 61 | Bladder | White | 8 | 1310 | 0.006 | 0.006 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | Asian | 1 | 17 | 0.105 | 0.105 | 0.034 | 0.175 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | NA | 10 | 92 | 0.110 | 0.109 | 0.066 | 0.162 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | White | 15 | 125 | 0.114 | 0.112 | 0.073 | 0.164 |
| NRAS | 12, 13, or 61 | Small bowel | Black | 2 | 25 | 0.066 | 0.054 | 0.005 | 0.197 |
| NRAS | 12, 13, or 61 | Small bowel | NA | 0 | 22 | 0.006 | 0.000 | 0.000 | 0.043 |
| NRAS | 12, 13, or 61 | Small bowel | White | 0 | 150 | 0.002 | 0.000 | 0.000 | 0.016 |
| NRAS | 12, 13, or 61 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | 12, 13, or 61 | Sex cord stromal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | 12, 13, or 61 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Vaginal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | 12, 13, or 61 | Thymic | Asian | 0 | 13 | 0.009 | 0.005 | 0.000 | 0.041 |
| NRAS | 12, 13, or 61 | Thymic | NA | 0 | 23 | 0.008 | 0.005 | 0.000 | 0.034 |
| NRAS | 12, 13, or 61 | Thymic | White | 1 | 108 | 0.009 | 0.006 | 0.000 | 0.029 |
| NRAS | 12, 13, or 61 | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | 12, 13, or 61 | SCLC | Asian | 0 | 15 | 0.007 | 0.004 | 0.000 | 0.032 |
| NRAS | 12, 13, or 61 | SCLC | NA | 0 | 30 | 0.006 | 0.004 | 0.000 | 0.024 |
| NRAS | 12, 13, or 61 | SCLC | White | 2 | 337 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | 12, 13, or 61 | Mesothelioma | Asian | 0 | 11 | 0.004 | 0.002 | 0.000 | 0.024 |
| NRAS | 12, 13, or 61 | Mesothelioma | Black | 0 | 10 | 0.004 | 0.002 | 0.000 | 0.022 |
| NRAS | 12, 13, or 61 | Mesothelioma | NA | 0 | 32 | 0.003 | 0.002 | 0.000 | 0.016 |
| NRAS | 12, 13, or 61 | Mesothelioma | White | 1 | 434 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Germ cell | Asian | 2 | 36 | 0.026 | 0.023 | 0.010 | 0.072 |
| NRAS | 12, 13, or 61 | Germ cell | Black | 0 | 23 | 0.020 | 0.020 | 0.002 | 0.042 |
| NRAS | 12, 13, or 61 | Germ cell | NA | 3 | 179 | 0.020 | 0.020 | 0.008 | 0.036 |
| NRAS | 12, 13, or 61 | Germ cell | Other | 0 | 37 | 0.020 | 0.020 | 0.002 | 0.038 |
| NRAS | 12, 13, or 61 | Germ cell | White | 14 | 603 | 0.022 | 0.022 | 0.013 | 0.034 |
| NRAS | 12, 13, or 61 | Nerve sheath | Black | 0 | 12 | 0.009 | 0.004 | 0.000 | 0.053 |
| NRAS | 12, 13, or 61 | Nerve sheath | NA | 1 | 26 | 0.022 | 0.012 | 0.001 | 0.102 |
| NRAS | 12, 13, or 61 | Nerve sheath | White | 0 | 105 | 0.005 | 0.003 | 0.000 | 0.024 |
| NRAS | 12, 13, or 61 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | 12, 13, or 61 | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | 12, 13, or 61 | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Asian | 0 | 21 | 0.022 | 0.018 | 0.000 | 0.071 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Black | 0 | 25 | 0.020 | 0.018 | 0.000 | 0.064 |
| NRAS | 12, 13, or 61 | B cell lymphoma | NA | 4 | 42 | 0.060 | 0.050 | 0.015 | 0.157 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Other | 1 | 12 | 0.047 | 0.030 | 0.007 | 0.181 |
| NRAS | 12, 13, or 61 | B cell lymphoma | White | 14 | 859 | 0.018 | 0.017 | 0.010 | 0.028 |
| NRAS | 12, 13, or 61 | Non-hodgkin lymphoma | White | 2 | 19 | 0.110 | 0.097 | 0.017 | 0.276 |
| NRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.057 | 0.045 | 0.000 | 0.191 |
| NRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | White | 3 | 23 | 0.108 | 0.098 | 0.024 | 0.254 |
| NRAS | 12, 13, or 61 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| NRAS | 12, 13, or 61 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | 12, 13, or 61 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.017 |
| NRAS | 12, 13, or 61 | Lung | White | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | 12, 13, or 61 | Peritoneal | White | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| NRAS | 12, 13, or 61 | Parathyroid | White | 2 | 14 | 0.149 | 0.132 | 0.023 | 0.367 |
| NRAS | G12 | Appendiceal | Black | 0 | 17 | 0.005 | 0.002 | 0.000 | 0.024 |
| NRAS | G12 | Appendiceal | NA | 0 | 33 | 0.004 | 0.002 | 0.000 | 0.018 |
| NRAS | G12 | Appendiceal | White | 1 | 280 | 0.004 | 0.003 | 0.000 | 0.013 |
| NRAS | G12 | CRC | Asian | 3 | 313 | 0.012 | 0.012 | 0.007 | 0.017 |
| NRAS | G12 | CRC | Black | 4 | 514 | 0.011 | 0.012 | 0.006 | 0.016 |
| NRAS | G12 | CRC | NA | 9 | 804 | 0.012 | 0.012 | 0.008 | 0.017 |
| NRAS | G12 | CRC | Native American | 0 | 17 | 0.012 | 0.012 | 0.006 | 0.020 |
| NRAS | G12 | CRC | Other | 3 | 139 | 0.013 | 0.012 | 0.008 | 0.022 |
| NRAS | G12 | CRC | White | 63 | 4922 | 0.012 | 0.012 | 0.010 | 0.015 |
| NRAS | G12 | CUP | Asian | 0 | 73 | 0.004 | 0.004 | 0.000 | 0.010 |
| NRAS | G12 | CUP | Black | 0 | 123 | 0.004 | 0.004 | 0.000 | 0.009 |
| NRAS | G12 | CUP | NA | 1 | 286 | 0.004 | 0.004 | 0.001 | 0.009 |
| NRAS | G12 | CUP | Other | 0 | 36 | 0.004 | 0.004 | 0.000 | 0.011 |
| NRAS | G12 | CUP | White | 8 | 1464 | 0.005 | 0.005 | 0.002 | 0.008 |
| NRAS | G12 | NSCLC | Asian | 2 | 624 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12 | NSCLC | Black | 1 | 717 | 0.002 | 0.002 | 0.001 | 0.004 |
| NRAS | G12 | NSCLC | NA | 3 | 849 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12 | NSCLC | Native American | 0 | 17 | 0.002 | 0.002 | 0.001 | 0.006 |
| NRAS | G12 | NSCLC | Other | 0 | 165 | 0.002 | 0.002 | 0.001 | 0.004 |
| NRAS | G12 | NSCLC | Undefined | 0 | 10 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12 | NSCLC | White | 12 | 7745 | 0.002 | 0.002 | 0.001 | 0.003 |
| NRAS | G12 | Breast | Asian | 0 | 334 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Breast | Black | 0 | 525 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Breast | NA | 1 | 3112 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Breast | Native American | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Breast | Other | 0 | 176 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Breast | White | 0 | 5174 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Soft tissue sarcoma | Asian | 0 | 143 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Soft tissue sarcoma | Black | 0 | 193 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Soft tissue sarcoma | NA | 1 | 350 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Soft tissue sarcoma | Other | 0 | 73 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Soft tissue sarcoma | White | 2 | 2005 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Pancreatic | Asian | 0 | 100 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Pancreatic | Black | 0 | 88 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Pancreatic | NA | 0 | 231 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Pancreatic | Other | 0 | 34 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Pancreatic | White | 2 | 2037 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G12 | Leukemia | Asian | 1 | 37 | 0.063 | 0.064 | 0.032 | 0.091 |
| NRAS | G12 | Leukemia | Black | 5 | 69 | 0.067 | 0.066 | 0.043 | 0.097 |
| NRAS | G12 | Leukemia | NA | 47 | 777 | 0.064 | 0.064 | 0.049 | 0.079 |
| NRAS | G12 | Leukemia | Other | 1 | 13 | 0.067 | 0.066 | 0.037 | 0.107 |
| NRAS | G12 | Leukemia | White | 49 | 662 | 0.069 | 0.069 | 0.054 | 0.087 |
| NRAS | G12 | Melanoma | Asian | 1 | 33 | 0.023 | 0.018 | 0.007 | 0.066 |
| NRAS | G12 | Melanoma | Black | 3 | 34 | 0.035 | 0.023 | 0.012 | 0.117 |
| NRAS | G12 | Melanoma | NA | 4 | 398 | 0.015 | 0.015 | 0.006 | 0.024 |
| NRAS | G12 | Melanoma | Other | 1 | 26 | 0.024 | 0.019 | 0.007 | 0.075 |
| NRAS | G12 | Melanoma | White | 39 | 2348 | 0.017 | 0.017 | 0.012 | 0.022 |
| NRAS | G12 | Head and neck | Asian | 1 | 94 | 0.004 | 0.003 | 0.001 | 0.018 |
| NRAS | G12 | Head and neck | Black | 0 | 62 | 0.003 | 0.003 | 0.000 | 0.009 |
| NRAS | G12 | Head and neck | NA | 0 | 292 | 0.003 | 0.002 | 0.000 | 0.007 |
| NRAS | G12 | Head and neck | Other | 0 | 28 | 0.003 | 0.003 | 0.000 | 0.012 |
| NRAS | G12 | Head and neck | White | 4 | 1264 | 0.003 | 0.003 | 0.001 | 0.006 |
| NRAS | G12 | Uterine | Asian | 1 | 108 | 0.007 | 0.007 | 0.001 | 0.021 |
| NRAS | G12 | Uterine | Black | 0 | 163 | 0.005 | 0.005 | 0.000 | 0.012 |
| NRAS | G12 | Uterine | NA | 0 | 190 | 0.005 | 0.005 | 0.000 | 0.012 |
| NRAS | G12 | Uterine | Other | 0 | 37 | 0.006 | 0.006 | 0.000 | 0.017 |
| NRAS | G12 | Uterine | White | 16 | 1753 | 0.008 | 0.008 | 0.005 | 0.013 |
| NRAS | G12 | Non-melanoma skin | Asian | 0 | 11 | 0.004 | 0.002 | 0.000 | 0.020 |
| NRAS | G12 | Non-melanoma skin | Black | 0 | 13 | 0.003 | 0.002 | 0.000 | 0.018 |
| NRAS | G12 | Non-melanoma skin | NA | 0 | 53 | 0.003 | 0.002 | 0.000 | 0.011 |
| NRAS | G12 | Non-melanoma skin | White | 1 | 436 | 0.002 | 0.002 | 0.000 | 0.008 |
| NRAS | G12 | MDS/MPN | Asian | 0 | 12 | 0.031 | 0.032 | 0.001 | 0.062 |
| NRAS | G12 | MDS/MPN | Black | 0 | 37 | 0.029 | 0.030 | 0.001 | 0.051 |
| NRAS | G12 | MDS/MPN | NA | 22 | 571 | 0.036 | 0.035 | 0.024 | 0.051 |
| NRAS | G12 | MDS/MPN | White | 19 | 584 | 0.033 | 0.033 | 0.022 | 0.046 |
| NRAS | G12 | Adrenocortical | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Ovarian | Asian | 0 | 134 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Ovarian | Black | 0 | 74 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Ovarian | NA | 0 | 239 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Ovarian | Other | 0 | 36 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Ovarian | White | 2 | 1852 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Esophagogastric | Asian | 0 | 115 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Esophagogastric | Black | 0 | 68 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Esophagogastric | NA | 0 | 191 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Esophagogastric | Other | 0 | 46 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Esophagogastric | White | 2 | 1379 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Thyroid | Asian | 0 | 66 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | Black | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | NA | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | Other | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | White | 0 | 803 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Cervical | Asian | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Cervical | Black | 0 | 19 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Cervical | NA | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Cervical | Other | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Cervical | White | 0 | 228 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Hepatobiliary | Asian | 1 | 97 | 0.007 | 0.006 | 0.002 | 0.016 |
| NRAS | G12 | Hepatobiliary | Black | 1 | 64 | 0.007 | 0.006 | 0.002 | 0.020 |
| NRAS | G12 | Hepatobiliary | NA | 1 | 235 | 0.006 | 0.006 | 0.002 | 0.013 |
| NRAS | G12 | Hepatobiliary | Other | 0 | 25 | 0.006 | 0.006 | 0.001 | 0.016 |
| NRAS | G12 | Hepatobiliary | White | 5 | 948 | 0.006 | 0.006 | 0.002 | 0.011 |
| NRAS | G12 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | T / NK neoplasms | White | 0 | 188 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | CNS | Asian | 0 | 154 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | CNS | Black | 0 | 131 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | CNS | NA | 1 | 817 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | CNS | Other | 1 | 108 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G12 | CNS | Undefined | 0 | 17 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G12 | CNS | White | 3 | 3331 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G12 | Prostate | Asian | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | Black | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | NA | 0 | 289 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | Other | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | White | 0 | 1882 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Anal | NA | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Neuroendocrine | Black | 0 | 23 | 0.004 | 0.002 | 0.000 | 0.020 |
| NRAS | G12 | Neuroendocrine | NA | 0 | 45 | 0.003 | 0.002 | 0.000 | 0.016 |
| NRAS | G12 | Neuroendocrine | White | 1 | 283 | 0.003 | 0.003 | 0.000 | 0.012 |
| NRAS | G12 | Bladder | Asian | 0 | 40 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G12 | Bladder | Black | 0 | 43 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G12 | Bladder | NA | 0 | 169 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Bladder | Other | 0 | 14 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G12 | Bladder | White | 2 | 1310 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | BLL/Lymphoma | Asian | 0 | 17 | 0.051 | 0.053 | 0.000 | 0.107 |
| NRAS | G12 | BLL/Lymphoma | NA | 5 | 92 | 0.060 | 0.058 | 0.025 | 0.103 |
| NRAS | G12 | BLL/Lymphoma | White | 10 | 125 | 0.070 | 0.068 | 0.037 | 0.117 |
| NRAS | G12 | Small bowel | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Small bowel | NA | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Small bowel | White | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G12 | Sex cord stromal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Vaginal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12 | Thymic | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | SCLC | Asian | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | SCLC | NA | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | SCLC | White | 0 | 337 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Germ cell | Asian | 2 | 36 | 0.018 | 0.011 | 0.003 | 0.079 |
| NRAS | G12 | Germ cell | Black | 0 | 23 | 0.009 | 0.007 | 0.000 | 0.029 |
| NRAS | G12 | Germ cell | NA | 1 | 179 | 0.008 | 0.007 | 0.001 | 0.018 |
| NRAS | G12 | Germ cell | Other | 0 | 37 | 0.008 | 0.007 | 0.000 | 0.024 |
| NRAS | G12 | Germ cell | White | 4 | 603 | 0.008 | 0.007 | 0.003 | 0.015 |
| NRAS | G12 | Nerve sheath | Black | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Nerve sheath | White | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G12 | Pheochromocytoma | White | 0 | 15 | 0.002 | 0.000 | 0.000 | 0.021 |
| NRAS | G12 | Pineal | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| NRAS | G12 | B cell lymphoma | Asian | 0 | 21 | 0.008 | 0.005 | 0.000 | 0.037 |
| NRAS | G12 | B cell lymphoma | Black | 0 | 25 | 0.007 | 0.005 | 0.000 | 0.034 |
| NRAS | G12 | B cell lymphoma | NA | 2 | 42 | 0.022 | 0.013 | 0.002 | 0.089 |
| NRAS | G12 | B cell lymphoma | Other | 0 | 12 | 0.009 | 0.005 | 0.000 | 0.046 |
| NRAS | G12 | B cell lymphoma | White | 3 | 859 | 0.005 | 0.004 | 0.001 | 0.010 |
| NRAS | G12 | Non-hodgkin lymphoma | White | 1 | 19 | 0.061 | 0.047 | 0.003 | 0.197 |
| NRAS | G12 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.043 | 0.031 | 0.000 | 0.159 |
| NRAS | G12 | T-lymphoblastic leukemia/lymphoma | White | 2 | 23 | 0.074 | 0.063 | 0.010 | 0.197 |
| NRAS | G12 | Retinoblastoma | NA | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | G12 | Retinoblastoma | White | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12 | Hodgkin lymphoma | White | 0 | 30 | 0.002 | 0.000 | 0.000 | 0.023 |
| NRAS | G12 | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.022 |
| NRAS | G12 | Peritoneal | White | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.038 |
| NRAS | G12 | Parathyroid | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G12C | Appendiceal | Black | 0 | 17 | 0.005 | 0.002 | 0.000 | 0.024 |
| NRAS | G12C | Appendiceal | NA | 0 | 33 | 0.004 | 0.002 | 0.000 | 0.018 |
| NRAS | G12C | Appendiceal | White | 1 | 280 | 0.004 | 0.003 | 0.000 | 0.013 |
| NRAS | G12C | CRC | Asian | 2 | 313 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | G12C | CRC | Black | 1 | 514 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12C | CRC | NA | 2 | 804 | 0.003 | 0.002 | 0.001 | 0.005 |
| NRAS | G12C | CRC | Native American | 0 | 17 | 0.003 | 0.002 | 0.001 | 0.007 |
| NRAS | G12C | CRC | Other | 0 | 139 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12C | CRC | White | 11 | 4922 | 0.002 | 0.002 | 0.001 | 0.004 |
| NRAS | G12C | CUP | Asian | 0 | 73 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | CUP | Black | 0 | 123 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | CUP | NA | 1 | 286 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G12C | CUP | Other | 0 | 36 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G12C | CUP | White | 1 | 1464 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12C | NSCLC | Asian | 0 | 624 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | Black | 0 | 717 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | NA | 2 | 849 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | NSCLC | Native American | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | NSCLC | Other | 0 | 165 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | NSCLC | Undefined | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12C | NSCLC | White | 1 | 7745 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Breast | Asian | 0 | 334 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | Black | 0 | 525 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | NA | 0 | 3112 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | Native American | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | Other | 0 | 176 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | White | 0 | 5174 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Asian | 0 | 143 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Black | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | NA | 0 | 350 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Other | 0 | 73 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | White | 0 | 2005 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Pancreatic | Asian | 0 | 100 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Pancreatic | Black | 0 | 88 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Pancreatic | NA | 0 | 231 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Pancreatic | Other | 0 | 34 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Pancreatic | White | 1 | 2037 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Leukemia | Asian | 0 | 37 | 0.005 | 0.005 | 0.000 | 0.015 |
| NRAS | G12C | Leukemia | Black | 0 | 69 | 0.005 | 0.005 | 0.000 | 0.012 |
| NRAS | G12C | Leukemia | NA | 3 | 777 | 0.005 | 0.005 | 0.001 | 0.009 |
| NRAS | G12C | Leukemia | Other | 0 | 13 | 0.006 | 0.005 | 0.000 | 0.017 |
| NRAS | G12C | Leukemia | White | 5 | 662 | 0.006 | 0.006 | 0.002 | 0.012 |
| NRAS | G12C | Melanoma | Asian | 0 | 33 | 0.004 | 0.004 | 0.000 | 0.016 |
| NRAS | G12C | Melanoma | Black | 1 | 34 | 0.010 | 0.005 | 0.001 | 0.054 |
| NRAS | G12C | Melanoma | NA | 0 | 398 | 0.003 | 0.003 | 0.000 | 0.007 |
| NRAS | G12C | Melanoma | Other | 0 | 26 | 0.005 | 0.004 | 0.000 | 0.018 |
| NRAS | G12C | Melanoma | White | 11 | 2348 | 0.004 | 0.004 | 0.002 | 0.007 |
| NRAS | G12C | Head and neck | Asian | 0 | 94 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Head and neck | Black | 0 | 62 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Head and neck | NA | 0 | 292 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Head and neck | Other | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Head and neck | White | 1 | 1264 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G12C | Uterine | Asian | 0 | 108 | 0.002 | 0.002 | 0.000 | 0.006 |
| NRAS | G12C | Uterine | Black | 0 | 163 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | G12C | Uterine | NA | 0 | 190 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | G12C | Uterine | Other | 0 | 37 | 0.002 | 0.002 | 0.000 | 0.008 |
| NRAS | G12C | Uterine | White | 5 | 1753 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12C | Non-melanoma skin | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-melanoma skin | Black | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-melanoma skin | NA | 0 | 53 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-melanoma skin | White | 0 | 436 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | MDS/MPN | Asian | 0 | 12 | 0.002 | 0.001 | 0.000 | 0.012 |
| NRAS | G12C | MDS/MPN | Black | 0 | 37 | 0.001 | 0.001 | 0.000 | 0.007 |
| NRAS | G12C | MDS/MPN | NA | 1 | 571 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | MDS/MPN | White | 0 | 584 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Adrenocortical | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Ovarian | Asian | 0 | 134 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | Black | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | NA | 0 | 239 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | Other | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | White | 0 | 1852 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Asian | 0 | 115 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Black | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | NA | 0 | 191 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Other | 0 | 46 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | White | 0 | 1379 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | Asian | 0 | 66 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | Black | 0 | 40 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | NA | 0 | 79 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | Other | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | White | 0 | 803 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Cervical | Asian | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Cervical | Black | 0 | 19 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Cervical | NA | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Cervical | Other | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Cervical | White | 0 | 228 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Hepatobiliary | Asian | 0 | 97 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G12C | Hepatobiliary | Black | 0 | 64 | 0.002 | 0.001 | 0.000 | 0.007 |
| NRAS | G12C | Hepatobiliary | NA | 1 | 235 | 0.002 | 0.002 | 0.000 | 0.008 |
| NRAS | G12C | Hepatobiliary | Other | 0 | 25 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | G12C | Hepatobiliary | White | 1 | 948 | 0.002 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | T / NK neoplasms | White | 0 | 188 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | CNS | Asian | 0 | 154 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | CNS | Black | 0 | 131 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | CNS | NA | 0 | 817 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | CNS | Other | 1 | 108 | 0.002 | 0.001 | 0.000 | 0.016 |
| NRAS | G12C | CNS | Undefined | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G12C | CNS | White | 1 | 3331 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Prostate | Asian | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | Black | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | NA | 0 | 289 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | Other | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | White | 0 | 1882 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Anal | NA | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Neuroendocrine | Black | 0 | 23 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Neuroendocrine | NA | 0 | 45 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Neuroendocrine | White | 0 | 283 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Bladder | Asian | 0 | 40 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G12C | Bladder | Black | 0 | 43 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | Bladder | NA | 0 | 169 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Bladder | Other | 0 | 14 | 0.001 | 0.001 | 0.000 | 0.007 |
| NRAS | G12C | Bladder | White | 1 | 1310 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12C | BLL/Lymphoma | Asian | 0 | 17 | 0.006 | 0.003 | 0.000 | 0.028 |
| NRAS | G12C | BLL/Lymphoma | NA | 0 | 92 | 0.004 | 0.003 | 0.000 | 0.018 |
| NRAS | G12C | BLL/Lymphoma | White | 1 | 125 | 0.006 | 0.004 | 0.000 | 0.022 |
| NRAS | G12C | Small bowel | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Small bowel | NA | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Small bowel | White | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G12C | Sex cord stromal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Vaginal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12C | Thymic | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | SCLC | Asian | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | SCLC | NA | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | SCLC | White | 0 | 337 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Germ cell | Asian | 0 | 36 | 0.002 | 0.001 | 0.000 | 0.010 |
| NRAS | G12C | Germ cell | Black | 0 | 23 | 0.002 | 0.001 | 0.000 | 0.010 |
| NRAS | G12C | Germ cell | NA | 1 | 179 | 0.003 | 0.002 | 0.000 | 0.012 |
| NRAS | G12C | Germ cell | Other | 0 | 37 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G12C | Germ cell | White | 0 | 603 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Nerve sheath | Black | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Nerve sheath | White | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G12C | Pheochromocytoma | White | 0 | 15 | 0.002 | 0.000 | 0.000 | 0.021 |
| NRAS | G12C | Pineal | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.048 |
| NRAS | G12C | B cell lymphoma | Asian | 0 | 21 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | NA | 0 | 42 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | Other | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | White | 0 | 859 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Non-hodgkin lymphoma | White | 0 | 19 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | G12C | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.028 |
| NRAS | G12C | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.023 |
| NRAS | G12C | Retinoblastoma | NA | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | G12C | Retinoblastoma | White | 0 | 25 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12C | Hodgkin lymphoma | White | 0 | 30 | 0.002 | 0.000 | 0.000 | 0.023 |
| NRAS | G12C | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.022 |
| NRAS | G12C | Peritoneal | White | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.038 |
| NRAS | G12C | Parathyroid | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G13 | Appendiceal | Black | 0 | 17 | 0.005 | 0.002 | 0.000 | 0.023 |
| NRAS | G13 | Appendiceal | NA | 0 | 33 | 0.004 | 0.002 | 0.000 | 0.018 |
| NRAS | G13 | Appendiceal | White | 1 | 280 | 0.004 | 0.003 | 0.000 | 0.013 |
| NRAS | G13 | CRC | Asian | 0 | 313 | 0.004 | 0.004 | 0.000 | 0.007 |
| NRAS | G13 | CRC | Black | 1 | 514 | 0.004 | 0.004 | 0.001 | 0.007 |
| NRAS | G13 | CRC | NA | 5 | 804 | 0.005 | 0.005 | 0.002 | 0.009 |
| NRAS | G13 | CRC | Native American | 0 | 17 | 0.005 | 0.005 | 0.000 | 0.012 |
| NRAS | G13 | CRC | Other | 0 | 139 | 0.004 | 0.004 | 0.000 | 0.008 |
| NRAS | G13 | CRC | White | 28 | 4922 | 0.005 | 0.005 | 0.004 | 0.007 |
| NRAS | G13 | CUP | Asian | 0 | 73 | 0.003 | 0.002 | 0.000 | 0.008 |
| NRAS | G13 | CUP | Black | 1 | 123 | 0.003 | 0.003 | 0.001 | 0.012 |
| NRAS | G13 | CUP | NA | 1 | 286 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | G13 | CUP | Other | 0 | 36 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | G13 | CUP | White | 3 | 1464 | 0.003 | 0.002 | 0.001 | 0.005 |
| NRAS | G13 | NSCLC | Asian | 1 | 624 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | NSCLC | Black | 1 | 717 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | NSCLC | NA | 0 | 849 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | NSCLC | Native American | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | NSCLC | Other | 0 | 165 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | NSCLC | Undefined | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | NSCLC | White | 2 | 7745 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Breast | Asian | 0 | 334 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Breast | Black | 1 | 525 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Breast | NA | 0 | 3112 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Breast | Native American | 0 | 11 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G13 | Breast | Other | 0 | 176 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Breast | White | 0 | 5174 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Soft tissue sarcoma | Asian | 0 | 143 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Soft tissue sarcoma | Black | 0 | 193 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Soft tissue sarcoma | NA | 3 | 350 | 0.008 | 0.007 | 0.001 | 0.019 |
| NRAS | G13 | Soft tissue sarcoma | Other | 0 | 73 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G13 | Soft tissue sarcoma | White | 0 | 2005 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Pancreatic | Asian | 0 | 100 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Pancreatic | Black | 0 | 88 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Pancreatic | NA | 0 | 231 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Pancreatic | Other | 0 | 34 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Pancreatic | White | 2 | 2037 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G13 | Leukemia | Asian | 1 | 37 | 0.029 | 0.028 | 0.014 | 0.047 |
| NRAS | G13 | Leukemia | Black | 2 | 69 | 0.029 | 0.028 | 0.015 | 0.046 |
| NRAS | G13 | Leukemia | NA | 21 | 777 | 0.028 | 0.028 | 0.019 | 0.038 |
| NRAS | G13 | Leukemia | Other | 0 | 13 | 0.028 | 0.028 | 0.012 | 0.047 |
| NRAS | G13 | Leukemia | White | 20 | 662 | 0.029 | 0.029 | 0.020 | 0.040 |
| NRAS | G13 | Melanoma | Asian | 0 | 33 | 0.013 | 0.013 | 0.002 | 0.026 |
| NRAS | G13 | Melanoma | Black | 1 | 34 | 0.015 | 0.014 | 0.005 | 0.036 |
| NRAS | G13 | Melanoma | NA | 4 | 398 | 0.013 | 0.013 | 0.006 | 0.020 |
| NRAS | G13 | Melanoma | Other | 0 | 26 | 0.013 | 0.013 | 0.002 | 0.027 |
| NRAS | G13 | Melanoma | White | 34 | 2348 | 0.014 | 0.014 | 0.010 | 0.019 |
| NRAS | G13 | Head and neck | Asian | 0 | 94 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Head and neck | Black | 0 | 62 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Head and neck | NA | 0 | 292 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Head and neck | Other | 0 | 28 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G13 | Head and neck | White | 2 | 1264 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Uterine | Asian | 0 | 108 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Uterine | Black | 1 | 163 | 0.003 | 0.001 | 0.000 | 0.017 |
| NRAS | G13 | Uterine | NA | 0 | 190 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Uterine | Other | 0 | 37 | 0.001 | 0.000 | 0.000 | 0.009 |
| NRAS | G13 | Uterine | White | 0 | 1753 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | Black | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | NA | 0 | 53 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | White | 0 | 436 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | MDS/MPN | Asian | 0 | 12 | 0.017 | 0.015 | 0.001 | 0.043 |
| NRAS | G13 | MDS/MPN | Black | 0 | 37 | 0.015 | 0.015 | 0.001 | 0.033 |
| NRAS | G13 | MDS/MPN | NA | 13 | 571 | 0.019 | 0.019 | 0.011 | 0.032 |
| NRAS | G13 | MDS/MPN | White | 7 | 584 | 0.015 | 0.014 | 0.007 | 0.024 |
| NRAS | G13 | Adrenocortical | NA | 0 | 26 | 0.008 | 0.004 | 0.000 | 0.039 |
| NRAS | G13 | Adrenocortical | White | 1 | 103 | 0.010 | 0.007 | 0.000 | 0.034 |
| NRAS | G13 | Ovarian | Asian | 0 | 134 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | Black | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | NA | 0 | 239 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | Other | 0 | 36 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | White | 0 | 1852 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Esophagogastric | Asian | 0 | 115 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Esophagogastric | Black | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Esophagogastric | NA | 1 | 191 | 0.003 | 0.001 | 0.000 | 0.014 |
| NRAS | G13 | Esophagogastric | Other | 0 | 46 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G13 | Esophagogastric | White | 0 | 1379 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Thyroid | Asian | 0 | 66 | 0.002 | 0.002 | 0.000 | 0.009 |
| NRAS | G13 | Thyroid | Black | 0 | 40 | 0.003 | 0.002 | 0.000 | 0.011 |
| NRAS | G13 | Thyroid | NA | 1 | 79 | 0.004 | 0.002 | 0.000 | 0.020 |
| NRAS | G13 | Thyroid | Other | 0 | 26 | 0.003 | 0.002 | 0.000 | 0.012 |
| NRAS | G13 | Thyroid | White | 1 | 803 | 0.002 | 0.002 | 0.000 | 0.006 |
| NRAS | G13 | Cervical | Asian | 0 | 27 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Cervical | Black | 0 | 19 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Cervical | NA | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Cervical | Other | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Cervical | White | 0 | 228 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Hepatobiliary | Asian | 0 | 97 | 0.003 | 0.003 | 0.000 | 0.008 |
| NRAS | G13 | Hepatobiliary | Black | 0 | 64 | 0.003 | 0.003 | 0.000 | 0.009 |
| NRAS | G13 | Hepatobiliary | NA | 1 | 235 | 0.003 | 0.003 | 0.001 | 0.009 |
| NRAS | G13 | Hepatobiliary | Other | 0 | 25 | 0.003 | 0.003 | 0.000 | 0.010 |
| NRAS | G13 | Hepatobiliary | White | 3 | 948 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | G13 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | T / NK neoplasms | Asian | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | T / NK neoplasms | Black | 0 | 18 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | T / NK neoplasms | NA | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | T / NK neoplasms | White | 0 | 188 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | CNS | Asian | 0 | 154 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | CNS | Black | 0 | 131 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | CNS | NA | 1 | 817 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | CNS | Other | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | CNS | Undefined | 0 | 17 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | CNS | White | 0 | 3331 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Prostate | Asian | 0 | 62 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | Black | 0 | 175 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | NA | 0 | 289 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | Other | 0 | 31 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | White | 0 | 1882 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Anal | NA | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G13 | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Neuroendocrine | Black | 0 | 23 | 0.004 | 0.002 | 0.000 | 0.020 |
| NRAS | G13 | Neuroendocrine | NA | 0 | 45 | 0.004 | 0.002 | 0.000 | 0.016 |
| NRAS | G13 | Neuroendocrine | White | 1 | 283 | 0.004 | 0.003 | 0.000 | 0.012 |
| NRAS | G13 | Bladder | Asian | 0 | 40 | 0.002 | 0.001 | 0.000 | 0.007 |
| NRAS | G13 | Bladder | Black | 0 | 43 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G13 | Bladder | NA | 0 | 169 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Bladder | Other | 0 | 14 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | G13 | Bladder | White | 2 | 1310 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | BLL/Lymphoma | Asian | 1 | 17 | 0.036 | 0.031 | 0.010 | 0.097 |
| NRAS | G13 | BLL/Lymphoma | NA | 2 | 92 | 0.029 | 0.027 | 0.009 | 0.058 |
| NRAS | G13 | BLL/Lymphoma | White | 4 | 125 | 0.031 | 0.030 | 0.012 | 0.060 |
| NRAS | G13 | Small bowel | Black | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Small bowel | NA | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Small bowel | White | 0 | 150 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.009 |
| NRAS | G13 | Sex cord stromal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G13 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Vaginal | White | 0 | 68 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Thymic | Asian | 0 | 13 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G13 | Thymic | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Thymic | White | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | SCLC | Asian | 0 | 15 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | SCLC | NA | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | SCLC | White | 0 | 337 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | Black | 0 | 10 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | NA | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | White | 0 | 434 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Germ cell | Asian | 0 | 36 | 0.004 | 0.003 | 0.000 | 0.013 |
| NRAS | G13 | Germ cell | Black | 0 | 23 | 0.004 | 0.003 | 0.000 | 0.013 |
| NRAS | G13 | Germ cell | NA | 1 | 179 | 0.004 | 0.003 | 0.001 | 0.011 |
| NRAS | G13 | Germ cell | Other | 0 | 37 | 0.004 | 0.003 | 0.000 | 0.013 |
| NRAS | G13 | Germ cell | White | 2 | 603 | 0.004 | 0.003 | 0.001 | 0.009 |
| NRAS | G13 | Nerve sheath | Black | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Nerve sheath | NA | 0 | 26 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Nerve sheath | White | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.031 |
| NRAS | G13 | Pheochromocytoma | White | 0 | 15 | 0.004 | 0.000 | 0.000 | 0.047 |
| NRAS | G13 | Pineal | White | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.030 |
| NRAS | G13 | B cell lymphoma | Asian | 0 | 21 | 0.005 | 0.003 | 0.000 | 0.020 |
| NRAS | G13 | B cell lymphoma | Black | 0 | 25 | 0.004 | 0.003 | 0.000 | 0.018 |
| NRAS | G13 | B cell lymphoma | NA | 1 | 42 | 0.007 | 0.004 | 0.001 | 0.039 |
| NRAS | G13 | B cell lymphoma | Other | 0 | 12 | 0.005 | 0.003 | 0.000 | 0.024 |
| NRAS | G13 | B cell lymphoma | White | 2 | 859 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | G13 | Non-hodgkin lymphoma | White | 0 | 19 | 0.002 | 0.000 | 0.000 | 0.029 |
| NRAS | G13 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.025 | 0.014 | 0.000 | 0.114 |
| NRAS | G13 | T-lymphoblastic leukemia/lymphoma | White | 1 | 23 | 0.038 | 0.027 | 0.001 | 0.134 |
| NRAS | G13 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | G13 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.019 |
| NRAS | G13 | Hodgkin lymphoma | White | 0 | 30 | 0.002 | 0.000 | 0.000 | 0.022 |
| NRAS | G13 | Lung | White | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | G13 | Peritoneal | White | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.058 |
| NRAS | G13 | Parathyroid | White | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.043 |
| NRAS | Q61 | Appendiceal | Black | 0 | 17 | 0.016 | 0.014 | 0.000 | 0.049 |
| NRAS | Q61 | Appendiceal | NA | 1 | 33 | 0.019 | 0.016 | 0.004 | 0.059 |
| NRAS | Q61 | Appendiceal | White | 4 | 280 | 0.015 | 0.014 | 0.005 | 0.031 |
| NRAS | Q61 | CRC | Asian | 6 | 313 | 0.022 | 0.022 | 0.013 | 0.033 |
| NRAS | Q61 | CRC | Black | 20 | 514 | 0.028 | 0.027 | 0.019 | 0.045 |
| NRAS | Q61 | CRC | NA | 15 | 804 | 0.021 | 0.021 | 0.014 | 0.029 |
| NRAS | Q61 | CRC | Native American | 1 | 17 | 0.025 | 0.023 | 0.014 | 0.049 |
| NRAS | Q61 | CRC | Other | 3 | 139 | 0.023 | 0.023 | 0.013 | 0.037 |
| NRAS | Q61 | CRC | White | 105 | 4922 | 0.022 | 0.022 | 0.018 | 0.026 |
| NRAS | Q61 | CUP | Asian | 0 | 73 | 0.009 | 0.009 | 0.001 | 0.019 |
| NRAS | Q61 | CUP | Black | 1 | 123 | 0.010 | 0.009 | 0.003 | 0.020 |
| NRAS | Q61 | CUP | NA | 2 | 286 | 0.009 | 0.009 | 0.003 | 0.016 |
| NRAS | Q61 | CUP | Other | 2 | 36 | 0.015 | 0.010 | 0.005 | 0.059 |
| NRAS | Q61 | CUP | White | 13 | 1464 | 0.009 | 0.009 | 0.005 | 0.014 |
| NRAS | Q61 | NSCLC | Asian | 2 | 624 | 0.005 | 0.005 | 0.002 | 0.008 |
| NRAS | Q61 | NSCLC | Black | 3 | 717 | 0.005 | 0.005 | 0.003 | 0.008 |
| NRAS | Q61 | NSCLC | NA | 6 | 849 | 0.006 | 0.006 | 0.003 | 0.009 |
| NRAS | Q61 | NSCLC | Native American | 0 | 17 | 0.006 | 0.006 | 0.002 | 0.010 |
| NRAS | Q61 | NSCLC | Other | 0 | 165 | 0.005 | 0.005 | 0.002 | 0.009 |
| NRAS | Q61 | NSCLC | Undefined | 0 | 10 | 0.006 | 0.006 | 0.002 | 0.010 |
| NRAS | Q61 | NSCLC | White | 48 | 7745 | 0.006 | 0.006 | 0.004 | 0.008 |
| NRAS | Q61 | Breast | Asian | 0 | 334 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | Black | 0 | 525 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | NA | 0 | 3112 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | Native American | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | Other | 0 | 176 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | White | 0 | 5174 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Soft tissue sarcoma | Asian | 1 | 143 | 0.009 | 0.009 | 0.002 | 0.018 |
| NRAS | Q61 | Soft tissue sarcoma | Black | 0 | 193 | 0.008 | 0.008 | 0.000 | 0.015 |
| NRAS | Q61 | Soft tissue sarcoma | NA | 5 | 350 | 0.011 | 0.010 | 0.005 | 0.021 |
| NRAS | Q61 | Soft tissue sarcoma | Other | 0 | 73 | 0.009 | 0.009 | 0.001 | 0.017 |
| NRAS | Q61 | Soft tissue sarcoma | White | 22 | 2005 | 0.010 | 0.010 | 0.007 | 0.015 |
| NRAS | Q61 | Pancreatic | Asian | 1 | 100 | 0.007 | 0.005 | 0.001 | 0.025 |
| NRAS | Q61 | Pancreatic | Black | 2 | 88 | 0.012 | 0.007 | 0.002 | 0.042 |
| NRAS | Q61 | Pancreatic | NA | 0 | 231 | 0.003 | 0.003 | 0.000 | 0.010 |
| NRAS | Q61 | Pancreatic | Other | 1 | 34 | 0.012 | 0.006 | 0.001 | 0.057 |
| NRAS | Q61 | Pancreatic | White | 5 | 2037 | 0.003 | 0.003 | 0.001 | 0.006 |
| NRAS | Q61 | Leukemia | Asian | 1 | 37 | 0.028 | 0.027 | 0.013 | 0.053 |
| NRAS | Q61 | Leukemia | Black | 1 | 69 | 0.027 | 0.027 | 0.010 | 0.045 |
| NRAS | Q61 | Leukemia | NA | 18 | 777 | 0.026 | 0.026 | 0.017 | 0.036 |
| NRAS | Q61 | Leukemia | Other | 1 | 13 | 0.031 | 0.028 | 0.015 | 0.073 |
| NRAS | Q61 | Leukemia | White | 22 | 662 | 0.030 | 0.029 | 0.021 | 0.042 |
| NRAS | Q61 | Melanoma | Asian | 4 | 33 | 0.156 | 0.161 | 0.066 | 0.231 |
| NRAS | Q61 | Melanoma | Black | 3 | 34 | 0.145 | 0.149 | 0.051 | 0.218 |
| NRAS | Q61 | Melanoma | NA | 74 | 398 | 0.184 | 0.184 | 0.149 | 0.219 |
| NRAS | Q61 | Melanoma | Other | 1 | 26 | 0.134 | 0.140 | 0.030 | 0.214 |
| NRAS | Q61 | Melanoma | White | 480 | 2348 | 0.202 | 0.202 | 0.186 | 0.219 |
| NRAS | Q61 | Head and neck | Asian | 0 | 94 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | Q61 | Head and neck | Black | 0 | 62 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | Q61 | Head and neck | NA | 0 | 292 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | Q61 | Head and neck | Other | 0 | 28 | 0.002 | 0.002 | 0.000 | 0.009 |
| NRAS | Q61 | Head and neck | White | 4 | 1264 | 0.003 | 0.002 | 0.001 | 0.006 |
| NRAS | Q61 | Uterine | Asian | 1 | 108 | 0.010 | 0.010 | 0.002 | 0.022 |
| NRAS | Q61 | Uterine | Black | 0 | 163 | 0.008 | 0.008 | 0.000 | 0.016 |
| NRAS | Q61 | Uterine | NA | 1 | 190 | 0.009 | 0.009 | 0.001 | 0.017 |
| NRAS | Q61 | Uterine | Other | 0 | 37 | 0.009 | 0.009 | 0.000 | 0.021 |
| NRAS | Q61 | Uterine | White | 23 | 1753 | 0.012 | 0.012 | 0.008 | 0.017 |
| NRAS | Q61 | Non-melanoma skin | Asian | 0 | 11 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | Q61 | Non-melanoma skin | Black | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | Q61 | Non-melanoma skin | NA | 0 | 53 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Non-melanoma skin | White | 0 | 436 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | MDS/MPN | Asian | 0 | 12 | 0.004 | 0.003 | 0.000 | 0.015 |
| NRAS | Q61 | MDS/MPN | Black | 0 | 37 | 0.004 | 0.003 | 0.000 | 0.012 |
| NRAS | Q61 | MDS/MPN | NA | 1 | 571 | 0.003 | 0.003 | 0.000 | 0.008 |
| NRAS | Q61 | MDS/MPN | White | 3 | 584 | 0.004 | 0.004 | 0.001 | 0.009 |
| NRAS | Q61 | Adrenocortical | NA | 0 | 26 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | Q61 | Adrenocortical | White | 0 | 103 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Ovarian | Asian | 1 | 134 | 0.012 | 0.012 | 0.003 | 0.021 |
| NRAS | Q61 | Ovarian | Black | 0 | 74 | 0.012 | 0.012 | 0.002 | 0.021 |
| NRAS | Q61 | Ovarian | NA | 3 | 239 | 0.013 | 0.012 | 0.005 | 0.022 |
| NRAS | Q61 | Ovarian | Other | 0 | 36 | 0.012 | 0.012 | 0.002 | 0.022 |
| NRAS | Q61 | Ovarian | White | 27 | 1852 | 0.014 | 0.013 | 0.009 | 0.019 |
| NRAS | Q61 | Esophagogastric | Asian | 1 | 115 | 0.004 | 0.003 | 0.001 | 0.014 |
| NRAS | Q61 | Esophagogastric | Black | 0 | 68 | 0.003 | 0.003 | 0.000 | 0.010 |
| NRAS | Q61 | Esophagogastric | NA | 0 | 191 | 0.003 | 0.003 | 0.000 | 0.008 |
| NRAS | Q61 | Esophagogastric | Other | 0 | 46 | 0.004 | 0.003 | 0.000 | 0.011 |
| NRAS | Q61 | Esophagogastric | White | 5 | 1379 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Thyroid | Asian | 10 | 66 | 0.149 | 0.145 | 0.090 | 0.229 |
| NRAS | Q61 | Thyroid | Black | 12 | 40 | 0.224 | 0.217 | 0.117 | 0.374 |
| NRAS | Q61 | Thyroid | NA | 8 | 79 | 0.121 | 0.120 | 0.064 | 0.184 |
| NRAS | Q61 | Thyroid | Other | 6 | 26 | 0.184 | 0.172 | 0.099 | 0.327 |
| NRAS | Q61 | Thyroid | White | 88 | 803 | 0.113 | 0.113 | 0.092 | 0.136 |
| NRAS | Q61 | Cervical | Asian | 0 | 27 | 0.006 | 0.005 | 0.000 | 0.021 |
| NRAS | Q61 | Cervical | Black | 0 | 19 | 0.007 | 0.005 | 0.000 | 0.023 |
| NRAS | Q61 | Cervical | NA | 1 | 77 | 0.007 | 0.006 | 0.001 | 0.025 |
| NRAS | Q61 | Cervical | Other | 0 | 15 | 0.007 | 0.005 | 0.000 | 0.024 |
| NRAS | Q61 | Cervical | White | 1 | 228 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | Q61 | Hepatobiliary | Asian | 2 | 97 | 0.013 | 0.012 | 0.006 | 0.030 |
| NRAS | Q61 | Hepatobiliary | Black | 0 | 64 | 0.011 | 0.011 | 0.002 | 0.022 |
| NRAS | Q61 | Hepatobiliary | NA | 4 | 235 | 0.013 | 0.012 | 0.006 | 0.025 |
| NRAS | Q61 | Hepatobiliary | Other | 0 | 25 | 0.012 | 0.011 | 0.003 | 0.026 |
| NRAS | Q61 | Hepatobiliary | White | 10 | 948 | 0.011 | 0.011 | 0.006 | 0.018 |
| NRAS | Q61 | Kidney | Asian | 0 | 33 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | Black | 0 | 77 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | NA | 0 | 169 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | White | 0 | 1113 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | T / NK neoplasms | Asian | 0 | 12 | 0.010 | 0.007 | 0.000 | 0.039 |
| NRAS | Q61 | T / NK neoplasms | Black | 0 | 18 | 0.009 | 0.006 | 0.000 | 0.035 |
| NRAS | Q61 | T / NK neoplasms | NA | 0 | 10 | 0.010 | 0.007 | 0.000 | 0.039 |
| NRAS | Q61 | T / NK neoplasms | White | 2 | 188 | 0.010 | 0.008 | 0.001 | 0.027 |
| NRAS | Q61 | CNS | Asian | 2 | 154 | 0.007 | 0.005 | 0.002 | 0.020 |
| NRAS | Q61 | CNS | Black | 1 | 131 | 0.006 | 0.005 | 0.002 | 0.016 |
| NRAS | Q61 | CNS | NA | 7 | 817 | 0.006 | 0.006 | 0.003 | 0.013 |
| NRAS | Q61 | CNS | Other | 0 | 108 | 0.005 | 0.004 | 0.001 | 0.012 |
| NRAS | Q61 | CNS | Undefined | 0 | 17 | 0.006 | 0.005 | 0.001 | 0.019 |
| NRAS | Q61 | CNS | White | 10 | 3331 | 0.004 | 0.004 | 0.002 | 0.006 |
| NRAS | Q61 | Prostate | Asian | 0 | 62 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | Q61 | Prostate | Black | 0 | 175 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | Q61 | Prostate | NA | 0 | 289 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | Q61 | Prostate | Other | 0 | 31 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | Q61 | Prostate | White | 4 | 1882 | 0.002 | 0.002 | 0.001 | 0.004 |
| NRAS | Q61 | Anal | NA | 0 | 13 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Anal | White | 0 | 126 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | Q61 | Neuroendocrine | Black | 0 | 23 | 0.004 | 0.002 | 0.000 | 0.021 |
| NRAS | Q61 | Neuroendocrine | NA | 0 | 45 | 0.004 | 0.002 | 0.000 | 0.016 |
| NRAS | Q61 | Neuroendocrine | White | 1 | 283 | 0.004 | 0.003 | 0.000 | 0.012 |
| NRAS | Q61 | Bladder | Asian | 0 | 40 | 0.005 | 0.004 | 0.000 | 0.015 |
| NRAS | Q61 | Bladder | Black | 0 | 43 | 0.004 | 0.004 | 0.000 | 0.014 |
| NRAS | Q61 | Bladder | NA | 2 | 169 | 0.006 | 0.005 | 0.001 | 0.019 |
| NRAS | Q61 | Bladder | Other | 0 | 14 | 0.005 | 0.004 | 0.000 | 0.019 |
| NRAS | Q61 | Bladder | White | 4 | 1310 | 0.004 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | BLL/Lymphoma | Asian | 0 | 17 | 0.025 | 0.023 | 0.001 | 0.061 |
| NRAS | Q61 | BLL/Lymphoma | NA | 3 | 92 | 0.028 | 0.026 | 0.009 | 0.060 |
| NRAS | Q61 | BLL/Lymphoma | White | 3 | 125 | 0.026 | 0.024 | 0.008 | 0.051 |
| NRAS | Q61 | Small bowel | Black | 2 | 25 | 0.066 | 0.054 | 0.005 | 0.197 |
| NRAS | Q61 | Small bowel | NA | 0 | 22 | 0.006 | 0.000 | 0.000 | 0.043 |
| NRAS | Q61 | Small bowel | White | 0 | 150 | 0.002 | 0.000 | 0.000 | 0.016 |
| NRAS | Q61 | Sex cord stromal | NA | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | Q61 | Sex cord stromal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | Q61 | Bone | Asian | 0 | 30 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Bone | Black | 0 | 32 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Bone | NA | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Bone | Other | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Bone | White | 0 | 391 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Vaginal | White | 0 | 68 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | Q61 | Thymic | Asian | 0 | 13 | 0.009 | 0.005 | 0.000 | 0.041 |
| NRAS | Q61 | Thymic | NA | 0 | 23 | 0.008 | 0.005 | 0.000 | 0.034 |
| NRAS | Q61 | Thymic | White | 1 | 108 | 0.009 | 0.006 | 0.000 | 0.029 |
| NRAS | Q61 | Ampullary | White | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | Q61 | SCLC | Asian | 0 | 15 | 0.007 | 0.004 | 0.000 | 0.032 |
| NRAS | Q61 | SCLC | NA | 0 | 30 | 0.006 | 0.004 | 0.000 | 0.024 |
| NRAS | Q61 | SCLC | White | 2 | 337 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | Q61 | Mesothelioma | Asian | 0 | 11 | 0.004 | 0.002 | 0.000 | 0.024 |
| NRAS | Q61 | Mesothelioma | Black | 0 | 10 | 0.004 | 0.002 | 0.000 | 0.022 |
| NRAS | Q61 | Mesothelioma | NA | 0 | 32 | 0.003 | 0.002 | 0.000 | 0.016 |
| NRAS | Q61 | Mesothelioma | White | 1 | 434 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | Q61 | Germ cell | Asian | 0 | 36 | 0.011 | 0.010 | 0.001 | 0.024 |
| NRAS | Q61 | Germ cell | Black | 0 | 23 | 0.011 | 0.010 | 0.001 | 0.025 |
| NRAS | Q61 | Germ cell | NA | 2 | 179 | 0.011 | 0.011 | 0.004 | 0.023 |
| NRAS | Q61 | Germ cell | Other | 0 | 37 | 0.011 | 0.010 | 0.001 | 0.023 |
| NRAS | Q61 | Germ cell | White | 8 | 603 | 0.012 | 0.011 | 0.006 | 0.021 |
| NRAS | Q61 | Nerve sheath | Black | 0 | 12 | 0.009 | 0.004 | 0.000 | 0.053 |
| NRAS | Q61 | Nerve sheath | NA | 1 | 26 | 0.022 | 0.012 | 0.001 | 0.102 |
| NRAS | Q61 | Nerve sheath | White | 0 | 105 | 0.005 | 0.003 | 0.000 | 0.024 |
| NRAS | Q61 | Penile | White | 0 | 20 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | Q61 | Pheochromocytoma | White | 0 | 15 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | Q61 | Pineal | White | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | Q61 | B cell lymphoma | Asian | 0 | 21 | 0.015 | 0.012 | 0.001 | 0.046 |
| NRAS | Q61 | B cell lymphoma | Black | 0 | 25 | 0.014 | 0.012 | 0.001 | 0.043 |
| NRAS | Q61 | B cell lymphoma | NA | 2 | 42 | 0.023 | 0.016 | 0.006 | 0.078 |
| NRAS | Q61 | B cell lymphoma | Other | 1 | 12 | 0.027 | 0.016 | 0.005 | 0.130 |
| NRAS | Q61 | B cell lymphoma | White | 9 | 859 | 0.012 | 0.012 | 0.006 | 0.020 |
| NRAS | Q61 | Non-hodgkin lymphoma | White | 1 | 19 | 0.061 | 0.046 | 0.003 | 0.199 |
| NRAS | Q61 | T-lymphoblastic leukemia/lymphoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.029 |
| NRAS | Q61 | T-lymphoblastic leukemia/lymphoma | White | 0 | 23 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | Q61 | Retinoblastoma | NA | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| NRAS | Q61 | Retinoblastoma | White | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | Q61 | Hodgkin lymphoma | White | 0 | 30 | 0.001 | 0.000 | 0.000 | 0.017 |
| NRAS | Q61 | Lung | White | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | Q61 | Peritoneal | White | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.025 |
| NRAS | Q61 | Parathyroid | White | 2 | 14 | 0.149 | 0.132 | 0.023 | 0.367 |
| NRAS | 12, 13, or 61 | Appendiceal | Female | 4 | 174 | 0.022 | 0.021 | 0.008 | 0.043 |
| NRAS | 12, 13, or 61 | Appendiceal | Male | 3 | 167 | 0.020 | 0.019 | 0.006 | 0.040 |
| NRAS | 12, 13, or 61 | CRC | Female | 132 | 3026 | 0.042 | 0.042 | 0.036 | 0.050 |
| NRAS | 12, 13, or 61 | CRC | Male | 134 | 3694 | 0.037 | 0.037 | 0.032 | 0.043 |
| NRAS | 12, 13, or 61 | CUP | Female | 14 | 1000 | 0.016 | 0.015 | 0.009 | 0.023 |
| NRAS | 12, 13, or 61 | CUP | Male | 19 | 988 | 0.018 | 0.018 | 0.012 | 0.026 |
| NRAS | 12, 13, or 61 | NSCLC | Female | 42 | 5722 | 0.008 | 0.008 | 0.006 | 0.010 |
| NRAS | 12, 13, or 61 | NSCLC | Male | 39 | 4406 | 0.008 | 0.008 | 0.006 | 0.011 |
| NRAS | 12, 13, or 61 | Breast | Female | 2 | 9283 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Breast | Male | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Female | 12 | 1413 | 0.010 | 0.010 | 0.005 | 0.015 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Male | 20 | 1360 | 0.013 | 0.013 | 0.008 | 0.020 |
| NRAS | 12, 13, or 61 | Pancreatic | Female | 8 | 1153 | 0.006 | 0.006 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | Pancreatic | Male | 5 | 1340 | 0.005 | 0.005 | 0.002 | 0.008 |
| NRAS | 12, 13, or 61 | Leukemia | Female | 79 | 637 | 0.121 | 0.120 | 0.100 | 0.144 |
| NRAS | 12, 13, or 61 | Leukemia | Male | 103 | 930 | 0.113 | 0.113 | 0.095 | 0.132 |
| NRAS | 12, 13, or 61 | Melanoma | Female | 218 | 1104 | 0.201 | 0.201 | 0.177 | 0.226 |
| NRAS | 12, 13, or 61 | Melanoma | Male | 431 | 1742 | 0.245 | 0.245 | 0.225 | 0.266 |
| NRAS | 12, 13, or 61 | Head and neck | Female | 4 | 564 | 0.007 | 0.006 | 0.003 | 0.013 |
| NRAS | 12, 13, or 61 | Head and neck | Male | 7 | 1179 | 0.006 | 0.006 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | Uterine | Female | 43 | 2253 | 0.019 | 0.019 | 0.014 | 0.025 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | Female | 0 | 183 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | Male | 1 | 330 | 0.003 | 0.002 | 0.000 | 0.010 |
| NRAS | 12, 13, or 61 | MDS/MPN | Female | 20 | 483 | 0.046 | 0.046 | 0.030 | 0.062 |
| NRAS | 12, 13, or 61 | MDS/MPN | Male | 40 | 724 | 0.053 | 0.052 | 0.039 | 0.069 |
| NRAS | 12, 13, or 61 | Adrenocortical | Female | 1 | 80 | 0.011 | 0.007 | 0.000 | 0.039 |
| NRAS | 12, 13, or 61 | Adrenocortical | Male | 0 | 54 | 0.006 | 0.003 | 0.000 | 0.030 |
| NRAS | 12, 13, or 61 | Ovarian | Female | 33 | 2336 | 0.014 | 0.014 | 0.010 | 0.019 |
| NRAS | 12, 13, or 61 | Esophagogastric | Female | 1 | 504 | 0.004 | 0.004 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Esophagogastric | Male | 8 | 1297 | 0.006 | 0.005 | 0.003 | 0.010 |
| NRAS | 12, 13, or 61 | Thyroid | Female | 65 | 537 | 0.122 | 0.122 | 0.099 | 0.147 |
| NRAS | 12, 13, or 61 | Thyroid | Male | 61 | 480 | 0.125 | 0.125 | 0.101 | 0.152 |
| NRAS | 12, 13, or 61 | Cervical | Female | 2 | 365 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | 12, 13, or 61 | Hepatobiliary | Female | 13 | 636 | 0.021 | 0.021 | 0.013 | 0.031 |
| NRAS | 12, 13, or 61 | Hepatobiliary | Male | 16 | 738 | 0.021 | 0.021 | 0.013 | 0.031 |
| NRAS | 12, 13, or 61 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | Female | 0 | 107 | 0.005 | 0.003 | 0.000 | 0.022 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | Male | 2 | 124 | 0.013 | 0.011 | 0.002 | 0.039 |
| NRAS | 12, 13, or 61 | CNS | Female | 8 | 1994 | 0.005 | 0.005 | 0.002 | 0.008 |
| NRAS | 12, 13, or 61 | CNS | Male | 17 | 2569 | 0.006 | 0.006 | 0.004 | 0.009 |
| NRAS | 12, 13, or 61 | Prostate | Male | 4 | 2436 | 0.002 | 0.002 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | 12, 13, or 61 | Neuroendocrine | Female | 2 | 166 | 0.010 | 0.009 | 0.002 | 0.027 |
| NRAS | 12, 13, or 61 | Neuroendocrine | Male | 1 | 193 | 0.008 | 0.007 | 0.001 | 0.021 |
| NRAS | 12, 13, or 61 | Bladder | Female | 3 | 393 | 0.007 | 0.007 | 0.003 | 0.014 |
| NRAS | 12, 13, or 61 | Bladder | Male | 7 | 1187 | 0.006 | 0.006 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | Female | 10 | 106 | 0.106 | 0.105 | 0.060 | 0.156 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | Male | 18 | 142 | 0.119 | 0.117 | 0.077 | 0.172 |
| NRAS | 12, 13, or 61 | Small bowel | Female | 1 | 78 | 0.012 | 0.009 | 0.001 | 0.036 |
| NRAS | 12, 13, or 61 | Small bowel | Male | 1 | 132 | 0.010 | 0.008 | 0.001 | 0.028 |
| NRAS | 12, 13, or 61 | Sex cord stromal | Female | 1 | 97 | 0.011 | 0.008 | 0.001 | 0.038 |
| NRAS | 12, 13, or 61 | Sex cord stromal | Male | 0 | 10 | 0.013 | 0.007 | 0.000 | 0.068 |
| NRAS | 12, 13, or 61 | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Vaginal | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | 12, 13, or 61 | Thymic | Female | 1 | 70 | 0.011 | 0.008 | 0.000 | 0.042 |
| NRAS | 12, 13, or 61 | Thymic | Male | 0 | 86 | 0.005 | 0.003 | 0.000 | 0.024 |
| NRAS | 12, 13, or 61 | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | 12, 13, or 61 | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | 12, 13, or 61 | SCLC | Female | 0 | 193 | 0.003 | 0.001 | 0.000 | 0.012 |
| NRAS | 12, 13, or 61 | SCLC | Male | 2 | 205 | 0.008 | 0.007 | 0.001 | 0.024 |
| NRAS | 12, 13, or 61 | Mesothelioma | Female | 0 | 145 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Mesothelioma | Male | 1 | 352 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Germ cell | Female | 3 | 175 | 0.021 | 0.021 | 0.008 | 0.038 |
| NRAS | 12, 13, or 61 | Germ cell | Male | 17 | 711 | 0.023 | 0.023 | 0.014 | 0.035 |
| NRAS | 12, 13, or 61 | Nerve sheath | Female | 1 | 80 | 0.014 | 0.012 | 0.001 | 0.041 |
| NRAS | 12, 13, or 61 | Nerve sheath | Male | 1 | 74 | 0.015 | 0.012 | 0.002 | 0.043 |
| NRAS | 12, 13, or 61 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | 12, 13, or 61 | Pheochromocytoma | Male | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.017 |
| NRAS | 12, 13, or 61 | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Female | 6 | 395 | 0.019 | 0.019 | 0.008 | 0.031 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Male | 14 | 567 | 0.023 | 0.022 | 0.013 | 0.035 |
| NRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Female | 1 | 12 | 0.122 | 0.110 | 0.017 | 0.294 |
| NRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Male | 2 | 11 | 0.148 | 0.133 | 0.031 | 0.355 |
| NRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Female | 1 | 12 | 0.082 | 0.071 | 0.011 | 0.218 |
| NRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Male | 2 | 28 | 0.077 | 0.069 | 0.016 | 0.181 |
| NRAS | 12, 13, or 61 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | 12, 13, or 61 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | 12, 13, or 61 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.011 |
| NRAS | 12, 13, or 61 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | 12, 13, or 61 | Lung | Male | 1 | 16 | 0.070 | 0.053 | 0.003 | 0.231 |
| NRAS | 12, 13, or 61 | Blastic plasmacytoid dendritic cell neoplasm | Male | 4 | 11 | 0.367 | 0.357 | 0.128 | 0.651 |
| NRAS | 12, 13, or 61 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.033 |
| NRAS | G12 | Appendiceal | Female | 1 | 174 | 0.005 | 0.003 | 0.000 | 0.018 |
| NRAS | G12 | Appendiceal | Male | 0 | 167 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G12 | CRC | Female | 37 | 3026 | 0.012 | 0.012 | 0.009 | 0.016 |
| NRAS | G12 | CRC | Male | 45 | 3694 | 0.012 | 0.012 | 0.009 | 0.016 |
| NRAS | G12 | CUP | Female | 4 | 1000 | 0.004 | 0.004 | 0.002 | 0.008 |
| NRAS | G12 | CUP | Male | 5 | 988 | 0.005 | 0.005 | 0.002 | 0.009 |
| NRAS | G12 | NSCLC | Female | 9 | 5722 | 0.002 | 0.002 | 0.001 | 0.003 |
| NRAS | G12 | NSCLC | Male | 9 | 4406 | 0.002 | 0.002 | 0.001 | 0.003 |
| NRAS | G12 | Breast | Female | 1 | 9283 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Breast | Male | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G12 | Soft tissue sarcoma | Female | 2 | 1413 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Soft tissue sarcoma | Male | 1 | 1360 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Pancreatic | Female | 1 | 1153 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Pancreatic | Male | 1 | 1340 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Leukemia | Female | 47 | 637 | 0.070 | 0.069 | 0.054 | 0.090 |
| NRAS | G12 | Leukemia | Male | 57 | 930 | 0.064 | 0.064 | 0.050 | 0.079 |
| NRAS | G12 | Melanoma | Female | 19 | 1104 | 0.017 | 0.017 | 0.012 | 0.024 |
| NRAS | G12 | Melanoma | Male | 29 | 1742 | 0.017 | 0.017 | 0.012 | 0.023 |
| NRAS | G12 | Head and neck | Female | 2 | 564 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | G12 | Head and neck | Male | 3 | 1179 | 0.003 | 0.003 | 0.001 | 0.006 |
| NRAS | G12 | Uterine | Female | 17 | 2253 | 0.008 | 0.007 | 0.004 | 0.012 |
| NRAS | G12 | Non-melanoma skin | Female | 0 | 183 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | G12 | Non-melanoma skin | Male | 1 | 330 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | G12 | MDS/MPN | Female | 13 | 483 | 0.031 | 0.031 | 0.018 | 0.044 |
| NRAS | G12 | MDS/MPN | Male | 28 | 724 | 0.036 | 0.036 | 0.025 | 0.051 |
| NRAS | G12 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Ovarian | Female | 2 | 2336 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Esophagogastric | Female | 0 | 504 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Esophagogastric | Male | 2 | 1297 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Thyroid | Female | 0 | 537 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | Male | 0 | 480 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Cervical | Female | 0 | 365 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Hepatobiliary | Female | 2 | 636 | 0.005 | 0.005 | 0.001 | 0.011 |
| NRAS | G12 | Hepatobiliary | Male | 7 | 738 | 0.008 | 0.008 | 0.003 | 0.016 |
| NRAS | G12 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | T / NK neoplasms | Male | 0 | 124 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | CNS | Female | 1 | 1994 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G12 | CNS | Male | 3 | 2569 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G12 | Prostate | Male | 0 | 2436 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Neuroendocrine | Female | 1 | 166 | 0.005 | 0.003 | 0.000 | 0.018 |
| NRAS | G12 | Neuroendocrine | Male | 0 | 193 | 0.002 | 0.001 | 0.000 | 0.010 |
| NRAS | G12 | Bladder | Female | 1 | 393 | 0.002 | 0.001 | 0.000 | 0.007 |
| NRAS | G12 | Bladder | Male | 1 | 1187 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | BLL/Lymphoma | Female | 4 | 106 | 0.052 | 0.052 | 0.017 | 0.093 |
| NRAS | G12 | BLL/Lymphoma | Male | 12 | 142 | 0.074 | 0.072 | 0.040 | 0.122 |
| NRAS | G12 | Small bowel | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Small bowel | Male | 0 | 132 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Sex cord stromal | Female | 0 | 97 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Sex cord stromal | Male | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.014 |
| NRAS | G12 | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Vaginal | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | SCLC | Female | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | SCLC | Male | 0 | 205 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Germ cell | Female | 1 | 175 | 0.008 | 0.007 | 0.001 | 0.018 |
| NRAS | G12 | Germ cell | Male | 6 | 711 | 0.008 | 0.008 | 0.003 | 0.016 |
| NRAS | G12 | Nerve sheath | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Nerve sheath | Male | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | G12 | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.038 |
| NRAS | G12 | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | G12 | B cell lymphoma | Female | 1 | 395 | 0.005 | 0.004 | 0.001 | 0.011 |
| NRAS | G12 | B cell lymphoma | Male | 4 | 567 | 0.006 | 0.006 | 0.002 | 0.013 |
| NRAS | G12 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.034 | 0.019 | 0.000 | 0.149 |
| NRAS | G12 | Non-hodgkin lymphoma | Male | 1 | 11 | 0.066 | 0.047 | 0.003 | 0.241 |
| NRAS | G12 | T-lymphoblastic leukemia/lymphoma | Female | 1 | 12 | 0.064 | 0.050 | 0.007 | 0.204 |
| NRAS | G12 | T-lymphoblastic leukemia/lymphoma | Male | 1 | 28 | 0.049 | 0.041 | 0.005 | 0.139 |
| NRAS | G12 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | G12 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.013 |
| NRAS | G12 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12 | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | G12 | Blastic plasmacytoid dendritic cell neoplasm | Male | 3 | 11 | 0.278 | 0.264 | 0.071 | 0.556 |
| NRAS | G12 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G12C | Appendiceal | Female | 1 | 174 | 0.005 | 0.003 | 0.000 | 0.018 |
| NRAS | G12C | Appendiceal | Male | 0 | 167 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G12C | CRC | Female | 7 | 3026 | 0.002 | 0.002 | 0.001 | 0.004 |
| NRAS | G12C | CRC | Male | 9 | 3694 | 0.002 | 0.002 | 0.001 | 0.004 |
| NRAS | G12C | CUP | Female | 1 | 1000 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12C | CUP | Male | 1 | 988 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12C | NSCLC | Female | 1 | 5722 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | Male | 2 | 4406 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Breast | Female | 0 | 9283 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | Male | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Female | 0 | 1413 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Male | 0 | 1360 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Pancreatic | Female | 0 | 1153 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Pancreatic | Male | 1 | 1340 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Leukemia | Female | 4 | 637 | 0.006 | 0.005 | 0.002 | 0.011 |
| NRAS | G12C | Leukemia | Male | 4 | 930 | 0.005 | 0.005 | 0.002 | 0.010 |
| NRAS | G12C | Melanoma | Female | 7 | 1104 | 0.005 | 0.005 | 0.002 | 0.010 |
| NRAS | G12C | Melanoma | Male | 5 | 1742 | 0.004 | 0.004 | 0.001 | 0.007 |
| NRAS | G12C | Head and neck | Female | 0 | 564 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Head and neck | Male | 1 | 1179 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12C | Uterine | Female | 5 | 2253 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12C | Non-melanoma skin | Female | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-melanoma skin | Male | 0 | 330 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | MDS/MPN | Female | 0 | 483 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | MDS/MPN | Male | 1 | 724 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Ovarian | Female | 0 | 2336 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Female | 0 | 504 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Male | 0 | 1297 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | Female | 0 | 537 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | Male | 0 | 480 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Cervical | Female | 0 | 365 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Hepatobiliary | Female | 1 | 636 | 0.002 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | Hepatobiliary | Male | 1 | 738 | 0.002 | 0.001 | 0.000 | 0.005 |
| NRAS | G12C | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | T / NK neoplasms | Male | 0 | 124 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | CNS | Female | 1 | 1994 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | CNS | Male | 1 | 2569 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Prostate | Male | 0 | 2436 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Neuroendocrine | Female | 0 | 166 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Neuroendocrine | Male | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bladder | Female | 1 | 393 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | G12C | Bladder | Male | 0 | 1187 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | BLL/Lymphoma | Female | 0 | 106 | 0.004 | 0.002 | 0.000 | 0.016 |
| NRAS | G12C | BLL/Lymphoma | Male | 1 | 142 | 0.006 | 0.004 | 0.000 | 0.022 |
| NRAS | G12C | Small bowel | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Small bowel | Male | 0 | 132 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Sex cord stromal | Female | 0 | 97 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Sex cord stromal | Male | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.014 |
| NRAS | G12C | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Vaginal | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | SCLC | Female | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | SCLC | Male | 0 | 205 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Germ cell | Female | 1 | 175 | 0.004 | 0.002 | 0.000 | 0.018 |
| NRAS | G12C | Germ cell | Male | 0 | 711 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Nerve sheath | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Nerve sheath | Male | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | G12C | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.038 |
| NRAS | G12C | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | G12C | B cell lymphoma | Female | 0 | 395 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | Male | 0 | 567 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Non-hodgkin lymphoma | Female | 0 | 12 | 0.002 | 0.000 | 0.000 | 0.028 |
| NRAS | G12C | Non-hodgkin lymphoma | Male | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.028 |
| NRAS | G12C | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | G12C | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12C | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | G12C | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.013 |
| NRAS | G12C | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12C | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12C | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | G12C | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.005 | 0.000 | 0.000 | 0.054 |
| NRAS | G12C | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G13 | Appendiceal | Female | 1 | 174 | 0.005 | 0.003 | 0.000 | 0.018 |
| NRAS | G13 | Appendiceal | Male | 0 | 167 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G13 | CRC | Female | 20 | 3026 | 0.006 | 0.006 | 0.004 | 0.009 |
| NRAS | G13 | CRC | Male | 14 | 3694 | 0.004 | 0.004 | 0.002 | 0.007 |
| NRAS | G13 | CUP | Female | 2 | 1000 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G13 | CUP | Male | 3 | 988 | 0.003 | 0.003 | 0.001 | 0.006 |
| NRAS | G13 | NSCLC | Female | 2 | 5722 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | NSCLC | Male | 2 | 4406 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Breast | Female | 1 | 9283 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Breast | Male | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G13 | Soft tissue sarcoma | Female | 1 | 1413 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Soft tissue sarcoma | Male | 2 | 1360 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Pancreatic | Female | 2 | 1153 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Pancreatic | Male | 0 | 1340 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Leukemia | Female | 18 | 637 | 0.028 | 0.028 | 0.019 | 0.040 |
| NRAS | G13 | Leukemia | Male | 26 | 930 | 0.028 | 0.028 | 0.020 | 0.038 |
| NRAS | G13 | Melanoma | Female | 8 | 1104 | 0.009 | 0.009 | 0.004 | 0.016 |
| NRAS | G13 | Melanoma | Male | 31 | 1742 | 0.017 | 0.017 | 0.011 | 0.024 |
| NRAS | G13 | Head and neck | Female | 2 | 564 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | G13 | Head and neck | Male | 0 | 1179 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Uterine | Female | 1 | 2253 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Non-melanoma skin | Female | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | Male | 0 | 330 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | MDS/MPN | Female | 9 | 483 | 0.017 | 0.017 | 0.010 | 0.028 |
| NRAS | G13 | MDS/MPN | Male | 11 | 724 | 0.016 | 0.016 | 0.009 | 0.025 |
| NRAS | G13 | Adrenocortical | Female | 1 | 80 | 0.011 | 0.008 | 0.000 | 0.038 |
| NRAS | G13 | Adrenocortical | Male | 0 | 54 | 0.007 | 0.004 | 0.000 | 0.030 |
| NRAS | G13 | Ovarian | Female | 0 | 2336 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Esophagogastric | Female | 1 | 504 | 0.001 | 0.001 | 0.000 | 0.006 |
| NRAS | G13 | Esophagogastric | Male | 0 | 1297 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Thyroid | Female | 1 | 537 | 0.002 | 0.002 | 0.000 | 0.006 |
| NRAS | G13 | Thyroid | Male | 1 | 480 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | G13 | Cervical | Female | 0 | 365 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Hepatobiliary | Female | 2 | 636 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | G13 | Hepatobiliary | Male | 2 | 738 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | G13 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | T / NK neoplasms | Female | 0 | 107 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | T / NK neoplasms | Male | 0 | 124 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | CNS | Female | 0 | 1994 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | CNS | Male | 1 | 2569 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Prostate | Male | 0 | 2436 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Neuroendocrine | Female | 1 | 166 | 0.005 | 0.003 | 0.000 | 0.017 |
| NRAS | G13 | Neuroendocrine | Male | 0 | 193 | 0.002 | 0.001 | 0.000 | 0.010 |
| NRAS | G13 | Bladder | Female | 0 | 393 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Bladder | Male | 2 | 1187 | 0.002 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | BLL/Lymphoma | Female | 3 | 106 | 0.032 | 0.030 | 0.011 | 0.061 |
| NRAS | G13 | BLL/Lymphoma | Male | 5 | 142 | 0.034 | 0.032 | 0.014 | 0.063 |
| NRAS | G13 | Small bowel | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Small bowel | Male | 0 | 132 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Sex cord stromal | Female | 1 | 97 | 0.011 | 0.008 | 0.000 | 0.037 |
| NRAS | G13 | Sex cord stromal | Male | 0 | 10 | 0.013 | 0.007 | 0.000 | 0.067 |
| NRAS | G13 | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Vaginal | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Thymic | Female | 0 | 70 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Thymic | Male | 0 | 86 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | SCLC | Female | 0 | 193 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | SCLC | Male | 0 | 205 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Mesothelioma | Female | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Mesothelioma | Male | 0 | 352 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Germ cell | Female | 1 | 175 | 0.005 | 0.004 | 0.001 | 0.015 |
| NRAS | G13 | Germ cell | Male | 2 | 711 | 0.003 | 0.003 | 0.001 | 0.008 |
| NRAS | G13 | Nerve sheath | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Nerve sheath | Male | 0 | 74 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.022 |
| NRAS | G13 | Pheochromocytoma | Male | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | G13 | Pineal | Male | 0 | 12 | 0.005 | 0.000 | 0.000 | 0.057 |
| NRAS | G13 | B cell lymphoma | Female | 1 | 395 | 0.004 | 0.004 | 0.001 | 0.010 |
| NRAS | G13 | B cell lymphoma | Male | 3 | 567 | 0.005 | 0.004 | 0.001 | 0.011 |
| NRAS | G13 | Non-hodgkin lymphoma | Female | 0 | 12 | 0.035 | 0.020 | 0.000 | 0.154 |
| NRAS | G13 | Non-hodgkin lymphoma | Male | 1 | 11 | 0.068 | 0.049 | 0.003 | 0.244 |
| NRAS | G13 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.024 | 0.014 | 0.000 | 0.105 |
| NRAS | G13 | T-lymphoblastic leukemia/lymphoma | Male | 1 | 28 | 0.031 | 0.023 | 0.001 | 0.109 |
| NRAS | G13 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.011 |
| NRAS | G13 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | G13 | Hodgkin lymphoma | Female | 0 | 16 | 0.002 | 0.000 | 0.000 | 0.018 |
| NRAS | G13 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | G13 | Lung | Male | 0 | 16 | 0.003 | 0.000 | 0.000 | 0.033 |
| NRAS | G13 | Blastic plasmacytoid dendritic cell neoplasm | Male | 1 | 11 | 0.101 | 0.079 | 0.004 | 0.317 |
| NRAS | G13 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | Q61 | Appendiceal | Female | 2 | 174 | 0.014 | 0.013 | 0.004 | 0.031 |
| NRAS | Q61 | Appendiceal | Male | 3 | 167 | 0.016 | 0.015 | 0.005 | 0.036 |
| NRAS | Q61 | CRC | Female | 75 | 3026 | 0.024 | 0.024 | 0.019 | 0.029 |
| NRAS | Q61 | CRC | Male | 75 | 3694 | 0.021 | 0.021 | 0.017 | 0.026 |
| NRAS | Q61 | CUP | Female | 8 | 1000 | 0.009 | 0.009 | 0.005 | 0.014 |
| NRAS | Q61 | CUP | Male | 11 | 988 | 0.010 | 0.010 | 0.006 | 0.017 |
| NRAS | Q61 | NSCLC | Female | 31 | 5722 | 0.006 | 0.006 | 0.004 | 0.007 |
| NRAS | Q61 | NSCLC | Male | 28 | 4406 | 0.006 | 0.006 | 0.004 | 0.008 |
| NRAS | Q61 | Breast | Female | 0 | 9283 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | Male | 0 | 48 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Soft tissue sarcoma | Female | 10 | 1413 | 0.009 | 0.008 | 0.004 | 0.014 |
| NRAS | Q61 | Soft tissue sarcoma | Male | 18 | 1360 | 0.012 | 0.012 | 0.007 | 0.018 |
| NRAS | Q61 | Pancreatic | Female | 5 | 1153 | 0.004 | 0.004 | 0.002 | 0.008 |
| NRAS | Q61 | Pancreatic | Male | 4 | 1340 | 0.004 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Leukemia | Female | 17 | 637 | 0.027 | 0.027 | 0.018 | 0.038 |
| NRAS | Q61 | Leukemia | Male | 26 | 930 | 0.028 | 0.028 | 0.019 | 0.038 |
| NRAS | Q61 | Melanoma | Female | 192 | 1104 | 0.178 | 0.178 | 0.155 | 0.202 |
| NRAS | Q61 | Melanoma | Male | 372 | 1742 | 0.211 | 0.211 | 0.192 | 0.231 |
| NRAS | Q61 | Head and neck | Female | 0 | 564 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | Q61 | Head and neck | Male | 4 | 1179 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Uterine | Female | 25 | 2253 | 0.011 | 0.011 | 0.007 | 0.016 |
| NRAS | Q61 | Non-melanoma skin | Female | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Non-melanoma skin | Male | 0 | 330 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | MDS/MPN | Female | 1 | 483 | 0.003 | 0.003 | 0.000 | 0.008 |
| NRAS | Q61 | MDS/MPN | Male | 3 | 724 | 0.004 | 0.003 | 0.001 | 0.009 |
| NRAS | Q61 | Adrenocortical | Female | 0 | 80 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Adrenocortical | Male | 0 | 54 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | Q61 | Ovarian | Female | 31 | 2336 | 0.013 | 0.013 | 0.009 | 0.018 |
| NRAS | Q61 | Esophagogastric | Female | 0 | 504 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | Q61 | Esophagogastric | Male | 6 | 1297 | 0.004 | 0.004 | 0.002 | 0.008 |
| NRAS | Q61 | Thyroid | Female | 64 | 537 | 0.121 | 0.120 | 0.098 | 0.145 |
| NRAS | Q61 | Thyroid | Male | 60 | 480 | 0.124 | 0.123 | 0.100 | 0.151 |
| NRAS | Q61 | Cervical | Female | 2 | 365 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | Q61 | Hepatobiliary | Female | 9 | 636 | 0.013 | 0.012 | 0.007 | 0.021 |
| NRAS | Q61 | Hepatobiliary | Male | 7 | 738 | 0.011 | 0.011 | 0.005 | 0.018 |
| NRAS | Q61 | Kidney | Female | 0 | 420 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | Male | 0 | 1002 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | T / NK neoplasms | Female | 0 | 107 | 0.005 | 0.003 | 0.000 | 0.022 |
| NRAS | Q61 | T / NK neoplasms | Male | 2 | 124 | 0.013 | 0.011 | 0.002 | 0.039 |
| NRAS | Q61 | CNS | Female | 7 | 1994 | 0.004 | 0.004 | 0.002 | 0.007 |
| NRAS | Q61 | CNS | Male | 13 | 2569 | 0.005 | 0.005 | 0.003 | 0.007 |
| NRAS | Q61 | Prostate | Male | 4 | 2436 | 0.002 | 0.002 | 0.000 | 0.004 |
| NRAS | Q61 | Anal | Female | 0 | 102 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Anal | Male | 0 | 47 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | Q61 | Neuroendocrine | Female | 0 | 166 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | Q61 | Neuroendocrine | Male | 1 | 193 | 0.004 | 0.003 | 0.000 | 0.016 |
| NRAS | Q61 | Bladder | Female | 2 | 393 | 0.004 | 0.004 | 0.001 | 0.011 |
| NRAS | Q61 | Bladder | Male | 4 | 1187 | 0.004 | 0.004 | 0.001 | 0.008 |
| NRAS | Q61 | BLL/Lymphoma | Female | 3 | 106 | 0.026 | 0.024 | 0.008 | 0.055 |
| NRAS | Q61 | BLL/Lymphoma | Male | 3 | 142 | 0.024 | 0.023 | 0.008 | 0.049 |
| NRAS | Q61 | Small bowel | Female | 1 | 78 | 0.012 | 0.009 | 0.001 | 0.036 |
| NRAS | Q61 | Small bowel | Male | 1 | 132 | 0.010 | 0.008 | 0.001 | 0.028 |
| NRAS | Q61 | Sex cord stromal | Female | 0 | 97 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Sex cord stromal | Male | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | Q61 | Bone | Female | 0 | 242 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Bone | Male | 0 | 328 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Vaginal | Female | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | Q61 | Thymic | Female | 1 | 70 | 0.011 | 0.008 | 0.000 | 0.042 |
| NRAS | Q61 | Thymic | Male | 0 | 86 | 0.005 | 0.003 | 0.000 | 0.024 |
| NRAS | Q61 | Ampullary | Female | 0 | 41 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | Q61 | Ampullary | Male | 0 | 65 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | Q61 | SCLC | Female | 0 | 193 | 0.003 | 0.001 | 0.000 | 0.012 |
| NRAS | Q61 | SCLC | Male | 2 | 205 | 0.008 | 0.007 | 0.001 | 0.024 |
| NRAS | Q61 | Mesothelioma | Female | 0 | 145 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | Q61 | Mesothelioma | Male | 1 | 352 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | Q61 | Germ cell | Female | 2 | 175 | 0.013 | 0.012 | 0.004 | 0.026 |
| NRAS | Q61 | Germ cell | Male | 9 | 711 | 0.013 | 0.012 | 0.006 | 0.021 |
| NRAS | Q61 | Nerve sheath | Female | 1 | 80 | 0.014 | 0.012 | 0.001 | 0.041 |
| NRAS | Q61 | Nerve sheath | Male | 1 | 74 | 0.015 | 0.012 | 0.002 | 0.043 |
| NRAS | Q61 | Penile | Male | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | Q61 | Pheochromocytoma | Male | 0 | 17 | 0.002 | 0.000 | 0.000 | 0.017 |
| NRAS | Q61 | Pineal | Male | 0 | 12 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | Q61 | B cell lymphoma | Female | 4 | 395 | 0.012 | 0.012 | 0.005 | 0.022 |
| NRAS | Q61 | B cell lymphoma | Male | 8 | 567 | 0.013 | 0.013 | 0.007 | 0.023 |
| NRAS | Q61 | Non-hodgkin lymphoma | Female | 1 | 12 | 0.062 | 0.045 | 0.002 | 0.222 |
| NRAS | Q61 | Non-hodgkin lymphoma | Male | 0 | 11 | 0.038 | 0.023 | 0.000 | 0.158 |
| NRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Female | 0 | 12 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.009 |
| NRAS | Q61 | Retinoblastoma | Female | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | Q61 | Retinoblastoma | Male | 0 | 28 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | Q61 | Hodgkin lymphoma | Female | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.011 |
| NRAS | Q61 | Hodgkin lymphoma | Male | 0 | 24 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | Q61 | Lung | Male | 1 | 16 | 0.070 | 0.053 | 0.003 | 0.231 |
| NRAS | Q61 | Blastic plasmacytoid dendritic cell neoplasm | Male | 0 | 11 | 0.007 | 0.000 | 0.000 | 0.082 |
| NRAS | Q61 | Peritoneal | Female | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.033 |
| NRAS | 12, 13, or 61 | Appendiceal | Metastasis | 4 | 174 | 0.022 | 0.021 | 0.008 | 0.043 |
| NRAS | 12, 13, or 61 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.022 | 0.019 | 0.001 | 0.060 |
| NRAS | 12, 13, or 61 | Appendiceal | Primary | 3 | 151 | 0.021 | 0.020 | 0.007 | 0.042 |
| NRAS | 12, 13, or 61 | CRC | Metastasis | 100 | 2352 | 0.041 | 0.041 | 0.035 | 0.049 |
| NRAS | 12, 13, or 61 | CRC | Not Applicable or Heme | 9 | 224 | 0.040 | 0.040 | 0.029 | 0.055 |
| NRAS | 12, 13, or 61 | CRC | Primary | 155 | 4113 | 0.039 | 0.039 | 0.033 | 0.044 |
| NRAS | 12, 13, or 61 | CRC | Unspecified | 2 | 31 | 0.042 | 0.040 | 0.028 | 0.066 |
| NRAS | 12, 13, or 61 | CUP | Metastasis | 19 | 1388 | 0.016 | 0.016 | 0.010 | 0.022 |
| NRAS | 12, 13, or 61 | CUP | Not Applicable or Heme | 5 | 229 | 0.019 | 0.018 | 0.010 | 0.034 |
| NRAS | 12, 13, or 61 | CUP | Primary | 6 | 311 | 0.018 | 0.018 | 0.010 | 0.031 |
| NRAS | 12, 13, or 61 | CUP | Unspecified | 3 | 60 | 0.023 | 0.019 | 0.011 | 0.060 |
| NRAS | 12, 13, or 61 | NSCLC | Metastasis | 26 | 3750 | 0.008 | 0.008 | 0.005 | 0.010 |
| NRAS | 12, 13, or 61 | NSCLC | Not Applicable or Heme | 4 | 223 | 0.010 | 0.009 | 0.006 | 0.021 |
| NRAS | 12, 13, or 61 | NSCLC | Primary | 50 | 6059 | 0.008 | 0.008 | 0.006 | 0.010 |
| NRAS | 12, 13, or 61 | NSCLC | Unspecified | 1 | 99 | 0.009 | 0.008 | 0.004 | 0.017 |
| NRAS | 12, 13, or 61 | Breast | Metastasis | 1 | 3094 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Breast | Not Applicable or Heme | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | 12, 13, or 61 | Breast | Primary | 1 | 6124 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Metastasis | 8 | 939 | 0.010 | 0.010 | 0.005 | 0.016 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.011 | 0.011 | 0.004 | 0.020 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Primary | 23 | 1686 | 0.012 | 0.012 | 0.008 | 0.018 |
| NRAS | 12, 13, or 61 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.011 | 0.011 | 0.002 | 0.022 |
| NRAS | 12, 13, or 61 | Pancreatic | Metastasis | 6 | 981 | 0.006 | 0.005 | 0.003 | 0.010 |
| NRAS | 12, 13, or 61 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.005 | 0.005 | 0.001 | 0.012 |
| NRAS | 12, 13, or 61 | Pancreatic | Primary | 7 | 1428 | 0.005 | 0.005 | 0.003 | 0.009 |
| NRAS | 12, 13, or 61 | Leukemia | Metastasis | 3 | 15 | 0.127 | 0.120 | 0.084 | 0.220 |
| NRAS | 12, 13, or 61 | Leukemia | Not Applicable or Heme | 107 | 923 | 0.117 | 0.116 | 0.099 | 0.136 |
| NRAS | 12, 13, or 61 | Leukemia | Primary | 40 | 412 | 0.109 | 0.109 | 0.082 | 0.133 |
| NRAS | 12, 13, or 61 | Leukemia | Unspecified | 32 | 217 | 0.129 | 0.126 | 0.100 | 0.174 |
| NRAS | 12, 13, or 61 | Melanoma | Metastasis | 422 | 1738 | 0.240 | 0.240 | 0.220 | 0.261 |
| NRAS | 12, 13, or 61 | Melanoma | Not Applicable or Heme | 38 | 188 | 0.206 | 0.207 | 0.154 | 0.255 |
| NRAS | 12, 13, or 61 | Melanoma | Primary | 189 | 898 | 0.212 | 0.212 | 0.186 | 0.238 |
| NRAS | 12, 13, or 61 | Melanoma | Unspecified | 0 | 22 | 0.134 | 0.150 | 0.000 | 0.246 |
| NRAS | 12, 13, or 61 | Head and neck | Metastasis | 4 | 731 | 0.006 | 0.006 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | Head and neck | Not Applicable or Heme | 0 | 67 | 0.006 | 0.006 | 0.000 | 0.013 |
| NRAS | 12, 13, or 61 | Head and neck | Primary | 7 | 938 | 0.007 | 0.006 | 0.003 | 0.012 |
| NRAS | 12, 13, or 61 | Uterine | Metastasis | 10 | 585 | 0.018 | 0.018 | 0.011 | 0.027 |
| NRAS | 12, 13, or 61 | Uterine | Not Applicable or Heme | 0 | 76 | 0.017 | 0.017 | 0.002 | 0.028 |
| NRAS | 12, 13, or 61 | Uterine | Primary | 32 | 1541 | 0.020 | 0.019 | 0.014 | 0.027 |
| NRAS | 12, 13, or 61 | Uterine | Unspecified | 1 | 51 | 0.019 | 0.019 | 0.006 | 0.037 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | Metastasis | 1 | 203 | 0.003 | 0.002 | 0.000 | 0.013 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.003 | 0.001 | 0.000 | 0.018 |
| NRAS | 12, 13, or 61 | Non-melanoma skin | Primary | 0 | 287 | 0.002 | 0.001 | 0.000 | 0.007 |
| NRAS | 12, 13, or 61 | MDS/MPN | Metastasis | 0 | 11 | 0.050 | 0.049 | 0.007 | 0.109 |
| NRAS | 12, 13, or 61 | MDS/MPN | Not Applicable or Heme | 38 | 915 | 0.045 | 0.045 | 0.032 | 0.059 |
| NRAS | 12, 13, or 61 | MDS/MPN | Primary | 20 | 250 | 0.067 | 0.065 | 0.042 | 0.104 |
| NRAS | 12, 13, or 61 | MDS/MPN | Unspecified | 2 | 31 | 0.057 | 0.053 | 0.022 | 0.117 |
| NRAS | 12, 13, or 61 | Adrenocortical | Metastasis | 1 | 55 | 0.014 | 0.010 | 0.001 | 0.055 |
| NRAS | 12, 13, or 61 | Adrenocortical | Primary | 0 | 72 | 0.006 | 0.003 | 0.000 | 0.027 |
| NRAS | 12, 13, or 61 | Ovarian | Metastasis | 15 | 1088 | 0.014 | 0.014 | 0.009 | 0.020 |
| NRAS | 12, 13, or 61 | Ovarian | Not Applicable or Heme | 3 | 160 | 0.015 | 0.014 | 0.008 | 0.026 |
| NRAS | 12, 13, or 61 | Ovarian | Primary | 15 | 1060 | 0.014 | 0.014 | 0.009 | 0.020 |
| NRAS | 12, 13, or 61 | Ovarian | Unspecified | 0 | 28 | 0.014 | 0.014 | 0.006 | 0.025 |
| NRAS | 12, 13, or 61 | Esophagogastric | Metastasis | 2 | 462 | 0.005 | 0.005 | 0.001 | 0.010 |
| NRAS | 12, 13, or 61 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.005 | 0.005 | 0.001 | 0.013 |
| NRAS | 12, 13, or 61 | Esophagogastric | Primary | 7 | 1283 | 0.005 | 0.005 | 0.002 | 0.009 |
| NRAS | 12, 13, or 61 | Esophagogastric | Unspecified | 0 | 14 | 0.006 | 0.005 | 0.001 | 0.017 |
| NRAS | 12, 13, or 61 | Thyroid | Metastasis | 43 | 402 | 0.113 | 0.113 | 0.084 | 0.141 |
| NRAS | 12, 13, or 61 | Thyroid | Not Applicable or Heme | 1 | 28 | 0.101 | 0.108 | 0.020 | 0.157 |
| NRAS | 12, 13, or 61 | Thyroid | Primary | 80 | 582 | 0.131 | 0.130 | 0.106 | 0.159 |
| NRAS | 12, 13, or 61 | Cervical | Metastasis | 1 | 136 | 0.007 | 0.005 | 0.001 | 0.020 |
| NRAS | 12, 13, or 61 | Cervical | Not Applicable or Heme | 0 | 12 | 0.008 | 0.005 | 0.000 | 0.029 |
| NRAS | 12, 13, or 61 | Cervical | Primary | 1 | 211 | 0.006 | 0.005 | 0.001 | 0.017 |
| NRAS | 12, 13, or 61 | Hepatobiliary | Metastasis | 9 | 438 | 0.021 | 0.021 | 0.012 | 0.032 |
| NRAS | 12, 13, or 61 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.020 | 0.020 | 0.003 | 0.036 |
| NRAS | 12, 13, or 61 | Hepatobiliary | Primary | 20 | 894 | 0.022 | 0.021 | 0.014 | 0.031 |
| NRAS | 12, 13, or 61 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | Metastasis | 0 | 10 | 0.010 | 0.006 | 0.000 | 0.048 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.008 | 0.006 | 0.000 | 0.033 |
| NRAS | 12, 13, or 61 | T / NK neoplasms | Primary | 2 | 187 | 0.010 | 0.009 | 0.001 | 0.028 |
| NRAS | 12, 13, or 61 | CNS | Metastasis | 4 | 409 | 0.007 | 0.006 | 0.003 | 0.014 |
| NRAS | 12, 13, or 61 | CNS | Not Applicable or Heme | 3 | 526 | 0.006 | 0.006 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | CNS | Primary | 18 | 3522 | 0.006 | 0.005 | 0.004 | 0.008 |
| NRAS | 12, 13, or 61 | CNS | Unspecified | 1 | 108 | 0.006 | 0.006 | 0.003 | 0.014 |
| NRAS | 12, 13, or 61 | Prostate | Metastasis | 1 | 901 | 0.002 | 0.001 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | Prostate | Not Applicable or Heme | 0 | 57 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | 12, 13, or 61 | Prostate | Primary | 3 | 1468 | 0.002 | 0.002 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | Prostate | Unspecified | 0 | 12 | 0.003 | 0.002 | 0.000 | 0.011 |
| NRAS | 12, 13, or 61 | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | Neuroendocrine | Metastasis | 1 | 143 | 0.009 | 0.008 | 0.001 | 0.022 |
| NRAS | 12, 13, or 61 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.009 | 0.007 | 0.000 | 0.029 |
| NRAS | 12, 13, or 61 | Neuroendocrine | Primary | 2 | 196 | 0.009 | 0.008 | 0.002 | 0.023 |
| NRAS | 12, 13, or 61 | Bladder | Metastasis | 2 | 389 | 0.006 | 0.006 | 0.002 | 0.012 |
| NRAS | 12, 13, or 61 | Bladder | Not Applicable or Heme | 0 | 25 | 0.007 | 0.006 | 0.000 | 0.019 |
| NRAS | 12, 13, or 61 | Bladder | Primary | 8 | 1164 | 0.007 | 0.006 | 0.003 | 0.011 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.070 | 0.065 | 0.001 | 0.177 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | Not Applicable or Heme | 18 | 109 | 0.151 | 0.148 | 0.092 | 0.227 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | Primary | 5 | 101 | 0.066 | 0.063 | 0.022 | 0.128 |
| NRAS | 12, 13, or 61 | BLL/Lymphoma | Unspecified | 5 | 25 | 0.160 | 0.148 | 0.066 | 0.317 |
| NRAS | 12, 13, or 61 | Small bowel | Metastasis | 1 | 78 | 0.010 | 0.006 | 0.000 | 0.038 |
| NRAS | 12, 13, or 61 | Small bowel | Primary | 0 | 128 | 0.004 | 0.002 | 0.000 | 0.018 |
| NRAS | 12, 13, or 61 | Sex cord stromal | Metastasis | 0 | 48 | 0.009 | 0.005 | 0.000 | 0.038 |
| NRAS | 12, 13, or 61 | Sex cord stromal | Primary | 1 | 54 | 0.015 | 0.011 | 0.001 | 0.054 |
| NRAS | 12, 13, or 61 | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | 12, 13, or 61 | Vaginal | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | 12, 13, or 61 | Vaginal | Primary | 0 | 60 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | 12, 13, or 61 | Thymic | Metastasis | 0 | 61 | 0.006 | 0.003 | 0.000 | 0.028 |
| NRAS | 12, 13, or 61 | Thymic | Primary | 1 | 84 | 0.010 | 0.007 | 0.000 | 0.037 |
| NRAS | 12, 13, or 61 | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | 12, 13, or 61 | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | 12, 13, or 61 | SCLC | Metastasis | 1 | 207 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | 12, 13, or 61 | SCLC | Primary | 1 | 183 | 0.006 | 0.005 | 0.001 | 0.017 |
| NRAS | 12, 13, or 61 | Mesothelioma | Metastasis | 0 | 82 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | 12, 13, or 61 | Mesothelioma | Primary | 1 | 408 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | 12, 13, or 61 | Germ cell | Metastasis | 6 | 274 | 0.022 | 0.022 | 0.012 | 0.036 |
| NRAS | 12, 13, or 61 | Germ cell | Not Applicable or Heme | 1 | 81 | 0.021 | 0.021 | 0.007 | 0.037 |
| NRAS | 12, 13, or 61 | Germ cell | Primary | 13 | 517 | 0.023 | 0.023 | 0.014 | 0.036 |
| NRAS | 12, 13, or 61 | Germ cell | Unspecified | 0 | 14 | 0.022 | 0.021 | 0.005 | 0.043 |
| NRAS | 12, 13, or 61 | Nerve sheath | Metastasis | 0 | 16 | 0.015 | 0.011 | 0.000 | 0.056 |
| NRAS | 12, 13, or 61 | Nerve sheath | Not Applicable or Heme | 1 | 17 | 0.029 | 0.017 | 0.002 | 0.129 |
| NRAS | 12, 13, or 61 | Nerve sheath | Primary | 1 | 117 | 0.013 | 0.011 | 0.001 | 0.037 |
| NRAS | 12, 13, or 61 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | 12, 13, or 61 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.033 |
| NRAS | 12, 13, or 61 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | 12, 13, or 61 | Pineal | Primary | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.026 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Metastasis | 2 | 57 | 0.023 | 0.021 | 0.010 | 0.047 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Not Applicable or Heme | 3 | 145 | 0.021 | 0.020 | 0.009 | 0.037 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Primary | 15 | 709 | 0.021 | 0.021 | 0.013 | 0.032 |
| NRAS | 12, 13, or 61 | B cell lymphoma | Unspecified | 0 | 51 | 0.019 | 0.019 | 0.004 | 0.035 |
| NRAS | 12, 13, or 61 | Non-hodgkin lymphoma | Primary | 1 | 14 | 0.080 | 0.061 | 0.003 | 0.259 |
| NRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 3 | 25 | 0.102 | 0.092 | 0.021 | 0.240 |
| NRAS | 12, 13, or 61 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.052 | 0.039 | 0.000 | 0.182 |
| NRAS | 12, 13, or 61 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| NRAS | 12, 13, or 61 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | 12, 13, or 61 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | 12, 13, or 61 | Lung | Primary | 1 | 17 | 0.065 | 0.049 | 0.003 | 0.217 |
| NRAS | 12, 13, or 61 | Parathyroid | Primary | 1 | 13 | 0.086 | 0.066 | 0.004 | 0.280 |
| NRAS | G12 | Appendiceal | Metastasis | 0 | 174 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G12 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.005 | 0.002 | 0.000 | 0.033 |
| NRAS | G12 | Appendiceal | Primary | 1 | 151 | 0.005 | 0.003 | 0.000 | 0.019 |
| NRAS | G12 | CRC | Metastasis | 31 | 2352 | 0.013 | 0.012 | 0.009 | 0.016 |
| NRAS | G12 | CRC | Not Applicable or Heme | 2 | 224 | 0.012 | 0.012 | 0.006 | 0.018 |
| NRAS | G12 | CRC | Primary | 49 | 4113 | 0.012 | 0.012 | 0.009 | 0.015 |
| NRAS | G12 | CRC | Unspecified | 0 | 31 | 0.012 | 0.012 | 0.005 | 0.020 |
| NRAS | G12 | CUP | Metastasis | 3 | 1388 | 0.004 | 0.003 | 0.001 | 0.007 |
| NRAS | G12 | CUP | Not Applicable or Heme | 3 | 229 | 0.008 | 0.006 | 0.002 | 0.023 |
| NRAS | G12 | CUP | Primary | 2 | 311 | 0.006 | 0.005 | 0.002 | 0.014 |
| NRAS | G12 | CUP | Unspecified | 1 | 60 | 0.008 | 0.006 | 0.002 | 0.031 |
| NRAS | G12 | NSCLC | Metastasis | 4 | 3750 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | NSCLC | Not Applicable or Heme | 3 | 223 | 0.007 | 0.004 | 0.001 | 0.023 |
| NRAS | G12 | NSCLC | Primary | 11 | 6059 | 0.002 | 0.002 | 0.001 | 0.003 |
| NRAS | G12 | NSCLC | Unspecified | 0 | 99 | 0.002 | 0.002 | 0.000 | 0.009 |
| NRAS | G12 | Breast | Metastasis | 0 | 3094 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Breast | Not Applicable or Heme | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Breast | Primary | 1 | 6124 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Soft tissue sarcoma | Metastasis | 0 | 939 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Soft tissue sarcoma | Not Applicable or Heme | 0 | 119 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Soft tissue sarcoma | Primary | 3 | 1686 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.002 | 0.001 | 0.000 | 0.010 |
| NRAS | G12 | Pancreatic | Metastasis | 2 | 981 | 0.002 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Pancreatic | Primary | 0 | 1428 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Leukemia | Metastasis | 0 | 15 | 0.063 | 0.064 | 0.026 | 0.096 |
| NRAS | G12 | Leukemia | Not Applicable or Heme | 65 | 923 | 0.068 | 0.068 | 0.055 | 0.084 |
| NRAS | G12 | Leukemia | Primary | 22 | 412 | 0.062 | 0.062 | 0.042 | 0.079 |
| NRAS | G12 | Leukemia | Unspecified | 17 | 217 | 0.069 | 0.068 | 0.050 | 0.098 |
| NRAS | G12 | Melanoma | Metastasis | 21 | 1738 | 0.013 | 0.013 | 0.008 | 0.019 |
| NRAS | G12 | Melanoma | Not Applicable or Heme | 1 | 188 | 0.011 | 0.010 | 0.001 | 0.024 |
| NRAS | G12 | Melanoma | Primary | 26 | 898 | 0.026 | 0.026 | 0.016 | 0.039 |
| NRAS | G12 | Melanoma | Unspecified | 0 | 22 | 0.014 | 0.013 | 0.000 | 0.045 |
| NRAS | G12 | Head and neck | Metastasis | 4 | 731 | 0.004 | 0.004 | 0.001 | 0.010 |
| NRAS | G12 | Head and neck | Not Applicable or Heme | 0 | 67 | 0.003 | 0.002 | 0.000 | 0.011 |
| NRAS | G12 | Head and neck | Primary | 1 | 938 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | G12 | Uterine | Metastasis | 4 | 585 | 0.007 | 0.007 | 0.003 | 0.013 |
| NRAS | G12 | Uterine | Not Applicable or Heme | 0 | 76 | 0.007 | 0.007 | 0.001 | 0.014 |
| NRAS | G12 | Uterine | Primary | 13 | 1541 | 0.008 | 0.008 | 0.004 | 0.012 |
| NRAS | G12 | Uterine | Unspecified | 0 | 51 | 0.007 | 0.007 | 0.001 | 0.015 |
| NRAS | G12 | Non-melanoma skin | Metastasis | 1 | 203 | 0.004 | 0.002 | 0.000 | 0.014 |
| NRAS | G12 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.003 | 0.001 | 0.000 | 0.019 |
| NRAS | G12 | Non-melanoma skin | Primary | 0 | 287 | 0.002 | 0.001 | 0.000 | 0.007 |
| NRAS | G12 | MDS/MPN | Metastasis | 0 | 11 | 0.032 | 0.032 | 0.001 | 0.074 |
| NRAS | G12 | MDS/MPN | Not Applicable or Heme | 28 | 915 | 0.032 | 0.032 | 0.022 | 0.044 |
| NRAS | G12 | MDS/MPN | Primary | 13 | 250 | 0.042 | 0.040 | 0.025 | 0.071 |
| NRAS | G12 | MDS/MPN | Unspecified | 0 | 31 | 0.029 | 0.030 | 0.001 | 0.059 |
| NRAS | G12 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Ovarian | Metastasis | 1 | 1088 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Ovarian | Not Applicable or Heme | 0 | 160 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Ovarian | Primary | 1 | 1060 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Ovarian | Unspecified | 0 | 28 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G12 | Esophagogastric | Metastasis | 0 | 462 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.001 | 0.001 | 0.000 | 0.007 |
| NRAS | G12 | Esophagogastric | Primary | 2 | 1283 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Esophagogastric | Unspecified | 0 | 14 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G12 | Thyroid | Metastasis | 0 | 402 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Thyroid | Primary | 0 | 582 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Cervical | Metastasis | 0 | 136 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Cervical | Not Applicable or Heme | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Cervical | Primary | 0 | 211 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Hepatobiliary | Metastasis | 2 | 438 | 0.006 | 0.006 | 0.002 | 0.012 |
| NRAS | G12 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.007 | 0.006 | 0.001 | 0.018 |
| NRAS | G12 | Hepatobiliary | Primary | 7 | 894 | 0.007 | 0.007 | 0.003 | 0.013 |
| NRAS | G12 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | CNS | Metastasis | 0 | 409 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12 | CNS | Not Applicable or Heme | 1 | 526 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | CNS | Primary | 4 | 3522 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G12 | CNS | Unspecified | 0 | 108 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | Prostate | Metastasis | 0 | 901 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | Not Applicable or Heme | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | Primary | 0 | 1468 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Prostate | Unspecified | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Neuroendocrine | Metastasis | 1 | 143 | 0.005 | 0.003 | 0.000 | 0.017 |
| NRAS | G12 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.004 | 0.002 | 0.000 | 0.023 |
| NRAS | G12 | Neuroendocrine | Primary | 0 | 196 | 0.003 | 0.002 | 0.000 | 0.011 |
| NRAS | G12 | Bladder | Metastasis | 0 | 389 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Bladder | Not Applicable or Heme | 0 | 25 | 0.002 | 0.001 | 0.000 | 0.012 |
| NRAS | G12 | Bladder | Primary | 2 | 1164 | 0.002 | 0.001 | 0.000 | 0.004 |
| NRAS | G12 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.039 | 0.032 | 0.000 | 0.120 |
| NRAS | G12 | BLL/Lymphoma | Not Applicable or Heme | 13 | 109 | 0.104 | 0.101 | 0.051 | 0.171 |
| NRAS | G12 | BLL/Lymphoma | Primary | 2 | 101 | 0.031 | 0.027 | 0.005 | 0.075 |
| NRAS | G12 | BLL/Lymphoma | Unspecified | 1 | 25 | 0.048 | 0.043 | 0.005 | 0.127 |
| NRAS | G12 | Small bowel | Metastasis | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Small bowel | Primary | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Sex cord stromal | Metastasis | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G12 | Sex cord stromal | Primary | 0 | 54 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12 | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12 | Vaginal | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G12 | Vaginal | Primary | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12 | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12 | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12 | SCLC | Metastasis | 0 | 207 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | SCLC | Primary | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12 | Germ cell | Metastasis | 1 | 274 | 0.007 | 0.006 | 0.001 | 0.015 |
| NRAS | G12 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.007 | 0.006 | 0.000 | 0.017 |
| NRAS | G12 | Germ cell | Primary | 6 | 517 | 0.009 | 0.009 | 0.004 | 0.019 |
| NRAS | G12 | Germ cell | Unspecified | 0 | 14 | 0.008 | 0.007 | 0.000 | 0.026 |
| NRAS | G12 | Nerve sheath | Metastasis | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12 | Nerve sheath | Primary | 0 | 117 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.035 |
| NRAS | G12 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | G12 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | G12 | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.045 |
| NRAS | G12 | B cell lymphoma | Metastasis | 2 | 57 | 0.016 | 0.009 | 0.002 | 0.066 |
| NRAS | G12 | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.004 | 0.004 | 0.000 | 0.013 |
| NRAS | G12 | B cell lymphoma | Primary | 3 | 709 | 0.005 | 0.004 | 0.001 | 0.011 |
| NRAS | G12 | B cell lymphoma | Unspecified | 0 | 51 | 0.005 | 0.004 | 0.000 | 0.018 |
| NRAS | G12 | Non-hodgkin lymphoma | Primary | 1 | 14 | 0.080 | 0.060 | 0.004 | 0.262 |
| NRAS | G12 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 2 | 25 | 0.068 | 0.058 | 0.009 | 0.185 |
| NRAS | G12 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.040 | 0.029 | 0.000 | 0.150 |
| NRAS | G12 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| NRAS | G12 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.014 |
| NRAS | G12 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G12 | Parathyroid | Primary | 0 | 13 | 0.004 | 0.000 | 0.000 | 0.044 |
| NRAS | G12C | Appendiceal | Metastasis | 0 | 174 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G12C | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.005 | 0.002 | 0.000 | 0.033 |
| NRAS | G12C | Appendiceal | Primary | 1 | 151 | 0.005 | 0.003 | 0.000 | 0.019 |
| NRAS | G12C | CRC | Metastasis | 4 | 2352 | 0.002 | 0.002 | 0.001 | 0.004 |
| NRAS | G12C | CRC | Not Applicable or Heme | 0 | 224 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | G12C | CRC | Primary | 12 | 4113 | 0.003 | 0.003 | 0.001 | 0.004 |
| NRAS | G12C | CRC | Unspecified | 0 | 31 | 0.003 | 0.002 | 0.000 | 0.007 |
| NRAS | G12C | CUP | Metastasis | 0 | 1388 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | CUP | Not Applicable or Heme | 1 | 229 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | G12C | CUP | Primary | 1 | 311 | 0.002 | 0.001 | 0.000 | 0.008 |
| NRAS | G12C | CUP | Unspecified | 0 | 60 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | G12C | NSCLC | Metastasis | 1 | 3750 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | Not Applicable or Heme | 1 | 223 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12C | NSCLC | Primary | 1 | 6059 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | NSCLC | Unspecified | 0 | 99 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Breast | Metastasis | 0 | 3094 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | Not Applicable or Heme | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Breast | Primary | 0 | 6124 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Metastasis | 0 | 939 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Not Applicable or Heme | 0 | 119 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Primary | 0 | 1686 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Pancreatic | Metastasis | 1 | 981 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Pancreatic | Primary | 0 | 1428 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Leukemia | Metastasis | 0 | 15 | 0.006 | 0.005 | 0.000 | 0.016 |
| NRAS | G12C | Leukemia | Not Applicable or Heme | 5 | 923 | 0.005 | 0.005 | 0.002 | 0.010 |
| NRAS | G12C | Leukemia | Primary | 2 | 412 | 0.005 | 0.005 | 0.002 | 0.011 |
| NRAS | G12C | Leukemia | Unspecified | 1 | 217 | 0.005 | 0.005 | 0.001 | 0.011 |
| NRAS | G12C | Melanoma | Metastasis | 5 | 1738 | 0.004 | 0.003 | 0.001 | 0.007 |
| NRAS | G12C | Melanoma | Not Applicable or Heme | 0 | 188 | 0.004 | 0.003 | 0.000 | 0.009 |
| NRAS | G12C | Melanoma | Primary | 7 | 898 | 0.006 | 0.005 | 0.002 | 0.012 |
| NRAS | G12C | Melanoma | Unspecified | 0 | 22 | 0.005 | 0.004 | 0.000 | 0.019 |
| NRAS | G12C | Head and neck | Metastasis | 1 | 731 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Head and neck | Not Applicable or Heme | 0 | 67 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Head and neck | Primary | 0 | 938 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Uterine | Metastasis | 1 | 585 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | G12C | Uterine | Not Applicable or Heme | 0 | 76 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | G12C | Uterine | Primary | 4 | 1541 | 0.002 | 0.002 | 0.001 | 0.005 |
| NRAS | G12C | Uterine | Unspecified | 0 | 51 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | G12C | Non-melanoma skin | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Non-melanoma skin | Primary | 0 | 287 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | MDS/MPN | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.022 |
| NRAS | G12C | MDS/MPN | Not Applicable or Heme | 0 | 915 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | MDS/MPN | Primary | 1 | 250 | 0.003 | 0.001 | 0.000 | 0.011 |
| NRAS | G12C | MDS/MPN | Unspecified | 0 | 31 | 0.002 | 0.000 | 0.000 | 0.012 |
| NRAS | G12C | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Ovarian | Metastasis | 0 | 1088 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | Not Applicable or Heme | 0 | 160 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | Primary | 0 | 1060 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Ovarian | Unspecified | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Metastasis | 0 | 462 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Primary | 0 | 1283 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Esophagogastric | Unspecified | 0 | 14 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | Metastasis | 0 | 402 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | Not Applicable or Heme | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Thyroid | Primary | 0 | 582 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Cervical | Metastasis | 0 | 136 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Cervical | Not Applicable or Heme | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Cervical | Primary | 0 | 211 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Hepatobiliary | Metastasis | 0 | 438 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.002 | 0.001 | 0.000 | 0.010 |
| NRAS | G12C | Hepatobiliary | Primary | 2 | 894 | 0.002 | 0.002 | 0.000 | 0.005 |
| NRAS | G12C | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | CNS | Metastasis | 0 | 409 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | CNS | Not Applicable or Heme | 0 | 526 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | CNS | Primary | 2 | 3522 | 0.001 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | CNS | Unspecified | 0 | 108 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Prostate | Metastasis | 0 | 901 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | Not Applicable or Heme | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | Primary | 0 | 1468 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Prostate | Unspecified | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Neuroendocrine | Metastasis | 0 | 143 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Neuroendocrine | Primary | 0 | 196 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Bladder | Metastasis | 0 | 389 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Bladder | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.012 |
| NRAS | G12C | Bladder | Primary | 1 | 1164 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G12C | BLL/Lymphoma | Metastasis | 0 | 13 | 0.006 | 0.003 | 0.000 | 0.026 |
| NRAS | G12C | BLL/Lymphoma | Not Applicable or Heme | 1 | 109 | 0.006 | 0.004 | 0.000 | 0.022 |
| NRAS | G12C | BLL/Lymphoma | Primary | 0 | 101 | 0.004 | 0.003 | 0.000 | 0.016 |
| NRAS | G12C | BLL/Lymphoma | Unspecified | 0 | 25 | 0.005 | 0.003 | 0.000 | 0.023 |
| NRAS | G12C | Small bowel | Metastasis | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Small bowel | Primary | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Sex cord stromal | Metastasis | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G12C | Sex cord stromal | Primary | 0 | 54 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12C | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | Vaginal | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | G12C | Vaginal | Primary | 0 | 60 | 0.000 | 0.000 | 0.000 | 0.006 |
| NRAS | G12C | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | G12C | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G12C | SCLC | Metastasis | 0 | 207 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | SCLC | Primary | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G12C | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Germ cell | Metastasis | 1 | 274 | 0.002 | 0.001 | 0.000 | 0.009 |
| NRAS | G12C | Germ cell | Not Applicable or Heme | 0 | 81 | 0.002 | 0.001 | 0.000 | 0.007 |
| NRAS | G12C | Germ cell | Primary | 0 | 517 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G12C | Germ cell | Unspecified | 0 | 14 | 0.002 | 0.001 | 0.000 | 0.015 |
| NRAS | G12C | Nerve sheath | Metastasis | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G12C | Nerve sheath | Primary | 0 | 117 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G12C | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.035 |
| NRAS | G12C | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | G12C | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | G12C | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.045 |
| NRAS | G12C | B cell lymphoma | Metastasis | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | B cell lymphoma | Not Applicable or Heme | 0 | 145 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | B cell lymphoma | Primary | 0 | 709 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G12C | B cell lymphoma | Unspecified | 0 | 51 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G12C | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12C | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.024 |
| NRAS | G12C | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.029 |
| NRAS | G12C | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| NRAS | G12C | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.014 |
| NRAS | G12C | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G12C | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G12C | Parathyroid | Primary | 0 | 13 | 0.004 | 0.000 | 0.000 | 0.044 |
| NRAS | G13 | Appendiceal | Metastasis | 1 | 174 | 0.004 | 0.003 | 0.000 | 0.016 |
| NRAS | G13 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.006 | 0.002 | 0.000 | 0.033 |
| NRAS | G13 | Appendiceal | Primary | 0 | 151 | 0.003 | 0.002 | 0.000 | 0.012 |
| NRAS | G13 | CRC | Metastasis | 16 | 2352 | 0.006 | 0.006 | 0.004 | 0.009 |
| NRAS | G13 | CRC | Not Applicable or Heme | 1 | 224 | 0.005 | 0.005 | 0.002 | 0.011 |
| NRAS | G13 | CRC | Primary | 17 | 4113 | 0.005 | 0.005 | 0.003 | 0.007 |
| NRAS | G13 | CRC | Unspecified | 0 | 31 | 0.005 | 0.005 | 0.001 | 0.012 |
| NRAS | G13 | CUP | Metastasis | 4 | 1388 | 0.003 | 0.003 | 0.001 | 0.006 |
| NRAS | G13 | CUP | Not Applicable or Heme | 1 | 229 | 0.003 | 0.003 | 0.001 | 0.009 |
| NRAS | G13 | CUP | Primary | 0 | 311 | 0.002 | 0.002 | 0.000 | 0.006 |
| NRAS | G13 | CUP | Unspecified | 0 | 60 | 0.003 | 0.002 | 0.000 | 0.008 |
| NRAS | G13 | NSCLC | Metastasis | 1 | 3750 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | NSCLC | Not Applicable or Heme | 0 | 223 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | NSCLC | Primary | 3 | 6059 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | NSCLC | Unspecified | 0 | 99 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Breast | Metastasis | 1 | 3094 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Breast | Not Applicable or Heme | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Breast | Primary | 0 | 6124 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Soft tissue sarcoma | Metastasis | 1 | 939 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Soft tissue sarcoma | Not Applicable or Heme | 0 | 119 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Soft tissue sarcoma | Primary | 2 | 1686 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.002 | 0.001 | 0.000 | 0.006 |
| NRAS | G13 | Pancreatic | Metastasis | 1 | 981 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Pancreatic | Primary | 1 | 1428 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Leukemia | Metastasis | 2 | 15 | 0.037 | 0.030 | 0.019 | 0.109 |
| NRAS | G13 | Leukemia | Not Applicable or Heme | 25 | 923 | 0.028 | 0.028 | 0.020 | 0.038 |
| NRAS | G13 | Leukemia | Primary | 10 | 412 | 0.028 | 0.027 | 0.017 | 0.040 |
| NRAS | G13 | Leukemia | Unspecified | 7 | 217 | 0.030 | 0.029 | 0.018 | 0.047 |
| NRAS | G13 | Melanoma | Metastasis | 25 | 1738 | 0.014 | 0.014 | 0.010 | 0.019 |
| NRAS | G13 | Melanoma | Not Applicable or Heme | 2 | 188 | 0.013 | 0.013 | 0.006 | 0.022 |
| NRAS | G13 | Melanoma | Primary | 12 | 898 | 0.014 | 0.013 | 0.009 | 0.020 |
| NRAS | G13 | Melanoma | Unspecified | 0 | 22 | 0.014 | 0.013 | 0.005 | 0.024 |
| NRAS | G13 | Head and neck | Metastasis | 0 | 731 | 0.001 | 0.001 | 0.000 | 0.003 |
| NRAS | G13 | Head and neck | Not Applicable or Heme | 0 | 67 | 0.001 | 0.001 | 0.000 | 0.007 |
| NRAS | G13 | Head and neck | Primary | 2 | 938 | 0.002 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Uterine | Metastasis | 0 | 585 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Uterine | Not Applicable or Heme | 0 | 76 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Uterine | Primary | 1 | 1541 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Uterine | Unspecified | 0 | 51 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Non-melanoma skin | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Non-melanoma skin | Primary | 0 | 287 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | MDS/MPN | Metastasis | 0 | 11 | 0.018 | 0.016 | 0.001 | 0.056 |
| NRAS | G13 | MDS/MPN | Not Applicable or Heme | 12 | 915 | 0.015 | 0.015 | 0.008 | 0.023 |
| NRAS | G13 | MDS/MPN | Primary | 8 | 250 | 0.024 | 0.022 | 0.011 | 0.047 |
| NRAS | G13 | MDS/MPN | Unspecified | 0 | 31 | 0.016 | 0.015 | 0.000 | 0.040 |
| NRAS | G13 | Adrenocortical | Metastasis | 1 | 55 | 0.014 | 0.009 | 0.001 | 0.052 |
| NRAS | G13 | Adrenocortical | Primary | 0 | 72 | 0.006 | 0.003 | 0.000 | 0.028 |
| NRAS | G13 | Ovarian | Metastasis | 0 | 1088 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | Not Applicable or Heme | 0 | 160 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | Primary | 0 | 1060 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Ovarian | Unspecified | 0 | 28 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Esophagogastric | Metastasis | 0 | 462 | 0.001 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.001 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Esophagogastric | Primary | 1 | 1283 | 0.001 | 0.001 | 0.000 | 0.002 |
| NRAS | G13 | Esophagogastric | Unspecified | 0 | 14 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G13 | Thyroid | Metastasis | 2 | 402 | 0.004 | 0.003 | 0.000 | 0.012 |
| NRAS | G13 | Thyroid | Not Applicable or Heme | 0 | 28 | 0.003 | 0.001 | 0.000 | 0.017 |
| NRAS | G13 | Thyroid | Primary | 0 | 582 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | Cervical | Metastasis | 0 | 136 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Cervical | Not Applicable or Heme | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Cervical | Primary | 0 | 211 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Hepatobiliary | Metastasis | 2 | 438 | 0.004 | 0.003 | 0.001 | 0.009 |
| NRAS | G13 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.004 | 0.003 | 0.000 | 0.013 |
| NRAS | G13 | Hepatobiliary | Primary | 2 | 894 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | G13 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | T / NK neoplasms | Metastasis | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | T / NK neoplasms | Primary | 0 | 187 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | CNS | Metastasis | 0 | 409 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | CNS | Not Applicable or Heme | 1 | 526 | 0.001 | 0.001 | 0.000 | 0.005 |
| NRAS | G13 | CNS | Primary | 0 | 3522 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | CNS | Unspecified | 0 | 108 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Prostate | Metastasis | 0 | 901 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | Not Applicable or Heme | 0 | 57 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | Primary | 0 | 1468 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Prostate | Unspecified | 0 | 12 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | G13 | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.005 |
| NRAS | G13 | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | Neuroendocrine | Metastasis | 0 | 143 | 0.003 | 0.002 | 0.000 | 0.012 |
| NRAS | G13 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.004 | 0.002 | 0.000 | 0.020 |
| NRAS | G13 | Neuroendocrine | Primary | 1 | 196 | 0.004 | 0.003 | 0.000 | 0.014 |
| NRAS | G13 | Bladder | Metastasis | 0 | 389 | 0.001 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | Bladder | Not Applicable or Heme | 0 | 25 | 0.002 | 0.001 | 0.000 | 0.013 |
| NRAS | G13 | Bladder | Primary | 2 | 1164 | 0.002 | 0.001 | 0.000 | 0.004 |
| NRAS | G13 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.032 | 0.030 | 0.003 | 0.077 |
| NRAS | G13 | BLL/Lymphoma | Not Applicable or Heme | 4 | 109 | 0.034 | 0.032 | 0.014 | 0.067 |
| NRAS | G13 | BLL/Lymphoma | Primary | 2 | 101 | 0.030 | 0.029 | 0.008 | 0.059 |
| NRAS | G13 | BLL/Lymphoma | Unspecified | 2 | 25 | 0.042 | 0.035 | 0.013 | 0.120 |
| NRAS | G13 | Small bowel | Metastasis | 0 | 78 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Small bowel | Primary | 0 | 128 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Sex cord stromal | Metastasis | 0 | 48 | 0.009 | 0.005 | 0.000 | 0.037 |
| NRAS | G13 | Sex cord stromal | Primary | 1 | 54 | 0.015 | 0.010 | 0.001 | 0.053 |
| NRAS | G13 | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Vaginal | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.013 |
| NRAS | G13 | Vaginal | Primary | 0 | 60 | 0.001 | 0.000 | 0.000 | 0.009 |
| NRAS | G13 | Thymic | Metastasis | 0 | 61 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Thymic | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.006 |
| NRAS | G13 | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | G13 | SCLC | Metastasis | 0 | 207 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | SCLC | Primary | 0 | 183 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | Metastasis | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Mesothelioma | Primary | 0 | 408 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | G13 | Germ cell | Metastasis | 0 | 274 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | G13 | Germ cell | Not Applicable or Heme | 1 | 81 | 0.006 | 0.004 | 0.001 | 0.023 |
| NRAS | G13 | Germ cell | Primary | 2 | 517 | 0.004 | 0.003 | 0.001 | 0.009 |
| NRAS | G13 | Germ cell | Unspecified | 0 | 14 | 0.005 | 0.003 | 0.000 | 0.020 |
| NRAS | G13 | Nerve sheath | Metastasis | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Nerve sheath | Not Applicable or Heme | 0 | 17 | 0.000 | 0.000 | 0.000 | 0.003 |
| NRAS | G13 | Nerve sheath | Primary | 0 | 117 | 0.000 | 0.000 | 0.000 | 0.002 |
| NRAS | G13 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.036 |
| NRAS | G13 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.033 |
| NRAS | G13 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G13 | Pineal | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.046 |
| NRAS | G13 | B cell lymphoma | Metastasis | 0 | 57 | 0.004 | 0.004 | 0.000 | 0.012 |
| NRAS | G13 | B cell lymphoma | Not Applicable or Heme | 1 | 145 | 0.005 | 0.004 | 0.001 | 0.014 |
| NRAS | G13 | B cell lymphoma | Primary | 3 | 709 | 0.004 | 0.004 | 0.001 | 0.010 |
| NRAS | G13 | B cell lymphoma | Unspecified | 0 | 51 | 0.004 | 0.004 | 0.000 | 0.013 |
| NRAS | G13 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | G13 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 1 | 25 | 0.036 | 0.026 | 0.001 | 0.123 |
| NRAS | G13 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.027 | 0.015 | 0.000 | 0.116 |
| NRAS | G13 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.001 | 0.000 | 0.000 | 0.012 |
| NRAS | G13 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.009 |
| NRAS | G13 | Hodgkin lymphoma | Primary | 0 | 35 | 0.002 | 0.000 | 0.000 | 0.019 |
| NRAS | G13 | Lung | Primary | 0 | 17 | 0.003 | 0.000 | 0.000 | 0.039 |
| NRAS | G13 | Parathyroid | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.035 |
| NRAS | Q61 | Appendiceal | Metastasis | 3 | 174 | 0.016 | 0.015 | 0.005 | 0.035 |
| NRAS | Q61 | Appendiceal | Not Applicable or Heme | 0 | 10 | 0.016 | 0.013 | 0.000 | 0.049 |
| NRAS | Q61 | Appendiceal | Primary | 2 | 151 | 0.015 | 0.014 | 0.004 | 0.033 |
| NRAS | Q61 | CRC | Metastasis | 53 | 2352 | 0.023 | 0.022 | 0.018 | 0.028 |
| NRAS | Q61 | CRC | Not Applicable or Heme | 6 | 224 | 0.024 | 0.023 | 0.016 | 0.037 |
| NRAS | Q61 | CRC | Primary | 89 | 4113 | 0.022 | 0.022 | 0.018 | 0.026 |
| NRAS | Q61 | CRC | Unspecified | 2 | 31 | 0.026 | 0.023 | 0.016 | 0.057 |
| NRAS | Q61 | CUP | Metastasis | 12 | 1388 | 0.009 | 0.009 | 0.005 | 0.014 |
| NRAS | Q61 | CUP | Not Applicable or Heme | 1 | 229 | 0.009 | 0.009 | 0.003 | 0.017 |
| NRAS | Q61 | CUP | Primary | 4 | 311 | 0.011 | 0.010 | 0.005 | 0.021 |
| NRAS | Q61 | CUP | Unspecified | 2 | 60 | 0.013 | 0.011 | 0.005 | 0.041 |
| NRAS | Q61 | NSCLC | Metastasis | 21 | 3750 | 0.006 | 0.006 | 0.004 | 0.008 |
| NRAS | Q61 | NSCLC | Not Applicable or Heme | 1 | 223 | 0.006 | 0.006 | 0.003 | 0.010 |
| NRAS | Q61 | NSCLC | Primary | 36 | 6059 | 0.006 | 0.006 | 0.004 | 0.008 |
| NRAS | Q61 | NSCLC | Unspecified | 1 | 99 | 0.006 | 0.006 | 0.003 | 0.012 |
| NRAS | Q61 | Breast | Metastasis | 0 | 3094 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | Not Applicable or Heme | 0 | 105 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Breast | Primary | 0 | 6124 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Soft tissue sarcoma | Metastasis | 7 | 939 | 0.009 | 0.009 | 0.005 | 0.014 |
| NRAS | Q61 | Soft tissue sarcoma | Not Applicable or Heme | 1 | 119 | 0.010 | 0.010 | 0.003 | 0.019 |
| NRAS | Q61 | Soft tissue sarcoma | Primary | 20 | 1686 | 0.011 | 0.011 | 0.007 | 0.016 |
| NRAS | Q61 | Soft tissue sarcoma | Unspecified | 0 | 29 | 0.010 | 0.010 | 0.002 | 0.020 |
| NRAS | Q61 | Pancreatic | Metastasis | 3 | 981 | 0.004 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Pancreatic | Not Applicable or Heme | 0 | 75 | 0.004 | 0.003 | 0.000 | 0.010 |
| NRAS | Q61 | Pancreatic | Primary | 6 | 1428 | 0.004 | 0.004 | 0.002 | 0.007 |
| NRAS | Q61 | Leukemia | Metastasis | 1 | 15 | 0.031 | 0.028 | 0.016 | 0.066 |
| NRAS | Q61 | Leukemia | Not Applicable or Heme | 22 | 923 | 0.026 | 0.026 | 0.018 | 0.036 |
| NRAS | Q61 | Leukemia | Primary | 12 | 412 | 0.028 | 0.028 | 0.019 | 0.041 |
| NRAS | Q61 | Leukemia | Unspecified | 8 | 217 | 0.030 | 0.029 | 0.019 | 0.050 |
| NRAS | Q61 | Melanoma | Metastasis | 376 | 1738 | 0.214 | 0.213 | 0.194 | 0.234 |
| NRAS | Q61 | Melanoma | Not Applicable or Heme | 35 | 188 | 0.185 | 0.185 | 0.138 | 0.234 |
| NRAS | Q61 | Melanoma | Primary | 153 | 898 | 0.173 | 0.173 | 0.148 | 0.199 |
| NRAS | Q61 | Melanoma | Unspecified | 0 | 22 | 0.123 | 0.137 | 0.002 | 0.218 |
| NRAS | Q61 | Head and neck | Metastasis | 0 | 731 | 0.001 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Head and neck | Not Applicable or Heme | 0 | 67 | 0.002 | 0.000 | 0.000 | 0.009 |
| NRAS | Q61 | Head and neck | Primary | 4 | 938 | 0.004 | 0.003 | 0.001 | 0.009 |
| NRAS | Q61 | Uterine | Metastasis | 6 | 585 | 0.011 | 0.011 | 0.006 | 0.017 |
| NRAS | Q61 | Uterine | Not Applicable or Heme | 0 | 76 | 0.010 | 0.010 | 0.002 | 0.019 |
| NRAS | Q61 | Uterine | Primary | 18 | 1541 | 0.011 | 0.011 | 0.007 | 0.016 |
| NRAS | Q61 | Uterine | Unspecified | 1 | 51 | 0.012 | 0.011 | 0.005 | 0.027 |
| NRAS | Q61 | Non-melanoma skin | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Non-melanoma skin | Not Applicable or Heme | 0 | 22 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | Non-melanoma skin | Primary | 0 | 287 | 0.000 | 0.000 | 0.000 | 0.001 |
| NRAS | Q61 | MDS/MPN | Metastasis | 0 | 11 | 0.010 | 0.003 | 0.000 | 0.069 |
| NRAS | Q61 | MDS/MPN | Not Applicable or Heme | 1 | 915 | 0.002 | 0.002 | 0.000 | 0.006 |
| NRAS | Q61 | MDS/MPN | Primary | 1 | 250 | 0.005 | 0.004 | 0.000 | 0.014 |
| NRAS | Q61 | MDS/MPN | Unspecified | 2 | 31 | 0.039 | 0.027 | 0.002 | 0.136 |
| NRAS | Q61 | Adrenocortical | Metastasis | 0 | 55 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Adrenocortical | Primary | 0 | 72 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Ovarian | Metastasis | 14 | 1088 | 0.013 | 0.013 | 0.008 | 0.019 |
| NRAS | Q61 | Ovarian | Not Applicable or Heme | 3 | 160 | 0.014 | 0.013 | 0.008 | 0.025 |
| NRAS | Q61 | Ovarian | Primary | 14 | 1060 | 0.013 | 0.013 | 0.009 | 0.019 |
| NRAS | Q61 | Ovarian | Unspecified | 0 | 28 | 0.013 | 0.013 | 0.005 | 0.024 |
| NRAS | Q61 | Esophagogastric | Metastasis | 2 | 462 | 0.004 | 0.003 | 0.001 | 0.008 |
| NRAS | Q61 | Esophagogastric | Not Applicable or Heme | 0 | 43 | 0.004 | 0.003 | 0.000 | 0.011 |
| NRAS | Q61 | Esophagogastric | Primary | 4 | 1283 | 0.003 | 0.003 | 0.001 | 0.007 |
| NRAS | Q61 | Esophagogastric | Unspecified | 0 | 14 | 0.004 | 0.003 | 0.000 | 0.014 |
| NRAS | Q61 | Thyroid | Metastasis | 41 | 402 | 0.107 | 0.108 | 0.079 | 0.136 |
| NRAS | Q61 | Thyroid | Not Applicable or Heme | 1 | 28 | 0.096 | 0.103 | 0.017 | 0.154 |
| NRAS | Q61 | Thyroid | Primary | 80 | 582 | 0.131 | 0.130 | 0.105 | 0.160 |
| NRAS | Q61 | Cervical | Metastasis | 1 | 136 | 0.007 | 0.005 | 0.001 | 0.020 |
| NRAS | Q61 | Cervical | Not Applicable or Heme | 0 | 12 | 0.008 | 0.005 | 0.000 | 0.029 |
| NRAS | Q61 | Cervical | Primary | 1 | 211 | 0.006 | 0.005 | 0.001 | 0.017 |
| NRAS | Q61 | Hepatobiliary | Metastasis | 5 | 438 | 0.012 | 0.011 | 0.006 | 0.020 |
| NRAS | Q61 | Hepatobiliary | Not Applicable or Heme | 0 | 34 | 0.011 | 0.011 | 0.001 | 0.025 |
| NRAS | Q61 | Hepatobiliary | Primary | 11 | 894 | 0.012 | 0.012 | 0.007 | 0.019 |
| NRAS | Q61 | Kidney | Metastasis | 0 | 445 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | Not Applicable or Heme | 0 | 24 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Kidney | Primary | 0 | 944 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | T / NK neoplasms | Metastasis | 0 | 10 | 0.010 | 0.006 | 0.000 | 0.048 |
| NRAS | Q61 | T / NK neoplasms | Not Applicable or Heme | 0 | 29 | 0.008 | 0.006 | 0.000 | 0.033 |
| NRAS | Q61 | T / NK neoplasms | Primary | 2 | 187 | 0.010 | 0.009 | 0.001 | 0.028 |
| NRAS | Q61 | CNS | Metastasis | 4 | 409 | 0.006 | 0.005 | 0.003 | 0.014 |
| NRAS | Q61 | CNS | Not Applicable or Heme | 1 | 526 | 0.004 | 0.004 | 0.001 | 0.008 |
| NRAS | Q61 | CNS | Primary | 14 | 3522 | 0.004 | 0.004 | 0.003 | 0.006 |
| NRAS | Q61 | CNS | Unspecified | 1 | 108 | 0.005 | 0.005 | 0.002 | 0.015 |
| NRAS | Q61 | Prostate | Metastasis | 1 | 901 | 0.002 | 0.001 | 0.000 | 0.004 |
| NRAS | Q61 | Prostate | Not Applicable or Heme | 0 | 57 | 0.002 | 0.002 | 0.000 | 0.007 |
| NRAS | Q61 | Prostate | Primary | 3 | 1468 | 0.002 | 0.002 | 0.000 | 0.004 |
| NRAS | Q61 | Prostate | Unspecified | 0 | 12 | 0.003 | 0.002 | 0.000 | 0.011 |
| NRAS | Q61 | Anal | Metastasis | 0 | 59 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Anal | Primary | 0 | 84 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | Neuroendocrine | Metastasis | 0 | 143 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | Q61 | Neuroendocrine | Not Applicable or Heme | 0 | 20 | 0.004 | 0.002 | 0.000 | 0.021 |
| NRAS | Q61 | Neuroendocrine | Primary | 1 | 196 | 0.004 | 0.003 | 0.000 | 0.015 |
| NRAS | Q61 | Bladder | Metastasis | 2 | 389 | 0.004 | 0.004 | 0.001 | 0.010 |
| NRAS | Q61 | Bladder | Not Applicable or Heme | 0 | 25 | 0.005 | 0.004 | 0.000 | 0.015 |
| NRAS | Q61 | Bladder | Primary | 4 | 1164 | 0.004 | 0.004 | 0.001 | 0.008 |
| NRAS | Q61 | BLL/Lymphoma | Metastasis | 0 | 13 | 0.024 | 0.021 | 0.000 | 0.068 |
| NRAS | Q61 | BLL/Lymphoma | Not Applicable or Heme | 3 | 109 | 0.026 | 0.024 | 0.008 | 0.054 |
| NRAS | Q61 | BLL/Lymphoma | Primary | 1 | 101 | 0.021 | 0.020 | 0.003 | 0.046 |
| NRAS | Q61 | BLL/Lymphoma | Unspecified | 2 | 25 | 0.037 | 0.028 | 0.009 | 0.125 |
| NRAS | Q61 | Small bowel | Metastasis | 1 | 78 | 0.010 | 0.006 | 0.000 | 0.038 |
| NRAS | Q61 | Small bowel | Primary | 0 | 128 | 0.004 | 0.002 | 0.000 | 0.018 |
| NRAS | Q61 | Sex cord stromal | Metastasis | 0 | 48 | 0.001 | 0.000 | 0.000 | 0.008 |
| NRAS | Q61 | Sex cord stromal | Primary | 0 | 54 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | Q61 | Bone | Metastasis | 0 | 203 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Bone | Not Applicable or Heme | 0 | 25 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Bone | Primary | 0 | 326 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Bone | Unspecified | 0 | 16 | 0.000 | 0.000 | 0.000 | 0.000 |
| NRAS | Q61 | Vaginal | Metastasis | 0 | 16 | 0.001 | 0.000 | 0.000 | 0.010 |
| NRAS | Q61 | Vaginal | Primary | 0 | 60 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | Q61 | Thymic | Metastasis | 0 | 61 | 0.006 | 0.003 | 0.000 | 0.028 |
| NRAS | Q61 | Thymic | Primary | 1 | 84 | 0.010 | 0.007 | 0.000 | 0.037 |
| NRAS | Q61 | Ampullary | Metastasis | 0 | 23 | 0.001 | 0.000 | 0.000 | 0.007 |
| NRAS | Q61 | Ampullary | Primary | 0 | 82 | 0.000 | 0.000 | 0.000 | 0.004 |
| NRAS | Q61 | SCLC | Metastasis | 1 | 207 | 0.006 | 0.005 | 0.001 | 0.016 |
| NRAS | Q61 | SCLC | Primary | 1 | 183 | 0.006 | 0.005 | 0.001 | 0.017 |
| NRAS | Q61 | Mesothelioma | Metastasis | 0 | 82 | 0.002 | 0.001 | 0.000 | 0.011 |
| NRAS | Q61 | Mesothelioma | Primary | 1 | 408 | 0.003 | 0.002 | 0.000 | 0.009 |
| NRAS | Q61 | Germ cell | Metastasis | 6 | 274 | 0.016 | 0.015 | 0.007 | 0.033 |
| NRAS | Q61 | Germ cell | Not Applicable or Heme | 0 | 81 | 0.010 | 0.010 | 0.000 | 0.024 |
| NRAS | Q61 | Germ cell | Primary | 5 | 517 | 0.011 | 0.011 | 0.004 | 0.020 |
| NRAS | Q61 | Germ cell | Unspecified | 0 | 14 | 0.013 | 0.011 | 0.000 | 0.037 |
| NRAS | Q61 | Nerve sheath | Metastasis | 0 | 16 | 0.015 | 0.011 | 0.000 | 0.056 |
| NRAS | Q61 | Nerve sheath | Not Applicable or Heme | 1 | 17 | 0.029 | 0.017 | 0.002 | 0.129 |
| NRAS | Q61 | Nerve sheath | Primary | 1 | 117 | 0.013 | 0.011 | 0.001 | 0.037 |
| NRAS | Q61 | Penile | Metastasis | 0 | 11 | 0.003 | 0.000 | 0.000 | 0.034 |
| NRAS | Q61 | Penile | Primary | 0 | 13 | 0.003 | 0.000 | 0.000 | 0.033 |
| NRAS | Q61 | Pheochromocytoma | Primary | 0 | 18 | 0.003 | 0.000 | 0.000 | 0.032 |
| NRAS | Q61 | Pineal | Primary | 0 | 14 | 0.002 | 0.000 | 0.000 | 0.026 |
| NRAS | Q61 | B cell lymphoma | Metastasis | 0 | 57 | 0.011 | 0.011 | 0.000 | 0.024 |
| NRAS | Q61 | B cell lymphoma | Not Applicable or Heme | 2 | 145 | 0.013 | 0.012 | 0.004 | 0.026 |
| NRAS | Q61 | B cell lymphoma | Primary | 10 | 709 | 0.013 | 0.013 | 0.007 | 0.021 |
| NRAS | Q61 | B cell lymphoma | Unspecified | 0 | 51 | 0.011 | 0.011 | 0.000 | 0.024 |
| NRAS | Q61 | Non-hodgkin lymphoma | Primary | 0 | 14 | 0.004 | 0.000 | 0.000 | 0.049 |
| NRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Not Applicable or Heme | 0 | 25 | 0.002 | 0.000 | 0.000 | 0.020 |
| NRAS | Q61 | T-lymphoblastic leukemia/lymphoma | Primary | 0 | 11 | 0.002 | 0.000 | 0.000 | 0.026 |
| NRAS | Q61 | Retinoblastoma | Not Applicable or Heme | 0 | 10 | 0.002 | 0.000 | 0.000 | 0.022 |
| NRAS | Q61 | Retinoblastoma | Primary | 0 | 41 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | Q61 | Hodgkin lymphoma | Primary | 0 | 35 | 0.001 | 0.000 | 0.000 | 0.015 |
| NRAS | Q61 | Lung | Primary | 1 | 17 | 0.065 | 0.049 | 0.003 | 0.217 |
| NRAS | Q61 | Parathyroid | Primary | 1 | 13 | 0.086 | 0.066 | 0.004 | 0.280 |
R version 4.2.1 (2022-06-23)
Platform: x86_64-apple-darwin21.5.0 (64-bit)
Running under: macOS Monterey 12.5.1
Matrix products: default
BLAS: /usr/local/Cellar/openblas/0.3.20/lib/libopenblasp-r0.3.20.dylib
LAPACK: /usr/local/Cellar/r/4.2.1/lib/R/lib/libRlapack.dylib
locale:
[1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8
attached base packages:
[1] stats graphics grDevices utils datasets methods base
other attached packages:
[1] here_1.0.1 gt_0.6.0 forcats_0.5.1 stringr_1.4.0
[5] dplyr_1.0.9 purrr_0.3.4 readr_2.1.2 tidyr_1.2.0
[9] tibble_3.1.8 ggplot2_3.3.6 tidyverse_1.3.2 magrittr_2.0.3
[13] workflowr_1.7.0
loaded via a namespace (and not attached):
[1] httr_1.4.3 sass_0.4.2 bit64_4.0.5
[4] vroom_1.5.7 jsonlite_1.8.0 modelr_0.1.8
[7] bslib_0.4.0 assertthat_0.2.1 getPass_0.2-2
[10] highr_0.9 googlesheets4_1.0.1 cellranger_1.1.0
[13] yaml_2.3.5 pillar_1.8.0 backports_1.4.1
[16] glue_1.6.2 digest_0.6.29 checkmate_2.1.0
[19] promises_1.2.0.1 rvest_1.0.2 colorspace_2.0-3
[22] htmltools_0.5.3 httpuv_1.6.5 pkgconfig_2.0.3
[25] broom_1.0.0 haven_2.5.0 scales_1.2.0
[28] processx_3.7.0 whisker_0.4 later_1.3.0
[31] tzdb_0.3.0 git2r_0.30.1 googledrive_2.0.0
[34] generics_0.1.3 ellipsis_0.3.2 cachem_1.0.6
[37] withr_2.5.0 cli_3.3.0 crayon_1.5.1
[40] readxl_1.4.0 evaluate_0.16 ps_1.7.1
[43] fs_1.5.2 fansi_1.0.3 xml2_1.3.3
[46] tools_4.2.1 hms_1.1.1 gargle_1.2.0
[49] lifecycle_1.0.1 munsell_0.5.0 reprex_2.0.1
[52] callr_3.7.1 compiler_4.2.1 jquerylib_0.1.4
[55] rlang_1.0.4 grid_4.2.1 rstudioapi_0.13
[58] rmarkdown_2.14 gtable_0.3.0 DBI_1.1.3
[61] R6_2.5.1 lubridate_1.8.0 knitr_1.39
[64] bit_4.0.4 fastmap_1.1.0 utf8_1.2.2
[67] rprojroot_2.0.3 stringi_1.7.8 parallel_4.2.1
[70] Rcpp_1.0.9 vctrs_0.4.1 dbplyr_2.2.1
[73] tidyselect_1.1.2 xfun_0.32